10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the fiscal year ended December 28, 2008

OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the transition period from              to             

Commission File Number 000-51666

SPANSION INC.

(DEBTOR-IN-POSSESSION as of March 1, 2009)

(Exact name of registrant as specified in its charter)

Delaware	20-3898239
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

915 DeGuigne Drive

P.O. Box 3453

Sunnyvale, CA 94088

(408) 962-2500

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Securities registered pursuant to Section 12(b) of the Act:

None

Securities registered pursuant to Section 12(g) of the Act:

Title of each class	Name of each exchange on which registered
Class A Common Stock, $0.001 Par Value Per Share	NASDAQ Stock Market LLC

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  ¨    No  x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes  ¨    No  x

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ¨    No  x

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ¨    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “accelerated filer,” “large accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer  ¨ Accelerated filer  x Non-accelerated filer  ¨ (Do not check if a smaller reporting company) Smaller reporting company  ¨

Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

The aggregate market value of Common Stock held by non-affiliates of the registrant based upon the closing sale price on the NASDAQ Global Select Market on June 29, 2008 was approximately $308.6 million. Shares held by each executive officer, director and by each person who owns 10 percent or more of the outstanding Common Stock have been excluded in that such persons may be deemed to be affiliates. This determination of affiliate status is not necessarily a conclusive determination for other purposes.

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Section 12, 13, or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.    Yes  ¨    No  x

The number of shares outstanding of each of the registrant’s classes of common stock as of the close of business on May 11, 2009:

Class	Number of Shares
Class A Common Stock, $0.001 par value	161,956,210

DOCUMENTS INCORPORATED BY REFERENCE

None

Spansion Inc.

FORM 10-K

For The Fiscal Year Ended December 28, 2008

INDEX

		Page
PART I
ITEM 1.	BUSINESS	4
ITEM 1A.	RISK FACTORS	19
ITEM 1B.	UNRESOLVED STAFF COMMENTS	43
ITEM 2.	PROPERTIES	43
ITEM 3.	LEGAL PROCEEDINGS	43
ITEM 4.	SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS	48
PART II
ITEM 5.	MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES	49
ITEM 6.	SELECTED FINANCIAL DATA	51
ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	52
ITEM 7A.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	80
ITEM 8.	FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA	83
ITEM 9.	CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE	146
ITEM 9A.	CONTROLS AND PROCEDURES	146
ITEM 9B.	OTHER INFORMATION	146
PART III
ITEM 10.	DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE	147
ITEM 11.	EXECUTIVE COMPENSATION	151
ITEM 12.	SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS	178
ITEM 13.	CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE	180
ITEM 14.	PRINCIPAL ACCOUNTANT FEES AND SERVICES	190
PART IV
ITEM 15.	EXHIBITS AND FINANCIAL STATEMENT SCHEDULES	192
SIGNATURES		201

PART I

Cautionary Statement Regarding Forward-Looking Statements

The statements in this report include forward-looking statements. These statements relate to future events or our future financial performance. Forward-looking statements may include words such as “may,” “will,” “should,” “expect,” “plan,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue” or other wording indicating future results or expectations. Forward-looking statements are subject to risks and uncertainties, and actual events or results may differ materially. Factors that could cause our actual results to differ materially include, but are not limited to, those discussed under “Risk Factors” in this report and the following factors: (i) risks and uncertainties relating to our Creditor Protection Proceedings including: (a) risks associated with our ability to: stabilize the business to maximize the chances of preserving all or a portion of the enterprise; develop, obtain required approvals for and successfully implement a comprehensive restructuring plan; narrow our strategic focus on the embedded portion of the integrated category of the Flash memory market in an effective and timely manner; identify, pursue and successfully execute our plan to execute a strategic alternative for our wireless business; resolve ongoing issues with creditors and other third parties whose interests may differ from ours; generate cash from operations and maintain adequate cash on hand; if necessary, arrange for sufficient debtor-in-possession or other financing; continue to maintain cash management arrangements and obtain any further approvals from the Creditors’ Committee, the Floating Rate Noteholders or other third parties, as necessary to continue such arrangements; obtain sufficient exit financing to support a comprehensive restructuring plan; realize full or fair value for any assets or business that may be divested as part of a comprehensive restructuring plan; attract and retain customers or avoid reduction in, or delay or suspension of, customer orders as a result of the uncertainty caused by the Creditor Protection Proceedings; maintain market share, as competitors move to capitalize on customer concerns; actively and adequately communicate on and respond to events, media and rumors associated with the Creditor Protection Proceedings that could adversely affect our relationships with customers, suppliers, partners and employees; retain and incentivize key employees and attract new employees; retain, or if necessary, replace major suppliers on acceptable terms and avoid disruptions in our supply chain; maintain current relationships with reseller partners, joint venture partners and strategic alliance partners; obtain court orders or approvals with respect to motions filed from time to time; prevent third parties from obtaining court orders or approvals that are contrary to our interests; reject, repudiate or terminate contracts; and (b) risks and uncertainties associated with: limitations on actions against any Debtor during the Creditor Protection Proceedings; the values, if any, that will be prescribed pursuant to any comprehensive restructuring plan to outstanding Spansion securities; the delisting of Spansion common stock from The NASDAQ Stock Market; the uncertainty of the existence of a trading market in our shares of common stock; claims not discharged in the Creditor Protection Proceedings and their effect on our results of operations and profitability; our ability to obtain additional financing in the future; our substantial indebtedness and its impact on our financial health and operation and (ii) risks and uncertainties relating to our business including: (a) our ability to improve our gross margins and to continue to implement successfully our cost reduction efforts; our ability to control our operating expenses, particularly our sales, general and administrative costs; our ability to obtain materials in support of our business at terms favorable to us; our ability to retain and expand our customer base in our focus markets, and our ability to retain and grow our share of business within our customer base; our ability to successfully introduce our next generation products to market in a timely manner; our ability to effectively and timely achieve volume production of our next generation products; our ability to increase market acceptance of our products based on our MirrorBit technology; our ability to penetrate further the integrated category of the Flash memory market with our high density products and expand the number of customers in emerging markets; our ability to successfully develop and transition to the latest technologies; our ability to develop our MirrorBit NAND2, EcoRAM and MirrorBit Eclipse architectures, introduce new products based on these architectures, and achieve customer acceptance of these products; our ability to develop systems-level solutions that provide value to customers of our products; our ability to enter new markets not traditionally served by Flash memory, for example, replacing DRAM in servers with EcoRAM; our ability to negotiate successfully patent and other intellectual property licenses and patent cross-licenses and acquire additional patents; and (b) the sustained and

3

expanding economic downturn and extraordinarily volatile market conditions and resulting negative impact on our business, results of operations and financial position and our ability to accurately forecast our results and cash position; cautious capital spending by customers as a result of factors including current economic uncertainties; fluctuations in foreign currency exchange rates; and the sufficiency of workforce and cost reduction initiatives. We undertake no obligation to revise or update any forward-looking statements to reflect any event or circumstance that arises after the date of this report, or to conform such statements to actual results or changes in our expectations.

ITEM 1. BUSINESS

Our Company

We are a semiconductor device company exclusively dedicated to designing, developing, manufacturing, marketing, licensing and selling Flash memory solutions. Our Flash memory is integrated into a broad range of electronic products, including mobile phones, consumer electronics, automotive electronics, networking and telecommunications equipment, servers and computer peripherals. Our Flash memory solutions are incorporated in products from original equipment manufacturers, or OEMs, in each of these markets, including all of the top ten mobile phone OEMs, all of the top ten consumer electronics OEMs and all of the top ten automotive electronics OEMs. We license our Flash memory technology to semiconductor manufacturers who use this technology to develop and manufacture a variety of semiconductor solutions.

We are headquartered in Sunnyvale, California, with research and development, manufacturing and assembly operations in the United States, Middle East, Europe and Asia. We operate three Flash memory wafer fabrication facilities, or fabs and four assembly and test facilities. For financial information about geographic areas and for information with respect to our sales, refer to the information set forth in Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations, beginning on page 52, below.

We were originally organized as a Flash memory manufacturing venture of Advanced Micro Devices, Inc. (AMD) and Fujitsu Limited (Fujitsu) in 1993 named Fujitsu AMD Semiconductor Limited, or FASL. The primary function of FASL was to manufacture and sell Flash memory wafers to AMD and Fujitsu, who in turn converted the Flash memory wafers into finished Flash memory products and sold them to their customers. AMD and Fujitsu were also responsible for all research and development and marketing activities and provided FASL with various support and administrative services.

By 2003, AMD and Fujitsu desired to expand the operations of FASL to: achieve economies of scale; add additional Flash memory wafer fabrication capacity; include assembly, test, mark and pack operations; include research and development capabilities and include various marketing and administrative functions. To accomplish these goals, in 2003, AMD and Fujitsu reorganized our business as a Flash memory company called FASL LLC, later renamed Spansion LLC, by integrating the manufacturing venture with other Flash memory assets of AMD and Fujitsu. From this reorganization until the beginning of the second quarter of fiscal 2006, we manufactured and sold finished Flash memory devices to customers worldwide through our two sole distributors, AMD and Fujitsu. Since the beginning of the second quarter of fiscal 2006, we have sold our products directly to our customers, including customers not served solely by Fujitsu. We currently rely on Fujitsu Microelectronics Limited (FML), through its subsidiary Fujitsu Electronics Inc. (FEI, together with FML and Fujitsu Limited, Fujitsu) , to act as the largest distributor of our products to customers in Japan and also as a nonexclusive distributor throughout the rest of the world, other than Europe and the Americas with limited exceptions. We were reorganized from Spansion LLC into Spansion Inc., a Delaware corporation, in connection with our initial public offering in December 2005.

On March 18, 2008, we completed the acquisition of all of the outstanding shares of Saifun Semiconductor Ltd. (Saifun), a provider of intellectual property (IP) solutions for the non-volatile memory (NVM) market. Saifun licenses it IP to semiconductor manufacturers that use this technology to develop and manufacture a variety of stand-alone and embedded NVM products. The acquisition of Saifun provides an opportunity for us to expand our product portfolio and enter into the technology licensing business.

4

Our mailing address and executive offices are located at 915 DeGuigne Drive, Sunnyvale, California 94088, and our telephone number is (408) 962-2500. References in this report to “Spansion,” “we,” “us,” “our,” or the “Company” shall mean Spansion Inc. and our consolidated subsidiaries, unless the context indicates otherwise. We post on the Investor Relations page of our Web site, www.spansion.com, a link to our filings with the Securities and Exchange Commission, or SEC, our Code of Ethics for our Chief Executive Officer, Chief Financial Officer, Corporate Controller and other Senior Finance Executives, our Code of Business Conduct, which applies to all directors and all our employees, and the charters of our Audit, Compensation, Finance and Nominating and Corporate Governance committees. Our filings with the SEC are posted as soon as reasonably practical after they are filed electronically with the SEC. Please note that information contained on our Web site is not incorporated by reference in, or considered to be a part of, this document. You can also obtain copies of these documents by writing to us at: Corporate Secretary, Spansion Inc., 915 DeGuigne Drive, Sunnyvale, California 94088, or emailing us at: Corporate.Secretary@spansion.com. These documents and filings are provided free of charge.

For fiscal 2008, our net sales were approximately $2.3 billion and our net loss was approximately $2.4 billion as compared with net sales of approximately $2.5 billion and net loss of approximately $263.5 million for fiscal 2007.

According to market research firm iSuppli, in 2008, we were responsible for approximately 38 percent of all NOR Flash memory net sales, making us the largest supplier of NOR Flash memory in the world. We were also one of the largest suppliers for the overall Flash memory market, with a 13 percent market share for 2008, based on end sales of our products. In 2007, based on iSuppli data, we were the largest supplier of NOR Flash memory, responsible for approximately 33 percent of all NOR Flash memory sales, and we were one of the largest suppliers for the overall Flash memory market, with a 12 percent market share, based on end sales of our products.

Creditor Protection Proceedings

On February 10, 2009, Spansion Japan Limited, a wholly-owned subsidiary of Spansion LLC (Spansion Japan), filed a proceeding under the Corporate Reorganization Law (Kaisha Kosei Ho) of Japan to obtain protection from Spansion Japan’s creditors (the Spansion Japan Proceeding) and successively the Spansion Japan Proceeding was formally commenced on March 3, 2009 (the Commencement Date), when the Tokyo District Court entered the commencement order and appointed the incumbent represented director of Spansion Japan as trustee. On March 1, 2009 (the Petition Date), Spansion Inc., Spansion Technology LLC, Spansion LLC, Spansion International, Inc. and Cerium Laboratories LLC (the Debtors), each filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (the Chapter 11 Cases). The Chapter 11 Cases, together with the Spansion Japan Proceeding are referred to collectively as the Creditor Protection Proceedings. Non-U.S subsidiaries that are not included in the Creditor Protection Proceedings continue to operate outside these Creditor Protection Proceedings.

Chapter 11 Cases

The Debtors continue to operate their businesses as “debtors-in-possession” under jurisdiction of the U.S. Bankruptcy Court and in accordance with the applicable provisions of the U.S. Bankruptcy Code and orders of the U.S. Bankruptcy Court. Under the U.S. Bankruptcy Code, the Debtors may assume, assume and assign, or reject certain executory contracts including unexpired leases, subject to the approval of the U.S. Bankruptcy Court and certain other conditions. Any reference to any such agreements or instruments and termination rights or a quantification of our obligations under any such agreements or instruments is qualified by any overriding rejection, repudiation or other rights the Debtors may have as a result of or in connection with the Creditor Protection Proceedings.

5

As required under the U.S. Bankruptcy Code, the United States Trustee for the District of Delaware (Trustee) appointed an official committee of unsecured creditors on March 12, 2009 (U.S. Creditors’ Committee). In addition, a group purporting to hold substantial amounts of our publicly traded Senior Secured Floating Rate Notes due 2013 has organized (the Floating Rate Noteholders). The role of the U.S. Creditors’ Committee and the Floating Rate Noteholders in the Creditor Protection Proceedings may develop and change over the course of such proceedings.

The U.S. Bankruptcy Court has approved payment of certain of the Debtors’ pre-petition obligations, including, among other things, employee wages, salaries and benefits, and other business-related payments necessary to maintain the operation of our businesses. The Debtors have retained, with U.S. Bankruptcy Court approval, legal and financial professionals to advise the Debtors on the Chapter 11 Cases and certain other “ordinary course” professionals. From time to time, the Debtors may seek U.S. Bankruptcy Court approval for the retention of additional professionals.

Spansion Japan Proceeding

Unlike a Chapter 11 proceeding in the United States, the Spansion Japan Proceeding conducted under the Corporate Reorganization Law is a receivership proceeding, meaning that a court-appointed trustee takes over the operation of the company. The Japanese Court accepted Spansion Japan’s proposal to appoint Mr. Masao Taguchi, Spansion Japan’s incumbent representative director, as the trustee.

The Corporate Reorganization Law creates protections that Spansion Japan would not have under ordinary circumstances. For example, subject to the applicable laws, Spansion Japan may at its discretion assume or reject certain executory contracts in existence as of the Commencement Date, including unexpired leases, while the counterparty’s termination rights on grounds that Spansion Japan has filed the reorganization proceeding are restricted. In addition, any liquidated damages arising from the rejection of such executory contracts will be treated as pre-petition obligations, so they are subject to the stay imposed pursuant to the Spansion Japan Proceeding. Thus, any reference to any such agreements, termination rights or a quantification of our obligations under any such agreements may be qualified by such overriding rejection or repudiation rights as Spansion Japan may have in connection with the Spansion Japan Proceeding.

The Japanese Court has approved payment by Spansion Japan of certain of its pre-petition obligations, including, among other things, business-related payments that fall within the scope of Spansion Japan’s ordinary course of business. Spansion Japan has retained in the trustee’s name, with the Japanese Court’s approval, legal and financial professionals to advise the company on issues relating to the Spansion Japan Proceeding. However, Spansion Japan is subject to the general supervision of the Japanese Court and the court-appointed supervisory attorney (chosa i’in) and is required to seek approvals, from time to time, from them on various issues relating to the proceeding. However, at any point during the Creditor Protection Proceedings, actions taken by either (i) Spansion Japan (at the direction of the Spansion Japan trustee or pursuant to orders of the Japanese Court or otherwise) or (ii) Spansion Inc. or Spansion LLC (pursuant to the order of the U.S Bankruptcy Court or otherwise), may adversely affect the ability of Spansion LLC and Spansion Japan to continue operating as a globally integrated unit from an operational perspective. For example, if Spansion LLC was required to transfer wafer production from the fabrication facilities owned and operated by Spansion Japan to Spansion LLC’s Fab 25 or to a third party, or if sales of Spansion Products in Japan were no longer to be able to be conducted by Spansion Japan, our business would be materially adversely affected.

Circumstances Leading to the Commencement of Creditor Protection Proceedings

A variety of external economic factors have contributed to the decline in our operating performance, such as persistent oversupply in the Flash memory industry compounded by the global economic recession, which significantly reduced demand for our products in the fourth quarter of 2008 and continues to negatively impact current demand. These two factors are further complicated by our inability to obtain the additional external financing necessary to meet capital expenditure needs and operational costs in a market characterized by swift technological advances and constantly changing manufacturing processes.

6

Our strategy was historically based on aggressive revenue and market share growth, leveraging advanced technology, and low cost, high-volume manufacturing. In our 2006 long range planning cycle, forecasted revenue growth supported the construction of a $1.2 billion advanced wafer fabrication facility (SP1). Debt financing was arranged and construction on SP1 commenced in early 2007.

Although we continued to increase our NOR memory market segment share according to third-party industry sources, steep average selling price (ASP) declines during the first half of 2007 negatively affected revenue, profitability and operating cash flow. At that time, we anticipated an improvement in the market environment for the second half of 2007 and aggressively continued the construction of SP1 and incurred associated capital expenditures with the ultimate goal of significant cost reductions that would enhance our competitive position.

During the second half of 2007, the ASP environment stabilized relative to earlier in the year. However, we faced customer qualification issues resulting in a shortfall of anticipated revenue and increased inventory levels which contributed to our failure to meet financial performance targets in the second half of 2007. For fiscal 2007, cash flow from operations was $216.3 million, which was significantly lower than anticipated. Driven by the facilitization of SP1 and investments in our research and development facilities, our capital spending in 2007 was approximately $1.1 billion.

Our 2008 operating plan included capital expenditures of approximately $535.0 million, of which approximately 80 percent were expected to occur in the first half of the year in order to complete the phase 1 facilitization of SP1. Upon completion of the first phase, SP1 was anticipated to generate approximately $300 million in revenue in 2008.

In the first quarter of 2008, we lost liquidity in our investment in $121.9 million of AAA/Aaa rated auction rate securities (the ARS) because the auctions in which these ARSs were traded failed. Throughout the second and third quarters of 2008, the credit markets continued to deteriorate and we intensified our cash management efforts. Operationally, the ramp-up of SP1 was delayed due to slower than expected customer qualifications and a sharp decline in the Japanese wireless market. In the third quarter of 2008, we engaged investment bankers and capital restructuring advisors to evaluate the situation and to accelerate plans to improve liquidity. Multiple initiatives were launched and/or accelerated, including efforts to sell production facilities, raise capital and seek liquidity options for the ARS.

In the fourth quarter of 2008, the macroeconomic environment deteriorated significantly, causing a sharp decline in worldwide demand for consumer goods, and consequently a sharp reduction of demand for our products. Furthermore, continued tightening of credit availability and general market liquidity initiatives curtailed our ability to execute the liquidity initiatives launched in the third quarter of 2008. As these events unfolded, we intensified our strategic restructuring efforts to include, among other things, pursuing a potential sale of some or all of our assets. The sharp decline in demand, coupled with our inability to execute liquidity initiatives limited our ability to generate sufficient funding for our operations and meet our debt servicing requirements, ultimately leading to the Creditor Protection Proceedings.

The Creditor Protection Proceedings allow us to continue operating our business while continuing to pursue a sale or standalone reorganization process. There is no assurance that we will be successful in completing a sale or reorganization.

Developments Related to our Creditor Protection Proceedings

• The Spansion Japan Proceeding and the Chapter 11 Cases constituted events of default under the instruments governing substantially all of the indebtedness issued or guaranteed by us. In addition, we may not be in compliance with certain other covenants under the indentures related to certain of our debt or lease instruments.

7

• In February 2009, we implemented a workforce reduction of approximately 2,400 employees or 28 percent of the existing employees. In an effort to further reduce costs as we continued our restructuring efforts and explored various strategic alternatives.

• On March 4, 2009, we received notice of a determination of the NASDAQ Listing Qualifications Department to delist our common stock from trading on NASDAQ Market because of the Chapter 11 Cases. On March 16, 2009, we received an additional notice of a determination for our failure to timely file our Annual Report on Form 10-K for the fiscal year ended December 28, 2008. On April 16, 2009, we received an additional notice of a determination that our failure to pay certain fees in accordance with NASDAQ Marketplace Rule 5210(d) is an additional basis for delisting our securities from the NASDAQ Global Select Market. On April 23, 2009, we attended a hearing to contest these delisting determinations. On May 5, 2009, NASDAQ denied our request for continued listing on The NASDAQ Stock Market and informed us that trading of shares of our common stock will be suspended effective at the open of business on Thursday, May 7, 2009. We do not intend to request a review of this decision, and expect NASDAQ to file an application on Form 25-NSE with the Securities and Exchange Commission to effect the delisting of our common stock. We expect that our common stock will be publicly traded on the Pink Sheets with ticker symbol “SPSN.PK.” However, because trading on the Pink Sheets requires a market maker to quote our common stock, trading on the Pink Sheets is not within our control and could be discontinued at any time if no market maker is willing to offer a quote.

• In connection with developing a plan of reorganization under the Creditor Protection Proceedings, we have decided to pursue a standalone strategy focused on the market for embedded applications and licensing our intellectual property portfolio. As a result, we plan to pursue strategic alternatives for our wireless business.

For a discussion of certain risks and uncertainties related to the Debtors’ Creditor Protection Proceedings, please refer to Item 1A. Risk Factors in this Annual Report on Form 10-K. In addition, we can not assure that potential adverse publicity associated with the Creditor Protection Proceedings and the resulting uncertainty regarding our future prospects will not materially hinder our ongoing business activities and our ability to operate, fund and execute our business plan by impairing relations with existing and potential customers; negatively impacting our ability to attract, retain and compensate key executives and to retain employees generally; limiting our ability to obtain trade credit; and impairing present and future relationships with vendors and service providers. Accordingly, no assurance can be given as to what values, if any, will be ascribed in the Chapter 11 Cases to each of the respective creditor and equity security holder constituencies or what types or amounts of distributions, if any, they would receive. If certain requirements of the U. S. Bankruptcy Code are met, a plan of reorganization can be confirmed notwithstanding rejection by a company’s equity security holders and notwithstanding the fact that such equity security holders do not receive or retain any property on account of their equity interests under the plan. Accordingly, we urge that appropriate caution be exercised with respect to existing and future investments in our common stock or other equity securities, or any claims relating to pre-petition liabilities.

Our Industry

Consumers are increasingly demanding access to digital content through sophisticated communications equipment, consumer electronic products and automotive electronics. People now expect to instantly access, store and interact with multimedia content, including photos, music, video and text files using such products as mobile phones, digital cameras, DVD players, digital HDTVs, set top boxes, or STBs, MP3 players, video players and automotive electronics such as navigation systems. The primary semiconductor component used to store and access this kind of digital content is Flash memory, and as a result, Flash memory has become one of the most critical components of electronic products. Most electronic products use Flash memory to store important program instructions, known as code, as well as multimedia or other digital content, known as data. Code storage allows the basic operating instructions, operating system software or program code to be retained, which allows an electronic product to function, while data storage allows digital content, such as multimedia

8

files, to be retained. There are two major architectures of Flash memory in the market today: NOR Flash memory, which is used for code and data storage in mobile phones and primarily for code storage in consumer and industrial electronics and NAND Flash memory, which is primarily used for data storage in removable memory applications such as Flash memory cards and USB drives, embedded applications such as MP3 players, high-end mobile phones and solid state drives (SSD).

The Flash memory market can be divided into two major categories based on application: the integrated category, which includes wireless and embedded applications, and the removable storage category, which includes Flash memory cards and USB drives. Within the integrated category, portable, battery-powered communications applications are referred to as “wireless” and all other applications, such as consumer, industrial, telecommunications and automotive electronics, are referred to as “embedded.” Based on iSuppli data, the wireless portion of the integrated category, which primarily consists of mobile phones, was the leading market for NOR Flash memory in fiscal 2008. For products we manufacture, we have focused historically on the integrated category of the Flash memory market, including wireless and embedded applications. Global demand for NAND Flash memory is growing faster than that of NOR Flash memory largely on the strength of growth in multimedia consumer applications such as MP3 audio players, video players and high-end mobile phones together with removable storage in applications such as Flash memory cards for digital photography, USB storage for general purpose use and an emerging trend for SSD solutions to replace hard drives in portable computer applications.

Products

Our current product portfolio is based on NOR architecture, and ranges from 1 megabit to 2 gigabits with a broad array of interfaces and features. Historically our products were based on floating gate technology; however, the majority of our new product designs use MirrorBit technology. Our products have traditionally been designed to support code and data storage applications, and serve the wireless and/or embedded applications in the integrated category of the Flash memory market.

In fiscal 2006, our net sales for wireless applications, such as mobile phones, accounted for a majority our net sales. However, in fiscal 2007, the net sales for embedded applications, such as gaming, set top boxes, DVD players and automotive and industrial electronics, grew as a proportion of our total net sales and we began to see a shift toward a balance between net sales of wireless and embedded applications. In fiscal 2008, the net sales of these two applications each represented approximately 50 percent of our total net sales. Sales of MirrorBit technology-based products increased from approximately 50 percent of our total net sales in fiscal 2006 to approximately 71 percent in fiscal 2007 and to approximately 79 percent in fiscal 2008. The remainder of our sales has been based on floating gate technology.

In connection with developing a plan of reorganization under the Creditor Protection Proceedings, we are pursuing a standalone business strategy focused on the market for embedded applications and licensing our intellectual property portfolio. As a result, we plan to pursue strategic alternatives for our wireless business.

Technology

We have developed two Flash memory technologies, single-bit-per-cell floating gate technology and one-, two- or more-bit-per-cell MirrorBit technology, with current MirrorBit products based primarily on two-bits per cell. Our products that are designed primarily for code storage and execution applications are based on NOR Flash memory architecture and utilize either traditional floating gate technology or our MirrorBit technology. Our products that are designed primarily for data storage applications utilize our MirrorBit ORNAND architecture based on MirrorBit NOR technology. We are currently developing MirrorBit NAND2 cell technology, with higher performance and lower cost structure than MirrorBit ORNAND for products designed to support enhanced data storage functionality with higher performance and lower cost structure than MirrorBit ORNAND products. We have created and own fundamental intellectual property in both floating gate and the charge trapping technology used for MirrorBit products.

9

Floating Gate Technology. Floating gate is the conventional memory cell technology that is utilized by most Flash memory companies today for both NOR and NAND products. A memory cell comprises a transistor having a source, a drain and a control gate to regulate the current flow between the source and the drain, thereby defining whether the memory cell stores a “0” bit or a “1” bit by storing charge in the cell storage medium. Floating gate is a memory cell technology in which the “floating gate” is a conductive storage medium between the control gate and the source and drain. It is referred to as a floating gate as it is electrically isolated or “floating” from the rest of the cell to ensure that stored charge does not leak away resulting in memory loss. We have created innovations in floating gate technology that have become industry standards, such as negative gate erase, single power supply and embedded programming algorithms, and we continue to hold a leading position in the NOR Flash memory segment with our products based on floating gate technology. Our products using floating gate technology are typically used for code storage in applications requiring very high read speeds or the ability to operate at extreme temperatures in harsh environments such as those found in automotive applications. The majority of low density applications also use products based on floating gate technology. In addition, floating gate technology intellectual property is a core component of our technology licensing business.

MirrorBit Technology. To achieve storage density of two bits per cell, we developed MirrorBit NOR technology. MirrorBit NOR technology stores two distinct charges in a single memory cell, with each charge equivalent to one bit of data thereby at least doubling the density, or storage capacity, of each memory cell and enabling higher density, lower cost products. This is made possible because MirrorBit technology stores charge in a nonconductive storage medium, silicon nitride, which eliminates the need for a floating gate, which is the conductive storage medium used by floating gate technology. While electrons stored in a particular location of a MirrorBit nitride cell stay in place, those stored in a floating gate diffuse, preventing the storage of more than one charge in a floating gate cell. This characteristic of MirrorBit technology that enables the storage of charge without it diffusing, moving or flowing throughout the storage region is referred to as charge trapping technology. The quantity of charge stored in each of the two charge storage locations in a MirrorBit cell can also be varied. The combination of the two charge locations and the ability to produce the equivalent of two bits of data in a single charge location results in a total of four bits per cell.

MirrorBit technology is the foundation for expanding our product roadmap with enhanced capabilities. For example, we are developing MirrorBit NAND2, a new MirrorBit cell technology that when combined in a NAND array architecture is designed to support enhanced performance and a process cost structure similar to floating gate NAND manufactured on the same process node. Also, we have leveraged our MirrorBit technology to expand our Flash memory offering into new areas such as Spansion EcoRAM solutions, which are designed to largely replace the use of DRAM with Flash memory based on MirrorBit technology in certain types of servers. We believe that Flash memory innovations made possible by MirrorBit technology will enable us to expand our opportunity in the Flash memory market through products and technology licensing.

Process Technology

Process technology refers to the particular method used to manufacture semiconductor integrated circuits. Like most semiconductor companies, we direct significant efforts toward the invention and development of manufacturing process technologies that achieve one or more of the following objectives: reduction of our manufacturing costs, improvement of our device performance and/or addition of product features and capabilities. We achieve these goals primarily through a combination of optimizing the number of process steps required to produce a product, and by reducing the scale or size of key structures in our integrated circuits such as the cells or transistors used to store charge and the surrounding circuits that manage and interface to these cells. We develop each process technology using particular design rules and refer to this as the process or technology node using nanometers as a measurement of length of certain critical structures in the process. By shrinking the transistors, we enable more transistors in the same area, which allows us to manufacture more bits per wafer at each successive process node, decreasing material cost per bit and increasing yield for a given density. During fiscal 2008, we offered products manufactured on technology nodes from 320-nanometer to 65-nanometer, utilizing MirrorBit and floating gate cell technology. We continue to manufacture products based

10

on floating gate technology at process nodes from 320-nanometer to 110-nanometer. However, during fiscal 2008, the majority of our wafer production was focused on the manufacture of MirrorBit products using 110- and 90-nanometer process technology. We also manufactured MirrorBit ORNAND products and MirrorBit NOR products on 65-nanometer process technology.

Architecture

Flash memory architecture may be defined as the connection of cells in a memory array with circuits that give access to and manage these cells for read, write and erase operations. Traditionally, customers requiring fast read performance and superior reliability have chosen a NOR architecture for program code storage as well as for combined code and data storage purposes. Flash memory customers requiring higher densities, faster write speeds and lower costs mostly for removable data storage applications have typically chosen a NAND architecture. Our products have historically implemented a NOR architecture and therefore have fast random and sequential read, fast random write and high reliability. To address applications in the integrated category of the market that use products with a NAND architecture, we developed an architecture called MirrorBit ORNAND based on our MirrorBit NOR technology.

In the second half of fiscal 2008, we started manufacturing products based on our new MirrorBit Eclipse architecture, which provides high-performance code execution and fast write capability.

In June 2008, we announced plans for Spansion EcoRAM, a system solution developed to replace DRAM in certain types of computing servers. The combination of the fast read and write speed and low energy consumption of Spansion EcoRAM devices in combination with Spansion EcoRAM accelerator technology is designed to enable significant cost and performance improvements in computing data centers.

In September 2008, we announced plans for products based on a new generation of MirrorBit ORNAND architecture, which we refer to as MirrorBit NAND2. The new architecture, planned for introduction at the 43-nanometer process node, is expected to leverage new Flash memory cell technology in a ORNAND Flash memory array that requires 25 percent fewer mask layers than our 65-nanometer MirrorBit NAND technology and is expected to support faster read speed performance, faster write speed performance and lower cost. In addition the MirrorBit NAND2 architecture is designed to support applications serviced through potential independent third parties who may choose to license the technology from Spansion.

Starting at the 65-nanometer process node, both new and existing architectures, such as MirrorBit NOR and MirrorBit Eclipse, include a new capability we refer to as Built In Self Test, or BIST. BIST is available because a microcontroller is designed and built into our Flash memory die. Within a customers’ application, this microcontroller manages the Flash memory, replacing the previous use of fixed function circuits dedicated to this task. However, at the test stage of our manufacturing process we can utilize this same microcontroller to perform self-testing of the Flash memory die. This ability for the die to test itself enables the use of lower cost testers and also permits all die on a wafer to be tested simultaneously. The ability to test all die on a wafer simultaneously is particularly significant in combination with 300-millimeter manufacturing. When using BIST, the test time for a 300-millimeter wafer is similar to a 200-millimeter wafer when producing the same Flash memory die. However, a 300-millimeter wafer can produce more than twice the number of die, effectively doubling test throughput and cutting the test cost in half. Utilizing BIST in the manufacturing processes enables us to significantly reduce test cost and support additional cost savings over conventional test processes using more expensive testers.

Wireless Products

Our products for wireless applications, particularly for mobile phones, offer a combination of low power consumption with fast performance and competitive cost structure for a wide range of customer platforms and wireless applications with different interface requirements. Key wireless products include the following:

WS and NS Families. The WS and NS product families, with a 1.8 volt interface, are used for a broad range of mobile phones from low-end to higher-end with capabilities such as complex ring tones, enhanced color displays,

11

higher resolution cameras and larger internal storage for multimedia content including music, videos and pictures. The WS and NS families, which include products based on floating gate and MirrorBit technology, combine a high performance burst-mode 1.8-volt interface, with Simultaneous Read/Write and Advanced Sector Protection features at 16-megabit to 512-megabit densities for code and data requirements. WS and NS products are usually combined with third-party SRAM, pSRAM or DRAM die in a single MCP to meet mobile phone memory needs.

PL and GL Families. The PL and GL product families, with a 3-volt interface, enable code and data applications in low-end and mid-range mobile phones. The PL and GL product families, which are manufactured using floating gate and MirrorBit technology, include products with a page-mode interface, simultaneous Read/ Write capability and Advanced Sector Protection at 16-megabit to 256-megabit densities for wireless applications providing scalable platforms for code and data applications. PL and GL products are usually combined with third-party SRAM and pSRAM die in a single MCP to meet mobile phone memory needs.

MS Family. The MS family, which includes 512-megabit to 2-gigabit density devices with a 1.8-volt interface, enables enhanced data applications in mid-range and higher-end mobile phones. The MS family, which is manufactured using ORNAND architecture based on MirrorBit NOR technology, includes an interface similar to floating gate NAND. MS products, on their own or together with code-optimized Flash memory products such as those from the WS and NS families, are usually combined with third-party low-power SDRAM die in a single MCP to meet mobile phone memory needs.

We have decided to pursue a standalone business strategy focused on the market for embedded applications and licensing our intellectual property portfolio. As a result, we plan to pursue strategic alternatives for our wireless business.

Embedded Products

We offer a variety of general purpose as well as highly optimized products to serve the diverse needs of the embedded portion of the integrated category. Key embedded products include the following:

AL and GL Families. The AL and GL product families address applications where high reliability coupled with low cost are important, including consumer, gaming, networking and telecommunications. The AL product family offers densities as low as 4 megabits, supports a simpler feature set and provides a standard interface for value-focused applications, such as DVD players. The GL product family offers densities up to 1 gigabit in production and includes a page-mode interface and Advanced Sector Protection to support high performance consumer applications, such as high-end STBs and digital video recorders, or DVRs. MirrorBit technology is utilized for the GL family, while both MirrorBit and floating gate technology are utilized for the AL family.

CD Family. The CD product family addresses automotive engine and transmission control applications, which require high reliability and feature rich, high performance solutions operating over wide temperature ranges. The CD product family combines a high performance burst-mode 2.5-volt interface, with Simultaneous Read/Write and Advanced Sector Protection at 16- and 32-megabit densities. Because engine and transmission control units must withstand extreme temperatures, this family operates at up to 145°C and is available in a fully tested die-only solution for incorporation into special customer modules. We use our floating gate technology to meet the extreme operating temperature range and very high reliability requirements of automotive Flash memory customers.

FL Family. The FL product family addresses the need for continued cost reduction in, for example, consumer electronics and industrial applications. The FL family utilizes our MirrorBit technology and a Serial Peripheral Interface with a low pin count package to provide low cost solutions at densities from 32 to 128 megabits.

Development Platforms

We provide development tools and subsystems to customers of our Flash memory products that help them easily and quickly design Flash memory devices into their integrated products. We assist these customers in

12

prototyping their designs with our Flash memory devices by providing the necessary hardware development tools and platforms for design, development, verification, evaluation and programming. Our goal is to streamline and simplify the design and development cycle by providing consistent and comprehensive tools to support the design and development process, from initial system bring-up to final product deployment.

For example, our Productivity, Adaptive Communication & Entertainment, or PACE, development platform offers customers of our Flash memory products the benefit of utilizing our products on fully functional cell phone and PDA platforms running with multiple operating systems and with a variety of popular baseband and CPU chipsets. We believe this reference platform can remove significant design overhead and complexity from product development cycles. Additionally, PACE enables system tuning and optimization before final product release. PACE is used in generating benchmarks, creating reference designs, debugging software, integrating new hardware platforms and systems and prototyping next generation wireless architectures.

Together with our key partners, we created the Platform Independent Storage Module, or PISMO, memory interface standard. PISMO is used to create standard memory modules recommended for development platforms and we offer comprehensive support of our Flash memory products on PISMO modules. PISMO modules enable our partners and customers to significantly reduce system development and debugging time and the PISMO standard is supported by a large number of system and chipset companies. PISMO allows design and system validation of memory combinations before any MCP is produced, allowing system design and software development to start while the final product is being manufactured. Together with our partners, we offer a comprehensive set of personal computer and embedded development environments based on PISMO.

Other examples of our development tools include Spansion USB Programmer, or SUP, and a variety of devices models. SUP is a portable Flash programmer system used to program and verify our Flash memory devices. The SUP provides basic programming and verification functions in addition to the ability to exercise our advanced Flash memory features and enhancements all through the USB port of any personal computer or laptop.

Sales and Marketing

We market and sell our products worldwide under the Spansion trademark. Since the beginning of the second quarter of fiscal 2006, we have sold our products to our customers directly or through distributors. We rely on Fujitsu to act as our largest distributor in Japan and our nonexclusive distributor throughout the rest of the world, other than Europe and the Americas, with limited exceptions.

We market our products through a variety of direct and indirect channels. We focus on direct relationships with many of the top mobile phone and embedded Flash memory customers worldwide. We supplement this effort with programs designed to support design-in of our products on reference designs, which are typically used by a broad base of wireless handset manufacturers when choosing Flash memory solutions and selectively by embedded Flash memory customers. In addition, for embedded Flash memory customers, we focus our marketing efforts on providers of complementary silicon to ensure our products interoperate effectively with the most widely used components in various embedded applications.

Our marketing activities targeting customers, reference design houses and our potential partners include a combination of direct marketing activities such as trade shows, events and marketing collateral and indirect activities such as public relations and other marketing communications activities.

Customers

We serve our customers worldwide directly or through our distributors, including Fujitsu, who buy products from us and resell them to their customers, either directly or through third-party distributors. Customers for our products consist of OEMs, original design manufacturers, or ODMs, and contract manufacturers. Among those customers, Nokia Corporation accounted for approximately 18 percent and 10 percent of our net sales in fiscal

13

2008 and fiscal 2007, respectively. For fiscal 2006, AMD accounted for approximately 13 percent of our net sales. For fiscal 2008, fiscal 2007 and fiscal 2006, Fujitsu accounted for approximately 29 percent, 35 percent and 36 percent of our net sales, respectively. We rely on Fujitsu to act as our largest distributor in Japan and as a nonexclusive distributor throughout the rest of the world, other than Europe and the Americas, with limited exceptions.

Original Equipment Manufacturers

OEMs consist primarily of foreign and domestic manufacturers of mobile phones, consumer electronics, automotive electronics and networking equipment companies, selected regional accounts and customers in other target applications.

Third-Party Distributors

Our third-party distributors typically resell to OEMs, ODMs and contract manufacturers. Sales through our direct distributors are typically made pursuant to agreements that provide return rights for discontinued products or for products that are not more than twelve months older than their manufacturing date code. In addition, some of our agreements with distributors may contain standard stock rotation provisions permitting limited levels of product returns. Our distribution agreement with Fujitsu grants limited stock rotation rights to Fujitsu and allows Fujitsu to provide similar limited rights to some of its distributors. However, to date, Fujitsu has not extended these rights to its distributors. Prior to December 2008, Spansion Japan recognized revenue on all its shipments to Fujitsu upon billing based on terms of the Spansion Fujitsu 2003 distribution agreement. In December 2008, Spansion Japan initiated a distribution agreement with a new distributor instead of selling directly through Fujitsu. Spansion Japan is employing a deferred revenue model for this distributor accounting for $0.9 million of the gross deferred revenue at December 28, 2008.

We generally warrant that products sold to our customers and our distributors will, at the time of shipment, be free from defects in workmanship and materials and conform to our approved specifications. Subject to specific exceptions, we offer a one-year limited warranty.

Research and Development

Research and development is critical to our success and is focused on process, product and system level development. We conduct our product and system engineering activities primarily in Sunnyvale, California and Kawasaki, Japan, with additional design and development engineering teams located in the United States, Europe and Asia. Our primary development focus is on MirrorBit products for the embedded category of the Flash memory market. We conduct our process development primarily in Sunnyvale, California, our Fab 25 facility located in Austin, Texas and our facilities in Aizu-Wakamatsu, Japan. Currently, we are developing new non-volatile memory process technologies with continuing refinement of our 65-nanometer process technology and plans for development of 45-nanometer and more advanced technology. In April 2009, we stopped further production of development wafers at our research and development manufacturing facility known as the Sub-micron Development Center, or SDC, in Sunnyvale, California, as part of our strategy to reduce research and development costs. We intend to create a restructuring plan that will include evaluation of all alternatives available to us for future research and development wafer production.

Our research and development expenses for fiscal 2008, fiscal 2007 and fiscal 2006 were approximately $431.8 million, $436.8 million, and $342.0 million, respectively. For more information, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

Manufacturing

We own and operate seven manufacturing facilities, of which three, Fab 25, JV3 and SP1, are wafer fabrication facilities and four are assembly and test facilities. Fab 25 and JV3 are in production with 200-millimeter wafers and we began production of 300-millimeter wafers at SP1 in fiscal 2008.

14

To augment our internal wafer fabrication capacity, we have foundry agreements with Semiconductor Manufacturing International Corporation, or SMIC, and Fujitsu Limited. We believe the arrangement with SMIC provides flexibility to support customer demand for advanced technology products if we are unable to support such demand from our own in house capacity. In addition, we believe the scale of 300-millimeter foundry manufacturing provides the ability to leverage the lower cost structure provided by such scale. Also, the deployment of leading edge technology in support of foundry manufacturing provides a more cost efficient solution for future research and development wafer production as an alternative to an in house dedicated research and development manufacturing facility for wafer production. We believe the arrangement with Fujitsu Limited, using our former JV1 and JV2 wafer fabrication facilities which we sold to them in April 2007, provides us with the ability to efficiently support the declining customer demand for legacy products on legacy production process nodes. However, in the future we may change the locations where our products are manufactured to reflect changes in customer demand. We have in the past, and may in the future, obtain foundry, subcontractor and other arrangements with third parties to meet demand.

The locations of our wafer fabrication facilities, the process technologies currently employed and the approximate clean room square footage are described in the table below.

Wafer Fabrication Facilities

Name/Location	Wafer Size (diameter in millimeters)	Process Technology (in nanometers)	Approximate Clean Room Square Footage
Austin, Texas
Fab 25	200	65 to 110	114,000
Aizu-Wakamatsu, Japan
JV3	200	110 to 170	120,000
SP1	300	65	95,000

The following table describes the location and approximate clean room square footage of our assembly and test facilities.

Assembly and Test Facilities

Location	Approximate Clean Room Square Footage
Bangkok, Thailand	26,597
Kuala Lumpur, Malaysia	20,350
Penang, Malaysia	50,275
Suzhou, China	16,528

Our manufacturing processes require many raw materials, such as silicon wafers, mold compound, substrates and various chemicals and gases, and the necessary equipment for manufacturing. We obtain these materials and equipment from a large number of suppliers located throughout the world.

Environmental Matters

Many of our facilities are located on properties or in areas with a long history of industrial activity. Prior to our reorganization in 2003, environmental audits were conducted for each of our manufacturing facilities. The audits described various conditions customary of facilities in our industry and, in particular, noted historical soil and groundwater contamination at our Sunnyvale, California facility arising from the leakage of chlorinated solvent storage tanks that previously had been located on this property. This property is listed on the U.S. Environmental Protection Agency’s Superfund National Priorities List. AMD, as the former owner of the property, is investigating and remediating this contamination.

15

In connection with our reorganization in 2003, each of AMD and Fujitsu agreed to indemnify us against losses arising out of the presence or release, prior to June 30, 2003, of hazardous substances at or from these and other sites they each contributed to us. Conversely, our subsidiary agreed to indemnify each of AMD and Fujitsu from and against liabilities arising out of events or circumstances occurring after June 30, 2003, in connection with the operation of our business. We also share some permits and facilities with AMD and Fujitsu. For example, our Aizu-Wakamatsu manufacturing facilities are located adjacent to other manufacturing facilities of Fujitsu. AMD and Fujitsu, on the one hand, and we, on the other, agreed to indemnify the other against liability arising from permit violations attributable to our respective activities. To the extent AMD and Fujitsu cannot meet their obligations under any of their indemnity agreements, or material environmental conditions arise, we may be required to incur costs to address these matters, which could have a material adverse effect on us.

We have made and will continue to make capital and other expenditures to comply with environmental laws, but we do not expect compliance with environmental requirements to result in material expenditures in the foreseeable future. Environmental laws and regulations are complex, change frequently and have tended to become more stringent over time—factors that could alter the current outlook. See “Risk Factors—We are subject to a variety of environmental laws that could result in liabilities.”

Competition

Our principal NOR Flash memory competitors are Numonyx B.V. and Samsung Electronics Co., Ltd. We increasingly compete with NAND Flash memory manufacturers where NAND Flash memory has the ability to replace NOR Flash memory in customer applications and as we develop data storage solutions based on MirrorBit NAND2 for the integrated category of the Flash memory market. Our principal NAND Flash memory competitors include Samsung Electronics Co., Ltd, Toshiba Corporation, Hynix Semiconductor Inc. and Numonyx B.V. In the future, our principal NAND Flash memory competitors may include Intel Corporation, Micron Technology, Inc., IM Flash Technology LLC (the joint venture between Intel Corporation and Micron Technology, Inc.) and SanDisk Corporation.

We believe Flash memory providers must possess the following attributes to remain competitive:

• strong relationships with OEMs, ODMs and contract manufacturers that are acknowledged leaders within their respective industries;

• discipline to continually reduce costs ahead of historically declining semiconductor market prices;

• strong market focus to identify emerging Flash memory applications;

• leadership in research and development;

• flexibility in manufacturing capacity and utilization so as to take advantage of industry conditions through market cycles;

• access to the financial resources needed to maintain a highly competitive technological position;

• focus on sustainable and profitable segments;

• the ability to establish and sustain strategic relationships and alliances with key industry participants; and

• rapid time to market for new products, measured by the time elapsed from first conception of a new product to its commercialization.

Employees

As of December 28, 2008, we had approximately 8,700 employees. All employees of our wholly owned Japanese subsidiary, Spansion Japan, except contract and temporary employees and those who are in managerial positions, are represented by the company union. In February 2009, we implemented a workforce reduction of approximately 2,400 employees or 28 percent of our existing employees.

16

Backlog

We generally manufacture and market standard lines of products. Consequently, a significant portion of our sales are made from inventory on a current basis. Sales are made primarily pursuant to purchase orders for current delivery or agreements covering purchases over a period of time. These orders or agreements may be revised or canceled without penalty. Generally, in light of current industry practice and experience, we do not believe that backlog information is necessarily indicative of actual sales for any succeeding period.

Intellectual Property and Licensing

Our success depends in part on our proprietary technology. While we attempt to protect our proprietary technology through patents, copyrights and trade secrets, we believe that our success will depend more upon technological expertise, continued development of new products, and successful cost reductions achievable by improving process technologies. In addition, we have access to intellectual property through certain cross-license arrangements with AMD and Fujitsu. There can be no assurance that we will be able to protect our technology or that competitors will not be able to develop similar technology independently. We currently have a number of United States and foreign patents and patent applications. There can be no assurance that the claims allowed on any patents we hold will be sufficiently broad to protect our technology, or that any patents will issue from any application pending or filed by us. In addition, there can be no assurance that any patents issued to us will not be challenged, invalidated or circumvented or that the rights granted thereunder will provide competitive advantages to us.

Rights to Intellectual Property

We rely on a combination of protections provided by contracts, including confidentiality and non-disclosure agreements, copyrights, patents, trademarks and common law rights, such as trade secrets, to protect our intellectual property. Our U.S. patents are potentially valid and enforceable for either 17 years from the date they were issued or 20 years from the date they were filed. Accordingly, some of our existing patents will only survive for a few more years while others will survive for approximately another 15 years. We do not believe that the expiration of any specific patent will have a material adverse effect on us. In addition, the duration of our valid and enforceable trademarks is indefinite.

AMD and Fujitsu have each contributed to us various intellectual property rights pursuant to an Amended and Restated Intellectual Property Contribution and Ancillary Matters Agreement. Under this agreement, we became owners, or joint owners with each of Fujitsu and AMD, of certain patents, patent applications, trademarks, and other intellectual property rights and technology. AMD and Fujitsu reserved rights, on a royalty-free basis, to practice the contributed patents and to license these patents to their affiliates and successors-in-interest to their semiconductor groups. AMD and Fujitsu each have the right to use the jointly-owned intellectual property for their own internal purposes and to license such intellectual property to others to the extent consistent with their non-competition obligations to us. Subject to our confidentiality obligations to third parties, and only for so long as AMD’s and Fujitsu’s ownership interests in us remain above specific minimum levels, we are obligated to identify any of our technology to each of AMD and Fujitsu, and to provide copies of and training with respect to that technology to them. In addition, we have granted a non-exclusive, perpetual, irrevocable, fully paid and royalty-free license of our rights in that technology to each of AMD and Fujitsu.

In connection with our reorganization in June 2003, we entered into separate patent cross-license agreements with each of AMD and Fujitsu in which we granted to AMD or Fujitsu, as applicable, and AMD or Fujitsu, as applicable, each granted to us, non-exclusive licenses under certain patents and patent applications of their semiconductor groups to make, have made, use, sell, offer to sell, lease, import and otherwise dispose of specific semiconductor-related products anywhere in the world. The patents and patent applications that are licensed are those with an effective filing date prior to the termination of our patent cross-license agreements. Each agreement will automatically terminate on the later of June 30, 2013 or the date AMD or Fujitsu, whichever

17

is the other party to the agreement, sells its entire equity interest in us. Each agreement may be terminated by a party on a change in control of the other party or its semiconductor group. The licenses to patents under license at the time of the termination will survive until the last such patent expires.

Under each agreement, in cases where there is a change of control of us or the other party (AMD or Fujitsu, or each of their semiconductor groups, as applicable), the other party shall have the right to terminate the agreement (or to invoke the provisions described in this paragraph if the agreement had been previously terminated) by giving 30 days written notice within 90 days after receiving notice of the change of control. If so terminated, the rights, licenses and immunities granted under the agreement will continue solely with respect to those licensed patents that are entitled to an effective filing date that is on or before, and are licensed as of, the date of such change of control, and will continue until the expiration of the last to expire of such licensed patents. Moreover, with respect to circuit patents, which are patents (other than process patents) covering elements relating to electrical signals to achieve a particular function, the rights, licenses and immunities granted to the party undergoing the change of control are limited solely to:

i. each existing and pending product of such party as of the date of change of control;

ii. each existing and pending product of the acquiring third party of such party as of the date of change of control that would have been in direct competition with products described in (i) above; and

iii. successor products of products described in (i) and (ii) above provided such successor product is based substantially on the same technology.

We will no longer make royalty payments associated with licenses that survive the termination of the cross-license agreement. In fiscal 2008, fiscal 2007 and fiscal 2006, we incurred royalty expenses of approximately $3 million, $3 million and $6 million, respectively, to each of AMD and Fujitsu under their respective patent cross-license agreements. The royalty rate we pay to each of AMD and Fujitsu under our patent cross-license agreements with them was reduced from one percent of net sales of our products to 0.5 percent on October 1, 2005, and was further reduced to 0.3 percent on December 21, 2005. Following the conversion of our Class D common stock into Class A common stock, the royalty rate was further reduced to 0.15 percent and declined to $0 in November 2008 and thereafter.

We may be subject to claims that we are infringing intellectual property rights of third parties through the manufacture and sale of our products and the operation of our business. Therefore, absent negotiating our own license agreements with the third parties who own such intellectual property, we will be vulnerable to claims by such parties that our products or operations infringe such parties’ patents or other intellectual property rights.

We will continue to attempt to negotiate our own agreements and arrangements with third parties for intellectual property and technology that is important to our business, including the intellectual property that we previously had access to through our relationship with AMD. We will also attempt to acquire new patents as our success in negotiating patent cross-license agreements with other industry participants will depend in large part upon the strength of our patent portfolio relative to that of the third party with which we are negotiating. If the third-party benefits from an existing patent cross-license agreement with AMD, in many cases it will retain the rights that it has under that agreement even after we cease to be an AMD subsidiary, including rights to utilize the patents that AMD and Fujitsu transferred to us in connection with our reorganization as Spansion LLC in June 2003 and in connection with our initial public offering. In many cases, any such third party will also retain such rights to utilize any patents that have been issued to us or acquired by us subsequent to our reorganization and prior to our no longer being a subsidiary of AMD. Our negotiating position will therefore be impaired, because the other party will already be entitled to utilize a large number, or even all, of our patents, while we will no longer have the right to utilize that party’s patents. As a result, we may be unable to obtain access to the other party’s patent portfolio on favorable terms or at all. Similarly, with respect to licenses from third parties for technology incorporated in our products or software used to operate our business, we may not be able to negotiate prices with these third parties on favorable terms. Third parties also may file lawsuits against us seeking damages (potentially including treble damages) or an injunction against the sale of our products that

18

incorporate allegedly infringed intellectual property or against the operation of our business as presently conducted. Such litigation could be extremely expensive and time-consuming. We cannot assure you that such litigation would be avoided or successfully concluded. The award of damages, including material royalty payments, or the entry of an injunction against the manufacture or sale of some or all of our products, would have a material adverse effect on us, or that we will continue to file or prosecute patent applications in the United States or abroad.

Patents and Patent Applications

As of December 28, 2008, we had 1,376 U.S. patents and 683 foreign patents as well as 638 patent applications pending in the United States. We expect to file future patent applications in both the United States and abroad on significant inventions, as we deem appropriate. In addition, under our cross-license agreement with AMD, AMD granted us the right to use a substantial number of patents that AMD owns. Similarly, under our cross-license agreement with Fujitsu, Fujitsu also granted us the right to use a substantial number of patents that Fujitsu owns. There can be no assurance that the claims allowed on any patents we hold will be sufficiently broad to protect our technology, or that any patents will issue from any application pending or filed by us.

ITEM 1A. RISK FACTORS

Investing in our common stock involves a high degree of risk. You should carefully consider the risks described below and the other information in this annual report. If any of the following risks materialize, our business could be materially harmed, and our financial condition and results of operations could be materially and adversely affected. As a result, the price of our common stock could decline, and you could lose all or part of your investment.

Certain statements in this report contain words such as “could,” “expect,” “may,” “anticipate,” “will,” “believe,” “intend,” “estimate,” “plan,” “envision,” “seek” and other similar language and are considered forward-looking statements. These statements are based on our current expectations, estimates, forecasts and projections about the operating environment, economies and markets in which we operate. In addition, other written or oral statements that are considered forward-looking may be made by us or others on our behalf. These statements are subject to important risks, uncertainties and assumptions, that are difficult to predict and actual outcomes may be materially different. The Creditor Protection Proceedings will have a direct impact on our business and exacerbate these risks and uncertainties. In particular, the risks described below could cause actual events to differ materially from those contemplated in forward-looking statements. Unless otherwise required by applicable securities laws, we do not have any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

The risks described below are not the only ones facing us. Additional risks not currently known to us or that we currently believe are immaterial may also impair our business, results of operations, financial condition and liquidity.

Risks Related to the Creditor Protection Proceedings

On February 10, 2009 (the Proceeding Date), Spansion Japan Limited, a wholly-owned subsidiary of Spansion LLC (Spansion Japan), filed a proceeding under the Corporate Reorganization Law (Kaisha Kosei Ho) of Japan to obtain protection from Spansion Japan’s creditors (the Spansion Japan Proceeding), and successively the Spansion Japan proceeding was formally commenced on March 3, 2009 (the Commencement Date), when the Tokyo District Court entered the commencement order and appointed the incumbent representative director of Spansion Japan as trustee. On March 1, 2009 (the Petition Date), Spansion Inc., Spansion Technology LLC, Spansion International, Inc. and Cerium Laboratories LLC each filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware (the Chapter 11 Cases, together with the Spansion Japan Proceeding, the Creditor Protection Proceedings). The following risks relate to the Creditor Protection Proceedings.

19

Our business, operations and financial position are subject to the risks and uncertainties associated with the Creditor Protection Proceedings.

For the duration of the Creditor Protection Proceedings, our business, operations and financial position will be subject to the risks and uncertainties associated with such proceedings. These risks, without limitation and in addition to the risks otherwise noted in this report, are comprised of:

Strategic risks, including risks associated with our ability to:

• stabilize the business to maximize the chances of preserving all or a portion of the enterprise;

• develop a comprehensive restructuring plan and narrow our strategic focus on the embedded solutions business in an effective and timely manner;

• resolve ongoing issues with creditors and other third parties whose interests may differ from ours;

• obtain creditor, court and any other requisite third party approvals for a comprehensive restructuring plan;

• successfully implement a comprehensive restructuring plan; and

• identify, pursue and successfully execute strategic alternatives for our wireless business.

Financial risks, including risks associated with our ability to:

• generate cash from operations and maintain adequate available cash;

• if necessary, arrange for sufficient debtor-in-possession or other financing during the Creditor Protection Proceedings;

• continue to maintain currently approved intercompany lending and transfer pricing arrangements and ongoing deployment of cash resources throughout the Company in connection with ordinary course intercompany trade obligations and requirements;

• continue to maintain our cash management arrangements; and obtain any further approvals from the court, creditors or other third parties, as necessary to continue such arrangements;

• raise capital to satisfy claims, including our ability to sell assets to satisfy claims against us;

• if necessary, obtain sufficient exit financing to support a comprehensive restructuring plan;

• maintain research and development investments; and

• realize full or fair value for any assets or business we may divest as part of a comprehensive restructuring plan.

Operational risks, including risks associated with our ability to:

• continue operating as a globally integrated unit with Spansion Japan due to actions taken by either (i) Spansion Japan (at the direction of the Spansion Japan trustee or pursuant to orders of the Japanese Court or otherwise) or (ii) Spansion Inc. or Spansion LLC (pursuant to the order of the U.S. Bankruptcy Court or otherwise);

• attract and retain customers despite the uncertainty caused by the Creditor Protection Proceedings;

• avoid reduction in, or delay or suspension of, customer orders as a result of the uncertainty caused by the Creditor Protection Proceedings, including uncertainty surrounding future research and development expenditures and manufacturing plans;

• maintain market segment share, as our competitors move to capitalize on customer concerns;

• operate our business effectively in consultation with the court and creditors;

20

• actively and adequately communicate on and respond to events, media and rumors associated with the Creditor Protection Proceedings that could adversely affect our relationships with customers, suppliers, partners and employees;

• retain and incentivize key employees and attract new employees;

• retain, or if necessary, replace major suppliers on acceptable terms;

• avoid disruptions in our supply chain as a result of uncertainties related to our Creditor Protection Proceedings; and

• maintain current relationships with strategic alliance partners.

Procedural risks, including risks associated with our ability to:

• obtain court orders or approvals with respect to motions we file from time to time, including motions seeking extensions of the applicable stays of actions and proceedings against us, or obtain timely approval of transactions outside the ordinary course of business, or other events that may require a timely reaction by us or present opportunities for us;

• resolve the claims made against us in such proceedings for amounts not exceeding our recorded liabilities subject to compromise;

• prevent third parties from obtaining court orders or approvals that are contrary to our interests, such as the termination or shortening of the exclusivity period in the United States during which we can propose and seek confirmation of a comprehensive restructuring plan or the conversion of our Chapter 11 Cases to Chapter 7 liquidation cases; in which case the U.S. Bankruptcy Court would sell the Debtors non-exempt property and distribute the proceeds to our creditors in accordance with the U.S. Bankruptcy Code; and

• reject, repudiate or terminate contracts.

Because of these risks and uncertainties, and because we have not yet completed a comprehensive restructuring plan, we cannot predict the ultimate outcome of the restructuring process, or predict or quantify the potential impact on our business, financial condition or results of operations. The Creditor Protection Proceedings provide us with a period of time to attempt to stabilize our operations and financial condition and develop a comprehensive restructuring plan. However, it is not possible to predict the outcome of these proceedings and, as such, the realization of assets and discharge of liabilities are each subject to significant uncertainty. Accordingly, substantial doubt exists as to whether we will be able to continue as a going concern. Our independent registered public accounting firm has included a going-concern explanatory paragraph in its report on our consolidated financial statements for the year ended December 28, 2008.

Our continuation as a going concern is dependent upon, among other things, our ability to develop, obtain confirmation or approval and implement a comprehensive restructuring plan; generate cash from operations, maintain adequate cash on hand and obtain sufficient other financing during the Creditor Protection Proceedings and thereafter; resolve ongoing issues with creditors and other third parties; and achieve profitability. Even assuming a successful emergence from the Creditor Protection Proceedings, we cannot assure you as to the overall long-term viability of our operational reorganization, including our ability to generate sufficient cash to support our operating needs, fulfill our transformation objectives and fund continued investment in technology and product development without incurring substantial indebtedness that will hinder our ability to compete, adapt to market changes and grow our business in the future. In addition, our ability to raise long-term financing will in part depend on the fair market valuation of our business at emergence and the amount of leverage already inherent in our balance sheet. The application of fresh start accounting principles in accordance with U.S. GAAP upon eventual emergence from bankruptcy may result in valuations of long-lived and intangible assets that are less than the carrying value of those assets as currently reflected in the financial statements, which may further hinder our ability to raise financing at or subsequent to emergence from the Creditor Protection Proceedings.

21

In addition, a long period of operating under Creditor Protection Proceedings may exacerbate the potential harm to our business and further restrict our ability to pursue certain business strategies or require us to take actions that we otherwise would not. These challenges are in addition to business, operational and competitive challenges that we would normally face absent the Creditor Protection Proceedings.

Continuing or increasing pressure on our business, cash and liquidity could materially and adversely affect our ability to fund and restructure our business operations, react to and withstand the current sustained and expanding economic downturn, as well as volatile and uncertain market and industry conditions, and develop and implement a comprehensive restructuring plan. Additional sources of funds may not be available.

Our restructuring measures in recent years have not provided adequate relief from the significant pressures we are experiencing. As global economic conditions dramatically worsened beginning the fourth quarter of 2008, we experienced significant pressure on our business and faced a deterioration of our cash and liquidity, globally as well as on a regional basis, as customers across all businesses suspended, delayed and reduced their expenditures. The extreme volatility in the financial, foreign exchange, equity and credit markets globally and the expanding economic downturn and potentially prolonged recessionary period have compounded the situation. We are continuing to experience significant pressure due to global economic conditions and additionally, we are seeing further impact to our business as a result of the Creditor Protection Proceedings.

Historically, we have deployed our cash throughout the enterprise, through a variety of intercompany borrowing and transfer pricing arrangements. As a result of the Creditor Protection Proceedings, cash in the various jurisdictions is generally available to fund operations in the particular jurisdictions, but generally is not freely transferable between jurisdictions or regions, other than as highlighted in “Liquidity and Capital Resources” in the Management’s Discussion and Analysis of Financial Condition and Results of Operations section of this report. Thus, there is greater pressure and reliance on cash balances and generation capacity in specific regions and jurisdictions.

We cannot assure you that any further required court approvals for any future financing transactions will be obtained. Furthermore, we cannot assure you that we will be able to continue to maintain ongoing deployment of cash resources throughout our organization worldwide in connection with ordinary course intercompany trade obligations. If our subsidiaries are unable to pay dividends or provide us with loans or other forms of financing in sufficient amounts, or if we continue to have restrictions on the transfer of cash between us and our subsidiaries, including those imposed by courts, foreign governments and commercial limitations on transfers of cash, our cash position would likely be under considerable pressure and our liquidity and our ability to meet our obligations would be adversely affected.

Access to additional funds from liquidity-generating transactions, debtor-in-possession financing arrangements or other sources of external financing may not be available to us and, if available, would be subject to market conditions and certain limitations including court approvals and other requisite approvals by other third parties. We cannot provide any assurance that our net cash requirements will be as we currently expect and will be sufficient for the successful development, approval and implementation of a comprehensive restructuring plan.

We must continue to restructure and transform our business and the assumptions underlying these efforts may prove to be inaccurate. We may not be able to successfully develop, obtain all requisite approvals for, or implement a comprehensive restructuring plan. Failure to obtain the requisite approvals for, or failure to successfully develop and implement our comprehensive restructuring plan within the time granted by the courts would probably lead to the liquidation of all of our assets.

Pursuant to the ongoing Creditor Protection Proceedings we are working on developing a comprehensive restructuring plan. In order to successfully emerge from the Creditor Protection Proceedings, our senior management will be required to spend significant amounts of time developing a comprehensive restructuring plan, instead of focusing exclusively on business operations. Although we have engaged consultants to assist

22

with the restructuring process, we cannot be certain that the diversion of management’s attention from business operations will not adversely affect us.

In connection with the transformation of our business, we have made, and will continue to make, judgments as to whether we should further reduce, relocate or otherwise change our workforce. Costs incurred in connection with workforce reduction efforts may be higher than estimated. In addition, our workforce reduction efforts may impair our ability to achieve our current or future business objectives. Any further workforce efforts including reductions may not occur on the expected timetable and may result in the recording of additional charges.

Further, we have made, and will continue to make, judgments as to whether we should limit investment in, exit, or dispose of certain parts of our business. The Creditor Protection Proceedings and the development of a comprehensive restructuring plan may result in the sale or divestiture of assets, but we cannot assure you that we will be able to complete any sale or divestiture on acceptable terms or at all. Any decision by management to further limit investment in, or exit or dispose of parts of our business may result in the recording of additional charges. As part of our review of our restructured business, we look at the recoverability of tangible and intangible assets. Future market conditions may indicate these assets are not recoverable based on changes in forecasts of future business performance and the estimated useful life of these assets, and this may trigger further write-downs of these assets which may have a material adverse effect on our business, results of operations and financial condition.

We also must obtain the approvals of the respective courts and creditors. For example, we must submit our restructuring plan for the Spansion Japan Proceeding by August 2009 and we may not receive the requisite approvals for such plan from the Tokyo District Court. Similarly, we must submit a comprehensive restructuring plan for the Chapter 11 Cases and we may not receive the requisite approvals from the U.S. Bankruptcy Court. Even if we do receive the requisite approvals, a dissenting holder of a claim against us may challenge and ultimately delay the final approval and implementation of a comprehensive restructuring plan. If we are not successful in developing a comprehensive restructuring plan, or if we are successful in developing it but do not receive the requisite approvals, it is unclear whether we would be able to restructure our business and what distributions, if any, holders of claims against us would receive. Should the applicable stay or moratorium period and any subsequent extension thereof not be sufficient to develop and implement a comprehensive restructuring plan or should such plan not be approved by creditors and the courts and, in any such case, we or Spansion Japan lose the protection of such stay or moratorium, substantially all of our debt obligations will become due and payable immediately, or subject to acceleration, creating an immediate liquidity crisis that in all likelihood would lead to the liquidation of all of our assets, in which case it is likely that holders of claims would receive substantially less favorable treatment than they would receive if we were able to emerge as a viable, reorganized entity.

Trading in our securities during the pendency of the Creditor Protection Proceedings is highly speculative and poses substantial risks. Our common stock has been delisted from The NASDAQ Stock Market, which makes our common stock significantly less liquid, and may have little or no value.

Our securities may have little or no value. Trading prices are very volatile and may bear little or no relationship to the actual recovery, if any, by the holders under any eventual court-approved comprehensive restructuring plan. In such plan, our existing securities, in particular our common stock, may be cancelled and holders may receive no payment or other consideration in return, or they may receive a payment or other consideration that is less than the trading price or the purchase price of such securities.

On May 5, 2009, The NASDAQ Stock Market informed us that trading of shares of our common stock has been suspended effective at the open of business on Thursday, May 7, 2009. We expect NASDAQ to file an application on Form 25-NSE with the Securities and Exchange Commission to effect the delisting of our common stock.

We have been informed that a market maker will enable our common stock to be traded on the Pink Sheets under the symbol “SPSN.PK.” However, because trading on the Pink Sheets requires a market maker to quote our common stock, trading on the Pink Sheets is not within our control and could be discontinued at any time if no market maker is willing to offer a quote.

23

Consequently, the liquidity of our common stock could be greatly impaired, not only in the number of shares which could be bought and sold, but also through difficulties in obtaining price quotations, reduction in our coverage by security analysts and in the news media and lower prices for our securities than might otherwise be attained. These circumstances could have an adverse effect on the ability of an investor to sell any shares of our common stock as well as on the selling price for such shares.

Furthermore, over-the-counter (OTC) transactions involve risks in addition to those associated with transactions on a stock exchange. Many OTC stocks trade less frequently and in smaller volumes than stocks listed on an exchange. Accordingly, OTC-traded shares are less liquid and are likely to be more volatile than exchange-traded stocks.

During the pendency of the Creditor Protection Proceedings, our financial results may be volatile and may not reflect historical trends.

During the pendency of the Creditor Protection Proceedings, we expect our financial results to continue to be volatile as asset impairments, asset dispositions, restructuring activities, contract terminations and rejections and claims assessments may significantly impact our consolidated financial statements. As a result, our historical financial performance is likely not indicative of our financial performance following the filing of the Creditor Protection Proceedings. Further, we may sell or otherwise dispose of assets and liquidate or settle liabilities, with court approval, for amounts other than those reflected in our historical financial statements. Any such sale or disposition and any comprehensive restructuring plan could materially change the amounts and classifications reported in our historical consolidated financial statements, which do not give effect to any adjustments to the carrying value of assets or amounts of liabilities that might be necessary as a consequence of a comprehensive restructuring plan.

U.S. and Japanese laws impair the ability of claimants to take action against us under our existing contracts, including the outstanding notes and related guarantees by us. Subject to limited exceptions, all actions are stayed and ultimate recoveries cannot be determined at this time.

Generally, in connection with the Creditor Protection Proceedings, all actions to enforce or otherwise effect payment or repayment of our liabilities preceding the Petition Date for the Debtors and the Commencement Date for Spansion Japan, as well as pending litigation against us, are stayed. The U.S. Bankruptcy Code provides for all actions and proceedings against the U.S. Debtors to be stayed while the Chapter 11 Cases are pending, and the Corporate Reorganization Law of Japan similarly provides for all actions and proceedings against Spansion Japan to be stayed while the Spansion Japan Proceeding is pending.

In particular, the rights of the indenture trustees (who represent the holders of debt securities issued by us) to enforce remedies for defaults under our debt securities are subject to the stays, and could be delayed or limited by the restructuring provisions of applicable creditor protection legislation. Moreover, we have not made, and will likely continue not to make, any payments under our various debt securities during the Creditor Protection Proceedings, and holders of our debt securities may not be compensated for any delays in payment of principal, interest and costs, if any, including the fees and disbursements of the trustees.

A comprehensive restructuring plan, if successfully developed and accepted by the requisite majorities of each affected class of creditors and approved by the relevant courts, would be binding on all creditors within each affected class, including those that did not vote to accept the proposal. The ultimate recovery to creditors and security holders, if any, will not be determined until a comprehensive restructuring plan is developed and approved. At this time we do not know what values, if any, will be prescribed pursuant to any such plan to the securities held by each of these constituencies, or what form or amounts of distributions, if any, they may receive on account of their interests.

24

If we are unable to attract and retain qualified personnel at reasonable costs, we may not be able to achieve our business objectives, and our ability to successfully emerge from the Creditor Protection Proceedings may be harmed.

We are dependent on the experience and industry knowledge of our senior management and other key employees to execute our current business plans and lead us, particularly during the Creditor Protection Proceedings and throughout the development and implementation of a comprehensive restructuring plan. Competition for certain key positions and specialized technical and sales personnel in the high-technology industry remains strong. Our deteriorating financial performance, along with the Creditor Protection Proceedings and workforce reduction create uncertainty that has led to an increase in unwanted attrition, and additional challenges in attracting and retaining new qualified personnel. We are at risk of losing or being unable to hire talent critical to a successful restructuring and ongoing operation of our business. Our ability to retain and attract critical talent is restricted in part by the Creditor Protection Proceedings that, among other things, limit our ability to implement a retention program or take other measures to attract new hires to the Company or motivate employees to remain with us. Our future success depends in part on our continued ability to hire, assimilate in a timely manner and retain qualified personnel, particularly in key senior management positions. If we are not able to attract, recruit or retain qualified employees (including as a result of headcount and salary reductions), we may not have the personnel necessary to develop and implement a comprehensive restructuring plan, and our business, results of operations and financial condition could be materially adversely impacted.

Our ability to independently manage our business is restricted during the Creditor Protection Proceedings, and steps or actions in connection therewith may require the approval of the respective courts, the creditors and the U.S. Trustee.

Pursuant to the various court orders and statutory regimes to which we are subject during the Creditor Protection Proceedings, some or all of the decisions with respect to our business may require consultation with, review by or ultimate approval of one or all of the respective courts in two jurisdictions, the U.S. general unsecured creditors’ committee and the Floating Rate Noteholders. The lack of independence and the related consulting and reporting requirements are expected to significantly extend the amount of time necessary for us to take necessary actions and conclude and execute on decisions, and may make it impossible for us to take actions that we believe are appropriate and necessary. We cannot assure you that the courts, the U.S. Creditors’ Committee, other creditors or the Floating Rate Noteholders will support our positions on matters presented to the courts in the future, or on any comprehensive restructuring plan, once developed and proposed. Disagreements between us and these various third parties could protract the Creditor Protection Proceedings, negatively impact our ability to operate and delay our emergence from the Creditor Protection Proceedings.

Transfers or issuances of our equity, or a debt restructuring, may impair or reduce our ability to utilize our net operating loss carryforwards and certain other tax attributes in the future.

Pursuant to U.S. tax rules, a corporation is generally permitted to deduct from taxable income in any year net operating losses (NOLs) carried forward from prior years. We have NOL carryforwards in the U.S. of approximately $657.0 million as of December 28, 2008. Our ability to utilize these NOL carryforwards could be subject to a significant limitation if we were to undergo an “ownership change” for purposes of Section 382 of the Internal Revenue Code of 1986, as amended, during or as a result of the Creditor Protection Proceedings. During the Creditor Protection Proceedings, the U.S. Bankruptcy Court has entered an order that places certain restrictions on trading in our common stock. However, we can provide no assurances that these limitations will prevent an “ownership change” or that our ability to utilize our NOL carryforwards may not be significantly limited as a result of our restructuring.

In fiscal 2008, NOL carryfowards in the U.S. of approximately $382.3 million were nonutilizable against future taxable income due to the company under going an “ownership change” for purposes of section 382 of the Internal Review Code of 1986, as amended. This resulted in the reduction of gross deferred tax assets in the amount of $133.8 million.

25

A restructuring of our debt pursuant to the Creditor Protection Proceedings may give rise to cancellation of indebtedness or debt forgiveness (COD), which if it occurs would generally be non-taxable. If the COD is non-taxable, we will be required to reduce our NOL carryforwards and other attributes such as capital loss carryforwards and tax basis in assets, by an amount equal to the non-recognized COD. Therefore, it is possible that, as a result of the successful completion of a comprehensive restructuring plan, we will have a reduction of NOL carryforwards and/or other tax attributes in an amount that cannot be determined at this time and that could have a material adverse effect on our financial position.

Risks Related to our Financial Condition

If we cannot generate sufficient operating cash flows and obtain external financing, we may be materially adversely affected.

As of December 28, 2008, we held cash and cash equivalents of $116.4 million and marketable securities of approximately $94.0 million. Our marketable securities consist solely of auction rate securities, auctions for which have not occurred since February 2008. Our capital expenditures, together with ongoing operating expenses, have been a substantial drain on our cash flows and have decreased our cash balances. In fiscal 2008, we increased cost cutting activities, including: salary reductions; cutting capital spending; freezing headcount; cutting research and development projects; and reducing administrative expenses. Many of these measures will not materially affect our cash outlays until fiscal 2009 or later. Some cost cutting activities may require initial cost outlays before the cost reductions are realized. We cannot assure you that we will be able to achieve anticipated expense reductions. If our expense reduction efforts are unsuccessful, our operating results and business may be materially adversely affected.

Additional funds from liquidity-generating transactions, debtor-in-possession financing arrangements or other sources of external financing may not be available to us. Such financing would be subject to certain limitations, including court approvals and other requisite approvals by other third parties. Our inability to obtain needed financing or to generate sufficient cash from operations may require us to abandon projects or curtail capital expenditures, or may have an adverse effect on our restructuring process. If we cannot generate sufficient operating cash flows or obtain external financing, we would be materially adversely affected.

Financial market conditions may impede access to or increase the cost of financing operations and investments.

The volatility and disruption in the capital and credit markets has reached unprecedented levels in recent months. These changes in U.S. and global financial and equity markets, including market disruptions and tightening of the credit markets, compounded by us being subject to the Creditor Protection Proceedings, may make it more difficult for us to obtain financing for our operations or investments or increase the cost of obtaining financing, which would materially adversely affect us.

We are party to several debt instruments for which, as a result of the Creditor Protection Proceedings, an event of default has occurred. In connection with our restructuring, we may enter into debt arrangements in the future, each of which may subject us to restrictive covenants which could limit our ability to operate our business.

As of December 28, 2008, we had an aggregate principal amount of approximately $1.5 billion in outstanding debt, almost all of which became due and immediately payable upon events of default triggered by the occurrence of recent events related to the Creditor Protection Proceedings. During the Creditor Protection Proceedings and upon emergence from them, we will likely need to incur additional indebtedness through arrangements such as credit agreements or term loans that may include restrictions and covenants that are similar or more restrictive than the covenants in our existing debt instruments. These restrictions and covenants limit, and any future covenants and restrictions likely will limit our ability to respond to market conditions, to make capital investments or to take advantage of business opportunities. Any debt arrangements we enter into would likely require us to make regular interest payments, which could adversely affect our results of operations.

26

We cannot assure you that in the future we will be able to satisfy or comply with the provisions, covenants, financial tests and ratios of our debt instruments, which can be affected by events beyond our control. If we fail to satisfy or comply with such provisions, covenants, financial tests and ratios, or if we disagree with our lenders about whether or not we are in compliance, we cannot assure you that we will be able to obtain waivers for any future failures to comply with our financial covenants or any other terms of the debt instruments. We also may not be able to obtain amendments which will prevent a failure to comply in the future. A breach of any of the provisions, covenants, financial tests or ratios under our debt instruments could result in a default under the applicable agreement, which in turn could trigger cross-defaults under other debt instruments, any of which would materially adversely affect us.

Our investments in marketable debt securities are subject to risks which may cause losses and affect the liquidity of these investments.

As of December 28, 2008, our marketable securities totaled approximately $94.0 million and consisted solely of AAA/Aaa securities with auction reset features (auction rate securities or ARS) whose underlying assets are student loans and are substantially backed by the U.S. government Federal Family Education Loan Program. During 2008, we experienced failed auctions of our ARS and we cannot assure you that any future auctions would be successful. In November 2008, we accepted an offer to participate in an auction rate securities settlement from UBS Bank USA (UBS), providing us the right, but not the obligation, to sell to UBS up to 100 percent of our ARS at par, commencing June 30, 2010. Our right to sell the ARS to UBS commencing June 30, 2010 through July 2, 2012 represents a put option for a payment equal to the par value of the ARS. Upon acceptance of the offer with UBS, we elected to measure the put option under the fair value option of SFAS No. 159 and recorded $27.5 million as the fair value of the put option asset as of December 28, 2008 and transferred our ARS from available-for-sale to trading investment securities as long term assets. The transfer to trading securities reflects management’s intent to exercise our put option during the period June 30, 2010 to July 3, 2012. In the third and fourth quarters of fiscal year 2008, we recognized other-than-temporary impairment charges of approximately $27.9 million, which were largely offset by the recording of the put option. To the extent market conditions result in changes in the fair value of our ARS, those conditions will also cause the fair value of our put option to change by a comparable offsetting amount.

The put option is subject to a number of risks. Given the substantial dislocation in the financial markets and among financial services companies, we cannot assure you that UBS will ultimately have the ability to repurchase our ARS at par, or at any other price during the put period described above. We will be required to periodically assess the economic ability of UBS to meet that obligation in assessing the fair value of the rights. Moreover, if we choose to not exercise or UBS is unable to honor the put option, our ability to liquidate our investments in the near term may be limited, and our ability to fully recover the carrying value of our investments may be limited or non-existent. If issuers of these securities are unable to successfully close future auctions or their credit ratings deteriorate, we may in the future be required to record further impairment charges on these investments. It could take until the final maturity of the underlying notes (up to 39 years) to realize our investments’ recorded value. We can provide no assurance as to when these investments will again become liquid or as to whether we may ultimately have to recognize additional impairment charges in our results of operations with respect to these investments. Delays in liquidating these securities in the future could have a material adverse effect on us.

For more information on the accounting for ARS, please see “Fair Value of Marketable Securities” section in Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations and also Note 17 of the Notes to Consolidated Financial Statements in this Annual Report.

On December 29, 2008, we entered into a Credit Line Agreement with UBS that provides up with an aggregate amount of $85 million in the form of an uncommitted revolving line of credit, which is secured by the auction rate securities we hold (the UBS Credit Line). The UBS Credit Line also provides, among other things, that (i) UBS may demand full or partial payment of the credit line at its sole discretion and without cause at any

27

time; and (ii) UBS may at any time in its sole discretion terminate and cancel the credit line; provided, however, that UBS is required to provide us alternative financing on substantially similar terms, unless the demand right was exercised as a result of certain specified events, of which the Creditor Protection Proceedings is one, or the customer relationship between UBS and us is terminated for cause by UBS. On December 29, 2008, we borrowed approximately $74.8 million under the UBS Credit Line. The Creditor Protection Proceedings constituted an event of default under the UBS Credit Line.

Sustained decrease in our market capitalization may be an indicator, under accounting principles generally accepted in the United States, of a potential future impairment of long lived tangible and intangible assets including goodwill which could result in significant charges to earnings.

During fiscal 2008, we experienced a sustained, significant decline in our stock price which resulted in our market capitalization falling below the recorded value of our consolidated net assets. Under accounting principles generally accepted in the United States, we were required to record an impairment charge because changes in circumstances or events (of which one of the several indicators of impairment that was considered jointly is a significant and other than temporary decrease in the our market capitalization) indicated that the carrying values of such assets exceeded their fair value and were not recoverable. This impairment of our net assets resulted in a charge to earnings. A further decline in our market capitalization could result in additional impairment charges, which could further materially and adversely affect our financial results.

Risks Related to our Business

The demand for our products depends in large part on continued growth in the industries into which they are sold. A decline in the markets served by any of these industries, or a decline in demand for Flash memory products in these industries, would have a material adverse effect on our results of operations.

Sales of our Flash memory products are dependent upon consumer demand for mobile phones, consumer electronics such as set top boxes and DVD players, automotive electronics, and industrial electronics such as networking equipment, personal computers and personal computer peripheral equipment such as printers and gaming systems. Sales of our products are also dependent upon the inclusion of increasing amounts of Flash memory content in some of these products.

In fiscal 2008, sales of our products were divided between wireless applications, such as mobile phones, and the combination of consumer and industrial applications such as gaming, set top boxes, DVD players, automotive and industrial electronics. For fiscal 2008, sales for wireless applications and consumer and industrial applications accounted for approximately 50 percent of our total net sales each, as compared to 54 percent and 45 percent, respectively for fiscal 2007, and 60 percent and 40 percent, respectively for fiscal 2006 This represented a shift from fiscal 2007 and fiscal 2006 when sales for wireless applications accounted for a majority of our sales. As a result of the credit market crisis, including uncertainties with respect to financial institutions and global capital markets, increases in energy costs and other macroeconomic challenges, consumer and corporate spending may be modified, delayed or reduced.

Our sales in fiscal 2008 were more heavily weighted in a category of products where the market may be declining. If demand for mobile phones, other consumer products or industrial products in the integrated category of the Flash memory market decline, or if our sales are below industry analysts’ expectations, our business could be materially adversely affected. Also, if the functionality of successive generations of such products does not require increasing Flash memory density or if such products no longer require Flash memory due to alternative technologies or otherwise, our operating results would be materially adversely affected.

Our business has been characterized by an average selling price that declines over time, which can negatively affect our results of operations.

As a semiconductor manufacturing company, our financial results are primarily dependent upon the difference between our average selling price per product and our average costs per product. Generally, we

28

endeavor to maintain or increase our average selling price while lowering our average costs, by improving our product mix, and selling more units. Historically, the selling prices of our products has decreased during the products’ lives, and we expect this trend to continue. When our selling prices decline, our net sales and gross margins also decline unless we are able to compensate by selling more units thereby reducing our manufacturing costs per product or introducing and selling new, higher margin products with higher densities and/or advanced features. If the average selling price for our products continues to decline, our operating results could be materially adversely affected.

During downturns, periods of extremely intense competition, or the presence of oversupply in the industry, the selling prices for our products has declined at a high rate over relatively short time periods as compared to historical rates of decline. We are unable to predict selling prices for any future periods and may experience unanticipated, sharp declines in selling prices for our products. When such pricing declines occur, we may not be able to mitigate the effects by selling more or higher margin units, or by reducing our manufacturing costs. In such circumstances, our operating results could be materially adversely affected.

The Flash memory market is highly cyclical and has experienced severe downturns that have materially adversely affected, and may in the future materially adversely affect, our business.

The Flash memory market is highly cyclical and is currently experiencing, and in the past has experienced severe downturns, generally as a result of wide fluctuations in supply and demand, constant and rapid technological change, continuous new product introductions and price erosion. Our financial performance has been, and may in the future be, adversely affected by these downturns. We have incurred substantial losses in past downturns, and as a result of the current downturn, due principally to:

• substantial declines in selling prices, particularly due to competitive pressures and an imbalance in product supply and demand;

• a decline in demand for end-user products that incorporate our products; and

• lower than expected demand in the distribution channels such as mobile phone OEMs.

Our historical financial information does not necessarily indicate what our results of operations, financial condition or cash flows will be in the future. If our net sales decline in the future, or if these or other similar conditions continue or occur again in the future, we would likely be materially adversely affected.

Our forecasts of customer demand for our products may be inaccurate, which could result in excess inventory and cause us to record write-downs that would adversely affect our gross margins.

We rely on our ability to forecast inventory and production mix in order to meet customer demand and produce requisite amounts of our products in order to fill current orders and future orders. Customer demand for our products may be difficult to predict because customers may change their inventory practices on short notice for any reason or they may cancel or defer product orders. The volatility and disruption in the capital and credit markets may make it more difficult for us to forecast demand because our customers may be increasingly focused on cash preservation and tighter inventory management. Finally, the uncertainty caused by the Creditor Protection Proceedings may also impact customer demand.

To forecast demand and value inventory, management considers, among other factors, the inventory on hand, historical customer demand data, backlog data, competitiveness of product offerings, market conditions and product life cycles. Historically, we have generally used a six-month demand forecast in assessing the salability of inventory on hand and did not value inventory in excess of six months of forecasted demand. Beginning in the second quarter of fiscal 2008, as part of a strategy to efficiently manage our new production capacity and to maintain strategic inventory levels of certain products, we have built and valued certain inventory to meet estimated demand as much as twelve months into the future.

29

If we anticipate future demand or market conditions to be less favorable than our previous projections, additional inventory write-downs may be required and would be reflected in cost of sales in the period the write-down is made. This would have a negative impact on our gross margin in that period. While we believe our understanding of the end markets we serve provides us with the ability to make reliable forecasts, we may be unable to forecast accurately. If we inaccurately forecast customer demand, it could result in excess or obsolete inventory that would reduce our profit margins, which would materially adversely affect us.

Any future business combinations, divestitures, acquisitions or mergers expose us to risks, including the risk that we may not be able to successfully integrate these businesses or achieve expected operating synergies.

During the Creditor Protection Proceedings we will, and upon emergence from them we may periodically, consider strategic transactions. We may evaluate acquisitions, divestitures, joint ventures, alliances or co-production programs as opportunities arise and we may be engaged in varying levels of negotiations with third parties at any time. We may not be able to effect transactions and if we enter into transactions, we also may not realize the benefits we anticipate. Moreover, the integration of companies that have previously been operated separately involves a number of risks. Consummating any acquisitions, divestitures, joint ventures, alliances or co-production programs could result in the incurrence of additional transaction-related expenses, as well as unforeseen contingent liabilities, which could materially adversely affect us.

We have lost rights to key intellectual property arrangements because we are no longer a beneficiary of AMD’s patent cross-license agreements and other licenses, which creates a greatly increased risk of patent or other intellectual property infringement claims against us.

As a subsidiary of Advanced Micro Devices, Inc. (AMD) until our initial public offering in December 2005, we were the beneficiary of AMD’s intellectual property arrangements with third parties, including patent cross-license agreements with other major semiconductor companies such as Intel, Motorola and IBM, and licenses from third parties for technology incorporated in our products and software used to operate our business. We are no longer a subsidiary of AMD. As a result, we may be subject to claims that we are infringing intellectual property rights of third parties through the manufacture and sale of our products and the operation of our business. Therefore, absent negotiating our own license agreements with the third parties who own such intellectual property, we will be vulnerable to claims by such parties that our products or operations infringe such parties’ patents or other intellectual property rights.

We may attempt to negotiate our own agreements and arrangements with third parties for intellectual property and technology that are important to our business, including the intellectual property that we previously had access to through our relationship with AMD. We may also attempt to acquire new patents as our success in negotiating patent cross-license agreements with other industry participants will depend in large part upon the strength of our patent portfolio relative to that of the third party with which we are negotiating. In many cases, third parties also have rights to utilize any patents that have been issued to us or acquired by us between the dates of our reorganization in 2003 and our initial public offering in 2005 or, in some cases, between the dates of our reorganization in 2003 and the conversion of the Class D common stock in 2006. Our negotiating position may therefore be impaired, because the other party will already be entitled to utilize a large number of our patents, while we will no longer have the right to utilize that party’s patents. As a result, we may be unable to obtain access to the other party’s patent portfolio on favorable terms or at all. Similarly, with respect to licenses from third parties for technology incorporated in our products or software used to operate our business, we may not be able to negotiate prices with these third parties on terms as favorable to us as those previously available to us because we are no longer able to take advantage of AMD’s size and purchasing power. These parties, and other third parties with whom AMD had no prior intellectual property arrangement, may file lawsuits against us seeking damages (potentially including treble damages) or an injunction against the sale of our products that incorporate allegedly infringed intellectual property or against the operation of our business as presently conducted. Such litigation could be extremely expensive and time consuming. We cannot assure you that such

30

litigation would be avoided or successfully concluded. The award of damages, including material royalty payments, or the entry of an injunction against the manufacture or sale of some or all of our products, would have a material adverse effect on us.

A significant market shift to NAND architecture would materially adversely affect us.

Flash memory products are generally based on either NOR or NAND architecture. To date, our Flash memory products have been based on NOR architecture which are typically produced at a higher cost-per-bit than NAND-based products. We have developed our MirrorBit ORNAND and MirrorBit Eclipse architectures to address certain portions of the integrated category of the Flash memory market served by NAND-based products, but we cannot be certain that our MirrorBit ORNAND- or Eclipse-based products will satisfactorily address those market needs.

In each of the last five years from 2004 to 2008, industry sales of NAND-based Flash memory products increased as a percentage of total Flash memory sales compared to sales of NOR-based Flash memory products, resulting in NAND vendors in aggregate gaining a greater share of the overall Flash memory market and NOR vendors in aggregate losing overall market share. In 2008, according to iSuppli, total sales for the Flash memory market reached approximately $17.9 billion, of which approximately 34 percent was classified as sales of NOR-based Flash memory products and approximately 66 percent was classified as sales of NAND-based Flash memory products. iSuppli estimates that sales of NAND-based Flash memory products declined by approximately 15 percent from 2007 to 2008 and will grow at a 5 percent compound annual growth rate from 2008 to 2013, while sales of NOR-based Flash memory products declined by approximately 21 percent from 2007 to 2008 and will decline by approximately 12 percent compound annual rate from 2008 to 2013. We expect the Flash memory market trend of decreasing market share for NOR-based Flash memory products relative to NAND-based Flash memory products to continue in the foreseeable future.

Moreover, the removable storage category of the Flash memory market, which is predominantly served by floating gate NAND vendors, is expected to constitute a significant portion of the Flash memory market for the foreseeable future. As mobile phones and other consumer electronics become more advanced, they will require higher density Flash memory to meet the increased data storage requirements associated with music downloads, photos and videos. Because storage requirements will increase to accommodate data-intensive applications, OEMs may increasingly choose higher density floating gate NAND-based Flash memory products over MirrorBit NOR-, ORNAND- or Eclipse-based Flash memory products for their applications. If this occurs and OEMs continue to prefer floating gate NAND-based products over those of MirrorBit NOR-, ORNAND—or Eclipse-based products for their applications, we may be materially and adversely affected. Moreover, some of our competitors are able to manufacture floating gate NAND-based Flash memory products on 300-millimeter wafers produced in much larger capacity fabs than our SP1 fab or the wafer manufacturing fabs of our third party wafer foundry. In addition, some of our competitors may choose to utilize more advanced manufacturing process technologies than we may have available to offer products competitive to ours at a lower cost. If floating gate NAND vendors continue to increase their share of the Flash memory market, our market share may decrease, which would materially adversely affect us.

In addition, even if products based on NAND architecture are unsuccessful in displacing products based on NOR architecture, the average selling price for our products may be adversely affected by a significant decline in the price for NAND-based products. Such a decline may result in downward price pressure in the overall Flash memory market affecting the price we can obtain for our NOR-based products, which would adversely affect us. We believe such downward pricing pressure was a factor in the significant declines in the selling prices of our products in 2007 and 2008. If the prices for NAND products do not improve, or continue to decline, we may be materially adversely affected.

31

We cannot be certain that our substantial investments in research and development will lead to timely improvements in technology or that we will have sufficient resources to invest in the level of research and development that is required to remain competitive.

In order to compete, we are required to make substantial investments in research and development for design, process technologies and production in an effort to design and manufacture advanced Flash memory products. For example, in fiscal 2008 and fiscal years 2007 and 2006, our research and development expenses were approximately $ 431.8 million, $436.8 million and $342.0 million, respectively, or approximately 19, 17 and 13 percent, respectively, of our net sales.

Currently, we are developing new non-volatile memory process technologies, including 45-nanometer process technologies. We cannot assure you that we will have sufficient resources to maintain the level of investment in research and development that is required for us to remain competitive, which could materially adversely affect us. Further, we cannot assure you that our investments in research and development will result in increased sales or competitive advantage, which could adversely affect our operating results.

If we fail to successfully develop, introduce and commercialize new products and technologies or to accelerate our product development cycle, we may be materially adversely affected.

Our success depends to a significant extent on the development, qualification, production, introduction and acceptance of new product designs and improvements that provide value to Flash memory customers. Our ability to develop and qualify new products and related technologies to meet evolving industry requirements at prices acceptable to our customers and on a timely basis affects our competitiveness in our target markets. If we are delayed in developing or qualifying new products or technologies, we could be materially adversely affected.

Competitors may introduce new memory or other technologies that may make our Flash memory products uncompetitive or obsolete.

Our competitors are working on a number of new technologies, including FRAM, MRAM, polymer, charge trapping and phase-change based memory technologies. One of our competitors began shipping products based on phase-change based memory technology in 2008. If such products are successfully developed and commercialized as a viable alternative to MirrorBit or floating gate Flash memory, these other products could pose a competitive threat to existing Flash memory companies, including us. In addition, some of Saifun’s licensees and customers are our competitors or work with our competitors and have licensed Flash memory intellectual property associated with charge trapping technology from Saifun. Use of this charge trapping intellectual property or use of independently developed charge trapping Flash memory technology by our competitors, if successfully developed and commercialized, may allow these competitors to develop Flash memory technology that may compete with our proprietary MirrorBit technology.

If we fail to successfully develop products based on our new MirrorBit ORNAND, MirrorBit Eclipse or MirrorBit NAND2 architectures, or if there is a lack of market acceptance of these products, our future operating results would be materially adversely affected.

We are attempting to position ourselves to address the increasing demand for data optimized Flash memory by offering higher density, lower cost and more versatile products based on our new MirrorBit ORNAND, MirrorBit Eclipse and MirrorBit NAND2 architectures. The success of these architectures requires that we timely and cost effectively develop, manufacture and market products based on these architectures that are competitive with floating gate NAND-based Flash memory solutions. While we have made some progress on developing and commercializing products based on these architectures, we may not be able to continue to do so in accordance with our product development plans or at a rate and cost structure required for us to remain competitive. If we fail to continue to develop and commercialize products based on these architectures on a timely basis at a competitive cost structure, our future operating results would be materially adversely affected. Furthermore, if market acceptance of products based on our MirrorBit architectures occurs at a slower rate than we anticipate, our ability to compete will be reduced, and we would be materially adversely affected. If we do not achieve market acceptance of these architectures or subsequent MirrorBit products, our future operating results would be materially adversely affected.

32

If we fail to successfully develop new applications and markets for our products our future operating results would be materially adversely affected.

We are developing new applications and opportunities for our products beyond our traditional customer base and in some cases plan to deploy our Flash memory solutions beyond current Flash memory markets. We expect these new applications to grow future net sales, future margin or a combination of both. However, some of these opportunities require that we are successful in creating, marketing, gaining customer acceptance of and deploying these new system architectures into a customer base where we do not have a historic business relationship and where our solution is required to replace established and proven solutions. In some cases our solutions rely on third parties to contribute a significant and necessary component of the solution without which the solution is nonviable. If we are unsuccessful in our attempts to bring new products to market, experience significant delays in generating sales, fail to establish the value of this solution or face competition from third parties or incumbent suppliers that result in lower margins than expected, then our future operating results would be materially adversely affected.

Our reliance on third-party manufacturers entails risks that could materially adversely affect us.

We have in the past and plan in the future to obtain foundry, subcontractor and other arrangements with third parties to meet demand. Foundry services suppliers, from which we may obtain foundry services in the future, include Fujitsu Microelectronics Limited (as a result of the sale of our JV1/JV2 manufacturing facilities in April 2007) and Semiconductor Manufacturing International Corporation from which we may obtain foundry services in the future. We also use independent contractors to perform some of the assembly, testing and packaging of our products. Third-party manufacturers are often under no obligation to provide us with any specified minimum quantity of product. We depend on these manufacturers to allocate to us a portion of their manufacturing capacity sufficient to meet our needs, to produce products of acceptable quality and at acceptable manufacturing yields and to deliver those products to us on a timely basis at acceptable prices. We also rely on these manufacturers to invest capital into their facilities to meet our needs. Given the Creditor Protection Proceedings and the current volatility and disruption in the capital and credit markets worldwide, we cannot assure you that they will make the investments in their facilities previously contemplated. We cannot assure you that these manufacturers will be able to meet our near-term or long-term manufacturing requirements and may not be able to attain qualification from our customers. In addition, any significant change in the payment terms we have with our key suppliers could adversely affect us.

These manufacturers also make products for other companies, including certain of our competitors, and/or for themselves and could choose to prioritize capacity for themselves or other customers beyond any minimum guaranteed amounts, reduce deliveries to us or, in the absence of price guarantees, increase the prices they charge us on short notice, such that we may not be able to pass cost increases on to our customers. The likelihood of this occurring may be greater as a result of the Creditor Protection Proceedings. Because it could take several quarters or more to establish a relationship with a new manufacturing partner, we may be unable to secure an alternative supply for specific products in a short timeframe or at all at an acceptable cost to satisfy our production requirements. In addition, we may be required to incur additional development, manufacturing and other costs to establish alternative sources of supply. Other risks associated with our increased dependence on third-party manufacturers include: their ability to adapt to our proprietary technology, reduced control over delivery schedules, quality assurance, manufacturing yields and cost, lack of capacity in periods of excess demand, misappropriation of our intellectual property, reduced ability to manage inventory and parts and risks associated with operating in foreign countries. If we are unable to secure sufficient or reliable suppliers of wafers or obtain the necessary assembling, testing and packaging services, our ability to meet customer demand for our products may be adversely affected, which could have a material adverse effect on us.

Industry overcapacity could require us to take actions which could have a material adverse effect on us.

Semiconductor companies with their own manufacturing facilities and specialist semiconductor foundries, which are subcontractors that manufacture semiconductors designed by others, have added significant capacity in

33

recent years. In 2008, the significant excess capacity led to oversupply and a downturn in the memory industry. The contraction of the worldwide economy, especially in the fourth quarter of 2008, further compounded industry over capacity. Continuing manufacturing overcapacity in the industry is having a material adverse effect on us. Furthermore, fluctuations in the growth rate of industry capacity relative to the growth rate in demand for Flash memory products can contribute to cyclicality in the Flash memory market, which may in the future negatively impact our selling prices and materially adversely affect us.

It is difficult to predict future growth or decline in the markets we serve, making it very difficult to estimate requirements for production capacity. If our target markets do not grow as we anticipate, we may under-utilize our manufacturing capacity. This may result in write-downs or write-offs of inventories and losses on products the demand for which is lower than we anticipate. In addition, during periods of industry overcapacity, customers do not generally order products as far in advance of the scheduled shipment date as they do during periods when our industry is operating closer to capacity, which can exacerbate the difficulty in forecasting capacity requirements.

Many of our costs are fixed. Additionally, pursuant to some of our subcontractor and foundry arrangements with third parties we may incur and pay penalties, according to which we have agreed to pay for a certain amount of product even if we do not accept delivery of all of such amount. Accordingly, during periods in which we under-utilize our manufacturing capacity as a result of reduced demand for some of our products, our costs cannot be reduced in proportion to the reduced net sales for such periods. When this occurs, our operating results are materially adversely affected.

Our customers’ ability to change booked orders may lead to excess inventory.

Because our manufacturing processes require long lead times, we use indicators such as booking rates in conjunction with other business metrics, to schedule production in our fabrication facilities. Consequently, when customers change orders booked with us, our planned manufacturing capacity may be greater or less than actual demand, resulting in less than optimal inventory levels. When this occurs, we adjust our production levels but such adjustments may not prevent our production of excess inventory in environments when bookings are strong. As a result, our business may be materially adversely affected.

Intense competition in the Flash memory market could materially adversely affect us.

Our principal NOR Flash memory competitors are Numonyx B.V. and Samsung Electronics Co., Ltd. Additional significant NOR Flash memory competitors include Silicon Storage Technology, Inc., Macronix International Co., Ltd., Toshiba Corporation and Sharp Electronics Corp.

We increasingly compete with NAND Flash memory manufacturers where NAND Flash memory has the ability to replace NOR Flash memory in customer applications and as we develop data storage solutions based on our MirrorBit ORNAND, MirrorBit Eclipse and MirrorBit NAND2 architectures for the integrated category and select portions of the removable category of the Flash memory market. Our principal NAND Flash memory competitors include Samsung Electronics Co., Ltd, Toshiba Corporation, Hynix Semiconductor Inc. and Numonyx. In the future our principal NAND Flash memory competitors may include Intel Corporation, Micron Technology, Inc., IM Flash Technology LLC, the joint venture between Intel and Micron Technology, Inc. and SanDisk Corporation.

The Flash memory market is characterized by intense competition. The basis of competition is cost, selling price, performance, quality, customer relationships and ability to provide value-added solutions. In particular, in the past, our competitors have aggressively priced their products, which resulted in a decreased selling prices for our products in the first half of fiscal 2007 and adversely impacted our results of operations. Some of our competitors, including Samsung, Toshiba and Sharp, are more diversified than we are and may be able to sustain lower operating margins in their Flash memory business based on the profitability of their other, non-Flash

34

memory businesses. In addition, capital investments by competitors have resulted in substantial industry manufacturing capacity, which may further contribute to a competitive pricing environment. Some of our competitors are able to manufacture floating gate NAND-based Flash memory products on 300-millimeter wafers produced in much larger capacity fabs than we may have access to or may choose to utilize more advanced manufacturing process technologies than we will have to offer products competitive to ours at a lower cost. Moreover, products based on our MirrorBit ORNAND-, MirrorBit Quad-, MirrorBit Eclipse- and MirrorBit NAND2-based architectures may not have the price, performance, quality and other features necessary to compete successfully for these applications.

We expect competition in the market for Flash memory devices to intensify as existing manufacturers introduce new products, new manufacturers enter the market, industry-wide production capacity increases and competitors aggressively price their Flash memory products to increase market share. The competition we face may also intensify, particularly in light of the Creditor Protection Proceedings, if our competitors, who may have greater financial resources than us, increase their focus on the Flash memory products, or segments of the Flash memory markets, that generate a significant portion of our net sales.

Competition also may increase if NOR memory vendors merge, if NAND memory vendors acquire NOR businesses or other NAND businesses, or if our competitors otherwise consolidate their operations. Furthermore, we face increasing competition from NAND Flash memory vendors in some portions of the integrated Flash memory market.

To compete successfully, we must decrease our manufacturing costs and develop, introduce and sell products at competitive prices that meet the increasing demand for greater Flash memory content in mobile phones, consumer electronics, automotive and other applications. If we are unable to compete effectively, we could be materially adversely affected.

Unless we maintain manufacturing efficiency, we may not become profitable and our future profitability could be materially adversely affected.

The Flash memory industry is characterized by rapid technological changes. For example, new manufacturing process technologies using smaller feature sizes and offering better performance characteristics are generally introduced every one to two years. The introduction of new manufacturing process technologies allows us to increase the functionality of our products while at the same time optimizing performance parameters, decreasing power consumption and/or increasing storage capacity. In addition, the reduction of feature sizes enables us to produce smaller chips offering the same functionality and thereby considerably reduces the costs per bit. In order to remain competitive, it is essential that we secure the capabilities to develop and qualify new manufacturing process technologies. For example, our leading Flash memory products must be manufactured at 65-nanometer and more advanced process technologies and on 300-millimeter wafers. If we are delayed in transitioning to these technologies and other future technologies, we could be materially adversely affected. As a result of the Creditor Protection Proceedings and in conjunction with developing a plan of reorganization, we may be forced to shut down or abandon current plans for our manufacturing facilities. These actions would likely exacerbate this risk.

Manufacturing our products involves highly complex processes that require advanced equipment. Our manufacturing efficiency is an important factor in our profitability, and we cannot be sure that we will be able to maintain or increase our manufacturing efficiency to the same extent as our competitors. For example, we continuously modify our manufacturing processes in an effort to improve yields and product performance and decrease costs. We are continuing to transition products to 65-nanometer process technology for the manufacture of some of our products. During periods when we are implementing new process technologies, manufacturing facilities may not be fully productive. We may fail to achieve acceptable yields or may experience product delivery delays as a result of, among other things, capacity constraints, delays in the development of new process technologies, changes in our process technologies, upgrades or expansion of existing facilities, impurities or

35

other difficulties in the manufacturing process. Any of these occurrences could adversely impact our relationships with customers, cause harm to our reputation in the marketplace, cause customers to move future business to our competitors or cause us to make financial concessions to our customers.

Improving our manufacturing efficiency in future periods is dependent on our ability to:

• develop advanced process technologies and advanced products that utilize those technologies;

• successfully transition to 65-nanometer and more advanced process technologies;

• continue to reduce test times;

• ramp product and process technology improvements rapidly and effectively to commercial volumes across our facilities;

• achieve acceptable levels of manufacturing wafer output and yields, which may decrease as we implement more advanced technologies; and

• maintain our quality controls and rely upon the quality and process controls of our suppliers.

If we cannot adequately protect our technology or other intellectual property in the United States and abroad, through patents, copyrights, trade secrets, trademarks and other measures, we may lose a competitive advantage and incur significant expenses.

We rely on a combination of protections provided by contracts, including confidentiality and non-disclosure agreements, copyrights, patents, trademarks and common law rights, such as trade secrets, to protect our intellectual property. However, we cannot assure you that we will be able to adequately protect our technology or other intellectual property from third-party infringement or from misappropriation in the United States and abroad. Any patent owned or licensed by us or issued to us could be challenged, invalidated or circumvented or rights granted under these patents or licenses may not provide a competitive advantage to us. Furthermore, patent applications that we file may not result in issuance of a patent or, if a patent is issued, the patent may not be issued in a form that is advantageous to us. Despite our efforts to protect our intellectual property rights, others may independently develop similar products, duplicate our products or design around our patents and other intellectual property rights. In addition, it is difficult to monitor compliance with, and enforce, our intellectual property on a worldwide basis in a cost-effective manner. Foreign laws may provide less intellectual property protection than afforded in the United States. If we cannot adequately protect our technology or other intellectual property rights in the United States and abroad, we may be materially adversely affected.

We are party to intellectual property litigation and may become party to other intellectual property claims or litigation that could cause us to incur substantial costs or pay substantial damages or prohibit us from selling our products.

We provide indemnities relating to non-infringement of patents and other intellectual property indemnities to certain of our customers in connection with the delivery, design, manufacture and sale of our products. From time to time, we may be notified, or third parties may bring actions against us based on allegations, that we are infringing the intellectual property rights of others. If any such claims are asserted against us, we may seek to obtain a license under the third party’s intellectual property rights. We cannot assure you that we will be able to obtain all of the necessary licenses on satisfactory terms, if at all. In the event that we cannot obtain a license, these parties may file lawsuits against us seeking damages (potentially including treble damages) or an injunction against the sale of our products that incorporate allegedly infringed intellectual property or against the operation of our business as presently conducted, which could result in our having to stop the sale of some of our products, increase the costs of selling some of our products, or cause damage to our reputation. The award of damages, including material royalty payments, or the entry of an injunction against the manufacture and sale of some or all of our products, would have a material adverse effect on us. We could decide, in the alternative, to redesign our products or to resort to litigation to challenge or defend such claims, either of which could be expensive and time-consuming and may have a material adverse effect on us.

36

For example, Tessera, Inc., LSI Corporation, Agere Systems, Inc. and Fast Memory Erase LLC filed lawsuits against us alleging that we have infringed certain of their respective patents. Tessera, LSI and Agere have sought to enjoin such alleged infringements, to recover an unspecified amount of damages, and to bar our importation and sale of allegedly infringing products. In addition, Fujitsu has informed us that Texas Instruments has asserted that a number of our products infringe some of Texas Instruments’ patents. Fujitsu has also informed us that it expects us to defend and indemnify Fujitsu against Texas Instruments’ claims. Fujitsu has provided us with formal notice that they believe we have a duty to defend or indemnify Fujitsu under the terms of our distribution agreement. Since then, we and Fujitsu have been discussing the issues raised by this notice, and if Fujitsu were to terminate our distribution agreement, we could be materially adversely affected. Defending these alleged infringement claims and similar claims could be extremely expensive and time-consuming and an award of damages or an injunction could have a material adverse effect on us. We cannot assure you that litigation related to the intellectual property rights of ours or others can be avoided or will be successfully concluded.

If essential equipment or adequate supplies of satisfactory materials are not available to manufacture our products, we could be materially adversely affected.

Our manufacturing operations depend upon obtaining deliveries of equipment and adequate supplies of materials on a timely basis. We purchase equipment and materials from a number of suppliers. From time to time, suppliers may extend lead times, limit supply to us or increase prices due to capacity constraints or other factors. Because the equipment that we purchase is complex, it is difficult for us to substitute one supplier for another or one piece of equipment for another. Some raw materials we use in the manufacture of our products are available from a limited number of suppliers or only from a limited number of suppliers in a particular region. In addition, we purchase raw materials such as gold which prices on the world markets have fluctuated significant during recent periods. Our manufacturing operations also depend upon the quality and usability of the materials we use in our products, including raw materials and wafers we receive from our suppliers. If the materials we receive from our suppliers do not meet our manufacturing requirements or product specifications, are not obtained in a timely manner or if there are significant increases in costs of materials, we may be materially adversely affected.

We also rely on purchasing commercial memory die such as DRAMs from third-party suppliers to incorporate these die into multi-chip package, or MCP, products. The availability of these third-party purchased commercial die is subject to market availability, and the process technology roadmaps and manufacturing capacities of our vendors. In addition, some of our major suppliers, including Samsung, are also our competitors. Interruption of supply from a competitor that is a supplier or otherwise or increased demand in the industry could cause shortages and price increases in various essential materials. If we are unable to procure these materials, or if the materials we receive from our suppliers do not meet our production requirements or product specifications, we may have to reduce our manufacturing operations or our manufacturing yields may be adversely affected. Such a reduction and yield issues have in the past and could in the future have a material adverse effect on us.

Costs related to defective products could have a material adverse effect on us.

One or more of our products may be found to be defective after the product has been shipped to customers in volume. The cost of product replacements or product returns may be substantial, and our reputation with our customers would be damaged. In addition, we could incur substantial costs to implement modifications to fix defects. Any of these problems could materially adversely affect us.

Unfavorable currency exchange rate fluctuations could adversely affect us.

As a result of our foreign operations, we have sales, expenses, assets and liabilities that are denominated in Japanese yen and other foreign currencies. For example:

• some of our manufacturing costs are denominated in Japanese yen, Chinese renminbi, and other foreign currencies such as the Thai baht and Malaysian ringgit;

37

• sales of our products to Fujitsu are denominated in both US dollars and Japanese yen; and

• some fixed asset purchases are denominated in Japanese yen and European Union euros.

Consequently, movements in exchange rates could cause our net sales and expenses to fluctuate, affecting our profitability and cash flows.

Worldwide economic and political conditions may adversely affect demand for our products.

We operate in more than ten countries and we derive a majority of our net sales outside the United States. Our business depends on the overall worldwide economic conditions and the economic and business conditions within our customers’ industries. Our business may also be affected by economic factors that are beyond our control, such as downturns in economic activity in a specific country or region. A further weakening of the worldwide economy or the economy of individual countries or the demand for our customers’ products may cause a greater decrease in demand for our products, which could materially adversely affect us.

Our consolidated financial results could also be significantly and adversely affected by geopolitical concerns and world events, such as wars and terrorist attacks. Our net sales and financial results have been and could be negatively affected to the extent geopolitical concerns continue and similar events occur or are anticipated to occur. In particular, consequences of military action in the Middle East have in the past, and may in the future, adversely affect demand for our products and our relationship with various third parties with which we collaborate. In addition, terrorist attacks may negatively affect our operations, directly or indirectly, and such attacks or related armed conflicts may directly impact our physical facilities or those of our suppliers or customers. Furthermore, these attacks may make travel and the transportation of our products more difficult and more expensive, which could materially adversely affect us.

The United States has been and may continue to be involved in armed conflicts that could have a further impact on our sales and our supply chain. Political and economic instability in some regions of the world may also result and could negatively impact our business. The consequences of armed conflicts are unpredictable, and we may not be able to foresee events that could have a material adverse effect on us. More generally, any of these events could cause consumer confidence and spending to decrease or result in increased volatility in the U.S. economy and worldwide financial markets. Any of these occurrences could have a material adverse effect on us.

Our operations in foreign countries are subject to political and economic risks, which could have a material adverse effect on us.

The majority of our wafer fabrication capacity is located in Japan, which is subject to the Spansion Japan Proceeding, and nearly all final test and assembly of our products is performed at our facilities in China, Malaysia and Thailand and by third parties in Taiwan and Japan. In addition, we have international sales operations and, as part of our business strategy, we are continuing to seek to expand our product sales in high growth markets. The political and economic risks associated with our sales to, and operations in, foreign countries include:

• expropriation;

• changes in political or economic conditions;

• changes in tax laws, trade protection measures and import or export licensing requirements;

• difficulties in protecting our intellectual property;

• difficulties in achieving headcount reductions;

• changes in foreign currency exchange rates;

• restrictions on transfers of funds and other assets of our subsidiaries between jurisdictions;

38

• changes in freight and interest rates;

• disruption in air transportation between the United States and our overseas facilities; and

• loss or modification of exemptions for taxes and tariffs.

We manufacture wafers in our JV3 and SP1 fabrication facilities in Japan. If we are required for any reason to transfer wafer production from our Japan facilities to our Fab 25 facility in Austin, Texas or to third party foundries, we may not be able to make this transition in a timely manner or find third-party manufacturers with sufficient capacity to produce wafers of acceptable quality at acceptable manufacturing yields and prices or to deliver wafers in a timely manner. If we are not able to successfully transition this manufacturing to other facilities, we may be materially adversely affected. In addition, our sales in Japan, and certain other locations throughout the world, are made through Spansion Japan. If Spansion Japan no longer manages these sales for us, we would be required to develop alternative methods of distributing and selling our products. To sell our products in Japan, we would have to establish a separate sales force and administrative support in Japan and continue to rely on Fujitsu as a distributor, or rely on another distributor. If we are unsuccessful in establishing alternative sales channels, our sales in Japan may decline and we may be materially adversely affected.

Our subsidiary, Saifun, conducts business in Israel, which is affected and surrounded by unstable political, economic and military conditions. We cannot predict the effect of continued or increased violence in Lebanon or Gaza, or the effect of military action elsewhere in the Middle East. Continued armed conflicts or political instability in the region would harm business conditions and could adversely affect the combined company’s results of operations. Furthermore, several countries continue to restrict or ban business with Israel and Israeli companies. These restrictive laws and policies may limit the combined company’s ability to make sales in those countries, and, as a global company, may limit our own ability to efficiently administer our worldwide resources.

Any conflict or uncertainty in the countries in which we operate, including public health or safety concerns, natural disasters or general economic factors, could have a material adverse effect on our business. Any of the above risks, should they occur, could have a material adverse effect on us.

We are subject to a variety of environmental laws that could result in liabilities.

Our properties and many aspects of our business operations are subject to various domestic and international environmental laws and regulations, including those relating to materials used in our products and manufacturing processes; chemical use and handling; waste minimization; discharge of pollutants into the environment; the treatment, transport, storage and disposal of solid and hazardous wastes; and remediation of contamination. Certain of these laws and regulations require us to obtain permits for our operations, including permits related to the discharge of air pollutants and wastewater. From time to time, our facilities are subject to investigation by governmental regulators. Environmental compliance obligations and liability risks are inherent in many of our manufacturing and other activities. Any failure to comply with applicable environmental laws, regulations or permits may subject us to a range of consequences, including fines, suspension of production, alteration of manufacturing processes, sales limitations, and criminal and civil liabilities or other sanctions. We could also be held liable for any and all consequences arising out of exposure to hazardous materials used, stored, released, disposed of by us or located at or under our facilities, or for other environmental or natural resource damage. Certain environmental laws, including the U.S. Comprehensive, Environmental Response, Compensation and Liability Act of 1980, or the Superfund Act, impose joint and several liability on current and previous owners or operators of real property for the cost of removal or remediation of hazardous substances and costs related to damages to natural resources. Liability can attach even if the owner or operator did not know of, or was not responsible for, the release of such hazardous substances. These environmental laws also can result in liability for persons, like us, who arrange for hazardous substances to be sent to disposal or treatment facilities, in the event such facilities are found to be contaminated. Such persons can be responsible for cleanup costs at a disposal or treatment facility, even if they never owned or operated the contaminated facility. One property where we currently conduct research and development operations is listed on the U.S. Environmental Protection Agency’s

39

Superfund National Priorities List. However, other parties currently are responsible for all investigation, cleanup and remediation activities. Although we have not been named a responsible party at this site, if we were so named, costs associated with the cleanup of the site could have material adverse effect upon us.

We have not been named a responsible party at any Superfund or other contaminated site. If we were ever so named, costs associated with the cleanup of the site could be material. Additionally, contamination that has not yet been identified could exist at one or more of our facilities, and identification of such contamination could have a material adverse effect on us.

Our business is subject to complex and dynamic environmental regulatory schemes. While we have budgeted for reasonably foreseeable environmental expenditures, we cannot assure you that environmental laws will not change or become more stringent in the future. Future environmental regulations could require us to procure expensive pollution abatement or remediation equipment; to modify product designs; or to incur other expenses associated with compliance with such regulations. For example, the European Union and China recently began imposing stricter requirements regarding reduced lead content in semiconductor packaging. Therefore, we cannot assure you that our costs of complying with current and future environmental and health and safety laws, or liabilities arising from past or future releases of, or exposure to, hazardous substances, will not have a material adverse effect on our business.

Our business, worldwide operations and the operations of our suppliers could be subject to natural disasters and other business disruptions, which could harm our future net sales and financial condition and increase our costs and expenses.

Our worldwide operations and business could be subject to natural disasters and other business disruptions, such as a world health crisis, fire, earthquake, tsunami, volcano eruption, flood, hurricane, power loss, power shortage, telecommunications failure or similar events, which could harm our future net sales and financial condition and increase our costs and expenses. For example, during the first quarter of fiscal 2008, our business was adversely affected by severe weather conditions in China which caused us to experience decreased demand for our products in that region. In addition, our corporate headquarters are located near major earthquake fault lines in California, and one of our two wafer fabrication facilities, as well as our new 300-millimeter wafer fabrication facility, SP1, are located near major earthquake fault lines in Japan. Also, our assembly and test facilities located in China, Malaysia and Thailand may be affected by tsunamis. In the event of a major earthquake or tsunami, we could experience loss of life of our employees, destruction of facilities or other business interruptions. If such business disruptions result in cancellations of customer orders or contribute to a general decrease in economic activity or demand for our products, or directly impact our marketing, manufacturing, financial, and logistics functions, our results of operations and financial condition could be materially adversely affected.

Furthermore, the operations of our suppliers could be subject to natural disasters and other business disruptions, which could cause shortages and price increases in various essential materials, such as liquid hydrogen, which are required to manufacture our products or commercial memory die such as DRAMs for incorporation into our MCP products. If we are unable to procure an adequate supply of materials that are required for us to manufacture our products, or if the operations of our other suppliers of such materials are affected by an event that causes a significant business disruption, then we may have to reduce our manufacturing operations. Such a reduction could in the future have a material adverse effect on us.

We may be delayed or prevented from taking actions that require the consent of Fujitsu, whose interests may differ from or conflict with our interests or those of our other stockholders, which could decrease the value of your shares.

Our bylaws provide that for so long as Fujitsu maintains an aggregate ownership interest in us of at least 10 percent, we will not be able to amend our certificate of incorporation or bylaws or effect any resolution to wind up Spansion Inc. or any other subsidiary without their prior consent.

40

We cannot assure you that the interests of Fujitsu will be aligned with our interests or those of our other stockholders with respect to such decisions. As a result, we may be unable to take steps that we believe are desirable and in the best interests of our stockholders. In addition, these consent rights could make an acquisition of us more difficult, even if the acquisition may be considered beneficial by some stockholders.

Third parties may seek to hold us responsible for liabilities of AMD and Fujitsu that we did not assume in our agreements.

Under our agreements with AMD and Fujitsu, we agreed to assume liabilities related to our business after June 30, 2003, and liabilities related to our business prior to June 30, 2003 if such liabilities were reflected as accruals or reserves on the AMD and Fujitsu contributed balance sheets. Our assumed liabilities include claims made with respect to Flash memory products sold after June 30, 2003, even if such products were manufactured prior to June 30, 2003, and warranty claims with respect to products sold prior to June 30, 2003 to the extent such warranty claims were reflected as accruals or reserves on the AMD and Fujitsu contributed balance sheets. The allocation of assets and liabilities between AMD, Fujitsu and us may not reflect the allocation that would have been reached between unaffiliated parties and may be less favorable to us as a result. Third parties may seek to hold us responsible for AMD’s and Fujitsu’s retained liabilities. If our losses for AMD’s and Fujitsu’s retained liabilities were significant and we were ultimately held liable for them, we cannot assure you that we would be able to recover the full amount of our losses.

We rely on Fujitsu Microelectronics Limited to be our largest distributor in Japan.

We currently rely on Fujitsu Microelectronics Limited (FML) through its subsidiary Fujitsu Electronics Inc. (FEI) to act as the largest distributor of our products to customers in Japan, which was an important geographic market in fiscal 2006, 2007 and 2008. Under our distribution agreement with FML, FML has agreed to use its best efforts to promote the sale of our products in Japan and to other customers served by FML. In the event that we reasonably determine that FML’s sales performance in Japan and to those customers served by FML is not satisfactory based on specified criteria, then we have the right to require FML to propose and implement an agreed-upon corrective action plan. If we reasonably believe that the corrective action plan is inadequate, we can take steps to remedy deficiencies ourselves through means that include appointing another distributor as a supplementary distributor to sell products in Japan and to customers served by FML. Pursuing these actions would be costly and disruptive to the sales of our products in Japan. If FML’s sales performance in Japan is unsatisfactory or if we are unable to successfully maintain our distribution agreement and relationship with FML and we can not timely find a suitable supplementary distributor, we could be materially adversely affected.

On December 28, 2007, we entered into an amendment to our distribution agreement which provides, among other terms, that FML no longer has territorial exclusivity in Japan, the distribution agreement would expire on September 30, 2008, and effective April 1, 2008 we may enter into distribution agreements with FML’s sub-distributors in Japan. We entered into a second amendment to our distribution agreement, effective September 30, 2008, extending the term of the agreement until we enter into a successor distribution agreement with FEI, or April 25, 2009. If FML or FEI unexpectedly terminates its distribution agreement with us, or otherwise ceases its support of our customers in Japan, we would be required to rely on a relationship with another distributor or establish our own local sales organization and support functions. We cannot be certain that we will be successful in selling our products to customers currently served by FML or new customers. If customers currently served by FML, or potential new customers, refuse to purchase our products directly from us or from another distributor, our sales in Japan may decline, and we could be materially adversely affected.

AMD and Fujitsu may continue to use all of our intellectual property and the intellectual property they have transferred to us.

In connection with our reorganization as Spansion LLC in June 2003, AMD and Fujitsu transferred approximately 400 patents and patent applications to us. In addition, AMD and Fujitsu contributed additional

41

patents to us at the time of our initial public offering. However, both AMD and Fujitsu have retained the rights to use any patents contributed to us for an unlimited period of time. In addition, under their respective patent cross-license agreements with us, AMD and Fujitsu have also obtained licenses to our present and future patents with effective filing dates prior to the later of June 30, 2013, or such date on which they have transferred all of their shares in us, although the scope of patents under license can be impacted by a change in control of the parties or their semiconductor groups. These licenses continue until the last to expire of the patents under license expires and provide AMD and Fujitsu with licenses to all of our present and future patents in existence through such cross-license termination date. Furthermore, we entered into an Amended and Restated Intellectual Property Contribution and Ancillary Matters Agreement with AMD and Fujitsu in connection with our reorganization as Spansion Inc. in December 2005. Pursuant to that agreement, subject to our confidentiality obligations to third parties, and only for so long as AMD’s and Fujitsu’s ownership interests in us remain above specific minimum levels, we are obligated to identify any of our technology to each of AMD and Fujitsu, and to provide copies of and training with respect to that technology to them. In addition, pursuant to this agreement we have granted a non-exclusive, perpetual, irrevocable fully paid and royalty-free license of our rights, other than patent and trademark rights, in that technology to each of AMD and Fujitsu. Under our non-competition agreement, both AMD and Fujitsu have agreed that they will not directly or indirectly engage in a business, and have agreed to divest any acquired business, that manufactures or supplies standalone semiconductor devices (including single chip, multiple chip or system devices) containing certain Flash memory, which is the business in which we primarily compete. With respect to each of AMD and Fujitsu, this non-competition restriction will last until the earlier of (i) two years from the date such stockholder’s ownership in us falls to or below five percent, or (ii) the dissolution of our company. After that time, should they ever decide to re-enter the Flash memory business, AMD or Fujitsu could use our present and future patents and technologies licensed by us to AMD and Fujitsu under the cross licenses and our Amended and Restated Intellectual Property Contribution and Ancillary Matters Agreement to compete against us. If either AMD or Fujitsu were to compete with us, we could be materially adversely affected.

We currently do not intend to pay dividends on our common stock and, consequently, our stockholders’ only opportunity to achieve a return on their investment is through appreciation in the price of our common stock.

We currently do not plan to pay dividends on shares of our common stock in the foreseeable future and are currently prohibited from doing so in specific circumstances under agreements governing our borrowing arrangements. In addition, because we are a holding company, our ability to pay cash dividends on shares of our common stock may be limited by restrictions on our ability to obtain sufficient funds through dividends from our subsidiaries, including the restrictions under the indenture governing the notes. Our common stock will rank junior as to payment of dividends to any series of preferred stock that we may issue in the future. Generally, unless full dividends including any cumulative dividends still owing on all outstanding shares of any preferred stock have been paid, no dividends will be declared or paid on our common stock. Consequently, your only opportunity to achieve a return on your investment in our company will be if the market price of our common stock appreciates.

Any future issuance of our preferred stock could adversely affect holders of our common stock.

Our board of directors is authorized to issue shares of preferred stock without any action on the part of our stockholders. Our board of directors also has the power, without stockholder approval, to set the terms of any such series of shares of preferred stock that may be issued, including voting rights, dividend rights and preferences over our common stock with respect to dividends or if we liquidate, dissolve or wind up our business and other terms. If we issue preferred stock in the future that has preference over our common stock with respect to the payment of dividends or upon our liquidation, dissolution or winding up of our affairs, or if we issue preferred stock with voting rights that dilute the voting power of our common stock, the rights of holders of our common stock or the market price of our common stock could be adversely affected.

42

Provisions in our corporate governance documents as well as Delaware law may delay or prevent an acquisition of us that stockholders may consider favorable, which could decrease the value of your shares.

Our certificate of incorporation and bylaws and Delaware law contain provisions that could make it more difficult for a third party to acquire us without the consent of our board of directors. These provisions include restrictions on the ability of our stockholders to remove directors, a classified board of directors and limitations on action by our stockholders by written consent. In addition, our board of directors has the right to issue preferred stock without stockholder approval, which could be used to make an acquisition of us more difficult. Although we believe these provisions protect our stockholders from coercive or otherwise unfair takeover tactics and thereby provide for an opportunity to receive a higher bid by requiring potential acquirers to negotiate with our board of directors, these provisions apply even if the offer may be considered beneficial by some stockholders.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

ITEM 2. PROPERTIES

Our principal engineering, manufacturing and administrative facilities as of December 28, 2008, comprise approximately 4.9 million square feet and are located in the United States, Italy, France, Israel, Japan, Korea, Malaysia, Thailand and China. Over 4.3 million square feet of this space is in buildings we own. The remainder of this space is leased. We lease from Fujitsu Limited (Fujitsu) approximately 1.3 million square feet of land in Aizu-Wakamatsu, Japan for our wafer fabs including the land upon which JV3 and SP1 are located and we lease office space in Aichi, Japan from a subsidiary of Fujitsu, Fujitsu VLSI. We lease approximately 635,000 square feet of land in Suzhou, China for our assembly and test facility. Our Fab 25 facility in Austin, Texas and our facility in Sunnyvale, California are encumbered by liens securing our senior secured term loan facility and our senior secured floating rate notes. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Contractual Obligations.”

Our facility leases have terms of generally one to five years. We currently do not anticipate difficulty in either retaining occupancy of any of our facilities through lease renewals prior to expiration or through month-to-month occupancy or replacing them with equivalent facilities. Our land lease in Aizu-Wakamatsu expires in 2033.

ITEM 3. LEGAL PROCEEDINGS

Tessera, Inc. v. Spansion LLC, et al., Civil Action No. 05-04063 (CW), in the United States District Court for the Northern District of California

On October 7, 2005, Tessera, Inc. filed a complaint, Civil Action No. 05-04063, for patent infringement against Spansion LLC in the United States District Court for the Northern District of California under the patent laws of the United States of America, 35 U.S.C. section 1, et seq., including 35 U.S.C. section 271. The complaint alleges that Spansion LLC’s Ball Grid Array (BGA) and multichip packages infringe the following Tessera patents: United States Patent No. 5,679,977, United States Patent No. 5,852,326, United States Patent No. 6,433,419 and United States Patent No. 6,465,893. On December 16, 2005, Tessera filed a First Amended Complaint naming Spansion Inc. and Spansion Technology Inc., our wholly owned subsidiary, as defendants. On January 31, 2006, Tessera filed a Second Amended Complaint adding Advanced Semiconductor Engineering, Inc., Chipmos Technologies, Inc., Chipmos U.S.A., Inc., Silicon Precision Industries Co., Ltd., Siliconware USA, Inc., ST Microelectronics N.V., ST Microelectronics, Inc., Stats Chippac Ltd., Stats Chippac, Inc., and Stats 34 Chippac (BVI) Limited. The Second Amended Complaint alleges that Spansion LLC’s BGA and multichip packages infringe the four Tessera patents identified above. The Second Amended Complaint further alleges that each of the newly named defendants is in breach of a Tessera license agreement and is infringing on a fifth

43

Tessera patent, United States Patent No. 6,133,627. The Second Amended Complaint seeks unspecified damages and injunctive relief. On February 9, 2006, Spansion filed an answer to the Second Amended Complaint and asserted counterclaims against Tessera. On April 18, 2006, U.S. District Court Judge Claudia Wilken issued a Case Management Order that set a trial date of January 28, 2008. On March 13, 2007, Judge Wilken issued an order vacating the trial date. On April 12, 2007, Judge Wilken issued an order referring case management scheduling issues to a Special Master, and directing that the court will appoint an expert in the case to testify on the ultimate merits of the technical issues relating to infringement and patent validity. On April 26, 2007, Spansion, along with other defendants, filed a motion to stay the District Court action pending resolution of the proceeding before the International Trade Commission described below. On May 24, 2007, Judge Wilken issued an order staying the District Court action until final resolution of the ITC action.

We believe that we have meritorious defenses against Tessera’s claims and we intend to defend the lawsuit vigorously.

Tessera ITC Action

On April 17, 2007, Tessera, Inc. filed a complaint under section 337 of the Tariff Act of 1930, 19 U.S.C. § 1337, in the United States International Trade Commission (“ITC”) against respondents ATI Technologies, Inc., Freescale Semiconductor, Inc., Motorola, Inc., Qualcomm, Inc., Spansion Inc., Spansion LLC and STMicroelectronics N.V. Tessera claims that “face up” and “stacked-chip” small format laminate Ball Grid Array (“BGA”) packages, including the Spansion 5185941F60 chip assembly, infringe certain specified claims of United States Patent Nos. 5,852,326 and 6,433,419 (“Asserted Patents”). The complaint requests that the ITC institute an investigation into the matter. The complaint seeks a permanent exclusion order pursuant to section 337(d) of the Tariff Act of 1930, as amended, excluding from entry into the United States all semiconductor chips with small format laminate BGA semiconductor packaging that infringe any of the Asserted Patents, and all products containing such infringing small format laminate BGA semiconductor packaged chips. The complaint also seeks a permanent cease and desist order pursuant to section 337(f) of the Tariff Act of 1930, as amended, directing respondents with respect to their domestic inventories to cease and desist from marketing, advertising, demonstrating, sampling, warehousing inventory for distribution, offering for sale, selling, distributing, licensing, or using any semiconductor chips with small format laminate BGA semiconductor packaging that infringe any of the Asserted Patents, and/or products containing such semiconductor chips. On May 15, 2007, the ITC instituted an investigation pursuant to 19 U.S.C. § 1337, entitled In the Matter of Certain Semiconductor Chips with Minimized Chip Package Size and Products Containing Same, Inv. No. 337-TA-605, identifying ATI Technologies, ULC, Freescale Semiconductor, Inc., Motorola, Inc., Spansion Inc., Spansion LLC and STMicroelectronics N.V. (“Respondents”) as respondents. On June 8, 2007, Respondents filed a motion to stay the ITC investigation pending reexamination of the Asserted Patents by the U.S. Patent and Trademark Office. On July 11, 2007, Administrative Law Judge Carl C. Charneski set an Initial Determination date of May 21, 2008 and a target date for completion of the ITC Investigation of August 21, 2008. On October 17, 2007, the ITC investigation was reassigned to Administrative Law Judge Theodore Essex, who set a hearing for February 25, 2008. On February 26, 2008, Judge Essex issued an Initial Determination granting respondents’ motion for a stay of the ITC investigation pending completion of the re-examination of the Asserted Patents by the U.S. Patent and Trademark Office. On March 4, 2008, Tessera filed, with the ITC, a Petition for Review of the Initial Determination Ordering Stay. On March 27, 2008, the ITC issued an order reversing Judge Essex’s Initial Determination, and denying respondents’ motion for a stay of the ITC investigation pending reexamination of the Asserted Patents. On May 13, 2008, Judge Essex set an Initial Determination date of October 20, 2008, with a hearing date of July 14, 2008, and a target date for completion of the ITC investigation of February 20, 2009. On July 14, 2008, Judge Essex held an evidentiary hearing in the ITC investigation, and completed the hearing on July 18, 2008. On October 16, 2008, Judge Essex issued an order resetting the Initial Determination date to December 1, 2008, and the target date for completion of the ITC investigation to April 3, 2009. On December 1, 2008, Judge Essex issued an Initial Determination, ruling that the accused small-format BGA packages of Spansion Inc. and Spansion LLC and the other Respondents did not infringe the asserted claims of the Asserted Patents and, therefore, Spansion Inc. and Spansion LLC and the other Respondents were

44

not in violation of section 337 of the Tariff Act of 1930. On December 15, 2008, Tessera filed with the ITC a petition to review the Initial Determination. On January 30, 2009, the ITC issued a notice to review in part Judge Essex’s decision finding no violation of section 337. On February 10, 2009, the ITC issued an order resetting the target date for completion of the ITC Investigation to April 14, 2009. On March 31, 2009 the ITC issued an order requesting additional briefing on certain remedy issues and resetting the target date for completion of the ITC Investigation to May 20, 2009.

We believe that we have meritorious defenses against Tessera’s claims and we intend to defend this proceeding vigorously.

LSI, Agere v. Spansion, Inc., et al.

On April 18, 2008, LSI Corporation and Agere Systems, Inc. filed a complaint, Civil Action No. 2—08 CV -165, in the United States District Court for the Eastern District of Texas, against defendants United Microelectronics Corporation, Integrated Device Technology, Inc., AMIC Technology Corporation, Elpida Memory, Inc., Freescale Semiconductor, Inc., Grace Semiconductor Manufacturing Corporation, Microchip Technology, Inc., Micromas Semiconductor Holding, AG, National Semiconductor Corporation, Nanya Technology Corporation, NXP B.V., ON Semiconductor Corporation, Powerchip Semiconductor Corporation, ProMOS Technologies, Inc., Spansion, Inc., STMicroelectronics NV and Vanguard International Semiconductor Corporation (“Defendants”). The complaint alleges that certain Spansion Flash products, including Spansion’s 4 Mb CMOS 3.0 Volt-only Simultaneous Read/Write Flash Memory and 1 G MirrorBit NOR Flash products, infringe at least claim 1 of U.S. Patent No. 5,227, 335 (the “Asserted Patent”). The complaint seeks a declaration that Spansion infringes the Asserted Patent, permanent injunctive relief and unspecified reasonable royalty and other damages, a trebling of damages for alleged willful conduct and attorney’s fees. On June 13, 2008 Defendants filed an Unopposed Motion to stay the Eastern District of Texas action pending resolution of an International Trade Commission investigation (“ITC”) that is described below. On June 13, 2008, Judge T. John Ward issued an order staying the Eastern District of Texas action until a final determination of the ITC investigation described below.

We believe that we have meritorious defenses against LSI’s and Agere’s claims and we intend to defend the lawsuit vigorously.

LSI, Agere ITC Investigation

On April 18, 2008, LSI Corporation and Agere Systems, Inc. (collectively “Complainants”) filed a complaint under section 337 of the Tariff Act of 1930, 19 U.S.C. § 1337, in the United States International Trade Commission (“ITC”) against respondents United Microelectronics Corporation, Integrated Device Technology, Inc., AMIC Technology Corporation, Elpida Memory, Inc., Freescale Semiconductor, Inc., Grace Semiconductor Manufacturing Corporation, Microchip Technology, Inc., Micromas Semiconductor Holding, AG, National Semiconductor Corporation, Nanya Technology Corporation, NXP B.V., ON Semiconductor Corporation, Powerchip Semiconductor Corporation, ProMOS Technologies, Inc., Spansion, Inc., STMicroelectronics NV and Vanguard International Semiconductor Corporation. The complaint alleges that certain Spansion Flash products, including Spansion’s 4 Mb CMOS 3.0 Volt-only Simultaneous Read/Write Flash Memory and 1 G MirrorBit NOR Flash products, infringe at least claim 1 of U.S. Patent No. 5,227,335 (the “Asserted Patent”). The complaint identifies, under the heading “Related Litigations,” other lawsuits involving the Asserted Patent, including Agere Systems, Inc. v Atmel Corporation, Civil Action No. 2:02-CV-864 (E.D. Pa.) (the “Atmel case”). The complaint requests that the ITC institute an investigation into the matter. The complainant seeks a permanent exclusion order pursuant to section 337(d) of the Tariff Act of 1930, as amended, excluding from entry into the United States all semiconductor IC devices and products containing same, made by a method that infringes one or more claims of the Asserted Patent. The complainant also seeks a permanent cease and desist order pursuant to section 337(1) of the Tariff Act of 1930, as amended, directing respondents to cease and desist from importing, selling, offering for sale, using, demonstrating, promoting, marketing, and/or advertising in the United States, or

45

otherwise transferring outside the United States for sale in the United States, semiconductor IC devices and products containing same made by a method that infringes one or more claims of the Asserted Patent. On May 16, 2008, the ITC instituted an investigation pursuant to 19 U.S.C. § 1337, entitled In the Matter of Certain Semiconductor Integrated Circuits Using Tungsten Metallization and Products Containing Same No. 337-TA-648, identifying United Microelectronics Corporation, Integrated Device Technology, Inc., AMIC Technology Corporation, Elpida Memory, Inc., Freescale Semiconductor, Inc., Grace Semiconductor Manufacturing Corporation, Microchip Technology, Inc., Micromas Semiconductor Holding, AG, National Semiconductor Corporation, Nanya Technology Corporation, NXP B.V., ON Semiconductor Corporation, Powerchip Semiconductor Corporation, ProMOS Technologies, Inc., Spansion, Inc., STMicroelectronics NV and Vanguard International Semiconductor Corporation (“Respondents”) as respondents. On June 5, 2008, respondents Elpida Memory, Inc., Freescale Semiconductor, Inc., Grace Semiconductor Manufacturing Corporation, Integrated Device Technology, Microchip Technology, Inc., Nanya Technology Corp., Powerchip Semiconductor Corp., Spansion Inc. and ST Microelectronics N.V. filed a joint motion for summary determination that Complainant is precluded from re-litigating an invalid patent, based upon the jury finding of invalidity and the court ruling affirming the invalidity finding of the Asserted Patent in the Atmel case. On June 27, 2008, Administrative Law Judge Carl L. Charneski set an Initial Determination date of May 21, 2009, with a hearing to be completed by March 13, 2009, and a target date for completion of the ITC investigation of August 21, 2009. On September 18, 2008, Judge Charneski granted Complainants’ motion to add five respondents, Dongbu HiTek Semiconductor Business; Jazz Semiconductor, Magnachip Semiconductor; Qimonda AG, and Tower Semiconductor, Ltd. On October 30, Judge Charneski denied Complainants’ request to add additional claims of infringement against Spansion, and also suspended the current procedural schedule. On November 5, 2008, Judge Charneski issued an order modifying procedural schedule, setting a hearing date of July 20, 2008 and issued a separate order setting an Initial Determination date of September 21, 2009, and a target date for completion of the ITC investigation of January 21, 2010. On December 11, 2008, Judge Charneski issued an Initial Determination denying respondents’ motion for summary determination that Complainant should be precluded from re-litigating an invalid patent. On February 3, 2009, the ITC issued an opinion affirming the ITC determination that Complainant is not precluded from re-litigating the validity of the patent.

We believe that we have meritorious defenses against LSI’s and Agere’s claims and we intend to defend this proceeding vigorously.

Fast Memory Erase LLC v. Spansion Inc., et al.

On June 9, 2008, Fast Memory Erase LLC filed a complaint in the U.S. District Court for the Northern District of Texas alleging patent infringement against Spansion Inc., Spansion LLC, Intel Corp., Numonyx B.V., Numonyx, Inc., Nokia Corp., Nokia Inc., Sony Ericsson Mobile Communications AB, Sony Ericsson Mobile Communications (USA), Inc., and Motorola, Inc. The case is styled, Fast Memory Erase, LLC v. Spansion Inc., Spansion LLC, et al., Case No. 3:08-CV-00977-M (N.D. Tex.). Fast Memory Erase’s complaint alleges that Spansion’s NOR Flash products using floating gate technology infringe one or more claims of U.S. Patent No. 6,236,608 (the ‘608 patent). Fast Memory Erase has also asserted U.S. Patent No. 6,303,959 (the ‘959 patent) in its complaint against the products of other defendants, namely Intel and Numonyx, but it has not asserted the ‘959 patent against any Spansion products. On December 22, 2008, Fast Memory Erase filed an amended complaint. In its amended complaint, Fast Memory Erase added Apple, Inc. as a defendant. Spansion has answered Fast Memory Erase’s complaint and amended complaint. Spansion’s answers assert that Spansion does not infringe the ‘608 patent and that the ‘608 patent is invalid. In its answers, Spansion also asserts counterclaims against Fast Memory Erase for declaratory judgments of non-infringement and invalidity. The case is currently stayed against Spansion as a result of Spansion’s Chapter 11 reorganization proceedings.

46

Spansion v. Samsung Patent Infringement Litigation

Spansion is currently a party to three patent infringement proceedings involving Samsung Electronics Co., Ltd.:

Samsung ITC Investigation

On November 17, 2008 Spansion Inc. and Spansion LLC filed a complaint under section 337 of the Tariff Act of 1930, 19 U.S.C. § 1337, in the United States International Trade Commission (“ITC”) against respondents Samsung Electronics Co., Ltd., Samsung Electronics America, Inc., Samsung International, Inc., Samsung Semiconductor, Inc., and Samsung Telecommunications America, LLC and Apple, Inc., Hon Hai Precision Industry Co., Ltd., AsusTek Computer Inc., Asus Computer International, Inc., Kingston Technology Company, Inc., Kingston Technology (Shanghai) Co. Ltd., Kingston Technology Far East Co., Kingston Technology Far East (Malaysia) Sdn. Bhd., Lenovo Group Limited, Lenovo (United States) Inc., Lenovo (Beijing) Limited, Lenovo Information Products (Shenzhen) Co., Ltd., Lenovo (Huiyang) Electronic Industrial Co., Ltd., Shanghai Lenovo Electronic Co., Ltd., PNY Technologies, Inc., Research In Motion, Ltd., Research In Motion Corporation, Sony Corporation, Sony Corporation of America, Sony Ericsson Mobile Communications AB, Sony Ericsson Mobile Communications (USA), Inc., Beijing SE Putian Mobile Communication Co., Ltd., Transcend Information Inc., Transcend Information Inc. (US), Transcend Information Inc. (Shanghai Factory), Verbatim Americas LLC, and Verbatim Corporation (collectively “Downstream Respondents”). In the ITC Complaint, Spansion alleges that Samsung and Downstream Respondents infringe United States Patent Nos. 6,380,029, 6,080,639, 6,376,877, and 5,715,194 (the “Asserted Patents”), which are owned by Spansion, through the unlawful importation into the United States of certain Samsung flash memory chips. The complaint seeks a permanent general exclusion order pursuant to section 337(d) of the Tariff Act of 1930, as amended, excluding from entry into the United States the Samsung chips that infringe any of the Asserted Patents, and all products produced by Downstream Respondents that contain such chips. The complaint also seeks a permanent cease and desist order pursuant to section 337(f) of the Tariff Act of 1930, as amended, prohibiting Samsung and Downstream Respondents from importing, selling for importation, using, offering for sale, selling after importation, building inventory for distribution, distributing, licensing, or otherwise transferring within the United States, Samsung chips that the Asserted Patents, and/or products containing such chips. On December 18, 2008 the ITC instituted an investigation pursuant to 19 U.S.C. § 1337, entitled In the Matter of Certain Flash Memory Chips and Products Containing Same, Inv. No. 337-TA-664, identifying Samsung and Downstream Respondents (“Respondents”) as respondents. On December 19, 2008, Administrative Law Judge Charles E. Bullock set a target date for completion of the ITC Investigation of April 19, 2010, and set the hearing to begin July 27, 2009. Subsequently, on February 9, 2009, Judge Bullock extended the target date for the investigation to June 18, 2010, and re-set the hearing to begin on September 28, 2009. Each of the Respondents has entered an appearance and answered the complaint. On January 30, 2009, the parties submitted their respective discovery statements, which included proposed discovery schedules, to Judge Bullock. On March 12, 2009 this action was stayed pending Bankruptcy Court approval of a settlement agreement between Spansion and Samsung.

Spansion v. Samsung District Court Action

On November 17, 2008, Spansion LLC filed a complaint, Civil Action No. 08-855-SLR, in the United States District Court for District of Delaware, against defendants Samsung Electronics Co. LTD., and Samsung Electronics America, Inc., Samsung Semiconductor, Inc., Samsung Telecommunications America, LLC, and Samsung Austin Semiconductor, LLC (“Samsung U.S.”). The complaint alleges that certain Samsung flash memory chips infringe United States Patent Nos. 6,455,888, 6,509,232, 5,831,901, 5,991,202, 6,433,383, and 6,246,610 (the “Spansion Patents”). The complaint seeks a judgment that Samsung infringes the Spansion Patents, permanent injunctive relief and damages, a trebling of damages for alleged willful conduct, and attorney’s fees, costs, and expenses. On January 8, 2009, Samsung U.S. answered the Complaint, and asserted a number of affirmative defenses. Samsung U.S.’s answer seeks a judgment of non-infringement as well as attorney’s fees, costs, and expenses in connection with defending against Spansion’s claims. On January 16, 2009, Samsung answered the Complaint, asserted affirmative defenses and counterclaimed that Spansion

47

infringes United States Patent Nos. 6,930,050, 5,748,531, 5,740,065, 5,567,987, and 5,173,442 (the “Samsung Patents”), owned by Samsung. Samsung’s counterclaim seeks a judgment that Spansion infringes the Samsung Patents, permanent injunctive relief and damages, a trebling of damages for alleged willful conduct, and attorney’s fees, costs, and expenses. On March 31, 2009 this action was stayed pending Bankruptcy Court approval of a settlement agreement between Spansion and Samsung.

Samsung v. Spansion Japan Ltd.

On January 28, 2009, Samsung filed two patent infringement actions in the Tokyo District Court in Japan against Spansion Japan Ltd. (“Spansion Japan”) alleging that certain flash memory chips manufactured or sold by Spansion Japan infringe certain Japanese patents allegedly owned by Samsung. The actions allege infringement of Japanese patents JP 3834189 and JP 3505324 respectively. The two actions have been consolidated for trial. The complaints seek both injunctive relief and damages. This action by Samsung against Spansion Japan was stayed pending Bankruptcy Court approval in the U.S. and Japan of a settlement agreement between Spansion and Samsung.

On April 7, 2009, Spansion announced that it has settled its patent infringement litigation with Samsung including the proceedings referenced above. As part of the settlement, Samsung will pay Spansion $70 million and both parties have exchanged rights in their patent portfolios in the form of licenses and covenants subject to a confidential settlement agreement. The settlement is subject to Bankruptcy Court approval in both the U.S. and Japan and, if approved, will end the patent disputes between the two companies.

Creditor Proceedings

Many creditors initiated proceedings against one or more of the Debtors referred to in the voluntary petitions under Chapter 11 of the U.S. Bankruptcy Code to collect amounts allegedly due those creditors. After the filing date of the petition all actions to enforce or otherwise effect payment or repayment of liabilities of any Debtor preceding the Petition Date, as well as pending litigation against any Debtor, are stayed as of the Petition Date. Absent further order of the applicable courts and subject to certain exceptions no party may take any action to recover on pre-petition claims against any Debtor.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

No matters were submitted to a vote of security holders during the fourth quarter of the fiscal year covered by this report.

48

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Price of Common Stock

Our Class A common stock was traded on the NASDAQ Global Select Market under the symbol “SPSN” from December 15, 2005 until May 6, 2009. The following table sets forth the high and low per share sale prices for our Class A common stock for fiscal 2008 and fiscal 2007 as reported on the NASDAQ Global Select Market.

	High		Low
Fiscal Year Ended December 28, 2008
Fourth Quarter	$	1.69	$	0.19
Third Quarter	$	3.05	$	1.56
Second Quarter	$	3.70	$	2.25
First Quarter	$	4.29	$	2.10
	High		Low
Fiscal Year Ended December 30, 2007
Fourth Quarter	$	8.68	$	3.96
Third Quarter	$	12.64	$	7.86
Second Quarter	$	12.83	$	9.49
First Quarter	$	15.05	$	11.32

As of May 11, 2009, there were 35 holders of record of our Class A common stock. Because many of our shares are held by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of stockholders represented by these record holders. The closing sale price of our common stock on May 11, 2009 was $0.13 per share.

We currently do not plan to pay dividends on shares of our common stock in the foreseeable future and are currently prohibited from doing so in specific circumstances under agreements governing our borrowing arrangements.

On March 4, 2009, we received notice of a determination of the NASDAQ Listing Qualifications Department to delist the our securities (trading symbol: SPSN), suspend trading in our common stock at the opening of business on March 13, 2009, in accordance with NASDAQ Marketplace Rules 4300, IM-4300 and 4450(f), and file a Form 25-NSE with the Securities and Exchange Commission removing our securities from listing and registration on The NASDAQ Stock Market. The NASDAQ Staff provided the following reasons for the delisting:

• the Chapter 11 Cases and the associated public interest concerns raised by them;

• concerns regarding the residual equity interest of the existing listed securities holders; and

• concerns about our ability to sustain compliance with all requirements for continued listing on The NASDAQ Stock Market.

On March 16, 2009, we received an additional notice of a determination by the NASDAQ Listing Qualifications Department to delist the Company’s securities under Marketplace Rule 4310(c)(14) for our failure to timely file our Annual Report on Form 10-K for the fiscal year ended December 28, 2008. On April 16, 2009, we received an additional notice of a determination that our failure to pay certain fees in accordance with NASDAQ Marketplace Rule 5210(d) is an additional basis for delisting our securities from The NASDAQ Stock Market. On April 23, 2009, we attended a hearing with the NASDAQ Listing Qualifications Panel to appeal the

49

proposed delisting. On May 5, 2009, NASDAQ denied our request for continued listing on The NASDAQ Stock Market and informed us that trading of shares of our common stock will be suspended effective at the open of business on Thursday, May 7, 2009. We do not intend to request a review of this decision, and expect NASDAQ to file an application on Form 25-NSE with the Securities and Exchange Commission to effect the delisting of our common stock.

As discussed in Item 1A, our common stock is currently traded on the Pink Sheets under the symbol “SPSN.PK” after being delisted from The NASDAQ Stock Market on May 7, 2009.

Furthermore, over-the-counter (OTC) transactions involve risks in addition to those associated with transactions on a stock exchange. Many OTC stocks trade less frequently and in smaller volumes than stocks listed on an exchange. Accordingly, OTC-traded shares are less liquid and are likely to be more volatile than exchange-traded stocks.

Stock Performance Graph

This performance graph shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or incorporated by reference into any filing of Spansion under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

The following graph shows a comparison from December 25, 2005 (the date our Class A common stock commenced trading on the Nasdaq Global Select Market) through December 28, 2008 of the cumulative total return for our Class A common stock, The Nasdaq Market Index and the S&P 500 Semiconductors Index. Such returns are based on historical results and are not intended to suggest future performance. Data for The Nasdaq Market Index and the S&P 500 Semiconductors Index assume reinvestment of dividends. We have never paid dividends on our Class A common stock and have no present plans to do so.

50

ITEM 6. SELECTED FINANCIAL DATA

The following summary historical financial data should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K.

Fiscal years in the table below included 52 weeks each, except for fiscal 2006 which included 53 weeks.

	Year Ended December 28, 2008			Year Ended December 30, 2007			Year Ended December 31, 2006			Year Ended December 25, 2005			Year Ended December 26, 2004
	(in thousands, except per share amounts)
Statement of Operations Data:
Net sales	$	1,630,573		$	1,627,253		$	1,310,479		$	—		$	—
Net sales to related parties/members		651,230			873,560			1,268,795			2,002,805			2,262,227
Total net sales		2,281,803			2,500,813			2,579,274			2,002,805			2,262,227
Cost of sales		2,193,345			2,065,143			2,063,639			1,809,929			1,840,862
Gross profit		88,458			435,670			515,635			192,876			421,365
Research and development		431,808			436,785			342,033			292,926			280,954
Sales, general and administrative		253,878			239,317			264,358			184,833			137,159
Acquisition related in-process research and development		10,800			—			—			—			—
Restructuring charges		11,161			—			—			—			—
Asset impairment charges(2)		1,652,622			—			—			—			—
Operating income (loss)		(2,271,811	)		(240,432	)		(90,756	)		(284,883	)		3,252
Interest and other income		5,200			32,595			11,681			3,173			3,198
Interest expense		(97,843	)		(80,803	)		(70,903	)		(45,032	)		(40,165	)
Loss before income taxes		(2,364,454	)		(288,640	)		(149,978	)		(326,742	)		(33,715	)
(Provision) benefit for income taxes(3)		(62,865	)		25,144			2,215			22,626			14,013
Net loss	$	(2,427,319	)	$	(263,496	)	$	(147,763	)	$	(304,116	)	$	(19,702	)
Net loss per share
Basic and diluted(1)	$	(15.64	)	$	(1.95	)	$	(1.15	)	$	(4.15	)	$	(0.27	)
Shares used in per share calculation:
Basic and diluted(1)		155,162			134,924			128,965			73,311			72,549
	December 28, 2008			December 30, 2007			December 31, 2006			December 25, 2005			December 26, 2004
Balance Sheet Data:
Cash, cash equivalents and marketable securities	$	116,387		$	415,742		$	885,769		$	725,816		$	196,138
Working capital (deficit)		(1,282,578	)		592,518			1,085,027			881,902			359,420
Total assets		1,775,444			3,815,645			3,549,717			3,301,965			2,919,515
Long-term debt and capital lease obligations, including current portion, and notes payable to banks under revolving loans		1,542,023			1,401,333			1,118,047			759,613			773,597
Total stockholders’ equity (deficit) /members’ capital		(548,316	)		1,632,448			1,845,760			1,921,977			1,647,207

(1) Diluted net loss per share is computed using the weighted-average number of common shares and excludes potential common shares, as their effect is antidilutive. The potential common shares that were antidilutive for fiscal 2008, fiscal 2007 fiscal 2006 and fiscal 2005 were approximately 24.8 million, 18.4 million, 16.8 million and 5.5 million shares, respectively, issuable upon exercise of outstanding stock options, upon vesting of outstanding restricted stock units and upon exchange of Spansion LLC’s 2.25% Exchangeable Senior Subordinated Debentures.

(2) Includes pre-tax impairment charges related to long-lived assets held for use of $1.6 billion and pre-tax impairment charges related to goodwill and definite-lived intangibles assets of $20.8 million and $53.5 million, respectively, in fiscal 2008.

(3) The provision for income taxes in fiscal 2008 includes an increase of $462.6 million in valuation allowances against deferred tax assets in foreign jurisdictions. This increase occurred because we do not believe it is more likely than not that these deferred tax assets will be realized in these jurisdictions.

51

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion of our financial condition and results of operations should be read in conjunction with the consolidated financial statements and related notes as of December 28, 2008 and December 30, 2007 and for the fiscal years ended December 28, 2008, December 30, 2007 and December 31, 2006, which are elsewhere in this Annual Report on Form10-K.

Creditor Protection Proceedings

On February 10, 2009, Spansion Japan Limited, a wholly-owned subsidiary of Spansion LLC (Spansion Japan), filed a proceeding under the Corporate Reorganization Law (Kaisha Kosei Ho) of Japan to obtain protection from Spansion Japan’s creditors (the Spansion Japan Proceeding) and successively the Spansion Japan Proceeding was formally commenced on March 3, 2009 (the Commencement Date), when the Tokyo District Court entered the commencement order and appointed the incumbent representative director of Spansion Japan as trustee. On March 1, 2009 (the Petition Date), Spansion Inc., Spansion Technology LLC, Spansion LLC, Spansion International, Inc. and Cerium Laboratories LLC (the Debtors), each filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (the Chapter 11 Cases). The Chapter 11 Cases, together with the Spansion Japan Proceeding are referred to collectively as the Creditor Protection Proceedings. Non-U.S subsidiaries that are not included in the Creditor Protection Proceedings continue to operate outside these Creditor Protection Proceedings.

Chapter 11 Cases

The Debtors continue to operate their businesses as “debtors-in-possession” under jurisdiction of the Bankruptcy Court and in accordance with the applicable provisions of the Bankruptcy Code and orders of the Bankruptcy Court. Under the Bankruptcy Code, the Debtors may assume, assume and assign, or reject certain executory contracts including unexpired leases, subject to the approval of the Bankruptcy Court and certain other conditions. Any reference to any such agreements or instruments and termination rights or a quantification of our obligations under any such agreements or instruments is qualified by any overriding rejection, repudiation or other rights the Debtors may have as a result of or in connection with the Creditor Protection Proceedings.

As required under the U.S. Bankruptcy Code, the United States Trustee for the District of Delaware (Trustee) appointed an official committee of unsecured creditors on March 12, 2009 (U.S. Creditors’ Committee). In addition, a group purporting to hold substantial amounts of our publicly traded Senior Secured Floating Rate Notes due 2013 has organized (the Floating Rate Noteholders). The role of the U.S. Creditors’ Committee and the Floating Rate Noteholders in the Creditor Protection Proceedings may develop and change over the course of such proceedings.

The Bankruptcy Court has approved payment of certain of the Debtors’ pre-petition obligations, including, among other things, employee wages, salaries and benefits, and certain business related payments like claims of transport companies and certain contractors in satisfaction of liens or interests. The Debtors have retained, with Bankruptcy Court approval, legal and financial professionals to advise the Debtors on the Chapter 11 Cases and certain other “ordinary course” professionals. From time to time, the Debtors may seek Bankruptcy Court approval for the retention of additional professionals.

Spansion Japan Proceeding

Unlike a Chapter 11 proceeding in the United States, the Spansion Japan Proceeding conducted under the Corporate Reorganization Law is a receivership proceeding, meaning that a court-appointed trustee takes over the operation of the company. The Japanese Court accepted Spansion Japan’s proposal to appoint Mr. Masao Taguchi, Spansion Japan’s incumbent representative director, as the trustee.

52

The Corporate Reorganization Law creates protections that Spansion Japan would not have under ordinary circumstances. For example, subject to the applicable laws Spansion Japan may at its discretion assume or reject certain executory contracts in existence as of the Commencement Date, including unexpired leases, while the counterparty’s termination rights on grounds that Spansion Japan has filed the reorganization proceeding are restricted. In addition, any liquidated damages arising from the rejection of such executory contracts will be treated as pre-petition obligations, so they are subject to the stay imposed pursuant to the Spansion Japan Proceeding. Thus, any reference to any such agreements, termination rights or a quantification of our obligations under any such agreements may be qualified by such overriding rejection or repudiation rights as Spansion Japan may have in connection with the Spansion Japan Proceeding.

The Japanese Court has approved payment by Spansion Japan of certain of its pre-petition obligations, including, among other things, business-related payments that fall within the scope of Spansion Japan’s ordinary course of business. Spansion Japan has retained in the trustee’s name, with the Japanese Court’s approval, legal and financial professionals to advise the company on issues relating to the Spansion Japan Proceeding. However, Spansion Japan is subject to the general supervision of the Japanese Court and the court-appointed supervisory attorney (chosa i’in) and is required to seek approvals, from time to time, from them on various issues relating to the proceeding. However, at any point during the Creditor Protection Proceedings, actions taken by either (i) Spansion Japan (at the direction of the Spansion Japan trustee or pursuant to orders of the Japanese Court or otherwise) or (ii) Spansion Inc. or Spansion LLC (pursuant to the order of the U.S Bankruptcy Court or otherwise), may adversely affect the ability of Spansion LLC and Spansion Japan to continue operating as a globally integrated unit from an operational perspective. For example, if Spansion LLC was required to transfer wafer production from the fabrication facilities owned and operated by Spansion Japan to Spansion LLC’s Fab 25 or to a third party, or if sales of Spansion Products in Japan were no longer to be able to be conducted by Spansion Japan, our business would be materially adversely affected.

Circumstances Leading to the Commencement of Creditor Protection Proceedings

A variety of external economic factors have contributed to the decline in our operating performance, such as persistent oversupply in the Flash memory industry, compounded by the global economic recession, which significantly reduced demand for our products in the fourth quarter of 2008 and continues to negatively impact current demand. These two factors are further complicated by our inability to obtain the additional external financing necessary to meet capital expenditure needs and operational costs in a market characterized by swift technological advances and constantly changing manufacturing processes.

Our strategy was historically based on aggressive revenue and market share growth, leveraging superior technology, and low cost, high-volume manufacturing. In our 2006 long range planning cycle, forecasted revenue growth supported the construction of a $1.2 billion advanced wafer fabrication facility (SP1). Debt financing was arranged and construction on SP1 commenced in early 2007.

Although we continued to increase our NOR memory market segment share according to third-party industry sources, steep average selling price (ASP) declines during the first half of 2007 negatively affected revenue, profitability, and operating cash flow. At that time, we anticipated an improvement in the market environment for the second half of 2007 and aggressively continued the construction of SP1 and incurred associated capital expenditures with the ultimate goal of significant cost reductions that would enhance our competitive advantage.

During the second half of 2007, the ASP environment stabilized relative to earlier in the year. However, we faced customer qualification issues resulting in a shortfall of anticipated revenue and increased inventory levels, which contributed to our failure to meet financial performance targets in the second half of 2007. For fiscal 2007, cash flow from operations was $216.3 million, which was significantly lower than anticipated. Driven by the facilitization of SP1 and investments in our research and development facilities, our capital spending in 2007 was approximately $1.1 billion.

53

Our 2008 operating plan included capital expenditures of approximately $535 million, of which approximately 80% were expected to occur in the first half of the year in order to complete the phase 1 facilitization of SP1. Upon completion of the first phase, SP1 was anticipated to generate approximately $300 million in revenue in 2008.

In the first quarter of 2008, we lost liquidity in our investment in $121.9 million of AAA/Aaa rated auction rate securities (ARS) because the auctions in which these ARS were traded had failed. Throughout the second and third quarters of 2008, the credit markets continued to deteriorate and we intensified our cash management process. Operationally, the ramp-up of SP1 was delayed due to slower than expected customer qualifications and a sharp decline in the Japanese wireless market. Consequently, the revenue generated by SP1 was lower than expected in the third quarter of 2008, and we engaged investment bankers and capital restructuring advisors to evaluate the situation and to accelerate plans to improve liquidity. Multiple initiatives were launched and/or accelerated, including efforts to sell production facilities, raise capital, and seek liquidity options for the ARS.

In the fourth quarter of 2008, the macroeconomic environment deteriorated significantly, causing a sharp decline in worldwide demand for consumer goods, and consequently a sharp reduction of demand for our products. Furthermore, continued tightening of credit availability and general market liquidity initiatives curtailed our ability to execute the liquidity initiatives launched in the third quarter of 2008. As these events unfolded, we intensified our strategic restructuring efforts to include, among other things, pursuing a potential sale of some or all of the Company’s assets. The sharp decline in demand, coupled with our inability to execute liquidity initiatives limited our ability to generate sufficient funding for our operations and meet our debt servicing requirements, ultimately leading to the Creditor Protection Proceedings.

The Creditor Protection Proceedings allows the Debtors to continue operating our business while continuing to pursue a sale process or a standalone restructuring plan. There is no assurance that the Debtors will be successful in completing a sale or reorganization.

Developments Related to our Creditor Protection Proceedings

• The Spansion Japan Proceeding and the Chapter 11 Cases constituted events of default under the instruments governing substantially all of the indebtedness issued or guaranteed by us, Spansion LLC, Spansion Technology LLC and Spansion Japan. In addition, we may not be in compliance with certain other covenants under the indentures related to certain of our debt or lease instruments.

• In February 2009, we implemented a workforce reduction of approximately 2,400 employees or 28 percent of the existing employees, in an effort to further reduce costs as we continued our restructuring efforts and explored various strategic alternatives.

• On March 4, 2009, we received notice of a determination of the NASDAQ Listing Qualifications Department to delist our common stock from trading on The NASDAQ Stock Market because of the Chapter 11 Cases. On March 16, 2009, we received an additional notice of a determination for our failure to timely file our Annual Report on Form 10-K for the fiscal year ended December 28, 2008. On April 16, 2009, we received an additional notice of a determination that our failure to pay certain fees in accordance with NASDAQ Marketplace Rule 5210(d) is an additional basis for delisting our securities from The NASDAQ Stock Market. On April 23, 2009, we attended a hearing to contest these delisting determinations. On May 5, 2009, NASDAQ denied our request for continued listing on The NASDAQ Stock Market and informed us that trading of shares of our common stock will be suspended effective at the open of business on Thursday, May 7, 2009. We do not intend to request a review of this decision, and expect NASDAQ to file an application on Form 25-NSE with the Securities and Exchange Commission to effect the delisting of our common stock. We expect that our common stock will be publicly traded on the Pink Sheets with ticker symbol “SPSN.PK.” However, because trading on the Pink Sheets requires a market maker to quote our common stock, trading on the Pink Sheets is not within our control and could be discontinued at any time if no market maker is willing to offer a quote.

54

• In connection with developing a plan of reorganization under the Creditor Protection Proceedings, we have decided to pursue a standalone strategy focused on the market for embedded applications and licensing our intellectual property portfolio. As a result, we plan to pursue strategic alternatives for our wireless business.

Basis of presentation and going concern

The accompanying audited consolidated financial statements have been prepared using the same U.S. GAAP and the rules and regulations of the U.S. Securities and Exchange Commission (SEC) as applied by us prior to the filing of the Chapter 11 Cases. The audited consolidated financial statements continue to be prepared using the going concern basis, which assumes that we will be able to realize our assets and discharge our liabilities in the normal course of business for the foreseeable future. The Creditor Protection Proceedings have provided us with a period of time to stabilize our operations and financial condition and develop a comprehensive restructuring plan, which will incorporate our standalone business strategy focused on the market for embedded applications and licensing of our intellectual property portfolio. Such restructuring plan does not currently contemplate liquidation of the Company. Accordingly, we believe that these actions make the going concern basis of presentation appropriate. However, it is not possible to predict the outcome of Creditor Protection Proceedings; therefore, the realization of assets and discharge of liabilities are each subject to significant uncertainty. Further, it is not possible to predict whether the actions taken in any restructuring will result in improvements to our financial condition sufficient to allow us to continue as a going concern. Accordingly, substantial doubt exists as to whether we will be able to continue as a going concern. If the going concern basis is not appropriate in future filings, adjustments will be necessary to the carrying amounts and/or classification of assets and liabilities in our consolidated financials statements included in such filings. Further, a comprehensive restructuring plan could materially change the carrying amounts and classifications reported in the consolidated financial statements of future filings. The accompanying audited consolidated financial statements reflect certain reclassifications of long-term debt to current portion of long-term debt as a result of conditions that arose subsequent to December 28, 2008.

For periods ending after the Petition Date, we will reflect adjustments to our financial statements in accordance with American Institute of Certified Public Accountants Statement of Position (SOP) No. 90-7, Financial Reporting by Entities in Reorganization Under the Bankruptcy Code (SOP 90-7), assuming that we will continue as a going concern. Accordingly, in our Quarterly Report on Form 10-Q for the quarter ended March 29, 2009, liabilities and obligations whose treatment and satisfaction is dependent on the outcome of the Creditor Protection Proceedings will be segregated and classified as Liabilities Subject to Compromise in the consolidated balance sheet. The ultimate amount of and settlement terms for our pre-petition liabilities are dependent on the outcome of the Creditor Protection Proceedings and, accordingly, are not presently determinable. Pursuant to SOP 90-7, professional fees associated with the Creditor Protection Proceedings and certain gains and losses resulting from reorganization or restructuring of our business will be reported separately as reorganization items. In addition, interest expense will be reported only to the extent that it will be paid during the Creditor Protection Proceedings or that it is probable that it will be an allowed claim under the creditor protection proceedings.

Furthermore, effective on the Commencement Date, pursuant to Financial Accounting Standards Board (FASB) Statement No. 160 (Statement 160), Noncontrolling Interests in Consolidated Financial Statements, an Amendment of ARB No. 51, we must deconsolidate Spansion Japan as, by virtue of the Spansion Japan Proceeding, and despite our 100% ownership interest, we are no longer deemed to control Spansion Japan. Spansion Japan will cease to be included in our consolidated operating results and financial position commencing with the presentation of our interim results for the first quarter of fiscal 2009. Transactions between us and Spansion Japan will be reflected in a manner similar to transactions with unrelated parties. We are currently assessing the impact the deconsolidation will have on our future operating results and financial position.

Our fiscal years end on the last Sunday of December. Fiscal 2008 and fiscal 2007 consisted of 52 weeks each. Fiscal 2006 consisted of 53 weeks.

55

Reporting Requirements

As a result of the Chapter 11 Cases, we are now periodically required to file various documents with, and provide certain information to, the United States Bankruptcy Court, including statements of financial affairs, schedules of assets and liabilities, and monthly operating reports in forms prescribed by federal bankruptcy law, as well as certain financial information on an unconsolidated basis. Such materials will be prepared according to requirements of federal bankruptcy law. While they accurately provide then-current information required under federal bankruptcy law, they are nonetheless unconsolidated, unaudited, and are prepared in a format different from that used in our consolidated financial statements filed under the securities laws and regulations. Accordingly, we believe that the substance and format do not allow meaningful comparison with our regular publicly-disclosed consolidated financial statements. Moreover, the materials filed with the Bankruptcy Court are not prepared for the purpose of providing a basis for an investment decision relating to our securities, or for comparison with other financial information filed with the SEC.

Overview

We are a semiconductor device company exclusively dedicated to designing, developing, manufacturing, licensing, marketing and selling Flash memory technology and solutions. There are two major architectures of Flash memory in the market today: NOR Flash memory, which is primarily used for code and data storage in mobile phones and automotive electronics and primarily for code storage in consumer and industrial electronics; and NAND Flash memory, which is primarily used for data storage in removable memory applications, such as Flash memory cards and USB drives, and applications such as MP3 players and high-end mobile phones.

The Flash memory market can be divided into two major categories based on application: the integrated category and the removable storage category. Within the integrated category, applications include portable, battery-powered electronics such as mobile phones, and consumer, industrial, telecommunications, computing and automotive electronics. Within the removable storage category, applications include Flash memory cards and USB drives. We focus primarily on providing NOR Flash memory solutions for the integrated category of the Flash memory market. Our Flash memory is integrated into a broad range of electronic products, including mobile phones, consumer electronics, automotive electronics, networking and telecommunications equipment, and personal computer peripherals.

We currently operate three Flash memory wafer fabrication facilities, one in the US and two in Japan. Our headquarters are located in Sunnyvale, California. In fiscal 2008, we sold products on technology nodes ranging from 320-nanometer to 65-nanometer, utilizing MirrorBit and floating gate cell technology. We serve our customers worldwide directly or through our distributors, including Fujitsu, who buy products from us and resell them to their customers, either directly or through third-party distributors. Customers for our products consist of OEMs, original design manufacturers (ODMs) and contract manufacturers.

During fiscal 2008 we heightened our focus on alignment and restructuring by undertaking a number of initiatives to improve our operating efficiencies and to reduce our operation costs. Specifically, we transferred certain general and administrative employee positions to more cost-effective regions, including China and Malaysia. We also established strategic partnerships in technology development and manufacturing, including our alliance with Semiconductor Manufacturing International Corporation. In addition, in February 2009, we carried out a workforce reduction of approximately 2,400 employees or 28 percent of our workforce in an effort to further reduce costs as we continued our restructuring efforts and explored various strategic alternatives.

We focused a significant amount of effort on the continued facilitization of SP1, the acquisition of Saifun Semiconductors Ltd., and the development of new technologies and architectures. We also developed EcoRAM, a new memory solution that is designed to extend the applicability of our technology beyond traditional Flash memory segments into higher margin markets, which we believe will enable significant cost and performance improvements in computing data centers. We also announced plans for products based on our new MirrorBit ORNAND2 architecture, which is expected to support faster read and write speed performance at a lower cost than our existing ORNAND products.

56

On March 18, 2008, we completed the acquisition of Saifun Semiconductor Ltd., a provider of intellectual property (IP) solutions for the non-volatile memory (NVM) market. Saifun licenses its IP to semiconductor manufacturers that use this technology to develop and manufacture a variety of stand-alone and embedded NVM products. The acquisition of Saifun provides an opportunity for us to expand our product portfolio and enter into the technology licensing business.

A variety of external economic factors have contributed to the decline in our operating performance, such as persistent oversupply in the Flash memory industry compounded by the global economic recession. The 2008 global economic downturn has caused a sharp decline in worldwide demand for consumer goods and, consequently, a sharp reduction in demand for our products, which resulted in significant declines in our manufacturing capacity utilization. In addition to these economic factors, the ramp-up of SP1 was delayed in the second half of 2008 due to slower than expected customer qualifications and the steep decline in the Japanese wireless market. These factors, among others, caused our stock price to drop significantly throughout 2008, resulting in a sustained market capitalization well below book value.

As a result, we performed an impairment analysis to determine if our long-lived assets were recoverable, using financial forecasts derived from the long-term financial outlook in light of fourth quarter market conditions and the challenging economic outlook. The impairment analysis determined that a total acquisition-related intangible asset and long-lived asset impairment charge of approximately $1.6 billion was required for the fourth quarter ended December 28, 2008, reflecting the low demand for semiconductor equipment worldwide, coupled with excess supply.

We also performed our annual goodwill impairment analysis in the fourth quarter of 2008. This analysis was based on the same forecasts and assumptions used for our long-lived assets discussed above, and determined that the implied fair value of our goodwill was zero. As a result, we recognized an impairment charge on our remaining goodwill of $20.8 million, reducing the goodwill balance to zero.

Our financial forecast used to assess recoverability and measure the impairment charges represents management’s best estimate and we believe that the underlying assumptions are reasonable based primarily on current product performance and customer acceptance. However, actual performance in the near-term and longer-term could be materially different from these forecasts, which could impact future estimates of cash flows and may result in further impairment of the carrying amount of long-lived assets. Developments pursuant to our Creditor Protection Proceedings could impact strategic decisions made in response to economic and competitive conditions, or impact relationships with significant customers. Accordingly, we may incur additional impairment losses in future periods if factors influencing our estimates of the undiscounted cash flows or other key assumptions change.

For fiscal 2008, our net sales were approximately $2.3 billion and our net loss was approximately $2.4 billion. For fiscal 2007, our net sales were approximately $2.5 billion and our net loss was approximately $263.5 million. For fiscal 2006, our net sales were approximately $2.6 billion and our net loss was approximately $147.8 million. Total net sales for fiscal 2008 decreased nine percent compared to the corresponding period of fiscal 2007, primarily attributable to a six percent decline in unit shipments and a three percent decline in blended ASPs in fiscal 2008. Total net sales for fiscal 2007 decreased three percent compared to the corresponding period of fiscal 2006, primarily attributable to a 10 percent decline in blended ASPs, which was partially offset by an increase of seven percent in unit shipments in fiscal 2007.

In light of the current economic environment and resulting lack of availability of external financing alternatives, one of our key priorities is to preserve cash. Our cash and cash equivalents, which consisted of cash and investments in money market funds, totaled $116.4 million at December 28, 2008 compared to $199.1 million at December 30, 2007. This decline in our cash and cash equivalents was primarily due to our significant losses. To that end, during 2008 we undertook, and plan to continue to undertake, a number of actions to improve our cost structure. For 2008, our capital expenditures decreased to $430.8 million compared to $1.1 billion in 2007.

57

Our current cash management system and cash on hand to fund our operations is subject to ongoing review and approval by the United States Bankruptcy Court, and may be affected by the Creditor Protection Proceedings. For a complete discussion of the risks facing our business, including our liquidity, please see the discussion on Liquidity and Capital Resources in this section and Part II, Item 1A “Risk Factors.”

Critical Accounting Policies

Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts in our consolidated financial statements. We evaluate our estimates on an on-going basis, including those related to our revenues, inventories, asset impairments, income taxes, stock-based compensation expenses and fair value of marketable securities. We base our estimates on experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. The actual results may differ from these estimates or our estimates may be affected by different assumptions or conditions. As a result of the Creditor Protection Proceedings, the realization of assets and liquidation of liabilities are subject to uncertainty. A plan of reorganization could materially change the amounts and classifications reported in the consolidated financial statements in future filings. However, the accompanying audited consolidated financial statements do not give effect to any adjustments to the carrying value of assets or amounts of liabilities that may occur as a consequence of confirmation of a plan of reorganization.

We believe the following critical accounting policies are the most significant to the presentation of our financial statements and require the most difficult, subjective and complex judgments.

Estimates of Sales Returns and Allowances

From time to time we may accept sales returns or provide pricing adjustments to customers who do not have contractual return or pricing adjustment rights. We record a provision for estimated sales returns and allowances on product sales in the same period that the related revenues are recorded, which primarily impacts gross margin. We base these estimates on actual historical sales returns, allowances, historical price reductions, market activity and other known or anticipated trends and factors. These estimates are subject to management’s judgment, and actual provisions could be different from our estimates and current provisions, resulting in future adjustments to our revenues and operating results.

Impairment of Long-Lived Assets including Acquisition-Related Intangible Assets

We consider quarterly whether indicators of impairment of long-lived assets and intangible assets are present. These indicators may include, but are not limited to, significant decreases in the market value of an asset, significant changes in the extent or manner in which an asset is used or an adverse change in our overall business climate. If these or other indicators are present, we test for recoverability of the asset (asset group) by determining whether the estimated undiscounted cash flows attributable to the asset (asset group) in question are less than their carrying value. If less, we recognize an impairment loss based on the excess of the carrying amount of the asset (asset group) over its respective fair value. Significant judgment is involved in determining whether impairment is measured at the individual asset or at an asset group level.

Our manufacturing processes are vertical in nature and we have multiple foundry, assembly and test facilities. As a result, the cash flows of our assets and liabilities below the entity level are not largely independent of one another and we concluded impairment should be evaluated at the single entity-wide asset group (i.e., consolidated Spansion) level. Fair value is determined by discounted future cash flows, appraisals or other methods. Significant judgment is involved in estimating future cash flows and deriving the discount rate to apply to the estimated future cash flows and in evaluating the results of appraisals or other valuation methods. If the asset (asset group)

58

determined to be impaired is to be held and used, we recognize an impairment loss through a charge to our operating results which also reduces the carrying basis of the related asset or assets in an asset group. The adjusted carrying value of the related asset (asset group) establishes a new cost basis and accumulated depreciation is reset to zero. The asset (asset group) is depreciated or amortized over the remaining estimated useful life of the asset. We also must make subjective judgments regarding the remaining useful life of the asset. If the asset (asset group) determined to be impaired is held for sale, we measure the new carrying value of the asset (asset group) at fair value less estimated cost to dispose, with the impairment loss being charged to operations.

We performed an impairment analysis in the fourth quarter of 2008 and recorded impairment charges of approximately $1.6 billion, including approximately $53.5 million related to acquisition-related intangible assets. We may incur additional impairment losses in future periods if factors influencing our estimates of the undiscounted cash flows or other key assumptions change.

Impairment of Goodwill

Goodwill represents the excess of the purchase price over the fair value of net tangible and identifiable intangible assets acquired. We recorded goodwill in the first quarter of fiscal 2008 in connection with our acquisition of Saifun. In accordance with the provisions of FASB Statement No. 142, Goodwill and Other Intangible Assets (SFAS 142), goodwill amounts are not amortized, but rather are tested for impairment at the reporting unit level at least annually, or more frequently if there are indicators of impairment present. We have determined that we have a single reporting unit and we perform the annual goodwill impairment analysis as of the last day of the fourth quarter of each fiscal year. Testing for goodwill impairment under SFAS 142 requires a two step approach. Under step one we evaluate whether fair value of the reporting unit is less than the carrying value, including goodwill. The fair value of the reporting unit is determined by generally accepted valuation techniques and may consider both the income and market approach, adjusted by an estimated control premium. The income approach requires estimates of future operating results and cash flows of Spansion discounted using estimated discount rates. The market approach involves estimating enterprise value using guideline public company multiples. If step one of the analysis demonstrates that the fair value of our reporting unit is below the carrying value we will proceed to step two. Under step two we estimate the fair values of all identifiable assets and liabilities of the reporting unit using the income, market or replacement cost approaches as appropriate. The excess of the fair value of the reporting unit over the fair values of the identified assets and liabilities is the implied fair value of goodwill. If the implied fair value of goodwill is lower than the carrying value of the goodwill, an impairment charge is recorded to reduce the carrying value to fair value. As a result of this analysis, we recorded a $20.8 million goodwill impairment charge in the fourth quarter of 2008.

The key assumptions used to measure the amount of impairment included projected Spansion cash flows and discount rates based on our weighted average cost of capital, adjusted for the risks associated with the operations. A variance in the discount rate could have had a significant impact on the amount of the goodwill impairment charge recorded. In the market approach, ten public companies operating in the same or similar line of business and with the same or similar operating characteristics and business description were used as guideline companies. A financial analysis comparing the operational metrics and marketplace activities relative to the selected companies was performed and results thereof were calculated and then compared, contrasted and assessed against our financial performance.

Income Taxes

Prior to our reorganization into Spansion Inc. we operated as a Delaware limited liability company that had elected to be treated as a partnership for U.S. federal tax reporting purposes and therefore, we were not a U.S. taxable entity. We now operate as Spansion Inc., which is a taxable entity for U.S. federal tax reporting purposes. Our foreign subsidiaries are wholly owned and are taxable as corporations in their respective foreign countries of formation. In determining taxable income for financial statement reporting purposes, we must make estimates and judgments. These estimates and judgments are applied in the calculation of specific tax liabilities and in the

59

determination of the recoverability of deferred tax assets, which arise from temporary differences between the recognition of assets and liabilities for tax and financial statement reporting purposes. The recognition and measurement of current and deferred income tax assets and liabilities impact our tax provision.

We must assess the likelihood that we will be able to recover our deferred tax assets. Unless recovery of these deferred tax assets is considered more likely than not, we must increase our provision for taxes by recording a charge to income tax expense, in the form of a valuation allowance against those deferred tax assets for which we believe it is not more likely than not they will be realized. We consider past performance, future expected taxable income and prudent and feasible tax planning strategies in determining the need for a valuation allowance.

In addition, the calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax rules and the potential for future adjustment by the relevant tax jurisdiction. If our estimates of these taxes are greater or less than actual results, an additional tax benefit or charge will result

Stock-Based Compensation Expenses

We estimated the fair value of our stock-based awards to employees using the Black-Scholes-Merton option pricing model, which requires the use of input assumptions, including expected volatility, expected life, expected dividend rate, and expected risk-free rate of return. The assumptions for expected volatility and expected life are the two assumptions that significantly affect the grant date fair value. Stock-based compensation expense recognized during a period is based on the higher of the grant-date fair value of the portion of share-based payment awards that is ultimately expected to vest, or actually vest, during the period. Compensation expense for all share-based payment awards was recognized using the straight-line attribution method reduced for estimated forfeitures.

We estimate volatility based on our recent historical volatility and the volatilities of our competitors who are in the same industry sector with similar characteristics (guideline companies) because of the lack of historical realized volatility data on our business. We have used the simplified calculation of expected life since our initial public offering on December 21, 2005 and continue to use this method upon the adoption of SAB 110, which is effective January 1, 2008, as we do not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term of share options since our initial public offering. If we determined that another method used to estimate expected volatility or expected life was more reasonable than our current methods, or if another method for calculating these input assumptions was prescribed by authoritative guidance, the fair value calculated for share-based awards could change significantly. Higher volatility and longer expected lives result in an increase to share-based compensation determined at the date of grant. In addition, we are required to develop an estimate of the number of share-based awards that will be forfeited due to employee turnover. Prior to the fourth quarter of fiscal 2007, we did not have sufficient historical forfeiture experience related to our own stock-based awards and therefore, estimated our forfeitures based on the average of our own fiscal 2006 forfeiture rate and historical forfeiture rates for Advanced Micro Devices, Inc. (AMD), as we believed these forfeiture rates to be the most indicative of our own expected forfeiture rate. Beginning the fourth quarter of fiscal 2007, we estimated forfeitures based on the weighted average of our own fiscal 2008, fiscal 2007 and fiscal 2006 forfeiture rates. These estimates will be revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

Inventory Valuation

At each balance sheet date, we evaluate our ending inventories for excess quantities and obsolescence. This evaluation includes analysis of sales levels by product and projections of future demand. These projections assist us in determining the carrying value of our inventory and are also used for near-term factory production planning. Historically, we have generally used a six-month demand forecast in assessing the salability of inventory on hand and did not value inventory in excess of six months of estimated demand. Beginning in the

60

second quarter of fiscal 2008, as part of a strategy to efficiently manage our new production capacity and to maintain strategic inventory levels of certain products, we have built and valued certain product inventory to meet estimated demand as much as twelve months into the future. We write off inventories that we consider obsolete and adjust remaining specific inventory balances to approximate the lower of our standard manufacturing cost or market value. Among other factors, management considers forecasted demand in relation to the inventory on hand, competitiveness of product offerings, market conditions and product life cycles when determining obsolescence and net realizable value. If we anticipate future demand or market conditions to be less favorable than our previous projections, additional inventory write-downs may be required and would be reflected in cost of sales in the period the write-down is made. This would have a negative impact on our gross margin in that period. We recorded an inventory write down of approximately $253.2 million in the fourth quarter of fiscal 2008 as a result of a weak economic outlook and an associated reduction in demand from previous forecasts. This contributed to an 11 percent decrease in gross margin. A continued weak economy could lead to additional write downs of inventory. If in any period we are able to sell inventories that were not valued or that had been written down in a previous period, related revenues would be recorded without any offsetting charge to cost of sales, resulting in a net benefit to our gross margin in that period.

Deferred Revenue

We sell to distributors and provide such distributors certain rights of return, stock rotation and price protection as discussed below. We defer the recognition of revenue and related product costs on these sales as deferred income on shipments until the merchandise is resold by our distributors. We also sell some of our products to certain distributors under sales arrangements with terms that do not allow for rights of returns or price protection on unsold products held by them. In these instances, we recognize revenue when we ship the product directly to the distributors.

Rights of return are granted whereby we are obligated to repurchase inventory from a distributor upon termination of the distributor’s sales agreement with us. However, we are not required to repurchase the distributor’s inventory under certain circumstances, such as the failure to return the inventory in saleable condition or we may only be required to repurchase a portion of distributor’s inventory, for example when distributor has terminated the agreement for its convenience.

Stock rotation rights are provided to distributors when we have given written notice to the distributor that a product is being removed from our published price list. The distributor has a limited period of time to return the product. All returns are for credit only; the distributor must order a quantity of products, the dollar value of which equals or exceeds the dollar value of the products being returned. Some distributors are also offered quarterly stock rotation. Such stock rotation is limited to a certain percentage of the previous three months’ net shipments.

A general price protection is granted to a distributor if we publicly announce a generally applicable price reduction relating specifically to certain products, whereby the distributor is entitled to a credit equal to the difference between the price paid by the distributor and the newly announced price.

Price protection adjustments are provided to distributors solely for those products that: 1) are shipped by us to the distributor during the period preceding the price reduction announcement by us, 2) are part of the distributor’s inventory at the time of the announcement, and 3) are located at geographic territories previously authorized by us.

In addition, if in our sole judgment, a distributor demonstrates that it needs a price lower than the current published price list in order to secure an order from the distributor’s customers, we may, but we have no obligation to, grant the distributor a credit to our current published price. The distributor must submit the request for a reduction in price prior to the sale of products to its customer. If the request is approved and the sale occurs, the distributor must make a claim with the proof of resale to end customers for a credit within a specified time period.

61

Gross deferred revenue and gross deferred cost of sales on shipments to distributors as of December 28, 2008 and December 30, 2007 are as follows:

	December 28, 2008			December 30, 2007
	(in thousands)
Deferred revenue	$	62,183		$	75,010
Less: deferred costs of sales		(31,845	)		(35,053	)
Deferred income on shipments(1)	$	30,338		$	39,957

(1) The deferred income on shipments of $35,285 thousand on the consolidated balance sheet as of December 28, 2008 included $4,947 thousand of defered revenue related to our licensing revenue that was excluded in the table above.

Our distributors provide us with periodic data regarding the product, price, quantity, and end customer when products are resold as well as the quantities of our products they still have in stock. We use estimates and apply judgments to reconcile distributors’ reported inventories to their activities. Error in our judgment could lead to inaccurate reporting of our revenues, deferred income and allowances on sales to distributors.

Prior to December 2008, Spansion Japan recognized revenue on all its shipments to Fujitsu upon billing based on terms of the Spansion Fujitsu 2003 distribution agreement. In December 2008, Spansion Japan initiated a distribution agreement with a new distributor instead of selling directly through Fujitsu. Spansion Japan is employing a deferred revenue model for this distributor accounting for $0.9 million of the gross deferred revenue at December 28, 2008.

Fair Value of Marketable Securities and Put Option

Our marketable securities at December 28, 2008 consist of approximately $94.0 million of ARS, valued at fair value ($121.9 million at par), which are backed by student loans and substantially all of which are guaranteed by the U.S. government Federal Family Education Loan Program (FFELP). These securities have credit ratings of AAA and Aaa. Prior to February 2008, these securities were publicly quoted and traded in the auctions relating to such investments.

Historically, the fair value of our ARS investments has approximated face value due to the frequent auction periods, generally every seven to 28 days, which provided liquidity to these investments. However, subsequent to February 2008, all auctions involving these securities have failed. The result of a failed auction is that these ARS will continue to pay interest in accordance with their terms at each respective auction date; however, liquidity of the securities will be limited until there is a successful auction, the issuer redeems the securities, the securities mature or until such time as other markets for these ARS investments develop. We cannot be certain regarding the amount of time it will take for an auction market or other markets to develop. Accordingly, we have concluded that the estimated fair value of the ARS no longer approximates the face value primarily due to the lack of liquidity.

At December 28, 2008, there was insufficient observable ARS market information available to determine the fair value of our ARS investments. Therefore, we estimated the fair values of our ARS investments at December 28, 2008 using a discounted cash flow (DCF) methodology. Significant assumptions considered in the DCF models were the credit quality of the instruments, the percentage and the types of guarantees (such as FFELP), the probability of the auction succeeding or the security being called prior to final maturity, and an illiquidity discount factor. The key assumptions used in the discounted cash flow analysis to determine the fair values as of December 28, 2008 were the discount factor to be applied and the period over which the cash flows would be expected to occur. The discount factor used was based on the three-month LIBOR (1.47 percent as of December 28, 2008) adjusted by 125 basis points (bps) to reflect the then current market conditions for instruments with similar credit quality at the date of the valuation. In addition, the discount factor was

62

incrementally adjusted for a liquidity discount of 125 bps to reflect the risk in the marketplace for these investments that has arisen due to the lack of an active market for these instruments. We applied this discount factor over the expected life of the estimated cash flows of our ARS with projected interest income of 2.69 percent per annum. The projected interest income is based on a trailing 12-month average 91-day T-bill rate at 1.49 percent as of December 28, 2008 plus 120 bps, which is the average annual yield of our ARS assuming auctions continue to fail.

The impairment in value, or $27.9 million out of a face value of approximately $121.9 million, was considered to be other than temporary and, accordingly, was recorded as an impairment charge in the consolidated statement of operations for the year ended December 28, 2008.

Our ARS have been classified as Level 3 assets in accordance with FASB Statement No. 157, Fair Value Measurements, as their valuation requires substantial judgment and estimation of factors that are not currently observable in the market due to the lack of trading in the securities. If different assumptions were used for the various inputs to the valuation approach including, but not limited to, assumptions involving the estimated lives of the ARS investments, the estimated cash flows over those estimated lives, and the estimated discount rates, especially the liquidity discount rate, applied to those cash flows, the estimated fair value of these investments could be significantly higher or lower than the fair value we determined as of December 28, 2008.

In November 2008, we accepted an offer to participate in an ARS settlement from UBS Bank USA (UBS), our broker, providing us the right, but not the obligation, to sell to UBS up to 100 percent of our ARS at par, commencing June 30, 2010. Our right to sell the ARS to UBS commencing June 30, 2010 through July 2, 2012 represents a put option for a payment equal to the par value of the ARS. Upon acceptance of the offer from UBS, we elected to measure the put option under the fair value option of FASB Statement 159 and recorded $27.5 million as the fair value of the put option asset as of December 28, 2008, with a corresponding credit to other income in the consolidated statement of operations for the year ended December 28, 2008. We also reclassified our ARS investments from available-for-sale to trading. Following these elections both the ARS and the put will be marked to market through earnings and the amounts of such adjustments should substantially offset each other.

Please see Part II, Item 1A “Risk Factors” and Note 17 of Notes to Consolidated Financial Statements for more information on our ARS and put option.

Results of Operations

Total Net Sales for Fiscal 2008, Fiscal 2007 and Fiscal 2006

The following is a summary of our total net sales for fiscal 2008, fiscal 2007 and fiscal 2006.

	Year Ended
	December 28, 2008	December 30, 2007		December 31, 2006
		(in thousands)
Total net sales	2,281,803	$	2,500,813	$	2,579,274

Total Net Sales Comparison for Fiscal 2008 and Fiscal 2007

Total net sales of approximately $2,281.8 million in fiscal 2008 decreased nine percent compared to total net sales in fiscal 2007. The decrease in total net sales was primarily attributable to an approximately six percent decrease in unit shipments and an approximately three percent decrease in blended ASPs. The decrease in unit shipments was primarily due to a sharp decline in the Japanese wireless market and a significant deterioration in the macroeconomic environment in the fourth quarter of 2008. This caused a decline in the worldwide demand for consumer goods, and consequently a reduction in demand for our products. The decrease in blended ASPs was primarily the result of price declines in the overall Flash memory market during fiscal 2008. Sales of MirrorBit products increased from approximately 71 percent of total net sales in fiscal 2007 to approximately 79 percent of total net sales in fiscal 2008.

63

Total Net Sales Comparison for Fiscal 2007 and Fiscal 2006

Total net sales of approximately $2,500.8 million in fiscal 2007 decreased three percent compared to total net sales in fiscal 2006. The decrease in total net sales was primarily attributable to an approximately 10 percent decrease in blended ASPs, which was partially offset by an approximately seven percent increase in unit shipments. The decrease in blended ASPs was primarily the result of sharp price declines in the overall semiconductor memory industry during the first half of 2007. During the second half of 2007, ASPs stabilized relative to the first half of 2007. We believe our increase in unit shipments resulted in large part from our increased share in the NOR segment of the Flash memory market.

Net Sales Comparison—WSD and CSID for Fiscal 2008 and Fiscal 2007

	Year Ended
	December 28, 2008		December 30, 2007		Variance in Dollars			Variance in Percent
	(in thousands)
Wireless Solutions Division (WSD)	$	1,133,181	$	1,362,508	$	(229,327	)	-17	%
Consumer, Set Top Box and Industrial Division (CSID)		1,134,466		1,130,265		4,201		0	%
Other		14,156		8,040		6,116		76	%
Total net sales	$	2,281,803	$	2,500,813	$	(219,010	)	-9	%

Net sales in our WSD decreased approximately 17 percent in fiscal 2008 as compared to fiscal 2007. The decrease was primarily attributable to an approximately 11 percent decline in blended ASPs and an approximately seven percent decline in our unit shipments. The decline in blended ASPs was primarily the result of price declines in the overall Flash memory market and lower than expected net sales from SP1, which generates higher ASPs than our other facilities.

Net sales in our CSID increased slightly in fiscal 2008 as compared to fiscal 2007. An approximately seven percent increase in blended ASPs, primarily as a result of increased sales of our high density MirrorBit products, was partially offset by an approximately six percent decrease in our unit shipments.

For fiscal 2008, our WSD and CSID each accounted for approximately 50 percent of our total net sales, as compared to 54 percent and 45 percent, respectively, for fiscal 2007. The change in percentage of net sales attributable to our two main divisions was primarily the result of the decline in blended ASPs for our WSD resulting in decreased net sales year-over-year and a slight increase in net sales for our CSID due to an increase in high density MirrorBit product sales.

Net Sales Comparison—WSD and CSID for Fiscal 2007 and Fiscal 2006

	Year Ended
	December 30, 2007		December 31, 2006		Variance in Dollars			Variance in Percent
	(in thousands)
Wireless Solutions Division (WSD)	$	1,362,508	$	1,549,155	$	(186,647	)	-12	%
Consumer, Set Top Box and Industrial Division (CSID)		1,130,265		1,025,229		105,036		10	%
Other		8,040		4,890		3,150		64	%
Total net sales	$	2,500,813	$	2,579,274	$	(78,461	)	-3	%

Net sales in our WSD decreased approximately 12 percent in fiscal 2007 as compared to fiscal 2006. The overall decline in blended ASPs in fiscal 2007 had a greater impact on the more competitive wireless market, resulting in our WSD net sales decline.

64

Net sales in our CSID increased 10 percent in fiscal 2007 as compared to fiscal 2006. The ASP decline was less severe in this business unit and the increase in CSID net sales was due to a higher acceptance of our high density MirrorBit products by our customers in the CSID business, which was a significant change from our historical trend of net sales of mid- and lower-density products. In addition, CSID was successful in fiscal 2007 in expanding in the serial peripheral interface market with our MirrorBit technology.

For fiscal 2007, our WSD accounted for approximately 54 percent of our total net sales, and our CSID accounted for approximately 45 percent of our total net sales, as compared to 60 percent and 40 percent, respectively, for fiscal 2006. We believe a combination of business conditions in the overall Flash memory market and our efforts to sell our products containing MirrorBit technology led to the large percentage shift between our two primary business divisions.

Gross Margin; Operating Expenses; Interest and Other Income, Net; Interest Expense and Income Tax (Provision) Benefit

The following is a summary of gross margin; operating expenses; interest and other income, net; interest expense and income tax (provision) benefit for fiscal 2008, fiscal 2007 and fiscal 2006.

	Year Ended
	December 28, 2008			December 30, 2007			December 31, 2006
	(in thousands)
Net sales	$	2,281,803		$	2,500,813		$	2,579,274
Cost of sales		2,193,345			2,065,143			2,063,639
Gross margin		4	%		17	%		20	%
Research and development		431,808			436,785			342,033
Sales, general and administrative		253,878			239,317			264,358
Acquisition related in-process research and development		10,800			—			—
Restructuring charges		11,161			—			—
Asset impairment charges		1,652,622			—			—
Operating loss		(2,271,811	)		(240,432	)		(90,756	)
Interest and other income, net		5,200			32,595			11,681
Interest expense		(97,843	)		(80,803	)		(70,903	)
Income tax (provision) benefit		(62,865	)		25,144			2,215

Gross margin

The decrease in gross margin in fiscal 2008 was primarily due to a $253.2 million inventory write-down as a result of a weak economic outlook and an associated reduction in customer demand from previous forecasts during the fourth quarter of fiscal 2008, the impact of our exit of 90-nanometer content delivery business resulting in $13 million charges to gross margin, an increase in our manufacturing costs related to SP1, and an approximately three percent decline in our blended ASP during the fourth quarter of fiscal 2008. This $253.2 million inventory write-down negatively impacted gross margin in fiscal 2008 by 11 percent. The overall decrease in gross margin was partially offset by our cost reduction efforts, improvement of cumulative product yields, reduction of test time and better pricing from suppliers. The gross margin for fiscal 2008 and fiscal 2007 included a portion of the gain recognized from the sale of JV1 and JV2, our two wafer fabrication facilities in Aizu-Wakamatsu, Japan (the JV1/JV2 Transaction). See Note 8 of Notes to Consolidated Financial Statements.

The decrease in gross margin in fiscal 2007 was primarily due to price declines in the Flash memory industry, which was partially offset by our cost reduction efforts and increased productivity and output of internal wafer fabrication facilities in fiscal 2007 as compared to fiscal 2006.

65

Research and development

Research and development expenses of approximately $431.8 million in fiscal 2008 reflected a decrease of one percent compared to approximately $436.8 million in fiscal 2007. The decrease in research and development expense in fiscal 2008 was primarily due to a decrease of approximately $22.6 million in development costs related to SP1 and Fab 25 and a decrease of approximately $4.7 million in outside services. The decrease was partially offset by an increase of approximately $15.6 million of research and development expenses related to Saifun and an increase of approximately $7.6 million of labor costs primarily related to the development of our next generation MirrorBit technology.

Research and development expenses of approximately $436.8 million in fiscal 2007 reflected an increase of 28 percent compared to approximately $342.0 million in fiscal 2006. The increase in research and development expense in fiscal 2007 was primarily due to an increase in 300-millimeter development costs at SP1 and the Submicron Development Center (SDC), which together represented approximately $62.7 million of the increase for fiscal 2007. During fiscal 2007, development costs from SP1 were included in research and development expenses, which in part caused the increase from fiscal 2006 research and development expenses. Also, approximately $19.2 million of the increase was due to higher labor costs during fiscal 2007, primarily related to increased headcount during the period, and approximately $11.5 million of the increase was due to a gain on the sale of our 200-millimeter equipment in fiscal 2006 with no comparable gain in fiscal 2007.

Sales, general and administrative

Sales, general and administrative expenses of approximately $253.9 million in fiscal 2008 increased five percent compared to approximately $239.3 million in fiscal 2007. The increase in sales, general and administrative expenses in fiscal 2008 was primarily due to higher legal fees and expenses, primarily related to litigation, and the inclusion of sales, general and administrative expenses related to the operations of Saifun. The higher legal fees and expenses represented approximately 71 percent of the increase in our total sales, general and administrative expenses in fiscal 2008.

Sales, general and administrative expenses of approximately $239.3 million in fiscal 2007 decreased 9 percent compared to approximately $264.4 million in fiscal 2006. Approximately 60 percent of the decrease was due to lower information technology and other administrative expenses as a result of the reduction in services provided by AMD. Since fiscal 2006, we have expanded our administrative functions and significantly reduced our reliance on administrative services provided by AMD. Also, approximately 24 percent of the decrease was due to outside consulting charges that were primarily related to operational efficiency initiatives incurred in fiscal 2006 which were not incurred in fiscal 2007.

Acquisition-related in-process research and development

In the first quarter of fiscal 2008, we expensed $10.8 million of Saifun acquisition-related IPR&D charges in connection with the acquisition of Saifun. Projects that qualify as IPR&D are those that have not reached technological feasibility and have no alternative future use at the time of the acquisition. We did not have a similar charge in prior years.

Restructuring charges

In the second quarter of fiscal 2008, we eliminated approximately 500 regular and contract positions, including positions which were unfilled at the time of elimination, and shut down a research center in Japan. In fiscal 2008, we incurred approximately $11.2 million of restructuring charges, of which approximately $4.6 million was related to manufacturing. We did not have similar charges in prior years.

Asset impairment charges

A variety of external economic factors have contributed to the decline in our operating performance, such as persistent oversupply in the Flash memory industry compounded by the global economic recession. The 2008

66

global economic downturn has caused a sharp decline in worldwide demand for consumer goods and, consequently, a sharp reduction in demand for our products, which resulted in significant declines in our manufacturing capacity utilization. In addition to these economic factors, the ramp-up of SP1 was delayed during the second half of 2008 due to slower than expected customer qualifications and the steep decline in the Japanese wireless market. These factors, among others, caused our stock price to drop significantly throughout 2008, resulting in a sustained market capitalization well below book value.

As a result, we believed our long-lived assets, including our acquisition-related intangible assets, may not be recoverable at December 28, 2008. Because of the vertical nature of our manufacturing operations and our multiple foundry, assembly and test facilities, we evaluated recoverability using a single entity-wide asset group that included all of our long-lived assets and related operating assets and liabilities. We prepared an undiscounted cash flow analysis and determined that the carrying value of the asset group exceeded the undiscounted cash flows expected from the use and eventual disposition of the asset group and, therefore, the asset group was not recoverable. Accordingly, we estimated the fair value of the asset group based on our cash flow forecast, discounted based on our weighted-average cost of capital. We measured the impairment as the difference between the fair value of the asset group and its carrying value.

As a result of this impairment analysis, we recorded a total long-lived asset impairment charge of approximately $1.6 billion for the fourth quarter ended December 28, 2008, reflecting the low demand for semiconductor equipment worldwide, coupled with excess supply. This charge is comprised of the following:

	In millions
Property, plant and equipment	$	1,578.4
Acquisition-related intangible assets		53.5
Total	$	1,631.9

We also performed our annual goodwill impairment analysis in the fourth quarter of 2008. This analysis was based on the same forecasts and assumptions used for our long-lived asset impairment analysis discussed above, and we determined that the implied fair value of our goodwill was zero. As a result, we recognized an impairment charge on our remaining goodwill of $20.8 million, reducing the goodwill balance to zero.

Interest and other income, net

Interest and other income, net, decreased by $27.4 million in fiscal 2008 compared to fiscal 2007, primarily due to the combined effect of decreases in our invested cash, cash equivalents and marketable securities balances, and a decrease in our average investment portfolio yield of approximately 2.7 percent. In addition, we recorded a charge of approximately $3.3 million due to other than temporary impairment of our marketable securities. The decrease in interest and other income, net, in fiscal 2008 as compared to fiscal 2007 was also due to the recognition of approximately $7.5 million of gain from the sale of land in Asia in the second quarter of fiscal 2007, which was partially offset by approximately $3.4 million of loss from an early extinguishment of debt in the same period.

Interest and other income, net, increased by $20.9 million in fiscal 2007 compared to fiscal 2006, primarily due to a $13.9 million decrease in loss on early extinguishment of debt and a $6.3 million increase in interest income for fiscal 2007 due to the combined effect of increases in our invested cash, cash equivalents and marketable securities balances, and an increase in our average investment portfolio yield of approximately 0.4 percent. The increase in interest and other income, net, for fiscal 2007 was also partially due to a $7.5 million gain realized on the sale of land in Asia in the second quarter of fiscal 2007 as compared to a $6.9 million gain on the sale of marketable securities in the second quarter of fiscal 2006.

Interest expense

Interest expense increased by approximately $17.0 million in fiscal 2008 as compared to fiscal 2007, primarily due to approximately $16.9 million of interest capitalized related to the build out of SP1 in 2007,

67

compared with approximately $6.5 million in 2008 and an approximately $8.2 million reduction in interest expense related to an adjustment to a capital lease obligation during fiscal 2007. The increase in interest expense incurred was partially offset by lower average interest rates on our debt portfolio in fiscal 2008. The average interest rates on our debt portfolio were 6.14 percent for fiscal 2008 as compared to 7.58 percent for fiscal 2007.

Interest expense increased by approximately $9.9 million in fiscal 2007 as compared to fiscal 2006, primarily due to the increase in average debt balances. The increase in the debt balance was primarily attributable to a borrowing of $500.0 million under the Senior Secured Term Loan Facility during the fourth quarter of fiscal 2006, subsequently replaced by the $625.0 million Senior Secured Floating Rate Notes during the second quarter of fiscal 2007, and a borrowing of $256.5 million under our Spansion Japan 2007 Credit Facility in 2007. The increase in interest expense incurred was partially offset by approximately $16.9 million of interest capitalized related to the build out of SP1, an approximately $8.2 million reduction in interest expense related to an adjustment to a capital lease obligation during fiscal 2007, and a lower average interest rate on our debt portfolio. The average interest rates for fiscal 2007 were 7.58 percent as compared to 7.85 percent for fiscal 2006.

Income tax

We recorded income tax expense of approximately $62.9 million in fiscal 2008, as compared to approximately $25.1 million of income tax benefit in fiscal 2007, and approximately $2.2 million of income tax benefit in fiscal 2006.

The income tax expense recorded for fiscal 2008 differs from the benefit for income taxes that would be derived by applying a U.S. statutory 35 percent rate to the loss before income taxes primarily because we can not benefit from U.S. operating losses due to lack of a history of earnings, an increase of $64.5 million in the valuation allowance associated with deferred tax assets of our Japanese subsidiary, and income that was incurred and tax effected in foreign jurisdictions with different tax rates.

The increase of $64.5 million in the valuation allowance associated with deferred tax assets of our Japanese subsidiary was recorded due to our change in judgment about the realizability of our Japanese deferred tax assets and the filing of the Spansion Japan Proceeding. We believe it is not more likely than not that these deferred tax assets will be realized in these jurisdictions.

The benefit for income taxes recorded for fiscal 2007 differs from the benefit for income taxes that would be derived by applying a U.S. statutory 35 percent rate to the loss before income taxes primarily due to our inability to benefit from U.S. operating losses due to lack of a history of earnings, a decrease of $21.0 million in the valuation allowance associated with deferred tax assets of our Japanese subsidiary and income that was incurred and tax effected in foreign jurisdictions with different tax rates.

The benefit for income taxes recorded for fiscal 2006 differs from the benefit for income taxes that would be derived by applying a U.S. statutory 35 percent rate to the loss before income taxes primarily due to our inability to benefit U.S. operating losses due to lack of a history of earnings, and income that was incurred and tax effected in foreign jurisdictions with different tax rates.

As of December 28, 2008, we recorded a valuation allowance of approximately $537.8 million against our U.S. deferred tax assets, net of deferred tax liabilities. This valuation allowance offsets all of our net U.S. deferred tax assets. As of December 28, 2008 we have also recorded valuation allowances of approximately $534.0 million against various foreign deferred tax assets for which we believe it is not more likely than not that they will be realized.

68

Other Items

In the second quarter of fiscal 2006, we began selling our products directly to AMD’s former customers and customers not served solely by Fujitsu. In the fourth quarter of fiscal 2008, we began selling our products directly to the customers and distributors previously served by Fujitsu. The following table summarizes net sales by geographic areas for the periods presented:

	Year ended
	December 28, 2008		December 30, 2007		December 31, 2006
	(in thousands)
Geographical sales(1):
Net sales to end customers(2):
United States of America	$	307,039	$	295,632	$	174,930
China		669,231		658,205		479,040
Korea		238,370		260,854		282,596
EMEA		351,052		333,430		312,114
Others		63,972		79,132		61,799
Net sales to related parties:
United States (net sales to AMD)(3)		—		—		336,172
Japan (net sales to Fujitsu )		652,139		873,560		932,623
Total	$	2,281,803	$	2,500,813	$	2,579,274

(1) Geographical sales are based on the customer’s bill-to location.

(2) Net sales to end customers represent sales since the end of the first quarter of fiscal 2006 to AMD’s former customers and customers not served solely by Fujitsu.

(3) For fiscal 2006, these represent sales during the first quarter.

The impact on our operating results from changes in foreign currency exchange rates has not been material, principally because our expenses denominated in yen are generally comparable to our sales denominated in yen, and we have entered into foreign currency exchange contracts to mitigate our exposure when yen denominated expenses and sales are not comparable.

Contractual Obligations

The following table summarizes our contractual obligations at December 28, 2008, as impacted by the Creditor Protection Proceedings. Amounts due under our revolving facilities, the terms of which are described below, are not included in the table. The table is supplemented by the discussion following the table.

	Total		2009		2010		2011		2012		2013		2014 and Beyond
	(in thousands)
Senior Secured Floating Rate Notes	$	625,000	$	625,000	$	—	$	—	$	—	$	—	$	—
Spansion Japan 2007 Credit Facility		287,963		121,247		166,715		—		—		—		—
Senior Notes		250,000		250,000		—		—		—		—		—
Exchangeable Senior Subordinated Debentures		207,000		207,000		—		—		—		—		—
Capital lease obligations		96,134		47,440		29,412		19,282		—		—		—
Other Credit Facility—Subsidiaries		138		138		—		—		—		—		—
Other long term liabilities		19,979		8,109		8,109		3,109		652		—		—
Operating leases(1)		25,568		15,521		5,651		2,458		962		401		575
Unconditional purchase commitments(2),(3)&(4)		284,872		129,861		87,784		44,566		20,246		2,415		—
Total contractual obligations	$	1,796,654	$	1,404,316	$	297,671	$	69,415	$	21,860	$	2,816	$	575

69

(1) Effective March 31, 2009, one operating lease was cancelled and as a result, future payments of $1.7 million due on this lease through 2011 are no longer payable.

(2) Unconditional purchase commitments (UPC) include agreements to purchase goods or services that are enforceable and legally binding on us and that specify all significant terms, including fixed or minimum quantities to be purchased; fixed, minimum or variable price provisions; and the approximate timing of the transaction. These agreements are related principally to inventory and other items. UPCs exclude agreements that are cancelable without penalty.

(3) Effective February 19, 2009, a UPC contract was terminated by one of our vendors due to our default on payments. As a result, the vendor has made a claim to the entire future UPC of approximately $210.9 million, payable through 2013. This claim has been stayed by the U.S. Bankruptcy Court.

(4) Effective March 1, 2009, a UPC contract was renegotiated, resulting in lowering our commitment by approximately $8.0 million through 2010.

Senior Secured Floating Rate Notes

In May 2007, Spansion LLC, our wholly owned operating company subsidiary, issued $625.0 million aggregate principal amount of the Senior Secured Floating Rate Notes due 2013 (the Notes). Interest on the Notes accrues at a rate per annum, reset quarterly, equal to the 3-month LIBOR plus 3.125 percent. Interest is payable on March 1, June 1, September 1 and December 1 of each year beginning September 1, 2007 until the maturity date of June 1, 2013. As of December 28, 2008, the Notes bear interest at approximately 5.33 percent.

In connection with the issuance of the Notes, we, Spansion LLC and Spansion Technology Inc. executed a pledge and security agreement pursuant to which and subject to exceptions specified therein, the Notes are secured by a first priority lien on all of Spansion LLC’s inventory (excluding returned inventory), equipment and real property and proceeds thereof (excluding receivables or proceeds arising from sales of inventory in the ordinary course of business), presently owned or acquired in the future by Spansion LLC and by each of the current and any future guarantors. The Notes are also secured by a second-priority lien that is junior to the liens securing Spansion LLC’s Senior Secured Revolving Credit Facility agreement, as amended, on substantially all other real and personal property and proceeds thereof, including receivables or proceeds arising from sales of inventory in the ordinary course of business presently owned or acquired in the future by us and by each of the current and any future guarantors. The Notes are further secured by certain deeds of trust related to real property owned by Spansion LLC in California and Texas. As of December 28, 2008, the Notes are collateralized by a first priority lien on our inventory and property, plant and equipment with a total net book value of approximately $632.6 million, and by a second priority lien on our accounts receivables with a net book value of approximately $145 million.

Upon the occurrence of a change of control of Spansion LLC, holders of the Notes may require Spansion LLC to repurchase the Notes for cash equal to 101 percent of the aggregate principal amount to be repurchased plus accrued and unpaid interest. Beginning June 1, 2008, Spansion LLC may redeem all or any portion of the Notes, at any time or from time to time at redemption prices specified therein.

Certain events are considered “Events of Default,” which may result in the accelerated maturity of the Notes, including:

• Spansion LLC’s failure to pay when due the principal or premium amount on any of the Notes at maturity, upon acceleration, redemption, optional redemption, required repurchase or otherwise;

• Spansion LLC’s failure to pay interest on any of the Notes for 30 days after the date when due;

• Spansion LLC’s or the guarantors’ failure to comply with certain restrictions on Spansion LLC’s or Guarantors’ ability to merge, consolidate or sell substantially all of its assets;

• Spansion LLC’s failure to perform or observe any other covenant or agreement in the Notes or in the Indenture for a period of 45 days after receiving notice of such failure;

70

• A default by Spansion LLC or any restricted subsidiary (as defined in the Indenture) under any indebtedness that results in acceleration of such indebtedness, or the failure to pay any such indebtedness at maturity, in an aggregate principal amount in excess of $50.0 million (or its foreign equivalent at the time);

• If any judgment or judgments for the payment of money in an aggregate amount in excess of $50.0 million (or its foreign equivalent at the time) is rendered against Spansion LLC, the guarantors or any significant subsidiary and is not waived, satisfied or discharged for any period of 60 consecutive days during which a stay of enforcement is not in effect;

• Certain events of bankruptcy, insolvency or reorganization with respect to Spansion LLC or any significant subsidiary;

• If any note guaranty ceases to be in full force and effect, other than in accordance with the terms of the Indenture, or a guarantor denies or disaffirms its obligations under its note guaranty, other than in accordance with the terms of the Indenture; or

• Any lien securing the collateral underlying the Notes at any time ceases to be in full force and effect, and does not constitute a valid and perfected lien on any material portion of the collateral intended to be covered thereby, if such default continues for 30 days after notice.

The Spansion Japan Proceedings constituted an event of default, causing acceleration of the outstanding obligations under the Notes. Subsequent to the filing for the Creditor Protection Proceedings, a group purporting to hold substantial amounts of our publicly traded Senior Secured Floating Rate Notes due 2013 has organized (the Floating Rate Noteholders). The role of the Floating Rate Noteholders in the Creditor Protection Proceedings may develop and change over the course of such proceedings.

Spansion Japan 2007 Credit Facility

On March 30, 2007, Spansion Japan entered into a committed senior facility agreement with certain Japanese financial institutions that provides Spansion Japan with a 48.4 billion yen senior secured term loan facility (approximately $533.8 million as of December 28, 2008).

Spansion Japan could pursuant to the terms of this facility, borrow amounts in increments of 1.0 billion yen (approximately $11.0 million as of December 28, 2008). Amounts borrowed under this facility bear interest at a rate equal to the three-month Tokyo Interbank Offered Rate (TIBOR), at the time of the drawdown, which resets quarterly, plus a margin of two percent per annum. Borrowing availability was based on capital deliveries for Spansion Japan’s SP1 facility. The drawdown period expired on March 31, 2008.

Pursuant to the terms of Spansion Japan 2007 Credit Facility, Spansion Japan is not permitted, among other things, to create any security interests or liens on any of its pledged assets and to sell or dispose of any of its pledged assets, subject to certain exceptions. This facility may be terminated in the event of default in accordance with the terms of this facility. Events of default under the facility include, among other things, the following: a default in performance of payment; if any of debt obligations of Spansion LLC exceeding $25.0 million, or of Spansion Japan exceeding 1.0 billion yen, are not paid when due; or if any debt obligations of Spansion Japan or Spansion LLC are accelerated or otherwise become due and payable, in each case if not cured within applicable time periods set forth in the Spansion Japan 2007 Credit Facility.

In March 2008, we borrowed an additional amount of 5.6 billion yen (approximately $61.8 million as of December 28, 2008) under this facility. We began to make quarterly principal installments in the second quarter of fiscal 2008. The facility bears interest at approximately 2.9 percent and is scheduled to be repaid in quarterly principal installments through the fourth quarter of fiscal 2010. This facility is collateralized by the assets of Spansion Japan with a net book value of 42.0 billion yen (approximately $463.1 million as of December 28, 2008).

71

As of December 28, 2008 and December 30, 2007, the outstanding balance under this facility was 26.1 billion yen (approximately $288.0 million) and 28.8 billion yen (approximately $256.5 million).

The Spansion Japan Proceedings constituted an event of default, causing acceleration of the outstanding obligations under the Spansion Japan 2007 Credit Facility. As the acceleration of the outstanding obligations was caused by the Spansion Japan Proceedings, which accord Spansion Japan protection from its creditors while it continues its restructuring efforts, payments under the Spansion Japan 2007 Credit Facility have been stayed and this facility continues to be classified under its contractual payment terms as of December 28, 2008.

Senior Notes

On December 21, 2005, we completed an offering of $250 million aggregate principal amount of 11.25% Senior Notes due 2016. The Senior Notes were issued at 90.302 percent of face value, resulting in net proceeds of approximately $218.1 million after deducting the initial purchasers’ discount and estimated offering expenses. The Senior Notes are general unsecured senior obligations of Spansion LLC and will rank equal in right of payment with any of our existing and future senior debt. Interest is payable on January 15 and July 15 of each year beginning July 15, 2006 until the maturity date of January 15, 2016.

Certain events may result in the accelerated maturity of the Senior Notes, including a default in any interest, principal or premium amount payment; a merger, consolidation or sale of all or substantially all of our property; a breach of covenants in the senior notes or the respective indenture; a default in certain debts; or if a court enters certain orders or decrees under any bankruptcy law. Upon occurrence of one of these events, the principal of and accrued interest on all of the senior notes, as the case may be, may become immediately due and payable. If we incur any judgment for the payment of money in an aggregate amount in excess of $50 million or take certain voluntary actions in connection to insolvency, all amounts on the Senior Notes shall become due and payable immediately.

On January 16, 2009, we delayed making the interest payment on our outstanding 11.25% Senior Notes due 2016, which was due January 15, 2009. Under the indenture governing the 11.25% Senior Notes (the Senior Notes Indenture), a failure to make an interest payment is subject to a 30-day cure period. We did not make this interest payment within the 30-day cure period, which expired on February 14, 2009. The failure to make the interest payment within the cure period is an event of default under the Senior Notes Indenture, which resulted in all obligations under the Senior Notes Indenture (approximately $266 million as of the date of the event of default) automatically becoming due and payable.

Exchangeable Senior Subordinated Debentures

In June 2006, Spansion LLC, our wholly owned operating subsidiary, issued $207.0 million of aggregate principal amount of 2.25% Exchangeable Senior Subordinated Debentures due 2016. The Debentures are general unsecured senior subordinated obligations and rank subordinate in right of payment to all of our senior indebtedness, including the Senior Notes, and senior in right of payment to all of our subordinated indebtedness. The Debentures bear interest at 2.25 percent per annum. Interest is payable on June 15 and December 15 of each year beginning December 15, 2006 until the maturity date of June 15, 2016.

The Debentures were not exchangeable prior to January 6, 2007. On January 6, 2007, the Debentures became exchangeable for shares of our Class A common stock, cash or a combination of cash and shares of such Class A common stock, at our option. Full conversion of the Debentures into shares would result in an initial exchange rate of 56.7621 shares of Class A common stock per debenture representing an initial exchange price of approximately $17.6174 per share of Spansion Inc. Class A common stock. The debentures have not been exchanged for Class A common stock as of December 28, 2008.

72

We, at any time prior to maturity may make an irrevocable election to satisfy the exchange obligation in cash up to 100 percent of the principal amount of the debentures exchanged, with any remaining amount to be satisfied in shares of Class A common stock or a combination of cash and shares of Class A common stock at the above exchange ratio. In the event that we make this irrevocable election, debenture holders may exchange their debentures only under the following circumstances:

• during any fiscal quarter after our fiscal quarter ending April 1, 2007 (and only during such fiscal quarter) if the sale price of Spansion Inc. Class A common stock, for at least 20 trading days during the period of 30 consecutive trading days ending on the last trading day of the previous fiscal quarter, is greater than or equal to 120 percent of the conversion price per share of the Spansion Inc. Class A common stock;

• subject to certain exceptions, during the five business day period following any five consecutive trading day period in which the trading price of the debentures for each day of such period was less than 98 percent of the product of the sale price of the Spansion Inc. Class A common stock and the number of shares issuable upon exchange of $1,000 principal amount of the debentures; or

• Upon the occurrence of specified corporate events that constitute a fundamental change of the Company under certain circumstances. The holders of the Debentures will have the ability to require the Company to repurchase the Debentures in whole or in part for cash in the event of a fundamental change of the Company. In such case, the repurchase price would be 100 percent of the principal amount of the Debentures plus any accrued and unpaid interest.

In May 2008, the FASB issued FSP APB 14-1, “Accounting for Convertible Debt Instruments That May Be Settled in Cash upon Conversion (Including Partial Cash Settlement)” (FSP APB 14-1). The FSP requires convertible debt which may be settled in cash upon conversion, including partial cash conversion, to be separated into debt and equity components at issuance with a value to be assigned to each component in a manner that will reflect the entity’s non convertible debt borrowing rate. The difference between the cash proceeds from debt issuance and the fair value assigned to the debt will be recorded as a debt discount and amortized to interest expense over the life of the debt. The effective date of this FSP is for financial statements issued for fiscal years beginning after December 15, 2008 and interim periods within those fiscal years and it does not permit earlier application. However, the transition guidance requires retroactive application to all periods presented. The FSP APB 14-1 will impact our accounting for our Exchangeable Senior Subordinated Debentures. The equity component would be included in the paid-in capital portion of stockholders’ equity on the balance sheet and the value of the equity component would be treated as an original issue discount for purposes of accounting for the debt component. Although FSB APB 14-1 will have no impact on our actual past or future cash flows, it will require us to record additional non-cash interest expense as the debt discount is amortized which will adversely impact earnings per share. Higher interest expense will result by recognizing accretion of the discounted carrying value of the 2.25% Exchangeable Senior Subordinated Debentures to their face amount as interest expense over the term of the debt. Interest expense associated with the 2.25% Exchangeable Debt for prior periods will also be higher than previously reported due to the retrospective application of FSP APB 14-1. Based on the preliminary analysis performed by us, the interest expense associated with our 2.25% Exchangeable Debt will be approximately $7.5 million, $6.5 million and $3.2 million higher for fiscal years 2008, 2007 and 2006, respectively, as a result of adopting this FSP.

The Spansion Japan Proceedings constituted an event of default, causing acceleration of the outstanding obligations under the Debentures.

Spansion Japan 2007 Revolving Credit Facility

On December 28, 2007, Spansion Japan entered into the Spansion Japan 2007 Revolving Credit Facility agreement with the several financial institutions that provides for a revolving credit facility in the aggregate principal amount of up to 14.0 billion yen (approximately $154.4 million as of December 28, 2008).

73

Available amounts for borrowing under this credit facility are limited to the amount of trade receivables held by Spansion Japan. If at anytime the aggregate amount of borrowings under this credit facility exceeds the amount of the trade receivables, Spansion Japan is obligated to prepay an amount such that the borrowings outstanding after such prepayment are below the level of the trade receivables. Borrowings may be for a term of one week or more, but not more than three months, as determined by Spansion Japan. Amounts borrowed under this credit facility bear interest at a rate equal to TIBOR, at the specified date preceding or at the time of the borrowing in accordance with the terms of this credit facility, plus a margin of 0.50 percent per annum.

Pursuant to the terms of this credit facility, Spansion Japan is not permitted, among other things, to create any security interests or liens on the trade receivables; change its primary business; subordinate the payment of its debt under this credit facility to the payment of any unsecured debts; and enter into any merger, company partition, exchange or transfer of shares, assign all or a part of its business or assets to a third party, or otherwise transfer all or a material part of its assets to a third party, subject to certain exceptions.

As of December 28, 2008, the outstanding balance under this facility is 6.5 billion yen (approximately $71.7 million). This amount bears interest at approximately 1.0 percent as of December 28, 2008. This facility will expire on December 28, 2009 and is extendable at each anniversary with an extension fee of 0.2 percent of the commitment amount.

The Spansion Japan Proceedings constituted an event of default, causing acceleration of the outstanding obligations under the Spansion Japan 2007 Revolving Credit Facility.

Senior Secured Revolving Credit Facility

On May 9, 2007, Spansion LLC, the agent and the other lenders party to the Senior Secured Revolving Credit Facility amended the credit agreement and the security agreement in connection therewith, and the Company, STI and Spansion International entered into certain new security agreements. Pursuant to the amendment to the revolving facility credit agreement, lenders consented to the incurrence of the Senior Secured Floating Rate Notes and the grant of related liens. This resulted in the revolving credit facility lenders and the Senior Secured Floating Rate Notes holders holding substantially similar security. The relative priorities of the classes of lenders in various types of collateral is set forth in an intercreditor agreement between the agent for the revolving credit facility lenders and the trustee and collateral agent for the Senior Secured Floating Rate Notes holders.

On December 23, 2008, Spansion LLC, the agent and other financial institutions entered into another amendment (the Amendment), which amended the Credit Agreement (as amended, the Agreement) and the Security Agreement. The Amendment, among other things, provides the following changes to the Agreement:

• Amounts available for borrowing under the Agreement have been reduced from up to an aggregate of $175 million to up to an aggregate of $45 million.

• Minimum cash flow requirements have been added to provide that on the last day of each of the following measurement periods Spansion is required, on a consolidated basis, to have cash flow of at least (or no more negative than):

Measurement Period	Cash Flow
The fiscal quarter ending on December 28, 2008	$	(90,000,000	)
The two consecutive fiscal quarters ending on March 29, 2009	$	(100,000,000	)
The three consecutive fiscal quarters ending on June 28, 2009	$	(70,000,000	)
The four consecutive fiscal quarters ending on September 27, 2009	$	(85,000,000	)
The five consecutive fiscal quarters ending on December 27, 2009	$	(120,000,000	)

74

• The minimum EBITDA requirements have been revised to provide that on the last day of each of the following fiscal quarters Spansion is required to maintain EBITDA, on a consolidated basis, as follows:

Period Ending	EBITDA
December 28, 2008	$	220,000,000
March 29, 2009	$	240,000,000
June 28, 2009	$	270,000,000
September 27, 2009	$	280,000,000
December 27, 2009	$	310,000,000

The Amendment also (i) imposes an availability block at all times in the amount of $25 million, (ii) permits certain indebtedness to be incurred by us from UBS Bank USA (UBS) and the incurrence of liens on certain auction rate securities created in favor of UBS to secure such indebtedness, and (iii) waives any existing EBITDA covenant default.

As of December 28, 2008, the total outstanding balance under this credit facility was $34 million. This amount bears interest at approximately 5.7 percent as of December 28, 2008. On February 20, 2009, we repaid the balance outstanding under this credit facility in full.

The Spansion Japan Proceedings constituted an event of default, causing acceleration of the outstanding obligations under the Senior Secured Revolving Credit Facility.

Spansion Penang Loan

On January 29, 2004, Spansion Penang entered into a financial arrangement with AMD. Under the terms of the arrangement, Spansion Penang borrowed approximately 29.0 million Malaysian ringgit (approximately $8.0 million based on the exchange rate as of January 29, 2004) from AMD to fund the purchase of manufacturing equipment. In January 2006, this loan was transferred from AMD to a third-party financial institution. The loan bears a fixed annual interest rate of 5.9 percent and is payable in equal, consecutive, monthly principal and interest installments through February 2009.

As of December 28, 2008 and December 30, 2007, the amount outstanding under this loan facility was approximately 0.48 million Malaysian ringgit (approximately $0.1 million) and 6.7 million Malaysian ringgit (approximately $2.0 million), respectively.

On February 5, 2009, we repaid the balance outstanding under this loan in full.

Spansion China 2008 Revolving Credit Facility

In June 2008, Spansion China entered into a revolving credit facility agreement with a local financial institution, effective as of June 27, 2008, in the aggregate principal amount of up to 80 million Yuan RMB (approximately $11.7 million as of December 28, 2008). The borrowings must be used for working capital purposes. The interest rate for each drawdown denominated in RMB is a floating rate that is benchmarked to the rate published by the People’s Bank of China for RMB loans with the same term and may, thereafter, be adjusted every month. The interest rate for each drawdown denominated in U.S. dollars is six-month LIBOR plus four percent and may, thereafter, be adjusted every six months. The last drawdown against this credit facility can be made on or before May 27, 2009.

As of December 28, 2008, we had no amounts outstanding under this credit facility and the Creditor Protection Proceedings did not have an impact on availability under this credit facility.

75

Obligations under Capital Leases

On March 26, 2008, we entered into an equipment lease agreement with a third-party financial institution. Under the lease agreement, we leased certain equipment for a period of 36 months, in the amount of approximately $52.1 million, beginning on March 27, 2008. We accounted for the lease transaction as a capital lease.

As of December 28, 2008 and December 30, 2007, we had aggregate outstanding capital lease obligations, net of imputed interest, of approximately $82.6 million and $74.0 million, respectively. The aggregate weighted average interest rate for the capital lease obligations was 11.6 percent as of December 28, 2008. Obligations under these lease agreements are collateralized by the assets leased and are payable through 2011. Leased assets consist principally of machinery and equipment.

As of December 28, 2008, the gross amount of assets recorded under capital leases and accumulated amortization thereon was approximately $180 million and $78 million, respectively. In addition, we recognized an impairment loss of approximately $61.9 million on the leased assets in the fourth quarter of fiscal 2008 as a result of the impairment review of long-lived assets As of December 30, 2007, the gross amount of assets recorded under capital leases and accumulated amortization thereon was approximately $169 million and $86, respectively. These leased assets are included in the related property, plant and equipment category. Amortization of assets recorded under capital leases is included in depreciation expense.

On March 28, 2009, we submitted a motion to the U.S. Bankruptcy Court for rejection of capital leases with future principal and interest payments of approximately $43.8 million through 2011. This motion, if approved, would allow for the rejection of these leases.

Other Financial Matters

In November 2008, we accepted an offer to participate in an auction rate securities settlement from UBS, our broker, providing us the right, but not the obligation, to sell to UBS up to 100 percent of our ARS at par, commencing June 30, 2010. Our right to sell the ARS to UBS commencing June 30, 2010 through July 2, 2012 represents a put option for a payment equal to the par value of the ARS. Therefore, upon acceptance of the offer from UBS, we elected to measure the put option under the fair value option of FASB Statement 159 and recorded $27.5 million as the fair value of the put option asset as of December 28, 2008, with a corresponding credit to other income in the consolidated statement of operations for the year ended December 28, 2008. Please see Note 17 of Notes to Consolidated Financial Statements for further disclosure regarding the accounting for the UBS put option.

Liquidity

Overview

Our cash and cash equivalents at December 28, 2008 totaled $116.4 million and consisted of cash and investments in money market funds.

The majority of our consolidated cash is held in the United States ($80.4 million) and Japan ($31.7 million). Historically, we concentrated much of our cash balances in the U.S. to maximize efficiency and investment returns, and deployed our cash throughout the Company and our subsidiaries through a variety of intercompany borrowing and transfer pricing arrangements. In addition, we were able to freely transfer funds to, from and amongst subsidiaries, as needed.

As a result of the Creditor Protection Proceedings, cash in the various consolidated entities is generally available to fund operations in their respective jurisdictions, but generally is not available to be freely transferred

76

to or amongst subsidiaries other than for normal course intercompany trade and pursuant to specific court- approved agreements as highlighted below. This has placed greater reliance on individual subsidiary cash balances, as our ability to fund specific needs in excess of our current intercompany cash flow arrangements becomes more restricted.

Since the Petition Date, we have generally maintained use of our cash management system, and consequently, have minimized disruption to our operations, pursuant to various court approvals obtained in connection with the Creditor Protection Proceedings. We continue to operate our business under the jurisdictions and orders of the applicable courts and in accordance with applicable legislation. We have received approval from the U.S.Bankruptcy Court for a number of motions enabling us to continue to operate our businesses in the ordinary course and transition into the creditor protection process while minimizing the disruption to our business. Among other things, we received approval to continue paying employee wages and certain benefits in the ordinary course, to pay certain of our pre-petition obligations, including business related payments like claims of transport companies and certain contractors in satisfaction of liens or interests, to continue our cash management system, and to continue honoring customer program obligations.

We have commenced several initiatives to generate cost reductions and decrease the rate of cash outflow during the Creditor Protection Proceedings. In February 2009, we implemented a workforce reduction of approximately 2,400 employees or 28 percent of our existing employees. We also conducted reviews of our real estate and other property leases, equipment leases and agreements, supplier and customer contracts and general discretionary spending.

However, the matters described herein, to the extent that they relate to future events or expectations, may be significantly affected by our Creditor Protection Proceedings. Those proceedings will involve, or may result in, various restrictions on our activities, limitations on financing, the need to obtain Bankruptcy Court approval for various matters and uncertainty as to relationships with vendors, suppliers, customers and others with whom we may conduct or seek to conduct business. In addition, there is no assurance that (i) we will be able to maintain our current cash management system, (ii) we will generate sufficient cash to fund our operations during this process, or (iii) that we will be able to access any alternative financing on acceptable terms or at all. For a complete discussion of the risks facing our business, including our liquidity, please see Part II, Item 1A “Risk Factors.”

Financial Condition (Sources and Uses of Cash)

Our cash and cash equivalents at December 28, 2008 totaled $116.4 million and consisted of cash and investments in money market funds. We are subject to certain restrictions on our distribution of cash contained in our third-party loan agreements described under the “Contractual Obligations” section above.

Our cash flows for fiscal 2008, fiscal 2007 and fiscal 2006 are summarized as follows:

	Year Ended
	December 28, 2008			December 30, 2007			December 31, 2006
	(in thousands)
Net cash provided by operating activities	$	262,552		$	216,339		$	451,617
Net cash used in investing activities		(331,746	)		(1,015,741	)		(603,547	)
Net cash provided by financing activities		8,752			250,377			396,969
Effect of exchange rate changes on cash		(22,263	)		(11,677	)		8,316
Net increase (decrease) in cash and cash equivalents	$	(82,705	)	$	(560,702	)	$	253,355

Net Cash Provided by Operating Activities

Net cash provided by operating activities was approximately $262.6 million in fiscal 2008. Non-cash items included in the net loss consisted primarily of approximately $633.7 million of depreciation and amortization,

77

approximately $1.7 billion of asset impairment charges, approximately $21.6 million in stock compensation costs, and approximately $10.8 million of acquisition related in-process research and development. The net changes in operating assets and liabilities in fiscal 2008 consisted primarily of a decrease in accounts receivables of approximately $141.2 million due to a decline in net sales as a result of the adverse market conditions and a decrease in inventory of approximately $204.7 million.

Net cash provided by operating activities was approximately $216.3 million in fiscal 2007. Non-cash items included in the net loss consisted primarily of approximately $517.3 million of depreciation and amortization and approximately $16.1 million in compensation cost recognized under stock plans and an increase of approximately $41.4 million in benefit for deferred income taxes. The net changes in operating assets and liabilities in fiscal 2007 were primarily attributable to a build of our inventory of approximately $128.5 million in order to meet the demand for our higher density products in the first quarter of fiscal 2008; an increase in accounts payable and accrued liabilities of approximately $137.0 million primarily due to our continued focus on cash management in fiscal 2007; and an increase in income taxes payable of approximately $9.4 million primarily due to the gain from the JV1/JV2 Transaction consummated in the second quarter of fiscal 2007.

Net Cash Used in Investing Activities

Net cash used in investing activities in fiscal 2008 was approximately $331.7 million, which consisted of approximately $430.8 million of capital expenditures used to purchase property, plant and equipment, principally related to our investment in 300-millimeter equipment at SP1 and in our Submicron Development Center (the SDC), offset by a cash inflow of approximately $133.7 million from the maturities and sale of marketable securities.

Net cash used in investing activities in fiscal 2007 was approximately $1,015.7 million, which consisted of approximately $1,115.6 million of capital expenditures used to purchase property, plant and equipment, principally related to our investment in 300-millimeter equipment at SP1 and the SDC, and approximately $90.7 million used in the purchase of marketable securities, and which was offset in part by cash proceeds of approximately $190.5 million from the sale of property, plant and equipment, primarily from the JV1/JV2 Transaction.

Net Cash Provided by Financing Activities

Net cash provided by financing activities was approximately $8.8 million in fiscal 2008. This amount included approximately $250.6 million of borrowing proceeds primarily from our Spansion Japan 2007 Revolving Credit Facility, Spansion Japan 2007 Credit Facility and Senior Secured Revolving Credit Facility, offset by approximately $241.8 million in repayments on debt (primarily under the Spansion Japan 2007 Revolving Credit Facility and Spansion Japan 2007 Credit Facility) and capital lease obligations.

Net cash provided by financing activities was approximately $250.4 million in fiscal 2007, primarily as a result of approximately $854.1 million of proceeds from the issuance of Senior Secured Floating Rate Notes, net of issuance costs, and borrowing under our Spansion Japan 2007 Credit Facility, offset by approximately $603.8 million in payments on debt and capital lease obligations, $500 million of which constituted repayment and early extinguishment of the Senior Secured Term Loan Facility.

On December 29, 2008, subsequent to our fiscal year end, we entered into the UBS Credit Line with UBS that provides up to an aggregate amount of up to $85 million in the form of an uncommitted revolving line of credit, which is secured by the ARS we currently hold. We borrowed approximately $74.8 million under the UBS Credit Line on December 29, 2008. This UBS Credit Line bears interest at a variable rate equal to the lesser of: (a) LIBOR, plus a percentage rate between 1.250 percent to 2.750 percent, and (b) the then applicable weighted average rate of interest or dividend rate paid to us by the issuer of the ARS. The Spansion Japan Proceedings constituted an event of default, causing acceleration of the outstanding obligations under this credit line.

78

Off-Balance-Sheet Arrangements

During the normal course of business, we make certain indemnities and commitments under which we may be required to make payments in relation to certain transactions. These indemnities include non-infringement of patents and intellectual property indemnities to our customers in connection with the delivery, design, manufacture and sale of our products, indemnities to various lessors in connection with facility leases for certain claims arising from such facility or lease, and indemnities to other parties to certain acquisition agreements. The duration of these indemnities and commitments varies, and in certain cases, is indefinite. We believe that substantially all of our indemnities and commitments provide for limitations on the maximum potential future payments we could be obligated to make. However, we are unable to estimate the maximum amount of liability related to our indemnities and commitments because such liabilities are contingent upon the occurrence of events which are not reasonably determinable. Management believes that any liability for these indemnities and commitments would not be material to our accompanying consolidated financial statements.

Recently Issued Accounting Pronouncements

In February 2007, the FASB issued Statement No. 159 (Statement 159), The Fair Value Option for Financial Assets and Financial Liabilities—Including an amendment of FASB Statement No. 115. Under Statement 159, a company may choose, at specified election dates, to measure eligible financial instrument and certain other items at fair value that are not otherwise required to be so measured. If a company elects the fair value option for an eligible item, changes in that item’s fair value in subsequent reporting periods must be recognized in current earnings. Statement 159 is effective as of the beginning of the fiscal years beginning after November 15, 2007. Upon initial adoption, this statement provides entities with a one-time chance to elect the fair value option for the eligible items. The effect of the first measurement to fair value should be reported as a cumulative-effect adjustment to the opening balance of retained earnings in the year the statement is adopted. We adopted Statement 159 at the beginning of our fiscal year 2008 and did not make any elections for fair value accounting. Therefore, we did not record a cumulative-effect adjustment to our opening retained earnings balance. However, we did elect the fair value option in accounting for the UBS put option asset as a result of management’s intent to exercise our put option during the period June 30, 2010 to July 3, 2012. For a complete discussion of the accounting for the UBS put option asset, please see Note16 of Notes to Consolidated Financial Statements.

In December 2007, the FASB issued Statement No. 160, Noncontrolling Interests in Consolidated Financial Statements—an Amendment of ARB No. 51. Statement 160 will require that noncontrolling interests in subsidiaries be reported as a component of stockholders’ equity in the consolidated balance sheet. Statement 160 also requires that earnings or losses attributed to the noncontrolling interests be reported as part of consolidated earnings and not as a separate component of income or expense, as well as requires disclosure of the attribution of consolidated earnings to the controlling and noncontrolling interests on the face of the consolidated statement of operations. Statement 160 is effective for fiscal years beginning after December 15, 2008 and must be applied on a prospective basis. As disclosed in Note 3 of Notes to Consolidated Financial Statements, we must, pursuant to Statement 160, deconsolidate Spansion Japan effective with the Commencement Date. We are currently assessing the impact this pronouncement will have on our future operating results and financial position.

In February 2008, the FASB issued FASB Staff Position (FSP) FAS 157-2, “Effective Date of FASB Statement No. 157,” which provides a one year deferral of the effective date of Statement 157 for non-financial assets and non-financial liabilities, except those that are recognized or disclosed in the financial statements at fair value at least annually. We adopted the provisions of Statement 157 with respect to our financial assets and liabilities only, and we will therefore adopt Statement 157 for non-financial assets and non-financial liabilities that are not measured at fair value on a recurring basis as of the beginning of the first quarter of fiscal 2009. This adoption is not expected to have a significant impact on our consolidated financial statements.

In March 2008, the FASB issued Statement No. 161 (Statement 161), Disclosures about Derivative Instruments and Hedging Activities—an amendment of FASB Statement No. 133 (Statement 133). Statement 161

79

changes the disclosure requirements for derivative instruments and hedging activities. Entities are required to provide enhanced disclosures about (a) how and why an entity uses derivative instruments, (b) how derivative instruments and related hedged items are accounted for under Statement 133 and its related interpretations, and (c) how derivative instruments and related hedged items affect an entity’s financial position, financial performance and cash flows. Statement 161 does not change the accounting for derivative instruments. The guidance in Statement 161 is effective for us beginning in the first quarter of fiscal 2009.

In May 2008, the FASB issued FSP APB 14-1, “Accounting for Convertible Debt Instruments That May Be Settled in Cash upon Conversion (Including Partial Cash Settlement)” (FSP APB 14-1). The FSP requires convertible debt which may be settled in cash upon conversion, including partial cash conversion, to be separated into debt and equity components at issuance with a value to be assigned to each component in a manner that will reflect the entity’s non convertible debt borrowing rate. The difference between the cash proceeds from debt issuance and the fair value assigned to the debt will be recorded as a debt discount and amortized to interest expense over the life of the debt. The effective date of this FSP is for financial statements issued for fiscal years beginning after December 15, 2008 and interim periods within those fiscal years and it does not permit earlier application. However, the transition guidance requires retroactive application to all periods presented. The FSP APB 14-1 will impact our accounting for our Exchangeable Senior Subordinated Debentures. The equity component would be included in the paid-in capital portion of stockholders’ equity on the balance sheet and the value of the equity component would be treated as an original issue discount for purposes of accounting for the debt component. Although FSB APB 14-1 will have no impact on the our actual past or future cash flows, it will require us to record additional non-cash interest expense as the debt discount is amortized which will adversely impact earnings per share. Higher interest expense will result by recognizing accretion of the discounted carrying value of the 2.25% Exchangeable Senior Subordinated Debentures to their face amount as interest expense over the term of the debt. Interest expense associated with the 2.25% Exchangeable Debt for prior periods will also be higher than previously reported due to the retrospective application of FSP APB 14-1. Based on the preliminary analysis performed by us, the interest expense associated with our 2.25% Exchangeable Debt will be approximately $3.2 million, $6.5 million and $7.5 million higher for fiscal years 2006, 2007 and 2008, respectively, as a result of adopting this FSP.

In October 2008, the FASB issued FSP FAS 157-3, “Determining the Fair Value of a Financial Asset in a Market That Is Not Active” which clarifies the application of Statement 157 when the market for a financial asset is inactive. Specifically, FSP FAS 157-3 clarifies how (1) management’s internal assumptions should be considered in measuring fair value when observable data are not present, (2) observable market information from an inactive market should be taken into account, and (3) the use of broker quotes or pricing services should be considered in assessing the relevance of observable and unobservable data to measure fair value. The guidance in FSP FAS 157-3 was effective immediately and we adopted its provisions with respect to our financial assets as of September 28, 2008.

In December 2008, the FASB issued FSP FAS 132(R)-1, “Employer’s Disclosures about Postretirement Benefit Plan Assets” which amends FASB Statement No. 132 (Revised 2003), Employers’ Disclosures about Pensions and Other Postretirement Benefits, to provide guidance on an employer’s disclosures about plan assets of a defined benefit pension or other postretirement plan. The disclosures about plan assets required by this FSP shall be provided for fiscal years ending after December 15, 2009. Upon initial application, the provisions of this FSP are not required for earlier periods that are presented for comparative purposes. This FSP does not affect the accounting treatment for postretirement benefit plans. We will adopt this FSP for the fiscal year ending December 27, 2009.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK

Interest Rate Risk

Our exposure to market risk for changes in interest rates relates primarily to our investment portfolio and debt. We usually invest our cash in investments with short term maturities or with frequent interest reset terms.

80

Accordingly, our interest income fluctuates with short-term market conditions. As of December 28, 2008, our investment portfolio consisted of money market funds and ARS. With the exception of our ARS, these were highly liquid investments. Due to the short-term nature of our investment portfolio, excluding ARS, our exposure to interest rate risk is minimal.

As of December 28, 2008, approximately 30 percent of the principal amounts outstanding under our unrelated third party debt obligations were fixed rate. Approximately 70 percent of our total debt obligations were variable rate. Changes in interest rates associated with the variable rate portion of our debt could result in a change to our interest expense. For example, a one percent aggregate change in interest rates would increase/decrease our interest expense by approximately $10 million annually. We continually monitor market conditions and may enter into hedges if deemed appropriate. We do not currently have any hedges of interest rate risk in place. We do not use derivative financial instruments for speculative or trading purposes.

Default Risk

We mitigate default risk in our investment portfolio by investing in only the highest credit quality securities and by constantly re-positioning our portfolio to respond appropriately to a significant reduction in the credit rating of any investment issuer or guarantor. The portfolio includes marketable securities with active markets to ensure portfolio liquidity.

There has been significant deterioration and instability in the financial markets during 2008. This period of extraordinary disruption and readjustment in the financial markets exposes us to additional investment risk. The value and liquidity of the securities in which we invest could deteriorate rapidly and the issuers of such securities could be subject to credit rating downgrades. In light of the current market conditions and these additional risks, we actively monitor market conditions and developments specific to the securities and security classes in which we invest. We believe that we take a conservative approach to investing our funds in that we invest only in highly-rated securities with relatively short maturities and do not invest in securities we believe involve a higher degree of risk. As of December 28, 2008, substantially all of our investments other than ARS are AAA/Aaa rated by at least one of the rating agencies. While we believe we take prudent measures to mitigate investment related risks, such risks cannot be fully eliminated, as there are circumstances beyond our control.

In November 2008, we accepted an offer to participate in an auction rate securities settlement from UBS, providing us the right, but not the obligation, to sell to UBS up to 100 percent of our ARS at par, commencing June 30, 2010. Our right to sell the ARS to UBS commencing June 30, 2010 through July 2, 2012 represents a put option for a payment equal to the par value of the ARS. Upon acceptance of the offer with UBS, we had approximately $94.0 million investments in ARS after recording an other-than-temporary impairment charge of $27.9 million as of December 28, 2008. Although we have recorded an impairment charge marking down the carrying value of these marketable securities at December 28, 2008, we cannot assure you that additional impairment charges will not be required in the future and UBS will ultimately have the ability to repurchase our ARS at par, or at any other price during the put period described above. During 2008, the market conditions for these ARS deteriorated due to the uncertainties in the credit markets. As a result, we were not able to sell our ARS as scheduled in the auction market. See “Part II, Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this report for further information.

81

The following table presents the cost basis, fair value and related weighted-average interest rates by year of maturity for our investment portfolio and debt obligations as of December 28, 2008 and comparable fair values as of December 30, 2007:

	2009			2010			2011		2012		2013		Thereafter		Total			2008 Fair value		2007 Fair value
	(in thousands , except for percentages)
Investment Portfolio
Cash equivalents:
Fixed rate amounts	$	—		$	—		$	—	$	—	$	—	$	—	$	—		$	—	$	29,869
Weighted-average rate		—			—			—		—		—		—		—
Variable rate amounts	$	74,100		$	—		$	—	$	—	$	—	$	—	$	74,100		$	74,100	$	66,500
Weighted-average rate		0.92	%		—			—		—		—		—		0.92	%
Marketable Securities:
Variable rate amounts	$	—		$	—		$	—	$	—	$	—	$	—	$	—		$	—	$	216,650
Weighted-average rate		—			—			—		—		—		—		—
Total Investment Portfolio	$	74,100		$	—		$	—	$	—	$	—	$	—	$	74,100		$	74,100	$	313,019
Debt Obligations
Debt—fixed rate amounts	$	457,138		$	—		$	—	$	—	$	—	$	—	$	457,138		$	18,580	$	327,799
Weighted-average rate		7.17	%		—			—		—		—		—		7.17	%
Debt—variable rate amounts	$	851,934		$	166,715			—	$	—	$	—	$	—	$	1,018,649		$	396,250	$	824,408
Weighted-average rate		4.91	%		4.84	%		—		—		—				4.90	%
Total Debt Obligations	$	1,309,072		$	166,715		$	—	$	—	$	—	$	—	$	1,475,787		$	414,830	$	1,152,207

Foreign Exchange Risk

As a result of our foreign operations, we have sales, expenses, assets and liabilities that are denominated in Japanese yen and other foreign currencies. For example,

• some of our manufacturing costs are denominated in Japanese yen, Chinese renminbi, and other foreign currencies such as the Thai baht and Malaysian ringgit;

• sales of our products to Fujitsu are denominated in both US dollars and Japanese yen; and

• some fixed asset purchases are denominated in Japanese yen and European Union euros.

Consequently, movements in exchange rates could cause our net sales and our expenses to fluctuate, affecting our profitability and cash flows. Moreover, we determine our total foreign currency exchange exposure using projections of long-term expenditures for items such as equipment and materials used in manufacturing. Failure to eliminate this exposure could have an adverse effect on our business, financial condition and results of operations.

As of December 28, 2008, we did not have any foreign currency forward contracts.

The following table provides information about our foreign currency forward contracts as of December 28, 2008 and December 30, 2007.

	As of December 28, 2008						As of December 30, 2007
	Notional Amount		Average Contract Rate		Estimated Fair Value		Notional Amount		Average Contract Rate		Estimated Fair Value
	(in thousands, except contract rates)
Foreign currency forward contracts:
Japanese yen	$	—	¥	—	$	—	$	120,500	¥	112.85	$	-604

82

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Consolidated Statements of Operations

(in thousands, except per share amounts)

	Year Ended December 28, 2008			Year Ended December 30, 2007			Year Ended December 31, 2006
Net sales	$	1,630,573		$	1,627,253		$	1,310,479
Net sales to related parties/members		651,230			873,560			1,268,795
Total net sales		2,281,803			2,500,813			2,579,274
Cost of sales (Note 8)		2,193,345			2,065,143			2,063,639
Research and development (Note 8 )		431,808			436,785			342,033
Sales, general and administrative (Note 8 )		253,878			239,317			264,358
Acquisition related in-process research and development		10,800			—			—
Restructuring charges (Note 18)		11,161			—			—
Asset impairment charges		1,652,622			—			—
Operating loss		(2,271,811	)		(240,432	)		(90,756	)
Interest and other income, net		5,200			32,595			11,681
Interest expense		(97,843	)		(80,803	)		(70,903	)
Other income (expense), net		(92,643	)		(48,208	)		(59,222	)
Loss before income taxes		(2,364,454	)		(288,640	)		(149,978	)
(Provision) benefit for income taxes		(62,865	)		25,144			2,215
Net loss	$	(2,427,319	)	$	(263,496	)	$	(147,763	)
Net loss per share:
Basic and diluted	$	(15.64	)	$	(1.95	)	$	(1.15	)
Shares used in per share calculation:
Basic and diluted		155,162			134,924			128,965

See accompanying notes

83

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Consolidated Balance Sheets

(in thousands, except par value and share amounts)

	December 28, 2008			December 30, 2007
Assets
Current assets:
Cash and cash equivalents	$	116,387		$	199,092
Marketable securities		—			216,650
Trade accounts receivable		132,099			184,873
Trade accounts receivable from related parties (Note 8 )		111,448			189,372
Allowance for doubtful accounts		(8,106	)		(6,156	)
Trade accounts receivable, net		235,441			368,089
Other receivables		7,789			—
Other receivables from related parties (Note 8)		6,127			11,873
Inventories:
Raw materials		16,305			31,877
Work-in-process		264,393			421,765
Finished goods		98,459			130,227
Total inventories		379,157			583,869
Deferred income taxes		3,213			26,607
Prepaid expenses and other current assets		35,225			46,452
Total current assets		783,339			1,452,632
Property, plant and equipment:
Land		37,355			27,662
Buildings and leasehold improvements		181,843			1,122,480
Equipment		551,567			4,411,666
Construction in progress		24,265			768,918
Total property, plant and equipment		795,030			6,330,726
Accumulated depreciation and amortization		—			(4,058,762	)
Property, plant and equipment, net		795,030			2,271,964
Deferred income taxes		—			29,957
Acquisition related intangible assets, net		1,646			—
Auction rate securities		94,014			—
Put option		27,465			—
Other assets		73,950			61,092
Total assets	$	1,775,444		$	3,815,645
Liabilities and Stockholders’ Equity (Deficit)
Current liabilities:
Notes payable to banks under revolving loans	$	105,687		$	—
Accounts payable		465,844			489,163
Accounts payable to related parties (Note 8 )		74,592			56,929
Accrued compensation and benefits		60,412			60,778
Accrued liabilities to related parties (Note 8 )		5,092			9,666
Other accrued liabilities		88,943			88,006
Income taxes payable		3,972			13,818
Deferred income on shipments to a related party		364			582
Deferred income on shipments		34,921			39,375
Current portion of long-term debt		1,187,027			68,705
Current portion of long-term obligations under capital leases		39,063			33,092
Total current liabilities		2,065,917			860,114

84

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Consolidated Balance Sheets—(Continued)

(in thousands, except par value and share amounts)

	December 28, 2008			December 30, 2007
Deferred income taxes		3,267			186
Long-term debt, less current portion		166,716			1,258,616
Long-term obligations under capital leases, less current portion		43,530			40,920
Other long-term liabilities		44,330			23,361
Commitments and contingencies
Stockholders’ equity (deficit):
Capital stock:
Preferred stock, $0.001 par value, 50,000,000 shares authorized, 0 shares issued outstanding		—			—
Class A common stock, $0.001 par value, 714,999,998 shares authorized, 161,102,495 and 135,371,515 shares issued and outstanding as of December 28, 2008 and December 30, 2007 (Note 20)		161			135
Class B common stock, $0.001 par value, 1 share authorized, 0 share issued and outstanding as of December 28, 2008 and December 30, 2007 (Note 20)		—			—
Class C common stock, $0.001 par value, 1 share authorized, 0 and 1 share issued and outstanding as of December 28, 2008 and December 30, 2007 (Note 20)		—			—
Additional paid-in capital		2,356,629			2,221,175
Accumulated deficit		(2,979,985	)		(552,667	)
Accumulated other comprehensive income (loss)		74,879			(36,195	)
Total stockholders’ equity (deficit)		(548,316	)		1,632,448
Total liabilities and stockholders’ equity (deficit)	$	1,775,444		$	3,815,645

See accompanying notes

85

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Consolidated Statements of Cash Flows

(in thousands)

	Year Ended December 28, 2008			Year Ended December 30, 2007			Year Ended December 31, 2006
Cash Flows from Operating Activities:
Net loss	$	(2,427,319	)	$	(263,496	)	$	(147,763	)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization		633,692			517,281			536,993
Asset impairment charges		1,652,622			—			—
Write-off of in-process research and development		10,800			—			—
Loss on pension curtailment		—			2,010			—
Loss on early extinguishment of debt		—			3,435			17,310
Provision for doubtful accounts		1,799			1,559			2,383
Provision (benefit) for deferred income taxes		49,887			(41,401	)		(2,528	)
Net gain on sale and disposal of property, plant, and equipment		(28,238	)		(30,172	)		(14,582	)
Other than temporary impairment on marketable securities		3,270			—			—
Other than temporary impairment on investments		2,648			—			—
Gain on sale of marketable securities		(621	)		—			(6,884	)
Compensation recognized under employee stock plans		21,578			16,138			17,424
Amortization of premium on floating rate notes and discount of senior subordinated and senior notes, net		2,257			2,309			3,158
Changes in operating assets and liabilities:
Decrease (increase) in trade accounts receivable from related parties		72,222			6,444			210,973
(Increase) decrease in other receivables from related parties		(742	)		(9,548	)		11,742
Decrease (increase) in trade account receivables		69,722			17,486			(202,359	)
Decrease (increase) in inventories		204,713			(128,489	)		4,304
Decrease (increase) in prepaid expenses and other current assets		14,799			(11,606	)		(2,374	)
(Increase) decrease in other assets		(1,183	)		(15,769	)		3,700
Increase (decrease) in accounts payable and accrued liabilities to related parties		18,262			40,763			(111,776	)
(Decrease) increase in accounts payable and accrued liabilities		(14,099	)		96,267			153,429
(Decrease) increase in accrued compensation and benefits		(8,883	)		(3,767	)		(13,403	)
Increase (decrease) in income taxes payable		(9,846	)		9,435			(8,725	)
Increase (decrease) in deferred income on shipments to a related party		(218	)		353			(31,672	)
Increase (decrease) in deferred income on shipments		(4,570	)		7,107			32,267
Net cash provided by operating activities		262,552			216,339			451,617
Cash Flows from Investing Activities:
Proceeds from sale of property, plant and equipment		6,743			190,532			20,075
Purchases of property, plant and equipment		(430,831	)		(1,115,598	)		(716,618	)
Business acquisitions, net of cash acquired		733			—			—
Proceeds from maturity and sale of marketable securities		133,695			891,250			372,583
Purchases of marketable securities		(36,950	)		(981,925	)		(279,587	)
Loan made to an investee		(5,136	)		—			—
Net cash used in investing activities		(331,746	)		(1,015,741	)		(603,547	)

86

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Consolidated Statements of Cash Flows—(Continued)

	Year Ended December 28, 2008			Year Ended December 30, 2007			Year Ended December 31, 2006
	(in thousands)
Cash Flows from Financing Activities:
Cash distributions to related parties for stock-based compensation (Note 8 )		—			—			(8,485	)
Proceeds from sale-leaseback transactions		—			—			48,236
Proceeds from borrowings, net of issuance costs		250,558			854,120			889,735
Payments on loans from related parties		—			—			(197,619	)
Payments on debt and capital lease obligations		(241,806	)		(603,819	)		(402,711	)
Proceeds from issuance of common stock, net of offering costs		—			76			67,813
Net cash provided by financing activities		8,752			250,377			396,969
Effect of exchange rate changes on cash and cash equivalents		(22,263	)		(11,677	)		8,316
Net (decrease) increase in cash and cash equivalents		(82,705	)		(560,702	)		253,355
Cash and cash equivalents at the beginning of period		199,092			759,794			506,439
Cash and cash equivalents at end of period	$	116,387		$	199,092		$	759,794
Supplemental Cash Flows Disclosures:
Interest paid (including $0, $0, $11,306 of interest related to obligations to related parties)	$	94,593		$	95,392		$	48,457
Income taxes paid (refunded)	$	(15,155	)	$	9,650		$	6,229
Non-cash investing and financing activities:
Equipment sales-leaseback transactions	$	—		$	—		$	45,956
Equipment capital leases	$	56,611		$	—		$	—
Accrued capital distributions to (contribution from) related party for stock-based compensation (Note 7)	$	—		$	—		$	(9,157	)
Issuance of common stock and stock options to acquire Saifun	$	108,898		$	—		$	—

See accompanying notes

87

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Consolidated Statements of Stockholders’ Equity (Deficit)

(in thousands)

	Shares	Amount		Additional Paid-In Capital			Accumulated Deficit			Accumulated Other Comprehensive Income (Loss)			Total Stockholders’ Equity (Deficit)
Balance at December 25, 2005	128,146	$	128	$	2,110,540		$	(131,418	)	$	(57,273	)	$	1,921,977
Comprehensive loss:
Net loss	—		—		—			(147,763	)		—			(147,763	)
Other comprehensive income:
Net unrealized gains on investment, net of taxes of $0	—		—		—			—			(407	)		(407	)
Net change in minimum pension liability, net of taxes of $0	—		—		—			—			7,412			7,412
Net change in cumulative translation adjustment	—		—		—			—			(11,801	)		(11,801	)
Reclassification adjustment for realized gain on sale of marketable securities included in net loss	—		—		—			—			(6,884	)		(6,884	)
Total other comprehensive loss	—		—		—			—			—			(11,680	)
Total comprehensive loss	—		—		—			—			—			(159,443	)
Adjustment to initially apply FASB Statement No. 158, net of tax	—		—		—			—			(10,753	)		(10,753	)
Stock-based compensation activity with related party, net	—		—		(415	)		—			—			(415	)
Discharge of stock-based compensation payable to AMD (Note 4)	—		—		9,157			—			—			9,157
Issuance of shares:
Vesting of RSUs	826		1		(1	)		—			—			—
Issuance of common stock in secondary offering, net of issuance costs of $2,133	5,247		5		67,808			—			—			67,813
Compensation recognized under employee stock plans	—		—		17,424			—			—			17,424
Balance at December 31, 2006	134,219		134		2,204,513			(279,181	)		(79,706	)		1,845,760
Comprehensive loss:
Net loss	—		—		—			(263,496	)		—			(263,496	)
Other comprehensive income:
Change in pension plan, net of taxes of $0	—		—		—			—			2,269			2,269
Net change in cumulative translation adjustment	—		—		—			—			41,242			41,242
Total other comprehensive income	—		—		—			—			—			43,511
Total comprehensive loss	—		—		—			—			—			(219,985	)
Adjustment to initially apply Issue 06-2	—		—		—			(10,150	)		—			(10,150	)
Adjustment to initially apply FIN 48	—		—		—			160			—			160
Adjustment to common stock issuance costs	—		—		466			—			—			466
Issuance of shares:
Vesting of RSUs	1,148		1		(1	)		—			—			—
Exercise of options	5		—		60			—			—			60
Compensation recognized under employee stock plans	—		—		16,137			—			—			16,137
Balance at December 30, 2007	135,372		135		2,221,175			(552,667	)		(36,195	)		1,632,448

88

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Consolidated Statements of Stockholders’ Equity (Deficit)—(Continued)

(in thousands)

				Additional Paid-In Capital			Accumulated Deficit			Accumulated Other Comprehensive Income (Loss)			Total Stockholders’ Equity (Deficit)
	Shares	Amount
Comprehensive loss:
Net loss	—		—		—			(2,427,318	)		—			(2,427,318	)
Other comprehensive income:
Net unrealized gain on investment	—		—		—			—			662			662
Change in pension plan, net of taxes of $0	—		—		—			—			(34,985	)		(34,985	)
Net change in cumulative translation adjustment	—		—		—			—			145,397			145,397
Total other comprehensive income	—		—		—			—			—			111,074
Total comprehensive loss	—		—		—			—			—			(2,316,244	)
Issuance of shares:
Vesting of RSUs	1,368		1		(1	)		—			—			—
Exercise of options	26		—		1			—			—			1
Issuance of common stock to acquire Saifun	22,729		23		108,876			—			—			108,899
Issuance of common stock to purchase asset	1,608		2		4,998			—			—			5,000
Compensation recognized under employee stock plans	—		—		21,580			—			—			21,580
Balance at December 28, 2008	161,103	$	161	$	2,356,629		$	(2,979,985	)	$	74,879		$	(548,316	)

See accompanying notes

89

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements

1. Nature of Operations

The Company

Spansion Inc. (the Company) is a semiconductor device company headquartered in Sunnyvale, California, with research and development, manufacturing and assembly operations in the United States, Middle East, Europe and Asia. The Company designs, develops, manufactures, markets, licenses and sells Flash memory technology and solutions.

The Company’s Flash memory devices primarily address the integrated category of the Flash memory market and are incorporated into a broad range of electronic products, including mobile phones, consumer electronics, automotive electronics, networking and telecommunications equipment, personal computers and PC peripheral applications. The Company licenses its Flash memory technology to semiconductor manufacturers who use this technology to develop and manufacture a variety of semiconductor solutions.

History of the Company

In 1993, Advanced Micro Devices, Inc. (AMD) and Fujitsu Limited (Fujitsu) formed a manufacturing venture, Fujitsu AMD Semiconductor Limited (FASL).

FASL produced wafers containing Flash memory circuits. These wafers were then sold to AMD and Fujitsu, who separated the circuits on each wafer into individual die, processed the die into finished goods and sold the finished Flash memory devices to their customers. AMD and Fujitsu performed all research and development activities for the design and development of Flash memory devices and developed the manufacturing processes that were to be used in the operation of the fabs to manufacture Flash memory devices. Through June 30, 2003, FASL contracted with AMD and Fujitsu for the receipt of certain support and administrative services.

As of June 30, 2003, in order to expand their existing manufacturing venture, AMD and Fujitsu formed a limited liability company called FASL LLC and later renamed Spansion LLC. In addition to its 49.992 percent ownership in FASL, AMD contributed to Spansion LLC its Flash memory inventory, its wafer manufacturing facility located in Austin Texas, its Flash memory research and development facility (the Submicron Development Center (SDC)) located in Sunnyvale, California, and its Flash memory assembly and test facilities located in Thailand, Malaysia and China. Fujitsu contributed to Spansion LLC its 50.008 percent ownership interest in FASL, its Flash memory inventory and its Flash memory assembly and test facilities located in Malaysia. Both AMD and Fujitsu transferred employees to Spansion LLC to perform various research and development, marketing and administration functions. AMD and Fujitsu also provided working capital to Spansion LLC in the form of cash contributions and loans. As a result, Spansion LLC began manufacturing finished Flash memory devices which through the first fiscal quarter of fiscal 2006 were exclusively sold to AMD and Fujitsu. In the second quarter of fiscal 2006, the Company began selling its products directly to customers previously served by AMD (see Note 8).

On December 21, 2005, Spansion LLC was reorganized into Spansion Inc. and completed its underwritten initial public offering (IPO) of its Class A common stock. The Company’s shares of Class A common stock trade on the Nasdaq Global Select Market under the symbol “SPSN,” although the Company is currently subject to delisting proceedings as a result of the Creditor Protection Proceedings (see Note 2).

On March 18, 2008, the Company completed the acquisition of all of the outstanding shares of Saifun Semiconductor Ltd. (Saifun), a provider of intellectual property (IP) solutions for the non volatile memory (NVM) market. Saifun licenses its IP to semiconductor manufacturers that use this technology to develop and manufacture a variety of stand alone and embedded NVM products.

90

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

2. Creditor Protection Proceedings

On February 10, 2009, Spansion Japan Limited, an indirect wholly owned subsidiary of Spansion Inc, filed a proceeding under the Corporate Reorganization Law (Kaisha Kosei Ho) of Japan to obtain protection from Spansion Japan’s creditors (the Spansion Japan Proceeding), and successively the Spansion Japan Proceeding was formally commenced on March 3, 2009 (the Commencement Date), when the Tokyo District Court entered the commencement order and appointed the incumbent representative director of Spansion Japan as trustee. On March 1, 2009, Spansion Inc, Spansion LLC, Spansion Technology LLC, Spansion International, Inc., and Cerium Laboratories LLC (collectively, the Debtors) each filed a voluntary petition for relief under Chapter 11 of the bankruptcy code in the Bankruptcy Court for the District of Delaware. The Chapter 11 Cases, together with the Spansion Japan Proceeding are referred to collectively as the Creditor Protection Proceedings. The Chapter 11 Cases are being jointly administered under Case No: 09-10690 (KJC).

The Debtors continue to operate their businesses as “debtors-in-possession” under jurisdiction of the Bankruptcy Court and in accordance with the applicable provisions of the Bankruptcy Code and orders of the Bankruptcy Court. Under the Bankruptcy Code, the Debtors may assume, assume and assign, or reject certain executory contracts including unexpired leases, subject to the approval of the Bankruptcy Court and certain other conditions. Any reference to any such agreements or instruments and termination rights or a quantification of the Debtors’ obligations under any such agreements or instruments is qualified by any overriding rejection, repudiation or other rights the Debtors may have as a result of or in connection with the Creditor Protection Proceedings.

As required under the U.S. Bankruptcy Code, the United States Trustee for the District of Delaware (Trustee) appointed an official committee of unsecured creditors on March 12, 2009 (U.S. Creditors’ Committee). In addition, a group purporting to hold substantial amounts of the Company’s publicly traded Senior Secured Floating Rate Notes has organized (the Floating Rate Noteholders). The role of the U.S. Creditors’ Committee and the Floating Rate Noteholders in the Creditor Protection Proceedings may develop and change over the course of such proceedings.

The Bankruptcy Court has approved payment of certain of the Debtors’ pre-petition obligations, including, among other things, employee wages, salaries and benefits, and certain business related payments like claims of transport companies and certain contractors in satisfaction of liens or interests. The Debtors have retained, with Bankruptcy Court approval, legal and financial professionals to advise the Debtors on the Chapter 11 Cases and certain other “ordinary course” professionals. From time to time, the Debtors may seek Bankruptcy Court approval for the retention of additional professionals.

Non-U.S subsidiaries that are not included in the Creditor Protection Proceedings continue to operate without the supervision of the Bankruptcy Court.

The Creditor Protection Proceedings allow the Debtors to continue operating their business while continuing to pursue a sale or standalone reorganization process. There is no assurance that the Debtors will be successful in completing a sale or reorganization.

Developments Related to the Company’s Creditor Protection Proceedings

• The Spansion Japan Proceeding and the Chapter 11 Cases constituted events of default under the instruments governing substantially all of the indebtedness issued or guaranteed by the Company, Spansion LLC, Spansion Technology LLC and Spansion Japan. In addition, the Company may not be in

91

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

compliance with certain other covenants under the indentures related to certain of its debt or lease instruments.

• In February 2009, the Company implemented a workforce reduction of approximately 2,400 employees or 28 percent of the Company’s existing employees, in an effort to further reduce costs as the Company continued its restructuring efforts and explored various strategic alternatives.

• On March 4, 2009, the Company received notice of a determination of the NASDAQ Listing Qualifications Department to delist its common stock from trading on The NASDAQ Stock Market because of the Chapter 11 Cases. On March 16, 2009, the Company received an additional notice of a determination for its failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 28, 2008. On April 16, 2009, the Company received an additional notice of a determination that its failure to pay certain fees in accordance with NASDAQ Marketplace Rule 5210(d) is an additional basis for delisting its securities from The NASDAQ Stock Market. On April 23, 2009, the Company attended a hearing to contest these delisting determinations. On May 5, 2009, NASDAQ denied the Company’s request for continued listing on The NASDAQ Stock Market and informed the Company that trading of shares of its common stock has been suspended effective at the open of business on Thursday, May 7, 2009. The Company does not intend to request a review of this decision, and expects NASDAQ to file an application on Form 25-NSE with the Securities and Exchange Commission to effect the delisting of our common stock. We expect that our common stock will be publicly traded on the Pink Sheets with a ticker symbol “SPSN.PK.” However, because trading on the Pink Sheets requires a market maker to quote our common stock, trading on the Pink Sheets is not within our control and could be discontinued at any time if no market maker is willing to offer a quote.

• In connection with developing a plan of reorganization under the Creditor Protection Proceedings, the Company has decided to pursue a standalone business strategy focused on the market for embedded applications and licensing its intellectual property portfolio. As a result, the Company plans to pursue strategic alternatives for its wireless business.

Business Operations

The businesses of the Debtors continue to operate under the jurisdictions and orders of the applicable courts and in accordance with applicable legislation. The Debtors received approval from the Bankruptcy Court for a number of motions enabling them to continue to operate their businesses generally in the ordinary course and transition into the creditor protection process while minimizing disruption to their business. Among other things, the Debtors received approval to continue paying employee wages and certain benefits in the ordinary course; to pay critical trade vendor claims; to generally continue their cash management system; and to continue honoring customer program obligations.

Under the U.S. Bankruptcy Code, the U.S. Debtors may assume, assume and assign, or reject certain executory contracts including unexpired leases, subject to the approval of the U.S. Court and certain other conditions.

3. Basis of Presentation

Basis of Presentation and Going Concern

The commencement of the Creditor Protection Proceedings raises substantial doubt as to whether Spansion will be able to continue as a going concern. The audited consolidated financial statements have been prepared using the same U.S. GAAP and the rules and regulations of the U.S. Securities and Exchange Commission (SEC) as applied by the Company prior to the Creditor Protection Proceedings. The audited consolidated financial

92

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

statements continue to be prepared using the going concern basis, which assumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Creditor Protection Proceedings provide the Company with a period of time to stabilize its operations and financial condition and develop a comprehensive restructuring plan, which will incorporate the Company’s standalone business strategy focused on the market for embedded applications and licensing of its intellectual property portfolio. However, it is not possible to predict the outcome of these proceedings and, as such, the realization of assets and discharge of liabilities are each subject to significant uncertainty. Further, it is not possible to predict whether the actions taken in any restructuring will result in improvements to the Company’s financial condition sufficient to allow it to continue as a going concern. If the going concern basis is not appropriate in future filings, adjustments will be necessary to the carrying amounts and/or classification of the Company’s assets and liabilities in its consolidated financial statements included in those filings. Further, a comprehensive restructuring plan could materially change the carrying amounts and classifications reported in the audited consolidated financial statements in future filings.

The audited consolidated financial statements do not purport to reflect or provide for the consequences of the Creditor Protection Proceedings. In particular, such consolidated financial statements do not purport to show: (a) as to assets, their realizable value on a liquidation basis or their availability to satisfy liabilities; (b) as to pre-petition liabilities, the amounts that may be allowed for claims or contingencies, or the status and priority thereof; (c) as to shareholders accounts, the effect of any changes that may be made in the Company’s capitalization; or (d) as to operations, the effect of any changes that may be made in the Company’s business.

American Institute of Certified Public Accountants Statement of Position 90-7, “Financial Reporting by Entities in Reorganization under the Bankruptcy Code” (SOP 90-7), which is applicable to companies in Chapter 11 of the Bankruptcy Code, generally does not change the manner in which financial statements are prepared. However, among other disclosures, it does require that the financial statements for periods subsequent to the filing of the Chapter 11 petition distinguish transactions and events that are directly associated with the reorganization from the ongoing operations of the business. Revenues, expenses, realized gains and losses, and provisions for losses that can be directly associated with the reorganization and restructuring of the business must be reported separately as reorganization items in the statements of operations. The balance sheet must distinguish prepetition liabilities subject to compromise from both those prepetition liabilities that are not subject to compromise and from post-petition liabilities. Liabilities that may be affected by a plan of reorganization must be reported at the amounts expected to be allowed, even if they may be settled for lesser amounts. In addition, reorganization items must be disclosed separately in the statement of cash flows. Spansion adopted SOP 90-7 effective March 1, 2009 and will segregate those items as outlined above for all reporting periods subsequent to such date.

Furthermore, effective on the Commencement Date, pursuant to FASB Statement No. 160 (Statement 160), Noncontrolling Interests in Consolidated Financial Statements, an Amendment of ARB No. 51, the Company must deconsolidate Spansion Japan as, by virtue of the Spansion Japan Proceeding, and despite its 100% ownership interest, the Company is no longer deemed to control Spansion Japan. Spansion Japan will cease to be included in the Company’s consolidated operating results and financial position commencing with the presentation of its interim results for the first quarter of fiscal 2009. Transactions between the Company and Spansion Japan will be reflected in a manner similar to transactions with unrelated parties. The Company is currently assessing the impact the deconsolidation will have on its future operating results and financial position.

93

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

Fiscal Year

The Company operates on a 52- to 53-week fiscal year ending on the last Sunday in December. The year ended December 28, 2008 and December 30, 2007 consisted of 52 weeks each. December 31, 2006 consisted of 53 weeks.

4. Summary of Significant Accounting Policies

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries after elimination of intercompany accounts and transactions.

Use of Estimates

The preparation of consolidated financial statements and disclosures in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of commitments and contingencies and the reported amounts of revenues and expenses during the reporting periods. Estimates are used to account for the fair value of certain marketable securities, revenue, the allowance for doubtful accounts, inventory valuation, valuation of acquired intangible assets, impairment of long-lived assets, income taxes, stock-based compensation expenses, product warranties and pension and postretirement benefits. Actual results may differ from those estimates, and such differences may be material to the financial statements.

Cash Equivalents

Cash equivalents consist of financial instruments that are readily convertible into cash and have original maturities of three months or less at the time of purchase.

Marketable Securities

The Company’s investments in marketable securities consist of auction rate securities (ARS), for which the underlying assets are student loans. As of December 30, 2007 and through October 2008, the investments in ARS were designated as available-for-sale and reported at fair value with the related unrealized gains and losses included in accumulated other comprehensive income (loss), net of tax, a component of stockholders equity. In November 2008, the Company reclassified its investments in ARS as trading securities and the investments are now adjusted to market through earnings each reporting period. The Company recognizes an impairment charge on available-for-sale marketable securities in earnings when the declines in the fair values of its investments below the cost basis are judged to be other-than-temporary. The Company considers various factors in determining whether to recognize a decline in value, including the length of time and extent to which the fair value has been less than the Company’s cost basis, the financial condition and near-term prospects of the issuer or investee, and the Company’s intent and ability to hold the investment for a period of time sufficient to allow for any anticipated recovery in market value. During fiscal 2008, and prior to their being reclassified to trading securities, the Company determined that the fair value its ARS was less than the carrying value and as a result, the Company recorded other than temporary impairment charges of $27.9 million for its ARS investments. The cost of securities sold is based on the specific identification method. The Company generally classifies investments in marketable securities as current when, at the date of acquisition, their remaining time to maturity is less than or equal to 12 months or, if the time to maturity is greater than 12 months, when they represent investments of cash that are intended to be used in current operations. Historically, given the liquidity created by

94

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

the auctions, ARS were presented as current assets. However, given the recently failed auctions, and based on the Company executing its put option agreement with UBS in November 2008 (see Note 17), the Company classified its investment in ARS as long-term on the accompanying consolidated balance sheet as of December 28, 2008.

Allowance for Doubtful Accounts

The Company maintains an allowance for doubtful accounts based on a variety of factors, including the length of time the receivable is past due, historical experience and the financial condition of customers.

The following describes activity in the accounts receivable allowance for doubtful accounts for the years ended December 28, 2008, December 30, 2007 and December 31, 2006.

Year	Balance at Beginning of Period		Additions Charged to Costs and Expenses		Deductions			Balance at End of Period
	(in thousands)
2008	$	6,156	$	2,276	$	(326	)	$	8,106
2007	$	4,597	$	1,559	$	—		$	6,156
2006	$	2,214	$	2,383	$	—		$	4,597

Inventories

Inventories are stated at standard cost adjusted to approximate the lower of actual cost (first-in, first-out method) or market. The Company records a provision for excess and obsolete inventory based on its estimated forecast of product demand. Demand for the Company’s products can fluctuate significantly from period to period. Historically, inventories in excess of forecasted customer demand over the next six months were not valued. However, beginning in the second quarter of fiscal 2008, as part of a strategy to efficiently manage its new production capacity and to maintain strategic inventory levels of certain products, the Company has built and valued certain inventory to meet estimated demand as much as twelve months into the future. Obsolete inventories are written off.

Revenue Recognition

Prior to the second quarter of fiscal 2006, the Company generally recognized revenue when AMD and Fujitsu, the Company’s sole distributors, sold its products to their OEM customers. In the second quarter of fiscal 2006, the Company began selling its products directly to the customers previously served by AMD. Since such time, the Company generally recognizes revenue when it has sold its products to its OEM customers and title and risk of loss for the products have transferred to the OEM. Estimates of product returns and sales allowances, related to reasons other than product quality, are based on actual historical experience and are recorded as a reduction in revenue at the time revenue is recognized.

Beginning in the second quarter of fiscal 2006, the Company also began selling directly to distributors to whom it provided similar rights of return, stock rotation and price protection previously offered by AMD. The Company defers the recognition of revenue and related product costs on these sales as deferred income until the merchandise is resold by its distributors. The Company also sells some of its products to certain distributors under sales arrangements with terms that do not allow for rights of returns or price protection on unsold products held by them. In these instances, the Company recognizes revenue when it ships the product directly to the distributors.

95

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

Fujitsu also sells the Company’s products to its distributors. The Company’s distribution agreement with Fujitsu grants limited stock rotation rights to Fujitsu and allows Fujitsu to provide similar limited rights to some of its distributors. However, to date, Fujitsu has not extended these rights to its distributors. Accordingly, the Company recognizes revenue for sale of products sold to Fujitsu when Fujitsu sells the Company’s products to its distributors.

The Company recognizes revenue net of sales taxes, use taxes and value-added taxes directly imposed by governmental authorities on the Company’s revenue producing transactions with its customers. The Company includes shipping costs related to products shipped to customers in cost of sales.

Property, Plant and Equipment

Property, plant and equipment are stated at cost. Depreciation and amortization are provided on a straight-line basis over the estimated useful lives of the assets. Estimated useful lives of property, plant and equipment for financial reporting purposes are as follows: machinery and equipment, two to seven years; buildings and building improvements, from five to twenty-six years; and leasehold improvements, the shorter of the remaining terms of the leases or the estimated economic useful lives of the improvements (see Note 5).

The Company capitalized interest costs of $6.5 million and $16.9 million during fiscal 2008 and fiscal 2007, respectively, in connection with its SP1construction activities in Japan.

Impairment of Long-Lived Assets including Acquisition-Related Intangible Assets

The Company accounts for the impairment of long-lived assets using Financial Accounting Standards Board (FASB) Statement No. 144 (Statement 144), Accounting for the Impairment or Disposal of Long-lived Assets. For long-lived assets other than goodwill, the Company evaluates whether an impairment loss has occurred for an asset (asset group) to be held and used when events and circumstances indicate that the carrying amount of an asset (asset group) might not be recoverable. For purposes of assessing recoverability and impairment of an asset (asset group) held and used, the Company groups assets at the lowest level for which there are identifiable independent cash flows. The Company assesses recoverability by determining whether the undiscounted cash flows estimated to be generated by an asset (asset group) are less than the carrying amount of the asset (asset group). If fair value of the asset (asset group) is less than the carrying value, the impairment loss is based on the excess of the carrying amount of the asset (asset group) over its fair value. The adjusted carrying value of the related asset (asset group) establishes the new cost basis and accumulated depreciation and amortization are reset to zero. For an asset (disposal group) held for sale, impairment losses are measured at the lower of the carrying amount of the asset (disposal group) or the fair value of the asset (disposal group). For an asset (asset group) to be disposed of other than by sale, impairment losses are measured based on the excess of the carrying amount of the asset (asset group) over its respective fair value. Fair value for purposes of measuring impairments is determined by discounted future cash flows, appraisals or other methods.

As a result of an impairment analysis performed during the fourth quarter of fiscal 2008, the Company recorded a total long-lived asset impairment charge of approximately $1.6 billion for the fourth quarter of fiscal 2008 (see Note 5).

Goodwill

Goodwill represents the excess of the purchase price over the fair value of net tangible and identifiable intangible assets acquired. The Company recorded goodwill in the first quarter of fiscal 2008 in connection with

96

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

its acquisition of Saifun (see Note 6). In accordance with the provisions of Financial Accounting Standards Board (FASB) Statement No. 142 (Statement 142), Goodwill and Other Intangible Assets, goodwill amounts are not amortized, but rather are tested for impairment at least annually, or more frequently if there are indicators of impairment present, at a level within the Company referred to as the reporting unit. The Company performs its annual goodwill impairment analysis as of the last day of the fourth quarter of each fiscal year. Testing for goodwill impairment under Statement 142 requires a two step approach. Under step one the Company evaluates whether fair value of reporting unit is less than the carrying value, including goodwill. The fair value of the reporting unit is determined by generally accepted valuation techniques and may consider both the income and market approach, adjusted by an estimated control premium. The income approach requires estimates of future operating results and cash flows of Spansion discounted using estimated discount rates. The market approach involves estimating enterprise value using guideline public company multiples. If step one of the analysis demonstrates that the fair value of the reporting unit is below the carrying value the Company will proceed to step two. Under step two the Company estimates the fair values of all identifiable assets and liabilities of the reporting unit using the income, market or replacement cost approaches as appropriate. The excess of the fair value of the reporting unit over the fair values of the identified assets and liabilities is the implied fair value of goodwill. If the implied fair value of goodwill is lower than the carrying value of the goodwill, an impairment charge is recorded to reduce the carrying value to fair value.

As a result of the Company’s annual review the Company recognized an impairment charge on its remaining goodwill of $20.8 million in the fourth quarter of fiscal 2008, reducing its goodwill balance to zero (see Note 6).

Product Warranties

The Company offers a one-year limited warranty for Spansion Flash memory devices (see Note 11). At the time revenue is recognized, the Company provides for estimated costs that may be incurred under product warranty, with the corresponding expense recognized in cost of sales. Estimates of warranty expense are based on the Company’s historical experience. Warranty accruals are evaluated periodically and are adjusted for changes in experience.

Foreign Currency Translation/Transactions

The functional currency of the Company and its foreign subsidiaries, except for its wholly owned subsidiary in Japan (Spansion Japan), is the U.S. dollar. Adjustments resulting from remeasuring the foreign currency denominated transactions and balances of these subsidiaries, other than Spansion Japan, into U.S. dollar are included in operations. Adjustments resulting from translating the foreign currency financial statements of Spansion Japan, for which the functional currency is the Japanese yen, into U.S. dollar denominations are included as a separate component of accumulated other comprehensive income (loss). Gains or losses resulting from transactions denominated in currencies other than the functional currencies of the Company and its subsidiaries are recorded in cost of sales. The aggregate exchange gain (loss) included in determining net loss was $1.6 million, $6.2 million and $(0.9) million for the years ended December 28, 2008, December 30, 2007 and December 31, 2006 respectively.

Derivative Financial Instruments

The Company has sales, expenses, assets and liabilities denominated in Japanese yen and other foreign currencies. Therefore, movements in exchange rates could cause net sales and expenses to fluctuate, affecting the Company’s profitability and cash flows. The Company has in the past used foreign currency forward contracts to

97

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

reduce its exposure to foreign currency exchange rate fluctuations. Realized and unrealized gains and losses associated with these foreign currency contracts are reflected in the Company’s balance sheet and recorded in other current assets or accrued liabilities. Changes in fair value and premiums paid for foreign currency contracts are recorded directly in cost of sales. The objective of these contracts is to reduce the impact of foreign currency exchange rate movements on the Company’s operating results. The Company does not use derivatives for speculative or trading purposes, nor does the Company designate its derivative instruments as hedging instruments, as defined by FASB Statement No. 133, Accounting for Derivative Instruments and Hedging Activities.

Research and Development Expenses

The Company expenses research and development costs in the period in which such costs are incurred.

Advertising Expenses

Advertising costs are expensed as incurred. Advertising expenses for the years ended December 28, 2008, December 30, 2007 and December 31, 2006 were approximately $3.4 million, $7.4 million and $8.1 million, respectively.

Net Loss per Share

Basic and diluted net loss per share is computed based on the weighted-average number of common shares outstanding during the period.

For the years ended December 28, 2008, December 30, 2007 and December 31, 2006 respectively, the Company excluded from its diluted per share computation approximately 24.8 million, 18.4 million and 16.8 million potential shares issuable upon exercise of outstanding stock options, upon vesting of outstanding restricted stock units and upon conversion of Spansion LLC’s 2.25% Exchangeable Senior Subordinated Debentures because they had an antidilutive effect due to net losses recorded in each of those periods.

Income Taxes

In determining taxable income for financial statement reporting purposes, the Company must make estimates and judgments. These estimates and judgments are applied in the calculation of specific tax liabilities and in the determination of the recoverability of deferred tax assets, which arise from temporary differences between the recognition of assets and liabilities for tax and financial statement reporting purposes.

The Company must assess the likelihood that it will be able to recover its deferred tax assets. Unless recovery of these deferred tax assets is considered more likely than not, the Company must increase its provision for taxes by recording a charge to income tax expense, in the form of a valuation allowance against those deferred tax assets for which it believes it is more likely than not they will be realized. The Company considers past performance, future expected taxable income and prudent and feasible tax planning strategies in determining the need for a valuation allowance.

In addition, the calculation of the Company’s tax liabilities involves the application of complex tax rules and the potential for future adjustment by the relevant tax jurisdiction. If the Company’s estimates of these taxes are greater or less than actual results, an additional tax benefit or charge will result.

In July 2006, the FASB issued Financial Interpretation No. 48 (FIN 48), Accounting for Uncertainty in Income Taxes, which clarifies the accounting for uncertainty in income taxes recognized in a company’s financial

98

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

statements in accordance with FASB Statement 109, Accounting for Income Taxes. The interpretation prescribes a recognition threshold and measurement attribute criteria for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The interpretation also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Adoption on January 1, 2007 did not have a material effect on the Company’s consolidated financial statements. As of the date of adoption, the Company’s total gross unrecognized tax benefits were $2.7 million, of which $0.2 million, if recognized, would affect the Company’s effective tax rate. The recognition of the remaining unrecognized tax benefits would be offset by a change in valuation allowance.

Accumulated Other Comprehensive Income (Loss)

The following are the components of accumulated other comprehensive income (loss):

	December 28, 2008			December 30, 2007
	(in thousands)
Unrecognized pension (expense) gain, net of tax benefits of ($6,337) in 2008 and ($5,429) in 2007	$	(33,012	)	$	1,972
Cumulative translation adjustment		107,891			(38,166	)
Total accumulated other comprehensive income (loss)	$	74,879		$	(36,196	)

Stock-Based Compensation

Spansion Stock-Based Incentive Compensation Plans

The Company accounts for its stock-based incentive compensation plans in accordance with FASB Statement No, 123 (revised 2004) (Statement 123(R), Share-Based Payment. The Company estimates the fair value of its stock-based awards to employees using Black-Scholes-Merton option pricing model. Stock-based compensation expense recognized during a period is based on the higher of the grant-date fair value of the portion of share-based payment awards that is ultimately expected to vest, or actually vests, during the period. Compensation expense for all share-based payment awards is recognized using the straight-line attribution method reduced for estimated forfeitures. Prior to the fourth quarter of 2007, the Company did not have sufficient historical forfeiture experience related to its own stock-based awards and therefore, estimated its forfeitures based on the average of its own fiscal 2006 forfeiture rate and AMD’s historical forfeiture rates, as the Company believed these forfeiture rates to be the most indicative of its own expected forfeiture rate. Beginning the fourth quarter of fiscal 2007, the Company estimated forfeitures based on the weighted average of its own fiscal 2007 and 2006 forfeiture rates. Statement 123(R) requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

Pension and Post-Retirement Benefits

The Company provides a pension plan for certain employees of Spansion Japan, and as a result, the Company has significant pension benefit costs and credits that are computed and recorded in its financial statements based on actuarial valuations. The actuarial valuations require assumptions and methods which must be used to develop the best estimate of the benefit costs. These valuation assumptions include salary growth, long-term return on plan assets, discount rates and other factors. The salary growth assumptions reflect the Company’s future and near-term outlook for salary growth within the industry. Long-term return on plan assets is determined based on historical results in the debt and equity markets and management’s expectation of the

99

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

current economic environment and the allocation target and expected future yields of each asset class. The discount rate assumption is based on current investment yields on Japanese government long-term bonds, as no deep corporate market exists for high quality corporate debt instruments. Actual results that differ from these assumptions are accumulated and amortized over the future life of the plan participants. While the Company believes that the assumptions used are appropriate, significant differences in actual experience or significant changes in assumptions would affect the pension costs and obligations.

Fair Value

The Company adopted FASB Statement No. 157 (Statement 157), Fair Value Measurements, effective January 1, 2008. Statement 157 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Statement 157 establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on the reliability of inputs as follows:

Level 1—Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date. Examples of the assets carried at Level 1 fair value generally are equities listed in active markets and investments in publicly traded mutual funds with quoted market prices.

Level 2—Inputs (other than quoted prices included in Level 1) are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the asset/liability’s anticipated life.

Level 3—Inputs reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.

The availability of observable inputs can vary and is affected by a wide variety of factors, including, for example, the type of a security, whether the security is new and not yet established in the marketplace, and other characteristics particular to a transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. When observable prices are not available, the Company either uses implied pricing from similar instruments or valuation models based on net present value of estimated future cash flows, adjusted as appropriate for liquidity, credit, market and/or other risk factors. Fair value is a market-based measure considered from the perspective of a market participant rather than an entity-specific measure. Therefore, even when market assumptions are not readily available, the Company’s own assumptions are set to reflect those it believes market participants would use in pricing the asset or liability at the measurement date. See Note 17 for fair value disclosure related to the Company’s marketable securities.

New Accounting Pronouncements

In February 2007, the FASB issued Statement No. 159 (Statement 159), The Fair Value Option for Financial Assets and Financial Liabilities—Including an amendment of FASB Statement No. 115. Under

100

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

Statement 159, a company may choose, at specified election dates, to measure eligible financial instrument and certain other items at fair value that are not otherwise required to be so measured. If a company elects the fair value option for an eligible item, changes in that item’s fair value in subsequent reporting periods must be recognized in current earnings. Statement 159 is effective as of the beginning of the fiscal years beginning after November 15, 2007. Upon initial adoption, this statement provides entities with a one-time chance to elect the fair value option for the eligible items. The effect of the first measurement to fair value should be reported as a cumulative-effect adjustment to the opening balance of retained earnings in the year the statement is adopted. The Company adopted Statement 159 at the beginning of its fiscal year 2008 and did not make any elections for fair value accounting. Therefore, the Company did not record a cumulative-effect adjustment to its opening retained earnings balance. However, the Company did elect the fair value option in accounting for the UBS put option asset as a result of management’s intent to exercise its put option during the period June 30, 2010 to July 3, 2012. See Note 17 for further disclosure regarding the accounting for the UBS put option.

In December 2007, the FASB issued Statement No. 160, Noncontrolling Interests in Consolidated Financial Statements—an Amendment of ARB No. 51. Statement 160 will require that noncontrolling interests in subsidiaries be reported as a component of stockholders’ equity in the consolidated balance sheet. Statement 160 also requires that earnings or losses attributed to the noncontrolling interests be reported as part of consolidated earnings and not as a separate component of income or expense, as well as requires disclosure of the attribution of consolidated earnings to the controlling and noncontrolling interests on the face of the consolidated statement of operations. Statement 160 is effective for fiscal years beginning after December 15, 2008 and must be applied on a prospective basis. As disclosed in Note 3, the Company must, pursuant to Statement 160, deconsolidate Spansion Japan effective with the Commencement Date. The Company is currently assessing the impact this pronouncement will have on its future operating results and financial position.

In February 2008, the FASB issued FASB Staff Position (FSP) FAS 157-2, Effective Date of FASB Statement No. 157, which provides a one year deferral of the effective date of Statement 157 for non-financial assets and non-financial liabilities, except those that are recognized or disclosed in the financial statements at fair value at least annually. The Company has adopted the provisions of Statement 157 with respect to its financial assets and liabilities only and it will therefore adopt Statement 157 for non-financial assets and non-financial liabilities that are not measured at fair value on a recurring basis as of the beginning of the first quarter of fiscal 2009. This adoption is not expected to have a significant impact on the Company’s consolidated financial statements.

In March 2008, the FASB issued Statement No. 161 (Statement 161), Disclosures about Derivative Instruments and Hedging Activities—an amendment of FASB Statement No. 133 (Statement 133). Statement 161 changes the disclosure requirements for derivative instruments and hedging activities. Entities are required to provide enhanced disclosures about (a) how and why an entity uses derivative instruments, (b) how derivative instruments and related hedged items are accounted for under Statement 133 and its related interpretations, and (c) how derivative instruments and related hedged items affect an entity’s financial position, financial performance and cash flows. Statement 161 does not change the accounting for derivative instruments. The guidance in Statement 161 is effective for the Company beginning in the first quarter of fiscal 2009.

In May 2008, the FASB issued FSP APB 14-1, Accounting for Convertible Debt Instruments That May Be Settled in Cash upon Conversion (Including Partial Cash Settlement) (FSP APB 14-1). The FSP requires convertible debt which may be settled in cash upon conversion, including partial cash conversion, to be separated into debt and equity components at issuance with a value to be assigned to each component in a manner that will reflect the entity’s non convertible debt borrowing rate. The difference between the cash proceeds from debt issuance and the fair value assigned to the debt will be recorded as a debt discount and amortized to interest

101

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

expense over the life of the debt. The effective date of this FSP is for financial statements issued for fiscal years beginning after December 15, 2008 and interim periods within those fiscal years and it does not permit earlier application. However, the transition guidance requires retroactive application to all periods presented. The FSP APB 14-1 will impact the Company’s accounting for its Exchangeable Senior Subordinated Debentures. The equity component would be included in the paid-in capital portion of stockholders’ equity on the balance sheet and the value of the equity component would be treated as an original issue discount for purposes of accounting for the debt component. Although FSB APB 14-1 will have no impact on the Company’s actual past or future cash flows, it will require the Company to record additional non-cash interest expense as the debt discount is amortized which will adversely impact earnings per share. Higher interest expense will result by recognizing accretion of the discounted carrying value of the 2.25% Exchangeable Senior Subordinated Debentures to their face amount as interest expense over the term of the debt. Interest expense associated with the 2.25% Exchangeable Debt for prior periods will also be higher than previously reported due to the retrospective application of FSP APB 14-1. Based on the preliminary analysis performed by the Company, the interest expense associated with its 2.25% Exchangeable Debt will be approximately $3.2 million, $6.5 million and $7.5 million higher for fiscal years 2006, 2007 and 2008, respectively, as a result of adopting this FSP.

In October 2008, the FASB issued FSP FAS 157-3, Determining the Fair Value of a Financial Asset in a Market That Is Not Active, which clarifies the application of Statement 157 when the market for a financial asset is inactive. Specifically, FSP FAS 157-3 clarifies how (1) management’s internal assumptions should be considered in measuring fair value when observable data are not present, (2) observable market information from an inactive market should be taken into account, and (3) the use of broker quotes or pricing services should be considered in assessing the relevance of observable and unobservable data to measure fair value. The guidance in FSP FAS 157-3 was effective upon issuance and the Company has adopted its provisions with respect to its financial assets as of September 28, 2008.

In December 2008, the FASB issued FSP FAS 132(R)-1, Employer’s Disclosures about Postretirement Benefit Plan Assets, which amends FASB Statement No. 132 (Revised 2003), Employers’ Disclosures about Pensions and Other Postretirement Benefits, to provide guidance on an employer’s disclosures about plan assets of a defined benefit pension or other postretirement plan. The disclosures about plan assets required by this FSP shall be provided for fiscal years ending after December 15, 2009. Upon initial application, the provisions of this FSP are not required for earlier periods that are presented for comparative purposes. This FSP does not affect the accounting treatment for postretirement benefit plans. The Company will adopt this FSP for the fiscal year ending December 27, 2009.

5. Impairment of Long-Lived Assets including Acquisition-Related Intangible Assets

A variety of external economic factors have contributed to the decline in the Company’s operating performance, such as persistent oversupply in the Flash memory industry compounded by the global economic recession. The 2008 global economic downturn has caused a sharp decline in worldwide demand for consumer goods and, consequently, a sharp reduction in demand for the Company’s products, which resulted in significant declines in the Company’s manufacturing capacity utilization as the Company reduced production. In addition to these economic factors, the ramp-up of SP1 was delayed during the second and third quarters of 2008 due to slower than expected customer qualifications and the steep decline in the Japanese wireless market. These factors, among others, caused the Company’s stock price to drop significantly throughout 2008, resulting in a sustained market capitalization well below book value.

Given these indicators of impairment, the Company believed its long-lived assets including its acquisition-related intangible assets, may not be recoverable at December 28, 2008. Because of the vertical nature of the Company’s manufacturing operations and its multiple foundry, assembly and test facilities, the cash flows of the

102

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

Company’s assets and liabilities below the entity level are not largely independent of one another and, therefore, the Company evaluated recoverability using a single, entity-wide asset group that included all of the Company’s long-lived assets and related operating assets and liabilities. The Company prepared an undiscounted cash flow analysis and determined that the carrying value of the asset group exceeded the undiscounted cash flows expected from the use and eventual disposition of the asset group and, therefore, the asset group was not recoverable. Accordingly, the Company estimated the fair value of the asset group based on a probability weighted cash flow forecast, discounted based on the Company’s weighted-average cost of capital. The total carrying value of the asset group exceeded management’s estimated fair value indicating an impairment loss. The excess carrying value of the asset group over its fair value was allocated on a pro rata basis to the individual assets in the asset group to adjust and reduce their carrying values. In this process, the adjusted carrying value of an individual asset was not reduced to below its individual fair value, if determinable. The adjusted carrying values of the assets established a new cost basis for the assets and depreciation and amortization was reset to zero.

As a result of this impairment analysis, the Company recorded a total long-lived asset impairment charge of approximately $1.6 billion for the fourth quarter ended December 28, 2008, reflecting the low demand for semiconductor equipment worldwide, coupled with excess supply. This charge is comprised of the following:

	in millions
Property, plant and equipment	$	1,578.4
Acquisition-related intangible assets		53.5
Total	$	1,631.9

6. Acquisition of Saifun Semiconductors Ltd. (Saifun)

On March 18, 2008, the Company completed the acquisition of all of the outstanding shares of Saifun Semiconductor Ltd., a publicly held company headquartered in Netanya, Israel (the Acquisition). The Company has included the results of operations of Saifun beginning March 18, 2008 in its consolidated statements of operations for the year ended December 28, 2008.

Saifun is a provider of intellectual property (IP) solutions for the non-volatile memory (NVM) market and licenses its IP to semiconductor manufacturers that use this technology to develop and manufacture a variety of non-volatile Flash memory based products including products that integrate Flash memory with logic as well as dedicated standalone Flash memory devices. The Company believes that the acquisition of Saifun provides the Company an opportunity to expand its product portfolio and enter into the technology licensing business.

The Company paid a consideration of approximately 22.7 million shares of the Company’s Class A common stock for all outstanding Saifun common shares. In addition, the Company also assumed all of the outstanding Saifun stock options which were converted into options to purchase approximately 4.3 million shares of the Company’s Class A common stock. The total purchase price for Saifun was $119.3 million and is comprised of:

	in millions
22.7 million shares of Class A common stock	$	98.4
Fair value of vested options and restricted stock units issued		10.5
Acquisition related transaction costs		10.4
Total purchase price	$	119.3

103

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

The fair value of the Company’s common stock issued was determined in accordance with EITF Issue No. 99-12, Determination of the Measurement Date for the Market Price of Acquirer Securities Issued in a Purchase Business Combination, which reflected the average of the closing prices of the Company’s common stock on the NASDAQ for the two trading days prior to and following December 13, 2007, the date that the number of issuable shares became fixed. The fair value of the Company’s options and restricted stock units was determined under FASB Statement 123R. The vested portion of these options and restricted stock units was valued at approximately $10.5 million. The unvested portion was valued at approximately $6.3 million and will be amortized ratably over the future remaining service periods.

In accordance with EITF Issue No. 04-1, Accounting for Pre-existing Relationships between the Parties to a Business Combination, the Company reviewed its existing contracts with Saifun as of the date of the acquisition to determine if such contracts included terms that were favorable or unfavorable when compared to pricing for current market transactions for the same or similar terms which will result in a settlement gain or loss as of this date. A settlement gain or loss is measured as the lesser of (a) the amount by which the agreements were favorable or unfavorable to market terms or (b) the stated settlement provisions of the agreements available to the Company. The Company concluded that the terms in the pre-existing relationship were neither favorable nor unfavorable and, accordingly, the Company recognized no gain or loss relating to its existing contracts with Saifun as of the acquisition date.

Purchase Price Allocation

The total purchase price was allocated to Saifun’s tangible and identifiable intangible assets and liabilities based on their estimated fair values as of March 18, 2008, as set forth below:

	in millions
Net tangible assets acquired	$	24.2
Existing technology		42.8
In process research and development		10.8
Non-competition agreement		1.3
Customer relationships		18.0
Trade name		1.4
Goodwill		20.8
Total purchase price	$	119.3

Management performed an analysis to determine the fair value of each tangible and identifiable intangible asset, including the portion of the purchase price attributable to acquired in-process research and development projects.

In-Process Research and Development

Of the total purchase price, approximately $10.8 million was allocated to in-process research and development (IPR&D) and was expensed in the first quarter of fiscal 2008. Projects that qualify as IPR&D represent those that have not reached technological feasibility and have no alternative future use at the time of the acquisition. These projects included development of top injection technology and Nitride-Read-Only-Memory (NROM) design projects.

The value assigned to IPR&D was determined using a discounted cash flow methodology, specifically an excess earnings approach, which estimates value based upon the discounted value of future cash flows expected

104

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

to be generated by the in-process projects, net of all contributory asset returns. The approach includes consideration of the importance of each project to the overall development plan, estimating costs to develop the purchased IPR&D into commercially viable products.

The discount rates applied to individual projects were selected after consideration of the overall estimated weighted average cost of capital and the discount rates applied to the valuation of the other assets acquired. Such weighted average cost of capital was adjusted to reflect the difficulties and uncertainties in completing each project and thereby achieving technological feasibility, the percentage of completion of each project, anticipated market acceptance and penetration, market growth rates and risks related to the impact of potential changes in future target markets. In developing the estimated fair values, the Company used a discount rate of 20.8 percent.

Other Acquisition Related Intangible Assets

The Company determined the fair value of other acquisition related intangible assets using income approaches and based the rates on the most current financial forecast available as of March 18, 2008. The discount rates used to discount net cash flows to their present values was 17.8 percent. The Company determined these discount rates after consideration of the Company’s estimated weighted average cost of capital. The Company recorded the excess of the purchase price over the net tangible and identifiable intangible assets as goodwill.

The estimated useful lives for the acquired intangible assets were based upon Saifun’s historical experience with technology life cycles, product roadmaps and Spansion’s intended future use of the intangible assets. The Company amortized acquisition related intangible assets using the straight-line method over their then estimated useful lives.

Existing technology represents Saifun’s core technology, Nitride-Read-Only-Memory (NROM) intellectual property. NROM technology doubles the storage of a Flash memory cell by creating two distinct and independent charges in a single cell. This technology asset was estimated to have a useful life of six years. As a result of the impairment review during the fourth quarter of 2008 (see Note 5), the Company recorded an impairment of $35.6 million, reducing the carrying value of NROM intellectual property to $1.6 million.

Customer relationships represent Saifun’s existing contractual relationships as of March 18, 2008, which were estimated to have an average useful life of seven years. As a result of the impairment review during the fourth quarter of 2008 (see Note 5), the Company recorded an impairment of $16.0 million, reducing the carrying value of Saifun customer relationships to $0.

Trade names were estimated to have an average useful life of four years. As a result of the impairment review during the fourth quarter of 2008 (see Note 5), the Company recorded an impairment of $1.1 million, reducing the carrying value of trade names to $0.

Non-competition agreements represent agreements with four key employees and were estimated to have a useful life of two years. As a result of the impairment review during the fourth quarter of 2008 (see Note 5), the Company recorded an impairment of $0.8 million, reducing the carrying value of the non-competition agreements to $0.

105

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

The changes in the carrying amount of acquisition-related intangible assets for 2008 were as follows:

(in millions)	Gross Cost		Accumulated Amortization			Impairment			Net Carrying Amount		Weighted Average Amortization in Months
Existing technology	$	42.8	$	(5.6	)	$	(35.6	)	$	1.6	72
Customer relationships		18.0		(2.0	)		(16.0	)		—	84
Trademarks and trade names		1.4		(0.3	)		(1.1	)		—	48
Non competition agreement		1.3		(0.5	)		(0.8	)		—	24
Total	$	63.5	$	(8.4	)	$	(53.5	)	$	1.6

Estimated future amortization expense related to existing technology is $0.3 million per year through 2013 and $0.1 million in 2014.

In the fourth quarter of 2008, pursuant to its accounting policy, the Company performed its annual analysis of goodwill. To perform step 1 of the analysis, the Company used a combination of the income approach and the guideline public company market approach, equally weighted. The income approach utilized the same forecast and other assumptions used to assess recoverability and measure impairment of its long-lived assets other than goodwill. The step 1 analysis indicated the fair value of its single reporting unit to be significantly below its carrying value and the step 2 analysis indicated the implied fair value of its goodwill was zero. As a result, the Company recognized an impairment charge on its remaining goodwill of $20.8 million, reducing its goodwill balance to zero.

Income Taxes

Deferred tax liabilities of $8.6 million were recorded when the acquisition occurred. At the end of fiscal 2008, the remaining deferred tax liabilities of $6.6 million were recorded as an income tax benefit because most of the acquisition related intangible assets were impaired.

Pro Forma Information

The following unaudited pro forma consolidated financial information gives effect to the Saifun acquisition as if it had occurred at the beginning of the fiscal periods presented. The pro forma consolidated financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition had taken place at the beginning of each of the periods presented nor is it indicative of future financial performance.

	Year Ended
	December 28, 2008			December 30, 2007
	(in thousands, except per share amounts)
Total net sales	$	2,284,333		$	2,518,756
Net loss	$	(2,432,868	)	$	(294,158	)
Basic and diluted net loss per share	$	(15.21	)	$	(1.87	)

106

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

7. Stock-Based Compensation

AMD Stock Options

Through December 25, 2005, AMD granted stock options to the Company’s employees with an aggregate grant-date value of approximately $19.4 million. The Company paid AMD approximately $8.5 million for stock options during the year ended December 31, 2006. On November 21, 2006, the Company closed a public offering of its Class A common stock held by AMD and Fujitsu. As a result of the offering, AMD’s ownership interest in the Company dropped below 30 percent and, by their terms all unvested AMD stock options and AMD RSU awards held by the Company’s employees were forfeited and cancelled. The Company wrote off its remaining liability to AMD of approximately $9.2 million against additional paid-in capital, a component of stockholders’ equity, because the original agreed upon value of these awards to be paid to AMD was recorded as a reduction of contributed capital, a component of stockholders’ equity. In addition, upon cancellation of the options in the fourth quarter of fiscal 2006, the Company reversed against additional paid-in capital approximately $6 million of previously recorded compensation expense associated with these forfeited and cancelled awards, which had been recorded using variable fair value accounting.

Spansion Stock-Based Incentive Compensation Plans

Plan Descriptions

2005 Equity Incentive Plan

In fiscal 2005, the Company’s stockholders approved the Spansion Inc. 2005 Equity Incentive Plan (the 2005 Plan) under which 9,500,000 shares of Class A common stock had been reserved and made available for issuance in the form of equity awards, including incentive and nonqualified stock options and RSU awards. On May 29, 2007, the Company’s stockholders approved the Spansion Inc. 2007 Equity Incentive Plan (the 2007 Plan) (see below); at that time, the Company discontinued granting awards under the 2005 Plan.

The 2005 Plan was administered by the Compensation Committee of the Company’s Board of Directors, and with respect to that plan, the Committee had the authority to, among other things, grant awards, delegate certain of its powers, accelerate or extend the vesting or exercisability of awards and determine the date of grant of an award. Shares that are subject to or underlie awards that expired or for any reason were cancelled, terminated or forfeited, or failed to vest after implementation of the 2007 Plan are again available for grant under the 2007 Plan. The maximum term of any stock option granted under the 2005 Plan is 10 years from the date of grant and the exercise price of each option is determined under the applicable terms and conditions as approved by the Compensation Committee.

The 2005 Plan provided for awards that may be granted to an officer or employee, a consultant or advisor, or a non-employee director of the Company or its subsidiaries; provided that, the incentive stock options granted under the 2005 Plan could be granted only to employees of the Company or its subsidiaries. The exercise price of each incentive stock option was required to be not less than 100 percent of the fair market value of the Company’s Class A common stock on the date of grant (not less than 110 percent if such stock option is granted to a person who has more than 10 percent of the total voting power of all classes of the Company’s stock).

The 2005 Plan provided for payment of the exercise price of options in the form of, among other things, cash, services rendered, notice and third party payments as authorized by the Compensation Committee, delivery of shares of common stock and cashless exercise with a third party who provides financing for the purposes of the purchase or exercise of the award.

107

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

The Compensation Committee could, in its discretion, accelerate vesting of awards under the plan under certain circumstances, including:

• the acquisition by a person other than AMD or its affiliates of more than 33 percent of either the then outstanding shares of the Company’s common stock or the combined voting power entitled to vote in the election of directors, except for any such acquisition by Fujitsu or its affiliates so long as such level of ownership is (1) less than AMD’s level of ownership in such securities and (2) not more than 40 percent of the Company’s outstanding shares of the Company’s common stock or the combined power entitled to vote in the election of directors;

• a change in the Board such that individuals who comprised the Board at the effective date of the 2005 Equity Incentive Plan cease to constitute at least a majority of the Board; and

• the consummation of a reorganization, share exchange, merger, consolidation, or a sale or other dispositions of all or substantially all of the Company’s assets.

Although grants are no longer awarded under the 2005 Plan, outstanding grants that were awarded under that plan continue to be administered by the Compensation Committee.

2007 Equity Incentive Plan

On May 29, 2007, the Company’s stockholders approved the Spansion Inc. 2007 Equity Incentive Plan (the 2007 Plan). The 2007 Plan is administered by the Compensation Committee of the Company’s Board of Directors, and with respect to this plan, the Committee has the authority to, among other things, grant awards, delegate certain of its powers, accelerate or extend the vesting or exercisability of awards and determine the date of grant of an award subject to certain restrictions. The 2007 Plan provides that grants may be awarded to an officer or employee, a consultant or advisor, or a non-employee director of the Company or its subsidiaries. Stock options and RSU awards issued under the 2007 Plan generally vest 25 percent after one year, and the balance vest ratably on a quarterly basis over the following three years and expire if not exercised by the seventh anniversary of the grant date. RSU awards have no exercise price or expiration date.

The maximum number of shares of the Company’s Class A Common Stock that may be issued or transferred pursuant to awards under the 2007 Plan equals the sum of: (1) 6,675,000 shares, plus (2) the number of shares that were available for award grant purposes under the 2005 Plan as of May 29, 2007, plus (3) the number of any shares subject to stock options and restricted stock or RSU awards granted under the 2005 Plan and outstanding as of May 29, 2007 which expire, or for any reason are cancelled or terminated, after that date without being exercised or paid. As of May 29, 2007, approximately 920,523 shares were available for award grant purposes under the 2005 Plan, and approximately 7,091,852 shares were subject to options and restricted stock or RSU awards then outstanding under the 2005 Plan.

The Compensation Committee may, in its discretion, accelerate vesting of awards under the plan under certain circumstances, including:

• the acquisition by a person of more than 33 percent of either the then outstanding shares of the Company’s common stock or the combined voting power entitled to vote in the election of directors.

• a change in the Board such that individuals who comprised the Board at the effective date of the 2005 Equity Incentive Plan cease to constitute at least a majority of the Board; and

• the consummation of a reorganization, share exchange, merger, consolidation, or a sale or other dispositions of all or substantially all of the Company’s assets.

108

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

Saifun Semiconductors Ltd. Employee Share Option Plans (Saifun Option Plans)

The Company assumed all outstanding option shares under the Saifun 1997, 2001 and 2003 plans (Saifun Option Plans), which were converted into options to purchase shares of the Company’s Class A common stock. Each option share assumed continues to have, and be subject to, the same terms and conditions of such options immediately prior to the acquisition date.

When Saifun implemented the Saifun Semiconductors Ltd. 2003 Share Option Plan (Saifun 2003 Plan), all Saifun shares that were then available for grant under the earlier Saifun share option plans were acquired by the Saifun 2003 Plan. At that time, Saifun stopped granting awards under the prior plans, and granted all subsequent awards under the Saifun 2003 Plan. The Saifun 2003 Plan provides that awards may be granted to employees, contractors, directors, and consultants of Saifun and Saifun subsidiaries, although certain option awards that are governed by specific Israeli tax rules may be granted to eligible employees and directors only.

For options granted under the Saifun Option Plans, the exercise period may not exceed 10 years from the date of grant. Options are granted with an exercise price equal to the market price of the stock at the date of grant or at a lower price as may be determined by the compensation committee of the board of directors at the date of grant. Prior to the Acquisition, option awards vested over a period of up to five years; restricted stock unit and option awards granted after the Acquisition will vest over a period of up to four years. Awards granted under any of the Saifun Option Plans from the inception of the Saifun 2003 Plan through the Acquisition that are forfeited or cancelled revert to the Saifun 2003 Plan reserve. Future awards granted under the Saifun 2003 Plan that are forfeited or cancelled will also revert to that plan’s reserve.

Shares Available to Grant

The numbers of shares of Class A common stock available for grant under the 2007 Plan and the Saifun 2003 Plan are as follows:

Number of shares available for grant:
Amount reserved for grant(1)	12,126,424
Shares available under the 2005 Plan(2)	602,480
Stock options granted through December 28, 2008, net of cancelled stock options	(6,648,801	)
RSU awards granted through December 28, 2008, net of cancelled RSU awards	(1,994,130	)
Shares available for grant under the 2007 Plan and Saifun 2003 Plan	4,085,973

(1) The 12,126,424 shares reserved for grant under the 2007 Plan consisted of 6,675,000 shares approved for grant under the 2007 Plan and 920,523 shares transferred from the 2005 Plan and 4,530,901 shares from Saifun Option Plans.

(2) The shares available under the 2005 Plan were related to stock options or RSU awards, which were cancelled subsequent to the adoption of the 2007 Plan and thus available for grant under the 2007 Plan.

109

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

Valuation and Expense Information

The following table sets forth the total recorded stock-based compensation expense for the Spansion Stock-Based Incentive Compensation Plans (Spansion Plans and Saifun Option Plans) by financial statement caption, resulting from the Company’s stock options and RSU awards for the years ended December 28, 2008, December 30, 2007 and December 31, 2006:

	Year Ended December 28, 2008		Year Ended December 30, 2007		Year Ended December 31, 2006
	( in thousands)
Cost of sales	$	5,340	$	4,539	$	5,650
Research and development		6,424		4,335		4,667
Sales, general and administrative		9,816		7,263		6,988
Stock-based compensation expense before income taxes(1)	$	21,580	$	16,137	$	17,305

(1) There is no income tax benefit relating to stock option expenses because all of the Company’s U.S. deferred tax assets, net of U.S. deferred tax liabilities, continue to be subjected to a full valuation allowance.

The weighted average fair value of the Company’s stock options granted in the years ended December 28, 2008 and December 30, 2007 under Spansion Plans and Saifun Option Plans was $1.89 and $4.81 per share, respectively. The fair value of each stock option was estimated at the date of grant using a Black-Scholes-Merton option pricing model, with the following assumptions for grants:

	Weighted Average for the Year Ended December 28, 2008		Weighted Average for the Year Ended December 30, 2007		Weighted Average for the Year Ended December 31, 2006
Expected volatility	48.66	%	48.50	%	58.00	%
Risk-free interest rate	2.67	%	4.73	%	4.82	%
Expected term (in years)	5.05		4.61		4.60
Dividend yield	0	%	0	%	0	%

The Company’s dividend yield is zero because the Company has never paid dividends and does not have plans to do so over the expected life of the stock options. The expected volatility is based on the Company’s historical volatility since its initial public offering in December 2005 and the volatilities of the Company’s competitors who are in the same industry sector with similar characteristics (guideline companies) given the limited historical realized volatility data of the Company. The risk-free interest rate is based on the yield from U.S. Treasury zero-coupon bond with a remaining term equal to the expected stock option life. The expected term is based on the “simplified method” provided in Staff Accounting Bulletin Topic 14, Share-Based Payment, for developing the estimate of the expected life of a “plain vanilla” stock option except for options granted to Saifun on the date of acquisition for which expected term was based on historical option exercise activity. Under this approach, the expected term is presumed to be the mid-point between the average vesting date and the end of the contractual term. The Company estimated forfeitures based on its historical forfeiture rates. Statement 123(R) requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates in order to derive the Company’s best estimate of awards ultimately expected to vest.

110

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

As of December 28, 2008, the total unrecognized compensation cost related to unvested stock options and RSU awards was approximately $38.5 million after reduction for estimated forfeitures, and such stock options and RSU awards will generally vest ratably through 2012.

Stock Option and Restricted Stock Unit Activity

The following table summarizes stock option activities and related information under Spansion Plans and Saifun Option Plans for the period presented:

	Number of Shares		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life (in years)	Aggregate Intrinsic Value (in thousands)
Options:
Outstanding as of December 31, 2006	2,134,906		$	12.63
Granted	1,770,062		$	10.39
Cancelled	(363,000	)	$	12.45
Exercised	(5,000	)	$	12.00
Outstanding as of December 30, 2007	3,536,968		$	11.53	5.66	$	—
Granted(1)	6,806,119		$	1.48
Cancelled	(537,156	)	$	6.32
Exercised	(26,534	)	$	0.08
Outstanding as of December 28 2008	9,779,397		$	4.85	6.42	$	675
Exercisable as of December 28, 2008	2,704,484		$	8.39	4.67	$	102

(1) The number of options granted in the year ended December 28, 2008 includes 4,364,829 shares of options granted in March 2008 under Saifun Option Plans in accordance with the provisions of the Acquisition Agreement.

The aggregate intrinsic value in the preceding table represents the total pretax intrinsic value, based on the Company’s closing stock price of $0.22 as of December 26, 2008, which was the last trading day prior to December 28, 2008, which would have been received by the stock option holders had all stock option holders exercised their stock options as of that date.

111

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

The following table summarizes RSU award activities and related information for the period presented:

	Number of Shares		Weighted- Average Grant-date Fair Value
Restricted Stock Units:
Unvested as of December 31, 2006	2,923,615		$	12.33
Granted	1,680,532		$	10.35
Cancelled	(303,430	)	$	11.95
Vested	(1,147,291	)	$	12.27
Unvested as of December 30, 2007	3,153,426		$	11.33
Granted	1,916,180		$	2.93
Cancelled	(400,909	)	$	8.74
Vested	(1,368,132	)	$	11.51
Unvested as of December 28, 2008	3,300,565		$	6.69

Employee Stock Purchase Plan

The 2005 Employee Stock Purchase Plan was approved by the Company’s Board of Directors but has not been implemented. This plan is intended to qualify as an “employee stock purchase plan” under Section 423 of the Internal Revenue Code with the purpose of providing eligible employees (including officers) and eligible employees of participating subsidiaries with an opportunity to purchase Class A common stock through payroll deductions. The 2005 Employee Stock Purchase Plan would allow eligible and participating employees to purchase, through payroll deductions, shares of Class A common stock at a discount, not to exceed 15 percent, applied to either (1) the fair market value per share of Class A common stock on the first business date of an offering period, or (2) the fair market value per share of Class A common stock on the last business date of that offering period. The Company has reserved 2,250,000 shares of Class A common stock available for issuance under this plan. As of December 28, 2008, no shares have been issued under this plan and the Company has not determined whether it will issue shares under this plan in the future.

8. Related Party Transactions

Prior to the second quarter of fiscal 2006, the Company relied on AMD and Fujitsu as sole distributors of its products. The Company also receives some administrative services from AMD. Upon the issuance of the Company’s Class A common stock to complete the acquisition of Saifun on March 18, 2008, AMD’s voting interest in the Company declined below 10 percent. Thereafter AMD is no longer deemed to be a related party of the Company as its percentage of voting interest in the Company fell below 10 percent and it has no representation on the Company’s board of directors.

112

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

The transactions with AMD for the period from December 31, 2007 to March 18, 2008, the closing date of the Saifun acquisition were not material. The following tables present the related party transactions and account balances between the Company and AMD:

	Year Ended December 30, 2007			Year Ended December 31, 2006
	(in thousands)
Net sales to AMD(1)	$	—		$	336,172
Cost of sales:
Royalties to AMD	$	3,184		$	6,228
Service fees to AMD(2):
Cost of sales	$	(1,395	)	$	3,276
Research and development		205			11,591
Sales, general and administrative		476			19,981
Total service fees to AMD	$	(714	)	$	34,848

(1) In the second quarter of fiscal 2006, the Company began selling its products directly to the customers previously served by AMD.

(2) Service fees to AMD are net of reimbursements from AMD, primarily for facility related charges.

	December 30, 2007
	(in thousands)
Trade accounts receivable from AMD, net of allowance for doubtful accounts	$	2,976
Other receivables from AMD	$	6,488
Accounts payable to AMD	$	3,597
Royalties payable to AMD	$	1,629

Prior to the fourth quarter of fiscal 2008, the Company relied on Fujitsu as a sole distributor of its products. In the fourth quarter of fiscal 2008, in addition to selling through Fujitsu, the Company began selling its products directly to the customers previously served by Fujitsu. The Company receives certain administrative services from Fujitsu, a holder of 10 percent or more of the Company’s voting securities. The charges for these services are negotiated annually between the Company and Fujitsu based on the Company’s expected requirements and the estimated future costs of the services to be provided. Fujitsu provides test and assembly services to the Company on a contract basis and also provides foundry and sort services to the Company since consummation of the JV1/JV2 transaction (the sale of the Company’s two wafer fabrication facilities located in Aizu-Wakamatsu, Japan) which occurred in the second quarter of fiscal 2007. The Company also purchases commercial die from Fujitsu, which is packaged together with the Company’s Flash memory devices. Fujitsu seconded certain employees to the Company until the second quarter of fiscal 2006. The company paid these employees directly.

The Company licenses certain intellectual property from Fujitsu in exchange for the payment of royalties to Fujitsu. These royalty expenses are recognized in cost of sales. The Company was required to pay Fujitsu semi- annual royalties based on net sales (minus the costs of commercial die). The royalty as a percentage of sales declined to zero in November 2008.

The Company entered into a five-year License Settlement Agreement with Fujitsu on September 11, 2008 resulting in the payment of quarterly royalties based on certain percentage thresholds of actual sales of the Company’s Flash memory products (minus sales by Fujitsu to Spansion under its existing foundry agreement for wafers which are incorporated into Spansion’s Flash memory products and to be sold by Spansion to Fujitsu

113

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

under the existing Distribution Agreement), subject to a maximum amount of $10 million over the five-year term. These royalty payments are recognized in cost of sales in the Company’s Income Statement.

Effective September 29, 2008, Fujitsu transferred to the Company and the Company retired the one share of Class C common stock. As a result of the transfer, Fujitsu no longer has a right to appoint any directors to the Company’s Board of Directors.

The following tables present the significant related party transactions and account balances between the Company and Fujitsu:

	Year Ended December 28, 2008			Year Ended December 30, 2007			Year Ended December 31, 2006
	(in thousands)
Net sales to Fujitsu	$	651,230		$	873,560		$	932,623
Cost of sales:
Royalties to Fujitsu	$	3,184		$	3,184		$	6,228
Other purchases of goods and services from Fujitsu and rental expense to Fujitsu		79,138			75,515			117,999
Subcontract manufacturing and commercial die purchases from Fujitsu		8,771			22,110			66,095
Wafer purchases, processing and sort services from Fujitsu(1)		244,317			188,133			—
Net gain recognized on sale of assets to Fujitsu on April 2, 2007(1)		(34,543	)		(30,191	)		—
Reimbursement on costs of employees seconded to Fujitsu(1)		(29,057	)		(21,040	)		—
Pension curtailment loss(1)		—			2,010			—
Equipment rental income from Fujitsu(1)		(3,692	)		(5,848	)		—
Administrative services income from Fujitsu(1)		(1,311	)		(1,138	)		—
	$	266,807		$	232,735		$	190,322
Service fees to Fujitsu:
Cost of sales	$	28		$	739		$	2,269
Research and development		10			950			2,453
Sales, general and administrative		610			1,079			4,220
Service fees to Fujitsu	$	648		$	2,768		$	8,942
Cost of employees seconded from Fujitsu:
Cost of sales	$	—		$	—		$	27
Research and development		—			—			61
Sales, general and administrative		—			—			95
Cost of employees seconded from Fujitsu	$	—		$	—		$	183

(1) These amounts relate to the JV1/JV2 Transaction which was consummated on April 2, 2007.

114

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

	December 28, 2008		December 30, 2007
	(in thousands)
Trade accounts receivable from Fujitsu	$	111,448	$	183,670
Other receivables from Fujitsu	$	6,127	$	5,385
Accounts payable to Fujitsu	$	74,592	$	53,332
Royalties payable to Fujitsu	$	1,617	$	1,629
Accrued liabilities to Fujitsu	$	3,475	$	6,461

9. Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, marketable securities, trade receivables and foreign currency forward contracts. The Company places its investments in cash equivalents and marketable securities with high quality credit financial institutions and, by policy, limits the amount of credit exposure with any one financial institution.

Concentration of credit risk with respect to trade receivables exists because the Company sells a significant portion of its products directly to Fujitsu. Trade accounts receivable from Fujitsu comprised approximately 47 percent and 50 percent of the total consolidated trade accounts receivable balance as of December 28, 2008 and December 30, 2007, respectively. However, the Company does not believe the receivable balances from Fujitsu subject the Company to significant credit risk as historical losses have not been significant and Fujitsu’s own customer base represents a large number of geographically diverse companies. Fujitsu is required to pay its trade receivables regardless of whether it can collect from its customers. The Company does not require collateral or other security from Fujitsu or other customers.

The counterparties relating to the Company’s financial activities, including investing, borrowing and foreign exchange hedging, consist of large international financial institutions. The Company does not believe that there is significant risk of nonperformance by these counterparties because the Company monitors their credit ratings and limits the financial exposure and the notional amount of agreements entered into with any one financial institution. While the notional amounts of derivative financial instruments are often used to express the volume of these transactions, the potential accounting loss on these transactions if all counterparties failed to perform is limited to the amounts, if any, by which the counterparties’ obligations under the contracts exceed the Company’s obligations to the counterparties. As of December 28, 2008 and December 30, 2007, the Company had a total notional amount of approximately $0 million and $120.5 million in outstanding foreign currency forward exchange contracts, respectively. As of December 30, 2007, the fair values of the Company’s foreign currency forward contracts were not significant.

115

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

10. Financial Instruments

Available-for-sale securities held by the Company as of December 28, 2008 and December 30, 2007 are as follows:

	Amortized Cost		Gross Unrealized Gains		Fair Value
	(in thousands)
2008
Cash equivalents:
Money market funds	$	74,118	$	—	$	74,118
2007
Cash equivalents:
Money market funds	$	66,500	$	—	$	66,500
Commercial paper		29,869		—		29,869
Total cash equivalents	$	96,369	$	—	$	96,369
Marketable securities:
Auction rate securities	$	216,650	$	—	$	216,650

As of December 28, 2008, the Company had approximately $94.0 million of marketable securities classified as trading securities and, accordingly, not included in the table above. These securities consist solely of ARS, substantially all of which are backed by pools of student loans guaranteed by the FFELP, and all were rated AAA/Aaa. Due to the failures in the auction markets subsequent to February 2008, the Company recorded approximately $27.9 million of other than temporary impairment on such securities as of December 28, 2008 and classified them as long-term (see Note 17).

As of December 28, 2008 and December 30, 2007, the Company’s amortized cost of the cash equivalents approximated the fair values of the securities and the unrealized gains and losses on these securities were not significant. The money market funds are available on demand. As of December 30, 2007, the Company’s amortized cost of marketable securities approximated the fair values of the securities and the unrealized gains and losses on these securities were not significant. All the commercial paper instruments had contractual maturities of less than one year for fiscal 2007. The ARS had underlying assets of municipal bonds and student loans with varying maturity dates.

Fair Value of Other Financial Instruments

Substantially all of the Company’s long-term debt is traded in the market and the fair value in the table below is based on the quoted market price as of the balance sheet date. The fair value of the Company’s long-term debt that is not traded in the market is estimated by considering the Company’s credit rating, the interest rates and the terms of the debt. The carrying amounts and estimated fair values of the Company’s debt instruments are as follows:

	December 28, 2008				December 30, 2007
	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
	(in thousands)
Total debt obligations	$	1,459,429	$	414,830	$	1,327,321	$	1,152,207

116

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

The fair value of the Company’s accounts receivable and accounts payable approximate their carrying value based on existing payment terms.

11. Warranties and Indemnities

The Company generally offers a one-year limited warranty for its Flash memory products.

Changes in the Company’s liability for product warranty during the years ended December 28, 2008, December 30, 2007, and December 31, 2006 are as follows:

	December 28, 2008			December 30, 2007			December 31, 2006
	(in thousands)
Balance, beginning of fiscal year	$	1,305		$	1,350		$	1,000
Provision for warranties issued		12,552			4,593			4,529
Settlements		(12,258	)		(2,065	)		(5,562	)
Changes in liability for pre-existing warranties during the period, including expirations		(110	)		(2,573	)		1,383
Balance, end of fiscal year	$	1,489		$	1,305		$	1,350

In addition to product warranties, the Company, from time to time in its normal course of business, indemnifies other parties with whom it enters into contractual relationships, including customers, directors, lessors and parties to other transactions with the Company, with respect to certain matters. The Company agrees to hold the other party harmless against specified losses, such as those arising from a breach of representations or covenants, third-party infringement claims or other claims made against certain parties. It is not possible to determine the maximum potential amount of liability under these indemnification obligations due to the limited history of indemnification claims and the unique facts and circumstances that are likely to be involved in each particular claim and indemnification provision.

12. Debt and Capital Lease Obligations

The following table discloses the company’s debt and capital lease obligations as of:

	December 28, 2008		December 30, 2007
	(in thousands)
Debt obligations:
Spansion China Bank Enterprise Cooperation Loan Facility	$	—	$	5,405
Senior Notes		233,025		230,628
Spansion Penang Loan		138		2,028
Exchangeable Senior Subordinated Debentures		207,000		207,000
Spansion Japan 2007 Credit Facility		287,963		256,503
Senior Secured Floating Rate Notes		625,617		625,757
Senior Secured Revolving Credit Facility		34,000		—
Spansion Japan 2007 Revolving Credit Facility		71,687		—
Obligations under capital leases		82,593		74,012
Total debt and capital lease obligations		1,542,023		1,401,333
Less current portion		1,331,777		101,797
Long-term debt and capital lease obligations, less current portion	$	210,246	$	1,299,536

117

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

Spansion China Bank Enterprise Cooperation Loan Facility

On December 1, 2005, Spansion China entered into a bank enterprise cooperation agreement with a local financial institution, effective as of October 24, 2005. Under the terms of the agreement, Spansion China may draw under two credit facilities, equal to $26 million and RMB 176 million (approximately $22 million as of October 24, 2005), respectively. Borrowings must be used for working capital purposes. The interest rate for each loan denominated in RMB is a floating rate per annum and is set at the time each loan agreement is entered into. The interest rate may thereafter be adjusted every 12 months at a rate equal to the benchmark rate published by the People’s Bank of China for RMB loans of the same term less a ten percent discount. The interest rate for each loan denominated in US dollars is a floating rate per annum and is initially set at the time each revolving loan agreement is entered into. The interest rate is thereafter adjusted every six months at a rate equal to the six-month London Interbank Offered Rate (LIBOR) plus one percent. The US dollar denominated loan agreements are unsecured. Under the terms of the agreements, Spansion China is prohibited from encumbering any of its assets.

As of December 30, 2007, the amount outstanding under the US dollar denominated loan agreement was approximately $5.4 million. There was no amount outstanding under the RMB credit facility. The two credit facilities terminated on June 22, 2008 and Spansion China repaid the remaining principal balance of approximately $5.4 million and accrued interest thereon.

Senior Notes

On December 21, 2005, the Company completed an offering of $250 million aggregate principal amount of 11.25% Senior Notes due 2016. The Senior Notes were issued at 90.302 percent of face value, resulting in net proceeds to the Company of approximately $218.1 million after deducting the initial purchasers’ discount and estimated offering expenses. The Senior Notes are general unsecured senior obligations of Spansion LLC and will rank equal in right of payment with any of the Company’s existing and future senior debt. Interest is payable on January 15 and July 15 of each year beginning July 15, 2006 until the maturity date of January 15, 2016.

Certain events may result in the accelerated maturity of the Senior Notes, including a default in any interest, principal or premium amount payment; a merger, consolidation or sale of all or substantially all of the Company’s property; a breach of covenants in the Senior Notes or the Senior Note indenture; a default in certain debts; or if a court enters certain orders or decrees under any bankruptcy law. Upon occurrence of one of these events, the principal of and accrued interest on all of the Senior Notes, as the case may be, may become immediately due and payable. If the Company incurs any judgment for the payment of money in an aggregate amount in excess of $50 million or takes certain voluntary actions in connection to insolvency, all amounts on the Senior Notes shall become due and payable immediately.

On January 16, 2009, the Company delayed making the interest payment on its Senior Notes due 2016, which was due January 15, 2009. Under the Senior Notes indenture, a failure to make an interest payment is subject to a 30-day cure period. The Company did not make this interest payment within the 30-day cure period, which expired on February 14, 2009. The failure to make the interest payment within the cure period is an event of default under the Senior Notes Indenture, which resulted in all obligations under the Senior Notes Indenture (approximately $266 million as of the date of the event of default) automatically becoming due and payable.

Spansion Penang Loan

On January 29, 2004, Spansion Penang entered into a financial arrangement with AMD. Under the terms of the arrangement, Spansion Penang borrowed approximately 29.0 million Malaysian ringgit (approximately $8.0

118

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

million based on the exchange rate as of January 29, 2004) from AMD to fund the purchase of manufacturing equipment. In January 2006, this loan was transferred from AMD to a third-party financial institution. The loan bears a fixed annual interest rate of 5.9 percent and is payable in equal, consecutive, monthly principal and interest installments through February 2009.

As of December 28, 2008 and December 30, 2007, the amount outstanding under this loan facility was approximately 0.48 million Malaysian ringgit (approximately $0.1 million) and 6.7 million Malaysian ringgit (approximately $2.0 million), respectively.

On February 5, 2009, Spansion Penang repaid the balance outstanding under this loan in full.

Exchangeable Senior Subordinated Debentures

In June 2006, Spansion LLC, the wholly owned operating subsidiary of the Company, issued $207.0 million of aggregate principal amount of 2.25% Exchangeable Senior Subordinated Debentures due 2016. The Debentures are general unsecured senior subordinated obligations and rank subordinate in right of payment to all of the Company’s senior indebtedness, including the Senior Notes, and senior in right of payment to all of the Company’s subordinated indebtedness. The Debentures bear interest at 2.25 percent per annum. Interest is payable on June 15 and December 15 of each year beginning December 15, 2006 until the maturity date of June 15, 2016.

The Debentures were not exchangeable prior to January 6, 2007. On January 6, 2007, the Debentures became exchangeable for shares of the Company’s Class A common stock, cash or a combination of cash and shares of such Class A common stock, at the Company’s option. Full conversion of the Debentures into shares would result in an initial exchange rate of 56.7621 shares of Class A common stock per debenture representing an initial exchange price of approximately $17.6174 per share of Spansion Inc. Class A common stock. The debentures have not been exchanged for Class A common stock as of December 28, 2008.

The Company, at any time prior to maturity may make an irrevocable election to satisfy the exchange obligation in cash up to 100 percent of the principal amount of the debentures exchanged, with any remaining amount to be satisfied in shares of Class A common stock or a combination of cash and shares of Class A common stock at the above exchange ratio. In the event that the Company makes this irrevocable election, debenture holders may exchange their debentures only under the following circumstances:

• during any fiscal quarter after the Company’s fiscal quarter ending April 1, 2007 (and only during such fiscal quarter) if the sale price of Spansion Inc. Class A common stock, for at least 20 trading days during the period of 30 consecutive trading days ending on the last trading day of the previous fiscal quarter, is greater than or equal to 120 percent of the conversion price per share of the Spansion Inc. Class A common stock;

• subject to certain exceptions, during the five business day period following any five consecutive trading day period in which the trading price of the debentures for each day of such period was less than 98 percent of the product of the sale price of the Spansion Inc. Class A common stock and the number of shares issuable upon exchange of $1,000 principal amount of the debentures; or

• Upon the occurrence of specified corporate events that constitute a fundamental change of the Company under certain circumstances. The holders of the Debentures will have the ability to require the Company to repurchase the Debentures in whole or in part for cash in the event of a fundamental change of the Company. In such case, the repurchase price would be 100 percent of the principal amount of the Debentures plus any accrued and unpaid interest.

119

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

In May 2008, the FASB issued FSP APB 14-1, Accounting for Convertible Debt Instruments That May Be Settled in Cash upon Conversion (Including Partial Cash Settlement) (FSP APB 14-1). The FSP requires convertible debt which may be settled in cash upon conversion, including partial cash conversion, to be separated into debt and equity components at issuance with a value to be assigned to each component in a manner that will reflect the entity’s non convertible debt borrowing rate. The difference between the cash proceeds from debt issuance and the fair value assigned to the debt will be recorded as a debt discount and amortized to interest expense over the life of the debt. The effective date of this FSP is for financial statements issued for fiscal years beginning after December 15, 2008 and interim periods within those fiscal years and it does not permit earlier application. However, the transition guidance requires retroactive application to all periods presented. The FSP APB 14-1 will impact the Company’s accounting for the Company’s Debentures. The equity component would be included in the paid-in capital portion of stockholders’ equity on the balance sheet and the value of the equity component would be treated as an original issue discount for purposes of accounting for the debt component. Although FSB APB 14-1 will have no impact on the Company’s actual past or future cash flows, it will require the Company to record additional non-cash interest expense as the debt discount is amortized which will adversely impact earnings per share. Higher interest expense will result by recognizing accretion of the discounted carrying value of the Debentures to their face amount as interest expense over the term of the debt. Interest expense associated with the Debentures for prior periods will also be higher than previously reported due to the retrospective application of FSP APB 14-1. Based on the preliminary analysis performed by the Company, the interest expense associated with the Debentures will be approximately $7.5 million, $6.5 million and $3.2 million higher for fiscal years 2008, 2007 and 2006, respectively, as a result of adopting this FSP.

The Spansion Japan Proceedings constituted an event of default, causing acceleration of the outstanding obligations under the Debentures.

Spansion Japan 2007 Credit Facility

On March 30, 2007, Spansion Japan entered into a committed senior facility agreement with certain Japanese financial institutions that provides Spansion Japan with a 48.4 billion yen senior secured term loan facility (approximately $533.8 million as of December 28, 2008).

Spansion Japan could, pursuant to the terms of this facility, borrow amounts in increments of 1.0 billion yen (approximately $11.0 million as of December 28, 2008). Amounts borrowed under this facility bear interest at a rate equal to the three-month Tokyo Interbank Offered Rate (TIBOR), at the time of the drawdown, which resets quarterly, plus a margin of two percent per annum. Borrowing availability was based on capital deliveries for Spansion Japan’s SP1 facility. The drawdown period expired on March 31, 2008.

Pursuant to the terms of Spansion Japan 2007 Credit Facility, Spansion Japan is not permitted, among other things, to create any security interests or liens on any of its pledged assets and to sell or dispose of any of its pledged assets, subject to certain exceptions. This facility may be terminated in the event of default in accordance with the terms of this facility. Events of default under the facility include, among other things, the following: a default in performance of payment; if any of debt obligations of Spansion LLC exceeding $25.0 million, or of Spansion Japan exceeding 1.0 billion yen, are not paid when due; or if any debt obligations of Spansion Japan or Spansion LLC are accelerated or otherwise become due and payable, in each case if not cured within applicable time periods set forth in the Spansion Japan 2007 Credit Facility.

In March 2008, Spansion Japan borrowed an additional amount of 5.6 billion yen (approximately $61.8 million as of December 28, 2008) under this facility. The Company began to make quarterly principal

120

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

installments in the second quarter of fiscal 2008. The facility bears interest at approximately 2.9 percent and is scheduled to be repaid in quarterly principal installments through the fourth quarter of fiscal 2010. This facility is collateralized by the assets of Spansion Japan with a net book value of 42.0 billion yen (approximately $463.1 million as of December 28, 2008).

As of December 28, 2008 and December 30, 2007, the outstanding balance under this facility was 26.1 billion yen (approximately $288.0 million) and 28.8 billion yen (approximately $256.5 million).

The Spansion Japan Proceedings constituted an event of default, causing acceleration of the outstanding obligations under the Spansion Japan 2007 Credit Facility. As the acceleration of the outstanding obligations was caused by the Spansion Japan Proceedings, which accord Spansion Japan protection from its creditors while it continues its restructuring efforts, payments under the Spansion Japan 2007 Credit Facility have been stayed and this facility continues to be classified under its contractual payment terms as of December 28, 2008.

Senior Secured Floating Rate Notes

In May 2007, Spansion LLC, the wholly owned operating company subsidiary of the Company, issued $625.0 million aggregate principal amount of the Senior Secured Floating Rate Notes due 2013 (the Notes). Interest on the Notes accrues at a rate per annum, reset quarterly, equal to the 3-month LIBOR plus 3.125 percent. Interest is payable on March 1, June 1, September 1 and December 1 of each year beginning September 1, 2007 until the maturity date of June 1, 2013. As of December 28, 2008, the Notes bear interest at approximately 5.33 percent.

In connection with the issuance of the Notes, the Company, Spansion LLC and Spansion Technology Inc. executed a pledge and security agreement pursuant to which and subject to exceptions specified therein, the Notes are secured by a first priority lien on all of Spansion LLC’s inventory (excluding returned inventory), equipment and real property and proceeds thereof (excluding receivables or proceeds arising from sales of inventory in the ordinary course of business), presently owned or acquired in the future by Spansion LLC and by each of the current and any future guarantors. The Notes are also secured by a second-priority lien that is junior to the liens securing Spansion LLC’s Senior Secured Revolving Credit Facility agreement, as amended, on substantially all other real and personal property and proceeds thereof, including receivables or proceeds arising from sales of inventory in the ordinary course of business presently owned or acquired in the future by the Company and by each of the current and any future guarantors. The Notes are further secured by certain deeds of trust related to real property owned by Spansion LLC in California and Texas. As of December 28, 2008, the Notes are collateralized by a first priority lien on the Company’s inventory and property, plant and equipment with a total net book value of approximately $632.6 million, and by a second priority lien on the Company’s accounts receivables with a net book value of approximately $145.4 million

Upon the occurrence of a change of control of Spansion LLC, holders of the Notes may require Spansion LLC to repurchase the Notes for cash equal to 101 percent of the aggregate principal amount to be repurchased plus accrued and unpaid interest. Beginning June 1, 2008, Spansion LLC may redeem all or any portion of the Notes, at any time or from time to time at redemption prices specified therein.

Certain events are considered “Events of Default,” which may result in the accelerated maturity of the Notes, including:

• Spansion LLC’s failure to pay when due the principal or premium amount on any of the Notes at maturity, upon acceleration, redemption, optional redemption, required repurchase or otherwise;

121

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

• Spansion LLC’s failure to pay interest on any of the Notes for 30 days after the date when due;

• Spansion LLC’s or the guarantors’ failure to comply with certain restrictions on Spansion LLC’s or Guarantors’ ability to merge, consolidate or sell substantially all of its assets;

• Spansion LLC’s failure to perform or observe any other covenant or agreement in the Notes or in the Indenture for a period of 45 days after receiving notice of such failure;

• A default by Spansion LLC or any restricted subsidiary (as defined in the Indenture) under any indebtedness that results in acceleration of such indebtedness, or the failure to pay any such indebtedness at maturity, in an aggregate principal amount in excess of $50.0 million (or its foreign equivalent at the time);

• If any judgment or judgments for the payment of money in an aggregate amount in excess of $50.0 million (or its foreign equivalent at the time) is rendered against Spansion LLC, the guarantors or any significant subsidiary and is not waived, satisfied or discharged for any period of 60 consecutive days during which a stay of enforcement is not in effect;

• Certain events of bankruptcy, insolvency or reorganization with respect to Spansion LLC or any significant subsidiary;

• If any note guaranty ceases to be in full force and effect, other than in accordance with the terms of the Indenture, or a guarantor denies or disaffirms its obligations under its note guaranty, other than in accordance with the terms of the Indenture; or

• Any lien securing the collateral underlying the Notes at any time ceases to be in full force and effect, and does not constitute a valid and perfected lien on any material portion of the collateral intended to be covered thereby, if such default continues for 30 days after notice.

The Spansion Japan Proceedings constituted an event of default, causing acceleration of the outstanding obligations under the Notes. Subsequent to the filing for the Creditor Protection Proceedings, a group purporting to hold substantial amounts of the Company’s publicly traded Senior Secured Floating Rate Notes due 2013 has organized (the Floating Rate Noteholders). The role of the Floating Rate Noteholders in the Creditor Protection Proceedings may develop and change over the course of such proceedings.

Senior Secured Revolving Credit Facility

On May 9, 2007, Spansion LLC, the agent and the other lenders party to the Senior Secured Revolving Credit Facility amended the credit agreement and the security agreement in connection therewith, and the Company, STI and Spansion International entered into certain new security agreements. Pursuant to the amendment to the revolving facility credit agreement, lenders consented to the incurrence of the Senior Secured Floating Rate Notes and the grant of related liens. This resulted in the revolving credit facility lenders and the Senior Secured Floating Rate Notes holders holding substantially similar security. The relative priorities of the classes of lenders in various types of collateral is set forth in an intercreditor agreement between the agent for the revolving credit facility lenders and the trustee and collateral agent for the Senior Secured Floating Rate Notes holders.

122

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

On December 23, 2008, Spansion LLC, the agent and other financial institutions entered into another amendment (the Amendment), which amended the Credit Agreement (as amended, the Agreement) and the Security Agreement. The Amendment, among other things, provides the following changes to the Agreement:

• Amounts available for borrowing under the Agreement have been reduced from up to an aggregate of $175 million to up to an aggregate of $45 million.

• Minimum cash flow requirements have been added to provide that on the last day of each of the following measurement periods Spansion is required, on a consolidated basis, to have cash flow of at least (or no more negative than):

Measurement Period:	Cash Flow
The fiscal quarter ending on December 28, 2008	$	(90,000,000	)
The two consecutive fiscal quarters ending on March 29, 2009	$	(100,000,000	)
The three consecutive fiscal quarters ending on June 28, 2009	$	(70,000,000	)
The four consecutive fiscal quarters ending on September 27, 2009	$	(85,000,000	)
The five consecutive fiscal quarters ending on December 27, 2009	$	(120,000,000	)

• The minimum EBITDA requirements have been revised to provide that on the last day of each of the following fiscal quarters Spansion is required to maintain EBITDA, on a consolidated basis, as follows:

Three-Month Period Ending:	EBITDA
December 28, 2008	$	220,000,000
March 29, 2009	$	240,000,000
June 28, 2009	$	270,000,000
September 27, 2009	$	280,000,000
December 27, 2009	$	310,000,000

The Amendment also (i) imposes an availability block at all times in the amount of $25 million, (ii) permits certain indebtedness to be incurred by the Company from UBS Bank USA (UBS) and the incurrence of liens on certain auction rate securities created in favor of UBS to secure such indebtedness, and (iii) waives any existing EBITDA covenant default.

As of December 28, 2008, the total outstanding balance under this credit facility was $34 million. This amount bears interest at approximately 5.7 percent as of December 28, 2008. On February 20, 2009, the Company repaid the balance outstanding under this credit facility in full.

The Spansion Japan Proceedings constituted an event of default, causing acceleration of the outstanding obligations under the Senior Secured Revolving Credit Facility.

Spansion Japan 2007 Revolving Credit Facility

On December 28, 2007, Spansion Japan entered into the Spansion Japan 2007 Revolving Credit Facility agreement with the several financial institutions that provides for a revolving credit facility in the aggregate principal amount of up to 14.0 billion yen (approximately $154.4 million as of December 28, 2008).

Available amounts for borrowing under this credit facility are limited to the amount of trade receivables held by Spansion Japan arising from the sale of the Company’s products to Fujitsu. If at anytime the aggregate amount of borrowings under this credit facility exceeds the amount of the trade receivables, Spansion Japan is obligated to prepay an amount such that the borrowings outstanding after such prepayment are below the level of

123

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

the trade receivables. Borrowings may be for a term of one week or more, but not more than three months, as determined by Spansion Japan. Amounts borrowed under this credit facility bear interest at a rate equal to TIBOR, at the specified date preceding or at the time of the borrowing in accordance with the terms of this credit facility, plus a margin of 0.50 percent per annum.

Pursuant to the terms of this credit facility, Spansion Japan is not permitted, among other things, to create any security interests or liens on the trade receivables; change its primary business; subordinate the payment of its debt under this credit facility to the payment of any unsecured debts; and enter into any merger, company partition, exchange or transfer of shares, assign all or a part of its business or assets to a third party, or otherwise transfer all or a material part of its assets to a third party, subject to certain exceptions.

As of December 28, 2008, the outstanding balance under this facility is 6.5 billion yen (approximately $71.7 million). This amount bears interest at approximately 1.0 percent as of December 28, 2008. This facility will expire on December 28, 2009 and is extendable at each anniversary with an extension fee of 0.2 percent of the commitment amount.

The Spansion Japan Proceedings constituted an event of default, causing acceleration of the outstanding obligations under the Spansion Japan 2007 Revolving Credit Facility.

Spansion China 2008 Revolving Credit Facility

In June 2008, Spansion China entered into a revolving credit facility agreement with a local financial institution, effective as of June 27, 2008, in the aggregate principal amount of up to 80 million Yuan RMB (approximately $11.7 million as of December 28, 2008). The borrowings must be used for working capital purposes. The interest rate for each drawdown denominated in RMB is a floating rate that is benchmarked to the rate published by the People’s Bank of China for RMB loans with the same term and may, thereafter, be adjusted every month. The interest rate for each drawdown denominated in U.S. dollars is six-month LIBOR plus four percent and may, thereafter, be adjusted every six months. The last drawdown against this credit facility can be made on or before May 27, 2009.

As of December 28, 2008, the Company had no amounts outstanding under this credit facility and the Creditor Protection Proceedings did not have an impact on availability under this credit facility.

Obligations under Capital Leases

On March 26, 2008, the Company entered into an equipment lease agreement with a third-party financial institution. Under the lease agreement, the company leased certain equipment for a period of 36 months, in the amount of approximately $52.1 million, beginning on March 27, 2008. The Company accounted for the lease transaction as a capital lease.

As of December 28, 2008 and December 30, 2007, the Company had aggregate outstanding capital lease obligations, net of imputed interest, of approximately $82.6 million and $74.0 million, respectively. The aggregate weighted average interest rate for the capital lease obligations was 11.6 percent as of December 28, 2008. Obligations under these lease agreements are collateralized by the assets leased and are payable through 2011. Leased assets consist principally of machinery and equipment.

As of December 28, 2008, the gross amount of assets recorded under capital leases and accumulated amortization thereon was approximately $180 million and $78 million, respectively. In addition, the Company

124

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

recognized an impairment loss of approximately $61.9 million on the leased assets in the fourth quarter of fiscal 2008 as a result of the impairment review of long-lived assets. As of December 30, 2007, the gross amount of assets recorded under capital leases and accumulated amortization thereon was approximately $169 million and $86 million, respectively. These leased assets are included in the related property, plant and equipment category. Amortization of assets recorded under capital leases is included in depreciation expense.

On March 28, 2009, the Company submitted a motion to the Bankruptcy Court for rejection of capital leases with future principal and interest payments of approximately $43.8 million through 2011. This motion, if approved, would allow for the rejection of these leases.

Scheduled Maturities of Debt and Future Minimum Capital Lease Payments

For each of the next five years and beyond, the Company’s debt and capital lease obligations outstanding as of December 28, 2008, as impacted by the Creditor Protection Proceedings, are as follows:

	Other Debt			Capital Leases
	(in thousands)
Fiscal 2009	$	1,309,072		$	47,440
Fiscal 2010		166,715			29,412
Fiscal 2011		—			19,282
Fiscal 2012		—			—
Fiscal 2013		—
2014 and beyond		—			—
	$	1,475,787		$	96,134
Less amount representing interest		—			(13,541	)
Less amount representing discount, net of premium		(16,359	)		—
Total	$	1,459,428		$	82,593

13. Commitments

Certain equipment and facilities are leased under various operating leases expiring at various dates through the year 2017. Certain of these leases contain renewal options. Rental expense was approximately $23.8 million, $33.3 million, and $28.9 million for the years ended December 28, 2008, December 30, 2007 and December 31, 2006, respectively.

Future minimum lease payments under operating leases and unconditional commitments to purchase manufacturing supplies and services (UPCs) as of December 28, 2008 are as follows:

	Operating Leases		UPCs
	(in thousands)
Fiscal 2009	$	15,521	$	129,861
Fiscal 2010		5,651		87,784
Fiscal 2011		2,458		44,566
Fiscal 2012		962		20,246
Fiscal 2013		401		2,415
2014 & beyond		575		0
	$	25,568	$	284,872

125

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

UPCs include agreements to purchase goods or services that are enforceable and legally binding on the Company and that specify all significant terms, including fixed or minimum quantities to be purchased; fixed, minimum or variable price provisions; and the approximate timing of the transaction. These agreements are related principally to inventory and other items. UPCs exclude agreements that are cancelable without penalty.

Effective February 19, 2009, a UPC contract was terminated by one of the Company’s vendors due to the Company’s default on payments. As a result, the vendor has made a claim to the entire future UPC of approximately $210.9 million, payable through 2013. This claim has been stayed by the U.S. Bankruptcy Court.

Effective March 1, 2009, a UPC contract was renegotiated, resulting in lowering the Company’s commitment by $8.0 million through September 2010.

Effective March 31, 2009, one operating lease was cancelled and as a result, future payments of $1.7 million due on this lease through 2011 are no longer payable.

The Company has made available a ten-year $12.5 million loan commitment facility to an investee of which $4.1 million was drawn down during 2008. Additional $5.3 million was drawn down in January 2009 resulting in a remaining available loan commitment facility of $3.1 million. Draw-downs on this facility are subject to the completion of pre-determined milestones. In light of the Creditor Protection Proceedings, further draw downs under the loan agreement will be subject to approval by the US Bankruptcy Court

14. Interest Income and Other Income, Net

	Year Ended December 28, 2008			Year Ended December 30, 2007			Year Ended December 31, 2006
	(in thousands)
Gain on sale of marketable securities	$	—		$	—		$	6,884
Other than temporary impairment on marketable securities, net of gain on put		(3,270	)		—			—
Loss on early extinguishment of debt		—			(3,435	)		(17,310	)
Interest income		8,162			28,410			21,738
Gain (loss) on sale of land		—			7,477			—
Other income, net		308			143			369
	$	5,200		$	32,595		$	11,681

126

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

15. Income Taxes

The provision (benefit) for income taxes consists of:

	Year Ended December 28, 2008			Year Ended December 30, 2007			Year Ended December 31, 2006
	(in thousands)
Current:
U.S. federal	$	(350	)	$	—		$	(2,065	)
U.S. state and local		57			237			24
Foreign national and local		6,992			(3,179	)		2,373
	$	6,699		$	(2,942	)	$	332
Deferred:
U.S. federal		—			—			2,253
U.S. state and local		—			—			—
Foreign national and local		56,166			(22,202	)		(4,800	)
		56,166			(22,202	)		(2,547	)
Provision/(benefit) for income taxes	$	62,865		$	(25,144	)	$	(2,215	)

Pre-tax profit (loss) from foreign operations was ($1.2) billion, $27 million, and $10 million for the fiscal years ended December 28, 2008, December 30, 2007, and December 31, 2006, respectively.

Deferred income taxes reflect the net tax effects of tax carryovers and temporary differences between the carrying amounts of assets and liabilities for financial reporting and the balances for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities as of December 28, 2008 and December 30, 2007 are as follows:

	December 28, 2008			December 30, 2007
	(in thousands)
Deferred tax assets:
Net operating loss carryovers	$	241,648		$	213,145
Deferred distributor income		9,260			9,747
Inventory valuation		143,668			37,145
Accrued expenses not currently deductible		8,118			11,772
Pension benefits		16,721			5,691
Property, plant and equipment		685,882			88,846
Capital leases		10,875			—
Federal and state tax credit carryovers		11,736			17,539
Stock-based compensation		4,579			3,495
Intangible		607			—
Other		1,082			1,519
Total deferred tax assets		1,134,176			388,899
Less: valuation allowance		(1,071,790	)		(273,713	)
		62,386			115,186

127

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

	December 28, 2008			December 30, 2007
	(in thousands)
Deferred tax liabilities:
Inventory valuation		(7,538	)		(9,290	)
Property, plant and equipment		(34,654	)		(38,444	)
Deduction not charged against book		(3,086	)		—
Capitalized interest		(14,205	)		(11,382	)
Unrealized gain on investments		(2,901	)		(398	)
Unrealized gain on balance sheet translation		—			16
Other		(2	)		(493	)
Total deferred tax liabilities		(62,386	)		(59,991	)
Net deferred tax assets	$	—		$	55,195

For 2008, the net deferred tax assets balance consists of $15.2 million of current deferred tax assets, $47.2 million of noncurrent tax assets, fully offset by $12.0 million current deferred tax liabilities, and $50.4 million of noncurrent deferred tax liabilities. For 2007, the net deferred tax assets of $55.2 million consist of $26.6 million of current deferred tax assets and $30.0 million of noncurrent tax assets and current deferred tax liabilities of $1.4 million.

In 2008, the net valuation allowance increased by $798.1 million over that of 2007 primarily due to losses and tax credits of $299.6 million generated in the U.S. and an increase of $457.9 million in the valuation allowance associated with the deferred tax assets of the Company’s Japanese subsidiary. The $457.9 million increase was due to the Company’s change in judgment about the realizability of the Company’s Japanese deferred tax assets. In 2007, the net valuation allowance increased by $116 million over that of 2006 primarily due to losses and tax credits generated in the U.S. There was also a decrease of $21.0 million in the valuation allowance associated with the deferred tax assets of the Company’s Japanese subsidiary due to the Company’s change in judgment about the realizability of the Company’s Japanese deferred tax assets. In 2006, the net valuation allowance increased by $94 million primarily due to losses and tax credits generated in the U.S. and the net reversal of certain deferred tax liabilities from the prior year. In all periods discussed above, management concluded that valuation allowances were necessary in certain jurisdictions due to the Company’s historic net operating losses in those jurisdictions.

As of December 28, 2008, the Company had U.S. federal and state net operating loss carryforwards of approximately $657.0 million and $92.8 million respectively. These net operating losses, if not utilized, expire from 2016 to 2028. The Company also had U.S. federal and state tax credit carryovers of $18.6 million which expire from 2018 to 2028. Included in this amount are California state tax credits of $12.8 million which can be carried forward indefinitely.

If the Company conducts an offering of its common stock, it may experience an “ownership change” as defined in the Internal Revenue Code such that its ability to utilize its federal net operating loss carryforwards of approximately $657.0 million as of December 28, 2008 may be limited under certain provisions of the Internal Revenue Code. As a result, the Company may incur greater tax liabilities than it would in the absence of such a limitation and any incurred liabilities could materially adversely affect it.

128

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

The table below displays the reconciliation between statutory federal income taxes and the total provision (benefit) for income taxes.

	Tax			Rate
	(in thousands, except for percentages)
Year ended December 28, 2008
Statutory federal income tax expense	$	(827,559	)	35.0	%
State taxes		(292	)	0.1	%
Foreign income at other than U.S. rates		(8,879	)	0.4	%
Valuation allowance		899,595		(38.1	)%
Provision for income taxes	$	62,865		(2.7	)%
Year ended December 30, 2007
Statutory federal income tax expense	$	(101,024	)	35.0	%
State taxes		237		(0.1	)%
Foreign income at other than U.S. rates		(13,594	)	4.7	%
Valuation allowance		89,237		(30.9	)%
Benefit for income taxes	$	(25,144	)	8.7	%
Year ended December 31, 2006
Statutory federal income tax expense	$	(52,493	)	35.0	%
State taxes		24		0.0	%
Foreign income at other than U.S. rates		(7,677	)	5.1	%
Reserve release		(6,399	)	4.3	%
Valuation allowance		64,330		(42.9	)%
Benefit for income taxes	$	(2,215	)	1.5	%

The Company’s operations in China and Malaysia currently operate under tax holidays, which will expire in whole or in part at various dates through 2013. Certain of the tax holidays may be extended if specific conditions are met. The net impact of these tax holidays was to decrease the Company’s net loss by approximately $7.3 million in fiscal year 2008 (less then $0.05 per share diluted) $4.1 million in fiscal year 2007 (less than $0.03 per share, diluted), and $2.3 million in fiscal year 2006 (less than $0.02 per share, diluted).

The Company has made no provision for U.S. income taxes on approximately $456 million of cumulative undistributed earnings of certain foreign subsidiaries at December 28, 2008 because it is the Company’s intention to reinvest such earnings permanently. If such earnings were distributed, the Company would incur additional income taxes of approximately $28 million (subject to an adjustment for foreign tax credits and after utilizing NOL tax attributes). These additional income taxes may not result in income tax expense or a cash payment to the Internal Revenue Service, but may result in the utilization of deferred tax assets that are currently subject to a valuation allowance.

129

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

The Company adopted the provisions of FASB Financial Interpretation No. 48 (FIN 48), Accounting for Uncertainty in Income Taxes, on January 1, 2007. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

	Gross Unrecognized Tax Benefit
	(in thousands)
Balance at January 1, 2007	$	2,688
Additions based on tax positions related to the current year		566
Additions for tax positions of prior years		122
Reductions for tax positions of prior years		(617	)
Settlements		(185	)
Balance at December 30, 2007	$	2,574
Additions based on tax positions related to the current year	$	1,132
Additions for tax positions of prior years		19
Reductions for tax positions of prior years		(763	)
Settlements		(149	)
Balance at December 28, 2008	$	2,813

The Company recognizes interest and penalties related to unrecognized tax benefits in income tax expenses and such amounts were immaterial in fiscal 2008.

The Company is subject to taxation in the United States and various states and foreign jurisdictions. The Company’s tax years 2004 through 2008 are subject to examination by the tax authorities. With few exceptions, the Company is not subject to U.S. federal, state, local or foreign examinations by tax authorities for years before 2004.

The Company does not believe that it is reasonably possible that the total amounts of unrecognized tax benefits will significantly increase or decrease within the next twelve months.

16. Employee Benefit Plans

Spansion Japan Pension Plan

Through August 2005, certain employees of Spansion Japan were enrolled in a defined benefit pension plan and/or a lump-sum retirement benefit plan sponsored by Fujitsu (Fujitsu Group Employee Pension Fund or EPF). The Company, by agreement with Fujitsu, is required to fund those proportional benefit obligations attributable to the Company’s employees enrolled in these plans. Until September 1, 2005, the Company accounted for its participation in these plans as multiemployer plans wherein the expense recorded for the plans was equal to its annual cash contributions.

On September 1, 2005, the Company adopted a new pension plan (Spansion Japan Pension Plan) and changed the formula to a cash balance formula. On September 9, 2005, the plan was approved by the Japanese government. The Spansion Japan Pension Plan has two components. The first component provides a lump-sum payment, or twenty-year certain annuity or twenty-year guaranteed life annuity. The second component consists of a lump-sum payment or an optional period certain annuity. Participants have the option to choose a cash payment in lieu of participation in the second component. The assets and obligations were transferred from the “EPF” to the newly adopted Spansion Japan pension plan.

As part of the transfer of benefits from the EPF, the Spansion Japan Pension Plan also received approximately $48.7 million in pension assets directly from the EPF trust.

130

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

As a result of the adoption of the Spansion Japan Pension Plan and amendment to a cash balance formula, a prior service cost base was established for approximately $12.5 million an unrecognized net loss base was established for approximately $7.7 million and an additional minimum liability was recognized for $20.3 million.

The below tables summarizes the funded status of the plan and the related amounts recognized in the statement of financial position as of:

	December 28, 2008			December 30, 2007
	(in thousands)
Change in Projected Benefit Obligation
Projected benefit obligation, beginning of year	$	(88,047	)	$	(80,056	)
Service cost		(5,365	)		(4,548	)
Interest cost		(1,905	)		(1,625	)
Fujitsu contributions		(1,170	)		(855	)
Actuarial gain		1,181			466
Benefits paid		4,747			3,451
Curtailments		—			96
Foreign currency exchange rate changes		(21,391	)		(4,976	)
Benefit obligation, end of year	$	(111,950	)	$	(88,047	)
	December 28, 2008			December 30, 2007
	(in thousands)
Change in Fair Value of Plan Assets
Fair value of plan assets, beginning of year	$	90,073		$	77,264
Actual return on plan assets		(31,422	)		2,945
Employer contribution		8,517			7,410
Fujitsu contributions		1,170			855
Benefits paid		(4,747	)		(3,451	)
Foreign currency exchange rate changes		22,663			5,050
Fair value of plan assets at end of year	$	86,254		$	90,073
	December 28, 2008			December 30, 2007
	(in thousands)
Funded status
Fair value of plan assets	$	86,254		$	90,073
Projected benefit obligation		(111,950	)		(88,047	)
Funded status of plan	$	(25,696	)	$	2,026
Amount recognized in the statement of financial position consist of:
Noncurrent asset	$	—		$	2,026
Noncurrent liability		25,696			—
	$	25,696		$	2,026
Amount recognized in accumulated other comprehensive income consist of:
Net actuarial loss	$	35,003		$	310
Prior service cost		7,553			8,173
	$	42,556		$	8,483

131

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

The Spansion Japan Pension Plan accumulated benefit obligation was $111.2 million as of December 28, 2008.

The projected benefit obligation, accumulated benefit obligation and fair value of plan assets for pension plans with a accumulated benefit obligation in excess of plan assets as of December 28, 2008 and December 30, 2007 were as follows:

	December 28, 2008		December 30, 2007
	(in thousands)
Accumulated benefit obligation, end of year
Projected benefit obligation, end of year*	$	111,950	$	—
Accumulated benefit obligation, end of year*		111,209		—
Fair value of plan assets, end of year*		86,254		—

* There are no unfunded accumulated benefit obligations as of December 30, 2007

The below table summarizes the weighted average assumptions used for purposes of calculating the benefit obligations as of December 28, 2008 and December 30, 2007:

	December 28, 2008		December 30, 2007
Discount rate	2.00	%	2.00	%
Average rate of compensation increase	2.70	%	2.70	%
Cash balance interest crediting rate	2.00	%	2.00	%

The Company uses Japanese government bonds for setting the discount rate. The discount rate is determined by currently looking to Japanese government bond yields of approximately the same duration as plan obligations. Given that the plan covers substantially active employees and the historically low turnover experience of covered participants, the Company currently looks to 20-year Japanese government bonds when setting the discount rate.

The below table summarizes the components of the net periodic pension expense:

	December 28, 2008			December 30, 2007			December 31, 2006
	(in thousands)
Service cost	$	5,365		$	4,548		$	5,123
Interest cost		1,905			1,625			1,517
Expected return on plan assets		(4,643	)		(3,610	)		(2,818	)
Amortization of prior service cost		620			601			741
Curtailment loss		—			2,010			—
Total net periodic pension expense	$	3,247		$	5,174		$	4,563

132

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

	December 28, 2008			December 30, 2007
	(in thousands)
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income:
Curtailment effects	$	—		$	(2,010	)
Current year actuarial loss		34,693			183
Amortization of prior service credit/(cost)		(620	)		(601	)
	$	34,073		$	(2,428	)
Total recognized in net periodic benefit cost and other comprehensive income	$	37,320		$	2,746

On April 2, 2007, in accordance with FASB Statement No. 88, Employers’ Accounting for Settlements and Curtailments of Defined Benefit Pension Plans and for Termination Benefits, the Company recorded a curtailment loss of approximately $2.0 million relating to the Spansion Japan Pension Plan as a result of entering into the Employer Secondment and Transfer Agreement with Fujitsu under the JV1/JV2 transaction (see Note 7 for details of this transaction).

The actuarial loss represents the actual changes in estimated obligation and plan assets that have not yet been recognized in the income statement. Actuarial losses are not recognized immediately, but instead are accumulated as a part of the unrecognized net loss balance and amortized into net periodic pension cost over the average remaining service period of participating employees as certain thresholds are met.

The estimated amount that will be amortized from accumulated other comprehensive income into net periodic benefit cost in 2009 are as follows (in thousands):

Actuarial loss/(gain)	$	1,579
Prior service cost/(credit)		740
	$	2,319

The below table summarizes the weighted average assumptions used for purposes of calculating the net periodic pension expense for the year ended:

	December 28, 2008		December 30, 2007		December 31, 2006
Discount rate	2.00	%	2.00	%	2.00	%
Expected long-term return on plan assets	4.40	%	4.40	%	4.40	%
Average rate of compensation increase	2.70	%	2.70	%	2.70	%
Cash balance interest crediting rate	2.00	%	2.00	%	2.00	%

133

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

The Spansion Japan Pension Plan’s investment policy is to invest in assets to best match liabilities and minimize underfunding and risks to the employer related to additional pension contributions. The Company is not currently anticipating investing in non-traditional investments. The long-term rate of return on plan assets is 4.40 percent. This assumption was determined using the building block approach based upon the best estimate range of equity securities (both foreign and domestic) earning 5.0 percent to 8.0 percent and debt securities (both foreign and domestic) earning 0.5 percent to 6.0 percent as summarized below:

Asset Category	Target Allocation of Plan Assets		Expected Return by Asset Class
Equity securities	68	%	6.30	%
Debt securities	29	%	3.40	%
Cash	3	%	—
Total	100	%

The weighted-average asset allocations by asset category at December 28, 2008 and December 30, 2007 are as follows:

Asset Category	December 28, 2008		December 30, 2007
Equity securities	68	%	40	%
Debt securities	29	%	56	%
Cash	3	%	4	%
Total	100	%	100	%

No plan assets are invested in employer securities and no future benefits are currently covered by insurance contracts issued by the insurer or related parties.

The Company expects to contribute $4.8 million to the Spansion Japan pension plan during the fiscal year ending December 27, 2009. Fujitsu also is expected to contribute $1.1 million to the Spansion Japan pension plan as a result of entering into the Employer Secondment and Transfer Agreement under the JV1/JV2 transaction (see Note 7).

The below table summarizes the benefits expected to be paid in each of the next five fiscal years, and in the aggregate for the five fiscal years thereafter:

Fiscal Year	Expected Benefit Payments
2009	$	738,000
2010	$	884,000
2011	$	1,146,000
2012	$	1,322,000
2013	$	1,558,000
2014-2018	$	12,391,000

134

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

Retirement Savings Plan

Effective June 30, 2003 and through January 11, 2007, the Company elected to participate in AMD’s retirement saving program, commonly known as a 401(k) plan. Effective January 12, 2007, the Company adopted its own retirement savings plan, also known as a 401(k) plan. Under these plans, the Company’s U.S. employees were able to contribute up to 89 percent of their pre-tax salary subject to Internal Revenue Service limits. The Company matches employee contributions at a rate of 50 cents on each dollar of the first six percent of participants’ contributions, to a maximum of three percent of eligible compensation. The Company’s total matching contributions to these 401(k) plans, collectively, were approximately $7.0 million, $6.3 million and $5.3 million for the years ended December 28, 2008, December 30, 2007 and December 31, 2006, respectively.

Subsequent to year end, and effective pay periods beginning February 23, 2009, the Company suspended matches to employee contributions as part of its cost reduction efforts.

17. Fair Value

As of December 28, 2008, the fair value measurements of the Company’s financial assets consisted of the following and which are categorized in the table below based upon the fair value hierarchy:

	Level 1		Level 2		Level 3		Total
	(in millions)
Money market funds	$	74	$	—	$	—	$	74
Long term—auction rate securities		—		—		94		94
Long term—put option		—		—		27		27
Total financial assets	$	74	$	—	$	121	$	195

The table below presents reconciliations for the Company’s Level 3 financial assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the year ended December 28, 2008:

	Year Ended December 28, 2008
	(in millions)
Beginning balance as of December 31, 2007	$	—
Transfer in		122
Other than temporary impairment		(28	)
Put option		27
Ending fair value as of December 28, 2008	$	121

Auction rate securities and put option

At December 28, 2008 the Company held $94.0 million of auction rate securities (ARS) valued at fair value ($121.9 million at par) which are backed by student loans and substantially all of which are guaranteed by the U.S. government Federal Family Education Loan Program (FFELP). These securities have credit ratings of AAA and Aaa. Prior to February 2008, these securities were publicly quoted and traded in auctions relating to such investments. The fair value of these securities approximated face value due to the frequent auction periods, generally every 7 to 28 days, which provided liquidity to these investments. However, subsequent to February 2008, all of these securities failed to be traded in these auctions. Given the failures in the auction markets, as well as the lack of any correlation of these instruments to other observable market data, there are no longer observable

135

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

inputs available as defined by Levels 1 and 2 of the fair value hierarchy of Statement 157 by which to value these securities. Therefore, these auction rate securities are classified within Level 3 and their valuation requires substantial judgment and estimation of factors that are not currently observable in the market due to the lack of trading in the securities.

In November 2008, the Company accepted an offer to participate in an auction rate securities settlement from UBS, its broker, providing the Company the right, but not the obligation, to sell to UBS up to 100 percent of its ARS at par, commencing June 30, 2010. In addition, accepting this offer allowed the Company, pursuant to a no net cost revolving credit facility, to borrow up to 75 percent of the market value of these securities, as determined by the broker. The credit facility will remain outstanding until the ARS are purchased by UBS commencing June 30, 2010, or sooner, to the extent UBS exercises its rights to call some or all of the ARS (see Note 21).

The Company’s right to sell the ARS to UBS commencing June 30, 2010 through July 2, 2012 represents a put option for a payment equal to the par value of the ARS. As the put option is non-transferable and cannot be attached to the ARS if they are sold to an entity other than UBS, it represents a freestanding instrument between the Company and UBS and which is separate from the ARS, which represents an investment security between the Company and the ARS Issuer. Upon acceptance of the offer from UBS, the Company elected to measure the put option under the fair value option of FASB Statement 159 and recorded $27.5 million as the fair value of the put option asset as of December 28, 2008, with a corresponding credit to other income in the consolidated statements of operations for the year ended December 28, 2008. Simultaneously, the Company transferred its ARS from available-for-sale to trading investment securities and has classified the ARS as long-term assets. The transfer to trading securities reflects management’s intent to exercise its put option during the period June 30, 2010 to July 3, 2012. Prior to its agreement with UBS, the Company’s intent was to hold the ARS until the market recovered. In the year ended December 28, 2008, the Company recognized an other-than-temporary impairment charge of approximately $27.9 million. The Company expects that future changes in the fair value of the put option will approximate fair value movements in the related ARS. The put option will continue to be measured at fair value utilizing Level 3 inputs until the earlier of its maturity or exercise. The Company has used a discounted cash flow model to estimate the fair value of the put option as of December 28, 2008. The valuation model is based on the following key assumptions:

• A discount rate based on the two-year LIBOR (0.65%), adjusted by 209 basis points (bps) to reflect the credit risk associated with the UBS put option.

• An expected life of 18 months

At December 28, 2008, there was insufficient observable ARS market information available to determine the fair value of the Company’s ARS investments. Therefore, the Company estimated the fair values of its ARS investments at December 28, 2008 using a DCF methodology. Significant inputs used in the DCF models were the credit quality of the instruments, the percentage and the types of guarantees (such as FFELP), the probability of the auction succeeding or the security being called prior to final maturity, and an illiquidity discount factor. The key assumptions used in the discounted cash flow analysis to determine the fair values as of December 28, 2008 were the discount factor to be applied and the period over which the cash flows would be expected to occur. The discount factor used was based on the three-month LIBOR (1.47% as of December 28, 2008) adjusted by 125 basis points (bps) to reflect the current market conditions for instruments with similar credit quality at the date of the valuation. In addition, the discount factor was incrementally adjusted for a liquidity discount of 125 bps to reflect the risk in the marketplace for these investments that has arisen due to the lack of an active market. The Company applied this discount factor over the expected life of the estimated cash flows of its ARS with projected interest income of 2.69 percent per annum. The projected interest income is based on a trailing

136

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

12-month average 91-day T-bill rate at 1.49 percent as of December 28, 2008 plus 120 bps, which is the average annual yield of the Company’s ARS assuming auctions continue to fail.

18. Restructuring Charges

In the second quarter of fiscal 2008, as part of its ongoing strategic effort to improve overall productivity, the Company eliminated regular and contract positions globally, through planned consolidations, attrition, and a reduction in regular, contract and temporary workers in manufacturing, engineering, management and administrative support functions.

Restructuring charges for the year ended December 28, 2008 were as follows:

	Year Ended December 28, 2008
	(in thousands)
Employee severance pay and benefits	$	10,986
Relocation of property, plant and equipment		132
Other		43
Total restructuring charges	$	11,161

The following table summarizes the restructuring activity for the year ended December 28, 2008:

	December 28, 2008
Accrued restructuring balance as of December 30, 2007	$	—
Additional accruals		11,161
Adjustments		(29	)
Cash payments		(10,799	)
Accrued restructuring balance as of December 28, 2008	$	333

The accrued restructuring balance was included in accrued compensation and benefits in the Company’s consolidated balance sheet as of December 28, 2008.

19. Segment Reporting

Prior to the acquisition of Saifun on March 18, 2008, the Company had historically operated and measured its results in one reportable segment which primarily related to the design, development, manufacture, marketing and sale of Flash memory products for the wireless and embedded applications in the integrated category of the Flash memory market. The acquisition (see Note 6 for further details) of Saifun, whose primary activity relates to the licensing of intellectual property to semiconductor manufacturers, resulted in the Company operating and tracking Saifun’s results as a separate operating segment. However, the Saifun operating segment is not considered to be a reportable segment as it has not exceeded the quantitative thresholds established in FASB Statement No 131, Disclosures about Segments of an Enterprise and Related Information.

137

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

The Company’s Chief Operating Decision Maker, the Chief Executive Officer, evaluates performance of the Company and makes decisions regarding allocation of resources based on total Company results. The Company therefore continues to disclose its results in one reportable segment only.

The following table presents a summary of net sales by business units for fiscal 2008, 2007 and 2006:

	Year Ended
	December 28, 2008		December 30, 2007		December 31, 2006
	(in thousands)
Wireless Solutions Division (WSD)	$	1,133,181	$	1,362,508	$	1,549,155
Consumer, Set Top Box and Industrial Division (CSID)		1,134,466		1,130,265		1,025,229
Other		14,156		8,040		4,890
Total net sales	$	2,281,803	$	2,500,813	$	2,579,274

The following table presents a summary of net sales by geographic areas for the periods presented:

	Year Ended
	December 28, 2008		December 30, 2007		December 31, 2006
	(in thousands)
Geographical sales(1):
Net sales to end customers(2):
United States of America	$	307,039	$	295,632	$	174,930
China		669,231		658,205		479,040
Korea		238,370		260,854		282,596
EMEA		351,052		333,430		312,114
Others		63,972		79,132		61,799
Net sales to related parties:
United States (net sales to AMD)(3)		—		—		336,172
Japan (net sales to Fujitsu)		652,139		873,560		932,623
Total	$	2,281,803	$	2,500,813	$	2,579,274

(1) Geographical sales are based on the customer’s bill-to location.

(2) Net sales to end customers represent sales since the end of the first quarter of fiscal 2006 to AMD’s former customers and customers not served solely by Fujitsu.

(3) For fiscal year 2006, these represent sales during the first quarter.

In the second quarter of fiscal 2006, the Company began to sell directly to AMD’s former customers and customers not served solely by Fujitsu (end customers). Among those customers, one customer accounted for approximately 18 percent, 10 percent and 12 percent of the Company’s net sales in fiscal 2008, 2007 and 2006, respectively.

138

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

Long-lived assets information is based on the physical location of the assets at the end of each fiscal year. The following table presents a summary of long-lived assets by geography:

	December 28, 2008		December 30, 2007
	(in thousands)
Geographical long-lived assets:
Net property, plant and equipment
United States	$	381,097	$	1,029,930
Japan		299,789		939,437
Other countries		114,143		302,597
Total	$	795,029	$	2,271,964

20. Capital Structure

Common Stock

In November 2006, the Company completed a secondary offering of Class A common stock held by AMD and Fujitsu. In connection with this offering, the Company also sold 5,247,000 shares of Class A common stock for which it received net proceeds of approximately $68 million. All of the outstanding shares of Class D common stock held by Fujitsu were converted into shares of Class A common stock on a one-for-one basis immediately prior to the completion of this offering by resolution of the Board of Directors.

In fiscal 2007, the Company repurchased the one share of Class B held by AMD. In September 2008, the Company repurchased the one share of Class C common stock from Fujitsu. As of December 28, 2008, the common stock outstanding consists of 161,102,495 shares of Class A common stock issued and outstanding.

Except as described below or as required by law, the holders of the Company’s common stock are entitled to one vote per share on all matters to be voted on by stockholders. Stockholders are not entitled to cumulative voting rights, and, accordingly, the holders of a majority of the shares voting for the election of directors can elect the entire board if they choose to do so and, in that event, the holders of the remaining shares will not be able to elect any person to the board of directors. Amendments to the Company’s certificate of incorporation that would alter or change the powers, preferences or special rights of any class of the Company’s common stock, so as to affect the holders of such class adversely, must be proposed in a resolution adopted by the Company’s board of directors, declaring its advisability, and must be approved by a majority of the votes entitled to be cast by the holders of the shares affected by the amendment, voting as a separate class.

The terms of the Company’s current credit arrangements and the indenture governing the Senior Notes restrict the Company’s ability to declare or pay dividends on its common stock. Holders of the common stock are entitled to receive such dividends, if any, as may be declared from time to time by the board of directors, in its discretion, from funds legally available therefore and subject to prior dividend rights of holders of any shares of preferred stock which may be outstanding. The Company does not anticipate paying dividends on the common stock in the foreseeable future. Upon liquidation or dissolution of the Company, subject to prior liquidation rights of the holders of any shares of preferred stock which may be outstanding, the holders of common stock are entitled to receive on a pro rata basis the Company’s remaining assets available for distribution. Holders of the Class A common stock have no preemptive or other subscription rights, and there are no redemption or sinking fund provisions with respect to such shares.

There are no conversion rights with respect to the Company’s Class A common stock.

139

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

In the event of the Company’s merger or consolidation with or into another company in connection with which shares of common stock are converted into or exchangeable for shares of stock, other securities or property (including cash), all holders of common stock will be entitled to receive the same kind and amount of shares of stock, other securities or property (including cash).

Preferred Stock

The Company’s board of directors has the authority, without action by the stockholders, to designate and issue preferred stock in one or more series and to designate the rights, preferences and privileges of each series, such as dividend rates, dividend rights, liquidation preferences, voting rights and the number of shares constituting any series and designation of such series, which may be greater than the rights of the common stock. It is not possible to state the actual effect of the issuance of any shares of preferred stock upon the rights of holders of the common stock until the board of directors determines the specific rights of the holders of such preferred stock. However, the effects might include, among other things:

• restricting dividends on the common stock;

• diluting the voting power of the common stock;

• impairing the liquidation rights of the common stock; or

• delaying or preventing a change of control of Spansion Inc. without further action by the stockholders.

21. Subsequent Events

In addition to the events identified in Note 2, the following significant events occurred subsequent to December 28, 2008:

Credit line agreement with Union Bank of Switzerland (UBS AG) secured by auction rate securities

In October 2008, UBS AG, the fund manager of the Company’s ARS, offered the Company the right to sell its ARS held with UBS Bank USA (UBS) to UBS AG at par value during a two-year period beginning June 30, 2010 and ending July 2, 2012. Under the offer, the Company would be entitled to enter into a Credit Line Agreement with UBS for up to 75 percent of the market value of the ARS (the UBS Credit Line).

The Company has accepted the offer in November 2008 and on December 29, 2008, the Company entered into the UBS Credit Line that provides up to an aggregate amount of up to $85 million in the form of an uncommitted revolving line of credit, which is secured by the ARS currently held by the Company. Variable rate advances under the UBS Credit Line will bear interest at a variable rate equal to the lesser of: (a) LIBOR, plus a percentage rate between 1.250 percent to 2.750 percent, and (b) the then applicable weighted average rate of interest or dividend rate paid to the Company by the issuer of the ARS.

On December 29, 2008, the Company borrowed approximately $74.8 million under the UBS Credit Line. The Creditor Protection Proceedings constituted an event of default under the UBS Credit Line.

140

Spansion Inc.

(Debtor-in-Possession as of March 1, 2009)

Notes to Consolidated Financial Statements—(Continued)

Amendments to the Foundry Agreement with Fujitsu

On December 31, 2008, the Company entered into amendments to the Amended and Restated Foundry Agreement with Fujitsu effective as of September 28, 2006 (the Foundry Agreement). The amendments consist of Amendment No. 2 (Amendment No. 2) and which provide as follows:

• Spansion and Fujitsu agree that the Term of the Foundry Agreement shall be extended to December 31, 2010;

• Amendment No. 2 also sets forth (i) the Company’s wafer purchase commitments and pricing on purchases from Fujitsu for each of the quarters of fiscal 2009 and( ii) both parties further agree to negotiate in good faith the wafer purchase commitments and pricing for fiscal 2010 by June 30, 2009; and

• Amendment No. 2 further states either party may at its option terminate the Foundry Agreement without penalty in the event that (i) the other Party fails to fulfill the obligation (ii) the other Party or any of its Affiliates fails to pay its material debts as they come due, makes an assignment for the benefit of creditors (or takes similar action under United States, Japanese or other applicable law), or files a voluntary petition in bankruptcy (or makes similar filing under United States, Japanese or other applicable law) or invokes any laws for the protection of debtors under United States, Japanese or other applicable law, or (iii) the other Party or any of its Affiliates has filed against it an involuntary petition in bankruptcy (or similar filing under United States, Japanese or other applicable law) and fails to obtain the dismissal of such petition within (30) days after its filing.

Further, Fujitsu may at its option terminate this Agreement without liability to Spansion in the event that Spansion or any of its Affiliates (Spansion Group) fails to make full payment to Fujitsu or any of its Affiliates within thirty (30) days of the due date of such payment.

Finally, if the Agreement is terminated by Fujitsu in accordance with above, Fujitsu may at its option terminate any effective purchase order at the time of termination at its sole discretion, without liability to Spansion. All other terms and conditions of the Foundry Agreement shall remain unchanged and in full force and effect.

Please refer to Note 8 for further details of the Company’s relationship and transactions with Fujitsu.

Exit or Disposal Activities

On February 23, 2009, the Company carried out a workforce reduction of approximately 2,400 employees, or 28 percent of its workforce in an effort to further reduce costs as the Company continued its restructuring efforts and explored various strategic alternatives.

Patent Litigation Settlement Agreement with Samsung Electronics Co., Ltd (Samsung)

On April 7, 2009, the Company announced that it has settled its patent litigation lawsuits with Samsung. As part of the settlement, Samsung will pay the Company $70 million and both parties have exchanged rights in their patent portfolios in the form of licenses and covenants subject to a confidential settlement agreement. The settlement is subject to approval of the Bankruptcy Court and, if approved, will end the patent disputes between the two companies.

141

Report of Ernst & Young LLP, Independent Registered Public Accounting Firm

The Board of Directors and Stockholders of

Spansion Inc.

We have audited the accompanying consolidated balance sheets of Spansion Inc. as of December 28, 2008 and December 30, 2007, and the related consolidated statements of operations, stockholders’ equity (deficit), and cash flows for each of the three fiscal years in the period ended December 28, 2008. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Spansion Inc. as of December 28, 2008 and December 30, 2007, and the consolidated results of its operations and its cash flows for each of the three fiscal years in the period ended December 28, 2008, in conformity with U.S. generally accepted accounting principles.

The accompanying consolidated financial statements have been prepared assuming that Spansion Inc. will continue as a going concern. As more fully described in Note 2 to the consolidated financial statements, on March 1, 2009, Spansion Inc. filed a voluntary petition for reorganization under Chapter 11 of the United States Bankruptcy Code. Uncertainties inherent in the bankruptcy process raise substantial doubt about Spansion Inc.’s ability to continue as a going concern. Management’s plans in regard to these matters also are described in Note 2. The accompanying consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), Spansion Inc.’s internal control over financial reporting as of December 28, 2008, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated April 29, 2009 expressed an unqualified opinion thereon.

/S/    ERNST & YOUNG LLP

San Francisco, California

April 29, 2009

142

Report of Ernst & Young LLP, Independent Registered Public Accounting Firm

The Board of Directors and Stockholders of

Spansion Inc.

We have audited Spansion Inc.’s internal control over financial reporting as of December 28, 2008, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (the COSO criteria). Spansion Inc.’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the company’s internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material misstatement exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, Spansion Inc. maintained, in all material respects, effective internal control over financial reporting as of December 28, 2008, based on the COSO criteria.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Spansion Inc. as of December 28, 2008 and December 30, 2007, and the related consolidated statements of operations, stockholders’ equity (deficit) and cash flows for each of the three fiscal years in the period ended December 28, 2008 and our report dated April 29, 2009 expressed an unqualified opinion thereon, and such report included an explanatory paragraph on the Company’s ability to continue as a going concern.

/s/    ERNST & YOUNG LLP

San Francisco, California

April 29, 2009

143

Management’s Report on Internal Control Over Financial Reporting

Internal control over financial reporting refers to the process designed by, or under the supervision of, our Chief Executive Officer and Chief Financial Officer, and effected by our Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles, and includes those policies and procedures that:

(1) Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company;

(2) Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and

(3) Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.

Internal control over financial reporting cannot provide absolute assurance of achieving financial reporting objectives because of its inherent limitations. Internal control over financial reporting is a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures. Internal control over financial reporting also can be circumvented by collusion or improper management override. Because of such limitations, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk. Management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company.

Management has used the framework set forth in the report entitled “Internal Control—Integrated Framework” published by the Committee of Sponsoring Organizations of the Treadway Commission to evaluate the effectiveness of the Company’s internal control over financial reporting. Management has concluded that the Company’s internal control over financial reporting was effective as of December 28, 2008. The Company’s independent registered public accounting firm, Ernst & Young LLP, has issued an attestation report on the Company’s internal control over financial reporting, which appears on page 142 of this Annual Report on Form 10-K.

144

Supplementary Financial Data

(Unaudited)

Quarter Ended

(in thousands, except per share amounts)

	December 28, 2008			September 28 2008			June 30 2008			March 30 2008			December 30, 2007			September 30 2007			July 1 2007			April 1 2007
Net sales	$	329,952		$	474,170		$	426,268		$	400,183		$	429,983		$	408,605		$	373,710		$	414,955
Net sales to related parties		137,999			156,690			186,452			170,089			222,818			202,464			235,462			212,816
Total net sales		467,951			630,860			612,720			570,272			652,801			611,069			609,172			627,771
Cost of sales		669,691			544,273			503,571			475,810			526,382			499,758			501,033			537,970
Gross profit (loss)		(201,740	)		86,587			109,149			94,462			126,419			111,311			108,139			89,801
Research and development		96,339			106,845			108,303			120,321			112,646			111,248			110,900			101,991
Sales, general and administrative		56,756			64,094			68,264			64,764			59,937			59,193			61,947			58,240
In-process research and development		—			—			—			10,800			—			—			—			—
Restructuring charges		(138	)		1,377			9,922			—			—			—			—			—
Asset impairment charges		1,652,622			—			—			—			—			—			—			—
Operating loss		(2,007,319	)		(85,729	)		(77,340	)		(101,423	)		(46,164	)		(59,130	)		(64,708	)		(70,430	)
Interest and other income (expense), net		12,371			(13,086	)		2,536			3,379			5,157			6,835			11,672			8,931
Interest expense		(24,336	)		(24,853	)		(27,663	)		(20,991	)		(15,487	)		(23,628	)		(17,542	)		(24,146	)
Income (loss) before income taxes		(2,019,284	)		(123,668	)		(102,467	)		(119,035	)		(56,494	)		(75,923	)		(70,578	)		(85,645	)
(Provision) benefit for income taxes		(55,670	)		(9,583	)		1,824			564			6,981			4,320			3,676			10,167
Net loss	$	(2,074,954	)	$	(133,251	)	$	(100,643	)	$	(118,471	)	$	(49,513	)	$	(71,603	)	$	(66,902	)	$	(75,478	)
Net income (loss) per share basic and diluted	$	(12.89	)	$	(0.83	)	$	(0.63	)	$	(0.85	)	$	(0.37	)	$	(0.53	)	$	(0.50	)	$	(0.56	)
Shares used in per share calculation basic and diluted		161,000			160,687			160,196			138,765			135,283			135,049			134,827			134,539
Common stock market price range
High	$	1.69		$	3.05		$	3.70		$	4.29		$	8.68		$	12.64		$	12.83		$	15.05
Low	$	0.19		$	1.56		$	2.25		$	2.10		$	3.96		$	7.86		$	9.49		$	11.32

145

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed with the objective of providing reasonable assurance that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and our management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

As of December 28, 2008, the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level.

See Management’s Report on Internal Control Over Financial Reporting in Item 8, which is incorporated herein by reference.

Changes in Internal Control over Financial Reporting

There was no change in our internal controls over financial reporting during our fourth quarter of fiscal 2008 that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

ITEM 9B. OTHER INFORMATION

None.

146

PART III

ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

The following table presents information with respect to our directors and executive officers as of April 29, 2009.

Name	Age	Position
John H. Kispert	45	President, Chief Executive Officer, Interim Chief Financial Officer and Director
Donald L. Lucas	79	Chairman of the Board of Directors
David K. Chao	42	Director
Gilles Delfassy	53	Director
Boaz Eitan	60	Director
John M. Stich	67	Director
Thomas T. Eby	48	Executive Vice President, Consumer, Set Top Box and Industrial Division
Ajit Manocha	59	Executive Vice President, Worldwide Operations
Ahmed Nawaz	59	Executive Vice President, Wireless Solutions Division

John H. Kispert has served as a Class A director and President and Chief Executive Officer of Spansion since February 2009. Mr. Kispert is currently also serving as Interim Chief Financial Officer. Mr. Kispert spent 13 years in a number of finance and operational roles at KLA-Tencor, including president, chief operations officer and chief financial officer. Prior to that, Mr. Kispert held several senior management positions with IBM. Mr. Kispert serves on the Board of Directors of Extreme Networks, Inc. Mr. Kispert holds a master’s degree in Business Administration from the University of California, Los Angeles and a bachelor’s degree in Political Science from Grinnell College.

Donald L. Lucas has served as Chairman of the Board of Directors and as a Class A Director since September 2007. Since 1967, Mr. Lucas has been actively engaged in venture capital activities as a private individual. He has been a director of Oracle Corporation since 1980 and serves as chairman of their executive committee. Mr. Lucas also currently serves as chairman of the board of directors of DexCom, Inc. and 51job, Inc., and as a director of Cadence Design Systems, Inc. and Vimicro Corp. Mr. Lucas received a bachelor’s degree from Stanford University and a master’s degree from the Stanford Graduate School of Business.

David K. Chao has served as a Class A Director since the consummation of our initial public offering in December 2005. Mr. Chao is a co-founder of DCM (formerly known as Doll Capital Management), a venture capital firm based in the Silicon Valley, and has been a general partner of DCM since 1996. Prior to founding DCM, Mr. Chao was a co-founder and member of the board of directors of Japan Communications, Inc. He also worked as a management consultant at McKinsey & Company and as a marketing manager at Apple Computer. Prior to these positions, he was an account executive for Recruit, a Japanese human resources, advertising and services company. Mr. Chao serves on the boards of numerous DCM portfolio companies, including 51job, Inc., where he has served since 2000. He is a management board member of the Stanford Graduate School of Business board of trustees and a member of The Thacher School board of trustees. Mr. Chao received a bachelor’s degree in economics and East Asian studies from Brown University and a master’s degree in business administration from Stanford University.

Gilles Delfassy has served as a Class A Director since September 2008, and served as a Class C Director from September 2007 until September 2008. Mr. Delfassy served as interim chief executive officer at Anadigics, Inc. from August 2008 until January 2009, where he also serves as a member of the board of directors. Until his retirement in January 2007, Mr. Delfassy served in various senior management positions at Texas Instruments Incorporated, which he joined in 1978, most recently as a senior vice president. Mr. Delfassy received an Engineering Diploma (equivalent to master’s of science in electrical engineering) at Ecole Nationale Superieure d’Electronique et d’ Automatique de Toulouse. He also graduated in Business Administration from Institute d’Administration des Entreprises de Paris.

147

Boaz Eitan has served as a Class A Director since March 2008. Dr. Eitan founded Saifun Semiconductors Ltd. (Saifun) in 1996 and served as its Chief Executive Officer and Chairman of the Board of Directors from 1996 to 2008, when Spansion acquired Saifun. Dr. Eitan served as our interim President in February 2009. Dr. Eitan resigned his employment with Spansion in March 2009. From 1992 to 1997, Dr. Eitan managed the Israeli design center of WaferScale Integration Inc., which he established in 1992. From 1983 to 1992, Dr. Eitan held various positions at WaferScale Integration Inc., including manager of the Device Physics group, director of memory products and Vice President of Product and Technology Development. From 1981 to 1983, Dr. Eitan served as a physicist at Intel Corporation’s research and development center in Santa Clara, California. Dr. Eitan holds a Ph.D. and an M.Sc. in Applied Physics and a B.Sc. in Mathematics and Physics from the Hebrew University, Jerusalem. He is the inventor of Saifun’s NROM technology. Dr. Eitan is named as the inventor of over 85 issued U.S. patents, over 45 pending U.S. patent applications and a number of issued non-U.S. patents and pending non-U.S. patent applications.

John M. Stich has served as a Class A Director since December 2006. He is the Honorary Consul General of Japan at Dallas. Previously, he spent 35 years at Texas Instruments, with his most recent position as chief marketing officer in Japan. He lived and worked for Texas Instruments in Asia for a total of 24 years where he held various additional management positions such as vice president of semiconductors for Texas Instruments Asia Ltd., managing director of Texas Instruments Hong Kong Ltd., and marketing director of Texas Instruments Taiwan Limited. Mr. Stich has been active in leading various industry associations, including serving as: governor of the American Chambers of Commerce in Japan and Hong Kong, and chairman of the Semiconductor Industry Association (Japan Chapter). Currently, he is a director of Stonestreet One, Inc. and Diodes Inc. In addition, Mr. Stich is a member of the Dallas/Taipei and Dallas/Sendai Sister City Committees, a member of the Advisory Council for Southern Methodist University’s Asian Studies Program, a director of the Japan America Society of Dallas/Fort Worth, Vice-Dean of the Consular Corps of Dallas/Fort Worth, and a member of the Pastoral Council of Prince of Peace church. Mr. Stich holds a bachelor’s degree in electrical engineering from Marquette University.

Thomas T. Eby has served as our Executive Vice President, Consumer, Set Top Box and Industrial Division since September 2007. He is responsible for the division’s marketing, product and platform engineering, infrastructure development and program management functions. From October 2005 until September 2007, Mr. Eby served as our Executive Vice President and Chief Marketing and Sales Officer, and from January 2005 until October 2005, he served as our Executive Vice President and Chief Marketing Officer. From July 2003 until December 2004, he was our Executive Vice President with responsibility for leading the integration of the former AMD and Fujitsu Limited assets that were contributed to Spansion LLC. Beginning in 1998, Mr. Eby served as a vice president of AMD, including roles as group vice president of AMD’s Communication Group, then as the group vice president of strategy & business development for AMD and later as senior vice president. In addition, Mr. Eby held a wide range of sales and marketing positions both in the United States and Europe. Mr. Eby holds a bachelor’s degree in electrical engineering and computer sciences from Princeton University.

Ajit Manocha has served as our Executive Vice President, Worldwide Operations since December 2007. He is responsible for all aspects of Spansion’s global manufacturing operations, IT and supply chain management, including product cost, yields, quality, reliability, on-time delivery, manufacturing cycle times and customer service. Before joining us, Mr. Manocha was executive vice president and chief manufacturing officer at NXP (formerly Philips Semiconductors), from May 2003 to December 2007, where he was responsible for heading up worldwide IC manufacturing, supply chain management and purchasing for the semiconductor division. From September 1995 until May 2003, Mr. Manocha held senior positions at Philips Semiconductors and made significant improvements in that company’s supply chain and was responsible for leading the manufacturing operations to world-class operational and financial performance. Before joining Philips Semiconductors, he held management positions at AT&T Microelectronics, where he was charged with developing new joint ventures and strategic alliances and played a lead role in the manufacturing joint venture of AT&T and Cirrus Logic. Mr. Manocha holds a bachelor of science degree from the University of Delhi, India and a master’s degree in physical chemistry from Kansas State University.

148

Ahmed Nawaz has served as our Executive Vice President, Wireless Solutions Division since November 2006. He is responsible for the division’s marketing, platform engineering, infrastructure development and program management functions. Prior to joining Spansion, Mr. Nawaz was an independent management consultant from January 2006 to November 2006. From March 2001 to December 2005, he was executive vice president of worldwide sales at Agere Systems. Prior to that, Mr. Nawaz was president of worldwide sales, strategy and business development, from April 2000 to March 2001, and president, integrated circuits division, from June 1998 to April 2000, of Lucent’s Microelectronics and Communications Technologies Group. He joined AT&T in 1992 and moved to Lucent following its spin-off from AT&T in 1996. Mr. Nawaz also spent 14 years in various design, engineering, marketing and general management positions in Texas Instruments Incorporated’s semiconductor group. Mr. Nawaz holds a master’s degree in electrical engineering from the University of Missouri and a master’s degree in business administration from Houston Baptist University.

Section 16(a) Beneficial Ownership Reporting Compliance

Section 16(a) of the Securities Exchange Act of 1934, as amended, requires our directors and executive officers (as defined under Section 16) and any persons holding more than ten percent of a registered class of equity securities to file reports of ownership and changes in ownership with the Securities and Exchange Commission. Their initial report must be filed using the Securities and Exchange Commission’s Form 3 and they must report subsequent stock purchases, sales, option exercises and other changes using the Securities and Exchange Commission’s Form 4, which must be filed within two business days of most transactions. In some cases, such as changes in ownership arising from gifts and inheritances, the Securities and Exchange Commission allows delayed reporting at year-end on the Securities and Exchange Commission’s Form 5. Officers, directors and persons who beneficially own more than ten percent of a registered class of our equity securities are required by Securities and Exchange Commission regulations to furnish us with copies of all reports they file pursuant to Section 16(a). We make the services of our legal department available to our officers and directors to assist them in meeting their filing obligations.

Based solely on our review of these reports and written representations from our directors and executive officers, we believe that during fiscal 2008, each of Spansion’s directors, executive officers and ten percent security-holders complied with all applicable Section 16(a) filing requirements, other than, due to an administrative error by Spansion, Messrs. Chao, Delfassy, Edwards, Lucas, Roberson and Stich and Ms. Hart each made one late Form 4 filing reporting one transaction.

Codes of Business Conduct and Ethics

The Board of Directors has adopted a code of conduct, entitled “Code of Business Conduct,” which applies to all directors and employees and which was designed to help directors and employees resolve ethical and compliance issues encountered in the business environment. The Code of Business Conduct governs matters such as conflicts of interest, compliance with laws, confidentiality of company information, encouraging the reporting of any illegal or unethical behavior, fair dealing and use of company assets. The Board of Directors has also adopted a Code of Ethics for the Chief Executive Officer, the Chief Financial Officer, the Corporate Controller and All Other Senior Finance Executives. The Code of Ethics governs matters such as financial reporting, conflicts of interest and compliance with laws, rules, regulations and Spansion’s policies.

Stockholders can access Spansion’s Principles of Corporate Governance, Code of Business Conduct and Code of Ethics at the Investor Relations page of our website at www.spansion.com or by writing to us at Corporate Secretary, Spansion Inc., 915 DeGuigne Drive, P.O. Box 3453, Sunnyvale, California 94088, or emailing us at Corporate.Secretary@spansion.com. We will provide this information free of charge. Please note that information contained on our website is not incorporated by reference in, or considered to be a part of, this document. We will post on our website any amendment to the Code of Ethics, as well as any waivers of the Code of Ethics, that are required to be disclosed by the rules of the Securities and Exchange Commission or The NASDAQ Stock Market.

149

Board of Directors

Our Board of Directors currently consists of six directors. In 2008, three of our directors resigned from the Board of Directors: Ms. Patti S. Hart, and Messrs. David E. Roberson and Robert L. Edwards. Our Certificate of Incorporation provides that the Board of Directors consists of three classes of directors, each serving staggered three-year terms. At each annual meeting of stockholders, directors will be elected for a term of three years to succeed those directors whose terms are expiring.

Our Certificate of Incorporation also provides that the holders of Class A Common Stock, voting together as a separate class, are entitled to vote for all Class A directors. Our Class B, Class C and Class D Common Stock have been retired and no shares are outstanding. Consequently, all of our directors are Class A Directors.

Our Board of Directors is currently composed of the following classes of directors:

Class	Expiration	Member
Class I	2009	David K. Chao Donald L. Lucas
Class II	2010	Boaz Eitan John M. Stich
Class III	2011	Gilles Delfassy John H. Kispert

Audit Committee

The Audit Committee, which has been established in accordance with Section 3(a)(58)(A) of the Securities Exchange Act of 1934, as amended, currently consists of Mr. John M. Stich, as Chair, Messrs. David K. Chao and Gilles Delfassy, each of whom was determined by the Board of Directors to be financially literate and “independent” as such term is defined for Audit Committee members by the NASDAQ Stock Market listing standards. Mr. Stich and Mr. Delfassy joined the Audit Committee in March 2008 and October 2008, respectively. Mr. Robert L. Edwards served as Chair of the Audit Committee until he resigned from the Board of Directors in October 2008. Mr. David E. Roberson served as a member of the Audit Committee until he resigned from the Board of Directors in June 2008. Ms. Patti S. Hart served as a member of the Audit Committee until March 2008. The Board of Directors determined that Mr. Edwards and Mr. Roberson were each an “audit committee financial expert” as defined under the rules of the Securities and Exchange Commission. No current member of the Audit Committee has been designated an “audit committee financial expert” by the Board of Directors. The Board believes that each of the members of the Audit Committee is financially literate and that at least one of the members of the Audit Committee qualifies as a “financial expert”, as defined by the rules and regulations of the SEC. However, the Board has elected to defer the formal designation of a financial expert pending the expected reconstitution of the Board of Directors following confirmation of a plan of reorganization by the U.S. Bankruptcy Court.

The Audit Committee assists the Board with its oversight responsibilities regarding our accounting and financial reporting processes, the audit of our financial statements, the integrity of our financial statements, our internal accounting and financial controls, our compliance with legal and regulatory requirements, the independent registered public accounting firm’s qualifications and independence and the performance of our internal audit function and the independent registered public accounting firm. The Audit Committee is also directly responsible for the appointment, compensation, retention and oversight of the work of the independent registered public accounting firm, which reports directly to the Audit Committee. The Audit Committee meets alone with our financial and legal personnel, our internal auditor and with our independent registered public accounting firm, who have free access to the Audit Committee at any time. The director of our Internal Audit Department reports directly to the Chair of the Audit Committee, confers regularly with our Chief Financial Officer and serves a staff function for the Audit Committee.

150

ITEM 11. EXECUTIVE COMPENSATION

Compensation Discussion and Analysis

Introduction

This Compensation Discussion and Analysis presents material information necessary to understand the objectives and policies of our compensation program for executive officers. Throughout this discussion, those individuals named in the Fiscal 2008 Summary Compensation Table on page 163 are referred to as our “Named Executive Officers” and the Compensation Committee of the Board of Directors is referred to as the “Committee.”

Economic Challenges for 2008 and 2009

The severe economic downturn in 2008 presented challenges for Spansion, along with many other companies, including many of Spansion’s customers. Beginning in the third quarter of 2008, Spansion implemented a series of significant cash management measures, which affected the way in which we compensated employees, including our executive officers. In February 2009, Dr. Bertrand Cambou, formerly the Chief Executive Officer of Spansion, resigned from his position and Mr. John H. Kispert was hired as our new Chief Executive Officer. Dr. Cambou’s severance agreement and Mr. Kispert’s employment agreement are described below. On March 1, 2009, Spansion Inc. and several of its subsidiaries filed voluntary petitions for relief under Chapter 11 of the United States Bankruptcy Code. We will reevaluate all compensation programs once we more fully understand the outcome of our restructuring efforts.

Roles and Responsibilities

The role of the Committee is to oversee Spansion’s compensation strategies and programs for our executive officers, including total compensation for the Named Executive Officers. The role of Spansion’s management is to review Spansion’s executive compensation programs, policies and governance and make recommendations regarding these matters. Management is responsible for, among other things:

• Reviewing the effectiveness of the compensation programs, including competitiveness and alignment with Spansion’s objectives;

• Recommending changes to compensation programs, as may be required, to ensure achievement of all program objectives; and

• Recommending salaries, bonuses and other awards for executive officers other than the Chief Executive Officer.

The Committee is authorized to engage its own independent advisors to provide advice on matters related to executive compensation and general compensation programs. During fiscal 2007, the Committee engaged Hewitt Associates (“Hewitt”) as its independent compensation consultant to provide advice on matters related to executive compensation and general compensation programs. During fiscal 2008, the Committee opted to minimize its use of independent advisors in an effort to reduce cost. In August 2008 the Committee engaged Compensia, Inc. (“Compensia”) as its independent compensation consultant to provide data and expertise related to the composition of the group of publicly traded semiconductor industry companies with which we compete for talent (collectively, the “Compensation Peer Group”). At the Committee’s request, Compensia attended the Committee’s September 2008 meeting in which the Compensation Peer Group was determined. The Committee, at its discretion, may replace Compensia or hire additional consultants at any time. Compensia is independent from Spansion because it does not provide any other services to Spansion and receives compensation from Spansion only for the services it provides to the Committee.

All other analyses related to executive compensation were conducted internally, relying primarily on data from Radford Associates, which provides compensation and benefits data specializing in the high technology

151

sector and Equilar, which provides executive compensation information based on publicly available information contained in SEC filings. Internal analyses included gathering and analyzing data, and reviewing and advising on principal aspects of executive compensation. Base salaries, bonuses, equity awards and change of control agreements for executive officers were among the items reviewed.

Compensation Program Philosophy and Objectives

Spansion has a market-based, “pay for performance” compensation philosophy that is designed to both attract and retain talented executive officers while supporting our business strategy. In line with that philosophy, a significant percentage of the total potential compensation for our executive officers is performance-based. We do not have a pre-established policy or target for allocating between cash and non-cash or short-term and long-term incentive compensation. Rather, the Committee periodically reviews relevant market data to determine the appropriate components of, and level for, our executive officers’ compensation.

The compensation program for our executive officers is designed to:

• Recognize and reward executives for achieving both company and individual performance objectives in support of Spansion’s business strategy;

• Provide competitive pay opportunities relative to the Compensation Peer Group;

• Align the respective interests of the executive officers and our stockholders through compensation that varies based on achievement of financial objectives; and

• Maintain flexible pay programs that can be modified to respond to changes in competitive trends and Spansion’s business strategy and financial position.

Setting Compensation

Generally, we set compensation for our Named Executive Officers in the same manner used to set compensation for our other executive officers. Details regarding the specific compensation for each of our Named Executive Officers for fiscal 2008 are set forth in the Fiscal 2008 Summary Compensation Table on page 163.

Competitive Market Data

In September 2007, based on the review and recommendations presented by Hewitt, and in consultation with Hewitt, the Committee reviewed and approved a revised Compensation Peer Group to be used for benchmarking and for setting executive compensation for fiscal 2008. To determine the appropriate Compensation Peer Group, the Committee considered companies within the semiconductor industry that have revenue, number of employees, market capitalization, location and scope of international operations similar to our corresponding components.

Based on the cited criteria, six companies (Advanced Micro Devices, Inc.; Agere Systems Inc.; Applied Materials, Inc.; Broadcom Corporation; Freescale Semiconductor; and Micron Technology, Inc.) were removed from our prior Compensation Peer Group and two companies (Amkor Technology, Inc. and Cypress Semiconductor Corporation) were added to the group. The Compensation Peer Group established for fiscal 2008 is as follows:

•      Altera Corporation •      Amkor Technology, Inc. •      Analog Devices, Inc. •      Atmel Corporation •      Cypress Semiconductor Corporation •      Fairchild Semiconductor •      Juniper Networks, Inc. •      KLA-Tencor Corporation •      Lam Research Corporation •      Linear Technology Corporation •      LSI Corporation •      Maxim Integrated Products, Inc. •      National Semiconductor Corporation •      Novellus Systems, Inc. •      NVIDIA Corporation •      ON Semiconductor Corp. •      SanDisk Corporation •      Xilinx, Inc.

152

In September 2008, based on the review and recommendations presented by Compensia, and in consultation with Compensia, the Committee reviewed and approved a new Compensation Peer Group to be used for benchmarking and for setting executive compensation for fiscal 2009. The Committee considered companies within the semiconductor industry that have revenue, net income, number of employees, market capitalization, location and scope of international operations similar to our corresponding components. The Committee will continue to periodically review and update the Compensation Peer Group, as appropriate. We anticipate an additional modification to the Compensation Peer Group in 2009 in order to reflect the organization following the restructuring resulting from the Creditor Protection Proceedings.

Based on the cited criteria, including a significant drop in market capitalization, ten companies (Altera Corporation; Analog Devices, Inc.; Juniper Networks, Inc.; KLA-Tencor Corporation; Lam Research Corporation; Linear Technology Corporation; Maxim Integrated Products, Inc.; Novellus Systems, Inc.; NVIDIA Corporation; and Xilinx, Inc.) were removed from our prior Compensation Peer Group, and seven companies (Conexant Systems, Inc.; Integrated Device Technology, Inc.; Micron Technology, Inc.; RF Micro Devices, Inc.; Skyworks Solutions, Inc.; SMART Modular Technologies, Inc.; and Vishay Intertechnology, Inc.) were added to the group. The Compensation Peer Group established in September 2008 for fiscal 2009 is as follows:

•      Amkor Technology, Inc. •      Atmel Corporation •      Conexant Systems, Inc. •      Cypress Semiconductor Corporation •      Fairchild Semiconductor Corporation •      Integrated Device Technology, Inc. •      LSI Corporation •      Micron Technology, Inc. •      National Semiconductor Corporation •      ON Semiconductor •      RF Micro Devices, Inc. •      SanDisk Corporation •      Skyworks Solutions, Inc. •      SMART Modular Technologies, Inc. •      Vishay Intertechnology, Inc.

Market Positioning

Total compensation targets for our Named Executive Officers, taking into consideration the targets for base salary, bonus and equity awards, are set between the 50^th and 60^th percentiles for compensation paid to similarly situated executives in the Compensation Peer Group. We set these targets slightly higher than the median compensation of executives in the Compensation Peer Group to better position Spansion to attract and retain highly qualified executive officers. As part of our annual compensation review process, total compensation targets were adjusted for our Named Executive Officers based on data for the 2008 Compensation Peer Group, using an expanded listing of companies only in the event that sufficient data was not available for the Compensation Peer Group. Largely as a result of the significant change to our Compensation Peer Group, the targets for base salary, total cash (calculated as base salary plus bonus) and total direct compensation (calculated as base salary plus bonus plus equity award) were increased in each case for all but one of the Named Executive Officers. The increase in base salary and total cash targets were the result of using an expanded listing of companies. As discussed below under Compensation Review, market data is just one consideration in setting actual compensation for our Named Executive Officers. Actual compensation may vary within a reasonable range of these targets based on additional factors, including current market conditions.

Our incentive compensation, including cash and equity, is structured so that when our corporate performance meets or exceeds our established objectives, executive officers have an opportunity to receive incentive compensation equal to or greater than comparable market targets. When our corporate performance does not meet our established objectives, executive officers receive incentive compensation that is generally below comparable market targets.

For fiscal 2008, total compensation for our Named Executive Officers was well below our collective compensation targets, primarily because no short term incentives were paid and Spansion’s stock value declined relatively more than the stock value of our Compensation Peer Group, resulting in below-market long-term incentive compensation.

153

Performance Evaluations

We conduct annual performance evaluations of all Spansion employees, including our Named Executive Officers. As part of the executive officer evaluation, we consider a number of performance criteria, including among other things, the Named Executive Officer’s ability to:

• Meet specific performance objectives;

• Set the strategy and direction of his organization, consistent with Spansion’s overall objectives; and

• Effectively lead his organization.

The Chief Executive Officer evaluates the performance of each of the other executive officers, including the other Named Executive Officers, and presents the evaluations to the Committee for review and approval. The Committee performs an independent evaluation of the Chief Executive Officer’s performance.

Compensation Review

In preparation for decisions regarding compensation actions for each of the Named Executive Officers for the upcoming year, the Committee reviews tally sheets that reflect total current compensation, equity awards (vested and unvested) and benefits information. In addition, the Committee considers each individual’s performance, contributions, role and responsibilities, leadership abilities, growth potential and compensation relative to peers within Spansion. The Committee also considers the competitive market for comparable executives in the Compensation Peer Group. Following this review, the Committee sets the compensation for the Chief Executive Officer and for the other executive officers, taking into consideration the Chief Executive Officer’s compensation recommendations for each of the other executive officers. The final compensation packages for all Named Executive Officers, including the Chief Executive Officer, contain the components described below.

2008 Executive Compensation Components

Spansion’s total rewards program was modified significantly in 2008 and 2009 to address changes in the economy and business operations, including the Creditor Protection Proceedings. Some highlights of these changes are as follows:

• Reduced base salaries for the Named Executive Officers in October 2008, and other employees, some of which were reinstated in February 2009.

• Established a Cash Management Bonus Plan, which was not paid when we did not meet the requisite corporate performance objective.

• Eliminated the U.S. Executive Car Allowance and Financial Planning perquisites in February 2009.

• Suspended the 401(k) match for all eligible employees in February 2009.

• Canceled short-term performance-based incentive plan payments for all employees for 2008.

• Canceled annual merit increases and annual stock awards in 2009.

• Implemented various plant shutdowns, furloughs and reduced workweeks based on our business requirements and cash management objectives.

Spansion seeks to achieve the compensation program objectives, as provided in the “Compensation Program Philosophy and Objectives” section above through five principal compensation components:

• Base salary;

• Short-term performance-based incentive compensation;

154

• Long-term equity-based incentive compensation;

• Change of control agreements; and

• Benefits and perquisites.

The details of Spansion’s practices with respect to each of these five principal compensation components, including the modifications highlighted above, are set forth below.

Base Salary

Spansion provides base salaries to compensate executive officers for services performed during the fiscal year. Each executive officer’s salary is intended to reflect the individual’s job responsibilities and value to Spansion in terms of expertise and performance, taking into account competitive market data and internal pay relationships. For our Named Executive Officers, generally, base salaries were targeted at the 60^th percentile of base salaries paid to similarly situated individuals in the Compensation Peer Group.

Base salaries for the Named Executive Officers are evaluated on an annual basis using the criteria described above. In March 2008, all Named Executive Officers, were eligible for a merit increase. Merit increases ranged from zero percent to ten percent, resulting in competitive base pay levels relative to the 2008 Compensation Peer Group. Following cost-cutting measures taken in October 2008, annual base salaries were reduced for each of the Named Executive Officers. The base salary for the CEO was reduced by 20 percent, while base salaries for the other Named Executive Officers (and other executive officers) were reduced by ten percent. There was no corresponding reduction in work for the executive officers.

Effective February 23, 2009, the Board of Directors approved an employee retention program that provides for, among other things, the reinstatement of full salary for the executive officers (other than the Chief Executive Officer) and certain other key employees. The purpose of the employee retention program is to provide an incentive for executive officers and certain other key employees to remain employed with us. The annualized base salaries as of the end of fiscal 2007, March 24, 2008, October 6, 2008 and February 23, 2009 for each of our Named Executive Officers were as follows:

	Base Salary as of December 30, 2007		Percent Increase on March 24, 2008	Salary as of March 24, 2008		Percent Reduction on October 6, 2008	Base Salary as of October 6, 2008		Reinstated Base Salary as of February 23, 2009
Bertrand F. Cambou	$	715,500	5%	$	751,275	20%	$	601,020		N/A
Dario Sacomani	$	405,000	10%	$	445,500	10%	$	400,950	$	445,500
James E. Doran	$	459,000	0%	$	459,000	10%	$	413,100		N/A
Thomas T. Eby	$	411,536	7%	$	440,343	10%	$	396,309	$	440,343
Ahmed Nawaz	$	425,000	7%	$	454,750	10%	$	409,275	$	454,750

In response to market conditions and in alignment with current market practices, Spansion does not plan to conduct a formal merit increase process for any of its employees for fiscal 2009. Consequently, we do not expect to provide merit-based salary increases in fiscal 2009 to any executive officers.

Short-Term Performance-Based Incentive Compensation

Our executive officers have an opportunity to earn annual cash awards under a short-term performance-based incentive compensation plan (the “STIP”) designed to compensate them for the achievement of pre-determined annual corporate objectives and individual objectives that correlate closely with the corporate objectives. At the beginning of each fiscal year, the Committee approves the target cash bonus opportunities and objectives for that year relevant to the STIP. Our STIP is referred to as the “Pay for Performance Plan.”

155

The target bonus opportunity for each executive officer is based on the individual’s position within Spansion and competitive data from the Compensation Peer Group, and is established as a percentage of base salary. For our Named Executive Officers, generally, awards are targeted between the 50^th and 60^th percentiles of bonus awards made to similarly situated individuals in the Compensation Peer Group. STIP payouts are contingent upon Spansion’s performance as measured against the pre-determined annual corporate objectives approved by the Committee. For fiscal 2008, approximately 80 percent of our Chief Executive Officer’s, and approximately 70 percent of the other Named Executive Officers’, bonus opportunity was based directly on Spansion’s achievement relative to these pre-determined annual objectives. If these objectives had been achieved, the remainder of the bonus opportunity for the executive officer would have been based on his individual performance, recognizing achievement against other critical objectives. If none of the annual corporate performance objectives are achieved, no bonuses are paid, irrespective of the executive officer’s performance. The Committee reviews and approves all recommended STIP payments for the executive officers.

In order to provide flexibility in the event of unforeseen circumstances, the STIP provides for management discretion to make adjustments to the plan. No individual has a vested entitlement to any payment under the STIP. Specifically, regardless of whether an award has been consistently paid over any period of time, Spansion, at its sole discretion, reserves the right to (i) increase or decrease targets and target percentages for each plan year, (ii) terminate the participation of any individual in the plan at any time for any legal reason, and/or (iii) modify or terminate the plan, in whole or in part, all with or without notice or cause.

In March 2008, the Committee established fiscal 2008 metrics which balanced operating profit, market share and the sale of advanced technology products that are key to Spansion’s future success. At that time, the Committee also set specific objectives for each metric. The objectives for each metric were set at performance levels that we believed would be very difficult to achieve. The final corporate performance metrics for fiscal 2008, and their relative weighting out of 100 percent, were as follows:

• Achieve breakeven on operating profit, including the effect of equity-based expense (70 percent weighting);

• Increase NOR segment share in the Flash memory market relative to fiscal 2007 (15 percent weighting); and

• Increase revenue from certain products based on specified advanced technologies relative to fiscal 2007 (15 percent weighting).

The target STIP award opportunities for our Named Executive Officers ranged from 70 percent to 125 percent of base salary, with actual awards determined as follows:

• No awards would be paid if Spansion did not achieve the minimum performance objectives for at least one of the metrics, and

• Payment of 7.5 percent to 200 percent of the target awards would be made depending on Spansion’s level of performance against each metric, assuming the minimum performance objective was achieved on at least one of the metrics and considering the relative weighting of each metric.

156

Prior to formal determination of Spansion’s performance against the 2008 objectives, the Committee, upon management recommendation, determined that it was in the best interest of Spansion to cancel any potential payments from the STIP for fiscal 2008. The table below describes for each Named Executive Officer for fiscal 2008 the target percentage of base salary, target amount attainable, payout opportunity range as a percent of base salary, award amount and award as a percent of base salary.

Named Executive Officer	Target Percent of Base Salary	Target Award Amount		Payout Range as Percent of Base Salary	Actual Award Amount		Award as Percent of Base Salary
Bertrand F. Cambou	125%	$	939,094	0% to 250%	$	0	0%
Dario Sacomani	70%	$	311,850	0% to 140%	$	0	0%
James E. Doran	70%	$	321,300	0% to 140%	$	0	0%
Thomas T. Eby	70%	$	308,240	0% to 140%	$	0	0%
Ahmed Nawaz	70%	$	318,325	0% to 140%	$	0	0%

The amounts of STIP awards for fiscal 2008 for Named Executive Officers are presented in the Non-Equity Incentive Plan Compensation column of the Fiscal 2008 Summary Compensation Table on page 163. The individual target awards and metrics for 2009 are currently under review in light of the Creditor Protection Proceedings. We believe our performance objectives will continue to be very difficult to achieve demonstrated by the fact that no STIP awards were achieved for fiscal 2006, only minimal award levels (i.e., 13 percent of target) were achieved for fiscal 2007, and no awards were paid for fiscal 2008.

Special Cash Management Incentive

In December 2008, the Committee approved a special incentive plan such that the Named Executive Officers, along with other employees subject to a salary reduction, were eligible to receive an award if certain cash management goals were achieved by April 2009. This plan was put into place to provide an incentive for the management team and others to help Spansion achieve desired levels of cash by the beginning of the second quarter of 2009. The current Named Executive Officers were eligible to receive 10 percent of their six months salary as of October 5, 2008. Spansion did not achieve its cash objectives, thus no award was paid.

Long-Term Equity-Based Incentive Compensation

A fundamental tenet of our compensation philosophy is that equity participation by our executive officers creates a vital long-term partnership between our executive officers and our stockholders. We believe that equity-based compensation promotes equity ownership among executive officers, drives performance toward the achievement of long-term stockholder value, provides balance to the awards provided under the STIP, and helps to promote the retention of the officers through vesting contingencies. One of our stockholder-approved equity plans is our long-term incentive plan (the “LTIP”), and it is designed to align the interests of executive officers over a multi-year period directly with the interests of stockholders.

The Committee administers the LTIP and approves target award levels based on data from the Compensation Peer Group and an executive’s position within Spansion. For our Named Executive Officers, generally, award levels are targeted at the 50^th percentile of equity awards made to similarly situated individuals in the Compensation Peer Group in an attempt to provide equity award opportunities that are competitive with those of our peers. The Committee reviews target award levels annually.

The LTIP provides for various awards in the form of stock options, stock appreciation rights, restricted stock units, stock bonuses, restricted stock, performance stock, stock units, phantom stock, dividend equivalents, and similar rights to purchase or acquire shares. To date, awards under the LTIP have been made in the forms of stock options and restricted stock units. Generally, employees below the vice president level are granted restricted stock unit awards and vice presidents and executive officers, including our Named Executive Officers, receive a combination of stock option and restricted stock unit awards. We use restricted stock units based on

157

competitive practice, to reduce the number of shares used and the FAS 123R expense and to ensure some value in a down market. We grant stock options to vice presidents and executive officers in order to tie their compensation more directly to total stockholder return.

The Committee approves all equity awards for executive officers and the annual equity awards granted to employees following Spansion’s annual performance evaluation process. The annual awards are generally granted in the second fiscal quarter, following the first quarter earnings release, at regularly scheduled Committee meetings. The Committee has delegated to our Grant Committee, which in fiscal 2008 consisted of our Chief Executive Officer, Chief Financial Officer and Chief Operating Officer, authority to approve stock option and restricted stock unit awards to non-executive officers, subject to established guidelines. The purpose of this delegation is to provide administrative flexibility to recognize new hires and promotions or achievements for employees below the level of executive officer. The Committee approves all equity awards granted to non-executive officers that are not within the guidelines established for the Grant Committee. The Committee also reviews all equity awards approved by the Grant Committee. As a result of the Creditor Protection Proceedings, we are in the process of developing a comprehensive restructuring plan that will require bankruptcy court approval for operating our business going forward. Consequently, it is currently unknown when or whether the Compensation Committee or Grant Committee will continue to grant equity awards to executive officers and employees, respectively, in fiscal 2009 in accordance with our past practice.

Each equity award granted under the LTIP typically vests over four years from the grant date. Prior to the exercise of a vested stock option or the vesting of a restricted stock unit, the holder of the stock option or restricted stock unit has no rights as a stockholder with respect to the shares subject to such awards. With limited exceptions, vesting ceases upon termination of employment.

The exercise price for a stock option awarded under the LTIP is equal to the closing price of Spansion’s Class A Common Stock, as quoted on The NASDAQ Stock Market, on the date the award is granted. Spansion has never granted a stock option with an exercise price that is less than the closing price of its Common Stock on the grant date, nor has it ever granted a stock option priced on a date other than the grant date.

The annual equity awards granted to our Named Executive Officers for fiscal 2008 consisted of a combination of stock option and restricted stock unit awards that ranged, in the aggregate, from 84,000 shares to 308,000 shares. Using a three-year average stock price, these awards were competitive relative to those of the 50^th percentile of the Compensation Peer Group. All of our Named Executive Officers were eligible for and received, in April 2008, an annual equity award for fiscal 2008. Due to Spansion’s low stock price, the current in-the-money position for equity awards is significantly less than the market and the FAS123R expense on our financial statements. The in-the-money position is shown below:

	In-the-Money for all equity awards including vested unexercised options and all unvested awards as of 12/28/08
Bertrand F. Cambou	$	32,816
Dario Sacomani	$	14,685
James E. Doran	$	11,389
Thomas T. Eby	$	13,303
Ahmed Nawaz	$	13,558

On May 5, 2009, The NASDAQ Stock Market informed us that trading of shares of our common stock has been suspended effective at the open of business on Thursday, May 7, 2009. We expect NASDAQ to file an application on Form 25-NSE with the Securities and Exchange Commission to effect the delisting of our common stock.

If Spansion decides to grant awards, and is authorized to do so by the U.S. Bankruptcy Court, our executive officers are eligible for annual equity awards in fiscal 2009, subject to the approval of the Committee. The awards for fiscal 2008 for each of our Named Executive Officers are shown in the Grants of Plan-Based Awards for Fiscal 2008 table on page 165.

158

Agreements with Executive Officers

Bertrand F. Cambou. On January 30, 2009, Dr. Bertrand Cambou resigned as our President and Chief Executive Officer and as a member of our Board of Directors, effective as of February 2, 2009. On February 4, 2009, we entered into a Separation Agreement and Release with Dr. Cambou, pursuant to which Dr. Cambou received a severance package that includes a lump-sum payment equal to one year of Dr. Cambou’s base salary of $751,274.94, plus we reimbursed out-of-pocket expenses incurred by Dr. Cambou in connection with the preparation of his 2008 tax returns. Under a separate Consulting Agreement, Dr. Cambou has agreed to provide transition services to us on a consultant basis for a four month period or less, at a monthly rate equal to 50 percent of his monthly base salary. Pursuant to the Separation Agreement and Release, Dr. Cambou released any and all claims against us and his rights under the change of control and severance agreement we entered into with him were terminated.

John H. Kispert. On February 2, 2009, the Board appointed Mr. Kispert as our President and Chief Executive Officer. In addition, the Board appointed Mr. Kispert to serve as a Class III member of the Board of Directors (as a Class A director). On February 12, 2009, we entered into an employment offer letter (the “Offer Letter”) with Mr. Kispert, pursuant to which he is entitled to compensation of $75,000 per month. We paid Mr. Kispert a nonrefundable advance of four months salary. In addition, Mr. Kispert is entitled to a bonus of $1.75 million upon the first to occur of either of the following transactions (each a “Transaction”):

• A merger or consolidation of Spansion with any other corporation which constitutes a change in ownership of the securities of Spansion representing more than fifty percent (50%) of the total voting power represented by Spansion’s then outstanding securities, other than a merger or consolidation which would result in holders of our pre-transaction debts generally holding at least fifty percent (50%) of the total voting power represented by the voting securities of Spansion or such surviving entity outstanding immediately after such merger or consolidation; or

• The sale, lease or other disposition by Spansion of all or substantially all of our assets, which occurs on the date that any one person, or more than one person acting as a group, acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such person or persons) assets from us that have a total gross fair market value equal to or more than eighty-five percent (85%) of the total fair market value of all of our assets immediately prior to such acquisition or acquisitions;

provided, however, that the payment of such bonus is subject to certain additional conditions as set forth in the Offer Letter.

Mr. Kispert also (i) receives comprehensive benefits, including medical, dental, life and disability coverage; and (ii) may participate in our 401(k) retirement savings plan and executive deferred compensation plan as long as such plans remain generally available to Spansion.

Dario Sacomani. On April 10, 2009, we entered into a Personal Leave Agreement and Release with Mr. Sacomani (the “Leave Agreement”). Under the terms of the Leave Agreement, Mr. Sacomani resigned as Executive Vice President and Chief Financial Officer of Spansion, effective immediately, but remains a part-time employee for a transition period of up to nine months. Mr. Sacomani also agreed to provide transition services during his leave. Mr. Sacomani continues to receive his current base salary and health insurance benefits through the transition period, as well as up to $7,500 in relocation expenses. Mr. Sacomani’s rights under the change of control and severance agreement we entered into with him were terminated upon his execution of the Leave Agreement.

Robert C. Melendres. On April 7, 2009, we entered into a Separation and Release Agreement with Mr. Melendres (the “Separation Agreement”). Under the terms of the Separation Agreement, Mr. Melendres, who resigned as Executive Vice President, Corporate Development, Chief Legal Officer and Corporate Secretary, effective April 6, 2009, received a severance package that includes a lump-sum payment equal to six months of Mr. Melendres’ base salary, less applicable withholding. Mr. Melendres also received health insurance

159

benefits through April 30, 2009. Pursuant to the Separation Agreement, Mr. Melendres released any and all claims against us and his rights under the change of control and severance agreement we entered into with him were terminated.

Change of Control Agreements

The Committee recognizes that from time to time Spansion may consider potential transactions that could result in a change of control of the ownership and management of Spansion. Therefore, the Committee determined that it is in the best interests of Spansion and its stockholders to provide our key executive officers with an incentive in the form of certain benefits to maintain their focus and dedication to Spansion notwithstanding a possible transaction that could result in a change of control. In 2007, the Committee consulted with Hewitt Associates regarding the type and level of benefits that similarly situated companies, including those in the Compensation Peer Group, provide for their key employees. Hewitt advised the Committee based on pertinent market data, including Institutional Shareholder Services’ (currently known as RiskMetrics Group) recommendations. Based largely on Hewitt’s advice, the Committee approved a form of change of control severance agreement (the “Agreement”) that would provide an incentive to executive officers for their continued service up to and after a change of control.

Under the terms of the Agreement, the executive officer would receive, subject to certain conditions, the following benefits in the event of a change of control and termination of employment:

• A lump sum separation payment;

• Acceleration of unvested equity;

• Reimbursement for premium payments for medical and dental COBRA continuation coverage for a limited time; and

• In certain cases, tax-related benefits.

We have entered into an Agreement with each of our Named Executive Officers. The benefits available to each Named Executive Officer under their respective Agreements are the same with the exception of the base salary portion of the lump sum separation payment and tax-related benefit. The base salary portion of the lump sum separation payment for each of Messrs. Eby and Nawaz, and formerly Messrs. Doran and Sacomani, is two times the aggregate of (i) his base salary and (ii) his target bonus opportunity under the STIP, whereas the base salary portion of the lump sum separation payment for Dr. Cambou was equal to three times the aggregate of (i) his base salary and (ii) his target bonus opportunity under the STIP. The disparity in the payout level between Dr. Cambou and the other Named Executive Officers was attributable to Dr. Cambou’s role as Chief Executive Officer and the particular importance of his continued dedication to Spansion at a time when Spansion could be considering a transaction that results in a change of control. In addition, the Agreements for Dr. Cambou and Messrs. Doran, Eby and Sacomani, which expire in November 2009, provided for reimbursement of any 280G excise tax they may be subject to as a result of benefits they receive under their respective Agreements (lump sum payments between one percent and fifteen percent above the 280G limits are reduced such that no excise tax applies). Our new form of change of control severance agreement does not provide for the reimbursement for excise tax. We have entered into this new form of change of control severance agreement with Mr. Nawaz. Additional details regarding our change of control severance agreements are set forth in the discussion under “Termination in Connection With a Change of Control” on page 169 and the tables that follow the discussion. The terms of our change of control severance agreements may be amended or nullified, completely or in part, as a result of our Creditor Protection Proceedings.

Benefits and Perquisites

Retirement Savings Plan. The Spansion Retirement Savings Plan (the “401(k) Plan”) is a tax-qualified 401(k) plan to which all U.S. employees may contribute on a before-tax basis up to the lesser of 89 percent of

160

eligible pay or the contribution limit prescribed by the Internal Revenue Code. Spansion contributes to each employee’s 401(k) account $0.50 on each $1 of pay deferred by employees under the 401(k) Plan. Spansion’s contributions are capped at three percent of the employee’s pay. All contributions to the 401(k) Plan, including Spansion’s matching contributions, are fully vested at the time the contribution is made. In February 2009, the Company determined that it was in the best interest of the shareholders to suspend the Spansion matching contribution to each employee’s 401(k) account.

Executive Deferred Compensation Program. Our U.S. executive officers, as well as our other U.S. executives, are eligible to participate in the Spansion Executive Deferred Compensation (“EDC”) Plan, which we put in place to mitigate the impact of our executive officers and other highly compensated employees being unable to make the maximum contribution permitted under the 401(k) plan due to certain limitations imposed by the Internal Revenue Code. For a detailed description of the EDC Plan, please refer to the discussion in the “Nonqualified Deferred Compensation for Fiscal 2008” section, below.” Currently, none of our executive officers participates in the EDC Plan.

Life and Long-Term Disability Insurance. We provide our U.S. executive officers with life insurance such that the executive officer’s beneficiary will receive a death benefit of up to three times the executive’s annual salary, to a maximum of $3 million. In addition, our executive officers are eligible to participate in our Executive Long-Term Disability Plan, which pays up to $20,000 a month if an executive is unable to work due to a disability.

Other Health and Welfare Benefits, Perquisites and Termination Provisions. Spansion offers health and welfare benefits, in accordance with applicable local regulations and competitive practice, to employees in all of the countries in which we operate. During fiscal 2008, our executive officers were eligible to participate in those plans offered in their respective work locations. We also provide our executive officers with a monthly automobile allowance and company-paid financial counseling benefits. The automobile allowance and financial counseling benefits were canceled in February 2009, following a review of competitive practices and affordability. No adjustments to salary were made as a result of the elimination of these plans. We may offer relocation benefits to employees when their job requires relocation. In the event that an executive officer voluntarily terminates his or her employment, additional benefits may be provided based on the circumstances of the termination as discussed on page 168 under Potential Payments upon Termination, a Change of Control or Other Event. Terminating executive officers may be required to repay to Spansion a portion of any relocation benefits, sign-on bonus or retention bonus, depending on the terms of their agreement with Spansion.

Tax and Accounting Implications

$1 Million Deduction Limit. Section 162(m) of the Internal Revenue Code generally limits a tax deduction to public corporations for certain executive compensation in excess of $1 million per fiscal year. Certain types of compensation are deductible only if performance criteria are approved by stockholders. The Committee will endeavor to structure compensation plans to achieve maximum deductibility under Section 162(m) with minimal sacrifices in flexibility and corporate objectives. While the Committee will consider deductibility under Section 162(m) with respect to future compensation arrangements with executive officers, deductibility will not be the sole factor used in ascertaining appropriate levels or modes of compensation. Since corporate objectives may not always be consistent with the requirements for full deductibility, certain compensation paid by Spansion in the future may not be fully deductible under Section 162(m). For 2008, all elements of compensation paid to the Named Executive Officers were fully deductible by Spansion.

Accounting for Equity-Based Compensation . Beginning on December 26, 2005, Spansion began accounting for equity-based awards in accordance with the requirements of FASB Statement 123(R) “Share-Based Payment.”

Impact of Section 409A . To avoid adverse 409A impact, Spansion does not grant stock options to U.S. employees with an exercise price less than the fair market value of the Company’s Class A Common Stock on the date of grant.

161

Compensation Committee Report

The Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis required by Item 402(b) of Regulation S-K with management and, based on such review and discussions, the Compensation Committee recommended to the Board of Directors that the Compensation Discussion and Analysis be included in this Annual Report on Form 10-K.

THE COMPENSATION COMMITTEE

Gilles Delfassy, Chair

Donald L. Lucas

John M. Stich

162

Fiscal 2008 Summary Compensation Table

The table below summarizes the total compensation paid to or earned by each of the Named Executive Officers for the fiscal year ended December 28, 2008. No defined benefit pension plan was offered to the Named Executive Officers in fiscal 2008, and none of the Named Executive Officers elected to defer compensation under our EDC Plan in fiscal 2008.

Spansion entered into an employment agreement with Mr. John H. Kispert when he joined Spansion as Chief Executive Officer in February 2009; see “Compensation Discussion and Analysis” above. All other employees, including the Named Executive Officers, agree to their employment-related compensation and benefits by executing our employment offer letter, which, in the case of Named Executive Officers, are filed with the Securities and Exchange Commission.

Name and Principal Position	Year	Salary ($)(1)	Bonus ($)		Stock Awards ($)(2)	Option Awards ($)(3)	Non-Equity Incentive Plan Compensation ($)	All Other Compensation ($)(4)		Total ($)
Bertrand F. Cambou(5)	2008	708,345	—		579,370	657,665	—	37,680		1,983,060
Former President and Chief Executive Officer	2007	703,038	—		477,435	539,066	125,000	39,447		1,883,986
	2006	692,787	—		573,961	359,421	—	42,108		1,668,277
Dario Sacomani(6)	2008	425,873	—		101,795	372,752	—	98,219	(8)	998,639
Former Executive Vice President and Chief Financial Officer	2007	395,769	—		54,183	321,852	60,000	143,016		974,820
	2006	315,865	187,500	(7)	—	235,698	—	80,516		819,579
James E. Doran(9)	2008	448,408	—		267,948	325,543	—	32,831		1,074,730
Former Executive Vice President and Chief Operating Officer	2007	448,538	—		230,592	281,310	80,000	32,629		1,073,069
	2006	427,345	—		286,990	199,679	—	38,387		952,401
Thomas T. Eby	2008	423,533	—		232,161	323,201	—	34,792		1,013,687
Executive Vice President, Consumer, Set-Top Box and Industrial Division	2007	404,368	—		190,971	275,021	40,000	50,172		960,532
	2006	388,186	—		229,578	199,679	—	37,933		855,376
Ahmed Nawaz	2008	437,391	—		160,777	240,441	—	39,013	(11)	877,622
Executive Vice President, Wireless Solutions Division	2007	425,000	—		116,608	190,410	40,000	236,559		1,008,577
	2006	49,038	400,000	(10)	4,908	9,327	—	12,834		476,107

(1) The amounts shown in the Salary column reflect 53 weeks of salary in fiscal 2006, 52 weeks of salary in fiscal 2007, and 52 weeks of salary in fiscal 2008 for the Named Executive Officers who were employed by Spansion for the full fiscal years. All Named Executive Officers were employed for the full years except for Mr. Sacomani, whose employment commenced on February 28, 2006, and Mr. Nawaz, whose employment commenced on November 20, 2006.

(2) The amounts shown in the Stock Awards column reflect the recognized compensation expense for stock awards, excluding the impact of service-based forfeitures for financial statement reporting purposes for the fiscal years ended December 31, 2006, December 30, 2007, and December 28, 2008. The amounts also reflect the grant date fair value of each restricted stock unit award computed in accordance with FAS 123(R). The assumption used in valuation of these awards are set forth in the notes to our consolidated financial statements, which are included in this Annual Report on Form 10-K. These amounts do not correspond to the actual value that will be recognized by the Named Executive Officers. The value of all unvested awards as of December 28, 2008 for Dr. Cambou and Messrs. Sacomani, Doran, Eby and Nawaz was $32,816, $14,685, $11,389, $13,303, and $13,558, respectively.

163

(3) The amounts shown in the Option Awards column reflect the recognized compensation cost for option awards, excluding the impact of service-based forfeitures for financial statement reporting purposes for the fiscal years ended December 31, 2006, December 30, 2007, and December 28, 2008 Black-Scholes-Merton assumptions used in the calculation of these amounts are disclosed in Note 7 of the notes to our audited consolidated financial statements included in this Annual Report on Form 10-K. These amounts do not correspond to the actual value that will be recognized by the Named Executive Officers, which was $0 for each of the above Named Executive Officers as of December 28, 2008.

(4) The amounts shown in the All Other Compensation column reflect the following compensation for each Named Executive Officer, although only values exceeding ten percent of the total amount of perquisites and personal benefits are specified in these footnotes:

• Matching 401(K) contributions in fiscal 2008 for each of Dr. Cambou and Messrs. Sacomani, Doran and Eby of $6,900,

• Life insurance premium: The value in fiscal 2006 for Messrs. Doran and Eby was $6,625 and $6,872, respectively.

• Car allowance (based on 52 weeks in fiscal 2008) for each of Dr. Cambou and Messrs. Sacomani, Doran, Eby and Nawaz of $24,000.

• Financial planning services: Dr. Cambou received a reimbursement in the amount of $6,000 in fiscal 2008. Mr. Nawaz received a reimbursement in the amount of $5,300 in fiscal 2008.

(5) Dr. Cambou resigned on January 30, 2009, effective February 2, 2009. Dr. Cambou has agreed to provide transition services to us as a consultant for a four month period.

(6) Mr. Sacomani resigned his position on April 10, 2009. He is currently a part-time employee for a transition period of up to nine months.

(7) The amount reflects a bonus paid as part of Mr. Sacomani’s employment arrangement.

(8) In addition to the note in footnote 4 above, the amount reflects temporary housing living expense paid by Spansion to Mr. Sacomani in the amount of $66,538 in fiscal 2008.

(9) Mr. Doran resigned on January 29, 2009, effective February 13, 2009, to accept a senior level position at another company.

(10) The amount reflects a bonus paid as part of Mr. Nawaz’s employment arrangement.

(11) In addition to the items noted in footnote 4 above, the amount reflects relocation benefits paid by Spansion to Mr. Nawaz in the amount of $2,033 in fiscal 2008.

164

Grants of Plan-Based Awards for Fiscal 2008

The table below summarizes all grants of plan-based awards to all Named Executive Officers during fiscal 2008, which ended on December 28, 2008. The stock option awards and the unvested portion of the stock awards identified in the table below are also reported in the Outstanding Equity Awards at Fiscal 2008 Year-End Table on page 166.

Name	Grant Date		Estimated Possible Payouts Under Non-Equity Incentive Plan Awards(1)			All Other Stock Awards: Number of Shares of Stock or Units(2) (#)	All Other Option Awards: Number of Securities Underlying Options(3) (#)	Exercise or Base Price of Option Awards ($ / Sh)	Grant Date Fair Value of Stock and Option Awards(4) ($)
			Threshold ($)	Target ($)	Maximum ($)
Bertrand F. Cambou	—			939,094	1,878,188
	4/28/2008	(5)	—	—	—	—	220,000	3.02	292,248
	4/28/2008	(6)	—	—	—	88,000	—	00.00	265,760
Dario Sacomani	—			311,850	623,700
	4/28/2008	(5)	—	—	—	—	120,000	3.02	159,408
	4/28/2008	(6)	—	—	—	48,000	—	00.00	144,960
James E. Doran	—			321,300	642,600
	4/28/2008	(5)	—	—	—	—	60,000	3.02	79,704
	4/28/2008	(6)	—	—	—	24,000	—	00.00	72,480
Thomas T. Eby	—			308,240	616,480
	4/28/2008	(5)	—	—	—	—	90,000	3.02	119,556
	4/28/2008	(6)	—	—	—	36,000	—	00.00	108,720
Ahmed Nawaz	—			318,325	636,650
	4/28/2008	(5)	—	—	—	—	90,000	3.02	119,556
	4/28/2008	(6)	—	—	—	36,000	—	00.00	108,720

(1) Reflect the target and maximum target bonus amounts for fiscal 2008 performance under the short-term performance-based incentive compensation plan, as described in “Compensation Discussion and Analysis—Short-Term Performance-Based Incentive Compensation.” There were no bonus payouts for fiscal 2008 as reflected in the “Non-Equity Incentive Plan Compensation” column of the Fiscal 2008 Summary Compensation Table.

(2) All restricted stock units granted to Named Executive Officers vest 25 percent on the anniversary of the grant date and the remainder vests in equal installments quarterly over the remaining 36 months.

(3) All stock options granted to Named Executive Officers vest 25 percent on the anniversary of the grant date and the remainder vests in equal installments quarterly over the remaining 36 months.

(4) Reflects the grant date fair value of each stock option and restricted stock unit award computed in accordance with FAS 123(R). The assumption used in valuation of these awards are set forth in the notes to our consolidated financial statements, which are included in this Annual Report on Form 10-K. These amounts do not correspond to the actual value that will be recognized by the Named Executive Officers.

(5) Represents an annual stock option award granted on April 28, 2008 under the 2007 Equity Incentive Plan.

(6) Represents an annual restricted stock unit award granted on April 28, 2008 under the 2007 Equity Incentive Plan.

165

Outstanding Equity Awards at Fiscal 2008 Year-End

The table below summarizes the outstanding Spansion equity awards held and exercisable by Named Executive Officers at the end of fiscal 2008. Spansion does not offer an equity incentive plan, as defined under Item 402(a)(6)(iii) of Regulation S-K.

	Option Awards					Stock Awards
	Number of Securities Underlying Unexercised Options (#)	Number of Securities Underlying Unexercised Options (#)		Option Exercise Price ($)	Option Expiration Date	Number of Shares or Units of Stock That Have Not Vested (#)(1)		Market Value of Shares or Units of Stock That Have Not Vested ($)(2)
Name	Exercisable	Unexercisable
Bertrand F. Cambou	154,687	70,313	(3)	12.00	12/15/2012	14,288	(4)	3,143
	70,312	117,188	(5)	10.41	04/20/2014	46,876	(7)	10,313
	—	220,000	(12)	3.02	04/28/2015	88,000	(13)	19,360
Dario Sacomani	85,937	39,063	(5)	14.74	03/03/2013	—		—
	28,125	46,875	(6)	10.41	04/20/2014	18,750	(7)	4,125
	—	120,000	(12)	3.02	04/28/2015	48,000	(13)	10,560
James E. Doran	85,937	39,063	(3)	12.00	12/15/2012	7,144	(4)	1,572
	30,937	51,563	(6)	10.41	04/20/2014	20,626	(7)	4,538
	—	60,000	(12)	3.02	04/28/2015	24,000	(13)	5,280
Thomas T. Eby	85,937	39,063	(3)	12.00	12/15/2012	5,716	(4)	1,258
	28,125	46,875	(6)	10.41	04/20/2014	18,750	(7)	4,125
	—	90,000	(12)	3.02	04/28/2015	36,000	(13)	7,920
Ahmed Nawaz	37,500	37,500	(8)	14.93	12/07/2013	10,000	(9)	2,200
	11,250	18,750	(6)	10.41	04/20/2014	7,500	(7)	1,650
	12,187	20,313	(10)	11.53	06/13/2014	8,125	(11)	1,788
	—	90,000	(12)	3.02	04/28/2015	36,000	(13)	7,920

(1) Each restricted stock unit represents a contingent right to receive one share of Spansion Class A Common Stock. There is no exercise price.

(2) Based on closing price of $0.22 of Spansion Class A Common Stock on December 26, 2008.

(3) The stock option was granted on December 15, 2005 and vests over a four-year period with 25 percent of the shares vesting on January 28, 2007, and the remaining shares vesting in equal quarterly installments over the remaining 36 months beginning April 28, 2007.

(4) The restricted stock unit award was granted on December 15, 2005 and vests over a four-year period, with 25 percent of the shares vesting on April 28, 2006, and the remaining shares vesting in equal quarterly installments over the remaining 36 months beginning July 28, 2006.

(5) The stock option was granted on March 3, 2006 and vests over a four-year period, with 25 percent of the shares vesting on January 28, 2007, and the remaining shares vesting in equal quarterly installments over the remaining 36 months beginning April 28, 2007.

(6) The stock option was granted on April 20, 2007 and vests over a four-year period, with 25 percent of the shares vesting on the anniversary of the date of grant and the remaining shares vesting in equal quarterly installments over the remaining 36 months beginning July 20, 2007.

(7) The restricted stock unit award was granted on April 20, 2007 and vest over a four-year period, with 25 percent of the shares vesting on the anniversary of the date of grant and the remaining shares vesting in equal quarterly installments over the remaining 36 months beginning July 20, 2007.

(8) The stock option was granted on December 7, 2006 and vests over a four-year period, with 25 percent of the shares vesting on the anniversary of the date of grant and the remaining shares vesting in equal quarterly installments over the remaining 36 months beginning December 7, 2007.

166

(9) The restricted stock unit award was granted on December 7, 2006 and vests over a four-year period with 25 percent of the shares vesting on the anniversary of the date of grant and the remaining shares vesting in equal quarterly installments over the remaining 36 months beginning December 7, 2007.

(10) The stock option was granted on June 13, 2007 and vests over a four-year period, with 25 percent of the shares vesting on the anniversary of the date of grant and the remaining shares vesting in equal quarterly installments over the remaining 36 months beginning September 13, 2008.

(11) The restricted stock unit award was granted on June 13, 2007 and vests over a four-year period with 25 percent of the shares vesting on the anniversary of the date of grant and the remaining shares vesting in equal quarterly installments over the remaining 36 months beginning September 13, 2008.

(12) The stock option was granted on April 28, 2008 and vests over a four-year period, with 25 percent of the shares vesting on the anniversary of the date of grant and the remaining shares vesting in equal quarterly installments over the remaining 36 months beginning April 28, 2009.

(13) The restricted stock unit award was granted on April 28, 2008 and vests over a four-year period with 25 percent of the shares vesting on the anniversary of the date of grant and the remaining shares vesting in equal quarterly installments over the remaining 36 months beginning April 28, 2009.

Although certain Named Executive Officers held Advanced Micro Devices, Inc.’s (AMD) stock options that were granted to them by AMD prior to our initial public offering in December 2005, those stock options expired in November 2008.

Option Exercises and Stock Vested for Fiscal 2008

The table below summarizes the Spansion restricted stock units vested by Named Executive Officers during fiscal 2008. There were no Spansion or AMD stock option exercises by Named Executive Officers during fiscal 2008.

	Stock Awards
Name	Number of Shares Acquired on Vesting (#)	Value Realized on Vesting ($)(1)
Bertrand F. Cambou	56,700	138,747
Dario Sacomani	11,250	29,981
James E. Doran	26,662	64,875
Thomas T. Eby	22,680	55,498
Ahmed Nawaz	14,375	32,978

(1) The value realized equals the fair market value of Spansion Class A Common Stock on the vesting date, as measured by the closing price on that date, multiplied by the number of shares that vested.

Pension Benefits for Fiscal 2008

We provide a defined benefit plan for certain employees of our subsidiary in Japan. We do not provide a defined benefit plan for any of our other employees. Therefore, none of our Named Executive Officers are entitled to receive any benefits from a defined benefit plan.

Nonqualified Deferred Compensation for Fiscal 2008

Our executive officers, and our other U.S. executives, are eligible to participate in the Spansion Executive Deferred Compensation Plan (the “EDC Plan”) previously referred to as Executive Investment Account Plan. Participants in the EDC Plan may defer up to 50 percent of base salary and up to 100 percent of bonus payments under the Short-Term Performance-Based Incentive Compensation Plan or Sales Incentive Plan. Spansion matches up to three percent of pay ($0.50 on each $1.00 of pay deferred under the EDC Plan) on the executive’s base salary in excess of the applicable compensation limit set by the Internal Revenue Code. Currently, none of our executive officers participate in the EDC Plan.

167

Potential Payments upon Termination, a Change of Control or Other Event

Following is a general discussion of the compensation available to our Named Executive Officers in the event an executive’s employment terminates. The actual payments can be determined only at the time of the executive’s separation from Spansion. For purposes of illustration, however, tables below reflect the compensation Spansion would have provided to the Named Executive Officers had their employments terminated effective December 28, 2008.

Termination for Any Reason

When employment terminates for any reason, each Named Executive Officer is entitled to receive compensation earned during the time the executive was employed. Such compensation includes:

• Compensation earned during the fiscal year;

• Vested equity awards issued under any Spansion equity plan pursuant to the applicable terms and conditions of each award;

• Amounts deferred under the EDC Plan;

• Benefits accrued under Spansion’s Retirement Savings Plan; and

• Accrued unused vacation pay.

Retirement

If employment termination is due to retirement (which is achieved when an employee has reached 60 years of age and has provided 15 years of service to Spansion), in addition to compensation listed above under “Termination for Any Reason,” each Named Executive Officer receives all or a pro rata portion of the payment he or she would otherwise have been entitled to receive under Spansion’s Short-Term Performance-Based Incentive Compensation Plan (“STIP”) so long as the Named Executive Officer was an active participant in the STIP for at least six months of the plan year.

Termination Due to Death

In the event employment termination is due to death, in addition to compensation listed above under “Termination for Any Reason,” each Named Executive Officer’s beneficiary receives all or a pro-rata portion of the payment he or she would otherwise have been entitled to receive under the STIP, as long as the Named Executive Officer was an active participant in the STIP for at least six months of the plan year, and life insurance benefits, and if eligible, a survivor income benefit. In addition, if the executive has at least 15 years of service, all equity awards that would have vested any time during the calendar year in which the death occurred are accelerated to vest on the executive’s employment termination date. Some awards also require the executive to be at least 50 years of age.

Termination Due to Disability

In the event employment termination is due to a disability, in addition to compensation listed above under “Termination for Any Reason,” each Named Executive Officer is eligible to receive benefits under the Spansion disability plans in which he or she participated at the time of the termination; and if the executive has at least 15 years of service, all equity awards that would have vested any time during the calendar year in which the disability occurred are accelerated to vest on the executive’s employment termination date. Some awards also require the executive to be at least 50 years of age.

168

Involuntary Termination in Connection with a Reduction in Force

In the event employment termination is involuntary due to a reduction in force, in addition to any compensation due under “Termination for Any Reason” and “Retirement” listed above, each Named Executive Officer receives, but only in return for executing a general release agreement: a lump sum payment based on length of service (the “Severance Pay Period”), payment for four months of medical COBRA continuation coverage, use of Spansion’s employee assistance program for a period of time, eight weeks base salary, any STIP award not yet paid following the close of a plan year, and, at Spansion’s discretion, additional compensation to be determined by Spansion for any sabbatical the executive had earned but not taken prior to the termination date. Additionally, vesting for Spansion equity awards held by the executive that would regularly vest during the Severance Pay Period is accelerated to vest on the executive’s employment termination date.

Spansion’s severance benefits were modified in February 2009 to include a subsidy for four months of COBRA medical continuation coverage and use of Spansion’s employee assistance plan for four months.

Termination in Connection With a Change of Control

In fiscal 2005, we entered into a Change of Control Severance Agreement (the “Initial COC Agreement”) with each of our then-current executive officers, including Dr. Cambou and Messrs. Doran, Eby, and Sacomani, four of our current Named Executive Officers. In September 2007, the Board of Directors, upon the recommendation of the Compensation Committee, approved an amended and restated form of the Initial COC Agreement (the “Amended COC Agreement”). The Amended COC Agreement incorporates deadlines for change of control payments in compliance with the regulations implementing section 409A of the Internal Revenue Code and is otherwise substantially similar to the Initial COC Agreement. Under the Amended COC Agreements, if within 24 months following a change of control (as described below), an executive officer’s employment was terminated by Spansion or its successor other than for Cause (as defined in the Amended COC Agreement) or by reason of death or disability, or if the executive officer terminated employment for Good Reason (as defined in the Amended COC Agreement), in addition to the compensation listed above under the heading “Termination of Employment for Any Reason,” the following would have occurred:

• The executive officer would have received a lump sum payment consisting of a pro rata portion of the executive officer’s actual bonus payment, if any, under the STIP, plus two times (three times in the case of the Chief Executive Officer) the aggregate of (i) the executive’s then current base salary and (ii) the executive’s target bonus opportunity under the STIP;

• Acceleration of all unvested equity granted to the executive officer under any Spansion equity incentive plan and held by the executive officer at the effective termination date;

• Payment of premiums incurred by the executive officer for medical and dental COBRA continuation coverage as of the effective termination date, and ending the earlier of 18 months from that termination date or the date the executive officer begins receiving comparable medical and dental benefits through other employment; and

• Upon a change of control, an executive may be subject to certain excise taxes pursuant to Section 4999 of the Internal Revenue Code, as amended (the “IRC”). Should change of control payments have exceeded 15 percent of the qualified 280G limit under Section 4999, the executive would have been reimbursed such that the after-tax benefit would have been the same as if no excise tax had been applied. Otherwise, calculated change-of-control payments in excess of the 280G limit would have been reduced such that the executive officer would not have been subject to any excise tax.

Generally, under the Amended COC Agreements, a change of control is conclusively presumed to have occurred on:

• The acquisition by any person, other than by us, of beneficial ownership of more than 33 percent of either our then-outstanding membership interests or shares of our common stock, or the combined voting power of our then-outstanding voting securities entitled to vote generally in the election of directors;

169

• A change of the majority of our board of directors as of a determination date (the “incumbent board”), provided, however, that any individual becoming a new board director subsequent to the determination date whose election or nomination for election by our security holders was approved by a vote of at least two-thirds of the members comprising the incumbent board shall be considered as though such individual were a member of the incumbent board;

• The consummation of a reorganization, merger, statutory share exchange or consolidation or similar transaction, a sale or other disposition of all or substantially all of our assets, or an acquisition of assets or stock of another entity, whereby the individuals and entities that were the beneficial owners of our then-outstanding common stock and other then-outstanding voting securities cease to own more than 50 percent of the then-outstanding equity interests and the combined voting power of our then-outstanding voting securities entitled to vote generally in the election of directors; or

• The approval by our stockholders of a complete liquidation or dissolution other than in the context of a transaction that does not constitute a change of control as described above.

In September 2007, the Committee approved a new form of change of control severance agreement (the “Current COC Agreement”) for use going forward for all new eligible executive officers. The Current COC Agreement is substantially similar to the Amended COC Agreement, except that the Current COC Agreement:

• Does not contain the provision allowing for a tax gross-up in connection with change of control payments that exceeded 15 percent of the qualified 280G limit under Section 4999 of the IRC;

• Includes an “alternative cap” provision allowing for the highest after-tax benefit without additional cost to Spansion; and

• Includes deadlines for change of control payments in accordance with the regulations implementing section 409A of the IRC.

In October 2007, we entered into a Current COC Agreement with Mr. Ahmed Nawaz. On November 26, 2007, we notified each of the executive officers with whom we entered into an Amended COC Agreement that we intend to cancel their respective Amended COC Agreements on or about November 27, 2009. When the Amended COC Agreements terminate, we expect to enter into a Current COC Agreement, or such other form of change of control agreement that the Board of Directors deems appropriate, with each executive officer who is eligible for such agreement at that time.

The forms of Initial COC Agreement, Amended COC Agreement and Current COC Agreement have been filed with the Securities and Exchange Commission. The terms of our change of control severance agreements may be amended or nullified, completely or in part, as a result of our Creditor Protection Proceedings.

The following tables show the potential payments that would have been made to each of the Named Executive Officers if their respective employment with us had terminated as of December 28, 2008, other than for Mr. Doran, who received no severance. None of the eligible Named Executive Officers would have exceeded the 280G limit by more than 15 percent, thus no tax gross-ups would have been provided. For the actual amounts paid to Dr. Cambou on the termination of his employment, please see the summary of his severance agreement on page 159.

170

Bertrand F. Cambou

Executive Benefits and Payments Upon Termination as of December 26, 2008	Voluntary Termination		Normal Retirement (60 years and 15 years Service)			Involuntary Not for Cause Termination (Reduction in Force)			For Cause Termination		Involuntary or for Good Reason Following Change of Control Within 24 Months			Death			Disability
Compensation:
Base Salary		—		—		$	161,813	(1)		—	$	1,803,060	(2)		—			—
Short-term Incentive		—		—	(3)	$	—	(4)		—	$	2,253,825	(5)		—	(4)		—
Long-term Incentive
Stock Options—Unvested and Accelerated		—		—			—	(6)		—		—	(6)		—			—
Restricted Stock Units—Unvested and Accelerated		—		—		$	2,603	(6)		—	$	32,816	(6)		—			—
Subtotal:		—		—		$	164,416			—	$	4,089,701			—			—
Benefits and Perquisites:
Post-Employment Health Insurance (COBRA)		—		—		$	4,781			—		24,036			—			—
Life Insurance Proceeds		—		—			—			—		—		$	1,000,000			—
Survivor Income Benefit		—		—			—			—		—		$	4,000			—
Accrued Vacation Pay	$	36,734	$	36,734		$	36,734		$	36,734	$	36,734		$	36,734		$	36,734
Sabbatical		—		—		$	23,116			—		—			—			—
Excise Tax Gross-up		—		—			—			—		—			—			—
Subtotal:	$	36,734	$	36,734		$	64,631		$	36,734	$	60,770		$	1,040,734		$	36,734
Vested Benefits:
Stock Awards		—		—			—	(6)		—		—	(6)		—	(6)		—	(6)
Retirement Savings Plan	$	548,238	$	548,238		$	548,238		$	548,238	$	548,238		$	548,238		$	548,238
Subtotal:	$	548,238	$	548,238		$	548,238		$	548,238	$	548,238		$	548,238		$	548,238
TOTAL	$	584,972	$	584,972		$	777,285		$	584,972	$	4,698,709		$	1,588,972		$	584,972

(1) Dr. Cambou was eligible to receive 14 weeks of severance pay upon an involuntary, not for cause, termination.

(2) Dr. Cambou was eligible to receive three times his annual base salary of $601,020 upon termination as described under “Termination in Connection with a Change of Control” above.

(3) Ineligible due to age and years of service requirements and no bonus payout in 2008.

(4) No bonus payout in 2008.

(5) Dr. Cambou was eligible to receive three times his annual target bonus of $751,275 upon termination in the event of a change of control as described under “Termination in Connection with a Change of Control” above.

(6) Stock value is calculated based on the fair market value of $0.22 on December 26, 2008, which was the last business day of fiscal 2008.

171

Dario Sacomani

Executive Benefits and Payments Upon Termination as of December 26, 2008	Voluntary Termination		Normal Retirement (60 years and 15 years Service)			Involuntary Not for Cause Termination (Reduction in Force)			For Cause Termination		Involuntary or for Good Reason Following Change of Control Within 24 Months			Death			Disability
Compensation:
Base Salary		—		—		$	77,106	(1)		—	$	801,900	(2)		—			—
Short-term Incentive		—		—	(3)	$	—	(4)		—	$	561,330	(5)		—	(4)		—
Long-term Incentive
Stock Options—Unvested and Accelerated		—		—			—	(6)		—		—	(6)		—			—
Restricted Stock Units—Unvested and Accelerated		—		—		$	413	(6)		—	$	14,685	(6)		—			—
Bonus Repayment		—		—			—			—		—			—			—
Subtotal:		—		—		$	77,519			—	$	1,377,915			—			—
Benefits and Perquisites:
Post-Employment Health Insurance (COBRA)		—		—		$	4,781			—	$	24,036			—			—
Life Insurance Proceeds		—		—			—			—		—		$	1,000,000			—
Survivor Income Benefit		—		—			—			—		—		$	4,000			—
Accrued Vacation Pay	$	21,788	$	21,788		$	21,788		$	21,788	$	21,788		$	21,788		$	21,788
Excise Tax Gross-Up		—		—			—			—		—			—			—
Subtotal:	$	21,788	$	21,788		$	26,569		$	21,788	$	45,824		$	1,025,788		$	21,788
Vested Benefits:
Stock Awards		—		—			—	(6)		—		—	(6)		—			—
Retirement Savings Plan	$	57,211	$	57,211		$	57,211		$	57,211	$	57,211		$	57,211		$	57,211
Subtotal:	$	57,211	$	57,211		$	57,211		$	57,211	$	57,211		$	57,211		$	57,211
TOTAL	$	78,999	$	78,999		$	161,299		$	78,999	$	1,480,950		$	1,082,999		$	78,999

(1) Mr. Sacomani was eligible to receive ten weeks of severance pay upon an involuntary, not for cause, termination.

(2) Mr. Sacomani was eligible to receive two times his annual base salary of $400,950 upon termination as described under “Termination in Connection with a Change of Control” above.

(3) Ineligible due to age and years of service requirements and no bonus payout in 2008.

(4) No bonus payout in 2008.

(5) Mr. Sacomani was eligible to receive two times his annual target bonus of $280,665 upon termination in the event of a change of control as described under “Termination in Connection with a Change of Control” above.

(6) Stock value is calculated based on the fair market value $0.22 on December 26, 2008, which was the last business day of fiscal 2008.

172

Thomas T. Eby

Executive Benefits and Payments Upon Termination as of December 26, 2008	Voluntary Termination		Normal Retirement (60 years and 15 years Service)			Involuntary Not for Cause Termination (Reduction in Force)			For Cause Termination		Involuntary or for Good Reason Following Change of Control Within 24 Months			Death			Disability
Compensation:
Base Salary		—		—		$	362,013	(1)		—	$	792,618	(2)		—			—
Short-term Incentive		—		—	(3)	$	—	(4)		—	$	554,833	(5)	$	—	(4)		—
Long-term Incentive
Stock Options—Unvested and Accelerated		—		—			—	(6)		—		—	(6)		—			—
Restricted Stock Units—Unvested and Accelerated		—		—		$	2,603	(6)		—	$	32,816	(6)		—			—
Subtotal:		—		—		$	364,616			—	$	1,380,267		$	—			—
Benefits and Perquisites:
Post-Employment Health Insurance (COBRA)		—		—		$	4,781			—	$	24,036			—			—
Life Insurance Proceeds		—		—			—			—		—		$	1,189,000			—
Survivor Income Benefit		—		—			—			—		—		$	4,000			—
Accrued Vacation Pay	$	33,682	$	33,682		$	33,682		$	33,682	$	33,682		$	33,682		$	33,682
Sabbatical		—		—		$	60,971			—		—			—			—
Excise Tax Gross-Up		—		—			—			—		—			—			—
Subtotal:	$	33,682	$	33,682		$	99,434		$	33,682	$	57,718		$	1,226,682		$	33,682
Vested Benefits:
Stock Awards		—		—			—	(6)		—		—	(6)		—			—
Retirement Savings Plan	$	553,952	$	553,952		$	553,952		$	553,952	$	553,952		$	553,952		$	553,952
Subtotal:	$	553,952	$	553,952		$	553,952		$	553,952	$	553,952		$	553,952		$	553,952
TOTAL	$	587,634	$	587,634		$	1,018,002		$	587,634	$	1,991,937		$	1,780,634		$	587,634

(1) Mr. Eby is eligible to receive 47.5 weeks of severance pay upon involuntary, not for cause, termination.

(2) Mr. Eby is eligible to receive two times his annual base salary of $396,309 upon termination as described under “Termination in Connection with a Change of Control” above.

(3) Ineligible due to age and years of service requirements and no bonus payout in 2008.

(4) No bonus payout in 2008.

(5) Mr. Eby is eligible to receive two times his annual target bonus of $277,416 upon termination in the event of a change of control as described under “Termination in Connection with a Change of Control” above.

(6) Stock value is calculated based on the fair market value $0.22 on December 26, 2008, which was the last business day of fiscal 2008.

173

Ahmed Nawaz

Executive Benefits and Payments Upon Termination as of December 26, 2008	Voluntary Termination		Normal Retirement (60 years and 15 years Service)			Involuntary Not for Cause Termination (Reduction in Force)			For Cause Termination		Involuntary or for Good Reason Following Change of Control Within 24 Months			Death			Disability
Compensation:
Base Salary		—		—		$	78,707	(1)		—	$	818,550	(2)		—			—
Short-term Incentive		—		—	(3)	$	—	(4)		—	$	572,985	(5)	$	—	(4)		—
Long-term Incentive
Stock Options—Unvested and Accelerated		—		—			—	(6)		—		—	(6)		—			—
Restricted Stock Units—Unvested and Accelerated		—		—		$	440	(6)		—	$	13,558	(6)		—			—
Subtotal:		—		—		$	79,147			—	$	1,405,093		$	—			—
Benefits and Perquisites:
Post-Employment Health Insurance (COBRA)		—		—		$	4,781			—	$	23,616			—			—
Life Insurance Proceeds		—		—			—			—		—		$	1,000,000			—
Survivor Income Benefit		—		—			—			—		—		$	4,000			—
Accrued Vacation Pay	$	27,081	$	27,081		$	27,081		$	27,081	$	27,081		$	27,081		$	27,081
Excise Tax Gross-Up		—		—			—			—		—			—			—
Subtotal	$	27,081	$	27,081		$	31,862		$	27,081	$	50,697		$	1,031,081		$	27,081
Vested Benefits:
Stock Awards		—		—			—	(6)		—		—	(6)		—			—
Retirement Savings Plan	$	36,180	$	36,180		$	36,180		$	36,180	$	36,180		$	36,180		$	36,180
Subtotal:	$	36,180	$	36,180		$	36,180		$	36,180	$	36,180		$	36,180		$	36,180
TOTAL	$	63,261	$	63,261		$	147,189		$	63,261	$	1,491,970		$	1,067,261		$	63,261

(1) Mr. Nawaz is eligible to receive 10 weeks of severance pay upon an involuntary, not for cause, termination.

(2) Mr. Nawaz is eligible to receive two times his annual base salary of $409,275 upon termination as described under “Termination in Connection with a Change of Control” above.

(3) Ineligible due to age and years of service requirements and no bonus payout in 2008.

(4) No bonus payout in 2008.

(5) Mr. Nawaz is eligible to receive two times his annual target bonus of $286,493 upon termination in the event of a change of control as described under “Termination in Connection with a Change of Control” above.

(6) Stock value is calculated based on the fair market value $0.22 on December 26, 2008, which was the last business day of fiscal 2008.

Compensation Committee Interlocks and Insider Participation

The individuals who served as members of the Compensation Committee during fiscal 2008 were Messrs. Delfassy, Stich and Roberson and Ms. Hart. No member of the Compensation Committee was at any time during fiscal 2008 or at any other time an officer or employee of Spansion, and no member had any relationship with Spansion requiring disclosure under Item 404 of Regulation S-K. None of our executive officers has served on the board of directors or compensation committee of any other entity that has or has had one or more executive officers who served as a member of the Board of Directors or the Compensation Committee during fiscal 2008.

174

Director Compensation

Spansion uses a combination of cash and equity-based incentive compensation to attract and retain qualified candidates to serve on the Board of Directors. Our independent director compensation is determined by the Board of Directors acting upon the recommendation of the Compensation Committee. In setting director compensation, our Board of Directors considers, among other things, the significant amount of time that directors spend in fulfilling their duties, the skill-level required by directors and competitive market data. Directors who are also employees of Spansion, or who are otherwise determined to not be independent, receive no additional compensation for service as a director. We may reimburse any of our directors and, in some circumstances, spouses who accompany directors, for travel, lodging and related expenses they incur in attending Board of Directors and Board committee meetings.

Cash Compensation

From the beginning of fiscal 2008 through September 2008, our independent directors received fees for their services as set forth in the table below. All annual cash compensation is paid in quarterly installments, in advance.

Annual Retainer(1)	$	60,000
Additional Annual Retainers
Chairperson	$	100,000
Audit Committee Chair	$	15,000
Compensation Committee Chair	$	7,500
Finance Committee Chair	$	7,500
Nominating and Corporate Governance Committee Chair	$	7,500
Strategy Committee Chair	$	7,500
Fees Per Board Meeting in Excess of Eight Board Meetings(2)	$	2,000
Fees Per Committee Meeting in Excess of Twelve Committee Meetings(2)	$	2,000

(1) All independent directors, including directors serving as Chairperson, receive this annual retainer.

(2) If in any calendar year an independent director is required to and does attend (i) more than eight meetings of our Board of Directors, such director will receive $2,000 for each Board meeting attended in excess of eight, or (ii) more than 12 meetings of a specific Board committee on which he or she serves, such director will receive $2,000 per such Board committee meeting in excess of 12.

In October 2008, the Board of Directors approved a temporary retainer and meeting fee reduction of ten percent for the independent directors. This reduction was in alignment with the temporary base salary reduction taken by all exempt employees as part of our efforts to preserve cash. The reduction was applied to the payment made for the fourth quarter of 2008 and the first quarter for 2009, and will remain in effect until the Board takes action to lift the reduction.

Equity-Based Incentive Compensation

Each independent director received an initial stock option award exercisable for 20,000 shares of our Class A Common Stock and an initial restricted stock unit award of 20,000 units that convert upon vesting into 20,000 shares of our Class A Common Stock. These awards were made at the time of our initial public offering of our Class A Common Stock in December 2005 or, if later, upon the director’s appointment to our Board of Directors. In addition, an independent director who serves as Chairperson of the Board received an additional initial restricted stock unit award of 10,000 units that convert upon vesting into 10,000 shares of our Class A Common Stock.

175

For each year of continued service, independent directors received an annual stock option award exercisable for 10,000 shares of our Class A Common Stock and an annual restricted stock unit award of 10,000 units that convert upon vesting into 10,000 shares of our Class A Common Stock. In addition, for each year of continued service, an independent director serving as the Chairperson of the Board received an additional annual stock option award exercisable for 5,000 shares of our Class A Common Stock and an additional annual restricted stock unit award of 5,000 units that convert upon vesting into 5,000 shares of our Class A Common Stock. All annual equity-based compensation is awarded to independent directors on the date of the annual stockholders meeting. At the annual stockholders meeting, each independent director who (i) joined our Board of Directors at or prior to the last annual stockholders meeting, or (ii) joined our Board of Directors after the last annual stockholders meeting but attended at least three meetings of the full Board of Directors, is entitled to receive an annual equity award at that annual stockholders meeting.

All stock option and restricted stock unit awards granted to our independent directors vest 25 percent on the anniversary of the grant date and the remainder vests in equal installments quarterly over the remaining 36 months, except for the stock option and restricted stock unit awards granted to our independent directors in December 2005 at the time of the initial public offering of our Class A Common Stock. Those awards vested 25 percent on January 28, 2007 and the remainder vests in equal installments quarterly over the remaining 36 months.

On February 10, 2009, our wholly-owned subsidiary in Japan (Spansion Japan) filed a proceeding under the Corporate Reorganization Law (Kaisha Kosei Ho) of Japan to obtain protection from Spansion Japan’s creditors (the Spansion Japan Proceeding) and successively the Spansion Japan Proceeding was formally commenced on March 3, 2009, when the Tokyo District Court entered the commencement order and appointed the incumbent represented director of Spansion Japan as trustee. On March 1, 2009, Spansion Inc., Spansion Technology LLC, Spansion LLC, Spansion International, Inc. and Cerium Laboratories LLC, each filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (the Chapter 11 Cases). The Chapter 11 Cases, together with the Spansion Japan Proceeding, are referred to collectively as the Creditor Protection Proceedings. As a result of the Creditor Protection Proceedings, we are in the process of developing a comprehensive restructuring plan that will require bankruptcy court approval for operating our business going forward. Consequently, it is currently unknown when or whether we will continue to grant equity awards to independent directors in accordance with our past practice.

Director Compensation Table for Fiscal 2008

The following table provides information concerning compensation expense paid to or earned by each of our independent directors for fiscal 2008. Mr. John H. Kispert, our President and Chief Executive Officer, Mr. Boaz Eitan, a director and former employee of our subsidiary in Israel, and Dr. Bertrand Cambou, our former President and Chief Executive Officer do not and did not receive additional compensation for their services as a director.

Name	Fees Earned or Paid in Cash(1) ($)	Stock Awards(2)(3)(4) ($)	Option Awards(2)(3)(4)(5) ($)	Total ($)
David K. Chao	58,500	90,384	48,268	197,152
Gilles Delfassy	62,063	45,045	19,504	126,612
Robert L. Edwards	56,250	76,016	38,245	170,511
Patti S. Hart	33,750	90,385	48,278	172,413
Donald L. Lucas	166,875	67,561	20,405	254,841
David E. Roberson	33,750	90,385	48,268	172,403
John M. Stich	63,750	76,423	38,451	178,624

(1) Messrs. Chao, Delfassy, Lucas and Stich earned $13,500, 15,188, $39,375 and 16,875, respectively, during the fourth quarter of fiscal 2008 but did not receive payment until the first quarter of fiscal 2009.

(2) On May 27, 2008, Messrs. Chao, Delfassy, Edwards, Lucas, Stich and Roberson and Ms. Hart received their annual stock option award exercisable for 10,000 shares of our Class A Common Stock and a restricted

176

stock unit award of 10,000 units that convert upon vesting into 10,000 shares of our Class A Common Stock. The grant date fair value computed in accordance with FAS 123(R) of the fiscal 2008 annual stock option awards and restricted stock unit awards was $12,228 and $27,800, respectively.

(3) On May 27, 2008, Mr. Lucas received an additional option award exercisable for 5,000 shares of our Class A Common Stock and an additional restricted stock unit award of 5,000 units that convert upon vesting into 5,000 shares of our Class A Common Stock for his services as Chairman of the Board. The grant date fair value computed in accordance with FAS 123(R) of the fiscal 2008 annual stock option awards and restricted stock unit awards was $6,120 and $13,900, respectively.

(4) As of December 28, 2008, the aggregate number of shares of Class A Common Stock underlying stock option and restricted stock unit awards for each of our independent directors was:

Name	Aggregate Number of Shares Underlying Stock Options	Aggregate Number of Shares Underlying Restricted Stock Units
David K. Chao	40,000	22,500
Gilles Delfassy	30,000	23,750
Robert L. Edwards	8,750	0
Patti S. Hart	13,750	0
Donald L. Lucas	35,000	35,625
David E. Roberson	13,750	0
John M. Stich	30,000	20,000

(5) The amounts shown reflect the recognized compensation expense for stock awards and option awards, as applicable, excluding the impact of service-based forfeitures for financial statement purposes for the fiscal year ended December 28, 2008. The assumption used in valuation of these awards are set forth in Note 7 of the notes to our consolidated financial statements in this Annual Report on Form 10-K. These amounts do not correspond to the actual value that will be recognized by the directors.

177

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The following table sets forth the beneficial owners of more than five percent of the outstanding shares of Spansion Class A Common Stock as of April 6, 2009. This information is based upon our records and other information available from outside sources. We are not aware of any other beneficial owner of more than five percent of any class of Spansion Common Stock. Except as otherwise indicated, to our knowledge, each person has sole investment and voting power with respect to the shares shown as beneficially owned.

Name and Address of Beneficial Owner	Number of Shares Beneficially Owned	Percent of Class Beneficially Owned(1)
Fujitsu Microelectronics Limited(2) Shinjuku Daiichi Seimei Building, 2-7-1 Nishi-Shinjuku, Shinjuku-ku Tokyo 163-0701, Japan	18,352,934	11.4	%
Donald Smith & Co., Inc.(3) 152 West 57th Street New York, NY 10019	15,827,943	9.8	%
Prudential Financial, Inc.(4)(5) 751 Broad Street Newark, NJ 07102-3777	14,681,430	9.1	%
AMD Investments, Inc.(6) One AMD Place Sunnyvale, CA 94088	14,037,910	8.7	%

(1) Based on 161,381,900 shares of Class A Common Stock outstanding as of April 6, 2009. Calculated in accordance with the rules of the Securities Exchange Act of 1934, as amended.

(2) Based on information set forth in a Schedule 13D/A filed with the Securities and Exchange Commission on March 24, 2008.

(3) Based on information set forth in a Schedule 13G/A filed with the Securities and Exchange Commission on February 17, 2009. According to the Schedule 13G/A, Donald Smith & Co., Inc. has sole voting power with respect to 11,899,681 shares and sole dispositive power with respect to 15,827,943 shares.

(4) Based on information set forth in a Schedule 13G/A filed with the Securities and Exchange Commission on February 6, 2009. According to the Schedule 13G/A, Prudential Financial, Inc. has sole voting power with respect to 2,957,015 shares, shared voting power with respect to 11,064,515 shares, sole dispositive power with respect to 2,957,015 shares and shared dispositive power with respect to 11,724,415 shares.

(5) According to information set forth in a Schedule 13G filed with the Securities and Exchange Commission on February 17, 2009, Prudential Financial, Inc. may be deemed to have the power to exercise or to direct the exercise of such voting and/or dispositive power of the securities held by Jennison Associates LLC.

(6) Based on information set forth in a Schedule 13D/A filed with the Securities and Exchange Commission on November 28, 2006 and in Forms 4 filed with the Securities and Exchange Commission on February 22, 2007, February 26, 2007, February 28, 2007 and September 19, 2007. AMD Investments, Inc. is a wholly owned subsidiary of AMD (U.S.) Holdings, Inc., which is a wholly owned subsidiary of Advanced Micro Devices, Inc. (AMD). AMD (U.S.) Holdings, Inc. and AMD are indirect beneficial owners of the reported securities.

178

Security Ownership of Directors and Executive Officers

The following table sets forth information known to us with respect to beneficial ownership of Spansion Class A Common Stock, as of April 6, 2009, for our current directors, each of our executive officers listed in the Fiscal 2008 Summary Compensation Table appearing in Item 11 of Part III of this Annual Report on Form 10-K, and all of our directors and executive officers as a group. This ownership information is based upon information provided by the individuals.

Name(1)	Shares Currently Owned		Shares Acquirable Currently or Within 60 Days	Aggregate Shares Beneficially Owned(2)	Percent of Class Beneficially Owned(2)(3)
John H. Kispert	—		—	—		*
Bertrand F. Cambou	182,995		—	182,995		*
David K. Chao	19,375		19,375	38,750		*
Gilles Delfassy	7,500		7,500	15,000		*
Boaz Eitan	7,905,021		—	7,905,021	4.9	%
Donald L. Lucas	11,250		7,500	18,750		*
John M. Stich	11,250	(4)	11,250	22,500		*
James E. Doran	54,217		—	54,217		*
Thomas T. Eby	46,516		126,561	173,077		*
Ahmed Nawaz	14,467		69,530	83,997		*
Dario Sacomani	15,000		126,561	141,561		*
All directors and executive officers as a group (12 persons)	8,275,091		393,589	8,668,680	5.4	%

 * Less than one percent.

(1) The address of each beneficial owner is 915 DeGuigne Drive, Sunnyvale, CA 94085-3836.

(2) The number and percentage of shares beneficially owned is determined under the rules of the Securities and Exchange Commission, and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership includes any shares as to which the individual has sole or shared voting power or investment power and also any share which the individual has the right to acquire within 60 days of April 6, 2009, through the exercise of any stock option or the vesting of any restricted stock unit. Unless otherwise indicated in the footnotes, each person has sole voting and investment power (or shares such powers with his or her spouse) with respect to the shares shown as beneficially owned.

(3) Percent of class beneficially owned is based on 161,381,900 shares of Spansion Class A Common Stock outstanding as of April 6, 2009.

(4) Represents the direct beneficial ownership of 1,250 shares and the indirect beneficial ownership of 10,000 shares that are held by Stich Family Holdings LLC.

179

Equity Compensation Plan Information

The following table summarizes the number of outstanding options, warrants and rights granted to employees and directors, as well as the number of securities remaining available for future issuance under Spansion’s 2005 Equity Incentive Plan (the “2005 Plan”), 2007 Equity Incentive Plan (the “2007 Plan”), Saifun Semiconductor Ltd. 1997 Share Option Plan (the “1997 Plan”), the Saifun Semiconductor Ltd. 2001 Share Option Plan (the “2001 Plan”) and the Saifun Semiconductor Ltd. 2003 Share Option Plan (the “2003 Plan”) as of December 28, 2008. The 1997 Plan, the 2001 Plan and the 2003 Plan were acquired in connection our acquisition of Saifun Semiconductor Ltd. on March 18, 2008.

	(a)		(b)			(c)
Plan category	Number of securities to be issued upon exercise of outstanding options, warrants and rights (#)		Weighted-average exercise price of outstanding options, warrants and rights ($)			Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) (#)
Equity compensation plans approved by security holders	13,079,962	(1)	$	4.85	(2)	4,085,973	(3)
Equity compensation plans not approved by security holders	—			—		—
Total	13,079,962					4,085,973

(1) Includes the following:

• 32,364 shares issuable upon exercise of outstanding stock options awarded under the 1997 Plan.

• 4,115,339 shares issuable upon exercise of outstanding stock options awarded under the 2003 Plan.

• 156,670 shares issuable upon vesting of outstanding restricted stock units awarded under the 2003 Plan.

• 3,156,451 shares issuable upon exercise of outstanding stock options awarded under the 2005 Plan.

• 1,380,796 shares issuable upon vesting of outstanding restricted stock units awarded under the 2005 Plan.

• 2,475,243 shares issuable upon exercise of outstanding stock options awarded under the 2007 Plan.

• 1,763,099 shares issuable upon vesting of outstanding restricted stock units awarded under the 2007 Plan.

(2) Represents a weighted average exercise price of $0.21 for stock options outstanding under the 2001 Plan and $0.56 for stock options outstanding under the 2003 Plan, $11.65 for stock options outstanding under the 2005 Plan, and $3.38 for stock options outstanding under the 2007 Plan. Excludes the following:

• 156,670 shares issuable upon vesting of outstanding restricted stock units awarded under the 2003 Plan.

• 1,380,796 shares issuable upon vesting of outstanding restricted stock units awarded under the 2005 Plan.

• 1,763,099 shares issuable upon vesting of outstanding restricted stock units awarded under the 2007 Plan.

(3) Includes 602,408 shares that were cancelled as of December 28, 2008 under the 2005 Plan and are now available to be issued under the 2007 Plan.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

Review and Approval of Transactions with Related Persons

The Audit Committee has adopted a written policy for approval of transactions between Spansion and its directors, director nominees, executive officers, greater than five percent beneficial owners and their respective immediate family members, where the amount involved in the transaction exceeds or is expected to exceed

180

$120,000 in a single calendar year. Some of the transactions described in this Form 10-K were approved by the Board of Directors before this policy was adopted.

The policy provides that the Audit Committee reviews certain transactions subject to the policy and determines whether or not to approve or ratify those transactions. In doing so, the Audit Committee takes into account, among other factors it deems appropriate:

• the related person’s interest in the transaction;

• the approximate dollar value of the amount involved in the transaction;

• the approximate dollar value of the amount of the related person’s interest in the transaction without regard to the amount of any profit or loss;

• whether the transaction was undertaken in the ordinary course of business of Spansion;

• whether the transaction with the related person is proposed to be, or was, entered into on terms no less favorable to Spansion than terms that could have been reached with an unrelated third party;

• the purpose of, and the potential benefits to Spansion of, the transaction; and

• any other information regarding the transaction or the related person in the context of the proposed transaction that would be material to investors in light of the circumstances of the particular transaction.

In addition, the Audit Committee has delegated authority to the Chair of the Audit Committee to pre-approve or ratify certain transactions. A summary of any new transactions pre-approved or ratified by the Chair is provided to the full Audit Committee for its review in connection with its next scheduled Audit Committee meeting.

The Audit Committee has considered and adopted standing pre-approvals under the policy for limited transactions with related persons. Pre-approved transactions include:

• employment of executive officers, subject to certain conditions;

• any compensation paid to a director if the compensation is required to be reported in Spansion’s proxy statement under Item 402 of Regulation S-K promulgated by the Securities and Exchange Commission;

• any transaction with another company at which a related person’s only relationship is as an employee (other than an executive officer or director) or beneficial owner of less than ten percent of that company’s equity, if the aggregate amount involved does not exceed the greater of $1,000,000, or two percent of that company’s total annual revenues;

• any charitable contribution, grant or endowment by the Company to a charitable organization, foundation or university at which a related person’s only relationship is as an employee (other than an executive officer or director), if the aggregate amount involved does not exceed the lesser of $1,000,000, or two percent of the charitable organization’s total annual receipts; and

• any transaction where the related person’s interest arises solely from the ownership of Spansion’s Class A Common Stock and all holders of Spansion’s Class A Common Stock received the same benefit on a pro rata basis.

A summary of new transactions covered by the standing pre-approvals described above is provided to the Audit Committee for its review at each regularly schedule Audit Committee meeting.

Overview

We have had ongoing relationships and transactions with Advanced Micro Devices, Inc. (“AMD”) and Fujitsu Limited. AMD ceased to be a related party on March 18, 2008, when its aggregate ownership interest in us fell below ten percent.

181

On March 18, 2008, we completed our acquisition of Saifun Semiconductors Limited (“Saifun”). In connection with the Saifun acquisition, the Board of Directors appointed Dr. Boaz Eitan, former Executive Vice President and Chief Executive Officer, Saifun, as a member of the Board effective as of the closing of the acquisition. Dr. Eitan serves as a Class II director and will serve until our 2010 annual meeting of stockholders or until his earlier removal, resignation or death. Also in connection with the Saifun acquisition, we entered into a Noncompetition and Retention Agreement with Dr. Eitan whereby he received an annual gross salary equal to the Israeli shekel equivalent of $260,000 (as determined according to the representative rate of exchange published by the Bank of Israel). In addition, Dr. Eitan was eligible for an annual performance bonus and one time retention bonus for remaining employed by Spansion at the one year anniversary of the closing of the Saifun acquisition. Payment of this bonus is now subject to review under the Creditor Protection Proceedings. Dr. Eitan resigned from his employment with Spansion in March 2009. The Noncompetition and Retention Agreement also contains a two-year non-competition provision and a two-year non-solicitation provision.

We are also currently party to several agreements with AMD and Fujitsu. These agreements include:

• the Amended and Restated Fujitsu Distribution Agreement;

• the Amended and Restated Intellectual Property Contribution and Ancillary Matters Agreement;

• the Amended and Restated Patent Cross-License Agreement with Fujitsu;

• the Amended and Restated Patent Cross-License Agreement with AMD;

• the Amended and Restated Non-Competition Agreement;

• various software license, maintenance, consulting and development agreements;

• various service agreements and leases; and

• agreements with Fujitsu related to the sale of our JV1 and JV2 wafer fabrication facilities (the “JV1/JV2 Facilities”) and certain equipment, assets and inventory located at these facilities (the “JV1/JV2 Transaction”).

Agreements and Arrangements

Amended and Restated Fujitsu Distribution Agreement

We and Fujitsu Microelectronics Limited (FML), through its subsidiary Fujitsu Electronics Inc. (FEI, together with FML and Fujitsu Limited, “Fujitsu”) are party to the Amended and Restated Fujitsu Distribution Agreement, which provides that Fujitsu acts as a distributor for sales of our products in Japan and throughout the rest of the world, except for Europe and the Americas, with limited exceptions. We license use of the Spansion trademark to Fujitsu so that our products are sold under our own brand name. We also indemnify Fujitsu from and against any third-party action claiming our products infringe upon a third-party’s intellectual property rights up to the amounts paid to Fujitsu by their customers for the affected products.

Under the Fujitsu Distribution Agreement, our prices are based on our recommended sales prices, subject to adjustment in certain cases based on Fujitsu’s sales prices to their customers, less an agreed-upon distribution margin. Fujitsu has agreed to use its best efforts to promote the sale of our products in Japan and to specified customers served by Fujitsu. In the event that we reasonably determine that Fujitsu’s sales performance is not satisfactory based on specified criteria, then we have the right to require Fujitsu to propose and implement an agreed-upon corrective action plan. If we reasonably believe that the corrective action plan is inadequate, we can take steps to remedy deficiencies ourselves through means that include selling products ourselves or appointing another distributor as a supplementary distributor. The Fujitsu Distribution Agreement will expire on June 25, 2009, although we and Fujitsu can mutually agree to terminate the agreement at any time. Either party can terminate the Fujitsu Distribution Agreement for a material breach of performance thereunder after a failure to cure the breach within 120 days. Currently, the distribution margin earned by Fujitsu on the sale of certain of our products is 4.3 percent.

182

We and Fujitsu entered into an agreement in September 2008, in which we agreed to pay Fujitsu royalties on certain of our products sold or transferred under the Fujitsu Distribution Agreement in exchange for Fujitsu’s release of claims on account of an alleged breach of our alleged obligation to defend and/or indemnify Fujitsu against assertions by a third party against our products. In fiscal 2008, we paid $0.4 million to Fujitsu under this agreement.

Amended and Restated Intellectual Property Contribution and Ancillary Matters Agreement

AMD and Fujitsu have each contributed to us various intellectual property rights and technologies pursuant to an Amended and Restated Intellectual Property Contribution and Ancillary Matters Agreement. Under this agreement, we became owners, or joint owners with each of Fujitsu and AMD, of certain patents, patent applications, trademarks, and other intellectual property rights and technology. AMD and Fujitsu reserved rights, on a royalty-free basis, to practice the contributed patents and to license these patents to their affiliates and successors-in-interest to their semiconductor groups. AMD and Fujitsu each have the right to use the jointly owned intellectual property for their own internal purposes and to license such intellectual property to others to the extent consistent with their non-competition obligations to us. Subject to our confidentiality obligations to third parties, and only for so long as AMD’s and Fujitsu’s ownership interests in us remain above specific minimum levels, we are obligated to identify any of our technology to each of AMD and Fujitsu, and to provide copies of and training with respect to that technology to them. In addition, we have granted a non-exclusive, perpetual, irrevocable fully paid and royalty-free license of our rights, other than patent and trademark rights, in that technology to each of AMD and Fujitsu. AMD may grant licenses under our patents, provided that these licenses are of no broader scope than, and are subject to the same terms and conditions that apply to, any license of AMD’s patents granted in connection with such license, and the recipient of such license grants to us a license of similar scope under its patents.

Amended and Restated Patent Cross-License Agreements

In connection with our reorganization as Spansion LLC in June 2003, we granted to each of AMD and Fujitsu, and AMD and Fujitsu each granted to us, non-exclusive licenses under certain patents and patent applications of their semiconductor groups to make, have made, use, sell, offer to sell, lease, import and otherwise dispose of certain semiconductor-related products anywhere in the world. The patents and patent applications that are licensed are those with an effective filing date prior to the termination of our patent cross-license agreements. The agreements will automatically terminate on the later of June 30, 2013 and the date AMD or Fujitsu, as applicable, sells its entire equity interest in us. The agreements may be terminated by a party on a change in control of the other party or its semiconductor group. The licenses to patents under license at the time of the termination will survive until the last such patent expires.

In cases where there is a change of control of us, AMD, Fujitsu, or the semiconductor group of AMD or Fujitsu, as the case may be, each other party to the cross-license agreement shall have the right to terminate the agreement (or to invoke the provisions described in this paragraph if the agreement had been previously terminated) by giving 30 days written notice within 90 days after receiving notice of the change of control. If so terminated, the rights, licenses and immunities granted under the agreement will continue solely with respect to those licensed patents that are entitled to an effective filing date that is on or before, and are licensed as of, the date of such change of control, and will continue until the expiration of the last to expire of such licensed patents. Moreover, with respect to circuit patents, which are patents (other than process patents) covering elements using electrical signals to achieve a particular function, the rights, licenses and immunities granted to the party undergoing the change of control are limited solely to:

• each existing and pending product of such party as of the date of change of control;

• each existing and pending product of the acquiring third party of such party as of the date of change of control that would have been in direct competition with products described in (i) above; and

• successor products of products described in (i) and (ii) above.

183

We will continue to make royalty payments associated with licenses that survive the termination of the agreement. We currently pay royalties to each of AMD and Fujitsu in the amount of 0.15 percent of net sales of our products. The royalty rates were further reduced to zero percent in November 2008. The royalty rates were negotiated by AMD, Fujitsu and us. In fiscal 2008, we incurred approximately $2.7 million of expenses related to royalties to each of AMD and Fujitsu, respectively, under the patent cross-license agreements we have with them.

Amended and Restated Non-Competition Agreement

We are party to a non-competition agreement with AMD and Fujitsu, whereby AMD and Fujitsu each agree not to directly or indirectly engage in a business that manufactures or supplies standalone semiconductor devices (including single chip, multiple chip or system devices) containing certain Flash memory, which is the business in which we primarily compete. This non-competition agreement does not prevent AMD or Fujitsu from manufacturing or selling products that incorporate Flash memory (whether it be Spansion Flash memory or a competitive product). Although AMD currently has no other operations that compete in the Flash memory market, Fujitsu currently produces and sells products that incorporate Spansion Flash memory or competitive Flash memory. Furthermore, AMD and Fujitsu each agree that if either of them acquires a business that has a division or other operations that manufactures or supplies standalone semiconductor devices (including single chip, multiple chip or system devices) containing certain Flash memory, AMD and Fujitsu will provide us with a right of first offer to acquire the competing division or operations. AMD and Fujitsu are required to use their commercially reasonable efforts to divest the competing division or operations if we do not purchase them. These non-competition obligations of AMD will last until the earlier of (i) the dissolution of our company, and (ii) two years after the date on which AMD’s ownership interest in us is less than or equal to five percent. These non-competition obligations of Fujitsu will last until the earlier of (i) the dissolution of our company, and (ii) two years after the date on which Fujitsu’s ownership interest in us is less than or equal to five percent.

We, AMD and Fujitsu also agreed not to solicit each other’s employees. Without our prior written consent, each of AMD and Fujitsu will not directly or indirectly either for itself or another person, (i) hire any individual employed by our company or (ii) solicit or encourage any individual to terminate his or her employment with our company. These obligations not to solicit or hire do not apply if (A) our company has terminated the employment of such individual or (B) at least two years has elapsed since such individual has voluntarily terminated his or her employment with our company. Similarly, without the prior written consent of AMD or Fujitsu, we agreed not to directly or indirectly either for ourselves or another person, (i) hire any individual employed by AMD or Fujitsu or (ii) solicit or encourage any individual to terminate his or her employment with AMD or Fujitsu. These obligations not to solicit or hire do not apply if (A) AMD or Fujitsu, as applicable, has terminated the employment of such individual or (B) at least two years has elapsed since such individual has voluntarily terminated his or her employment with AMD or Fujitsu, as applicable. These non-solicitation obligations of AMD will last until the earlier of (i) the dissolution of our company, and (ii) two years after the date on which AMD’s ownership interest in us is less than or equal to five percent. These non-solicitation obligations of Fujitsu will last until the earlier of (i) the dissolution of our company, and (ii) two years after the date on which Fujitsu’s ownership interest in us is less than or equal to five percent. These non-solicitation obligations of our company with respect to AMD employees or Fujitsu employees will terminate at the same time as the non-solicitation obligations of AMD or Fujitsu, as applicable, terminate.

AMD/Fujitsu Service Agreements

We were party to various service agreements with each of AMD and Fujitsu (including certain of Fujitsu’s subsidiaries). Under its IT Services Agreement and General Services Agreement, AMD provided certain administrative services to us. Under its IT Services Agreement and General Services Agreement, Fujitsu provided, among other things, information technology, research and development, quality assurance, insurance, facilities, environmental, and human resources services primarily to our manufacturing facilities in Japan. For services rendered, AMD and Fujitsu were each paid fees in an amount equal to cost plus five percent except for services procured by AMD and Fujitsu from third parties, which were provided to us at cost. AMD and Fujitsu

184

each had the right to approve certain amendments to the other’s service agreements with us. The AMD services agreement expired on June 30, 2007. The services that were previously provided under the AMD services agreement are currently provided to us on a purchase order basis. The Fujitsu services agreement expired on March 31, 2009, however, we are in the process of negotiating an extension. For fiscal 2008, the total charges to us for services from AMD were approximately $0.2 million and the total charges to us for services from Fujitsu were approximately $18.4 million.

Fujitsu Manufacturing Services Agreement

Prior to September 30, 2006, we were party to an agreement pursuant to which Fujitsu provided manufacturing services to us at volumes ordered by us and prices established on a quarterly basis. Prices were on the basis of product-type and were equal to Fujitsu’s good faith estimate of its projected material, labor and overhead costs for the applicable product-type plus three percent. If Fujitsu’s aggregate expended labor and overhead costs for the manufacturing services actually purchased by us during a fiscal quarter were less than 97 percent of the projected labor and overhead costs for such fiscal quarter, then we were required to pay Fujitsu the amount of such deficiency in order to protect Fujitsu’s labor and overhead commitments from situations where the actual amounts of services purchased by us were materially different from projected orders. These services consisted of assembly and testing services for our products. The Manufacturing Services Agreement expired on September 30, 2006. Currently, such manufacturing services are provided by Fujitsu to us on a purchase order basis. As a result of manufacturing services provided by Fujitsu, we incurred approximately $1.0 million of expenses in fiscal 2008.

Remediation Agreement

In connection with our reorganization as of June 30, 2003, AMD contributed to us assets, including real property located in Sunnyvale, California, which is a Superfund listed property under CERCLA. A clean up order was issued by the San Francisco Bay Regional Water Quality Control Board, and a record of decision for remedial action for the site was issued by the U.S. Environmental Protection Agency in 1991, pursuant to which AMD must conduct groundwater remediation activities. To clarify their respective responsibilities regarding the release of hazardous substances at the Sunnyvale property prior to its contribution to Spansion, we entered into a remediation agreement with AMD and Fujitsu, pursuant to which AMD covenants to conduct remediation activities in accordance with the U.S. EPA’s record of decision and the San Francisco Bay Regional Water Quality Control Board’s order. AMD also agreed to indemnify Fujitsu and us against any losses incurred by Fujitsu and us in connection with this environmental condition for actions taken prior to the contribution of the property to Spansion.

Software Agreements

We are party to various software license, maintenance, consulting services, and development agreements with AMD relating to certain AMD manufacturing software. Under a software license agreement, AMD granted us various licenses to use certain AMD manufacturing software in our manufacturing facilities. We also have granted AMD corresponding licenses to use improvements made to the software by us. Under a software maintenance and services agreement, AMD agreed to provide us software maintenance and support for the AMD manufacturing software. Under a consulting services agreement, AMD agreed to provide certain manufacturing software consulting services as may be mutually agreed upon between AMD and us. Additionally, under a joint development agreement, we have agreed with AMD to jointly develop manufacturing software in accordance with statements of work that may be mutually agreed upon from time to time. The software license agreement has no expiration date, but may be terminated by AMD upon a breach by us of the terms of the agreement, our insolvency, or a change of control as defined in the agreement. The software maintenance and services agreement expired on December 15, 2007, but automatically is renewed for additional one year terms unless either party provides 120 days notice to the contrary. The consulting services agreement expired on December 31, 2007. The joint development agreement expires on December 31, 2011 unless terminated earlier in accordance with the terms of the agreement. For fiscal 2008, the total amount that we paid to AMD under these agreements was approximately $0.5 million.

185

Leases

In connection with our reorganization, Fujitsu’s subsidiary, Fujitsu VLSI, agreed to lease premises in Aichi, Japan, to Spansion Japan for a term of one year, to be automatically renewed for one-year periods unless three months prior notice is given by either party. Under this lease, Fujitsu VLSI also provided various office services to Spansion Japan. We paid Fujitsu VLSI approximately $21,000 per month (based on the exchange rate as of December 28, 2008) through August 2008, when the lease was terminated.

We lease from Fujitsu the land upon which JV3 and SP1, our fabrication facilities in Aizu-Wakamatsu, Japan, are located. As a result of our lease with Fujitsu, we incurred approximately $1.8 million in expenses in fiscal 2008.

We agreed to lease approximately 170,000 square feet of space at our facilities in Austin, Texas to AMD for a term of two years expiring December 31, 2007. On December 19, 2007, we agreed to extend the term of the lease for the majority of the premises to June 30, 2008, and for a small portion of the premises to December 31, 2008. The space is used for office, warehouse, and data center purposes. Under the terms of the lease, AMD paid a quarterly rental equal to a percentage of the total operating expenses of the premises. We received from AMD approximately $1.9 million in fiscal 2008.

Stockholders Agreement

We are party to a Stockholders Agreement with AMD and Fujitsu that imposes certain restrictions and obligations on AMD and Fujitsu and on their respective shares of our common stock and that provides for certain matters pertaining to our management and governance. Pursuant to the Stockholders Agreement, AMD and Fujitsu agree to vote all shares of common stock held by them or their affiliates so as to cause the election of each Class A director proposed for election by the nominating committee of our board of directors. The Stockholders Agreement also provided for certain rights relating to the appointment of directors to serve on our Board. These rights have terminated.

We will allow AMD or Fujitsu, as the case may be, to have one representative attend the meetings of our board of directors as a non-voting participant for so long as such stockholder owns at least five percent of our capital stock, on an as converted to common stock basis.

Neither stockholder can transfer shares in an amount equal to or greater than one percent of the then outstanding common stock to any entity whose principal business competes with us, without first obtaining the consent of the non-transferring stockholder, such consent not to be unreasonably withheld after June 30, 2007.

The Stockholders Agreement also provides for our cooperation with information. AMD and Fujitsu are both publicly traded companies, each of which is subject to legal and stock exchange reporting and other disclosure requirements. Accordingly, we will agree with AMD and Fujitsu to provide, subject to limitations, various financial and other information relating to us and to assist them in connection with their respective reporting, disclosure and other obligations. Each party has agreed that it will use any information provided under the agreement, unless otherwise made public, only in connection with these obligations and that it will not use the information for any other purpose, including in connection with the sale or purchase of securities issued by us.

Pursuant to the Stockholders Agreement, we have agreed to grant AMD and Fujitsu rights to request us to register all or any part of their shares of Class A Common Stock under the Securities Act of 1933, as amended. In addition, subject to limitations, AMD and Fujitsu have rights to request that their shares be included in any registration of our common stock that we initiate.

With the exception of board observer rights and registration rights, AMD’s rights under the Stockholders Agreement terminated on March 18, 2008, when AMD’s aggregate ownership interest in us fell below ten percent.

186

Commercial Die Purchases

We purchased from Fujitsu approximately $7.8 million of commercial die that we incorporate in our multi-chip package products during fiscal 2007. The prices paid by us to Fujitsu for these commercial die are determined through a bidding process that we use with our other suppliers. In selecting commercial die suppliers, we consider a number of factors, including price and whether the product design used by our end customer incorporates commercial die of specified suppliers. We believe that we could obtain a similar volume of commercial die from alternative sources without a material adverse effect on our operations, although there may be some delay due to the time required to qualify an alternate supplier.

JV1/JV2 Transaction

Asset Purchase Agreement

On September 28, 2006, Spansion Japan entered into an Asset Purchase Agreement with Fujitsu, pursuant to which Spansion Japan sold to Fujitsu, effective as of the JV1/JV2 Closing, the JV1/JV2 Facilities, and certain of its assets, including inventory, located in the JV1/JV2 Facilities. The purchase price for the JV1/JV2 Facilities was approximately $150 million plus the value of the inventory as of the JV1/JV2 Closing.

The obligations of Spansion Japan under the Asset Purchase Agreement are being guaranteed by Spansion Inc., Spansion LLC and Spansion Technology Inc. The sale of the JV1/JV2 Facilities closed on April 2, 2007.

Master Lease Agreement

In connection with the sale of the JV1/JV2 Facilities, on September 28, 2006 Spansion Japan and Fujitsu entered into a Master Lease Agreement for certain equipment, located at the JV1/JV2 Facilities and identified on equipment schedules agreed to by the parties. Effective upon the JV1/JV2 Closing, Spansion Japan began to lease to Fujitsu the equipment under the Master Lease Agreement. The initial term of each lease schedule will continue for the number of months specified in the applicable schedule unless otherwise terminated in accordance with the terms of the applicable schedule or the Master Lease Agreement. Fujitsu has the option to renew or extend the lease term for any or all of the equipment at the end of the initial term or any extension thereof for up to six months. If specified demand targets for wafers are not met, and subject to conditions described in the Master Lease Agreement, each of Spansion Japan and Fujitsu will have a right to terminate the lease of some or all of the leased equipment on or after June 30, 2008, by giving notice to the other party prior to December 31, 2007.

Subject to the terms of the Master Lease Agreement, Fujitsu will have a right of first refusal in the event of the sale by Spansion Japan of any equipment for a purchase price equal to the highest offer received from a third party. In addition, subject to the terms of the Master Lease Agreement, Fujitsu will have the option to purchase any or all of the equipment at the expiration of the applicable term, upon any early lease termination or if any equipment is not returned in its proper condition for a purchase price equal to the fair market value of the equipment at the time of purchase or any other purchase price as may be set forth in the applicable schedule.

The obligations of Spansion Japan under the Master Lease Agreement are being guaranteed by Spansion Inc., Spansion LLC and Spansion Technology Inc. Fujitsu paid approximately $1.8 million in fees to Spansion Japan in fiscal 2008 under the Master Lease Agreement.

Foundry Agreement

In connection with the sale of the JV1/JV2 Facilities, Spansion Japan and Fujitsu entered into a Foundry Agreement, pursuant to which Fujitsu provides certain foundry services for the manufacture of our products at the JV1/JV2 Facilities.

187

Pursuant to the Foundry Agreement, Fujitsu began to provide foundry services to us commencing upon the JV1/JV2 Closing. The Foundry Agreement also includes minimum capacity and purchase commitments between both the parties resulting in financial penalties if such capacity and purchase commitments are not achieved. The term of the Foundry Agreement ends on December 31, 2010. Spansion Japan and Fujitsu have agreed to enter into discussions to decide whether or not to extend the term of the Foundry Agreement by December 31, 2008, and Fujitsu has agreed to give Spansion Japan at least 12-months prior notice of its intent to cease providing foundry services to Spansion Japan under the Foundry Agreement. Either Spansion Japan or Fujitsu may terminate the Foundry Agreement in the event that the other party fails to correct or cure its material breach under the Foundry Agreement within 60 days of receipt of written notice from the non-defaulting party specifying such breach. We incurred approximately $100.5 million in expenses in fiscal 2008 under the Foundry Agreement.

Secondment and Transfer Agreement

In connection with the sale of the JV1/JV2 Facilities, Spansion Japan and Fujitsu entered into a Secondment and Transfer Agreement, or Secondment Agreement, pursuant to which Spansion Japan seconds certain employees to Fujitsu commencing upon the JV1/JV2 Closing. In addition, certain employees will ultimately be transferred to Fujitsu. Unless the parties otherwise agree, the period of secondment for seconded employees not designated for transfer ended June 30, 2008, and will end no later than December 31, 2009 for seconded employees designated for transfer.

The seconded employees remain employees of Spansion Japan and remain eligible to participate in Spansion Japan’s various benefit plans, and Fujitsu is required to reimburse Spansion Japan for all compensation and expenses associated with such seconded employees and incurred by Spansion Japan during the secondment period.

The Secondment Agreement can be terminated (i) by the mutual written agreement of Spansion Japan and Fujitsu, (ii) by either Spansion Japan or Fujitsu in the event that the other party materially defaults in the performance of a material obligation under the Secondment Agreement and the breaching party has not cured such breach within 120 days after receipt of notice of default by the non-breaching party and (iii) by either Spansion Japan or Fujitsu in the event that the other party is subject to bankruptcy or insolvency proceedings. The Secondment Agreement automatically terminates (i) on the transfer date of the last of the transferred employees or (ii) upon the termination of the Foundry Agreement unless otherwise agreed by Spansion Japan and Fujitsu. Fujitsu paid approximately $29.1 million in fees to Spansion Japan in fiscal 2008 under the Secondment Agreement.

Wafer Processing Services Agreement

In connection with the JV1/JV2 Closing, on April 2, 2007, Spansion Japan and Fujitsu entered into a Wafer Processing Services Agreement (the “Wafer Processing Agreement”), pursuant to which Fujitsu provides certain wafer processing services to Spansion Japan at the JV1/JV2 Facilities. The term of the Wafer Processing Agreement commenced on April 2, 2007 and is effective until December 31, 2009. The Wafer Processing Agreement will automatically terminate upon termination or expiration of that certain Foundry Agreement dated as of September 28, 2006, among Spansion Japan, Spansion Inc., Spansion LLC and Spansion Technology Inc. and Fujitsu. Either Spansion Japan or Fujitsu may terminate the Wafer Processing Agreement in the event that the other party fails to correct or cure any material breach by such other party of any covenant or obligation under the Wafer Processing Agreement within 60 days of receipt of written notice from the non-defaulting party specifying such breach. We incurred approximately $1.8 million in expenses in fiscal 2008 under the Wafer Processing Services Agreement.

188

Sort Services Agreement

In connection with the JV1/JV2 Closing, on April 2, 2007, Spansion Japan and Fujitsu entered into a Sort Services Agreement (the “Sort Services Agreement”), pursuant to which Fujitsu provides probe testing services of Spansion Japan’s wafers at the JV1/JV2 Facilities. The term of the Sort Services Agreement commenced on April 2, 2007 and was effective until the Sort Services Agreement was terminated March 31, 2009. Spansion Japan may terminate the Sort Services Agreement in its sole discretion with 60 days’ prior written notice to Fujitsu, and either Spansion Japan or Fujitsu may terminate the Sort Services Agreement in the event that the other party fails to correct or cure any material breach by such other party of any covenant or obligation under the Sort Services Agreement within 60 days of receipt of written notice from the non-defaulting party specifying such breach. We incurred approximately $11.9 million in expenses in fiscal 2008 under the Sort Services Agreement.

Rental Agreement

In connection with the JV1/JV2 Closing, on April 2, 2007, Spansion Japan and Fujitsu Semiconductor Technology, Inc., a Japanese corporation (“FSET”), entered into a Rental Agreement (the “Rental Agreement”), pursuant to which Spansion Japan rents certain equipment (the “Rental Equipment”) to FSET for the sole purpose of fulfilling the obligations of Fujitsu in the Sort Services Agreement. Spansion Japan will retain title to the Rental Equipment at all times, and FSET is prohibited form selling, pledging or otherwise encumbering or disposing of the Rental Equipment. The term of the Rental Agreement commenced on April 2, 2007 and was effective until March 31, 2009, which is when the Sort Services Agreement was terminated. FSET paid approximately $1.9 million in fees to Spansion Japan in fiscal 2008 under the Rental Agreement.

Services Agreement

In connection with the JV1/JV2 Closing, on April 2, 2007, Spansion Japan and FSET entered into a Services Agreement (the “Services Agreement”), pursuant to which Spansion Japan provides certain human resource services and information technology (“IT”) services to FSET (collectively, the “Services”). Any services are to be provided pursuant to statements of works, which may be updated by Spansion Japan and FSET from time to time upon mutual agreement. Spansion Japan will provide the Services to FSET at cost plus five percent (5%). Pursuant to the Services Agreement, Spansion Japan shall perform the Services with the same degree of accuracy, quality and completeness as it would provide similar services to its own divisions or affiliates (“Service Level”).

The term of the Services Agreement commenced on April 2, 2007 and is effective until March 31, 2009. FSET may terminate all or a part of any individual Service at any time with six months’ advance notice to Spansion Japan. FSET may also terminate all or a part of any individual Service if Spansion Japan’s provision of such Service fails to comply with the applicable Service Level for such Service and Spansion Japan fails to correct its performance failure within 60 days of receipt of written notice from FSET of such failure. In addition, FSET may terminate the Services Agreement in the event that Spansion Japan fails to correct or cure any material breach of any obligation under the Services Agreement within 90 days of receipt of written notice from FSET of such breach, and Spansion Japan may terminate the Services Agreement in the event FSET fails to make any payments due to Spansion Japan under the Services Agreement within 90 days of receipt of written notice from Spansion Japan of such default in payment. FSET paid approximately $1.3 million in fees to Spansion Japan in fiscal 2008 under the Services Agreement.

Eitan-Mehulal Law Group

We have an ongoing engagement with Eitan-Mehulal Law Group (the “Eitan Firm”), a law firm where the spouse of Dr. Boaz Eitan, a member of our Board of Directors, is a founder and partner. The Eitan Firm provides us with legal services for mergers and acquisitions, commercial, corporate and intellectual property matters. In fiscal 2008, we paid approximately $0.9 million to the Eitan Firm for legal services.

189

Makovsky, Harpaz Advocates

We have an ongoing engagement with Makovsky, Harpaz Advocates (the “Makovsky Firm”), a law firm where the brother-in-law of Dr. Boaz Eitan, a member of our Board of Directors, is a partner. The Makovsky Firm provides us with legal services for employment and litigation matters. In fiscal 2008, we paid approximately $0.06 million to the Makovsky Firm for legal services.

Director Independence

The Board of Directors affirmatively determines the independence of each director and nominee for election as a director in accordance with the elements of independence set forth in The NASDAQ Stock Market listing standards. On May 1, 2009, the Board conducted a review of director independence. During this review, the Board considered transactions and relationships between each director or any member of his or her immediate family and Spansion and our subsidiaries and affiliates. The Board also considered whether there were any transactions or relationships between directors or any member of their immediate families (or any entity on which a director or an immediate family member is an executive officer, general partner or significant equity holder) and members of Spansion’s executive team or their affiliates. The purpose of this review was to determine whether any transactions or relationships exist that are inconsistent with a determination of director independence.

As part of this review, the Board of Directors considered: (i) the ownership interest that Mr. Chao’s firm, DCM, has in Vendavo, Inc., which provides software we purchased through an agreement with SAP Inc.; (ii) Mr. Delfassy’s service on the board of directors of Discretix Inc., which licenses software to us; and (iii) Mr. Lucas’ service on the board of directors of Cadence Design Systems, Inc., which provides equipment and services to us. The Board determined that none of these relationships violate the elements of independence set forth in the NASDAQ Stock Market listing standards and, therefore, four of the six members of Spansion’s Board of Directors are independent directors. More specifically, the Board of Directors affirmatively determined that each of the following non-employee directors is independent:

• David K. Chao	• Donald L. Lucas
• Gilles Delfassy	• John M. Stich

In addition, the Board affirmatively determined that Mr. Kispert is not independent because he is the President and Chief Executive Officer of Spansion and that Dr. Eitan is not independent because he served as Executive Vice President and Chief Executive Officer, Saifun, our wholly owned subsidiary.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

Audit Committee Pre-Approval Policy

The Audit Committee has established a pre-approval policy for audit, audit-related and tax services that can be performed by the independent auditors without specific authorization from the Audit Committee, subject to certain restrictions. The pre-approval policy identifies the specific services pre-approved by the Audit Committee and the applicable limitations, while ensuring the independence of the independent auditors to audit Spansion’s financial statements is not impaired. Under the pre-approval policy, the Audit Committee pre-approves all audit and non-audit services not prohibited by law to be provided by the independent registered public accounting firm. Such pre-approval authority for non-audit services may be delegated by the Audit Committee to one or more of its members. Any pre-approval decisions must be consistent with the guidelines and fee levels or budgeted amounts established annually by the Audit Committee, provided that the member or members to whom such authority is delegated shall report any pre-approval decisions to the full Audit Committee at its next regular meeting. Any proposed services exceeding the fee levels or budgeted amounts established by the Audit Committee must be specifically approved by the Audit Committee. All Ernst & Young LLP services and fees in fiscal 2007 and fiscal 2008 were pre-approved by the Audit Committee.

190

Service Fees Paid to the Independent Registered Public Accounting Firm

Audit Fees. Audit fees of Ernst & Young LLP during fiscal 2007 and fiscal 2008 were associated with the annual audit of our consolidated financial statements, statutory audits required internationally, and fees related to other regulatory filings. Audit fees for fiscal 2007 and fiscal 2008 included fees related to Ernst & Young LLP’s audit of the effectiveness of Spansion’s internal controls pursuant to Section 404 of the Sarbanes-Oxley Act. Audit fees for fiscal 2007 were approximately $2.3 million. Audit fees for fiscal 2008 were approximately $4.2 million.

Audit-Related Fees. Fees for audit-related services rendered by Ernst & Young LLP were approximately $0.2 million in each of fiscal 2008 and fiscal 2007.

Tax Fees. Tax fees paid to Ernst & Young LLP for fiscal 2008 were approximately $20,000. Tax fees paid to Ernst & Young LLP for fiscal 2007 were approximately $0.1 million.

All Other Fees. There were no other fees paid to Ernst & Young LLP for fiscal 2008 and fiscal 2007.

191

PART IV

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

1. Financial Statements

The financial statements are set forth in Item 8 of this Annual Report on Form 10-K.

2. Exhibits

The exhibits listed in the accompanying Index to Exhibits are filed as part of, or incorporated by reference into, this Annual Report on Form 10-K (except for such exhibits that are marked on such exhibit list as furnished and not filed). The following is a list of such Exhibits:

Exhibit Number	Description of Exhibits
2.1(a)	Agreement and Plan of Merger and Reorganization, dated as of October 7, 2007, by and among Spansion Inc., Atlantic Star Merger Sub Ltd. and Saifun Semiconductors Ltd., filed as Exhibit 2.1 to Spansion’s Current Report on Form 8-K dated October 9, 2007, is hereby incorporated by reference.
2.1(b)	Amendment to Agreement and Plan of Merger and Reorganization, dated as of December 12, 2007, by and among Spansion Inc., Atlantic Star Merger Sub Ltd. and Saifun Semiconductors Ltd., filed as Exhibit 2.1 to Spansion’s Current Report on Form 8-K dated December 13, 2007, is hereby incorporated by reference.
3.1	Amended and Restated Certificate of Incorporation, filed as Exhibit 3.1 to Spansion’s Current Report on Form 8-K dated December 21, 2005, is hereby incorporated by reference.
3.2	Amended and Restated Bylaws of Spansion Inc., as amended, filed as Exhibit 3.2 to Spansion’s Annual Report on Form 10-K dated February 28, 2008, is hereby incorporated by reference.
4.1	Specimen of Class A Common Stock Certificate, filed as Exhibit 4.1 to Spansion’s Amendment No. 6 to Form S-1 Registration Statement (No. 333-124041), is hereby incorporated by reference.
4.2	Indenture, dated as of December 21, 2005, between Spansion LLC, Spansion Inc., Spansion Technology Inc. and Wells Fargo Bank, N.A., governing the 11.25% Senior Notes due 2016, filed as Exhibit 4.1 to Spansion’s Current Report on Form 8-K dated December 21, 2005, is hereby incorporated by reference.
4.3	Specimen of 11.25% Senior Notes due 2016, filed as Exhibit 4.2 to Spansion’s Current Report on Form 8-K dated December 21, 2005, is hereby incorporated by reference.
4.4	Indenture, dated as of June 12, 2006, between Spansion LLC, Spansion Inc., Spansion Technology Inc. and Wells Fargo Bank, N.A, including the form of 2.25% Exchangeable Senior Subordinated Debenture due 2016, filed as Exhibit 4.1 to Spansion’s Current Report on Form 8-K dated June 15, 2006, is hereby incorporated by reference.
4.5	Indenture, dated May 18, 2007, by and among Spansion LLC, Spansion Inc., Spansion Technology Inc. and Wells Fargo Bank, National Association, including the form of Senior Secured Floating Rate Note due 2013, filed as Exhibit 4.1 to Spansion’s Current Report on Form 8-K dated May 21, 2007, is hereby incorporated by reference.
10.1	Spansion Inc. 2005 Employee Stock Purchase Plan, filed as Exhibit 10.18 to Spansion’s Current Report on Form 8-K dated December 21, 2005, is hereby incorporated by reference.
10.2(a)***	Spansion Inc. 2005 Equity Incentive Plan, filed as Exhibit 10.17 to Spansion’s Current Report on Form 8-K dated December 21, 2005, is hereby incorporated by reference.

192

Exhibit Number	Description of Exhibits
10.2(b)***	U.S. Employees Stock Option Terms and Conditions for Grants on or after December 15, 2005, filed as Exhibit 10.2(b) to Spansion’s Annual Report on Form 10-K dated February 28, 2008, is hereby incorporated by reference.
10.2(c)***	U.S. Employees Restricted Stock Unit Terms and Conditions for Grants on or after December 15, 2005, filed as Exhibit 10.2(c) to Spansion’s Annual Report on Form 10-K dated February 28, 2008, is hereby incorporated by reference.
10.2(d)***	Non-U.S. Employees Stock Option Terms and Conditions for Grants on or after December 15, 2005, filed as Exhibit 10.2(d) to Spansion’s Annual Report on Form 10-K dated February 28, 2008, is hereby incorporated by reference.
10.2(e)***	Non-U.S. Employees Restricted Stock Unit Terms and Conditions for Grants on or after December 15, 2005, filed as Exhibit 10.2(e) to Spansion’s Annual Report on Form 10-K dated February 28, 2008, is hereby incorporated by reference.
10.3(a)***	Spansion 2007 Equity Incentive Plan, filed as Exhibit 10.73 to Spansion’s Quarterly Report on Form 10-Q for the quarter ended July 1, 2007, is hereby incorporated by reference.
10.3(b)***	U.S. Employees Stock Option Terms and Conditions for Awards Under 2007 Equity Plan.
10.3(c)***	U.S. Employees Restricted Stock Unit Terms and Conditions for Awards Under 2007 Equity Plan, filed as Exhibit 10.3(c) to Spansion’s Annual Report on Form 10-K dated February 28, 2008, is hereby incorporated by reference.
10.3(d)***	Non-U.S. Employees Stock Option Terms and Conditions for Awards Under 2007 Equity Plan, filed as Exhibit 10.3(d) to Spansion’s Annual Report on Form 10-K dated February 28, 2008, is hereby incorporated by reference.
10.3(e)***	Non-U.S. Employees Restricted Stock Unit Terms and Conditions for Awards Under 2007 Equity Plan, filed as Exhibit 10.3(e) to Spansion’s Annual Report on Form 10-K dated February 28, 2008, is hereby incorporated by reference.
10.3(f)***	U.S. Non-Employee Directors Stock Option Terms and Conditions for Awards Under 2007 Equity Incentive Plan
10.3(g)***	U.S. Non-Employee Directors Restricted Stock Unit Terms and Conditions for Awards Under 2007 Equity Incentive Plan
10.3(h)	Spansion 2007 Equity Incentive Plan Appendix, filed as Exhibit 10.5 to Spansion’s Quarterly Report on Form 10-Q for the quarter ended September 28, 2008, is hereby incorporated by reference.
10.3(i)***	Israel Employees Form of Option Award Agreement for Section 102(b)(2) Options Granted Under 2007 Equity Incentive Plan
10.3(j)***	Israel Employees Form of Restricted Stock Unit Award Agreement for Section 102(b)(2) RSUs Granted Under 2007 Equity Incentive Plan
10.3(k)***	Israel Employees Form of Option Award Agreement for Section 102(b)(2) Options Granted Under the Saifun Semiconductors Ltd. 2003 Share Option Plan
10.3(l)***	Israel Employees Form of Restricted Stock Unit Award Agreement for Section 102(b)(2) RSUs Granted Under the Saifun Semiconductors Ltd. 2003 Share Option Plan
10.4	Form of Indemnification Agreement with Directors and Executive Officers, filed as Exhibit 10.3 to Spansion’s Amendment No. 4 to Form S-1 Registration Statement (No. 333-124041), is hereby incorporated by reference.

193

Exhibit Number	Description of Exhibits
10.5(a)***	Form of Spansion Inc. Change of Control Severance Agreement, as amended, filed as Exhibit 10.30 to Spansion’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2007, is hereby incorporated by reference.
10.5(b)***	Form of Amended and Restated Spansion Inc. Change of Control Severance Agreement, filed as Exhibit 10.30 to Spansion’s Form 10-Q for the quarter ended September 30, 2007, is hereby incorporated by reference.
10.6(a)***	Spansion LLC Employment Offer Letter to Bertrand F. Cambou, dated as of April 6, 2005, filed as Exhibit 10.52 to Spansion’s Amendment No. 4 to Form S-1 Registration Statement (No. 333-124041), is hereby incorporated by reference.
10.6(b)***	Separation Agreement and Release between Spansion Inc. and Bertrand F. Cambou, dated as of February 4, 2009.
10.7***	Spansion LLC Employment Offer Letter to Thomas T. Eby, dated as of September 15, 2005, filed as Exhibit 10.53 to Spansion’s Amendment No. 4 to Form S-1 Registration Statement (No. 333-124041), is hereby incorporated by reference.
10.8(a)***	Spansion LLC Employment Offer Letter to Robert C. Melendres, dated as of December 17, 2004, filed as Exhibit 10.54 to Spansion’s Amendment No. 4 to Form S-1 Registration Statement (No. 333-124041), is hereby incorporated by reference.
10.8(b)***	Separation Agreement and Release between Spansion Inc. and Robert C. Melendres, dated as of April 7, 2009.
10.9***	Employment Offer Letter, dated as of February 9, 2006, between Spansion LLC and Dario Sacomani, filed as Exhibit 10.65 to Spansion’s Annual Report on Form 10-K dated March 15, 2006, is hereby incorporated by reference.
10.10***	Summary of Compensation Arrangements for Executive Officers, filed as Exhibit 99.1 to Spansion’s Current Report on Form 8-K dated March 14, 2008, is hereby incorporated by reference.
10.11(a)***	Form of Saifun Semiconductors Ltd. 2003 Share Option Plan Agreement, filed as Exhibit 10.55(e) to Spansion’s Quarterly Report on Form 10-Q for the quarter ended March 30, 2008, 2008, is hereby incorporated by reference.
10.11(b)***	Form of Saifun Semiconductors Ltd. 2003 Share Option Plan Agreement, filed as Exhibit 10.55(f) to Spansion’s Quarterly Report on Form 10-Q for the quarter ended March 30, 2008, is hereby incorporated by reference.
10.12***	Noncompetition and Retention Agreement between Spansion Inc. and Boaz Eitan, dated as of March 18, 2008, filed as Exhibit 10.60(a) to Spansion’s Quarterly Report on Form 10-Q dated for the quarter ended March 30, 2008, is hereby incorporated by reference.
10.13(a)***	Temporary Living Expenses and Relocation Expenses Agreement between Spansion LLC and Dario Sacomani, executed on May 7, 2008, filed as Exhibit 10.61 to Spansion’s Quarterly Report on Form 10-Q for the quarter ended March 30, 2008, is hereby incorporated by reference.
10.13(b)***	Personal Leave Agreement and Release between Spansion Inc. and Dario Sacomani, dated as of April 10, 2009.
10.14***	Employment Offer Letter for John H. Kispert, dated February 12, 2009, filed as Exhibit 10.1 to Spansion’s Current Report on Form 8-K dated February 17, 2009, is hereby incorporated by reference.
10.15***	Spansion Amended and Restated Executive Deferred Compensation Plan effective January 1, 2008.

194

Exhibit Number	Description of Exhibits
10.16***	Stockholders Agreement, dated as of December 21, 2005, by and among AMD Investments, Spansion Inc., Advanced Micro Devices, Inc., and Fujitsu Limited, filed as Exhibit 10.3 to Spansion’s Current Report on Form 8-K dated December 21, 2005, is hereby incorporated by reference.
10.17***	Form of Spansion Inc. Change of Control Severance Agreement filed as Exhibit 10.27(a) to Spansion’s Annual Report on Form 10-K dated February 28, 2008, is hereby incorporated by reference.
10.18(a)	Amended and Restated Fujitsu Distribution Agreement between Spansion Inc. and Fujitsu Microelectronics Ltd., as successor-in-interest to Fujitsu Ltd., filed as Exhibit 10.4 to Spansion’s Current Report on Form 8-K dated December 21, 2005, is hereby incorporated by reference.
10.18(b)	Amendment No. 1 to the Amended and Restated Fujitsu Distribution Agreement between Spansion Inc. and Fujitsu Microelectronics Ltd., as successor-in-interest to Fujitsu Ltd., effective as of October 1, 2007 between Spansion Inc. and Fujitsu Limited, filed as Exhibit 10.8 to Spansion’s Annual Report on Form 10-K dated December 27, 2008, is hereby incorporated by reference.
10.18(c)	Amendment No. 2 to the Amended and Restated Fujitsu Distribution Agreement between Spansion Inc. and Fujitsu Microelectronics Ltd., as successor-in-interest to Fujitsu Ltd., effective as of September 28, 2008 between Spansion Inc. and Fujitsu Limited, filed as Exhibit 10.4 to Spansion’s Quarterly Report on Form 10-Q for the quarter ended September 28, 2008, is hereby incorporated by reference.
10.19	Amended and Restated Fujitsu-Spansion Patent Cross-License Agreement between Fujitsu Limited and Spansion Inc., filed as Exhibit 10.5 to Spansion’s Current Report on Form 8-K dated December 21, 2005, is hereby incorporated by reference.
10.20	Amended and Restated AMD-Spansion Patent Cross-License Agreement between Advanced Micro Devices, Inc. and Spansion Inc., filed as Exhibit 10.6 to Spansion’s Current Report on Form 8-K dated December 21, 2005, is hereby incorporated by reference.
10.21	Amended and Restated Intellectual Property Contribution and Ancillary Matters Agreement among Fujitsu Limited, Advanced Micro Devices, Inc., AMD Investments, Inc. and Spansion Inc., filed as Exhibit 10.7 to Spansion’s Current Report on Form 8-K dated December 21, 2005, is hereby incorporated by reference.
10.22	Amended and Restated Information Technology Services Agreement between Spansion Inc. and Fujitsu Limited, filed as Exhibit 10.8 to Spansion’s Current Report on Form 8-K dated December 21, 2005, is hereby incorporated by reference.
10.23	Amended and Restated General Administrative Services Agreement between Spansion Inc. and Fujitsu Limited, filed as Exhibit 10.10 to Spansion’s Current Report on Form 8-K dated December 21, 2005, is hereby incorporated by reference.
10.24	Amended and Restated General Administrative Services Agreement between Spansion Inc. and Advanced Micro Devices, Inc., filed as Exhibit 10.11 to Spansion’s Current Report on Form 8-K dated December 21, 2005, is hereby incorporated by reference.
10.25	Amended and Restated Reverse General Administrative Services Agreement between Spansion Inc. and Advanced Micro Devices, Inc., filed as Exhibit 10.12 to Spansion’s Current Report on Form 8-K dated December 21, 2005, is hereby incorporated by reference.
10.26*	Amended and Restated Non-Competition Agreement among Spansion Inc., Advanced Micro Devices, Inc. and Fujitsu Limited, filed as Exhibit 10.13 to Spansion’s Current Report on Form 8-K dated December 21, 2005, is hereby incorporated by reference.

195

Exhibit Number	Description of Exhibits
10.27	Remediation Agreement among Advanced Micro Devices, Inc., Fujitsu Limited and FASL LLC, dated as of June 30, 2003, filed as Exhibit 10.15 to Spansion’s Amendment No. 1 to Form S-1 Registration Statement (No. 333-124041), is hereby incorporated by reference.
10.28	Manufacturing Services Agreement, dated June 30, 2003, between FASL LLC and Fujitsu Limited, filed as Exhibit 10.30 to Spansion’s Amendment No. 2 to Form S-1 Registration Statement (No. 333-124041), is hereby incorporated by reference.
10.29	Form of Amendment to Manufacturing Services Agreement between FASL LLC and Fujitsu Limited, filed as Exhibit 10.35 to Spansion’s Amendment No. 3 to Form S-1 Registration Statement (No. 333-124041), is hereby incorporated by reference.
10.30*	Master Semiconductor Foundry and Technology Transfer Agreement, dated August 11, 2005, between Spansion LLC and Taiwan Semiconductor Manufacturing Company, filed as Exhibit 10.33 to Spansion’s Amendment No. 9 to Form S-1 Registration Statement (No. 333-124041), is hereby incorporated by reference.
10.31*	Foundry Agreement, dated March 31, 2005, between Spansion Japan and Fujitsu Limited, filed as Exhibit 10.34 to Spansion’s Amendment No. 3 to Form S-1 Registration Statement (No. 333-124041), is hereby incorporated by reference.
10.32(a)	Foundry Agreement, effective as of September 28, 2006, by and among Spansion Japan Limited, Spansion Inc., Spansion Technology Inc. and Spansion LLC, in their capacities as guarantors of Spansion Japan Limited, and Fujitsu Limited, filed as Exhibit 10.74 to Spansion’s Quarterly Report on Form 10-Q for the quarter ended October 1, 2006, is hereby incorporated by reference.
10.32(b)	Amendment No. 1 to the Amended and Restated Foundry Agreement, effective March 21, 2008 and entered into as of June 19, 2008, by and among Spansion Japan Limited, Spansion Inc., Spansion Technology, Inc. and Spansion LLC, in their capacities as guarantors of Spansion Japan Limited, and Fujitsu Limited and its assignee, Fujitsu Microelectronics Limited, filed as Exhibit 10.37(a) to Spansion’s Quarterly Report on Form 10-Q for the quarter ended June 29, 2008, is hereby incorporated by reference.
10.32(c)	Amendment No. 2 to the Amended and Restated Foundry Agreement, effective as of March 21, 2008 and entered into as of December 31, 2008, by and among Spansion Japan Limited, Spansion Inc., Spansion Technology, Inc. and Spansion LLC, in their capacities as guarantors of Spansion Japan Limited, and Fujitsu Limited and its assignee, Fujitsu Microelectronics Limited.
10.32(d)	Waiver of Payment Terms, dated June 30, 2008, by Fujitsu Microelectronics Limited, and agreed to by Spansion Inc., Spansion Technology, Inc., Spansion LLC and Spansion Japan Limited, filed as Exhibit 10.37(b) to Spansion’s Quarterly Report on Form 10-Q for the quarter ended June 29, 2008, is hereby incorporated by reference.
10.33(a)	Secondment and Transfer Agreement, dated as of September 28, 2006, between Spansion Japan Limited and Fujitsu Limited, filed as Exhibit 10.75 to Spansion’s Quarterly Report on Form 10-Q for the quarter ended October 1, 2006, is hereby incorporated by reference.
10.34(a)	Schedule to Lease Agreement, dated as of September 28, 2006, between Banc of America Leasing & Capital, LLC and Spansion LLC, filed as Exhibit 10.62(k) to Spansion’s Quarterly Report on Form 10-Q for the quarter ended October 1, 2006, is hereby incorporated by reference.
10.34(b)	Schedule to Lease Agreement, dated as of September 28, 2006, between Banc of America Leasing & Capital, LLC and Spansion LLC, filed as Exhibit 10.62(l) to Spansion’s Quarterly Report on Form 10-Q for the quarter ended October 1, 2006, is hereby incorporated by reference.

196

Exhibit Number	Description of Exhibits
10.34(c)	Schedule to Lease Agreement, dated as of September 28, 2006, between Banc of America Leasing & Capital, LLC and Spansion LLC, filed as Exhibit 10.62(m) to Spansion’s Quarterly Report on Form 10-Q for the quarter ended October 1, 2006, is hereby incorporated by reference.
10.34(d)	Schedule to Lease Agreement, dated as of September 28, 2006, between Banc of America Leasing & Capital, LLC and Spansion LLC, filed as Exhibit 10.62(n) to Spansion’s Quarterly Report on Form 10-Q for the quarter ended October 1, 2006, is hereby incorporated by reference.
10.35(a)*	Foundry Agreement by and between Semiconductor Manufacturing International Corporation and Spansion LLC dated August 31, 2007, filed as Exhibit 10.1 to Spansion’s Quarterly Report on Form 10-Q for the quarter ended September 28, 2008, is hereby incorporated by reference.
10.35(b)*	First Amendment to the Foundry Agreement by and between Semiconductor Manufacturing International Corporation and Spansion LLC dated August 15, 2008, filed as Exhibit 10.2 to Spansion’s Quarterly Report on Form 10-Q for the quarter ended September 28, 2008, is hereby incorporated by reference.
10.36	Agreement by and among Spansion Inc., Fujitsu Limited and Fujitsu Microelectronics Limited dated September 11, 2008, filed as Exhibit 10.3 to Spansion’s Quarterly Report on Form 10-Q for the quarter ended September 28, 2008, is hereby incorporated by reference.
10.37	Amendment No. 1 to Credit Agreement, dated April 7, 2006, among Spansion LLC, Bank of America, N.A., and the lenders party thereto, filed as Exhibit 10.41(a) to Spansion’s Form 10-Q for the quarter ended March 26, 2006, is hereby incorporated by reference.
10.38	Amendment No. 4 to Credit Agreement and Consent, dated as of March 24, 2008, among Spansion LLC, Spansion Inc., Bank of America, N.A., and the lenders party thereto, filed as Exhibit 10.23(c) to Spansion’s Quarterly Report on Form 10-Q for the quarter ended March 30, 2008, is hereby incorporated by reference.
10.39	Amendment No. 5 to Credit Agreement and Amendment No. 3 to Security Agreement dated as of December 23, 2008 among Spansion LLC, Spansion Inc. and Bank of America, N.A., and the lenders party thereto.
10.40	Continuing Guaranty to the Credit Agreement, dated April 21, 2006, between Spansion Inc. and Bank of America, N.A., filed as Exhibit 10.41(c) to Spansion’s Form 10-Q for the quarter ended March 26, 2006, is hereby incorporated by reference.
10.41(a)	Facility Agreement, dated as of March 30, 2007, among Spansion Japan Limited, GE Capital Leasing Corporation, Sumisho Lease Co., Ltd., Mitsui Leasing & Development, Ltd., and certain lenders thereto, filed as Exhibit 10.65 to Spansion’s Quarterly Report on Form 10-Q for the quarter ended April 1, 2007, is hereby incorporated by reference.
10.41(b)	Amendment No. 1 to Facility Agreement, dated as of August 1, 2007, among Spansion Japan Limited, GE Capital Leasing Corporation, Sumisho Lease Co., Ltd., Mitsui Leasing & Development, Ltd., and certain lenders thereto, filed as Exhibit 10.65(b) to Spansion’s Quarterly Report on Form 10-Q for the quarter ended July 1, 2007, is hereby incorporated by reference.
10.41(c)	Amendment No. 2 to Facility Agreement, dated as of December 13, 2007, among Spansion Japan Limited, GE Capital Leasing Corporation, Sumisho Lease Co., Ltd., Mitsui Leasing & Development, Ltd., and certain lenders thereto.

197

Exhibit Number	Description of Exhibits
10.41(d)	Amendment No. 3 to Facility Agreement, dated as of February 18, 2008, among Spansion Japan Limited, GE Capital Leasing Corporation, Sumisho Lease Co., Ltd., Mitsui Leasing & Development, Ltd., and certain lenders thereto, filed as Exhibit 10.40(c) to Spansion’s Quarterly Report on Form 10-Q for the quarter ended March 30, 2008, is hereby incorporated by reference
10.41(e)	Amendment No. 4 and Waiver to Facility Agreement, dated as of November 5, 2008, among Spansion Japan Limited, GE Financial Services Corporation (formerly known as GE Capital Leasing Corporation), as Administrative Agent, and certain lenders thereto.
10.42	Security Agreement, dated September 19, 2005, between Spansion LLC, as Grantor, and Bank of America, N.A., as Agent, filed as Exhibit 10.42 to Spansion’s Amendment No. 4 to Form S-1 Registration Statement (No. 333-124041), is hereby incorporated by reference.
10.43	Stock Pledge, dated September 19, 2005, between Spansion LLC, as Pledgor, and Bank of America, N.A., as Agent, filed as Exhibit 10.43 to Spansion’s Amendment No. 4 to Form S-1 Registration Statement (No. 333-124041), is hereby incorporated by reference.
10.44	Joinder Agreement to the Credit Agreement, dated April 21, 2006, among Spansion Inc., Bank of America, N.A., and the lenders party to the Credit Agreement, filed as Exhibit 10.41(b) to Spansion’s Form 10-Q for the quarter ended March 26, 2006, is hereby incorporated by reference.
10.45	Security Agreement, dated as of March 30, 2007, between Spansion Japan Limited and GE Capital Leasing Corporation filed as Exhibit 10.66 to Spansion’s Annual Report on Form 10-K dated February 27, 2007, is hereby incorporated by reference.
10.46(a)	Security Agreement, dated as of March 30, 2007, among Spansion Japan Limited, GE Capital Leasing Corporation, and certain secured parties thereto, filed as Exhibit 10.67 to Spansion’s Annual Report on Form 10-K dated February 27, 2007, is hereby incorporated by reference.
10.46(b)	Amendment to Security Agreement, dated as of April 26, 2007, among Spansion Japan Limited, GE Capital Leasing Corporation and the Finance Parties, filed as Exhibit 10.67(b) to Spansion’s Quarterly Report on Form 10-Q for the quarter ended July 1, 2007, is hereby incorporated by reference.
10.47	Pledge and Security Agreement, dated May 18, 2007, by and among Spansion Inc., Spansion LLC, Spansion Technology Inc. and Wells Fargo, National Association, filed as Exhibit 10.1 to Spansion’s Current Report on Form 8-K dated May 21, 2007, is hereby incorporated by reference.
10.48(a)	Deed of Trust, Security Agreement, Assignment of Rents and Financing Statement (Santa Clara County, California), effective as of May 18, 2007, by Spansion LLC to First American Title Insurance Company, as trustee, for the benefit of Wells Fargo Bank, National Association, as collateral agent, filed as Exhibit 10.2 to Spansion’s Current Report on Form 8-K dated May 21, 2007, is hereby incorporated by reference.
10.49(b)	Amendment No. 1 to Deed of Trust, Security Agreement, Assignment of Rents and Financing Statement (Santa Clara County, California), effective as of June 7, 2007, by Spansion LLC to First American Title Insurance Company, as trustee, for the benefit of Wells Fargo Bank, National Association, as collateral agent, filed as Exhibit 10.1 to Spansion’s Current Report on Form 8-K dated June 7, 2007, is hereby incorporated by reference.
10.50	Second Deed of Trust, Security Agreement, Assignment of Rents and Financing Statement (Santa Clara County, California), effective as of May 18, 2007, by Spansion LLC to PRLAP, Inc., as Trustee, for the benefit of Bank of America, N.A., as administrative agent, filed as Exhibit 10.3 to Spansion’s Current Report on Form 8-K dated May 21, 2007, is hereby incorporated by reference.

198

Exhibit Number	Description of Exhibits
10.51(a)	Deed of Trust, Security Agreement, Assignment of Rents and Financing Statement (Travis County, Texas), effective as of May 18, 2007, by Spansion LLC to R. J. Dold, as trustee, for the benefit of Wells Fargo Bank, National Association, as collateral agent, filed as Exhibit 10.4 to Spansion’s Current Report on Form 8-K dated May 21, 2007, is hereby incorporated by reference
10.51(b)	Amendment No. 1 to Deed of Trust, Security Agreement, Assignment of Rents and Financing Statement (Travis County, Texas), effective as of June 7, 2007, by Spansion LLC to R. J. Dold, as trustee, for the benefit of Wells Fargo Bank, National Association, as collateral agent, filed as Exhibit 10.2 to Spansion’s Current Report on Form 8-K dated June 7, 2007, is hereby incorporated by reference.
10.52	Form of Voting Undertaking between Spansion and certain shareholders of Saifun Semiconductors Ltd., filed as Exhibit 10.1 to Spansion’s Current Report on Form 8-K dated October 9, 2007, is hereby incorporated by reference.
10.53	Revolving Credit Facility Agreement by and among Spansion Japan Limited, The Bank of Tokyo-Mitsubishi UFJ, Ltd. and the lenders party thereto, dated as of December 28, 2007, filed as Exhibit 10.48 to Spansion’s Annual Report on Form 10-K dated February 28, 2008, is hereby incorporated by reference.
10.54	Credit Line Account Application and Agreement for Organizations and Businesses between Spansion LLC and UBS Bank USA, dated as of December 29, 2008.
10.55(a)	Lease Agreement, dated as of September 30, 2005, between Banc of America Leasing & Capital, LLC and Spansion LLC, filed as Exhibit 10.1(a) to Spansion’s Current Report on Form 8-K dated December 27, 2005, is hereby incorporated by reference.
10.55(b)	Amended Schedule to Lease Agreement, dated as of December 23, 2005, between General Electric Capital Corporation and Spansion LLC, filed as Exhibit 10.1(b) to Spansion’s Current Report on Form 8-K dated December 27, 2005, is hereby incorporated by reference.
10.55(c)	Amended Schedule to Lease Agreement, dated as of December 23, 2005, between Banc of America Leasing & Capital, LLC and Spansion LLC, filed as Exhibit 10.1(c) to Spansion’s Current Report on Form 8-K dated December 27, 2005, is hereby incorporated by reference.
10.55(d)	Amended Schedule to Lease Agreement, dated as of December 23, 2005, between Banc of America Leasing & Capital, LLC and Spansion LLC, filed as Exhibit 10.1(d) to Spansion’s Current Report on Form 8-K dated December 27, 2005, is hereby incorporated by reference.
10.55(e)	Amended Schedule to Lease Agreement, dated as of December 23, 2005, between General Electric Capital Corporation and Spansion LLC, filed as Exhibit 10.1(e) to Spansion’s Current Report on Form 8-K dated December 27, 2005, is hereby incorporated by reference.
10.55(f)	Amended Schedule to Lease Agreement, dated as of December 23, 2005, between ORIX Financial Services, Inc. and Spansion LLC, filed as Exhibit 10.1(f) to Spansion’s Current Report on Form 8-K dated December 27, 2005, is hereby incorporated by reference.
10.55(g)	Amended Schedule to Lease Agreement, dated as of December 23, 2005, between Merrill Lynch Capital and Spansion LLC, filed as Exhibit 10.1(g) to Spansion’s Current Report on Form 8-K dated December 27, 2005, is hereby incorporated by reference.
10.55(h)	Amended Schedule to Lease Agreement, dated as of December 23, 2005, between Macquarie Electronics USA Inc. and Spansion LLC, filed as Exhibit 10.1(h) to Spansion’s Current Report on Form 8-K dated December 27, 2005, is hereby incorporated by reference.
10.55(i)	Amended Schedule to Lease Agreement, dated as of December 21, 2005, between Macquarie Electronics USA Inc. and Spansion LLC, filed as Exhibit 10.1(i) to Spansion’s Current Report on Form 8-K dated December 27, 2005, is hereby incorporated by reference.

199

Exhibit Number	Description of Exhibits
10.55(j)	Amended Schedule to Lease Agreement, dated as of December 21, 2005, between Merrill Lynch Capital and Spansion LLC, filed as Exhibit 10.1(j) to Spansion’s Current Report on Form 8-K dated December 27, 2005, is hereby incorporated by reference.
10.56	Amendment Agreement dated December 30, 2005 to Master Lease Agreement dated January 5, 2005, between Spansion Japan Limited and Sumicrest Leasing Limited, filed as Exhibit 10.1 to Spansion’s Current Report on Form 8-K dated January 5, 2006, is hereby incorporated by reference.
10.57	Master Lease Agreement, dated as of September 28, 2006, by and among Spansion Japan Limited, Spansion Inc., Spansion Technology Inc. and Spansion LLC, in their capacities as guarantors of Spansion Japan Limited, and Fujitsu Limited, filed as Exhibit 10.73 to Spansion’s Quarterly Report on Form 10-Q for the quarter ended October 1, 2006, is hereby incorporated by reference.
10.58	Master Rental Agreement between Spansion LLC and Macquarie Electronics USA Inc., dated as of March 26, 2008, filed as Exhibit 10.59 to Spansion’s Quarterly Report on Form 10-Q dated for the quarter ended March 30, 2008, is hereby incorporated by reference.
10.59	Settlement Agreement among Spansion LLC, Spansion Inc. and Samsung Electronics Co., Ltd., dated as of March 16, 2009.
21	Subsidiaries of Spansion Inc.
23.1	Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm.
31.1	Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act 2002.
31.2	Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**	Certification of the Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**	Certification of the Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

* Confidential treatment has been granted with respect to portions of this exhibit.

** Exhibits 32.1 and 32.2 are being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liability of that section, nor shall such exhibits be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise specifically stated in such filing.

*** Management Agreement or Compensation Plan.

200

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: May 12, 2009	SPANSION INC.
	By:	/S/    JOHN H. KISPERT
	John H. Kispert President, Chief Executive Officer and Interim Chief Financial Officer

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints John H. Kispert and Donald L. Lucas, and each of them, their true and lawful attorneys-in-fact, each with full power of substitution, for them in any and all capacities, to sign any amendments to this report on Form 10-K and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact or their substitute or substitutes may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1933, this report has been signed below by the following persons, on behalf of the registrant and in the capacities and on the dates indicated.

Signature	Title	Date
/S/    JOHN H. KISPERT         John H. Kispert	President, Chief Executive Officer, Interim Chief Financial Officer and Director (Principal Executive Officer)	May 12, 2009
/S/    JOHN H. KISPERT         John H. Kispert	President, Chief Executive Officer, Interim Chief Financial Officer and Director (Principal Financial and Accounting Officer)	May 12, 2009
/S/    DONALD L. LUCAS         Donald L. Lucas	Chairman of the Board of Directors	April 29, 2009
/S/    DAVID K. CHAO         David K. Chao	Director	April 30, 2009
/S/    GILLES DELFASSY         Gilles Delfassy	Director	April 30, 2009
/S/    BOAZ EITAN         Boaz Eitan	Director	May 1, 2009
/S/    JOHN M. STICH         John M. Stich	Director	April 30, 2009

201

EX-10.3(B)

Exhibit 10.3(b)

U.S. EMPLOYEES

STOCK OPTION TERMS AND CONDITIONS

FOR AWARDS UNDER 2007 EQUITY INCENTIVE PLAN

Congratulations on being granted stock options under Spansion’s 2007 Equity Incentive Plan. The number of shares of your award, the exercise price and the vesting schedule are in your stock option Award Notice. Your award is subject to the provisions of your Award Notice, these Terms and Conditions, and the Plan document (collectively, the “Terms”). Your options are non-qualified options and are not intended to qualify as “incentive stock options” under Section 422 of the U.S. Internal Revenue Code. Your options have been granted to you in addition to, and not instead of, any other form of compensation.

In addition to these Terms and Conditions, you should carefully read your Award Notice and the other Plan documents, which are available on the Company’s designated stock administrator’s web site.

Vesting of Your Stock Options

Except as stated below, your options that have not expired or terminated vest according to the schedule in your Award Notice if you are an active employee of Spansion or its subsidiaries through the entire vesting period. You may exercise the options (i.e, purchase shares) only after they have vested. Once options vest, you have the right to exercise them until they expire or terminate.

If Spansion Experiences Certain Corporate Events

• If Spansion experiences a “Change in Control” as described in the Plan, your outstanding unvested stock options may become 100% vested and exercisable, at Spansion’s discretion.

• If Spansion undergoes certain other corporate events described in the Plan where it does not survive, or does not survive as a public company, outstanding unexercised options will become 100% vested.

If You Die or Become Totally Disabled

• If you have at least 15 years of service and your employment is terminated due to your death or total disability, you become immediately vested as of the employment termination date in options that would have vested in the calendar year in which the employment terminated.

• There is no such accelerated vesting of options if your employment is terminated because of your death or disability and you have less than 15 years of service.

If Your Employment Terminates and You Are Eligible under a Spansion Severance Plan

• If you meet eligibility requirements under a Spansion severance plan, you become immediately vested as of the employment termination date in options that would have vested during the severance pay period.

See the section “Termination of Vested Stock Options” for information on length of time to exercise after employment termination.

Exercising Your Vested Stock Options

Once your options vest, they are available for you to exercise (purchase Spansion common stock at the exercise price) until they expire or terminate, whichever is earlier. Your final opportunity to exercise your vested options is the earlier of the last regular trading day of Spansion before the Expiration Date of the options, or the last regular trading day of Spansion before the options terminate in the case of an earlier termination of the options. (If you wait until the last possible day to exercise your options, please remember that a limit order — a request to sell shares at a certain dollar amount — may not take place on the same day, and you risk the possibility of your options expiring.)

1

To exercise vested options, you must: provide the Company’s designated stock administrator with notice of the number of shares you wish to purchase and pay the total exercise price, and any required tax withholdings. For more information on how to exercise vested options, see http://spansionweb/index.php?b=soeip&a=finance

You may not exercise an option for a fractional share of stock.

Other Requirements to Exercise Your Vested Stock Options

You must (i) open and maintain a brokerage account at the Company’s designated stock broker and (ii) not decline an award. If you do not take action as directed in your Award Notice to decline the award, you are deemed to have accepted the award, subject to all applicable Terms. You may not be allowed to exercise your options if you fail to comply with these Terms.

Tax Payments

You agree to be responsible for any and all required taxes that may result from your exercise of options, and you agree that Spansion may deduct from your pay funds to cover any applicable withholding taxes.

Early Termination of Your Stock Options

Your Award Notice discloses the Expiration Date for your options. However, there are other situations than those listed above where your options may terminate before the Expiration Date. For example:

• If your employment terminates before the Expiration Date, your unvested options terminate immediately and your vested options will terminate within a certain period of time after the employment termination date. For details on these time periods, see the Termination of Vested Stock Options section, below.

• If your employment becomes inactive under an approved separation agreement, unless the separation agreement provides otherwise, your unvested options terminate as of the date your employment becomes inactive.

• Upon certain corporate events described in the Plan, options that have been accelerated to vest before the event, but that you have not yet exercised, may terminate at the time of the event.

Termination of Vested Stock Options

• The table below shows how long you have after your employment termination date to exercise vested options that have not expired.

• At the close of business on the last day of the applicable time period, the vested options will terminate.

• Terminated options will not be reinstated, even if you are rehired by Spansion the day after your employment terminated.

Months to Exercise Vested Options

After Termination of Employment

Years of Service	Months to Exercise
Less than 15	12
15 but less than 20	24	*
20 or more	36	*

* If you terminate employment to work for a competitor of Spansion, this extension does not apply and you have 12 months to exercise your options.

2

• In no event will an exercise period extend beyond the Expiration Date of an option.

• If Spansion terminates your employment for what it, in its sole discretion, considers good cause, it has the right to cancel all your options, whether vested or unvested.

Non-Transferability of Stock Options

Your stock options and related rights are not transferable except as stated in the Plan. Such transfers include but are not limited to transfers:

• By a qualified domestic relations order (QDRO), stock options transferred by a QDRO expire twelve months after the date of transfer

• According to the last valid beneficiary designation you provided Spansion

• By the laws of descent and distribution if you have no valid beneficiary designation on file with Spansion.

Plan Amendment

The Plan is discretionary in nature and Spansion has the right to amend or terminate the Plan, in whole or in part, at any time and for any reason, with or without notice to Plan participants.

No Guaranty of Continued Employment

Nothing in the Plan Terms entitles you to employment with Spansion, or if already employed, to continued employment with Spansion or change the status of your at-will employment.

Governing Law

Your award and the Terms shall be governed by the laws of the State of Delaware without regard to any Delaware conflict of law principles.

Electronic Delivery

Spansion may deliver any documents related to your options by electronic means or request your consent to participate in the Plan by electronic means. You hereby consent to receive such documents by electronic delivery and agree to participate in the Plan through an on-line or electronic system established and maintained by Spansion or another third party designated by Spansion.

Severability

If one or more of the provisions of the Terms and Conditions shall be held unenforceable, the enforceability of the remaining provisions shall not be affected and shall be deemed null and void; however, to the extent permissible by law, any provisions which could be deemed null and void shall first be revised retroactively to permit these Terms and Conditions to be interpreted to carry out their intent and the intent of the Plan.

Entire Agreement

The Plan Terms constitute the entire agreement and supersede all prior agreements between you and Spansion regarding the subject matter of the Terms. Spansion may, however, unilaterally waive any provision in the Terms as long as such waiver does not adversely affect your rights under the Plan; if Spansion does waive a provision, such waiver is not a future waiver of that provision or a waiver of any other provision.

3

EX-10.3(F)

Exhibit 10.3(f)

U.S. NON-EMPLOYEE DIRECTORS

STOCK OPTION TERMS AND CONDITIONS

FOR AWARDS UNDER 2007 EQUITY INCENTIVE PLAN

Congratulations on being granted stock options under Spansion’s 2007 Equity Incentive Plan. The number of shares of your award, the exercise price and the vesting schedule are in your stock option Award Notice. Your award is subject to the provisions of your Award Notice, these Terms and Conditions, and the Plan document (collectively, the “Terms”). Your options are non-qualified options and are not intended to qualify as “incentive stock options” under Section 422 of the U.S. Internal Revenue Code. Your options have been granted to you in addition to, and not instead of, any other form of compensation.

In addition to these Terms and Conditions, you should carefully read your Award Notice and the other Plan documents, which are available on the Company’s designated stock administrator’s web site.

Vesting of Your Stock Options

Except as stated below, your options that have not expired or terminated vest according to the schedule in your Award Notice if you are a director through the entire vesting period. You may exercise the options (i.e, purchase shares) only after they have vested. Once options vest, you have the right to exercise them until they expire or terminate.

If Spansion Experiences Certain Corporate Events

• If Spansion experiences a “Change in Control” as described in the Plan, your outstanding unvested stock options may become 100% vested and exercisable, at Spansion’s discretion.

• If Spansion undergoes certain other corporate events described in the Plan where it does not survive, or does not survive as a public company, outstanding unexercised options will become 100% vested.

If You Die or Become Totally Disabled

• If you have at least 15 years of service as a Spansion director and your service terminates due to your death or total disability, you become immediately vested as of the service termination date in options that would have vested in the calendar year in which the service terminated.

• There is no such accelerated vesting of options if your service terminates because of your death or disability and you have less than 15 years of service.

See the section “Termination of Vested Stock Options” for information on length of time to exercise after your service terminates.

Exercising Your Vested Stock Options

Once your options vest, they are available for you to exercise (purchase Spansion common stock at the exercise price) until they expire or terminate, whichever is earlier. Your final opportunity to exercise your vested options is the earlier of the last regular trading day of Spansion before the Expiration Date of the options, or the last regular trading day of Spansion before the options terminate in the case of an earlier termination of the options. (If you wait until the last possible day to exercise your options, please remember that a limit order — a request to sell shares at a certain dollar amount — may not take place on the same day, and you risk the possibility of your options expiring.)

To exercise vested options, you must: provide the Company’s designated stock administrator with notice of the number of shares you wish to purchase and pay the total exercise price.

You may not exercise an option for a fractional share of stock.

1

Other Requirements to Exercise Your Vested Stock Options

You must (i) open and maintain a brokerage account at the Company’s designated stock broker and (ii) not decline an award. If you do not take action as directed in your Award Notice to decline the award, you are deemed to have accepted the award, subject to all applicable Terms. You may not be allowed to exercise your options if you fail to comply with these Terms.

Tax Payments

You agree to be responsible for any and all required taxes that may result from your exercise of options.

Early Termination of Your Stock Options

Your Award Notice discloses the Expiration Date for your options. However, there are other situations than those listed above where your options may terminate before the Expiration Date. For example:

• If your service terminates before the Expiration Date, your unvested options terminate immediately and your vested options will terminate within a certain period of time after the service termination date. For details on these time periods, see the Termination of Vested Stock Options section, below.

• Upon certain corporate events described in the Plan, options that have been accelerated to vest before the event, but that you have not yet exercised, may terminate at the time of the event.

Termination of Vested Stock Options

The table below shows how long you have after your service terminates to exercise vested options that have not expired.

At the close of business on the last day of the applicable time period, the vested options will terminate.

• Terminated options will not be reinstated, even if you rejoin Spansion’s board of directors after your current service terminates.

Months to Exercise Vested Options

After Termination of Service

Years of Service	Months to Exercise
Less than 15	12
15 but less than 20	24
20 or more	36

• In no event will an exercise period extend beyond the Expiration Date of an option.

• If Spansion terminates your service for what it, in its sole discretion, considers good cause, it has the right to cancel all your options, whether vested or unvested.

Non-Transferability of Stock Options

Your stock options and related rights are not transferable except as stated in the Plan. Such transfers include but are not limited to transfers:

• By a qualified domestic relations order (QDRO), stock options transferred by a QDRO expire twelve months after the date of transfer

• According to the last valid beneficiary designation you provided Spansion

• By the laws of descent and distribution if you have no valid beneficiary designation on file with Spansion.

2

Plan Amendment

The Plan is discretionary in nature and Spansion has the right to amend or terminate the Plan, in whole or in part, at any time and for any reason, with or without notice to Plan participants.

Governing Law

Your award and the Terms shall be governed by the laws of the State of Delaware without regard to any Delaware conflict of law principles.

Electronic Delivery

Spansion may deliver any documents related to your options by electronic means or request your consent to participate in the Plan by electronic means. You hereby consent to receive such documents by electronic delivery and agree to participate in the Plan through an on-line or electronic system established and maintained by Spansion or another third party designated by Spansion.

Severability

If one or more of the provisions of the Terms and Conditions shall be held unenforceable, the enforceability of the remaining provisions shall not be affected and shall be deemed null and void; however, to the extent permissible by law, any provisions which could be deemed null and void shall first be revised retroactively to permit these Terms and Conditions to be interpreted to carry out their intent and the intent of the Plan.

Entire Agreement

The Plan Terms constitute the entire agreement and supersede all prior agreements between you and Spansion regarding the subject matter of the Terms. Spansion may, however, unilaterally waive any provision in the Terms as long as such waiver does not adversely affect your rights under the Plan; if Spansion does waive a provision, such waiver is not a future waiver of that provision or a waiver of any other provision.

3

EX-10.3(G)

Exhibit 10.3(g)

U.S. NON-EMPLOYEE DIRECTORS

RESTRICTED STOCK UNIT TERMS AND CONDITIONS

FOR AWARDS UNDER 2007 EQUITY INCENTIVE PLAN

Congratulations on being granted restricted stock units (RSUs) under Spansion’s 2007 Equity Incentive Plan. The number of shares of your award and the vesting schedule are stated in your RSU Award Notice. Your award is subject to the provisions of your Award Notice, these Terms and Conditions, and the Plan (collectively, the “Terms”).

In addition to these Terms and Conditions, you should carefully read your Award Notice and the other Plan documents, which are available on the designated stock administrator’s web site.

Vesting of Your RSUs

An RSU represents a commitment by Spansion to issue one share of Spansion common stock for each RSU awarded on the date the RSU vests, subject to your meeting all applicable requirements. The vesting date is the date on which the restrictions lapse. After vesting, RSUs are converted into full-value shares of Spansion common stock if the applicable Terms have been satisfied. Except as otherwise stated below, your RSUs vest according to the schedule in your Award Notice if you are a director through the entire vesting period.

If Spansion Experiences Certain Corporate Events

• If Spansion experiences a “Change in Control” as described in the Plan, your outstanding RSUs may become 100% vested, at Spansion’s discretion.

• If Spansion undergoes certain other corporate events described in the Plan, where it does not survive, or does not survive as a public company, your outstanding RSUs will become 100% vested.

If You Die or Become Totally Disabled

• If you have at least 15 years of service and your service terminates because of your death or total disability, you become immediately vested as of the service termination date in any RSUs that would have vested in the calendar year in which the service terminated.

• There is no such accelerated vesting of RSUs if your service terminates because of your death or disability and you have less than 15 years of service.

Other Requirements to Receive Shares

You must (i) open and maintain a brokerage account at the Company’s designated stock broker and (ii) not decline the award. If you do not take action as directed in your Award Notice to decline the award, you are deemed to have accepted the award, subject to all applicable Terms. Spansion may refuse to deliver shares to you if you fail to comply with your obligations under the Terms.

Tax Payments

You agree to be responsible for any and all required taxes that may result from your receipt of shares.

Early Termination of Your RSUs

Your Award Notice discloses the Expiration Date for your RSUs. However if your service terminates before the Expiration Date, your unvested RSUs terminate immediately. Terminated RSUs will not be reinstated, even if you rejoin Spansion’s board of directors after your current service terminates.

1

Non-Transferability of RSUs

Your RSUs and related rights are not transferable except as stated in the Plan. Such transfers include but are not limited to transfers:

• By a qualified domestic relations order (QDRO), RSUs transferred by a QDRO expire twelve months after the date of transfer

• According to the last valid beneficiary designation you provided Spansion

• By the laws of descent and distribution if you have no valid beneficiary designation on file with Spansion.

Governing Law

Your award and the Terms shall be governed by the laws of the State of Delaware without regard to any Delaware conflict of law principles.

Electronic Delivery

Spansion may deliver any documents related to your RSUs by electronic means or request your consent to participate in the Plan by electronic means. You consent to receive such documents by electronic delivery and agree to participate in the Plan through an on-line or electronic system established and maintained by Spansion or another third party designated by Spansion.

Severability

If one or more of the provisions of the Terms and Conditions shall be held unenforceable, the enforceability of the remaining provisions shall not be affected and the unenforceable provisions shall be null and void; however, to the extent permissible by law, any provisions which could be null and void shall first be revised retroactively to permit these Terms and Conditions to be interpreted to carry out their intent and the intent of the Plan.

Entire Agreement

The Plan Terms constitute the entire agreement and supersede all prior understandings and agreements between you and Spansion regarding the subject matter of the Terms. Spansion may, however, unilaterally waive any provision in the Terms as long as such waiver does not adversely affect your interests; if Spansion does waive any provision, such waiver does not constitute a subsequent waiver of the same provision or a waiver of any other provision.

2

EX-10.3(I)

Exhibit 10.3(i)

OPTION AWARD AGREEMENT

FOR SECTION 102(b)(2) OPTIONS GRANTED UNDER THE

SPANSION INC. 2007 EQUITY INCENTIVE PLAN

Name: ________________________________ (“Optionee”)

Date of Grant: ___________________________

Shares: _____________________________

Vesting Schedule:

Number of Shares	Vesting Date*
<<Shares_Period_1>>	<<Vest_Date_Period_1>>
<<Shares_Period_2>>	<<Vest_Date_Period_2>>
<<Shares_Period_3>>	<<Vest_Date_Period_3>>
<<Shares_Period_4>>	<<Vest_Date_Period_4>>

* if you are an active employee of Spansion or its subsidiaries through the entire vesting period

Exercise Price per Share: __________

Award Expiration Date: ___________

Type of Option: Section 102(b)(2) Option - Capital Route

Trustee: Tamir Fishman Trusts 2004 Ltd

Congratulations on being granted Spansion stock options under the Spansion Inc. 2007 Equity Incentive Plan (the “Plan”). Your award is subject to the provisions of the Plan, this Option Award Agreement (the “Agreement”), the agreement between Spansion (the “Company”) and the Trustee (the “Trust Agreement”) and Section 102 of the Israeli Income Tax Ordinance (New Version), 1961 and any regulations, rules or orders promulgated thereunder, including the Income Tax Rules (Tax Relief for Issuance of Shares to Employees), 2003, all as amended from time to time (collectively, “Section 102”).

In the event of a conflict between the general terms and conditions of the Plan and this Agreement, the terms and conditions of the Plan shall prevail. However, this Agreement sets out specific terms for your award, and those terms will prevail over more general terms in the Plan on the same issue, if any, or in the event of a conflict between such terms.

ISSUANCE OF OPTIONS. The Options will be registered in the name of the Trustee as required by law to qualify under Section 102, for your benefit.

• The Trustee will hold the options or the Shares to be issued upon exercise of the options for the Lock-up Period, as set forth in the Plan.

• You release the Trustee from any liability in respect of any action or decision duly taken to comply with the terms of the Plan and this Agreement, in connection with any award granted to you under the Plan.

• You agree to execute any and all documents which the Company or the Trustee may reasonably determine to be necessary in order to comply with Section 102.

NON TRANSFERABILITY OF STOCK OPTIONS. Your stock options and related rights are not transferable except by the laws of descent and distribution.

EXERCISING YOUR VESTED STOCK OPTIONS.

• Once your options vest, they are available for you to exercise (purchase Spansion common stock at the exercise price) until they expire or terminate, whichever is earlier. Your final opportunity to exercise your vested options is the earlier of the last regular trading day of the Company on or before the expiration date of the options, or the last regular trading day of the Company on or before the options terminate in the case of an earlier termination of the options.

• You may not exercise an option for a fractional share of stock.

• The options, or any part thereof, shall be exercisable by your signing and returning to the Company or its agent a notice of exercise in a form approved by the Company, together with payment of the aggregate purchase price, including any applicable tax withholdings, in accordance with the provisions of the Plan.

• In connection with the issuance of shares upon the exercise of any of the options, you agree to sign any and all documents required by law and/or the Company.

• After an executed notice of exercise has been delivered to the Company or its agent, you may not rescind or revise it.

TAX PAYMENT.

• You agree to be solely responsible for paying any and all taxes arising from the grant or exercise of any option, from the payment for shares covered by this option, or from any other event or act (of the Company, and/or its subsidiaries or affiliates, or you) relating to the options or shares issued upon exercise of options. The Company and/or its subsidiaries or affiliates, and/or the Trustee shall withhold taxes according to the requirements under the applicable laws, rules, and regulations, including withholding taxes at source.

2

• Furthermore, you agree to indemnify the Company and/or its subsidiaries and affiliates and/or the Trustee and hold them harmless against and from any and all liability for any such tax or interest or penalty thereon, including without limitation, liabilities relating to the necessity to withhold, or to have withheld, any such tax from any payment made to you for which you are responsible.

• The Company or any of its subsidiaries or affiliates and the Trustee may make such provisions and take such steps as it/they may deem necessary or appropriate for the withholding of all taxes required by law to be withheld with respect to options granted under the Plan and the exercise of such options, including, but not limited, to (i) deducting the amount so required to be withheld from any other amount then or thereafter payable to you, including by deducting any such amount from your salary or other amounts payable to the you, to the maximum extent permitted under law and/or (ii) requiring you to pay to the Company or any of its subsidiaries or affiliates the amount so required to be withheld as a condition of the issuance, delivery, distribution or release of any shares and/or (iii) by causing the exercise and sale of any options or shares held by or on behalf of you to cover such liability up to the amount required to satisfy minimum statutory withholding requirements. In addition, you agree to pay any amount that exceeds the tax to be withheld and transferred to the tax authorities, pursuant to applicable Israeli tax regulations.

TERMINATION OF VESTED STOCK OPTIONS

• In no event may you exercise your options after the Award Expiration Date as provided above.

• In the event that your employment or other service terminates, the outstanding vested options on the date of such termination, shall be exercisable for (i) three months after such termination (except in the case of termination by reason of death or Disability (as defined in the Plan); or (ii) six months after such termination by reason of your death or Disability. Notwithstanding the foregoing, in the event of your death within three months after the date of termination, your estate or heirs, as applicable, may exercise all options that are vested and exercisable at the time of your employment termination within six months after your death.

• Notwithstanding the above, in the event that your employment or other service terminates for Cause (as defined in the Plan), all unexercised options (whether vested or not) shall terminate.

• For purposes of this section “TERMINATION OF VESTED STOCK OPTIONS,” termination of your employment or other service shall be deemed effective as detailed in Section 10.5 of the Plan.

TAX ADVICE. Nothing in the Agreement is intended to serve as tax or investment advice, or to provide rules and regulations that may apply to your personal tax situation. You are advised to consult with your tax advisor with respect to the tax consequences of receiving or exercising your options.

3

SECURITIES LAWS.

• Shares shall not be issued pursuant to the exercise of an option unless the exercise of such option and the issuance and delivery of such Shares shall comply with applicable securities and other laws and shall be further subject to the approval of counsel for the Company with respect to such compliance. The inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company’s counsel to be necessary to the lawful issuance and sale of any shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or sell such shares as to which such requisite authority shall not have been obtained.

• You understand and agree that the Company may cause legends to be placed upon any certificate(s) evidencing ownership of the shares that may be required by the Company or by state, federal or foreign securities laws.

ACKNOWLEDGMENT OF NATURE OF PLAN AND OPTIONS. In accepting the award, you acknowledge:

• the Plan is discretionary in nature and may be modified, suspended or terminated by Spansion at any time, without notice to participants;

• an award does not create any contractual or other right to receive future awards, or other benefits instead of options;

• all decisions with respect to option awards are at the sole discretion of Spansion;

• your participation in the Plan is voluntary;

• options awards are not part of any contract you might have, are not compensation for services rendered to Spansion or Saifun Semiconductors Ltd. (“Saifun”), and are not used for calculating any severance, resignation, termination, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments;

• neither an award nor any provision of the terms and conditions that govern an award provides any employment right or contract, including any right to continued employment or other service;

• neither termination of options based on termination of employment or other service, or in accordance with some other Plan provision, nor any diminution in value of the options, results in any claim or right to compensation or damages, and you irrevocably release Spansion from, and waive, any such alleged claim or right that may arise; and

• in the event of termination of your employment (involuntary or otherwise), your right to receive awards options and/or vest in them under the Plan will terminate as of the date designated by the Company as the last day of your active employment or other service with the Company or a subsidiary of the Company and shall not be extended by any notice or similar period that may be required by applicable local law during which the Company may determine, at its sole option, that your employment or other service is no longer active.

4

DATA PRIVACY NOTICE AND CONSENT. In accepting an option award, you consent to the collection, use and transfer, in electronic or other form, of your personal Data, as described below, by and among Spansion and its subsidiaries and affiliates for the exclusive purpose of implementing, administering and managing your participation in the Plan.

In addition, you understand: (i) Spansion may hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in Spansion, details of all options or any other entitlement to shares awarded, canceled, vested, unvested or outstanding in your favor (“Data”), for the purpose of implementing, administering and managing the Plan; (ii) Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, including to third parties outside of Israel and further transfers thereafter, or elsewhere, and that the third parties’ countries may have different data privacy laws and protections than your country; and (iii) you may request a list with the names and addresses of such third parties by contacting your local human resources representative. You also authorize the third parties to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing your participation in the Plan, including any required transfer of such Data to a broker, escrow agent or other third party with whom the shares may be deposited. You understand (i) Data will be held only as long as is necessary to implement, administer and manage your participation in the Plan and (ii) you may, at any time, view Data, request additional information about the storage and processing of Data, and require necessary changes to be made to Data. You further understand you may refuse or withdraw your consent to the above at no cost by contacting in writing your local human resources representative and that such refusal or withdrawal of consent may affect your ability to participate in the Plan. If you have questions about this Data Privacy Notice and Consent, you may contact your local human resources representative.

GOVERNING LAW. Except with respect to applicability of Section 102 to your award, your award and the applicable terms and conditions will be governed by the laws of the United States of America, State of Delaware, without regard to any Delaware conflict of law principles.

ELECTRONIC DELIVERY. To the extent permitted by law, Spansion may deliver any documents related to your options by electronic means or request your consent to participate in the Plan by electronic means. You hereby consent to receive such documents by electronic delivery and agree to participate in the Plan through an on-line or electronic system established and maintained by Spansion or another third party designated by Spansion.

5

SEVERABILITY. If one or more of the provisions of this Agreement shall be held unenforceable, the enforceability of the remaining provisions shall not be affected; to the extent permissible by law, any provisions which could be deemed null and void shall first be revised retroactively to permit these Terms and Conditions to be interpreted to carry out their intent and the intent of the Plan.

LANGUAGE. If you have received the terms of this Agreement or any other Plan-related document translated into a language other than English and if the translated version is different than the English version, the English version will control.

ENTIRE AGREEMENT. This Agreement, together with the Plan and Trust Agreement constitute the entire agreement and supersede any and all prior agreements between you and Spansion and you and Saifun regarding the subject matter hereof. Spansion may, however, unilaterally waive any provision in the terms and conditions as long as such waiver does not adversely affect your rights under the Plan; if Spansion does waive a provision, such waiver is not a future waiver of that provision or a waiver of any other provision.

SUCCESSORS AND ASSIGNS. This Agreement shall be binding upon and shall inure to the benefit of Spansion, its successors and assigns, and Spansion shall require such successor or assign to expressly assume and agree to perform this Agreement in the same manner and to the same extent that it would be required to perform it if no such succession or assignment had taken place.

SIGNATURE

By signing below, you agree

• the options are granted under and governed by (i) this Agreement, (ii) the Plan, a copy of which has been made available for your review, (iii) Section 102(b)(2) of the Income Tax Ordinance (New Version) – 1961 and the rules promulgated in connection therewith, and (iv) the Trust Agreement, a copy of which has been made available for your review;

• the options will be issued to the Trustee to hold on your behalf, pursuant to Section 102;

• you are familiar with the terms and provisions of Section 102, particularly the capital gains route described in subsection (b)(2) thereof; and

• you will not require the Trustee to release the options or shares to you, or to sell the options or shares to a third party, during the Lock-up Period, unless permitted to do so by applicable law.

Optionee’s Signature Date

6

EX-10.3(J)

Exhibit 10.3(j)

RESTRICTED STOCK UNIT AWARD AGREEMENT

FOR SECTION 102(b)(2) RSUs GRANTED UNDER THE

SPANSION INC. EQUITY INCENTIVE PLAN

Name:                                     (“Recipient”)

Date of Grant:                     

No. of Shares:                 

Vesting Schedule:

Number of Shares	Vesting Date*
<<Shares_Period_1>>	<<Vest_Date_Period_1>>
<<Shares_Period_2>>	<<Vest_Date_Period_2>>
<<Shares_Period_3>>	<<Vest_Date_Period_3>>
<<Shares_Period_4>>	<<Vest_Date_Period_4>>

* if you are an active employee of Spansion or its subsidiaries through the entire vesting period

Award Expiration Date:                 

Type of RSU: Section 102(b)(2) RSU - Capital Route

Trustee: Tamir Fishman Trusts 2004 Ltd

Congratulations on being granted Spansion RSUs under the Spansion Inc. 2007 Equity Incentive Plan (the “Plan”). Your award is subject to the provisions of the Plan, this Award Agreement (the “Agreement”), the agreement between Spansion (the “Company”) and the Trustee (the “Trust Agreement”) and Section 102 of the Israeli Income Tax Ordinance (New Version), 1961 and any regulations, rules or orders promulgated thereunder, including the Income Tax Rules (Tax Relief for Issuance of Shares to Employees), 2003, all as amended from time to time (collectively, “Section 102”).

In the event of a conflict between the general terms and conditions of the Plan and this Agreement, the terms and conditions of the Plan shall prevail. However, this Agreement sets out specific terms for your award, and those terms will prevail over more general terms in the Plan on the same issue, if any, or in the event of a conflict between such terms.

ISSUANCE OF RSUS. The RSUs will be registered in the name of the Trustee as required by law to qualify under Section 102, for your benefit.

• The Trustee will hold the RSUs or the Shares to be issued upon vesting of the RSUs for the Lock-up Period, as set forth in the Plan.

• You release the Trustee from any liability in respect of any action or decision duly taken to comply with the terms of the Plan and this Agreement, in connection with any award granted to you under the Plan.

• You agree to execute any and all documents which the Company or the Trustee may reasonably determine to be necessary in order to comply with Section 102.

NON TRANSFERABILITY OF RSUS. Your RSUs and related rights are not transferable except by the laws of descent and distribution.

VESTING OF YOUR RSUS.

• An RSU represents a commitment by Spansion to issue one share of Spansion common stock for each RSU awarded on the date the RSU vests, subject to your meeting all applicable requirements. The vesting date is the date on which the restrictions lapse. After vesting, RSUs are converted into full-value shares of Spansion common stock if the applicable terms have been satisfied. Except as otherwise stated below, your RSUs vest as set forth above in this Agreement if you are an active employee through the entire vesting period.

• In no event will your RSUs vest after the Award Expiration Date as provided above.

• In connection with the issuance of shares upon vesting of the RSUs, you agree to sign any and all documents required by law and/or the Company.

TAX PAYMENT.

• You agree to be solely responsible for paying any and all taxes arising from the grant or vesting of RSUs, from the payment for and/or issuance and/or sale of shares covered by RSUs, or from any other event or act (of the Company, and/or its subsidiaries or affiliates, or you) relating to the RSUs or shares issued upon vesting of RSUs. The Company and/or its subsidiaries or affiliates, and/or the Trustee shall withhold taxes according to the requirements under the applicable laws, rules, and regulations, including withholding taxes at source.

• Furthermore, you agree to indemnify the Company and/or its subsidiaries and affiliates and/or the Trustee and hold them harmless against and from any and all liability for any such tax or interest or penalty thereon, including without limitation, liabilities relating to the necessity to withhold, or to have withheld, any such tax from any payment made to you for which you are responsible.

2

• The Company or any of its subsidiaries or affiliates and the Trustee may make such provisions and take such steps as it/they may deem necessary or appropriate for the withholding of all taxes required by law to be withheld with respect to RSUs granted under the Plan and the vesting of such RSUs and/or the issuance or sale of shares covered by the RSUs, including, but not limited, to (i) deducting the amount so required to be withheld from any other amount then or thereafter payable to you, including by deducting any such amount from your salary or other amounts payable to the you, to the maximum extent permitted under law and/or (ii) requiring you to pay to the Company or any of its subsidiaries or affiliates the amount so required to be withheld as a condition of the issuance, delivery, distribution or release of any shares and/or (iii) by causing the sale of any shares held by or on behalf of you to cover such liability up to the amount required to satisfy minimum statutory withholding requirements. In addition, you agree to pay any amount that exceeds the tax to be withheld and transferred to the tax authorities, pursuant to applicable Israeli tax regulations.

TERMINATION OF RSUS

• In no event will your RSUs vest after the Award Expiration Date as provided above.

• Notwithstanding the above, in the event that your employment or other service terminates for Cause (as defined in the Plan), all RSUs (whether vested or not) shall terminate.

• For purposes of this section “TERMINATION OF RSUS,” termination of your employment or other service shall be deemed effective as detailed in Section 10.5 of the Plan.

TAX ADVICE. Nothing in the Agreement is intended to serve as tax or investment advice, or to provide rules and regulations that may apply to your personal tax situation. You are advised to consult with your tax advisor with respect to the tax consequences of receiving or vesting your RSUs and/or the issuance or sale of shares covered by the RSUs.

SECURITIES LAWS.

• Shares shall not be issued unless the vesting of RSUs and the issuance and delivery of the underlying shares comply with applicable securities and other laws and shall be further subject to the approval of counsel for the Company with respect to such compliance. The inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company’s counsel to be necessary to the lawful issuance and sale of any shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or sell such shares as to which such requisite authority shall not have been obtained.

3

• You understand and agree that the Company may cause legends to be placed upon any certificate(s) evidencing ownership of the shares that may be required by the Company or by state, federal or foreign securities laws.

ACKNOWLEDGMENT OF NATURE OF PLAN AND RSUS. In accepting the award, you acknowledge:

• the Plan is discretionary in nature and may be modified, suspended or terminated by Spansion at any time, without notice to participants;

• an award does not create any contractual or other right to receive future awards, or other benefits instead of RSUs;

• all decisions with respect to RSU awards are at the sole discretion of Spansion;

• your participation in the Plan is voluntary;

• RSU awards are not part of any contract you might have, are not compensation for services rendered to Spansion or Saifun Semiconductors Ltd. (“Saifun”), and are not used for calculating any severance, resignation, termination, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments;

• neither an award nor any provision of the terms and conditions that govern an award provides any employment right or contract, including any right to continued employment or other service;

• neither termination of RSUs based on termination of employment or other service, or in accordance with some other Plan provision, nor any diminution in value of the RSUs, results in any claim or right to compensation or damages, and you irrevocably release Spansion from, and waive, any such alleged claim or right that may arise; and

• subject to the specific vesting terms of your award, in the event of termination of your employment (involuntary or otherwise), your right to receive awards of RSUs and/or vest in them under the Plan will terminate as of the date designated by the Company as the last day of your active employment or other service with the Company or a subsidiary of the Company and shall not be extended by any notice or similar period that may be required by applicable local law during which the Company may determine, at its sole option, that your employment or other service is no longer active.

DATA PRIVACY NOTICE AND CONSENT. In accepting an RSU award, you consent to the collection, use and transfer, in electronic or other form, of your personal Data, as described below, by and among Spansion and its subsidiaries and affiliates for the exclusive purpose of implementing, administering and managing your participation in the Plan.

In addition, you understand: (i) Spansion may hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in Spansion, details of all RSUs or any

4

other entitlement to shares awarded, canceled, vested, unvested or outstanding in your favor (“Data”), for the purpose of implementing, administering and managing the Plan; (ii) Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, including to third parties outside of Israel and further transfers thereafter, or elsewhere, and that the third parties’ countries may have different data privacy laws and protections than your country; and (iii) you may request a list with the names and addresses of such third parties by contacting your local human resources representative. You also authorize the third parties to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing your participation in the Plan, including any required transfer of such Data to a broker, escrow agent or other third party with whom the shares may be deposited. You understand (i) Data will be held only as long as is necessary to implement, administer and manage your participation in the Plan and (ii) you may, at any time, view Data, request additional information about the storage and processing of Data, and require necessary changes to be made to Data. You further understand you may refuse or withdraw your consent to the above at no cost by contacting in writing your local human resources representative and that such refusal or withdrawal of consent may affect your ability to participate in the Plan. If you have questions about this Data Privacy Notice and Consent, you may contact your local human resources representative.

GOVERNING LAW. Except with respect to applicability of Section 102 to your award, your award and the applicable terms and conditions will be governed by the laws of the United States of America, State of Delaware, without regard to any Delaware conflict of law principles.

ELECTRONIC DELIVERY. To the extent permitted by law, Spansion may deliver any documents related to your RSUs by electronic means or request your consent to participate in the Plan by electronic means. You hereby consent to receive such documents by electronic delivery and agree to participate in the Plan through an on-line or electronic system established and maintained by Spansion or another third party designated by Spansion.

SEVERABILITY. If one or more of the provisions of this Agreement shall be held unenforceable, the enforceability of the remaining provisions shall not be affected; to the extent permissible by law, any provisions which could be deemed null and void shall first be revised retroactively to permit these Terms and Conditions to be interpreted to carry out their intent and the intent of the Plan.

LANGUAGE. If you have received the terms of this Agreement or any other Plan-related document translated into a language other than English and if the translated version is different than the English version, the English version will control.

ENTIRE AGREEMENT. This Agreement, together with the Plan and Trust Agreement constitute the entire agreement and supersede any and all prior agreements between you and Spansion and you and Saifun regarding the subject matter hereof. Spansion may, however, unilaterally waive any provision in the terms and conditions as long as such waiver does not adversely affect your rights under the Plan; if Spansion does waive a provision, such waiver is not a future waiver of that provision or a waiver of any other provision.

5

SUCCESSORS AND ASSIGNS. This Agreement shall be binding upon and shall inure to the benefit of Spansion, its successors and assigns, and Spansion shall require such successor or assign to expressly assume and agree to perform this Agreement in the same manner and to the same extent that it would be required to perform it if no such succession or assignment had taken place.

SIGNATURE

By signing below, you agree

• the RSUs are granted under and governed by (i) this Agreement, (ii) the Plan, a copy of which has been made available for your review, (iii) Section 102(b)(2) of the Income Tax Ordinance (New Version) – 1961 and the rules promulgated in connection therewith, and (iv) the Trust Agreement, a copy of which has been made available for your review;

• the RSUs will be issued to the Trustee to hold on your behalf, pursuant to Section 102;

• you are familiar with the terms and provisions of Section 102, particularly the capital gains route described in subsection (b)(2) thereof; and

• you will not require the Trustee to release the RSUs or shares to you, or to sell the shares issued upon vesting of the RSUs to a third party, during the Lock-up Period, unless permitted to do so by applicable law.

Recipient’s Signature Date

6

EX-10.3(K)

Exhibit 10.3(k)

OPTION AWARD AGREEMENT

FOR SECTION 102(b)(2) OPTIONS GRANTED UNDER THE

SAIFUN SEMICONDUCTORS LTD. 2003 SHARE OPTION PLAN

Name: ______________________________ (“Optionee”)

Date of Grant: ______________________

Shares: _____________________

Vesting Schedule:

Number of Shares	Vesting Date*
<<Shares_Period_1>>	<<Vest_Date_Period_1>>
<<Shares_Period_2>>	<<Vest_Date_Period_2>>
<<Shares_Period_3>>	<<Vest_Date_Period_3>>
<<Shares_Period_4>>	<<Vest_Date_Period_4>>

* if you are an active employee of Spansion or its subsidiaries through the entire vesting period

Exercise Price per Share: _____________

Award Expiration Date: ___________

Type of Option: Section 102(b)(2) Option - Capital Route

Trustee: Tamir Fishman Trusts 2004 Ltd

Congratulations on being granted Spansion stock options under the Spansion Inc. 2007 Equity Incentive Plan (the “Plan”). Your award is subject to the provisions of the Plan, this Option Award Agreement (the “Agreement”), the agreement between Spansion (the “Company”) and the Trustee (the “Trust Agreement”) and Section 102 of the Israeli Income Tax Ordinance (New Version), 1961 and any regulations, rules or orders promulgated thereunder, including the Income Tax Rules (Tax Relief for Issuance of Shares to Employees), 2003, all as amended from time to time (collectively, “Section 102”).

In the event of a conflict between the general terms and conditions of the Plan and this Agreement, the terms and conditions of the Plan shall prevail. However, this Agreement sets out specific terms for your award, and those terms will prevail over more general terms in the Plan on the same issue, if any, or in the event of a conflict between such terms.

ISSUANCE OF OPTIONS. The Options will be registered in the name of the Trustee as required by law to qualify under Section 102, for your benefit.

• The Trustee will hold the options or the Shares to be issued upon exercise of the options for the Lock-up Period, as set forth in the Plan.

• You release the Trustee from any liability in respect of any action or decision duly taken to comply with the terms of the Plan and this Agreement, in connection with any award granted to you under the Plan.

• You agree to execute any and all documents which the Company or the Trustee may reasonably determine to be necessary in order to comply with Section 102.

NON TRANSFERABILITY OF STOCK OPTIONS. Your stock options and related rights are not transferable except by the laws of descent and distribution.

EXERCISING YOUR VESTED STOCK OPTIONS.

• Once your options vest, they are available for you to exercise (purchase Spansion common stock at the exercise price) until they expire or terminate, whichever is earlier. Your final opportunity to exercise your vested options is the earlier of the last regular trading day of the Company on or before the expiration date of the options, or the last regular trading day of the Company on or before the options terminate in the case of an earlier termination of the options.

• You may not exercise an option for a fractional share of stock.

• The options, or any part thereof, shall be exercisable by your signing and returning to the Company or its agent a notice of exercise in a form approved by the Company, together with payment of the aggregate purchase price, including any applicable tax withholdings, in accordance with the provisions of the Plan.

• In connection with the issuance of shares upon the exercise of any of the options, you agree to sign any and all documents required by law and/or the Company.

• After an executed notice of exercise has been delivered to the Company or its agent, you may not rescind or revise it.

TAX PAYMENT.

• You agree to be solely responsible for paying any and all taxes arising from the grant or exercise of any option, from the payment for shares covered by this option, or from any other event or act (of the Company, and/or its subsidiaries or affiliates, or you) relating to the options or shares issued upon exercise of options. The Company and/or its subsidiaries or affiliates, and/or the Trustee shall withhold taxes according to the requirements under the applicable laws, rules, and regulations, including withholding taxes at source.

2

• Furthermore, you agree to indemnify the Company and/or its subsidiaries and affiliates and/or the Trustee and hold them harmless against and from any and all liability for any such tax or interest or penalty thereon, including without limitation, liabilities relating to the necessity to withhold, or to have withheld, any such tax from any payment made to you for which you are responsible.

• The Company or any of its subsidiaries or affiliates and the Trustee may make such provisions and take such steps as it/they may deem necessary or appropriate for the withholding of all taxes required by law to be withheld with respect to options granted under the Plan and the exercise of such options, including, but not limited, to (i) deducting the amount so required to be withheld from any other amount then or thereafter payable to you, including by deducting any such amount from your salary or other amounts payable to the you, to the maximum extent permitted under law and/or (ii) requiring you to pay to the Company or any of its subsidiaries or affiliates the amount so required to be withheld as a condition of the issuance, delivery, distribution or release of any shares and/or (iii) by causing the exercise and sale of any options or shares held by or on behalf of you to cover such liability up to the amount required to satisfy minimum statutory withholding requirements. In addition, you agree to pay any amount that exceeds the tax to be withheld and transferred to the tax authorities, pursuant to applicable Israeli tax regulations.

TERMINATION OF VESTED STOCK OPTIONS

• In no event may you exercise your options after the Award Expiration Date as provided above.

• In the event that your employment or other service terminates, the outstanding vested options on the date of such termination, shall be exercisable for (i) three months after such termination (except in the case of termination by reason of death or Disability (as defined in the Plan); or (ii) six months after such termination by reason of your death or Disability. Notwithstanding the foregoing, in the event of your death within three months after the date of termination, your estate or heirs, as applicable, may exercise all options that are vested and exercisable at the time of your employment termination within six months after your death.

• Notwithstanding the above, in the event that your employment or other service terminates for Cause (as defined in the Plan), all unexercised options (whether vested or not) shall terminate.

• For purposes of this section “TERMINATION OF VESTED STOCK OPTIONS,” termination of your employment or other service shall be deemed effective as detailed in Section 10.5 of the Plan.

TAX ADVICE. Nothing in the Agreement is intended to serve as tax or investment advice, or to provide rules and regulations that may apply to your personal tax situation. You are advised to consult with your tax advisor with respect to the tax consequences of receiving or exercising your options.

3

SECURITIES LAWS.

• Shares shall not be issued pursuant to the exercise of an option unless the exercise of such option and the issuance and delivery of such Shares shall comply with applicable securities and other laws and shall be further subject to the approval of counsel for the Company with respect to such compliance. The inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company’s counsel to be necessary to the lawful issuance and sale of any shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or sell such shares as to which such requisite authority shall not have been obtained.

• You understand and agree that the Company may cause legends to be placed upon any certificate(s) evidencing ownership of the shares that may be required by the Company or by state, federal or foreign securities laws.

ACKNOWLEDGMENT OF NATURE OF PLAN AND OPTIONS. In accepting the award, you acknowledge:

• the Plan is discretionary in nature and may be modified, suspended or terminated by Spansion at any time, without notice to participants;

• an award does not create any contractual or other right to receive future awards, or other benefits instead of options;

• all decisions with respect to option awards are at the sole discretion of Spansion;

• your participation in the Plan is voluntary;

• options awards are not part of any contract you might have, are not compensation for services rendered to Spansion or Saifun Semiconductors Ltd. (“Saifun”), and are not used for calculating any severance, resignation, termination, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments;

• neither an award nor any provision of the terms and conditions that govern an award provides any employment right or contract, including any right to continued employment or other service;

• neither termination of options based on termination of employment or other service, or in accordance with some other Plan provision, nor any diminution in value of the options, results in any claim or right to compensation or damages, and you irrevocably release Spansion from, and waive, any such alleged claim or right that may arise; and

• in the event of termination of your employment (involuntary or otherwise), your right to receive awards options and/or vest in them under the Plan will terminate as of the date designated by the Company as the last day of your active employment or other service with the Company or a subsidiary of the Company and shall not be extended by any notice or similar period that may be required by applicable local law during which the Company may determine, at its sole option, that your employment or other service is no longer active.

4

DATA PRIVACY NOTICE AND CONSENT. In accepting an option award, you consent to the collection, use and transfer, in electronic or other form, of your personal Data, as described below, by and among Spansion and its subsidiaries and affiliates for the exclusive purpose of implementing, administering and managing your participation in the Plan.

In addition, you understand: (i) Spansion may hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in Spansion, details of all options or any other entitlement to shares awarded, canceled, vested, unvested or outstanding in your favor (“Data”), for the purpose of implementing, administering and managing the Plan; (ii) Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, including to third parties outside of Israel and further transfers thereafter, or elsewhere, and that the third parties’ countries may have different data privacy laws and protections than your country; and (iii) you may request a list with the names and addresses of such third parties by contacting your local human resources representative. You also authorize the third parties to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing your participation in the Plan, including any required transfer of such Data to a broker, escrow agent or other third party with whom the shares may be deposited. You understand (i) Data will be held only as long as is necessary to implement, administer and manage your participation in the Plan and (ii) you may, at any time, view Data, request additional information about the storage and processing of Data, and require necessary changes to be made to Data. You further understand you may refuse or withdraw your consent to the above at no cost by contacting in writing your local human resources representative and that such refusal or withdrawal of consent may affect your ability to participate in the Plan. If you have questions about this Data Privacy Notice and Consent, you may contact your local human resources representative.

GOVERNING LAW. Except with respect to applicability of Section 102 to your award, your award and the applicable terms and conditions will be governed by the laws of the United States of America, State of Delaware, without regard to any Delaware conflict of law principles.

ELECTRONIC DELIVERY. To the extent permitted by law, Spansion may deliver any documents related to your options by electronic means or request your consent to participate in the Plan by electronic means. You hereby consent to receive such documents by electronic delivery and agree to participate in the Plan through an on-line or electronic system established and maintained by Spansion or another third party designated by Spansion.

5

SEVERABILITY. If one or more of the provisions of this Agreement shall be held unenforceable, the enforceability of the remaining provisions shall not be affected; to the extent permissible by law, any provisions which could be deemed null and void shall first be revised retroactively to permit these Terms and Conditions to be interpreted to carry out their intent and the intent of the Plan.

LANGUAGE. If you have received the terms of this Agreement or any other Plan-related document translated into a language other than English and if the translated version is different than the English version, the English version will control.

ENTIRE AGREEMENT. This Agreement, together with the Plan and Trust Agreement constitute the entire agreement and supersede any and all prior agreements between you and Spansion and you and Saifun regarding the subject matter hereof. Spansion may, however, unilaterally waive any provision in the terms and conditions as long as such waiver does not adversely affect your rights under the Plan; if Spansion does waive a provision, such waiver is not a future waiver of that provision or a waiver of any other provision.

SUCCESSORS AND ASSIGNS. This Agreement shall be binding upon and shall inure to the benefit of Spansion, its successors and assigns, and Spansion shall require such successor or assign to expressly assume and agree to perform this Agreement in the same manner and to the same extent that it would be required to perform it if no such succession or assignment had taken place.

SIGNATURE

By signing below, you agree

• the options are granted under and governed by (i) this Agreement, (ii) the Plan, a copy of which has been made available for your review, (iii) Section 102(b)(2) of the Income Tax Ordinance (New Version) – 1961 and the rules promulgated in connection therewith, and (iv) the Trust Agreement, a copy of which has been made available for your review;

• the options will be issued to the Trustee to hold on your behalf, pursuant to Section 102;

• you are familiar with the terms and provisions of Section 102, particularly the capital gains route described in subsection (b)(2) thereof; and

• you will not require the Trustee to release the options or shares to you, or to sell the options or shares to a third party, during the Lock-up Period, unless permitted to do so by applicable law.

Optionee’s Signature Date

6

EX-10.3(L)

Exhibit 10.3(l)

RESTRICTED STOCK UNIT AWARD AGREEMENT

FOR SECTION 102(b)(2) RSUs GRANTED UNDER THE

SAIFUN SEMICONDUCTORS LTD. 2003 SHARE OPTION PLAN

Name: ____________________________ (“Recipient”)

Date of Grant: _____________________

No. of Shares: __________________

Vesting Schedule:

Number of Shares	Vesting Date*
<<Shares_Period_1>>	<<Vest_Date_Period_1>>
<<Shares_Period_2>>	<<Vest_Date_Period_2>>
<<Shares_Period_3>>	<<Vest_Date_Period_3>>
<<Shares_Period_4>>	<<Vest_Date_Period_4>>

* if you are an active employee of Spansion or its subsidiaries through the entire vesting period

Award Expiration Date: ________

Type of RSU: Section 102(b)(2) RSU - Capital Route

Trustee: Tamir Fishman Trusts 2004 Ltd

Congratulations on being granted Spansion RSUs under the Spansion Inc. 2007 Equity Incentive Plan (the “Plan”). Your award is subject to the provisions of the Plan, this Award Agreement (the “Agreement”), the agreement between Spansion (the “Company”) and the Trustee (the “Trust Agreement”) and Section 102 of the Israeli Income Tax Ordinance (New Version), 1961 and any regulations, rules or orders promulgated thereunder, including the Income Tax Rules (Tax Relief for Issuance of Shares to Employees), 2003, all as amended from time to time (collectively, “Section 102”).

In the event of a conflict between the general terms and conditions of the Plan and this Agreement, the terms and conditions of the Plan shall prevail. However, this Agreement sets out specific terms for your award, and those terms will prevail over more general terms in the Plan on the same issue, if any, or in the event of a conflict between such terms.

ISSUANCE OF RSUS. The RSUs will be registered in the name of the Trustee as required by law to qualify under Section 102, for your benefit.

• The Trustee will hold the RSUs or the Shares to be issued upon vesting of the RSUs for the Lock-up Period, as set forth in the Plan.

• You release the Trustee from any liability in respect of any action or decision duly taken to comply with the terms of the Plan and this Agreement, in connection with any award granted to you under the Plan.

• You agree to execute any and all documents which the Company or the Trustee may reasonably determine to be necessary in order to comply with Section 102.

NON TRANSFERABILITY OF RSUS. Your RSUs and related rights are not transferable except by the laws of descent and distribution.

VESTING OF YOUR RSUS.

• An RSU represents a commitment by Spansion to issue one share of Spansion common stock for each RSU awarded on the date the RSU vests, subject to your meeting all applicable requirements. The vesting date is the date on which the restrictions lapse. After vesting, RSUs are converted into full-value shares of Spansion common stock if the applicable terms have been satisfied. Except as otherwise stated below, your RSUs vest as set forth above in this Agreement if you are an active employee through the entire vesting period.

• In no event will your RSUs vest after the Award Expiration Date as provided above.

• In connection with the issuance of shares upon vesting of the RSUs, you agree to sign any and all documents required by law and/or the Company.

TAX PAYMENT.

• You agree to be solely responsible for paying any and all taxes arising from the grant or vesting of RSUs, from the payment for and/or issuance and/or sale of shares covered by RSUs, or from any other event or act (of the Company, and/or its subsidiaries or affiliates, or you) relating to the RSUs or shares issued upon vesting of RSUs. The Company and/or its subsidiaries or affiliates, and/or the Trustee shall withhold taxes according to the requirements under the applicable laws, rules, and regulations, including withholding taxes at source.

• Furthermore, you agree to indemnify the Company and/or its subsidiaries and affiliates and/or the Trustee and hold them harmless against and from any and all liability for any such tax or interest or penalty thereon, including without limitation, liabilities relating to the necessity to withhold, or to have withheld, any such tax from any payment made to you for which you are responsible.

2

• The Company or any of its subsidiaries or affiliates and the Trustee may make such provisions and take such steps as it/they may deem necessary or appropriate for the withholding of all taxes required by law to be withheld with respect to RSUs granted under the Plan and the vesting of such RSUs and/or the issuance or sale of shares covered by the RSUs, including, but not limited, to (i) deducting the amount so required to be withheld from any other amount then or thereafter payable to you, including by deducting any such amount from your salary or other amounts payable to the you, to the maximum extent permitted under law and/or (ii) requiring you to pay to the Company or any of its subsidiaries or affiliates the amount so required to be withheld as a condition of the issuance, delivery, distribution or release of any shares and/or (iii) by causing the sale of any shares held by or on behalf of you to cover such liability up to the amount required to satisfy minimum statutory withholding requirements. In addition, you agree to pay any amount that exceeds the tax to be withheld and transferred to the tax authorities, pursuant to applicable Israeli tax regulations.

TERMINATION OF RSUS

• In no event will your RSUs vest after the Award Expiration Date as provided above.

• Notwithstanding the above, in the event that your employment or other service terminates for Cause (as defined in the Plan), all RSUs (whether vested or not) shall terminate.

• For purposes of this section “TERMINATION OF RSUS,” termination of your employment or other service shall be deemed effective as detailed in Section 10.5 of the Plan.

TAX ADVICE. Nothing in the Agreement is intended to serve as tax or investment advice, or to provide rules and regulations that may apply to your personal tax situation. You are advised to consult with your tax advisor with respect to the tax consequences of receiving or vesting your RSUs and/or the issuance or sale of shares covered by the RSUs.

SECURITIES LAWS.

• Shares shall not be issued unless the vesting of RSUs and the issuance and delivery of the underlying shares comply with applicable securities and other laws and shall be further subject to the approval of counsel for the Company with respect to such compliance. The inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company’s counsel to be necessary to the lawful issuance and sale of any shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or sell such shares as to which such requisite authority shall not have been obtained.

3

• You understand and agree that the Company may cause legends to be placed upon any certificate(s) evidencing ownership of the shares that may be required by the Company or by state, federal or foreign securities laws.

ACKNOWLEDGMENT OF NATURE OF PLAN AND RSUS. In accepting the award, you acknowledge:

• the Plan is discretionary in nature and may be modified, suspended or terminated by Spansion at any time, without notice to participants;

• an award does not create any contractual or other right to receive future awards, or other benefits instead of RSUs;

• all decisions with respect to RSU awards are at the sole discretion of Spansion;

• your participation in the Plan is voluntary;

• RSU awards are not part of any contract you might have, are not compensation for services rendered to Spansion or Saifun Semiconductors Ltd. (“Saifun”), and are not used for calculating any severance, resignation, termination, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments;

• neither an award nor any provision of the terms and conditions that govern an award provides any employment right or contract, including any right to continued employment or other service;

• neither termination of RSUs based on termination of employment or other service, or in accordance with some other Plan provision, nor any diminution in value of the RSUs, results in any claim or right to compensation or damages, and you irrevocably release Spansion from, and waive, any such alleged claim or right that may arise; and

• subject to the specific vesting terms of your award, in the event of termination of your employment (involuntary or otherwise), your right to receive awards of RSUs and/or vest in them under the Plan will terminate as of the date designated by the Company as the last day of your active employment or other service with the Company or a subsidiary of the Company and shall not be extended by any notice or similar period that may be required by applicable local law during which the Company may determine, at its sole option, that your employment or other service is no longer active.

DATA PRIVACY NOTICE AND CONSENT. In accepting an RSU award, you consent to the collection, use and transfer, in electronic or other form, of your personal Data, as described below, by and among Spansion and its subsidiaries and affiliates for the exclusive purpose of implementing, administering and managing your participation in the Plan.

In addition, you understand: (i) Spansion may hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in Spansion, details of all RSUs or any

4

other entitlement to shares awarded, canceled, vested, unvested or outstanding in your favor (“Data”), for the purpose of implementing, administering and managing the Plan; (ii) Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, including to third parties outside of Israel and further transfers thereafter, or elsewhere, and that the third parties’ countries may have different data privacy laws and protections than your country; and (iii) you may request a list with the names and addresses of such third parties by contacting your local human resources representative. You also authorize the third parties to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing your participation in the Plan, including any required transfer of such Data to a broker, escrow agent or other third party with whom the shares may be deposited. You understand (i) Data will be held only as long as is necessary to implement, administer and manage your participation in the Plan and (ii) you may, at any time, view Data, request additional information about the storage and processing of Data, and require necessary changes to be made to Data. You further understand you may refuse or withdraw your consent to the above at no cost by contacting in writing your local human resources representative and that such refusal or withdrawal of consent may affect your ability to participate in the Plan. If you have questions about this Data Privacy Notice and Consent, you may contact your local human resources representative.

GOVERNING LAW. Except with respect to applicability of Section 102 to your award, your award and the applicable terms and conditions will be governed by the laws of the United States of America, State of Delaware, without regard to any Delaware conflict of law principles.

ELECTRONIC DELIVERY. To the extent permitted by law, Spansion may deliver any documents related to your RSUs by electronic means or request your consent to participate in the Plan by electronic means. You hereby consent to receive such documents by electronic delivery and agree to participate in the Plan through an on-line or electronic system established and maintained by Spansion or another third party designated by Spansion.

SEVERABILITY. If one or more of the provisions of this Agreement shall be held unenforceable, the enforceability of the remaining provisions shall not be affected; to the extent permissible by law, any provisions which could be deemed null and void shall first be revised retroactively to permit these Terms and Conditions to be interpreted to carry out their intent and the intent of the Plan.

LANGUAGE. If you have received the terms of this Agreement or any other Plan-related document translated into a language other than English and if the translated version is different than the English version, the English version will control.

ENTIRE AGREEMENT. This Agreement, together with the Plan and Trust Agreement constitute the entire agreement and supersede any and all prior agreements between you and Spansion and you and Saifun regarding the subject matter hereof. Spansion may, however, unilaterally waive any provision in the terms and conditions as long as such waiver does not adversely affect your rights under the Plan; if Spansion does waive a provision, such waiver is not a future waiver of that provision or a waiver of any other provision.

5

SUCCESSORS AND ASSIGNS. This Agreement shall be binding upon and shall inure to the benefit of Spansion, its successors and assigns, and Spansion shall require such successor or assign to expressly assume and agree to perform this Agreement in the same manner and to the same extent that it would be required to perform it if no such succession or assignment had taken place.

SIGNATURE

By signing below, you agree

• the RSUs are granted under and governed by (i) this Agreement, (ii) the Plan, a copy of which has been made available for your review, (iii) Section 102(b)(2) of the Income Tax Ordinance (New Version) – 1961 and the rules promulgated in connection therewith, and (iv) the Trust Agreement, a copy of which has been made available for your review;

• the RSUs will be issued to the Trustee to hold on your behalf, pursuant to Section 102;

• you are familiar with the terms and provisions of Section 102, particularly the capital gains route described in subsection (b)(2) thereof; and

• you will not require the Trustee to release the RSUs or shares to you, or to sell the shares issued upon vesting of the RSUs to a third party, during the Lock-up Period, unless permitted to do so by applicable law.

Recipient’s Signature Date

6

EX-10.6(B)

Exhibit 10.6(b)

SEPARATION AGREEMENT AND RELEASE

This Separation Agreement and Release (“Agreement”) is made by and between Dr. Bertrand Cambou (“Executive”) and Spansion, Inc. (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”).

RECITALS

WHEREAS, Executive was employed by the Company as its Chief Executive Officer, pursuant to employment terms set forth in an offer letter signed by Executive on April 8, 2005 (the “Offer Letter”);

WHEREAS, Executive signed an agreement dated January 7, 2002 with Advanced Micro Devices, Inc. and a Spansion LLC Agreement with the Company on April 8, 2005 (collectively, the “Confidentiality Agreements”);

WHEREAS, Executive signed an acknowledgement agreeing to abide by the Spansion Inc. Insider Trading Policy (the “Insider Trading Policy Acknowledgement”);

WHEREAS, Executive agreed to a Change of Control Severance Agreement with the Company on March 6, 2006, and further agreed to an amendment to such agreement by signing an Amended and Restated Spansion Inc. Change of Control Severance Agreement on November 1, 2007 (collectively, the “Change of Control Agreement”), the conditions of which have not been triggered and under which the Company owes no further duties or obligations to Executive, and which is wholly superseded and voided by this Agreement;

WHEREAS, Executive separated from employment with the Company effective February 2, 2009 at 5:00 p.m. PST (the “Separation Date”);

WHEREAS, Executive will provide certain transition services to the Company as a consultant (the “Transition Services”); and

WHEREAS, the Parties wish to resolve any and all disputes, claims, complaints, grievances, charges, actions, petitions, and demands that the Executive may have against the Company and any of the Releasees as defined below, including, but not limited to, any and all claims arising out of or in any way related to Executive’s employment with or separation from the Company;

NOW, THEREFORE, in consideration of the mutual promises made herein, the Company and Executive hereby agree as follows:

COVENANTS

1. Resignation. Executive resigned his employment with the Company and further voluntarily resigned from Company’s Board of Directors, effective as of February 2, 2009 at 5:00 p.m. PST. In connection with said resignation from employment and resignation form the Board of Directors, Executive also agreed to execute any necessary forms or other documents required to effect such resignation as a matter of state or federal law.

2. Consideration. The Company agrees to pay Executive a lump sum equivalent to one (1) year of Executive’s base salary, for a total of Seven Hundred Fifty-One Thousand, Two Hundred and Seventy-Four Dollars and Ninety-Four Cents ($751,274.94), less applicable withholding. This lump sum payment will be made to Executive on the Effective Date of this Agreement. Executive acknowledges and agrees that the consideration provided to him hereunder fully satisfies any obligation that the Company had to pay Executive wages or any other compensation for any of the services that Executive rendered to the Company, that the amount paid is in excess of any disputed wage claim, if any, that Executive may have. To the extent any wage dispute exists, Executive specifically acknowledges that the consideration paid shall be deemed to be paid first in satisfaction of any disputed wage claim with the remainder sufficient to act as consideration for the release of claims set forth herein, and that Executive has not earned and is not entitled to receive any additional wages or other form of compensation from the Company.

3. Stock. The Parties agree that Executive will be considered to have vested in his stock options, restricted stock units and any other equity awards up to the Separation Date, and no more. Each of Executive’s equity awards shall continue to be governed by the terms and conditions (including, but not limited to, with respect to the exercise of vested stock options) of the applicable Company equity plan under which the award was granted and applicable equity award agreement (each an “Equity Award Document,” and together, the “Equity Award Documents”). Executive specifically acknowledges that notwithstanding anything to the contrary provided for in his Equity Award Documents, he shall not continue to vest in any stock options, restricted stock units or any other equity awards as a result of the Consulting Agreement provided for in Section 7 of this Agreement.

4. Benefits. Executive’s health insurance benefits shall cease on the last day of February 2009, subject to Executive’s right to continue his group health insurance coverage at his own expense under Title X of the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), whereby Executive shall pay one hundred percent (100%) of premium amount plus a two percent (2%) administrative fee for continued group health insurance coverage. Executive’s participation in all benefits and incidents of employment, including, but not limited to, vesting in stock options, and the accrual of bonuses, vacation, and paid time off, ceased as of the Separation Date.

5. Tax Preparation Benefits. The Company shall reimburse Executive for costs directly related to preparing his personal income tax returns for the 2008 taxable year for applicable state and federal tax authorities, provided that, such expenses must be incurred by Executive prior to December 31, 2009. Such reimbursements, which shall not exceed $7,500 shall be treated as taxable income to Executive and shall be made, if at all, by March 15, 2010.

6. Payment of Salary and Receipt of All Benefits. Executive acknowledges and represents that, other than the consideration set forth in this Agreement, the Company has paid or provided all salary, wages, bonuses, accrued vacation/paid time off, leave, housing allowances, relocation costs, interest, severance, outplacement costs, fees, reimbursable expenses, commissions, stock, stock options, vesting, and any and all other benefits and compensation due to Executive. Executive further acknowledges and represents that he has received any leave to which he was entitled or which he requested, if any, under the California Family Rights Act and/or the Family

Page 2 of 18

Medical Leave Act, and that he did not sustain any workplace injury, during his employment with the Company.

7. Transition Services. The Parties agree to enter into a Consulting Agreement essentially in the form attached hereto as Exhibit I (the “Consulting Agreement”), whereby Executive will provide certain consulting services to the Company, subject to mutually agreed upon Statement of Work that shall constitute Exhibit A to the Consulting Agreement (“Statement of Work”). The Statement of Work will include, but not be limited to, the following agreed upon terms: (i) Executive will provide the Company with consulting services including, but not limited to, the transitioning of Executive’s responsibilities, with the specific description of such contractual duties to be reasonably agreed upon and reduced to writing in the Statement of Work; (ii) Executive will provide up to eighty (80) hours of consulting services per month; (iii) the Consulting Agreement shall continue for a term of four (4) months or less, as provided under Section 5 therein; and (iv) the Company will pay Executive Thirty One Thousand Three Hundred Three Dollars and Twelve Cents ($31,303.12) per month, conditioned upon his satisfaction of and compliance with the terms and conditions of the Consulting Agreement. Nothing in this Agreement or the Consulting Agreement pertaining to Executive’s anticipated role as a Consultant shall in any way be construed to constitute Executive as a continuing agent, officer, employee, or representative of the Company, but Executive shall perform the services under the Consulting Agreement solely as an independent contractor.

8. Release of Claims. Executive agrees that the foregoing consideration represents settlement in full of all outstanding obligations owed to Executive by the Company and its current and former officers, directors, Executives, agents, investors, attorneys, shareholders, administrators, affiliates, benefit plans, plan administrators, insurers, divisions, and subsidiaries, and predecessor and successor corporations and assigns (collectively, the “Releasees”). Executive, on his own behalf and on behalf of his respective heirs, family members, executors, agents, and assigns, hereby and forever releases the Releases from, and agrees not to sue concerning, or in any manner to institute, prosecute, or pursue, any claim, complaint, charge, duty, obligation, or cause of action relating to any matters of any kind, whether presently known or unknown, suspected or unsuspected, that Executive may possess against any of the Releasees arising from any omissions, acts, facts, or damages that have occurred up until and including the Effective Date of this Agreement, including, without limitation:

a. any and all claims relating to or arising from Executive’s employment relationship with the Company and the termination of that relationship;

b. any and all claims relating to, or arising from, Executive’s right to purchase, or actual purchase of shares of stock of the Company, including, without limitation, any claims for fraud, misrepresentation, breach of fiduciary duty, breach of duty under applicable state corporate law, and securities fraud under any state or federal law;

c. any and all claims for wrongful discharge of employment; termination in violation of public policy; discrimination; harassment; retaliation; breach of contract, both express and implied; any obligations under the Change of Control Agreement; any obligations under the Offer Letter; breach of covenant of good faith and fair dealing, both express and implied; promissory estoppel; negligent or intentional infliction of emotional distress; fraud; negligent or

Page 3 of 18

intentional misrepresentation; negligent or intentional interference with contract or prospective economic advantage; unfair business practices; defamation; libel; slander; negligence; personal injury; assault; battery; invasion of privacy; false imprisonment; conversion; and disability benefits;

d. any and all claims for violation of any federal, state, or municipal statute, including, but not limited to, Title VII of the Civil Rights Act of 1964; the Civil Rights Act of 1991; the Rehabilitation Act of 1973; the Americans with Disabilities Act of 1990; the Equal Pay Act; the Fair Labor Standards Act, except as prohibited by law; the Fair Credit Reporting Act; the Age Discrimination in Employment Act of 1967; the Older Workers Benefit Protection Act; the Employee Retirement Income Security Act of 1974; the Worker Adjustment and Retraining Notification Act; the Family and Medical Leave Act, except as prohibited by law; the Sarbanes-Oxley Act of 2002; the Uniformed Services Employment and Reemployment Rights Act; the California Family Rights Act; the California Labor Code, except as prohibited by law; the California Workers’ Compensation Act, except as prohibited by law; and the California Fair Employment and Housing Act;

e. any and all claims for violation of the federal or any state constitution;

f. any and all claims arising out of any other laws and regulations relating to employment or employment discrimination;

g. any claim for any loss, cost, damage, or expense arising out of any dispute over the non-withholding or other tax treatment of any of the proceeds received by Executive as a result of this Agreement; and

h. any and all claims for attorneys’ fees and costs.

Executive agrees that the release set forth in this section shall be and remain in effect in all respects as a complete general release as to the matters released. This release does not extend to any obligations incurred under this Agreement. This release does not release claims that cannot be released as a matter of law, including, but not limited to: (1) Executive’s right to file a charge with or participate in a charge by the Equal Employment Opportunity Commission, or any other local, state, or federal administrative body or government agency that is authorized to enforce or administer laws related to employment, against the Company (with the understanding that any such filing or participation does not give Executive the right to recover any monetary damages against the Company; Executive’s release of claims herein bars Executive from recovering such monetary relief from the Company); (2) claims under Division 3, Article 2 of the California Labor Code (which includes California Labor Code section 2802 regarding indemnity for necessary expenditures or losses by Executive); and (3) claims prohibited from release as set forth in California Labor Code section 206.5 (specifically “any claim or right on account of wages due, or to become due, or made as an advance on wages to be earned, unless payment of such wages has been made”).

9. Acknowledgment of Waiver of Claims under ADEA. Executive understands and acknowledges that he is waiving and releasing any rights he may have under the Age Discrimination in Employment Act of 1967 (“ADEA”), and that this waiver and release is knowing and voluntary. Executive understands and agrees that this waiver and release does not apply to any rights or claims that may arise under the ADEA after the Effective Date of this Agreement. Executive understands and acknowledges that the consideration given for this waiver and release is in addition to anything

Page 4 of 18

of value to which Executive was already entitled. Executive further understands and acknowledges that he has been advised by this writing that: (a) he should consult with an attorney prior to executing this Agreement; (b) he has twenty-one (21) days within which to consider this Agreement; (c) he has seven (7) days following his execution of this Agreement to revoke this Agreement; (d) this Agreement shall not be effective until after the revocation period has expired; and (e) nothing in this Agreement prevents or precludes Executive from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties, or costs for doing so, unless specifically authorized by federal law. In the event Executive signs this Agreement and returns it to the Company in less than the 21-day period identified above, Executive hereby acknowledges that he has freely and voluntarily chosen to waive the time period allotted for considering this Agreement.

10. California Civil Code Section 1542. Executive acknowledges that he has been advised to consult with legal counsel and is familiar with the provisions of California Civil Code Section 1542, a statute that otherwise prohibits the release of unknown claims, which provides as follows:

A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.

Executive, being aware of said code section, agrees to expressly waive any rights he may have thereunder, as well as under any other statute or common law principles of similar effect.

11. No Pending or Future Lawsuits. Executive represents that he has no lawsuits, claims, or actions pending in his name, or on behalf of any other person or entity, against the Company or any of the other Releasees. Executive also represents that he does not intend to bring any claims on his own behalf or on behalf of any other person or entity against the Company or any of the other Releasees.

12. Trade Secrets and Confidential Information/Company Property. Executive reaffirms and agrees to observe and abide by the terms of the Confidentiality Agreements, specifically including the provisions therein regarding nondisclosure of the Company’s trade secrets and confidential and proprietary information, and non-solicitation of Company Executives. Executive’s signature below constitutes his certification under penalty of perjury that he has returned all documents and other items provided to Executive by the Company, developed or obtained by Executive in connection with his employment with the Company, or otherwise belonging to the Company.

13. No Cooperation. Executive further agrees that he will not knowingly encourage, counsel, or assist any attorneys or their clients in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints by any third party against any of the Releasees, unless under a subpoena or other court order to do so or as related directly to the ADEA waiver in this Agreement. Executive agrees both to immediately notify the Company upon receipt of any such subpoena or court order, and to furnish, within three (3) business days of its receipt, a

Page 5 of 18

copy of such subpoena or other court order. If approached by anyone for counsel or assistance in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints against any of the Releasees, Executive shall state no more than that he cannot provide counsel or assistance.

14. Non-Disparagement and Communications with Company Employees, Customers and Business Partners. Executive agrees to refrain from any disparagement, defamation, libel, or slander of any of the Releasees, and agrees to refrain from any tortious interference with the contracts and relationships of any of the Releasees. Executive further agrees that he will refrain from discussing Company confidential business or financial information with third parties, including the Company’s actual and potential customers or business partners. Executive further agrees that he will not discuss the Company’s business with Company employees, customers, or business partners without the written consent of the Company’s President or his designee. Executive shall direct any inquiries by potential future employers to the Company’s human resources department, which shall use its best efforts to provide only the Executive’s last position and dates of employment.

15. Breach. Executive acknowledges and agrees that any material breach of this Agreement, unless such breach constitutes a legal action by Executive challenging or seeking a determination in good faith of the validity of the waiver herein under the ADEA, or of any provision of the Confidentiality Agreements shall entitle the Company immediately to recover and/or cease providing the consideration provided to Executive under this Agreement, except as provided by law. Except as provided by law, Executive shall also be responsible to the Company for all costs, attorneys’ fees, and any and all damages incurred by the Company in (a) enforcing Executive’s obligations under this Agreement or the Confidentiality Agreements, including the bringing of any action to recover the consideration, and (b) defending against a claim or suit brought or pursued by Executive in violation of the terms of this Agreement.

16. No Admission of Liability. Executive understands and acknowledges that this Agreement constitutes a compromise and settlement of any and all actual or potential disputed claims by Executive. No action taken by the Company hereto, either previously or in connection with this Agreement, shall be deemed or construed to be (a) an admission of the truth or falsity of any actual or potential claims or (b) an acknowledgment or admission by the Company of any fault or liability whatsoever to Executive or to any third party.

17. Non-Solicitation. Executive agrees that for a period of twelve (12) months immediately following the Effective Date of this Agreement, Executive shall not directly or indirectly solicit any of the Company’s employees to leave their employment at the Company.

18. Costs. The Parties shall each bear their own costs, attorneys’ fees, and other fees incurred in connection with the preparation of this Agreement.

19. ARBITRATION. THE PARTIES AGREE THAT ANY AND ALL DISPUTES ARISING OUT OF THE TERMS OF THIS AGREEMENT OR THE CONSULTING AGREEMENT, INCLUDING BUT NOT LIMITED TO THEIR INTERPRETATION AND ANY OF THE MATTERS HEREIN RELEASED, SHALL BE SUBJECT TO ARBITRATION IN SANTA CLARA COUNTY, BEFORE JUDICIAL ARBITRATION & MEDIATION SERVICES, INC. (“JAMS”), PURSUANT TO ITS EMPLOYMENT ARBITRATION RULES &

Page 6 of 18

PROCEDURES (“JAMS RULES”). THE ARBITRATOR MAY GRANT INJUNCTIONS AND OTHER RELIEF IN SUCH DISPUTES. THE ARBITRATOR SHALL ADMINISTER AND CONDUCT ANY ARBITRATION IN ACCORDANCE WITH CALIFORNIA LAW, INCLUDING THE CALIFORNIA CODE OF CIVIL PROCEDURE, AND THE ARBITRATOR SHALL APPLY SUBSTANTIVE AND PROCEDURAL CALIFORNIA LAW TO ANY DISPUTE OR CLAIM, WITHOUT REFERENCE TO ANY CONFLICT-OF-LAW PROVISIONS OF ANY JURISDICTION. TO THE EXTENT THAT THE JAMS RULES CONFLICT WITH CALIFORNIA LAW, CALIFORNIA LAW SHALL TAKE PRECEDENCE. THE DECISION OF THE ARBITRATOR SHALL BE FINAL, CONCLUSIVE, AND BINDING ON THE PARTIES TO THE ARBITRATION. THE PARTIES AGREE THAT THE PREVAILING PARTY IN ANY ARBITRATION SHALL BE ENTITLED TO INJUNCTIVE RELIEF IN ANY COURT OF COMPETENT JURISDICTION TO ENFORCE THE ARBITRATION AWARD. THE PARTIES TO THE ARBITRATION SHALL EACH PAY AN EQUAL SHARE OF THE COSTS AND EXPENSES OF SUCH ARBITRATION, AND EACH PARTY SHALL SEPARATELY PAY FOR ITS RESPECTIVE COUNSEL FEES AND EXPENSES; PROVIDED, HOWEVER, THAT THE ARBITRATOR SHALL AWARD ATTORNEYS’ FEES AND COSTS TO THE PREVAILING PARTY, EXCEPT AS PROHIBITED BY LAW. THE PARTIES HEREBY AGREE TO WAIVE THEIR RIGHT TO HAVE ANY DISPUTE BETWEEN THEM RESOLVED IN A COURT OF LAW BY A JUDGE OR JURY. NOTWITHSTANDING THE FOREGOING, THIS SECTION WILL NOT PREVENT EITHER PARTY FROM SEEKING INJUNCTIVE RELIEF (OR ANY OTHER PROVISIONAL REMEDY) FROM ANY COURT HAVING JURISDICTION OVER THE PARTIES AND THE SUBJECT MATTER OF THEIR DISPUTE RELATING TO THIS AGREEMENT AND THE AGREEMENTS INCORPORATED HEREIN BY REFERENCE. SHOULD ANY PART OF THE ARBITRATION AGREEMENT CONTAINED IN THIS PARAGRAPH CONFLICT WITH ANY OTHER ARBITRATION AGREEMENT BETWEEN THE PARTIES, THE PARTIES AGREE THAT THIS ARBITRATION AGREEMENT SHALL GOVERN.

20. Tax Consequences. The Company makes no representations or warranties with respect to the tax consequences of the payments and any other consideration provided to Executive or made on his behalf under the terms of this Agreement. Executive agrees and understands that he is responsible for payment, if any, of local, state, and/or federal taxes on the payments and any other consideration provided hereunder by the Company and any penalties or assessments thereon. Executive further agrees to indemnify and hold the Company harmless from any claims, demands, deficiencies, penalties, interest, assessments, executions, judgments, or recoveries by any government agency against the Company for any amounts claimed due on account of (a) Executive’s failure to pay or the Company’s failure to withhold, or Executive’s delayed payment of, federal or state taxes, or (b) damages sustained by the Company by reason of any such claims, including attorneys’ fees and costs.

2 1. Section 409A. The foregoing provisions are intended to comply with the requirements of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) and the final Treasury Regulations and any guidance promulgated thereunder (“Section 409A”) so that none of the severance payments and benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A, and any ambiguities herein will be interpreted to so comply. Executive and the Company agree to work together in good faith to consider amendments to this Agreement and to take such

Page 7 of 18

reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition prior to actual payment to Executive under Section 409A.

22. Authority. The Company represents and warrants that the undersigned has the authority to act on behalf of the Company and to bind the Company and all who may claim through it to the terms and conditions of this Agreement. Executive represents and warrants that he has the capacity to act on his own behalf and on behalf of all who might claim through him to bind them to the terms and conditions of this Agreement. Each Party warrants and represents that there are no liens or claims of lien or assignments in law or equity or otherwise of or against any of the claims or causes of action released herein.

23. No Representations. Executive represents that he has had an opportunity to consult with an attorney, and has carefully read and understands the scope and effect of the provisions of this Agreement. Executive has not relied upon any representations or statements made by the Company that are not specifically set forth in this Agreement.

24. Severability. In the event that any provision or any portion of any provision hereof or any surviving agreement made a part hereof becomes or is declared by a court of competent jurisdiction or arbitrator to be illegal, unenforceable, or void, this Agreement shall continue in full force and effect without said provision or portion of provision. Notwithstanding, to the extent the Company’s obligation to pay the Consideration provided for under Section 2 (Consideration) of this Agreement is deemed illegal, unenforceable, or void, and the Company fails to otherwise provide for the Consideration as provided, the Parties shall not remain bound by the terms of this Agreement, and it shall become null and void.

25. Attorneys’ Fees. Except with regard to a legal action challenging or seeking a determination in good faith of the validity of the waiver herein under the ADEA, in the event that either Party brings an action to enforce or effect its rights under this Agreement, the prevailing Party shall be entitled to recover its costs and expenses, including the costs of mediation, arbitration, litigation, court fees, and reasonable attorneys’ fees incurred in connection with such an action.

26. Entire Agreement. This Agreement, together with the Consulting Agreement and exhibits thereto, represent the entire agreement and understanding between the Company and Executive concerning the subject matter of this Agreement and Executive’s employment with and separation from the Company and the events leading thereto and associated therewith, and supersedes and replaces any and all prior agreements and understandings concerning the subject matter of this Agreement and Executive’s relationship with the Company, with the exception of the Confidentiality Agreements, the Equity Award Documents, and the Insider Trading Policy Acknowledgement.

27. No Oral Modification. This Agreement may only be amended in a writing signed by Executive and the Company’s Chief Executive Officer.

28. Governing Law. This Agreement shall be governed by the laws of the State of California, without regard for choice-of-law provisions. Executive consents to personal and exclusive jurisdiction and venue in the State of California.

Page 8 of 18

29. Effective Date. Each Party has seven (7) days after that Party signs this Agreement to revoke it. This Agreement will become effective on the eighth (8th) day after Executive signed this Agreement, so long as it has been signed by the Parties and has not been revoked by either Party before that date (the “Effective Date”). In the event Executive revokes, he agrees to hand deliver and advise the Company of his revocation by no later than close of business on the seventh (7th) day after Executive signed this Agreement. Executive understands that this Agreement shall be null and void if not executed by the Executive within the twenty-one (21) day period set forth under Section 9 above.

30. Counterparts. This Agreement may be executed in counterparts and by facsimile, and each counterpart and facsimile shall have the same force and effect as an original and shall constitute an effective, binding agreement on the part of each of the undersigned.

31. Voluntary Execution of Agreement. Executive understands and agrees that he executed this Agreement voluntarily, without any duress or undue influence on the part or behalf of the Company or any third party, with the full intent of releasing all of his claims against the Company and any of the other Releasees. Executive acknowledges that:

(a) He has read this Agreement;

(b) He has been represented in the preparation, negotiation, and execution of this Agreement by legal counsel of his own choice or has elected not to retain legal counsel;

(c) He understands the terms and consequences of this Agreement and of the releases it contains; and

(d) He is fully aware of the legal and binding effect of this Agreement.

IN WITNESS WHEREOF, the Parties have executed this Agreement on the respective dates set forth below.

		DR. BERTRAND CAMBOU, an individual
Dated:	2/4/09	/s/ Bertrand Cambou
		Dr. Bertrand Cambou
		SPANSION, INC.
Dated:	2/4/09	By	/s/ Robert Melendres
			Robert Melendres
			Executive Vice President and General Counsel

Page 9 of 18

EXHIBIT I

SPANSION, INC. CONSULTING AGREEMENT

This Consulting Agreement (“Agreement”) is made and entered into as of February 4, 2009 (“Effective Date”), by and between Spansion, Inc. (or “Company”), and Dr. Bertrand Cambou (“Consultant”). Company desires to retain Consultant as an independent contractor to perform consulting services for Company and Consultant is willing to perform such services, on terms set forth more fully below. In consideration of the mutual promises contained herein, the parties agree as follows:

1. SERVICES AND COMPENSATION

(a) Statements of Work. From time to time, Company and Consultant may agree on certain services to be performed under this Agreement, and in that case, shall prepare a statement of work in substantially the form set forth in Exhibit A (“Statement of Work”). Each Statement of Work, upon execution by both of the parties hereto, will be incorporated into this Agreement.

(b) Services. Consultant shall perform for Company the services (“Services”) described in each Statement of Work.

(c) Fees. The Company shall pay Consultant the compensation set forth in the applicable Statement of Work for the performance of the Services. Such fees may be on a time and materials basis, or on a milestone basis, or otherwise as agreed by the parties.

(d) Reports. Consultant also agrees that Consultant will, from time to time during the term of this Agreement or any extension thereof, keep the Company advised as to Consultant’s progress in performing the Services under this Agreement. Consultant further agrees that Consultant will, as requested by the Company, prepare written reports with respect to such progress. The Company and Consultant agree that the time required to prepare such written reports will be considered time devoted to the performance of the Services.

2. CONFIDENTIALITY

(a) Definition. “Confidential Information” means any Company proprietary information, technical data, trade secrets or know-how, including, but not limited to, research, product plans, products, services, customers, customer lists, markets, software, developments, inventions, processes, formulas, technology, designs, drawings, engineering, hardware configuration information, marketing, finances or other business information disclosed by Company either directly or indirectly in writing, orally or by drawings or inspection of parts or equipment.

(b) Non-Use and Non-Disclosure. Consultant shall not, during or subsequent to the term of this Agreement, use Company’s Confidential Information for any purpose whatsoever other than the performance of the Services on behalf of Company or disclose Company’s Confidential Information to any third party. It is understood that said Confidential Information will remain the sole property of Company. Consultant further shall take all reasonable precautions to prevent any unauthorized disclosure of such Confidential Information. Confidential Information does not include information which: (1) is known to Consultant at the time of disclosure to Consultant by Company, as evidenced by written records of Consultant; (2) has become publicly known and made

Page 10 of 18

generally available through no wrongful act of Consultant; or (3) has been rightfully received by Consultant from a third party who is authorized to make such disclosure. Without Company’s prior written approval, Consultant shall not directly or indirectly disclose to anyone the existence of this Agreement or the fact that Consultant has this arrangement with Company.

(c) Former Employer’s or Client’s Confidential Information. Consultant agrees that Consultant shall not, during the term of this Agreement, improperly use or disclose any proprietary information or trade secrets of any former or current employer or other person or entity with which Consultant has an agreement or duty to keep in confidence information acquired by Consultant, if any, and that Consultant shall not bring onto the premises of Company any unpublished document or proprietary information belonging to such employer, person or entity unless consented to in writing by such employer, person or entity. Consultant shall indemnify and hold Company harmless from and against all claims, liabilities, damages and expenses, including reasonable attorneys’ fees and costs of suit, arising out of or in connection with any violation or claimed violation of a third party’s rights resulting in whole or in part from Company’s use of the work product of Consultant under this Agreement.

(d) Third Party Confidential Information. Consultant recognizes that Company has received and in the future will receive from third parties their confidential or proprietary information subject to a duty on Company’s part to maintain the confidentiality of such information and to use it only for certain limited purposes. Consultant agrees that Consultant owes Company and such third parties, during the term of this Agreement and thereafter, a duty to hold all such confidential or proprietary information in the strictest confidence and not to disclose it to any person, fm or corporation or to use it except as necessary in carrying out the Services for Company consistent with Company’s agreement with such third party.

(e) Return of Materials. Upon the termination of this Agreement, or upon Company’s earlier request, Consultant shall deliver to Company all of Company’s property or Confidential Information that Consultant may have in Consultant’s possession or control.

3. OWNERSHIP

(a) Assignment. Consultant agrees that all copyrightable material, notes, records, drawings, designs, inventions, improvements, developments, discoveries and trade secrets conceived, made or discovered by Consultant, solely or in collaboration with others, during the term of this Agreement which relate in any manner to the business of Company that Consultant may be directed to undertake, investigate or experiment with, or which Consultant may become associated with in work, investigation or experimentation in the line of business of Company in performing the Services hereunder (collectively, “Work Product”), are the sole property of Company. Consultant further shall assign (or cause to be assigned) and does hereby assign fully to Company all Work Product and any copyrights, patents, mask work rights or other intellectual property rights relating thereto.

(b) Further Assurances. Consultant shall assist Company, or its designee, at Company’s expense, in every proper way to secure Company’s rights in the Work Product and any copyrights, patents, mask work rights or other intellectual property rights relating thereto in any and all countries, including the disclosure to Company of all pertinent information and data with respect

Page 11 of 18

thereto, the execution of all applications, specifications, oaths, assignments and all other instruments that Company deems necessary in order to apply for and obtain such rights and in order to assign and convey to Company, its successors, assigns and nominees the sole and exclusive right, title and interest in and to such Work Product, and any copyrights, patents, mask work rights or other intellectual property rights relating thereto. Consultant further agrees that Consultant’s obligation to execute or cause to be executed, when it is in Consultant’s power to do so, any such instrument or papers will continue after the termination of this Agreement.

(c) Pre-Existing Materials. Consultant agrees that if in the course of performing the Services, Consultant incorporates into any Invention developed hereunder any invention, improvement, development, concept, discovery or other proprietary information owned by Consultant or in which Consultant has an interest, (1) Consultant shall inform Company, in writing before incorporating such invention, improvement, development, concept, discovery or other proprietary information into any Invention; and (2) Company is hereby granted and shall have a nonexclusive, royalty-free, perpetual, irrevocable, worldwide license to make, have made, modify, use and sell such item as part of or in connection with such Invention. Consultant shall not incorporate any invention, improvement, development, concept, discovery or other proprietary information owned by any third party into any Invention without Company’s prior written permission.

(d) Attorney in Fact. Where Company is unable because of Consultant’s unavailability, dissolution, mental or physical incapacity, or for any other reason, to secure Consultant’s signature to apply for or to pursue any application for any United States or foreign patents or mask work or copyright registrations covering the Work Product assigned to Company above, then Consultant hereby irrevocably designates and appoints Company and its duly authorized officers and agents as Consultant’s agent and attorney in fact, to act for and in Consultant’s behalf and stead to execute and file any such applications and to do all other lawfully permitted acts to further the prosecution and issuance of patents, copyright and mask work registrations thereon with the same legal force and effect as if executed by Consultant.

(e) Warranty. Consultant hereby represents and warrants that: (1) all Work Product will be the original work of Consultant; (2) the Work Product will not infringe the copyright, patent, trade secret, or any other intellectual property right of any third party; (3) the Work Product will not be obscene, libelous, or violate the right of privacy or publicity of any third party; (4) the Work Product will not contain any virus, trap door, worm, or any other device that is injurious or damaging to software or hardware used in conjunction with the Work Product; (5) any software or data portions of the Work Product will operate correctly and consistently; and (6) Company shall retain and own all right, title and interest in and to all Work Product and any information delivered and/or shared hereunder.

4. CONFLICTING OBLIGATIONS

(a) Conflicts. Consultant certifies that Consultant has no outstanding agreement or obligation that is in conflict with any of the provisions of this Agreement, or that would preclude Consultant from complying with the provisions hereof, and further certifies that Consultant will not enter into any such conflicting agreement during the term of this Agreement.

Page 12 of 18

(b) Duty of Non-Competition During Consulting Term. Consultant explicitly agrees that during the term of this Agreement that he shall not, other than on behalf of the Company or with the prior written consent of the Company, (i) serve as a partner, employee, independent contractor, consultant, advisor, officer, director, proprietor, manager, agent, associate, or (ii) directly or indirectly own (except for passive ownership of one percent (1%) or less of any entity whose securities have been registered under the Securities Act of 1933 or Section 12 of the Securities Exchange Act of 1934), purchase, invest in, organize, or take preparatory steps for the organization of, or (iii) directly or indirectly build, design, finance, acquire, lease, control, operate, manage, invest in, work, consult for, or otherwise affiliate with, any firm, partnership, corporation, entity or business that engages or participates in any business in direct or indirect competition with the Company’s business. Consultant represents that he (i) is familiar with the foregoing covenant not to compete, (ii) is fully aware of his obligations hereunder, and (iii) acknowledges the reasonableness and necessity of this covenant, including the reasonableness in duration and scope, as necessary for the Company to avoid the actual or threatened misappropriation of the Company’s trade secrets and confidential information.

(c) Substantially Similar Designs. In view of Consultant’s access to the Company’s trade secrets and proprietary know-how, Consultant agrees that Consultant will not, without the Company’s prior written approval, design identical or substantially similar designs as those developed under this Agreement for any third party during the term of this Agreement and for a period of 12 months after the termination of this Agreement. Consultant acknowledges that the obligations in Section 4 are ancillary to Consultant’s nondisclosure obligations under Section 2.

5. TERM AND TERMINATION

(a) Term. This Agreement will commence on the Effective Date and will continue until the earlier of: (1) final completion of the Services, (2) the 4 month anniversary of the Effective Date, or (3) termination as provided below (the “Consulting Term”).

(b) Termination. Either party may terminate this Agreement or any Statement of Work without cause upon giving one (1) weeks prior written notice thereof to the other party in accordance with Section 6 (e) of this Agreement. If a party terminates this Agreement under the prior sentence, Company shall pay to Consultant the fees for any Services performed before the effective date of termination on a time and materials basis. If the fees for the applicable Statement of Work are paid on a milestone basis, such fees will not exceed the amount associated with the next uncompleted milestone. Company may terminate this Agreement immediately and without prior notice if Consultant refuses to or is unable to perform the Services, and either party may terminate this Agreement immediately and without prior written notice if the other party is in breach of any material provision of this Agreement. Any post-terminations payments to Consultant provided herein may be subject to reductions as provided under Section 5 (d) of this Agreement.

(c) Survival. Upon such termination all rights and duties of the parties toward each other will cease except:

(i) Company shall pay, within 30 days after the effective date of termination, all amounts owing to Consultant for Services completed and accepted by Company

Page 13 of 18

prior to the termination date and related expenses, if any, in accordance with the provisions of Section 1 (Services and Compensation); and

(ii) Sections 2 (Confidentiality), 3 (Ownership), 4 (Conflicting Obligations), 5 (Term and Termination), and 6 (Miscellaneous) will survive termination of this Agreement, as will the entirety of the Separation Agreement and Release entered into by the parties as of February 2009.

(d) Supplemental Release. Upon the completion of the Consulting Term, Consultant agrees to execute the Supplemental Release attached hereto as Exhibit B (“Supplemental Release”). Consultant agrees that his failure to execute and return the Supplemental Release within five (5) business days of the end of the Consulting Term shall entitle the Company to immediately recover and/or cease providing the equivalent of one (1) month’s compensation, as provided under this Agreement. Consultant further agrees that he shall be responsible to the Company for all costs, attorneys’ fees, and any and all damages incurred by the Company in the bringing of any action to recover said compensation.

6. MISCELLANEOUS

(a) Services and Information Prior to Effective Date. All Services performed by Consultant and all information and other materials disclosed between the parties prior to the Effective Date shall be governed by the terms of this Agreement, except where those Services are covered by a separate consulting agreement between Consultant and Company.

(b) Nonassignment/Binding Agreement. The parties acknowledge that the unique nature of Consultant’s services is substantial consideration for the parties’ entering into this Agreement. Neither this Agreement nor any rights under this Agreement may be assigned or otherwise transferred by Consultant, in whole or in part, whether voluntarily or by operation of law, without the prior written consent of Company, which consent will not be unreasonably withheld. Subject to the foregoing, this Agreement will be binding upon and will inure to the benefit of the parties and their respective successors and assigns. Any assignment in violation of the foregoing will be null and void.

(c) Nonsolicitation. From the date of this Agreement until 12 months after the termination of this Agreement (the “Restricted Period”), Consultant will not, without the Company’s prior written consent, directly or indirectly solicit any of the Company’s employees to leave their employment at the Company.

(d) Indemnity. Consultant agrees to indemnify and hold harmless the Company and its directors, officers and employees from and against all taxes, losses, damages, liabilities, costs and expenses, including attorneys’ fees and other legal expenses, arising directly or indirectly from or in connection with (i) any negligent, reckless or intentionally wrongful act of Consultant or Consultant’s assistants, employees or agents, (ii) a determination by a court or agency that the Consultant or any of Consultant’s assistants, employees or agents is not an independent contractor with respect to the Company, (iii) any breach by the Consultant or Consultant’s assistants, employees or agents of any of the covenants contained in this Agreement, (iv) any failure of Consultant to perform the Services in accordance with all applicable laws, rules and regulations, or

Page 14 of 18

(v) any violation or claimed violation of a third party’s rights resulting in whole or in part from the Company’s use of the work product of Consultant under this Agreement.

(e) Notices. Any notice required or permitted under the terms of this Agreement or required by law must be in writing and must be (a) delivered in person, (b) sent by first class registered mail, or air mail, as appropriate, or (c) sent by overnight air courier, in each case properly posted and fully prepaid to the appropriate address as set forth in this Agreement. Either party may change its address for notices by notice to the other party given in accordance with this Section. Notices will be deemed given at the time of actual delivery in person, three (3) business days after deposit in the mail as set forth above, or one (1) day after delivery to an overnight air courier service.

(f) Waiver. Any waiver of the provisions of this Agreement or of a party’s rights or remedies under this Agreement must be in writing to be effective. Failure, neglect, or delay by a party to enforce the provisions of this Agreement or its rights or remedies at any time, will not be construed as a waiver of such party’s rights under this Agreement and will not in any way affect the validity of the whole or any part of this Agreement or prejudice such party’s right to take subsequent action. No exercise or enforcement by either party of any right or remedy under this Agreement will preclude the enforcement by such party of any other right or remedy under this Agreement or that such party is entitled by law to enforce.

(g) Severability. If any term, condition, or provision in this Agreement is found to be invalid, unlawful or unenforceable to any extent, the parties shall endeavor in good faith to agree to such amendments that will preserve, as far as possible, the intentions expressed in this Agreement. If the parties fail to agree on such an amendment, such invalid term, condition or provision will be severed from the remaining terms, conditions and provisions, which will continue to be valid and enforceable to the fullest extent permitted by law. Notwithstanding, to the extent the Company’s obligation to pay the compensation provided for under this Agreement is found to be invalid, unlawful or unenforceable, and the Parties fail in good faith to agree to an amendment that preserves, as far as possible, the intentions expressed in this Agreement, the Parties shall not be further bound by the remaining terms, conditions or provisions of this Agreement.

(h) Integration. This Agreement, all Statements of Work, the Supplemental Release, and the Separation Agreement and Release agreed to by the Parties in February 2009 contain the entire agreement of the parties with respect to the subject matter of this Agreement and supersede all previous communications, representations, understandings and agreements, either oral or written, between the parties with respect to said subject matter. No terms, provisions or conditions of any purchase order, acknowledgement or other business form that either party may use in connection with the transactions contemplated by this Agreement will have any effect on the rights, duties or obligations of the parties under, or otherwise modify, this Agreement, regardless of any failure of a receiving party to object to such terms, provisions or conditions. This Agreement may not be amended, except by a writing signed by both parties.

(i) Confidentiality of Agreement. Consultant shall not disclose any terms of this Agreement to any third party if such disclosure is without the consent of Company, except as required by securities or other applicable laws.

Page 15 of 18

(j) Counterparts. This Agreement may be executed in counterparts, each of which so executed will be deemed to be an original and such counterparts together will constitute one and the same agreement.

(k) Governing Law. This Agreement will be interpreted and construed in accordance with the laws of the State of California and the United States of America, without regard to conflict of law principles.

(l) Independent Contractor. It is the express intention of the parties that Consultant is an independent contractor. Nothing in this Agreement, including the election of the Rules in the arbitration provision, will in any way be construed to constitute Consultant as an agent, employee or representative of Company, but Consultant shall perform the Services hereunder as an independent contractor. Without limiting the generality of the foregoing, Consultant is not authorized to bind the Company to any liability or obligation or to represent that Consultant has any such authority. Consultant shall furnish (or reimburse Company for) all tools and materials necessary to accomplish this contract, and will incur all expenses associated with performance, except as expressly provided on the applicable Statement of Work. Consultant acknowledges and agrees that Consultant is obligated to report as income all compensation received by Consultant pursuant to this Agreement, and Consultant acknowledges its obligation to pay all self-employment and other taxes thereon.

(m) Benefits. Consultant acknowledges that Consultant will receive no Company-sponsored benefits from Company either as a Consultant or employee, where benefits include without limitation paid vacation, sick leave, medical insurance, welfare plan, and retirement plan and 401(k) plan participation. If Consultant is reclassified by a state or federal agency or court as an employee, Consultant will become a reclassified employee and will receive no benefits, even if, by the terms of Company’s benefit plans in effect at the time of such reclassification, Consultant would otherwise be eligible for such benefits.

(n) Attorney’s Fees. In any court action at law or equity which is brought by one of the parties to enforce or interpret the provisions of this Agreement, the prevailing party will be entitled to reasonable attorney’s fees, in addition to any other relief to which that party may be entitled.

The parties have executed this Agreement below to indicate their acceptance of its terms.

DR. BERTRAND CAMBOU		SPANSION, INC.
By:	/s/ Bertrand F. Cambou	By:	/s/ Robert Melendres
Print Name:	Dr. Bertrand Cambou	Print Name:	Robert Melendres
Title:	Consultant	Title:	Executive VP & General Counsel
Address:	[address]

Page 16 of 18

EXHIBIT A – STATEMENT OF WORK

Statement of Work with Milestone Schedule

Services to be performed by Consultant:

• [Services to be performed by Consultant]

• [Services to be performed by Consultant]

• [Services to be performed by Consultant]

Terms and Conditions:

• [Terms and Conditions]

• [Terms and Conditions]

Deliverables and Milestone Schedule

Consultant shall perform the tasks assigned by Company (each a “Milestone”) in accordance with the following schedule indicating each deliverable item of work product (“Deliverable”), and the associated due date and payment.

MILESTONE SCHEDULE

Deliverable	Due Date	Payment
[Deliverable	Due Date	Payment]
[Deliverable	Due Date	Payment]

Compensation of Consultant:

Consultant may revise these rates from time to time but shall give Company 30 days prior written notice of any such revision.

(a) Rate of pay: $31,303.12 per month

(b) Total payment limitation: $125,212.48

(c) Advance payment: $0

(d) Expenses authorized for reimbursement by Company:                     

(e) Other:                                                                                                   

(f) Expected duration of project: four (4) months                                  

DR. BERTRAND CAMBOU		SPANSION, INC.
By:	/s/ Dr. Bertrand Cambou	By:	/s/ Robert Melendres
Print Name:	Dr. Bertrand Cambou	Print Name:	Robert Melendres
Title:	Consultant	Title:	Executive VP & General Counsel

Page 17 of 18

EXHIBIT B – SUPPLEMENTAL RELEASE

In consideration for the mutual promises and consideration provided both herein and in the Separation Agreement and Release, dated February 4, 2009 (the “Agreement”) between Dr. Bertrand Cambou and Spansion, Inc. (collectively, the “Parties”), the Parties hereby extend such release and waiver to any claims that may have arisen between the Effective Date and Dr. Cambou’s signature date, below.

The undersigned Parties further acknowledge that the terms of Sections 6, 8, and 19 of the Agreement shall apply to this Supplemental Release and are incorporated herein.

IN WITNESS WHEREOF, the Parties have executed this Agreement on the respective dates set forth below.

		DR. BERTRAND CAMBOU, an individual
Dated:	2/4/09	/s/ Bertrand F.Cambou
		Dr. Bertrand Cambou
		SPANSION, INC.
Dated:	2/4/09	By	/s/ Robert Melendres
			Robert Melendres
			Executive Vice President and General Counsel

Page 18 of 18

EX-10.8(B)

Exhibit 10.8(b)

SEPARATION AGREEMENT AND RELEASE

This Separation Agreement and Release (“Agreement”) is made by and between Robert C. Melendres (“Executive”) and Spansion, Inc. (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”).

RECITALS

WHEREAS, Executive was employed by the Company as its Executive Vice President, Corporate Development, Chief Legal Officer and Corporate Secretary, pursuant to employment terms set forth in an offer letter signed by Executive on January 4, 2005 the “Offer Letter”);

WHEREAS, Executive signed an agreement dated July 18, 2002 with Advanced Micro Devices, Inc. and a Spansion LLC Agreement with the Company on January 1, 2005 (collectively, the “Confidentiality Agreements”);

WHEREAS, Executive signed an acknowledgement agreeing to abide by the Spansion Inc. Insider Trading Policy (the “Insider Trading Policy Acknowledgement”);

WHEREAS, Executive agreed to a Change of Control Severance Agreement with the Company on March 2006, and further agreed to an amendment to such agreement by signing an Amended and Restated Spansion Inc. Change of Control Severance Agreement on November 2007 (collectively, the “Change of Control Agreement”), the conditions of which have not been triggered and under which the Company owes no further duties or obligations to Executive, and which is wholly superseded and voided by this Agreement;

WHEREAS, Executive separated from employment with the Company effective April 6, 2009 at 5:00 p.m. PST (the “Separation Date”); and

WHEREAS, the Parties wish to resolve any and all disputes, claims, complaints, grievances, charges, actions, petitions, and demands that the Executive may have against the Company and any of the Releasees as defined below, including, but not limited to, any and all claims arising out of or in any way related to Executive’s employment with or separation from the Company;

NOW, THEREFORE, in consideration of the mutual promises made herein, the Company and Executive hereby agree as follows:

COVENANTS

1. Resignation. Executive resigned his employment with the Company effective as of April 6, 2009 at 5:00 p.m. PST. In connection with said resignation from employment Executive also agreed to execute any necessary forms or other documents required to effect such resignation as a matter of state or federal law.

2. Consideration. The Company agrees to pay Executive a lump sum equivalent to six (6) months of Executive’s base salary, for a total of Two hundred eighteen thousand seven hundred Dollars and Zero Cents (218,700.00), less applicable withholding. This lump sum payment will be made to Executive on the Effective Date of this Agreement. Executive acknowledges and agrees

that the consideration provided to him hereunder fully satisfies any obligation that the Company had to pay Executive wages or any other compensation for any of the services that Executive rendered to the Company, that the amount paid is in excess of any disputed wage claim, if any, that Executive may have. To the extent any wage dispute exists, Executive specifically acknowledges that the consideration paid shall be deemed to be paid first in satisfaction of any disputed wage claim with the remainder sufficient to act as consideration for the release of claims set forth herein, and that Executive has not earned and is not entitled to receive any additional wages or other form of compensation from the Company.

3. Stock. The Parties agree that Executive will be considered to have vested in his stock options, restricted stock units and any other equity awards up to the Separation Date, and no more. Each of Executive’s equity awards shall continue to be governed by the terms and conditions (including, but not limited to, with respect to the exercise of vested stock options) of the applicable Company equity plan under which the award was granted and applicable equity award agreement (each an “Equity Award Document,” and together, the “Equity Award Documents”).

4. Benefits. Executive’s health insurance benefits shall cease on the last day of April 2009, subject to Executive’s right to continue his group health insurance coverage at his own expense under Title X of the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), whereby Executive shall pay one hundred percent (100%) of premium amount plus a two percent (2%) administrative fee for continued group health insurance coverage. Executive’s participation in all benefits and incidents of employment, including, but not limited to, vesting in stock options, and the accrual of bonuses, vacation, and paid time off, ceased as of the Separation Date.

5. Payment of Salary and Receipt of All Benefits. Executive acknowledges and represents that, other than the consideration set forth in this Agreement, the Company has paid or provided all salary, wages, bonuses, accrued vacation/paid time off, leave, housing allowances, relocation costs, interest, severance, outplacement costs, fees, reimbursable expenses, commissions, stock, stock options, vesting, and any and all other benefits and compensation due to Executive. Executive further acknowledges and represents that he has received any leave to which he was entitled or which he requested, if any, under the California Family Rights Act and/or the Family Medical Leave Act, and that he did not sustain any workplace injury, during his employment with the Company.

6. Release of Claims. Executive agrees that the foregoing consideration represents settlement in full of all outstanding obligations owed to Executive by the Company and its current and former officers, directors, Executives, agents, investors, attorneys, shareholders, administrators, affiliates, benefit plans, plan administrators, insurers, divisions, and subsidiaries, and predecessor and successor corporations and assigns (collectively, the “Releasees”). Executive, on his own behalf and on behalf of his respective heirs, family members, executors, agents, and assigns, hereby and forever releases the Releasees from, and agrees not to sue concerning, or in any manner to institute, prosecute, or pursue, any claim, complaint, charge, duty, obligation, or cause of action relating to any matters of any kind, whether presently known or unknown, suspected or unsuspected, that Executive may possess against any of the Releasees arising from any omissions, acts, facts, or damages that have occurred up until and including the Effective Date of this Agreement, including, without limitation:

a. any and all claims relating to or arising from Executive’s employment relationship with the Company and the termination of that relationship;

Page 2 of 8

b. any and all claims relating to, or arising from, Executive’s right to purchase, or actual purchase of shares of stock of the Company, including, without limitation, any claims for fraud, misrepresentation, breach of fiduciary duty, breach of duty under applicable state corporate law, and securities fraud under any state or federal law;

c. any and all claims for wrongful discharge of employment; termination in violation of public policy; discrimination; harassment; retaliation; breach of contract, both express and implied; any obligations under the Change of Control Agreement; any obligations under the Offer Letter; breach of covenant of good faith and fair dealing, both express and implied; promissory estoppel; negligent or intentional infliction of emotional distress; fraud; negligent or intentional misrepresentation; negligent or intentional interference with contract or prospective economic advantage; unfair business practices; defamation; libel; slander; negligence; personal injury; assault; battery; invasion of privacy; false imprisonment; conversion; and disability benefits;

d. any and all claims for violation of any federal, state, or municipal statute, including, but not limited to, Title VII of the Civil Rights Act of 1964; the Civil Rights Act of 1991; the Rehabilitation Act of 1973; the Americans with Disabilities Act of 1990; the Equal Pay Act; the Fair Labor Standards Act, except as prohibited by law; the Fair Credit Reporting Act; the Age Discrimination in Employment Act of 1967; the Older Workers Benefit Protection Act; the Employee Retirement Income Security Act of 1974; the Worker Adjustment and Retraining Notification Act; the Family and Medical Leave Act, except as prohibited by law; the Sarbanes-Oxley Act of 2002; the Uniformed Services Employment and Reemployment Rights Act; the California Family Rights Act; the California Labor Code, except as prohibited by law; the California Workers’ Compensation Act, except as prohibited by law; and the California Fair Employment and Housing Act;

e. any and all claims for violation of the federal or any state constitution;

f. any and all claims arising out of any other laws and regulations relating to employment or employment discrimination;

g. any claim for any loss, cost, damage, or expense arising out of any dispute over the non-withholding or other tax treatment of any of the proceeds received by Executive as a result of this Agreement; and

h. any and all claims for attorneys’ fees and costs.

Executive agrees that the release set forth in this section shall be and remain in effect in all respects as a complete general release as to the matters released. This release does not extend to any obligations incurred under this Agreement. This release does not release claims that cannot be released as a matter of law, including, but not limited to: (1) Executive’s right to file a charge with or participate in a charge by the Equal Employment Opportunity Commission, or any other local, state, or federal administrative body or government agency that is authorized to enforce or administer laws related to employment, against the Company (with the understanding that any such filing or participation does not give Executive the right to recover any monetary damages against the

Page 3 of 8

Company; Executive’s release of claims herein bars Executive from recovering such monetary relief from the Company); (2) claims under Division 3, Article 2 of the California Labor Code (which includes California Labor Code section 2802 regarding indemnity for necessary expenditures or losses by Executive); and (3) claims prohibited from release as set forth in California Labor Code section 206.5 (specifically “any claim or right on account of wages due, or to become due, or made as an advance on wages to be earned, unless payment of such wages has been made”).

7. Acknowledgment of Waiver of Claims under ADEA. Executive understands and acknowledges that he is waiving and releasing any rights he may have under the Age Discrimination in Employment Act of 1967 (“ADEA”), and that this waiver and release is knowing and voluntary. Executive understands and agrees that this waiver and release does not apply to any rights or claims that may arise under the ADEA after the Effective Date of this Agreement. Executive understands and acknowledges that the consideration given for this waiver and release is in addition to anything of value to which Executive was already entitled. Executive further understands and acknowledges that he has been advised by this writing that: (a) he should consult with an attorney prior to executing this Agreement; (b) he has twenty-one (21) days within which to consider this Agreement; (c) he has seven (7) days following his execution of this Agreement to revoke this Agreement; (d) this Agreement shall not be effective until after the revocation period has expired; and (e) nothing in this Agreement prevents or precludes Executive from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties, or costs for doing so, unless specifically authorized by federal law. In the event Executive signs this Agreement and returns it to the Company in less than the 21-day period identified above, Executive hereby acknowledges that he has freely and voluntarily chosen to waive the time period allotted for considering this Agreement.

8. California Civil Code Section 1542. Executive acknowledges that he has been advised to consult with legal counsel and is familiar with the provisions of California Civil Code Section 1542, a statute that otherwise prohibits the release of unknown claims, which provides as follows:

A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.

Executive, being aware of said code section, agrees to expressly waive any rights he may have thereunder, as well as under any other statute or common law principles of similar effect.

9. No Pending or Future Lawsuits. Executive represents that he has no lawsuits, claims, or actions pending in his name, or on behalf of any other person or entity, against the Company or any of the other Releasees. Executive also represents that he does not intend to bring any claims on his own behalf or on behalf of any other person or entity against the Company or any of the other Releasees.

10. Trade Secrets and Confidential Information/Company Property. Executive reaffirms and agrees to observe and abide by the terms of the Confidentiality Agreements, specifically

Page 4 of 8

including the provisions therein regarding nondisclosure of the Company’s trade secrets and confidential and proprietary information, and non-solicitation of Company Executives. Executive’s signature below constitutes his certification under penalty of perjury that he has returned all documents and other items provided to Executive by the Company, developed or obtained by Executive in connection with his employment with the Company, or otherwise belonging to the Company.

11. No Cooperation. Executive further agrees that he will not knowingly encourage, counsel, or assist any attorneys or their clients in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints by any third party against any of the Releasees, unless under a subpoena or other court order to do so or as related directly to the ADEA waiver in this Agreement. Executive agrees both to immediately notify the Company upon receipt of any such subpoena or court order, and to furnish, within three (3) business days of its receipt, a copy of such subpoena or other court order. If approached by anyone for counsel or assistance in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints against any of the Releasees, Executive shall state no more than that he cannot provide counsel or assistance.

12. Non-Disparagement and Communications with Company Employees, Customers and Business Partners. Executive agrees to refrain from any disparagement, defamation, libel, or slander of any of the Releasees, and agrees to refrain from any tortious interference with the contracts and relationships of any of the Releasees. Executive further agrees that he will refrain from discussing Company confidential business or financial information with third parties, including the Company’s actual and potential customers or business partners. Executive further agrees that he will not discuss the Company’s business with Company employees, customers, or business partners without the written consent of the Company’s President or his designee. Executive shall direct any inquiries by potential future employers to the Company’s human resources department, which shall use its best efforts to provide only the Executive’s last position and dates of employment.

13. Breach. Executive acknowledges and agrees that any material breach of this Agreement, unless such breach constitutes a legal action by Executive challenging or seeking a determination in good faith of the validity of the waiver herein under the ADEA, or of any provision of the Confidentiality Agreements shall entitle the Company immediately to recover and/or cease providing the consideration provided to Executive under this Agreement, except as provided by law. Except as provided by law, Executive shall also be responsible to the Company for all costs, attorneys’ fees, and any and all damages incurred by the Company in (a) enforcing Executive’s obligations under this Agreement or the Confidentiality Agreements, including the bringing of any action to recover the consideration, and (b) defending against a claim or suit brought or pursued by Executive in violation of the terms of this Agreement.

14. No Admission of Liability. Executive understands and acknowledges that this Agreement constitutes a compromise and settlement of any and all actual or potential disputed claims by Executive. No action taken by the Company hereto, either previously or in connection with this Agreement, shall be deemed or construed to be (a) an admission of the truth or falsity of any actual or potential claims or (b) an acknowledgment or admission by the Company of any fault or liability whatsoever to Executive or to any third party.

Page 5 of 8

15. Non-Solicitation. Executive agrees that for a period of twelve (12) months immediately following the Effective Date of this Agreement, Executive shall not directly or indirectly solicit any of the Company’s employees to leave their employment at the Company.

16. Costs. The Parties shall each bear their own costs, attorneys’ fees, and other fees incurred in connection with the preparation of this Agreement.

17. Tax Consequences. The Company makes no representations or warranties with respect to the tax consequences of the payments and any other consideration provided to Executive or made on his behalf under the terms of this Agreement. Executive agrees and understands that he is responsible for payment, if any, of local, state, and/or federal taxes on the payments and any other consideration provided hereunder by the Company and any penalties or assessments thereon. Executive further agrees to indemnify and hold the Company harmless from any claims, demands, deficiencies, penalties, interest, assessments, executions, judgments, or recoveries by any government agency against the Company for any amounts claimed due on account of (a) Executive’s failure to pay or the Company’s failure to withhold, or Executive’s delayed payment of, federal or state taxes, or (b) damages sustained by the Company by reason of any such claims, including attorneys’ fees and costs.

18. Section 409A. The foregoing provisions are intended to comply with the requirements of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) and the final Treasury Regulations and any guidance promulgated thereunder (“Section 409A”) so that none of the severance payments and benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A, and any ambiguities herein will be interpreted to so comply. Executive and the Company agree to work together in good faith to consider amendments to this Agreement and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition prior to actual payment to Executive under Section 409A.

19. Authority. The Company represents and warrants that the undersigned has the authority to act on behalf of the Company and to bind the Company and all who may claim through it to the terms and conditions of this Agreement. Executive represents and warrants that he has the capacity to act on his own behalf and on behalf of all who might claim through him to bind them to the terms and conditions of this Agreement. Each Party warrants and represents that there are no liens or claims of lien or assignments in law or equity or otherwise of or against any of the claims or causes of action released herein.

20. No Representations. Executive represents that he has had an opportunity to consult with an attorney, and has carefully read and understands the scope and effect of the provisions of this Agreement. Executive has not relied upon any representations or statements made by the Company that are not specifically set forth in this Agreement.

21. Severability. In the event that any provision or any portion of any provision hereof or any surviving agreement made a part hereof becomes or is declared by a court of competent jurisdiction or arbitrator to be illegal, unenforceable, or void, this Agreement shall continue in full force and effect without said provision or portion of provision. Notwithstanding, to the extent the Company’s obligation to pay the Consideration provided for under Section 2 (Consideration) of this Agreement is deemed illegal, unenforceable, or void, and the Company fails to otherwise provide for the Consideration as provided, the Parties shall not remain bound by the terms of this Agreement, and it shall become null and void.

Page 6 of 8

22. Attorneys’ Fees. Except with regard to a legal action challenging or seeking a determination in good faith of the validity of the waiver herein under the ADEA, in the event that either Party brings an action to enforce or effect its rights under this Agreement, the prevailing Party shall be entitled to recover its costs and expenses, including the costs of mediation, arbitration, litigation, court fees, and reasonable attorneys’ fees incurred in connection with such an action.

23. Entire Agreement. This Agreement represents the entire agreement and understanding between the Company and Executive concerning the subject matter of this Agreement and Executive’s employment with and separation from the Company and the events leading thereto and associated therewith, and supersedes and replaces any and all prior agreements and understandings concerning the subject matter of this Agreement and Executive’s relationship with the Company, with the exception of the Confidentiality Agreements, the Equity Award Documents, and the Insider Trading Policy Acknowledgement.

24. No Oral Modification. This Agreement may only be amended in a writing signed by Executive and the Company’s Chief Executive Officer.

25. Governing Law. This Agreement shall be governed by the laws of the State of California, without regard for choice-of-law provisions. Executive consents to personal and exclusive jurisdiction and venue in the State of California.

26. Effective Date. Each Party has seven (7) days after that Party signs this Agreement to revoke it. This Agreement will become effective on the eighth (8th) day after Executive signed this Agreement, so long as it has been signed by the Parties and has not been revoked by either Party before that date (the “Effective Date”). In the event Executive revokes, he agrees to hand deliver and advise the Company of his revocation by no later than close of business on the seventh (7th) day after Executive signed this Agreement. Executive understands that this Agreement shall be null and void if not executed by the Executive within the twenty-one (21) day period set forth under Section 9 above.

27. Counterparts. This Agreement may be executed in counterparts and by facsimile, and each counterpart and facsimile shall have the same force and effect as an original and shall constitute an effective, binding agreement on the part of each of the undersigned.

28. Voluntary Execution of Agreement. Executive understands and agrees that he executed this Agreement voluntarily, without any duress or undue influence on the part or behalf of the Company or any third party, with the full intent of releasing all of his claims against the Company and any of the other Releasees. Executive acknowledges that:

(a) He has read this Agreement;

(b) He has been represented in the preparation, negotiation, and execution of this Agreement by legal counsel of his own choice or has elected not to retain legal counsel;

Page 7 of 8

(c) He understands the terms and consequences of this Agreement and of the releases it contains; and

(d) He is fully aware of the legal and binding effect of this Agreement.

IN WITNESS WHEREOF, the Parties have executed this Agreement on the respective dates set forth below.

	ROBERT C. MELENDRES, an individual
Dated: April 7, 2009	/s/ Robert C. Melendres
	Robert C. Melendres
	SPANSION, INC.
Dated: April 7, 2009	By	/s/ John Kispert
		John Kispert
		President and CEO

Page 8 of 8

EX-10.13(B)

Exhibit 10.13(b)

PERSONAL LEAVE AGREEMENT AND RELEASE

This Personal Leave Agreement and Release (“Agreement”) is made by and between Dario Sacomani (“Executive”) and Spansion Inc. (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”).

RECITALS

WHEREAS, Executive was employed by the Company as its Executive Vice President and Chief Financial Officer, pursuant to employment terms set forth in an offer letter signed by Executive on February 28, 2006 (the “Offer Letter”);

WHEREAS, Executive signed a confidentiality agreement with the Company on March 9, 2006 (the “Confidentiality Agreements”);

WHEREAS, Executive signed an acknowledgement agreeing to abide by the Spansion Inc. Insider Trading Policy (the “Insider Trading Policy Acknowledgement”);

WHEREAS, on April 10, 2009 (the “Resignation Date”), Executive tendered his resignation from his position with the Company as Executive Vice President and Chief Financial Officer;

WHEREAS, conditioned upon Executive’s compliance with the terms of this Agreement, the Parties agree that Executive may continue as a part-time non-officer employee of the Company for a transition period of up to nine (9) months (“Personal Leave Period”), beginning effective the Resignation Date and continuing until January 9, 2010, or the end of the Personal Leave Period, whichever occurs earlier (the “Final Termination Date”);

WHEREAS, Executive agreed to a Change of Control Severance Agreement with the Company on June 9, 2006, and further agreed to an amendment to such agreement by signing an Amended and Restated Spansion Inc. Change of Control Severance Agreement on October 24, 2007 (collectively, the “Change of Control Agreement”), the conditions of which have not been triggered, will not be triggered by the terms of this Agreement, and which is wholly superseded and nullified by this Agreement; and

WHEREAS, the Parties wish to resolve any and all disputes, claims, complaints, grievances, charges, actions, petitions, and demands that the Executive may have against the Company and any of the Releasees as defined below, including, but not limited to, any and all claims arising out of or in any way related to Executive’s employment with the Company, the transitional employment, or the resignations provided for herein.

NOW, THEREFORE, in consideration of the mutual promises made herein, the Company and Executive hereby agree as follows:

COVENANTS

1. Resignation. Executive acknowledges that he resigned from his position as Executive Vice President and Chief Financial Officer with the Company effective the Resignation Date defined above. Effective immediately, Executive hereby further resigns as an officer or director of any of

the Company’s subsidiaries in which he serves in such capacities. Effective the Final Termination Date, Executive will be deemed to have fully and voluntarily resigned from employment with the Company, and the Company shall have no further obligations to Executive. Executive agrees, upon request from the Company, to execute any forms or other documents necessary to legally effect such resignations.

2. Personal Leave Period.

a. Limited Duties During Personal Leave Period. Executive agrees to provide reasonable assistance to the Company during the Personal Leave Period (also called “CFO Transition Period”). “Reasonable assistance” shall mean providing the Company limited employment services not to exceed 20 hours per month, unless Executive agrees otherwise, and shall include but not be limited to Executive (i) remaining responsible for special projects assigned to him by the Company from time to time; (ii) transitioning of Executive’s duties to other Company employees; and (iii) making himself generally available to the CEO or other senior management for questions, communications, and other general information exchange. Executive acknowledges and agrees that he shall have no authority to bind or act as an agent of the Company during the CFO Transition Period, except as expressly authorized in writing by the CEO, and agrees not to hold himself out as having any greater authority.

b. Salary Continuation During Personal Leave Period. The Company agrees to pay Executive his base salary, less applicable withholding, as in effect on the Resignation Date, through and including the Final Termination Date. Pay during the Personal Leave Period shall be in accordance with the Company’s regular payroll practices.

c. Benefits During Personal Leave Period. Subject to the requirements of the Company’s group benefits plans, the Company agrees to continue Executive health insurance benefits during the CFO Transition Period. Should Executive become ineligible for the Company’s group health insurance benefits, the Company agrees to reimburse Executive for the payments Executive makes for coverage under Title X of the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”) provided Executive timely elects and pays for COBRA coverage, with COBRA reimbursements available through the end of the CFO Transition Period or until Executive has secured other employment, whichever occurs first. COBRA reimbursements shall be made by the Company to Executive consistent with the Company’s normal expense reimbursement policy, provided that Executive submits documentation to the Company substantiating his payments for COBRA coverage. Executive’s participation in all other benefits and incidents of employment, including, but not limited to the accrual of vacation and paid time off, shall be suspended during the CFO Transition Period.

d. No Equity Vesting During CFO Transition Period. The Parties expressly agree that Executive will be considered to have vested in his stock options, restricted stock units and any other equity awards only to, but not including, the Resignation Date. All vesting will be suspended during the CFO Transition Period, and the required exercise or forfeiture of any equity awards shall be tolled until the Final Termination Date. Executive agrees to cooperate in the execution of any documents or agreements necessary to effectuate the foregoing. Except as provided herein, each of Executive’s equity awards shall continue to be governed by the terms and conditions of the applicable Company equity plan under which the award was granted and applicable equity award agreement (each an “Equity Award Document,” and together, the “Equity Award Documents”).

Page 2 of 8

e. Voluntary Early Resignation. Nothing in this Agreement shall operate or be construed to preclude Executive from seeking or obtaining new employment, subject to such new employment remaining consistent with Executive’s contractual and other legal obligations to the Company. Executive agrees to immediately notify the Company in writing of his acceptance of new employment. The last date of the month Executive accepts new employment shall constitute the Final Termination Date, unless the Final Termination Date otherwise occurs earlier. Executive remains free at any time within the Personal Leave Period to end his services to the Company upon written notice, with the date such notice is received by the Company constituting the Final Termination Date.

3. Relocation Expense Reimbursement. To facilitate Executive joining his family in Chicago, Illinois, the Company agrees to reimburse Executive, up to a maximum reimbursement of Seven Thousand Five Hundred Dollars ($7,500.00), for any expenses related to his relocation to Chicago, Illinois (the “Relocation Expense Reimbursements”). The Relocation Expense Reimbursements shall be made to Executive by the Company consistent with the Company’s normal expense reimbursement policy, provided that Executive submits documentation to the Company substantiating his payments for relocation-related expenses. Executive acknowledges and agrees that all other housing-related benefits, including temporary living arrangements, end effective April 30, 2009, and that he is not otherwise entitled to any housing-related benefits.

4. Payment of Salary and Receipt of All Benefits. Executive acknowledges and represents that the Company has paid or provided all salary, wages, bonuses, accrued vacation/paid time off, housing allowances, relocation costs, interest, severance, outplacement costs, fees, commissions, stock, stock options, vesting, and any and all other benefits and compensation due to Executive thru the Effective Date (as defined below). Executive represents that he has submitted all expense reports and once all outstanding expense reports as of April 10, 2009 are paid there is no further reimbursable expenses due from the Company. Executive further acknowledges and represents that he has either not request, or he has received, any leave to which he was entitled, if any, under the California Family Rights Act, the Family Medical Leave Act, the Americans with Disabilities Act, and/or the Fair Employment and Housing Act, and that he did not sustain any workplace injury during his employment with the Company.

5. Release of Claims. Executive agrees that terms provided for under this Agreement represent settlement in full of any and all outstanding obligations owed to Executive by the Company and its current and former officers, directors, Executives, agents, investors, attorneys, shareholders, administrators, affiliates, benefit plans, plan administrators, insurers, divisions, and subsidiaries, and predecessor and successor corporations and assigns (collectively, the “Releasees”). Executive, on his own behalf and on behalf of his respective heirs, family members, executors, agents, and assigns, hereby and forever releases the Releasees from, and agrees not to sue concerning, or in any manner to institute, prosecute, or pursue, any claim, complaint, charge, duty, obligation, or cause of action relating to any matters of any kind, whether presently known or unknown, suspected or unsuspected, that Executive may possess against any of the Releasees arising from any omissions, acts, facts, or damages that have occurred up until and including the Effective Date of this Agreement, including, without limitation:

a. any and all claims relating to or arising from Executive’s employment relationship with the Company, resignation thereof, and changes to that relationship reflected herein;

Page 3 of 8

b. any and all claims relating to, or arising from, Executive’s right to purchase, or actual purchase of shares of stock of the Company, including, without limitation, any claims for fraud, misrepresentation, breach of fiduciary duty, breach of duty under applicable state corporate law, and securities fraud under any state or federal law;

c. any and all claims for wrongful discharge of employment; termination in violation of public policy; discrimination; harassment; retaliation; breach of contract, both express and implied; any obligations under the Change of Control Agreement; any obligations under the Offer Letter; breach of covenant of good faith and fair dealing, both express and implied; promissory estoppel; negligent or intentional infliction of emotional distress; fraud; negligent or intentional misrepresentation; negligent or intentional interference with contract or prospective economic advantage; unfair business practices; defamation; libel; slander; negligence; personal injury; assault; battery; invasion of privacy; false imprisonment; conversion; and disability benefits;

d. any and all claims for violation of any federal, state, or municipal statute, including, but not limited to, Title VII of the Civil Rights Act of 1964; the Civil Rights Act of 1991; the Rehabilitation Act of 1973; the Americans with Disabilities Act of 1990; the Equal Pay Act; the Fair Labor Standards Act; the Fair Credit Reporting Act; the Age Discrimination in Employment Act of 1967; the Older Workers Benefit Protection Act; the Employee Retirement Income Security Act of 1974; the Worker Adjustment and Retraining Notification Act; the Family and Medical Leave Act; the Sarbanes-Oxley Act of 2002; the Uniformed Services Employment and Reemployment Rights Act; the California Family Rights Act; the California Labor Code; the California Workers’ Compensation Act; and the California Fair Employment and Housing Act;

e. any and all claims for violation of the federal or any state constitution;

f. any and all claims arising out of any other laws and regulations relating to employment or employment discrimination;

g. any claim for any loss, cost, damage, or expense arising out of any dispute over the non-withholding or other tax treatment of any of the proceeds received by Executive as a result of this Agreement; and

h. any and all claims for attorneys’ fees and costs.

Executive agrees that the release set forth in this section shall be and remain in effect in all respects as a complete general release as to the matters released. This release does not extend to any obligations incurred under this Agreement. This release does not release claims that cannot be released as a matter of law, including, but not limited to, Executive’s right to file a charge with or participate in a charge by the Equal Employment Opportunity Commission, or any other local, state, or federal administrative body or government agency that is authorized to enforce or administer laws related to employment, against the Company (with the understanding that any such filing or participation does not give Executive the right to recover any monetary damages against the Company; Executive’s release of claims herein bars Executive from recovering such monetary relief from the Company). Executive represents that he has made no assignment or transfer of any right, claim, complaint, charge, duty, obligation, demand, cause of action, or other matter waived or released by this Section.

Page 4 of 8

6. Acknowledgment of Waiver of Claims under ADEA. Executive understands and acknowledges that he is waiving and releasing any rights he may have under the Age Discrimination in Employment Act of 1967 (“ADEA”), and that this waiver and release is knowing and voluntary. Executive understands and agrees that this waiver and release does not apply to any rights or claims that may arise under the ADEA after the Effective Date of this Agreement. Executive understands and acknowledges that the consideration given for this waiver and release is in addition to anything of value to which Executive was already entitled. Executive further understands and acknowledges that he has been advised by this writing that: (a) he should consult with an attorney prior to executing this Agreement; (b) he has twenty-one (21) days within which to consider this Agreement; (c) he has seven (7) days following his execution of this Agreement to revoke this Agreement; (d) this Agreement shall not be effective until after the revocation period has expired; and (e) nothing in this Agreement prevents or precludes Executive from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties, or costs for doing so, unless specifically authorized by federal law. In the event Executive signs this Agreement and returns it to the Company in less than the 21-day period identified above, Executive hereby acknowledges that he has freely and voluntarily chosen to waive the time period allotted for considering this Agreement.

7. California Civil Code Section 1542. Executive acknowledges that he has been advised to consult with legal counsel and is familiar with the provisions of California Civil Code Section 1542, a statute that otherwise prohibits the release of unknown claims, which provides as follows:

A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.

Executive, being aware of said code section, agrees to expressly waive any rights he may have thereunder, as well as under any other statute or common law principles of similar effect.

8. No Pending or Future Lawsuits. Executive represents that he has no lawsuits, claims, or actions pending in his name, or on behalf of any other person or entity, against the Company or any of the other Releasees. Executive also represents that he does not intend to bring any claims on his own behalf or on behalf of any other person or entity against the Company or any of the other Releasees.

9. Trade Secrets and Confidential Information/Company Property. Executive reaffirms and agrees to observe and abide by the terms of the Confidentiality Agreements, including but not limited to the duration of the CFO Transition Period, specifically including the provisions therein regarding nondisclosure of the Company’s trade secrets and confidential and proprietary information, and non-solicitation of Company employees.

10. No Cooperation. Executive further agrees that he will not knowingly encourage, counsel, or assist any attorneys or their clients in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints by any third party against any of the

Page 5 of 8

Releasees, unless under a subpoena or other court order to do so or as related directly to the ADEA waiver in this Agreement. Executive agrees both to immediately notify the Company upon receipt of any such subpoena or court order, and to furnish, within three (3) business days of its receipt, a copy of such subpoena or other court order. If approached by anyone for counsel or assistance in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints against any of the Releasees, Executive shall state no more than that he cannot provide counsel or assistance.

11. Non-Disparagement and Communications with Company Employees, Customers and Business Partners. Executive agrees to refrain from any disparagement, defamation, libel, or slander of any of the Releasees, and agrees to refrain from any tortious interference with the contracts and relationships of any of the Releasees during the CFO Transition Period. Executive further agrees that he will refrain from discussing Company confidential business or financial information with third parties, including the Company’s actual and potential customers or business partners. Executive further agrees that he will not discuss the Company’s business with Company employees, customers, or business partners except as requested by the Company’s Chief Executive Officer or his designee during the CFO Transition Period.

12. Breach. In addition to the rights provided in the “Attorneys’ Fees” section below, Executive acknowledges and agrees that any material breach of this Agreement, unless such breach constitutes a legal action by Executive challenging or seeking a determination in good faith of the validity of the waiver herein under the ADEA, or of any provision of the Confidentiality Agreement shall entitle the Company immediately to recover and/or cease providing the salary provided during the CFO Transition Period, except to the extent required by law, and to obtain damages, except as provided by law. Except as provided by law, Executive shall also be responsible to the Company for all costs, attorneys’ fees, and any and all damages incurred by the Company in (a) enforcing Executive’s obligations under this Agreement or the Confidentiality Agreement, including the bringing of any action to recover payments in the event of a breach, and (b) defending against a claim or suit brought or pursued by Executive in violation of the terms of this Agreement.

13. No Admission of Liability. Executive understands and acknowledges that this Agreement constitutes a compromise and settlement of any and all actual or potential disputed claims by Executive. No action taken by the Company hereto, either previously or in connection with this Agreement, shall be deemed or construed to be (a) an admission of the truth or falsity of any actual or potential claims or (b) an acknowledgment or admission by the Company of any fault or liability whatsoever to Executive or to any third party.

14. Non-Solicitation. Executive agrees that for a period of twelve (12) months immediately following the Effective Date of this Agreement, Executive shall not directly or indirectly solicit any of the Company’s employees to leave their employment at the Company.

15. Costs. The Parties shall each bear their own costs, attorneys’ fees, and other fees incurred in connection with the preparation of this Agreement.

16. Tax Consequences. The Company makes no representations or warranties with respect to the tax consequences of the payments or other consideration provided to Executive or made on his behalf under the terms of this Agreement. Executive agrees and understands that he is responsible for payment, if any, of local, state, and/or federal taxes on the payments and any other consideration provided hereunder by the Company and any penalties or assessments thereon. Executive further

Page 6 of 8

agrees to indemnify and hold the Company harmless from any claims, demands, deficiencies, penalties, interest, assessments, executions, judgments, or recoveries by any government agency against the Company for any amounts claimed due on account of (a) Executive’s failure to pay or the Company’s failure to withhold, or Executive’s delayed payment of, federal or state taxes, or (b) damages sustained by the Company by reason of any such claims, including attorneys’ fees and costs.

17. Section 409A. The foregoing provisions are intended to comply with the requirements of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) and the final Treasury Regulations and any guidance promulgated thereunder (“Section 409A”) so that none of the severance payments and benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A, and any ambiguities herein will be interpreted to so comply. Executive and the Company agree to work together in good faith to consider amendments to this Agreement and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition prior to actual payment to Executive under Section 409A.

18. Authority. The Company represents and warrants that the undersigned has the authority to act on behalf of the Company and to bind the Company and all who may claim through it to the terms and conditions of this Agreement. Executive represents and warrants that he has the capacity to act on his own behalf and on behalf of all who might claim through him to bind them to the terms and conditions of this Agreement. Each Party warrants and represents that there are no liens or claims of lien or assignments in law or equity or otherwise of or against any of the claims or causes of action released herein.

19. No Representations. Executive represents that he has had an opportunity to consult with an attorney, and has carefully read and understands the scope and effect of the provisions of this Agreement. Executive has not relied upon any representations or statements made by the Company that are not specifically set forth in this Agreement.

20. Severability. In the event that any provision or any portion of any provision hereof or any surviving agreement made a part hereof becomes or is declared by a court of competent jurisdiction or arbitrator to be illegal, unenforceable, or void, this Agreement shall continue in full force and effect without said provision or portion of provision. Notwithstanding, to the extent the Company’s obligation to pay the Consideration provided for under Section 2 (Consideration) of this Agreement is deemed illegal, unenforceable, or void, and the Company fails to otherwise provide for the Consideration as provided, the Parties shall not remain bound by the terms of this Agreement, and it shall become null and void.

21. Attorneys’ Fees. Except with regard to a legal action challenging or seeking a determination in good faith of the validity of the waiver herein under the ADEA, in the event that either Party brings an action to enforce or effect its rights under this Agreement, the prevailing Party shall be entitled to recover its costs and expenses, including the costs of mediation, arbitration, litigation, court fees, and reasonable attorneys’ fees incurred in connection with such an action.

22. Entire Agreement. This Agreement represents the entire agreement and understanding between the Company and Executive concerning the subject matter of this Agreement and Executive’s employment with the Company and the changes to that employment relationship provided for herein, and the events leading thereto and associated therewith, and supersedes and

Page 7 of 8

replaces any and all prior agreements and understandings concerning the subject matter of this Agreement and Executive’s relationship with the Company, including but not limited to the Change of Control Agreement, with the exception of the Confidentiality Agreements, the Equity Award Documents, and the Insider Trading Policy Acknowledgement.

23. No Oral Modification. This Agreement may only be amended in a writing signed by Executive and the Company’s Chief Executive Officer.

24. Governing Law. This Agreement shall be governed by the laws of the State of California, without regard for choice-of-law provisions. Executive consents to personal and exclusive jurisdiction and venue in the State of California.

25. Counterparts. This Agreement may be executed in counterparts and by facsimile, and each counterpart and facsimile shall have the same force and effect as an original and shall constitute an effective, binding agreement on the part of each of the undersigned.

26. Voluntary Execution of Agreement. Executive understands and agrees that he executed this Agreement voluntarily, without any duress or undue influence on the part or behalf of the Company or any third party, with the full intent of releasing all of his claims against the Company and any of the other Releasees. Executive acknowledges that:

(a) He has read this Agreement;

(b) He has been represented in the preparation, negotiation, and execution of this Agreement by legal counsel of his own choice or has elected not to retain legal counsel;

(c) He understands the terms and consequences of this Agreement and of the releases it contains; and

(d) He is fully aware of the legal and binding effect of this Agreement.

IN WITNESS WHEREOF, the Parties have executed this Agreement on the respective dates set forth below.

	DARIO SACOMANI, an individual
Dated: April 10, 2009	/s/ Dario Sacomani
	Dario Sacomani

	SPANSION INC.
Dated: April 10, 2009	By	/s/ John Kispert
		John Kispert
		President and CEO

Page 8 of 8

EX-10.15

Exhibit 10.15

SPANSION EXECUTIVE DEFERRED COMPENSATION PLAN

AMENDED AND RESTATED EFFECTIVE AS OF JANUARY 1, 2008

ARTICLE I. DEFINITIONS AND CONSTRUCTION

1.1 Definitions. Where the following words and phrases appear in the Plan, they shall have the respective meanings set forth below, unless their context clearly indicates to the contrary.

(a) Account: The Plan account holding Participant’s Deferred Compensation as well as Company Matching Contribution Amounts, if any, for such Participant, plus earnings and losses thereon. Participant’s Deferred Compensation and Company Matching Contributions, if any, shall be segregated into Grandfathered Benefits and 409A Benefits and separately accounted for as set forth in Article IV.

The Plan shall establish a separate 409A Benefits Sub account for each Plan Year beginning on and after January 1, 2005, which shall hold all amounts credited to a Participant’s Account for the applicable Plan Year.

(b) Base Salary: A Participant’s annual base salary excluding bonus, sales incentive compensation, profit sharing, and all other remuneration for services rendered to Company and prior to reduction for any salary contributions to a plan established pursuant to Code Section 125 or qualified pursuant to Code Section 401(k).

(c) Beneficiary or Beneficiaries: The person or persons, including a trustee, personal representative or other fiduciary, last designated in writing by a Participant or alternate payee in accordance with Article 8.4.

(d) Board: The Board of Directors of Spansion Inc.

(e) Bonus: Bonuses or sales incentive compensation paid under the plan(s) listed on Exhibit A, as such Exhibit may be revised from time to time.

(f) Code: The Internal Revenue Code of 1986, as amended from time to time.

(g) Committee: A committee appointed by the Board to administer the Plan in accordance with Article X, and/or such committee’s agents and designees and vendors retained by such agents and designees.

(h) Company: Spansion Inc., a corporation organized and existing under the laws of the State of Delaware. Where applicable, Company also shall mean Spansion LLC.

(i) Company Contribution Account: The bookkeeping sub account maintained by the Company for each Participant that is credited with Company Matching Contributions, if any, as permitted pursuant to Article III, and earnings and losses on such amounts credited or debited pursuant to Article 4.2.

(j) Company Matching Contribution: The discretionary amount, if any, contributed by the Company or a Participating Employer, at each company’s sole discretion, as a matching contribution for each Participant for a Plan Year. Such amount may differ from Participant to Participant both in amount and as percentage of Compensation.

(k) Compensation: Base Salary and Bonuses earned by the Participant for services rendered to the Company during a Plan Year.

(l) Deferred Compensation: Amounts contributed to the Plan from a Participant’s Base Salary and/or Bonus.

(m) Deferral Account: The bookkeeping sub account maintained by the Company for each Participant to which is credited Deferred Compensation pursuant to Article 3.1, and earnings and losses on such amounts credited or debited pursuant to Article IV.

(n) Disability: A Participant shall be considered to have a “disability” if he or she (i) is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, or (ii) is, by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, receiving income replacement benefits for a period of not less than three months under an accident and health plan covering the Employee that is sponsored by the Company.

(o) Distributable Amount: The balance in the Participant’s Deferral Account and Company Contribution Account.

(p) Early Distribution: An election by a Participant in accordance with Article VII to receive a withdrawal of amounts from his Grandfathered Benefits Sub account prior to the time at which such Participant would otherwise be entitled to such amounts under his existing distribution elections.

(q) Effective Date: January 1, 2008, except as otherwise provided herein.

(r) Election Period: The period prior to each Plan Year during which employees may make elections to defer compensation under the Plan’s terms.

(s) Eligible Employee: An Employee of the Company or a Participating Employer whose position is at director level or above.

(t) Employee: Any individual on the payroll of the Company or a Participating Employer whose wages are subject to withholding for purposes of Federal income taxes and for purposes of the Federal Insurance Contributions Act.

(u) ERISA: The Employee Retirement Income Security Account of 1974, as amended from time to time.

(v) 409A Benefits: The portion of a Participant’s Account credited for Plan Years beginning on and after January 1, 2005.

(w) Grandfathered Benefits: The portion of a Participant’s Account credited for Plan Years beginning prior to January 1, 2005.

(x) Initial Election Period: The 30-day period immediately following the date an individual becomes an Eligible Employee.

2

(y) Investment Fund(s) or Fund: The investment fund(s) designated by the Committee from time to time, at its sole discretion, for the hypothetical investment of Participants’ Accounts pursuant to Article V.

(z) Participant: An Eligible Employee participating in the Plan in accordance with the provisions of Article II.

(aa) Participating Employer: A controlled group member company, an affiliated management or service group member company, a subsidiary or joint venture of the Company, or other related business entity as defined in Code Sections 414(b), (c) or (m); provided any determination under Code Sections 414(b) or (c) shall be made by replacing the generally applicable references to eighty percent (80%) common control with a level of common ownership of not less than fifty percent (50%).

(bb) Plan: The Spansion Executive Deferred Compensation Plan, as amended from time to time. Until January 1, 2008, the Plan was called the Spansion Executive Investment Account Plan.

(cc) Plan Year: Every January 1 through December 31.

(dd) Scheduled Withdrawal Date: The distribution date elected by the Participant for an in-service withdrawal of amounts from such Accounts deferred in a given Plan Year, and earnings and losses attributable thereto.

(ee) Separation From Service or Separates from Service: The termination of a Participant’s employment with the Company or with a Participating Employer in accordance with the Company’s policies and procedures that is not an authorized leave of absence (as determined under the Company’s or Participating Employer’s standard leave policies); provided, however, that the Company or Participating Employer and the Participant reasonably anticipate that no further services will be performed after the termination date or that the level of bona fide services the Participant will perform after such date (whether as an employee or as an independent contractor) would permanently decrease to no more than 20 percent (20%) of the average level of bona fide services performed (whether as an employee or an independent contractor) over the immediately preceding 36-month period (or the full period of services to the Company or Participating Employer if the Participant has been providing services to the Company or Participating Employer for less than 36 months). For this purpose, a transfer of a Participant’s employment to a subsidiary or affiliate of the Company shall not be treated as a “Separation from Service” with the Company if the Company is under “common control” with the subsidiary or affiliate. For this purpose, “common control” shall be determined as provided in Code Section 414(b) or 414(c), but using a common ownership level of not less than fifty percent (50%). Notwithstanding the preceding, any determination of Separation from Service shall be consistent with the requirements of Treasury Regulations Section 1.409A-1(h).

In the event that employees of a subsidiary of the Company are permitted to participate in this Plan and such subsidiary ceases to be owned by the Company in connection with a “spin-off” transaction (which may occur in a single transaction or as the culmination of several related events) in which the Company ceases to own more than fifty percent (50%) of the subsidiary, and the employees of such subsidiary do not experience a termination of employment with the subsidiary, any determination of whether individuals have experienced a “Separation from Service” shall be made by reference to their employment status with the subsidiary.

3

(ff) Specified Employee: The term “Specified Employee” means Spansion’s Corporate Vice Presidents, Executive Vice Presidents and Chief Executive Officer.

(gg) Unforeseeable Financial Emergency: A severe financial hardship to the Participant resulting from any of the following:

(1) An illness or accident of the Participant or the illness or accident of the Participant’s spouse or dependent (as defined in Code Section 152(a));

(2) Loss of the Participant’s property due to casualty; or

(3) Any other similar extraordinary and unforeseeable circumstances arising as a result of events beyond the Participant’s control.

Any determination of Unforeseeable Financial Emergency shall be made in accordance with the requirements of Code Section 409A and any guidance issued thereunder.

(hh) Valuation Date: Each day the Nasdaq is open for business.

1.2 Number and Gender. Wherever appropriate herein, words used in the singular shall be considered to include the plural, and words used in the plural shall be considered to include the singular. The masculine gender, where appearing in the Plan, shall be deemed to include the feminine gender.

1.3 Headings. The headings of Articles and Sections herein are included solely for convenience, and if there is any conflict between such headings and the text of the Plan, the text shall control.

ARTICLE II. PARTICIPATION

2.1 Participation.

(a) Prior to the first day of each Plan Year, each Eligible Employee will be offered an opportunity to elect to defer Compensation for the following year. Any such Eligible Employee shall become a Participant in the Plan by electing to defer a portion of his Compensation by submitting an election that conforms to the requirements of the Plan, on a form or electronic method provided by the Committee.

(b) A Participant who transfers employment from the Company to a Participating Employer shall continue to be classified as a Participant for purposes of this Plan.

(c) Notwithstanding subsection (a) above, if an Employee first becomes an Eligible Employee on a date outside of the annual deferral election period held in the Plan Year in which he became so eligible, such Eligible Employee may make a deferral election within the 30-day period following the date he becomes an Eligible Employee.

4

ARTICLE III. CONTRIBUTIONS

3.1 Participant’s Deferred Compensation. Each Participant may elect to defer a portion of his Compensation in accordance with this Article III.

(a) General Rule. A Participant may elect to defer Compensation earned on or after the time at which the Participant elects to defer in accordance with Article 2.1 and the amount shall be a flat dollar amount or a percentage, not to exceed 50 percent (50%) of the Base Salary and/or one-hundred percent (100%) of the Bonuses, provided that the total amount of Deferred Compensation shall be limited in any calendar year if necessary, to satisfy Social Security Tax (including Medicare), income tax and employee benefit plan withholding requirements as determined in the sole and absolute discretion of the Committee.

(1) A Participant’s initial election to defer Compensation shall be made prior to the end of his Initial Election Period and shall be effective with respect to Compensation received after such deferral election is processed and shall be irrevocable for that Plan Year.

(2) Other than Article 3.1(a)(1) above, A Participant’s election to defer Compensation for any Plan Year shall be made during the Election Period for the Plan Year and shall be irrevocable for such Plan Year.

(b) Cancellation of Deferral Election. A Participant may not cancel or modify his Compensation Deferral election applicable to a Plan Year at any time during that Plan Year.

(c) Crediting of Deferrals. Compensation deferrals made by a Participant shall be credited to such Participant’s Deferral Account as of a date determined in accordance with procedures established from time to time by the Committee.

3.2 Company Contribution Account. The Committee shall establish and maintain a Company Contribution Account for each Participant in the Plan. As of any date or dates selected by the Company, the Company may credit a Participant’s Company Contribution Account with an amount of Company Matching Contributions, if any, which the Company in its sole discretion shall determine. Such credits may be made on behalf of some Participants but not others, and such credits may vary in amount among individual Participants. Each Participant’s Company Contribution Account shall be further divided into separate investment fund sub accounts corresponding to the investment fund(s) elected by the Participant pursuant to Article V.

3.3. Trust Establishment and Funding. The Company may, but is not obligated to, establish a grantor trust of the Company with an institutional trustee to set aside assets to fund its obligations under this Plan. Although the principal of the trust and any earnings thereon shall be held separate and apart from other funds of the Company and would be used exclusively for the uses and purposes of Plan Participants and Beneficiaries, neither the Participants nor their Beneficiaries would have any preferred claim on, or any beneficial ownership in, any assets of the trust prior to the time such assets are paid to the Participants or Beneficiaries as benefits and all rights created under this Plan shall be unsecured contractual rights of Plan Participants and Beneficiaries against the Company. Any assets held in a trust established by the Company to fund its obligations under this Plan will be subject to the claims of the Company’s general creditors under federal and state law in the event of insolvency as defined in applicable trust agreement.

5

ARTICLE IV. ALLOCATIONS TO PARTICIPANTS’ ACCOUNTS

4.1 Account Records. The Committee shall create and maintain adequate records reflecting the interests under the Plan of each Participant, former Participant and Beneficiary. Such records shall consist of Participants’ Accounts (including applicable sub accounts) reflecting all credits and debits made to such Accounts in the manner described in this Article IV.

(a) Deferred Compensation shall be credited to the Participant’s Deferral Account.

(b) Company Matching Contributions, if any, shall be credited to the Participant’s Company Contribution Account.

(c) Each Participant’s Account, which is initially divided into his Deferral Account and Company Contribution Account, shall be further segregated into separate sub accounts for Grandfathered Benefits and 409A Benefits, each of which shall be accounted for separately.

(1) Grandfathered Benefits shall be credited into a sub account with that portion of a Participant’s Deferral Account and Company Contribution Account, if any, as applicable, that was 100% vested as of December 31, 2004.

(2) 409A Benefits shall be credited into a sub account with that portion of a Participant’s Deferral Account and Company Contribution Account, if any, as applicable, that was not 100% vested as of December 31, 2004, and with all subsequent amounts credited to the Participant’s Account for Plan Years beginning on and after January 1, 2005.

4.2 Allocation of Net Income or Loss and Changes in Value. The Committee shall credit allocable net income (net loss) to each Participant’s Account according to the hypothetical investments made by a Participant pursuant to the terms of Article V.

(a) As of each Valuation Date, the Committee shall determine the fair market value and net income (net loss) of each Investment Fund for the period elapsed since the immediately preceding Valuation Date. The net income (or net loss) of each Investment Fund since the immediately preceding Valuation Date shall be ascertained by the Committee in such manner as it deems appropriate, which may include expenses, if any, of administering the Investment Fund and the Plan.

(b) As of each Valuation Date the Committee shall credit allocable net income (or net loss), to each Participant’s Account based on the hypothetical investments elected by such Participant as provided in Article V. Each Participant’s Account shall be credited with (or debited for) that portion of such net income (or net loss) which occurred since the immediately preceding Valuation Date.

(c) Prior to the allocation of any income or loss under this Section, the value of each Participant’s Account shall be reduced by the amount of any distributions made there from since the immediately preceding Valuation Date.

(d) So long as there is a balance credited to any Account, such Account shall continue to share in earnings (or loss) allocations pursuant to this Section IV.

6

ARTICLE V. INVESTMENT ELECTIONS

5.1 Investment Elections. For purposes of crediting earnings and losses and valuation of each Participant’s Account, each Participant’s Account shall be deemed to be invested in the Investment Funds.

5.2 Designation of Investment Funds.

(a) At the time of making the deferral elections described in Article 3.1, the Participant shall designate, on a form or electronic system provided by the Committee, the investment fund(s) in which the Participant’s Account will be deemed to be invested for purposes of determining the amount of earnings to be credited to that Account. Such Participant may designate one or more of such Investment Funds for the investment of the amounts credited to such Account in such increments as the Committee may prescribe.

(b) The Committee shall from time to time select, add, and/or delete Investment Funds for purposes of the investment of Participants’ Accounts.

(c) If a Participant fails to make a proper designation, then his Account shall be deemed to be invested in the Investment Fund or Investment Funds designated by the Committee from time to time.

(d) A Participant may change his investment designation for either current Account balances or future amounts to be credited to his Account, or both, over which he has been given investment discretion by the Committee. Any such change shall be made in accordance with the procedures established by the Committee, and the frequency of such changes may be limited by the Committee.

(e) A Participant’s investment designations shall be made solely for purposes of crediting earnings and/or losses to his Account under Section 4.2 of this Plan. The Committee shall not, in any way, be bound to actually invest any amounts set aside pursuant to Article XI below to satisfy its obligations under this Plan in accordance with such selections.

ARTICLE VI. VESTING

A Participant shall be 100% vested in his Account.

ARTICLE VII. IN-SERVICE WITHDRAWALS

7.1 General Rules.

(a) Benefit Amount. A Participant’s Plan benefit shall be the value of his Account is determined as of the end of the month immediately preceding the time of payment of such Account in accordance with Article 7.2 or Article 7.3, as applicable.

7

7.2 Rules Governing Grandfathered Benefits Only.

(a) In-Service Distributions With Scheduled Withdrawal Date(s). Consistent with the Plan’s prior terms and operation, a Participant may at any time make an irrevocable election, effective not earlier than one year from the date the election is filed, to have his Grandfathered Benefits paid to him on up to four fixed dates as specified in such election.

(1) The amount(s) designated in Article 7.1(a)(1), above, shall be paid as soon as practicable after the Participant’s Scheduled Withdrawal Date(s), as determined in accordance with Section 1.1(dd).

(2) A Participant may extend the Scheduled Withdrawal Date for any Plan Year, provided such election is made at least one year before the Scheduled Withdrawal Date. The Participant shall have the right to twice so modify any Scheduled Withdrawal Date.

(3) If a Participant separates from service prior to the Scheduled Withdrawal Date, other than by reason of death, the portion of the Participant’s Account associated with a Scheduled Withdrawal Date that has not occurred prior to such termination, shall be distributed in a lump sum.

(4) In the event that a Participant designates a Scheduled Withdrawal Date for some or all contributions made to his Account for a Plan Year, the amount subject to such distribution election shall be accounted for in a manner which allows separate accounting for the deferral of Compensation and investment gains and losses associated with such Plan Year’s deferral of Compensation.

(b) In-Service Distribution Without Scheduled Withdrawal Date. A Participant shall be permitted to elect an Early Distribution from his Account prior to the elected payment date, subject to the following restrictions:

(1) The election to take an Early Distribution shall be made by making an election pursuant to the Plan’s then current administrative procedures.

(2) The amount of the Early Distribution may equal up to ninety percent (90%) of the Participant’s Grandfathered Benefits. An amount equal to ten percent (10%) of the amount of the Early Distribution shall be permanently forfeited from Participant’s Account and the Company shall have no obligation to the Participant or his Beneficiary with respect to such forfeited amount.

(3) The amount described in Article 7.1(b)(2), above, shall be paid in cash in a single lump sum distribution as soon as practicable after the end of the calendar month in which the Early Distribution election is received.

(4) If a Participant receives an Early Distribution of either all or a part of his Grandfathered Benefits the Participant will be ineligible to participate in the Plan for at least twelve (12) consecutive months following the date of distribution. This suspension period shall begin as soon as administratively feasible; provided, however, that, to the extent required to comply with Code Section 409A, it shall be delayed until the first day of the immediately following Plan Year.

(5) All Early Distributions shall be made on a pro rata basis from a Participant’s Deferral Account and Company Contribution Account and each Investment Fund in such sub account.

8

7.3 Rules Governing 409A Benefits Only.

(a) Scheduled In-Service Distributions.

(1) At the time a Participant makes his deferral election for a Plan Year, the Participant may also file an irrevocable election to have all the amount credited to his 409A Benefits for such Plan Year paid directly to him in a single lump sum cash payment on a designated date This election shall be irrevocable as of the date the election is made.

(2) Distribution made pursuant to an election filed under this subsection may not commence until at least one (1) full year has elapsed following the date that such election is made.

(3) The amount(s) designated in Article 7.3(a)(1), above, shall be paid as soon as practicable after the Scheduled Withdrawal Date(s), as determined in accordance with Section 1.1(dd).

(4) The distribution election may be modified by the Participant to provide that the date on which distribution is to be made or commence shall be a date subsequent to the date payment would otherwise be made or commence; provided, however, that the following requirements are also met:

A. The Participant must submit this election at least twelve (12) months prior to the date the payment is scheduled to be made (or the installment payments are scheduled to commence) pursuant to the existing distribution election.

B. The new election will not be effective until twelve (12) months have elapsed after the date on which the new election is received.

C. The new election provides that payment will not be made or commence for at least five (5) years from the date payment would otherwise have been made or commenced.

D. No more than two (2) postponements may be filed for any scheduled in-service distribution.

(5) If a Participant Separates from Service prior to the date on which an in-service payment is scheduled to be made under this subsection, his election shall be terminated and his Account shall be distributed as provided in Section 8.3 below.

(b) Unforeseeable Financial Emergency. In the event that the Committee, upon written petition of the Participant, determines that the Participant has suffered an Unforeseeable Financial Emergency, the Participant shall be entitled to withdraw from that portion of his 409A Benefits an amount that may not exceed the amount necessary to satisfy such emergency, plus amounts necessary to pay taxes reasonably anticipated as a result of the distribution, after taking into account the extent to which such hardship is or may be relieved through (i) reimbursement, (ii) compensation by insurance or otherwise, or (iii) liquidation of the Participant’s assets (to the extent the liquidation of such assets would not itself cause severe financial hardship).

(1) If the Participant’s 409A Benefits is deemed to be invested in more than one Investment Fund, such withdrawal shall be made pro rata from each Investment Fund in which such 409A Benefits is deemed to be invested.

9

(2) The amount will be paid as soon as administratively practical following approval from the Committee.

(3) This Article 7.2(b) shall not apply to a Participant following his Separation from Service with an Employer, and in the event of such separation, the amounts credited to the Participant’s 409A Benefits sub account shall be payable to him only in accordance with Article VIII.

ARTICLE VIII. BENEFIT DISTRIBUTIONS

8.1 General Rules.

(a) Benefit Amount. A Participant’s Plan benefit shall be the value of his Account determined as of the end of the calendar quarter immediately preceding the time of payment of such Account in accordance with Article 8.2 or Article 8.3, as applicable.

(b) Triggering Events. A Participant’s Plan benefit shall become payable upon the earliest to occur of the following events, each of which shall be classified as a “Triggering Event”:

(1) A Participant’s Separation from Service from all Participating Employers for any reason;

(2) The death of the Participant; or

(3) The Disability of the Participant, but only with respect to 409A Benefits;

Notwithstanding the preceding sentence, with respect solely to 409A Benefits, if a Participant is a Specified Employee and Separates from Service for a reason other than death, distribution of the portion of such Participant’s Account attributable to 409A Benefits may not commence earlier than six months after the date of his Separation from Service.

8.2 Rules Governing Form and Timing of Payment of Grandfathered Benefits Only.

(a) Commencement of Payments. Grandfathered Benefits shall be paid, or payments shall commence, as soon as administratively practicable following the end of the calendar quarter during which a Triggering Event occurs. A Participant’s benefit shall be paid to the Participant unless the Triggering Event is the death of the Participant, in which case the Participant’s benefit shall be paid to the Participant’s designated Beneficiary as provided in Article 8.4.

(b) Form of Payment. Grandfathered Benefits shall be paid in cash in a single lump sum payment unless the Participant’s Grandfathered Benefits balance exceeds $25,000, in which event the Participant may elect to have such balance paid in substantially equal annual installments over a fixed number of years, no less than three years and no more than 10 years. However, such optional form of payment must be elected by the Participant, on a form provided by and submitted to the Committee, at least one year before the Participant Separates from Service with the Company or with a Participating Employer.

10

A Participant may modify, on a form provided by and submitted to the Administrator, the form of benefit that he or she has previously elected, provided such modification form is submitted to the Administrator at least one (1) year before the Participant terminates employment with Company.

(c) Timing of Payment. A payment made in the form of a single lump sum payment shall be made during the calendar quarter next following the date a Participant has Separated from Service. If distribution is to be paid in series of annual installments, each installment payment will be made during the first calendar quarter of the Plan Year following the Participant’s Separation from Service and the first calendar quarter of each subsequent Plan Year.

The Participant’s Account shall continue to be credited with earnings pursuant to Section 4.2 of the Plan until all amounts credited to his Account under the Plan have been distributed.

(d) Death of Participant. If a Participant dies prior to the date the payment of his Grandfathered Benefits begins or, if applicable, is completed, such benefits shall be paid to Participant’s Beneficiary designated in accordance with Article 8.4 in a single lump sum cash payment unless payments had commenced in a series of annual installments pursuant to Participant’s election, in which case such installment payments shall continue and be paid to his Beneficiary. With respect to a lump sum payment, such payment shall be made during the next calendar quarter period following the death of the Participant.

8.3 Rules Governing Form and Timing of Payment of 409A Benefits Only.

(a) Commencement of Payments. A Participant’s 409A Benefits shall be paid, or payment shall commence as soon as administratively practicable during the next calendar quarter following the Triggering Event. Notwithstanding the preceding or any other provision of the Plan to the contrary, if a payment is made upon Separation from Service (not by reason of death or Disability) of a Participant who is a Specified Employee on the effective date of his Separation from Service, such Participant’s distribution may not commence earlier than six months following the effective date of Separation from Service (or upon his death, if earlier). Participant’s 409A Benefits shall be paid directly to the Participant, unless the Triggering Event is the death of the Participant, in which case such amounts shall be paid to the Participant’s Beneficiary.

(b) Form of Payment. A Participant’s 409A Benefits shall be paid to the Participant, or, in the event of such Participant’s death, to his Beneficiary, in one of the following forms:

(1) In a single lump sum cash payment; or

(2) In annual cash installments for a term from three to 10 years. This form of payment will apply only if the value of the Participant’s 409A Benefits is not less than $25,000. If such value is less than $25,000 on the date a Triggering Event occurs, distribution shall be in the form of a single lump sum cash payment.

(c) Time and Applicability of Election. A Participant must elect one of the forms of payment listed in Article 8.3(b), above, at the time the deferral election is made. Such election shall be effective solely with respect to the amounts deferred pursuant to the election,

11

shall be irrevocable by the Participant except as provided in Article 8.3(d), and shall remain in effect for all periods of a Participant’s participation in the Plan. In the event a Participant fails to timely elect the form of payment, the Participant shall be deemed to have elected payment in the form of a single lump sum cash payment.

(d) Timing of Payment. A payment made in the form of a single lump sum payment shall be made during the calendar quarter next following the date a Participant has Separated from Service. If distribution is to be paid in series of annual installments, each installment payment will be made during the first calendar quarter of the Plan Year following the Participant’s Separation from Service and the first calendar quarter of each subsequent Plan Year, unless the participant is a Specified Employee, in which case the first installment will be paid the later of (i) the first calendar quarter of the Plan Year following the Participant’s Separation from Service or (ii) the quarter following six months after Separation from Service.

The Participant’s Account shall continue to be credited with earnings pursuant to Section 4.2 of the Plan until all amounts credited to his Account under the Plan have been distributed.

(e) Change in the Form of Payment. A modification of the Participant’s previous distribution election shall not be effective unless all of the following requirements are satisfied:

(1) The modified election shall not be effective until 12 months have elapsed after the date on which the modified election is filed with the Committee.

(2) Except in the case of modified elections relating to distributions on account of death, Disability, or Unforeseeable Financial Emergency, the modified election must provide that payment will not be made or commence for at least five years from the date payment would otherwise have been made or commenced.

(3) A modified election relating to a distribution to be made on a specified future date or under a fixed payment schedule shall be filed at least 12 months prior to the date of the then current elected scheduled payment and limited to two changes.

(4) A modified election shall not accelerate the time or schedule of any payment under the Plan, except as may be permitted pursuant to applicable Treasury Regulations.

Solely for purposes of applying the election modification restrictions described in this Article 8.3(d), a Participant’s election to be paid in installment payments shall be treated as an election of a single lump sum cash payment to be made on the date the installment payments are scheduled to commence.

(f) Death of Participant. If a Participant dies prior to the date the payment of his 409A Benefits begins, such benefits shall be paid to such Participant’s Beneficiary designated in accordance with Section 8.4 in a single lump sum cash payment, notwithstanding any other form of payment elected by such Participant unless payment had commenced in a series of annual installments pursuant to Participant’s election, in which case such installment payments shall continue as elected and be paid to his Beneficiary.

12

(g) Disability of Participant. If a Participant becomes Disabled prior to the date he Separates from Service, payment of his 409A Benefits shall commence as soon as administratively feasible following the first day of the calendar quarter immediately following the date on which he became Disabled and shall be in the form designated for distributions made in connection with a Separation from Service. If a Participant’s distribution election provides for a delay in the commencement of payments and the Participant has a Separation from Service prior to the date such benefit payments commence, his distribution shall be treated as being made on account of Separation from Service and shall be subject to the limitations under Section 8.1(b) hereof.

8.4 Designation of Beneficiaries.

(a) Each Participant shall have the right to designate the beneficiary or beneficiaries to receive payment of his benefits in the event of his death. Each such designation shall be made by making a beneficiary designation in the form prescribed by the Committee and filing such form with the Committee during the life of such Participant. Any such beneficiary designation may be changed at any time by execution and filing of a new designation in accordance with this subsection. The preceding notwithstanding, (i) if a Participant has designated his spouse as his Beneficiary, such designation shall be void and of no effect upon the divorce of the Participant and such spouse, unless the Participant notifies the Committee to the contrary in writing after the date of such divorce, and (ii) if a Participant who is married on the date of his death has designated an individual or entity other than his surviving spouse as his Beneficiary, such designation shall not be valid unless (a) such surviving spouse has consented thereto in writing, and such consent (i) acknowledges the effect of such specific designation, (ii) either consents to the specific designated Beneficiary (which designation may not subsequently be changed by the Participant without spousal consent) or expressly permits such designation by the Participant without the requirement of further consent by such spouse, and (iii) is witnessed by a notary public, or (b) the consent of such spouse cannot be obtained because such spouse cannot be located or because of other circumstances that the Committee in its discretion determines warrants a waiver of such consent. Any such consent by such surviving spouse shall be irrevocable.

(b) If at the time of the death of the Participant no beneficiary designation form is on file with the Committee, or such beneficiary designation form is not valid or effective for any reason as determined by the Committee, then the deemed Beneficiary(ies) for purposes of receiving Plan benefits shall be as follows and in the same priority:

(1) If a Participant has a surviving spouse at the time of such Participant’s death, his deemed Beneficiary shall be such surviving spouse;

(2) If a Participant has no surviving spouse at the time of such Participant’s death, his deemed Beneficiary shall be such Participant’s issue by right of representation, his or her parents, or his or her estate, in that order.

(3) In the event any amount is payable under the Plan to a minor, payment shall not be made to the minor, but instead be paid (i) to that person’s living parent(s) as custodian(s), (ii) if that person’s parents are then divorced, and one parent is the sole custodial parent, to such custodial parent, or (iii) if no parent of that person is then living, to a court-appointed custodian to hold the funds for the minor. If no parent or court-appointed custodian is living, the Committee will determine to whom the payment shall be made on behalf of the minor.

Payment by the Company pursuant to this section of all benefits owed hereunder shall terminate any and all liability of the Company.

13

8.5 Payments Pursuant to a Qualified Domestic Relations Order. To the extent that a Participant’s benefits are partitioned under an order which satisfies the requirements to be a Qualified Domestic Relations Order, as defined in ERISA Section 206(d) if it were issued with regard to a retirement plan qualified under Code Section 401(a) (a “QDRO”), the “alternate payee’s” benefits shall be paid in cash, in a single lump sum, as soon as administratively practicable following the date the QDRO is approved by the Committee. In the event that an alternate payee dies prior to the date that his benefits are eligible for distribution hereunder, his benefits shall be fully vested and shall be paid to the alternate payee’s Beneficiary as soon as administratively feasible following his date of death. Payments made to an alternate payee, or an alternate payee’s Beneficiary, shall be in the form of a single lump sum cash payment.

8.6 Unclaimed Benefits. In the case of a benefit payable to or on behalf of a Participant, if the Committee after a reasonable search is unable to locate the Participant or Beneficiary to whom such benefit is payable, upon the Committee’s determination thereof, such benefit shall be forfeited to the Company. The Committee shall adopt procedures concerning the process that will be followed to locate a Participant or Beneficiary under this Article 8.6. Notwithstanding the foregoing, if subsequent to any such forfeiture the Participant or Beneficiary to whom such benefit is payable makes a valid claim for such benefit within a reasonable (as determined by and in the discretion of the Committee) period of time following the date such benefit became payable, such forfeited benefit shall be payable pursuant to Plan provisions.

ARTICLE IX. TRANSITION RULES

9.1 Deferral Elections for Plan Years 2005 through 2007. After enactment of Code Section 409A and pending the issuance of Final Treasury Regulations under Code Section 409A, this Plan was administered in the following manner:

(a) Participants could no longer change their deferral elections quarterly effective 1/1/2005.

(b) Participants were required to make elections to defer Compensation related to services performed during the calendar year commencing on January 1, 2006 before December 31, 2005.

(c) Participants were required to make elections to defer Compensation related to services performed during the calendar year commencing on January 1, 2007 before December 31, 2006.

(d) During the Plan Year ending December 31, 2005, Participants were permitted to make new deferral elections for the bonus payable in 2005 and new distribution elections for amounts credited to their Accounts. The distribution elections were not effective until January 1, 2006. These actions were documented by a Plan amendment adopted prior to December 31, 2005.

(e) Newly Eligible Employees were permitted to file an election to defer Compensation in a manner consistent with the Proposed Regulations issued under Code Section 409A.

14

9.2 Distribution Elections.

(a) Grandfathered Benefits. Distribution elections applicable to Grandfathered Benefits have been consistently administered in accordance with such elections. Such elections have been modified only as permitted under the Plan’s terms as applicable prior to the adoption of Code Section 409A.

(b) 409A Benefits.

(1) Effective with respect to the Plan Years beginning January 1, 2005, January 1, 2006, and January 1, 2007, at the time a Participant made an election to defer an amount attributable to 409A Benefits, the Participant was required to make an election as to the form of distribution of such amount, as provided in Article 8.3(b). If no such election was made, the distribution of such amount will be in the form of a single lump sum cash payment.

(2) Each Participant shall be permitted to make a new payment election with respect to his 409A Benefits during the period between January 1, 2008 and December 31, 2008. Such new payment election may specify (i) a new distribution date and a new payment method for all 409A Benefits, and (ii) limit its application to the sub account(s) holding contributions for one or more designated Plan Years. Elections made under this subsection shall be applicable for periods on or after January 1, 2009. Payment dates and methods permitted under this Article 9.2(b) shall include, but not be limited to, the methods and elections permitted under Articles 7.2(a) and 8.3(b). A Participant shall make new payment elections in accordance with procedures established by the Committee.

ARTICLE X. ADMINISTRATION OF PLAN

10.1 Appointment of Administration Committee. The general administration of the Plan shall be vested in a committee (“Committee”), which shall be appointed by the Company’s Board of Directors (the “Board”). Any individual(s), whether or not an employee of the Company, is eligible to be a member of the Committee.

10.2 Term, Vacancies, Resignation, and Removal. Each member of the Committee shall serve until he resigns, dies, or is removed by the Board. At any time during his term of office, a member of the Committee may resign by giving written notice to the Board and the Committee. At any time during his term of office, and for any reason, a member of the Committee may be removed by the Board with or without cause, and the Board may in its discretion fill any vacancy that may result therefrom. Any member of the Committee who is an employee of the Company or a Participating Employer shall automatically cease to be a member of the Committee as of the date he or she ceases to be employed by the Company or a Participating Employer. Vacancies in the Committee shall be filled by the Board.

10.3 Self-Interest of Committee Members. No member of the Committee shall have any right to vote or decide upon any matter relating solely to himself or herself under the Plan (including, without limitation, Committee decisions under Article II) or to vote in any case in which his individual right to claim any benefit under the Plan is particularly involved. In any case in which a Committee member is so disqualified to Account and the remaining members do not form a quorum, those remaining members shall appoint a temporary substitute member to exercise all the powers of the disqualified member concerning the matter in which he or she is disqualified.

15

10.4 Committee Powers and Duties. The Committee shall administer and enforce the Plan according to the terms and provisions hereof, and pursuant to the delegation by the Board, and shall have all powers necessary to accomplish these purposes, including, but not by way of limitation, the complete and absolute discretion to construe all provisions of the Plan and make all factual determinations and the right, power, authority, and duty:

(a) To make rules, regulations, and bylaws for the administration of the Plan that are not inconsistent with the terms and provisions hereof, and to enforce the terms of the Plan and the rules and regulations promulgated thereunder by the Committee;

(b) To construe in its sole discretion all terms, provisions, conditions, and limitations of the Plan;

(c) To correct any defect or to supply any omission or to reconcile any inconsistency that may appear in the Plan in such manner and to such extent as it shall deem in its discretion expedient to effectuate the purposes of the Plan;

(d) To employ and compensate such administrators, accountants, attorneys, investment advisors, and other agents, employees, and independent contractors as the Committee may deem necessary or advisable for the proper and efficient administration of the Plan;

(e) To determine in its sole discretion all questions relating to eligibility;

(f) To establish or designate Investment Funds as provided in Article V;

(g) To determine whether and when there has been a termination of a Participant’s employment with the Company or an Employer, and the reason for such termination;

(h) To make a determination in its sole discretion as to the right of any person to a benefit under the Plan and to prescribe procedures to be followed by distributees in obtaining benefits hereunder; and

(i) To receive and review reports from the trustee as to the financial condition of the trust fund, including its receipts and disbursements.

(j) To amend the Plan, in accordance with its decisions and the decisions of the Board, and in accordance with Article 12.4.

Notwithstanding the preceding, with respect to amounts attributable to 409A Benefits and with respect to administration of the Plan on and after January 1, 2005, the Committee shall administer and interpret the Plan in compliance with Code Section 409A and all related guidance issued pursuant to such Code Section.

10.5 Account Statements. The Committee shall provide each Participant with a statement of his Account on a frequency of no less than annually.

10.6 Claims Review.

(a) A person who believes that he is being denied a benefit to which he is entitled under this Plan (hereinafter referred to as “Claimant”) must file a written request for such benefit with the Committee, setting forth his claim. The request must be submitted to the Administrative Committee, c/o Spansion Benefits Manager, 915 Deguigne Dr., P.O. Box 3453, Mail Stop 210, Sunnyvale, CA 94088.

16

(b) In any case in which a claim for Plan benefits of a Participant or Beneficiary is denied or modified, the Committee shall furnish written notice to the claimant within ninety days (or within one hundred eighty (180) days if additional information requested by the Committee necessitates an extension of the ninety (90) day period and, in which case, the claimant shall be informed of such extension prior to the end of the initial ninety-day period), which notice shall:

(1) State the specific reason or reasons for the denial or modification;

(2) Provide specific reference to pertinent Plan provisions on which the denial or modification is based;

(3) Provide a description of any additional material or information necessary for the Participant, his beneficiary, or representative to perfect the claim and an explanation of why such material or information is necessary; and

(4) Explain the Plan’s claim review procedure as contained herein.

(c) In the event a claim for Plan benefits is denied or modified, if the Participant, his Beneficiary, or a representative of such Participant or Beneficiary desires to have such denial or modification reviewed, he must, within sixty (60) days following receipt of the notice of such denial or modification, submit a written request for review by the appeals committee of the initial decision. In connection with such request, the Participant, his Beneficiary, or the representative of such Participant or Beneficiary may review any pertinent documents upon which such denial or modification was based and may submit issues and comments in writing. Within sixty (60) days following such request for review the appeals committee shall, after providing a full and fair review, render its final decision to the Committee and provide the decision in writing to the Participant, his Beneficiary, or the representative of such Participant or Beneficiary stating specific reasons for such decision and making specific references to pertinent Plan provisions upon which the decision is based, and a description of any additional material or information necessary for the Claimant to perfect his claim and an explanation of why such material or such information is necessary. If special circumstances require an extension of such sixty-day period, the Committee’s decision shall be rendered as soon as possible, but not later than one hundred twenty (120) days after receipt of the request for review. If an extension of time for review is required, written notice of the extension shall be furnished to the Participant, Beneficiary, or the representative of such Participant or Beneficiary prior to the commencement of the extension period.

(d) Compliance with the claims review procedures set forth in this Article 10.6 shall be a condition precedent to the filing of a lawsuit by a Participant, his Beneficiary, or any person claiming through a participant or Beneficiary in connection with a Plan benefit, and a failure to timely exhaust the administrative remedies set forth herein shall bar any such proceeding in federal or state court.

10.7 Written Elections. To the extent any election is required to be submitted in writing under this Plan’s terms, a Participant may submit such election using any electronic, telephonic or alternative election delivery method.

10.8 Obligation to Supply Information. An Employer whose employees are Participants shall supply full and timely information to the Committee, including, but not limited to, information relating to each Participant’s Compensation, age, retirement, death, or other cause of Separation from Service and such other pertinent facts as the Committee may require. When making a determination in connection with the Plan, the Committee shall be entitled to rely upon the aforesaid information furnished by such Employer.

17

10.9 Indemnity. To the extent permitted by applicable law, the Company and each participating Employer shall indemnify and hold harmless each member of the Committee and other employees of the Company or any Employer to whom Plan administrative functions have been delegated by the Committee against any and all expenses and liabilities arising out of such individual’s administrative functions or fiduciary responsibilities under or incident to the Plan, including any expenses and liabilities that are caused by or result from an act or omission constituting the negligence of such individual in the performance of such functions or responsibilities, but excluding expenses and liabilities that are caused by or result from such individual’s own gross negligence or willful misconduct. Expenses against which such individual shall be indemnified hereunder shall include, without limitation, the amounts of any settlement or judgment, costs, counsel fees, and related charges reasonably incurred in connection with a claim asserted or a proceeding brought or settlement thereof.

10.10 Compensation. The Committee shall serve without compensation. The Committee is authorized to employ such legal counsel as it may deem advisable to assist in the performance of its duties, which shall be at the Company’s expense. Expenses and fees in connection with the administration of the Plan shall be paid by the Company or by the participants at the Company’s discretion.

ARTICLE XI. PURPOSE AND UNFUNDED NATURE OF THE PLAN

11.1 Purpose of Plan. The Company intends and desires by the adoption and maintenance of the Plan to recognize the value to the Company of the past and present services of executives covered by the Plan and to encourage and ensure their continued service with the Company by making more adequate provision for their future retirement security.

11.2 Unfunded Nature of Plan. The Plan is intended to constitute an unfunded, unsecured plan of deferred compensation for a select group of management or highly compensated employees of the Company or an Employer. Further, it is the intention of the Company, as Plan sponsor, that the Plan be “unfunded” for purposes of the Code and Title I of ERISA. The Plan constitutes a mere promise by the Company to make benefit payments in the future. Plan benefits herein provided are to be paid out of an Employer’s general assets, and Participants shall have the status of general unsecured creditors of the Company.

11.3 Funding of Obligation. The adoption of this Plan and any setting aside of amounts by the Company from which to discharge their obligations hereunder shall not be deemed to create a trust; legal and equitable title to any funds so set aside shall remain with the Company, and any recipient of benefits hereunder shall have no security or other interest in such funds. Any and all funds so set aside shall remain subject to the claims of the general creditors of the Company, present and future. This provision shall not require the Company to set aside any funds, but the Company may set aside funds if it chooses to do so.

ARTICLE XII. MISCELLANEOUS

12.1 Not A Contract of Employment. The adoption and maintenance of the Plan shall not be deemed to be a contract between the Company and any person or to be consideration for the employment of any person. Nothing herein contained shall be deemed to give any person the right to be retained in the employ of the Company or a Participating Employer or to restrict the right of the Company or Participating Employer to discharge any person at any time, nor shall the Plan be deemed to give the Company or a Participating Employer the right to require any person to remain in the employ of the Company or such Participating Employer or to restrict any person’s right to terminate his employment at any time.

18

12.2 Alienation of Interest Forbidden. The interest of a Participant or his Beneficiary(ies) may not be sold, transferred, assigned, or encumbered in any manner, either voluntarily or involuntarily, and any attempt to so anticipate, alienate, sell, transfer, assign, pledge, encumber, or charge the same shall be null and void, nor shall the benefits hereunder be liable for or subject to the debts, contracts, liabilities, engagements, or torts of any person to whom such benefits or funds are payable, nor shall they be an asset in bankruptcy or subject to garnishment, attachment, or other legal or equitable proceedings. The preceding notwithstanding, the Committee shall comply with the terms and provisions of an order that would qualify as a QDRO.

12.3 Withholding. All Deferred Compensation, Company Matching Contributions, if any, and benefit payments provided for under the Plan shall be subject to all applicable required withholding and other deductions as determined by the Company.

12.4 Amendment and Termination.

(a) Amendment and Termination with Respect to Grandfathered Benefits Only. The portion of the Plan that affects Grandfathered Benefits may be amended at any time, in whole or in part, provided however, that no amendment may be made that would reduce a Participant’s vested interest in his Grandfathered Benefits as of the date of adoption of such amendment. The Board on behalf of the Company has the absolute and unconditional right to terminate the Plan solely with respect to Grandfathered Benefits at any time. In the event that the Plan is so terminated, notwithstanding any other form of benefit elected by the Participant, the balance of each Participant’s Grandfathered Benefits shall be paid to such Participant or his Beneficiary in the manner selected by the Board or the Committee in their discretion (notwithstanding any other form of benefit elected by such Participant), which may include the payment of a single lump sum cash payment within 30 days, in full satisfaction of all of such Participant’s or Beneficiary’s benefits hereunder.

(b) Amendment and Termination with Respect to 409A Benefits Only. The portion of the Plan that affects 409A Benefits may be amended at any time, in whole or in part, provided, however, that such amendments shall not violate the requirements of Code Section 409A. In addition, the Board on behalf of the Company has the absolute and unconditional right to terminate the portion of the Plan that is subject to Code Section 409A upon occurrence of any one of the following events:

(1) Within 12 months of the Company’s dissolution, taxed under Code Section 331 or with the approval of a bankruptcy court pursuant to 11 U.S.C. Section 503(b)(1)(A), provided that the amounts deferred under the Plan are included in the Participants’ gross income in the latest of:

A. The calendar year in which Plan termination occurs;

B. The calendar year in which such amounts are no longer subject to a substantial risk of forfeiture; or

C. The first calendar year in which payment of such amounts is administratively practicable.

19

(2) Within the 30 days preceding or the 12 months following a Change of Control (within the meaning of Code Section 409A and related guidance issued thereunder), provided all substantially similar arrangements sponsored by the Company are also terminated, so that the Participant and all participants under substantially similar arrangements are required to receive all amounts of compensation deferred under the terminated arrangements within 12 months of the date of termination of the arrangements.

(3) At the discretion of the Company, provided that all of the following requirements are satisfied:

A. All arrangements sponsored by the Company that would be aggregated with any terminated arrangement under Treasury Regulation Section 1.409A-1(c), if the same Participant participated in all of the arrangements, are terminated;

B. No payments other than payments that would be payable under the terms of the arrangements if the termination had not occurred are made within 12 months of the termination of the arrangements;

C. All payments are made within 24 months of the termination of the arrangements; and

D. The Company does not adopt a new arrangement that would be aggregated with any terminated arrangement under Treasury Regulation Section 1.409A-1(c), if the same Participant participated in both arrangements, at any time within five (5) years following the date of termination of the arrangement.

(4) Such other events and conditions as the Commissioner of Internal Revenue may prescribe in generally applicable guidance published in the Internal Revenue Bulletin.

12.5 Severability. If any provision of the Plan shall be held illegal or invalid for any reason, said illegality or invalidity shall not affect the remaining provisions hereof; instead, each provision shall be fully severable, and the Plan shall be construed and enforced as if said illegal or invalid provision had never been included herein.

12.6 Receipt or Release. Any payment to a Participant or Beneficiary in accordance with the provisions of the Plan shall, to the extent thereof, be in full satisfaction of all claims against the Committee and the Company. The Committee may require such Participant or Beneficiary, as a condition precedent to such payment, to execute a receipt and release to such effect.

12.7 Governing Laws. All provisions of the Plan shall be construed in accordance with the laws of the State of California except to the extent preempted by federal law.

20

Exhibit A

Pay for Performance Plan

Sales Incentive Compensation Plan

21

EX-10.32(C)

Exhibit 10.32(c)

AMENDMENT NO. 2

TO THE

AMENDED AND RESTATED FOUNDRY AGREEMENT

DATED SEPTEMBER 28, 2006

THIS AMENDMENT NO. 2 (this “Amendment”) to the Amended and Restated Foundry Agreement made and entered into as of September 28, 2006, as amended effective as of June 19, 2008 (the “Agreement”), by and between Spansion Inc., a Delaware corporation, Spansion Technology, Inc., a Delaware corporation, and Spansion LLC, a Delaware limited liability company, solely in their capacities as guarantors of Spansion’s obligations hereunder and under the Agreement (“Guarantors”), Spansion Japan Limited, a Japanese corporation (“Spansion”), and Fujitsu Limited, a Japanese corporation (“Fujitsu”), and assigned by Fujitsu to Fujitsu Microelectronics Limited, a Japanese corporation (“FML”), effective March 21, 2008, is made and entered into to be effective as of December 31, 2008 (the “Amendment Date”).

Whereas, Spansion and FML wish to further amend the Agreement,

Now, therefore, it is agreed that the Agreement shall be modified as follows:

1. Pursuant to Section 16.1.2 of the Agreement, Spansion and FML hereby agree that the Term of the Agreement shall be extended to December 31, 2010.

2. Notwithstanding anything to the contrary set forth in Sections 2.6.1 through 2.6.6 of the Agreement, FML and Spansion hereby agree that the Subsequent Period Commitment and Subsequent Period Price for each Quarter of 2009 are as defined on Exhibit J attached to this Amendment. Spansion and FML further agree that except as otherwise expressly provided in Exhibit J, the Subsequent Period Remedies for each Quarter of 2009 shall remain as set forth in Sections 2.2 and 2.3 of the Agreement. Furthermore, FML and Spansion will negotiate in good faith to agree by June 30, 2009 upon (i) Spansion’s purchase commitment for each Quarter of 2010 (the “2010 Wafer Commitment”), (ii) Wafer prices for each Quarter of 2010 (the “2010 Wafer Price”), and (iii) any remedy available to (x) FML in case of failure by Spansion to satisfy its minimum purchase commitment, and (y) Spansion in case of failure by FML to make available to Spansion the corresponding minimum manufacturing capacity (the “2010 Remedies”). In this regard, FML and Spansion acknowledge that the 2010 Wafer Price shall be determined based on the 2009 Wafer Price of 45,000 Japanese yen per Wafer with consideration of the projected combined loading of the fab including Spansion wafers and FML wafers and of the volume level of Spansion’s purchase commitment in 2010 which is targeted to be 20,000 Wafers per Quarter.

3. Section 16.2 of the Agreement is amended to read in its entirety as follows:

“Notwithstanding the provisions of Section 16.1, either Party may at its option terminate this Agreement, without liability to the other Party, in the event that (i) the other Party fails to correct or cure any material breach by such other Party of any covenant or obligation under this Agreement within sixty (60) days after receipt by such other Party of a written notice from the non-defaulting Party specifying such breach, (ii) the other Party or any of its Affiliates fails to pay

1

its material debts as they come due, makes an assignment for the benefit of creditors (or takes similar action under United States, Japanese or other applicable law), or files a voluntary petition in bankruptcy (or makes a similar filing under United States, Japanese or other applicable law) or otherwise invokes any laws for the protection of debtors under United States, Japanese or other applicable law, or (iii) the other Party or any of its Affiliates has filed against it an involuntary petition in bankruptcy (or similar filing under United States, Japanese or other applicable law) and fails to obtain the dismissal of such petition within thirty (30) days after its filing. Further, FML may at its option terminate this Agreement, without liability to Spansion or any of its Affiliates, by delivery of written notice to Spansion in the event that Spansion or any of its Affiliates (“Spansion Group”) fails to make in full a payment to FML or any of its Affiliates (“FML Group”) pursuant to an agreement between a member of the FML Group and a member of the Spansion Group (including, without limitation, this Agreement) within thirty (30) days of the due date of such payment.”

4. Notwithstanding anything to the contrary set forth in Section 16.3 of the Agreement, if the Agreement is terminated by FML in accordance with Section 16.2 thereof (as amended as provided above in this Amendment), FML may at its option terminate any effective purchase order at the time of termination at its sole discretion, without liability to Spansion.

5. All capitalized terms used but not defined in this Amendment shall have the meanings assigned to such terms in the Agreement.

6. All terms and conditions of the Agreement not specifically modified by this Amendment shall remain unchanged and in full force and effect. This Amendment shall be deemed a part of and construed in accordance with the Agreement. This Amendment may be executed in counterparts.

2

IN WITNESS WHEREOF, the Parties hereto have caused this Amendment to be duly signed and executed to be effective as of the Amendment Date.

FUJITSU MICROELECTRONICS LIMITED
By:	/s/ Koichi Ishizaka
Name:	Koichi Ishizaka
Title:	Corporate Senior Vice President
SPANSION INC.
By:	/s/ Ajit Manocha
Name:	Ajit Manocha
Title:	EVP, WW Operations
SPANSION TECHNOLOGY, INC.
By:	/s/ Ajit Manocha
Name:	Ajit Manocha
Title:	EVP, WW Operations

3

SPANSION LLC
By:	/s/ Ajit Manocha
Name:	Ajit Manocha
Title:	EVP, WW Operations
SPANSION JAPAN LIMITED
By:	/s/ Masao Taguchi
Name:	Masao Taguchi
Title:	President, Spansion Japan

4

EXHIBIT J

Subsequent Period Commitment for each Quarter of 2009

Wafers Per Quarter

1Q CY09		2Q CY 09	2H (3Q-4Q) CY09*
25,000	**	35,000	85,000

* Aggregate number of Wafers for the third and fourth Quarters of 2009

** Consists of January 2009: 7,000 Wafers; February 2009: 8,000 Wafers; and March 2009: 10,000 Wafers

FML and Spansion agree that Spansion will have the right to defer its purchase of up to 15,000 Wafers out of the 85,000 aggregate Wafers committed for the third and fourth Quarters of 2009 to the first Quarter of 2010 (such Wafers to be deferred to the first Quarter of 2010 will be hereinafter called “Push Out Wafers”). FML and Spansion will negotiate in good faith to agree by March 31, 2009, as to the specific Subsequent Period Commitment for each of the third and fourth Quarters of 2009 and the number of Push Out Wafers, provided however that, in any event the aggregate of the Subsequent Period Commitment for the third and fourth Quarters of 2009 and the number of Push Out Wafers shall be 85,000 Wafers.

Subsequent Period Price for each Quarter of 2009

Wafer Price for each Quarter of 2009 shall be 45,000 Japanese Yen. However, in the event that Spansion fails to purchase its Subsequent Period Commitment for any Quarter of 2009 (or any month of the first Quarter of 2009 as provided above), then Spansion shall pay FML an amount equal to the product obtained by multiplying (i) 0.80, by (ii) 45,000 Japanese Yen, by (iii) the difference between (x) the Subsequent Period Commitment for that Quarter (or month of the first Quarter of 2009, as applicable), and (y) the number of Wafers actually purchased by Spansion under the Agreement during that Quarter (or month).

EX-10.39

Exhibit 10.39

AMENDMENT NO. 5 TO CREDIT AGREEMENT

AND AMENDMENT NO. 3 TO SECURITY AGREEMENT

This Amendment No. 5 to Credit Agreement and Amendment No. 3 to Security Agreement (this “Amendment”), dated as of December 23, 2008, amends that certain Credit Agreement, dated as of September 19, 2005 (as amended, the “Agreement”), among the financial institutions from time to time parties thereto (such financial institutions, together with their respective successors and assigns, are referred to hereinafter each individually as a “Lender” and collectively as the “Lenders”), Bank of America, N.A., with an office at 55 South Lake Avenue, Suite 900, Pasadena, California 91101, as administrative agent for the Lenders (in its capacity as agent, the “Agent”), Spansion LLC, a Delaware limited liability company (“Borrower”), and Spansion Inc., a Delaware corporation (“Parent”), and amends that certain Security Agreement, dated as of September 19, 2005 (as amended, the “Security Agreement”). Capitalized terms used and not otherwise defined herein shall have the meanings assigned to such terms in the Agreement.

RECITALS

WHEREAS, Borrower, the Lenders and the Agent have entered into the Agreement and Borrower and Agent have entered into the Security Agreement;

WHEREAS, Borrower desires to amend the Agreement and Security Agreement; and

WHEREAS, the Agent and the Lenders are willing to do so, subject to the terms and conditions stated herein.

NOW, THEREFORE, in consideration of the premises herein contained and other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Agent, the Required Lenders, and the Borrower hereby agree as follows.

AGREEMENT

Section 1. Amendments to the Agreement. The Agent, the Required Lenders, and the Borrower agree that the Agreement is hereby amended as follows

A. Section 1.1 of the Agreement is hereby amended in its entirety to read as follows:

1.1 Total Facility. Subject to all of the terms and conditions of this Agreement, the Lenders agree to make available a total credit facility of up to $45,000,000 (the “Total Facility”) to the Borrower from time to time during the term of this Agreement. The Total Facility shall be composed of a revolving line of credit consisting of Revolving Loans and Letters of Credit described herein.

B. Solely upon the effectiveness of the consent set forth in Section 3 below, Section 7.13 of the Agreement will be automatically amended by deleting the “and” immediately prior to clause (i) and adding the following clause (j) at the end of such Section:

“, and (j) the UBS Debt.”

1

C. Solely upon the effectiveness of the consent set forth in Section 3 below, Section 7.14 of the Agreement will be automatically amended by deleting the “and” immediately prior to clause (c) and adding the following clause (d) at the end of such Section:

“, and (d) the UBS Debt.”

D. Section 7.22 of the Agreement is hereby amended in its entirety to read as follows:

7.22 Minimum Cash Flow. On a consolidated basis, the Borrower (or, following the Approved Restructuring, Parent) shall have Cash Flow on the last day of each of the measurement periods set forth in the table below (each such day a “determination date”), calculated for the measurement periods ending on each such determination date, of at least (or no more negative than) the amount in such table corresponding to such measurement period date (amounts appearing in parentheses are negative):

Measurement Period	Cash Flow
The fiscal quarter ending on December 28, 2008	($	90,000,000	)
The two consecutive fiscal quarters ending on March 29, 2009	($	100,000,000	)
The three consecutive fiscal quarters ending on June 28, 2009	($	70,000,000	)
The four consecutive fiscal quarters ending on September 27, 2009	($	85,000,000	)
The five consecutive fiscal quarters ending December 27, 2009	($	120,000,000	)

Minimum Cash Flow levels for each fiscal quarter in any Fiscal Year commencing with Fiscal Year 2010 shall be determined by Agent, based upon the Latest Projections for such Fiscal Year delivered to Agent in accordance with Section 5.2(f). Such financial projections must credibly reflect expected performance by Borrower in each quarter of such Fiscal Year and shall otherwise be satisfactory to Agent in its reasonable credit judgment.

E. Section 7.23 of the Agreement is hereby amended in its entirety to read as follows:

7.23 Minimum EBITDA. On a consolidated basis, the Borrower (or, following the Approved Restructuring, Parent) shall have EBITDA on the last day of each of the fiscal quarters set forth in the table below (each such day a “determination date”), calculated for the four fiscal quarter period ending on each such determination date, of at least the amount in such table corresponding to such determination date:

Period Ending	EBITDA
December 28, 2008	$	220,000,000
March 29, 2009	$	240,000,000
June 28, 2009	$	270,000,000
September 27, 2009	$	280,000,000
December 27, 2009	$	310,000,000

2

Minimum EBITDA levels for each fiscal quarter in any Fiscal Year commencing with Fiscal Year 2010 shall be determined by Agent, based upon the Latest Projections for such Fiscal Year delivered to Agent in accordance with Section 5.2(f). Such financial projections must credibly reflect expected performance by Borrower in each quarter of such Fiscal Year and shall otherwise be satisfactory to Agent in its reasonable credit judgment.

F. Article 7 of the Agreement is hereby amended by adding the following Section 7.34 at the end of such Article:

7.34 Amendment to The UBS Loan Documents; Restriction on UBS Accounts. Neither the Parent nor any Borrower shall (a) amend, modify, or change, or shall permit or agree to, any amendment, modification, or change to the UBS Loan Documents, or (b) notwithstanding anything to the contrary contained in any Loan Document, maintain any securities, money market or deposit account with UBS other than the securities account in which the UBS Collateral is maintained, and Borrower further agrees that at no time shall such account contain any securities or assets other than the UBS Collateral.

G. Section 9.1(d) (Events of Default) of the Agreement is hereby amended to add to the first line thereof, after the reference to “Noteholder Obligations” the following:

“, the UBS Debt”

H. Annex A to the Agreement is hereby amended by adding the following definitions in the appropriate alphabetical order:

“Amendment No. 5” means that certain Amendment No. 5 to Credit Agreement, dated as of December     , 2008 by and among Parent and Borrowers, on the one hand and Agent and the Lenders, on the other hand.

“AR Securities” means those certain auction rate securities more specifically described in Schedule ARS-1 to the Credit Agreement.

“Availability Block” means a reserve established by Agent in an amount equal to $25,000,000.

“Cash Flow” means, with respect to any fiscal period of Parent, the amount equal to EBITDA, minus Fixed Charges minus, Capital Expenditures (excluding Capital Expenditures funded with Debt (other than Revolving Loans and other revolving advances or revolving loans under any of Parents’ or Borrowers’ credit facilities), but

3

including, without duplication, principal payments with respect to such Debt), plus the net cash proceeds arising from: (i) the sale of any capital assets, and (ii) the sale by Borrower or Parent of its stock issued in connection with a round of equity financing (so long as the issuance of such stock is permitted hereunder).

“Fixed Charge Coverage Ratio” means, with respect to any fiscal period of Parent, the ratio of (a) the sum of EBITDA, minus Capital Expenditures (excluding Capital Expenditures funded with Debt (other than Revolving Loans and other revolving advances or revolving loans under any of Parent’s or Borrowers’ credit facilities)), to (b) Fixed Charges.

“Fixed Charges” means, with respect to any fiscal period of Parent on a consolidated basis, without duplication, cash interest expense, scheduled principal payments of Debt (other than any repayments of Revolving Loans and any other revolving advances or loans under any of Parent’s or Borrowers’ credit facilities), and Federal, state, local and foreign income taxes.

“UBS Collateral” has the meaning specified in Section 3 of Amendment No. 5.

“UBS Debt” has the meaning specified in Section 3 of Amendment No. 5.

“UBS Loan Documents” has the meaning specified in Section 3 of Amendment No. 5.

I. The definition of “Applicable Margin” contained in Annex A to the Agreement is hereby amended in its entirety to read as follows:

“Applicable Margin” means:

(i) with respect to Base Rate Revolving Loans and all other Obligations (other than the LIBOR Rate Loans, the Unused Line Fee and the Letter of Credit Fee), 1.50%;

(ii) with respect to LIBOR Revolving Loans, 3.50%;

(iii) with respect to the Unused Line Fee, 0.50%; and

(iv) with respect to the Letter of Credit Fee, 3.50%.

Commencing on January 1, 2009, the Applicable Margins shall be adjusted (up or down) prospectively on a quarterly basis as determined by the Borrower’s consolidated financial performance, calculated pursuant to the terms of the last paragraph of this definition. Adjustments in Applicable Margins shall be determined by reference to the following grid:

Applicable Margins
Level	Fixed Charge Coverage Ratio	Base Rate Revolving Loans	LIBOR Revolving Loans	Letter of Credit Fee	Unused Line Fee
I	> 1.50	1.25%	3.25%	3.25%	0.50%
II	< 1.50, but > 1.25	1.50%	3.50%	3.50%	0.50%
III	< 1.25, but > 1.00	1.75%	3.75%	3.75%	0.50%
IV	< 1.00	2.25%	4.25%	4.25%	0.50%

4

The adjustment to the Applicable Margins effective on January 1, 2009 will be based on Parent’s and Borrowers’ Fixed Charge Coverage Ratio as reflected in the Financial Statements for the third fiscal quarter of 2008. All subsequent adjustments in the Applicable Margins shall be implemented quarterly on a prospective basis, for each calendar month commencing at least 5 days after the deadline date that such quarterly unaudited or annual audited (as applicable) Financial Statements evidencing the need for an adjustment are required to be delivered pursuant to the terms hereunder. Concurrently with the delivery of each quarterly unaudited or annual audited (as applicable) Financial Statement, the Borrower shall deliver to the Agent a certificate, signed by its chief financial officer or vice president of finance (or any other officer, acceptable to Agent, having similar responsibility and authority), setting forth in reasonable detail the basis for the continuance of, or any change in, the Applicable Margins. Failure to timely deliver such quarterly unaudited or annual audited (as applicable) Financial Statements (including the Financial Statements with respect to the third fiscal quarter of 2008) as required pursuant to the terms hereunder shall, in addition to any other remedy provided for in this Agreement, result in an increase in the Applicable Margins to the highest level set forth in the foregoing grid, until the first day of the first calendar month following the delivery of the quarterly unaudited or annual audited (as applicable) Financial Statements demonstrating that such an increase is not required. If a Default or Event of Default has occurred and is continuing at the time any reduction in the Applicable Margins is to be implemented, no reduction may occur until the first day of the first calendar month following the date on which such Default or Event of Default is waived or cured.

J. The definition of “Bank Products” contained in Annex A to the Agreement is hereby amended to read as follows:

“Bank Products” means any one or more of the following types of services or facilities extended to the Borrower by the Bank or any affiliate of the Bank in reliance on the Bank’s agreement to indemnify such affiliate: (i) credit cards; (ii) ACH Transactions; (iii) cash management, including controlled disbursement services; (iv) Hedge Agreements; and (v) all leases of Equipment and other assets financed by Bank or any of its affiliates.

5

K. The definition of “EBITDA” contained in Annex A to the Agreement is hereby amended to read as follows:

“EBITDA” means, with respect to any fiscal period of a Person, such Person’s Adjusted Net Earnings from Operations, plus, to the extent deducted in the determination of Adjusted Net Earnings from Operations for that fiscal period: (i) interest expenses, (ii) Federal, state, local and foreign income taxes, (iii) depreciation, amortization, and (iv) non-recurring, non-cash charges relating to any fixed asset write-off or write-down, with respect to impairment charges and asset write-offs or write-downs related to tangible or intangible assets, long-lived assets and investments, provided, however that such write-offs and write-downs set forth in this clause (iv) may only be added to such Person’s Adjusted Net Earnings from Operations to the extent that the same: (x) were not reflected in Borrowers’ projections delivered to Agent on or about November 25, 2008, (y) have been approved by Agent in its reasonable discretion, and (z) may not exceed the greater of (A) $200,000,000 during any one fiscal quarter of Borrowers, or (B) $400,000,000 during any fiscal year of Borrowers.

L. The definition of “Maximum Revolver Amount” contained in Annex A to the Agreement is hereby amended to read as follows:

“Maximum Revolver Amount” means $45,000,000.

M. Solely upon the effectiveness of the consent set forth in Section 3 below, the definition of “Permitted Liens” contained in Annex A to the Agreement will be automatically amended by deleting the “and” immediately after clause (k), adding an “and” after clause (l) and adding the following clause (m) at the end of such definition:

“(m) Liens held by the UBS Lenders on the UBS Collateral in connection with the UBS Debt.”

N. The definition of “Reserves” contained in Annex A to the Agreement is hereby amended to read as follows:

“Reserves” means reserves that limit the availability of credit hereunder, consisting of reserves against Availability and Eligible Accounts, established by Agent from time to time in Agent’s reasonable credit judgment. Without limiting the generality of the foregoing, the following reserves shall be deemed to be a reasonable exercise of Agent’s credit judgment: (a) Bank Product Reserves, (b) a reserve for accrued and unpaid interest on the Obligations, (c) Environmental Compliance Reserves, (d) a reserve for dilution, and (e) the Availability Block.

O. Schedule C-1 to the Agreement is hereby amended and restated in its entirety to read as set forth on Annex I attached hereto and by this reference made a part of the Agreement, as amended hereby.

P. Schedule ARS-1 attached hereto is hereby added to the Agreement.

Section 2. Amendments to the Security Agreement. The Agent and the Borrower agree that the Security Agreement is hereby amended as follows

6

A. The definition of “Cash Dominion Period” contained in the Security Agreement is hereby amended to read as follows:

“Cash Dominion Period” means a period of one or more days commencing upon (i) the occurrence of Availability (as defined in the Credit Agreement), without taking into account the Availability Block, measuring less than $35,000,000 and ending upon (ii) the occurrence of Availability (as defined in the Credit Agreement), without taking into account the Availability Block, measuring more than $35,000,000 for a sixty (60) consecutive day period.

Section 3. Limited Consents.

(a) Parent and the Borrowers have requested that Agent and the Lenders consent to the incurrence of Debt by Spansion LLC in the amount of $85,000,000 to UBS AG (the “UBS Debt”). Agent and the Lenders hereby consent to the UBS Debt (and to the security interest and liens on the UBS Collateral) subject to the following conditions: (i) no later than one week prior to the funding of the UBS Debt, Agent shall have received a copy of the loan documents with respect to the UBS Debt (the UBS Loan Documents”) and the same will be reasonably satisfactory to Agent in its sole discretion, (ii) the UBS Debt shall be secured solely by the AR Securities and any securities account where the same are maintained (the “UBS Collateral”), and (iii) upon funding of the UBS Debt, all proceeds thereof shall be deposited in a deposit or investment account subject to a control agreement reflecting Agent as the secured party and shall be otherwise used and maintained in accordance with the terms of the Agreement and the Security Agreement.

(b) Parent and the Borrowers have requested that Agent and the Lenders consent to the dissolution (the “Saifun Dissolution”) of Saifun Semiconductor USA, Inc. (“Saifun”). Notwithstanding anything to the contrary in the Agreement, Agent and the Lenders hereby consent to the Saifun Dissolution so long as: (i) all assets currently owned by Saifun (if any) are transferred to Spansion LLC and (ii) no liabilities are transferred to Parent or any Borrower as a result of the Saifun Dissolution.

(c) The foregoing consents shall not waive any other requirement or hinder, restrict or otherwise modify Agent’s and Lenders’ rights and remedies following the occurrence of any Default or Event of Default under the Credit Agreement. Except as otherwise expressed herein, the text of the Credit Agreement and the other Loan Documents shall remain in full force and effect, and Agent and Lenders hereby reserve the right to require strict compliance in the future with all terms and conditions of the Credit Agreement and the other Loan Documents.

Section 4. Waiver.

(i) Agent and the Lenders hereby waive, solely with respect to the measurement period ended September 28, 2008, the Event of Default under Section 9.1(c) of the Credit Agreement as a result of Borrower’s violation of the EBITDA covenant set forth in Section 7.23 for such periods (the “Waived Default”).

(ii) The waivers in this Section 4 shall become effective only in accordance with Section 5 hereof and then only in this specific instance and for the specific purposes set forth herein. The waivers in this Section 4 do not allow for any other or further departure from the terms and conditions of the Credit Agreement, as amended hereby, or any of the other Loan Documents, which terms and conditions shall remain in full force and effect.

Section 5. Conditions Precedent. The effectiveness of this Amendment is subject to the satisfaction of the following conditions precedent:

A. Amendment. A fully executed copy of this Amendment signed by the Borrower and the Required Lenders, and acknowledged by the Guarantor, shall be delivered to the Agent.

7

B. Assignment and Acceptance Agreements. Fully executed Assignment and Acceptance Agreements: (i) by and between Bank of America, N.A. and GE Business Financial Services Inc. and (ii) by and between Bank of America, N.A. and Wells Fargo Foothill, Inc.

C. Amendment Fee. The Borrower shall deliver to the Agent for the ratable benefit of the Lenders (pursuant to their respective Pro Rata Shares as amended hereby), an amendment fee in the amount of $225,000, which fee is fully earned and payable as of the date all parties to this Amendment execute the same (or release signatures pages that have been delivered and held in escrow).

Section 6. Miscellaneous.

A. Survival of Representations and Warranties. All representations and warranties made in the Agreement or any other document or documents relating thereto, including, without limitation, any Loan Document furnished in connection with this Amendment, shall survive the execution and delivery of this Amendment and the other Loan Documents, and no investigation by the Agent or the Lenders or any closing shall affect the representations and warranties or the right of the Agent or the Lenders to rely thereon.

B. Reference to Agreement. The Agreement and each of the other Loan Documents, and any and all other agreements, documents or instruments now or hereafter executed and delivered pursuant to the terms hereof, or pursuant to the terms of the Agreement as amended hereby, are hereby amended so that any reference therein to the Agreement shall mean a reference to the Agreement as amended hereby.

C. Agreement Remains in Effect. The Agreement and the other Loan Documents, as amended hereby, remain in full force and effect and the Borrower ratifies and confirms its agreements and covenants contained therein. The Borrower hereby confirms that, after giving effect to this Amendment, no Event of Default or Default exists as of the effective date of this Amendment.

D. Severability. Any provision of this Amendment held by a court of competent jurisdiction to be invalid or unenforceable shall not impair or invalidate the remainder of this Amendment and the effect thereof shall be confined to the provision so held to be invalid or unenforceable.

E. APPLICABLE LAW. THIS AMENDMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE INTERNAL LAWS (AS OPPOSED TO THE CONFLICT OF LAWS PROVISIONS PROVIDED THAT PERFECTION ISSUES WITH RESPECT TO ARTICLE 9 OF THE UCC MAY GIVE EFFECT TO APPLICABLE CHOICE OR CONFLICT OF LAW RULES SET FORTH IN ARTICLE 9 OF THE UCC) OF THE STATE OF CALIFORNIA.

F. Successors and Assigns. This Amendment is binding upon and shall inure to the benefit of the Agent, the Lenders, and the Borrower and their respective successors and assigns; provided, however, that the Borrower may not assign or transfer any of its rights or obligations hereunder without the prior written consent of the Lenders.

G. Counterparts. This Amendment may be executed in one or more counterparts, each of which when so executed shall be deemed to be an original, but all of which when taken together shall constitute one and the same instrument.

8

H. Headings. The headings, captions and arrangements used in this Amendment are for convenience only and shall not affect the interpretation of this Amendment.

I. NO ORAL AGREEMENTS. THIS AMENDMENT, TOGETHER WITH THE OTHER LOAN DOCUMENTS AS WRITTEN, REPRESENTS THE FINAL AGREEMENT AMONG THE AGENT, THE LENDERS, AND THE BORROWER AND MAY NOT BE CONTRADICTED BY EVIDENCE OF PRIOR, CONTEMPORANEOUS OR SUBSEQUENT ORAL AGREEMENTS OF THE PARTIES. THERE ARE NO UNWRITTEN ORAL AGREEMENTS AMONG THE AGENT, THE LENDERS, AND THE BORROWER.

*****

9

IN WITNESS WHEREOF, the parties have executed this Amendment on the date first above written.

“BORROWER”
SPANSION LLC,
a Delaware limited liability company
By:	/s/ Eric Branderiz
Name:	Eric Branderiz
Title:	Corporate VP of Finance, Corporate Controller

Amendment No. 5 to Credit Agreement and

Amendment No. 3 to Security Agreement

S-1

“PARENT”
SPANSION INC.,
a Delaware corporation
By:	/s/ Eric Branderiz
Name:	/s/ Eric Branderiz
Title:	Corporate VP, Corporate Controller

Amendment No. 5 to Credit Agreement and

Amendment No. 3 to Security Agreement

S-2

“AGENT”
BANK OF AMERICA, N.A., as the Agent
By:	/s/ Steven W. Sharp
Name:	Steven W. Sharp
Title:	Vice President

Amendment No. 5 to Credit Agreement and

Amendment No. 3 to Security Agreement

S-3

“LENDERS”
BANK OF AMERICA, N.A.,
By:	/s/ Steven W. Sharp
Name:	Steven W. Sharp
Title:	Vice President

Amendment No. 5 to Credit Agreement and

Amendment No. 3 to Security Agreement

S-4

Each of the undersigned parties (each, a “Guarantor”), (i) consents to and approves the execution and delivery of this Amendment by the parties hereto, (ii) agrees that this Amendment does not and shall not limit or diminish in any manner the obligations of the Guarantor pursuant to the guarantee delivered in connection with the Agreement (the “Guarantee”) by the undersigned and that such obligations would not be limited or diminished in any manner even if Guarantor had not reaffirmed this Amendment, (iii) agrees that this Amendment shall not be construed as requiring the consent of the Guarantor in any other circumstance, (iv) reaffirms each of its obligations under the Guarantee, and (v) agrees that the Guarantee remain in full force and effect and is hereby ratified and confirmed.

“GUARANTORS”
SPANSION INTERNATIONAL, INC.,
a Delaware corporation
By:	/s/ Eric Branderiz
Name:	Eric Branderiz
Title:	Corporate VP, Corporate Controller

Amendment No. 5 to Credit Agreement and

Amendment No. 3 to Security Agreement

S-5

SPANSION INC.,
a Delaware corporation
By:	/s/ Eric Branderiz
Name:	Eric Branderiz
Title:	Corporate VP, Corporate Controller

Amendment No. 5 to Credit Agreement and

Amendment No. 3 to Security Agreement

S-6

CERIUM LABORATORIES LLC,
a Delaware limited liability company
By:	/s/ Eric Branderiz
Name:	Eric Branderiz
Title:	Corporate VP, Corporate Controller

Amendment No. 5 to Credit Agreement and

Amendment No. 3 to Security Agreement

S-7

SPANSION TECHNOLOGY, LLC,
a Delaware corporation
By:	/s/ Mark Mohler
Name:	Mark Mohler
Title:	Treasurer

Amendment No. 5 to Credit Agreement and

Amendment No. 3 to Security Agreement

S-8

Annex I

SCHEDULE C-1

COMMITMENTS

Lender	Revolving Loan Commitment		Pro Rata Share
			(3 decimals)
Bank of America, N.A.	$	45,000,000	100.000	%

EX-10.41(C)

Exhibit 10.41(c)

To: The Finance Parties, as defined in the below-mentioned Facility Agreement

December 13, 2007

Dear Sir:

Request for Amendment No. 2

We refer to the senior facility agreement dated 30 March 2007 (the “Facility Agreement”) between, among others, Spansion Japan Limited and GE Capital Leasing Corporation as Administrative Agent and its subsequent amendment dated 1 August 2007.

Capitalized terms used in this letter, unless otherwise defined herein, shall have the meaning given to them in the Facility Agreement.

The Borrower hereby requests that Clause 3.1(c) be deleted and replaced in its entirety with the following provision:

“(c) refinancing all Refinancing Financial Indebtedness of the Borrower to third parties and financing the acquisition of any equipment and tools installed to SP1, other than the Manufacturing Equipment and those equipment and tools financed under Clause 3.1(b), in an amount no greater than the aggregate of the funding amount as indicated in Schedule 7 (Refinancing Financial Indebtedness Repayment Amount).”

Also, the Borrower hereby requests that Clause 5.3(b)(ii) be deleted and replaced in its entirety with the following provision:

“(ii) in relation to each other Loan, an amount equal to the aggregate amount of the relevant Utilization Funding Amount and the total of the funding amounts as indicated in Schedule 7 (Refinancing Financial Indebtedness Repayment Amount) in respect of the equipment and tools which have been purchased by the Borrower and for which financing has not been provided by the Lenders pursuant to this Clause.”

We hereby request confirmation of the Lenders’ consent to the above amendments by your countersignature and return of the enclosed copy of this letter.

The provisions of the Facility Agreement and the other Finance Documents shall, save as amended by this letter, continue in full force and effect.

This letter shall be governed by and controlled in accordance with Japanese law.

EX-10.41(E)

Exhibit 10.41(e)

To: The Finance Parties, as defined in the below-mentioned Facility Agreement

November 5, 2008

Dear Sir or Madam:

Request for Amendment No. 4 and Waiver

We refer to the senior facility agreement dated 30 March 2007 (the “Facility Agreement:”) between, among others, Spansion Japan Limited and GE Financial Services Corporation (formerly known as GE Capital Leasing Corporation) as Administrative Agent.

Capitalised terms used in this letter, unless otherwise defined herein, shall have the meaning given to them in the Facility Agreement.

We hereby request the following amendments to the Facility Agreement:

(1) that sub-paragraphs (e) and (f) of the definition of “Permitted Financial Indebtedness” in Clause 1.1 be deleted in their entirety and replaced with the following:

“(e) which is indebtedness to Spansion Inc. or any of its Subsidiaries;

(f) arising under an advance or deferred purchase agreement if such agreement is in respect of the supply of assets or services purchased in the ordinary course of business and payment is due more than 90 days after the date of supply; or

(g) not otherwise permitted by paragraphs (a) to (f) above and the outstanding principal amount of which does not exceed:

(i) in relation to revolving credit facilities of the Borrower, ¥18,000,000,000 (or its equivalent); and

(ii) in relation to any other debt of the Borrower, ¥2,500,000,000 (or its equivalent),

in each case, in aggregate for the Borrower at any time.”

(2) that Clause 21.5(a) be deleted and replaced in its entirety with:

“(a)

(i) Any indebtedness constituting trade credit extended to the Borrower on normal commercial terms by a person in the ordinary course of that person’s trading activities is not paid when due and such failure continues for a period of more than ten (10) Business Days after the Borrower receives written notice of the commencement or threatened commencement of any legal action or actions to compel payment or otherwise recover such indebtedness, or

(ii) any Financial Indebtedness of the Borrower other than that described in sub-paragraph (i) above is not paid when due nor paid prior to the expiry of:

(A) any grace period or cure period applicable to an agreement described at sub-paragraph (f) of the definition of “Permitted Financial Indebtedness” in Clause 1.1; or

(B) any originally applicable grace period or cure period in relation to any other Financial Indebtedness.”

(3) that Clause 21.5(b) be deleted and replaced in its entirety with the following provision:

“(b)

(i) Any indebtedness constituting trade credit extended to the Parent on normal commercial terms by a person in the ordinary course of that person’s trading activities is not paid when due and such failure continues for a period of more than ten (10) Business Days after the Parent receives written notice of the commencement or threatened commencement of any legal action or actions to compel payment or otherwise recover such indebtedness; or

(ii) any Financial Indebtedness of the Parent other than that described in sub-paragraph (i) above is not paid when due nor paid within 30 days of the expiry of any applicable grace period or cure period.”

(4) that Clause 21.6 be amended by adding the following phrase at the end of subparagraph (a) thereof: “, other than any negotiations relating to the rescheduling of any debt or indebtedness under an advance or deferred purchase agreement or constituting trade credit that is not caused by suspension or threatened suspension of the making of any payment on account of such debt or indebtedness.”

Borrower represents and warrants to the Finance Parties that as of the date of this letter, it has performed all such acts and executed all such documents as are required under the Security Agreement governed by Japanese law and dated 30 March 2007 among the Security Agent, the financial institutions listed therein and the Borrower, to create a security interest over the assets acquired by it under each advance or deferred purchase agreement for the supply of assets to which it or the Parent is a party.

Further, we hereby request that you agree to waive any Event of Default caused by any events or circumstances, that:

(a) have occurred or, prior to the date that the amendment requested herein is effected, do occur;

(b) result from any negotiations that the Borrower or the Parent has had or, prior to the date that the amendment requested herein is effected, does have, with any of its trade vendors or other unsecured creditors regarding concessions and/or any extension of payment terms, any deferrals of payments to its trade creditors or other unsecured creditors, and any similar actions or initiatives that the Borrower or the Parent has taken with respect to its trade vendors and other secured creditors: as part of its efforts to manage its liquidity and conduct its business; and

(c) do not, after effecting the amendment requested herein, constitute an Event of Default under the Facility Agreement as amended.

Please kindly indicate your acceptance to the above by countersigning this letter.

The provisions of the Facility Agreement and the other Finance Documents shall, save as amended by this letter, continue in full force and effect.

This letter is designated as a Finance Document.

This letter shall be governed by and construed in accordance with Japanese law.

Yours faithfully,

For and on behalf of

Spansion Japan Limited

EX-10.54

Exhibit 10.54

		UBS Bank USA
			Variable Credit Line Account Number: (if applicable)
			5V	66035	CP
			Fixed Credit Line Account Number: (if applicable)
Credit Line Account Application and Agreement for Organizations and Businesses			5F
			SS# / TIN
	HB			Internal Use Only

For Internal Use Only
Variable Credit Line Account at UBS Bank USA
Spansion LLC	5V	66035	CP
Fixed Credit Line Account at UBS Bank USA
	5F

Collateral Account(s) at UBS Financial Services Inc.

Insert the information below for each UBS Financial Services Inc account to be pledged to secure the Borrower’s credit line.

Full Collateral (Securities) Account Title	Branch	Account Number	FA#
1)    Spansion LLC	CP	15255	CPG2
2)
3)
4)
5)
6)

Credit Line Account

Select the type of credit line account:

þ    Variable Credit Line Account

¨    Fixed Credit Line Account

¨    Both

If you do not indicate your preference you will be deemed to have

selected the “Both” option.

Account Ownership	Select the Organization/Business Structure:
Is this entity/organization a business that provides commercial goods or services (i.e., an operating entity? þ  Yes    ¨  No Any changes or corrections to the information on this application must be initialed by you.	¨    Corporation ¨    Corp- Subchapter ‘S’ þ     Limited Liability Company (LLC) ¨    Limited Liability Partnership (LLP) ¨    Limited Liability-Limited Partnership (LLLP) ¨    Sole Proprietorship ¨    Partnership-General ¨    Partnership-Limited ¨    Association ¨    Partnership-Invest Club ¨    Invest Club Membership	¨    Fed Charter-Credit Union ¨    Foundation-not for profit ¨    Endowment-not for profit ¨    State Charter-S&L Bank ¨    State Charter-Savings Bank ¨    State Charter-Comm Bank ¨    State Charter-Trust Co. ¨    State Charter-Credit Union ¨    State Charter-Indus Loan ¨    Fed Charter-Savings Assoc ¨    Fed Charter-Nat’l Bank	¨    Fed Charter-Trust Co. ¨    Govt Agency-Federal ¨    Govt Agency-Local Ent ¨    Govt Agency-State
Borrower Information This section should be completed by the Organization/Business.
Borrower Organization/Business Name Spansion LLC		Location of Address þ     Business - Primary	¨      Other (please specify)
Organization/Business is (please complete each item that applies):
1)    þ Incorporated 2)    þ For Profit	¨      Unincorporated ¨      Not For Profit	Street Address (if a P.O. Box, complete the Additional Address Information on page 3): 915 DeGuigne Drive               P.O. Box 3453
Industry Group (e.g., Construction, Service, etc.):		City:    Sunnyvale                        State:    CA                         ZIP:  94085
Is the Organization/Business publicly listed?        ¨  No    þ  Yes;    specify:		Business Telephone Number:   408-962-2500
NASDAQ	SPSN
Exchange (NYSE, AMEX, or NASDAQ)	Ticker Symbol
Place of Formation / Incorporation
þ    USA (if formed/incorporated, specify State):	DELAWARE
¨    Other (specify)
TIN:	Date of Incorporation / Establishment:
65-1180482	04/15/2003

HB Rev 11/08 HB LOAD SPEDOC UX E HB V102	©2008 UBS Bank USA. All rights reserved.
	Sign and date the application on page 4

	UBS Bank USA
		Variable Credit Line Account Number: (if applicable)
		5V	66035	CP
		Fixed Credit Line Account Number: (if applicable)
		5F
		SS# / TIN
			Internal Use Only

Borrower Financial and Ownership Information
Annual Income:		Liquid Assets:		Is the Borrower an officer or member of the board of directors of UBS AG, its subsidiaries or affiliates?*
0		$625,506,000
Net Worth		Fiscal Year End (indicate month)		¨    Yes     þ    No    If yes, please specify:
$1,632,448,000		DEC
Do you receive a substantial amount of your revenue/wealth (over 50%) (trade/export) from a country outside of the United States?				Subsidiary or Affiliate		Employee Name and SS#
¨    Yes    þ    No    If yes specify: Country(ies): Does the Borrower own 10% or more of the shares of any publicly traded company?				Is the Borrower an immediate family member of an executive officer or member of the board of directors of UBS AG? Immediate family member means a spouse or any other relative residing in the Borrower’s household to whom the Borrower lends financial support.
				¨    Yes     þ    No    If yes, please specify:
¨    Yes    þ    No    If yes, please specify company and %:				Subsidiary or Affiliate		Employee Name and SS#
			%	Will any of the loan proceeds be used to repay any debt or obligation owed to, or purchase an asset from, UBS AG or its subsidiaries or affiliates?
				¨    Yes     þ    No    If yes, please specify:
Are any of the Borrowers, business owners or directors/principal officers a control person of UBS AG or its subsidiaries or affiliates?*				Subsidiary or Affiliate
¨    Yes    þ    No    If yes, please specify company and %:
			%
*For purposes these questions, “control” means a person or entity that either (a) owns, controls or has the power to vote 25% or more of any class of voting securities, (b) has the ability to control the election of the majority of the directors of a company, or (c) has the power to exercise a controlling influence over management policies. A person or entity is presumed to have control of a company if the person or entity owns, controls or has the power to vote 10% or more of any class of voting securities of the company and (i) the person is an executive officer or director of the company or (ii) no other person has a greater percentage of that class of voting securities. Principal Officer/Beneficial Owner Complete this section for the Principal Officer(s) of the borrower, or beneficial owner for an LLC. To include additional principal officers please photocopy this page and submit it with the application.
Prinicipal Officer Name                                             SS#				Prinicipal Officer Name                                             SS#
Dario Sacomani, EVP & CFO Spansion Inc.				Mark Mohler, Treasurer Spansion Inc.
Country of Citizenship:                Date of Birth    [Date of Birth]				Country of Citizenship:                Date of Birth    [Date of Birth]
þ    USA                              ¨    Other (specify)				þ    USA                              ¨    Other (specify)
Passport/CEDULA and Green Card#: (If non-U.S. and no SS# specified)				Passport/CEDULA and Green Card#: (If non-U.S. and no SS# specified)
[Passport Number]	/			[Passport Number]	/
Passport/CEDULA Country of Issuance:				Passport/CEDULA Country of Issuance:
Street Address:				Street Address:
915 DeGuigne Drive				915 DeGuigne Drive
City:                            State:                             ZIP				City:                            State:                             ZIP
Sunnyvale                         CA                             94085				Sunnyvale                            CA                             94085
Telephone Number:				Telephone Number:

HB Rev 11/08 HB LOAD SPEDOC UX E HB V102 2 ©2008 UBS Bank USA.  All rights reserved. Sign and date the application on page 4

	UBS Bank USA
		Variable Credit Line Account Number: (if applicable)
		5V	66035	CP
		Fixed Credit Line Account Number: (if applicable)
		5F
		SS# / TIN
Credit Line Account Features			Internal Use Only

Check Writing	Alternate Mailing Address for Checks
If you would like to receive Credit Line checks for your credit line account, please enroll below:	Print the mailing address for the delivery of checks if different from the address on the checks:
¨  Check here if you would like Credit Line checks.
Check will be in the name of the Borrower.
Please print the address that you would like to appear on your checks.
	Wire Instructions for Loan Payment: (In US Dollars)
	Bank Name: UBS AG
	Wire System Address: ABA 026007993
	For Further Credit to the Account of: UBS Bank USA
	Account Number: 101-WA-792479-000
	For the Benefit of: Full Name
	Account Number: 5[F or V] 00000

Senior Political Affiliation
I)	Is client, any authorized signatories, beneficial owners, trustees, power of attorneys of other individuals with authority to effect transactions a current U.S. political official (as defined in B below)? þ No ¨ Yes if yes, complete:
	A)  Official’s Name:
	B)  Current Position:	¨	President	¨	Vice President	¨	US Cabinet Member
		¨	Member of the House of Representatives			¨	Supreme Court Justice
		¨	Chairman of the Joint Chiefs of Staff			¨	Governor
		¨	Senator
	C)  Relationship to Client(s):	¨	Self	¨	Immediate family member	¨	Close associate
		¨	Associated with business or trust
II)	Is client, any authorized signatories, beneficial owners, trustees, power of attorneys or other individuals with authority to effect transactions, or any of their immediate family members or close associates a current or former Senior non-U.S. political official, or Senior/Influential representative of a major non-U.S. political party or state owned enterprise of national importance? þ No ¨ Yes if yes, complete:
	Political Official’s Name:
	Current or Former Position:
	Relationship to Client(s):	¨	Self	¨	Immediate family member	¨	Close associate
		¨	Associated with business or trust

Duplicate Party Addendum
Complete this section for each Duplicate Party to receive a duplicate credit line account statement.
		Internal Location Code (UBS Financial Services, Inc. use only)
Name:		Country of Citizenship:
		¨    USA	¨    Other(specify):
Street Address		City:		State:	ZIP:
Additional Address Information
If the Borrower’s mailing address is a P.O. Box please provide a legal residence address below.
First Name:	Last Name:	Street Address:
Location of Address
¨    Business - Primary
¨    Business - Secondary		City:		State:	ZIP:
¨    Other (Specify)

      HB Rev 11/08 HB LOAD SPEDOC UX E HB V102 3 ©2008 UBS Bank USA  All rights reserved. Sign and date the application on page 4

	UBS Bank USA
		Variable Credit Line Account Number: (if applicable)
		5V	66035	CP
		Fixed Credit Line Account Number: (if applicable)
		5F
		SS# / TIN
Credit Line Agreement			Internal Use Only

Borrower Agreement

BY SIGNING BELOW, THE BORROWER UNDERSTANDS, ACKNOWLEDGES AND AGREES THAT:

A The Borrower has received and read a copy of this Borrower Agreement, the attached Credit Line Account Application and Agreement (including the Credit Line Agreement following this Borrower Agreement) and the Loan Disclosure Statement explaining the risk factors that the Borrower should consider before obtaining a loan secured by the Borrower securities account. The Borrower agrees to be bound by the terms and conditions contained in the Credit Line Account Application and Agreement (including the Credit Line Agreement following this Borrower Agreement) (which terms and conditions are incorporated by reference). Capitalized terms used in this Borrower Agreement have the meanings set forth in the Credit Line Agreement.

B THE BORROWER UNDERSTANDS AND AGREES THAT UBS BANK USA MAY DEMAND FULL OR PARTIAL PAYMENT OF THE CREDIT LINE OBLIGATIONS, AT ITS SOLE OPTION AND WITHOUT CAUSE, AT ANY TIME, AND THAT NEITHER FIXED RATE ADVANCES NOR VARIABLE RATE ADVANCES ARE EXTENDED FOR ANY SPECIFIC TERM OR DURATION. THE BORROWER UNDERSTANDS AND AGREES THAT ALL ADVANCES ARE SUBJECT TO COLLATERAL MAINTENANCE REQUIREMENTS. THE BORROWER UNDERSTANDS THAT UBS BANK USA MAY, AT ANY TIME, IN ITS DISCRETION. TERMINATE AND CANCEL THE CREDIT LINE REGARDLESS OF WHETHER OR NOT AN EVENT HAS OCCURRED.

C UNLESS DISCLOSED IN WRITING TO UBS BANK USA AT THE TIME OF THIS AGREEMENT, AND APPROVED BY UBS BANK USA, THE BORROWER AGREES NOT TO USE THE PROCEEDS OF ANY ADVANCE EITHER TO PURCHASE, CARRY OR TRADE IN SECURITIES OR TO REPAY ANY DEBT (I) USED TO PURCHASE, CARRY OR TRADE IN SECURITIES OR (II) TO ANY AFFILIATE OF UBS BANK USA. THE BORROWER WILL BE DEEMED TO REPEAT THIS AGREEMENT EACH TIME THE BORROWER REQUESTS AN ADVANCE.

D THE BORROWER UNDERSTANDS THAT BORROWING USING SECURITIES AS COLLATERAL ENTAILS RISKS. SHOULD THE VALUE OF THE SECURITIES IN THE COLLATERAL ACCOUNT DECLINE BELOW THE REQUIRED COLLATERAL MAINTENANCE REQUIREMENTS, UBS BANK USA MAY REQUIRE THAT THE BORROWER POST ADDITIONAL COLLATERAL REPAY PART OR ALL OF THE BORROWER’S LOAN AND/OR SELL THE BORROWER’S SECURITIES. ANY REQUIRED LIQUIDATIONS MAY INTERRUPT THE BORROWER’S LONG-TERM INVESTMENT STRATEGIES AND MAY RESULT IN ADVERSE TAX CONSEQUENCES.

E Neither UBS Bank USA nor UBS Financial Services Inc. provides legal or tax advice and nothing herein shall be construed as providing legal or tax advice.

F Upon execution of this Credit Line Account Application and Agreement, the Borrower declares that all of the information requested in the Application and supplied by the Borrower is true and accurate and further agrees to promptly notify UBS Bank USA in writing of any material changes to any or all of the information contained in the Application including information relating to the Borrower’s financial situation.

G Subject to any applicable financial privacy laws and regulations, data regarding the Borrower and the Borrower’s securities accounts may be shared with UBS Bank USA affiliates. Subject to any applicable financial privacy laws and regulations, the Borrower requests that UBS Bank USA share such personal financial data with non-affiliates of UBS Bank USA as is necessary or advisable to effect, administer or enforce, or service, process or maintain, all transactions and accounts contemplated by this Agreement.

H The Borrower authorizes UBS Bank USA and UBS Financial Services Inc. to obtain a credit report or other credit references concerning the Borrower (including making verbal or written inquiries concerning credit history) or to otherwise verify or update credit information given to UBS Bank USA at any time. The Borrower authorizes the release of this credit report or other information to UBS Bank USA affiliates as it deems necessary or advisable to effect, administer or enforce, or to service, process or maintain all transactions and accounts contemplated by this Agreement, and for the purpose of offering additional products, from time to time, to the Borrower. The Borrower authorizes UBS Bank USA

to exchange Borrower information with any party it reasonably believes is conducting a legitimate credit inquiry in accordance with the Fair Credit Reporting Act. UBS Bank USA may also share credit or other transactional experience with the Borrower’s designated UBS Financial Services Inc Financial Advisor or other parties designated by the Borrower.

I UBS Bank USA is subject to examination by various Federal, state and self-regulatory organizations and the books and records maintained by UBS Bank USA are subject to inspection and subpoena by these regulators and by federal, state, and local law enforcement officials. The Borrower also acknowledges that such regulators and officials may, pursuant to treaty or other arrangements, in turn disclose such information to the officials or regulators of other countries, and that U.S. courts may be required to compel UBS Bank USA to disclose such information to the officials or regulators of other countries. The Borrower agrees that UBS Bank USA may disclose to such regulators and officials information about the Borrower and transactions in the credit line account or other accounts UBS Bank USA without notice to the Borrower. In addition, UBS Bank USA may in the context of a private dispute be required by subpoena or other judicial process to disclose information or produce documentation related to the Borrower, the credit line account or other accounts at UBS Bank USA. The Borrower acknowledges and agrees that UBS Bank USA reserves the right, in its sole discretion, to respond to subpoena and judicial process as it deems appropriate.

J To help the government fight the funding of terrorism and money laundering activities, Federal law requires all financial institutions to obtain, verify, and record information that identifies each person who opens an account. When the Borrrower opens an account with UBS Bank USA, UBS Bank USA will ask for the Borrower’s name, address, and other information that will allow UBS Bank USA to identify the Borrower. UBS Bank USA may also ask to see other identifying documents. UBS Financial Services Inc. and UBS Bank USA are firmly committed to compliance with all applicable laws, rules and regulations, including those related to combating money laundering. The Borrower understands and agrees that the Borrower must take all necessary steps to comply with the anti-money laundering laws, rules and regulations of the Borrower’s country of origin, country of residence and the situs of the Borrower’s transaction.

K UBS Bank USA and its affiliates will act as creditors and, accordingly, their interests may be inconsistent with, and potentially adverse to, the Borrower’s interests. As a lender and consistent with normal lending practice, UBS Bank USA may take any steps necessary to perfect its interest in the Credit Line, issue a call for additional collateral or force the sale of the Borrower’s securities if the Borrower’s actions or inactions call the Borrower’s creditworthiness into question. Neither UBS Bank USA nor UBS Financial Services Inc. will act as Client’s investment advisor with respect to any liquidation. In fact UBS Bank USA will act as a creditor and UBS Financial Services Inc. will act as a securities intermediary

L The Borrower understands that, if the Collateral Account is a managed account with UBS Financial Services Inc., (i) in addition to any fees payable to UBS Financial Services Inc. in connection with the Borrower’s managed account, interest will be payable to the Bank on an amount advanced to the Borrower in connection with the Credit Line Account, and (ii) the performance of the managed account might not exceed the managed account fees and the interest expense payable to the Bank in which case the Borrower’s overall rate of return will be less than the costs associated with the managed account.

M UBS Bank USA may provide copies of all credit line account statements to UBS Financial Services Inc. and to any Guarantor. The Borrower acknowledges and agrees that UBS Bank USA may share any and all information regarding the Borrower and the Borrower’s accounts at UBS Bank USA with UBS Financial Services Inc. UBS Financial Services Inc. may provide copies of all statements and confirmations concerning each Collateral Account to UBS Bank USA at such times and in such manner as UBS Bank USA may request and may share with UBS Bank USA any and all information regarding the Borrower and the Borrower’s accounts with UBS Financial Services Inc.

IN WITNESS WHEREOF, the undersigned (“Borrower”) has signed this Agreement, or has caused this Agreement to be signed in its name by its duly authorized
representatives, as of the date indicated below.	DATE: 12/23/08

Name of Borrower: Spansion LLC–

By:	/s/ Eric Branderiz	Title : Corporate VP & Corporate Controller Spansion Inc. Managing Member Spansion LLC
	(Signature of Authorized Signatory of Borrower) Eric Branderiz	(Title of Authorized Signatory of Borrower)
By:	/s/ Mark Mohler	Title: Treasurer Spansion Inc. Managing Member Spansion LLC
	(Signature of Authorized Signatory of Borrower)* Mark Mohler	(Title of Authorized Signatory of Borrower)

The authorized signatory of the Borrower must be one of the Authorized Persons designated on the applicable UBS Bank USA supplemental form executed by the Borrower (e.g., the Supplemental Corporate Resolution Form (HP Form)).

HB Rev 11/08 HB LOAD SPEDOC UX E HB V102 4 ©2008 UBS Bank USA  All rights reserved. Sign and date the application on page 4

	UBS Bank USA
		Variable Credit Line Account Number: (if applicable)
		5V	66035	CP
		Fixed Credit Line Account Number: (if applicable)
		5F
		SS# / TIN
Credit Line Agreement			Internal Use Only

Credit Line Agreement - Demand Facility

THIS CREDIT LINE AGREEMENT (as it may be amended, supplemented or otherwise modified from time to time, this “Agreement”) is made by and between the party or parties signing as the Borrower on the Application to which this Agreement is attached (together and individually, the “Borrower”) and UBS Bank USA (the “Bank”) and, together with the Application, establishes the terms and conditions that will govern the uncommitted demand loan facility made available to the Borrower by the Bank. This Agreement becomes effective upon the earlier of (i) notice from the Bank (which notice may be oral or written) to the Borrower that the Credit Line has been approved and (ii) the Bank making an Advance to the Borrower.

1) Definitions

- “Advance” means any Fixed Rate Advance or Variable Rate Advance made by the Bank pursuant to this Agreement.

- “Advance Advice” means a written or electronic notice by the Bank, sent to the Borrower, the Borrower’s financial advisor at UBS Financial Services Inc. or any other party designated by the Borrower to receive the notice, confirming that a requested Advance will be a Fixed Rate Advance and specifying the amount, fixed rate of interest and Interest Period for the Fixed Rate Advance.

- “Application” means the Credit Line Account Application and Agreement that the Borrower has completed and submitted to the bank and into which this Agreement is incorporated by reference.

- “Approved Amount” means the maximum principal amount of Advances that is permitted to be outstanding under the Credit Line at any time, as specified in writing by the Bank.

- “Breakage Costs” and “Breakage Fee” have the meaning specified in Section 6(b).

- “Business Day” means a day on which both of the Bank and UBS Financial Services Inc. are open for business. For notices and determinations of LIBOR, Business Day must also be a day for trading by and between banks in U.S. dollar deposits in the London interbank market.

- “Collateral” has the meaning specified in Section 8(a).

- “Collateral Account” means, individually and collectively, each account of the Borrower or Pledgor at UBS Financial Services Inc. or UBS International Inc., as applicable, that is either identified as a Collateral Account on the Application to which this Agreement is attached or subsequently identified as a Collateral Account by the Borrower or Pledgor, either directly or indirectly through the Borrower’s or Pledgor’s UBS Financial Services Inc. financial advisor, together with all successors to those identified accounts, irrespective of whether the successor account bears a different name or account number.

- “Credit Line” has the meaning specified in Section 2(a).

- “Credit Line Account” means each Fixed Rate Account and each Variable Rate Account of the Borrower that is established by the Bank in connection with this Agreement and either identified on the Application or subsequently identified as a Credit Line Account by the Bank by notice to the Borrower, together with all successors to those identified accounts, irrespective of whether any successor account bears a different name or account number.

- “Credit Line Obligations” means, at any time of determination, the aggregate of the outstanding principal amounts of all Advances, together with all accrued but unpaid interest on the outstanding principal amounts, any and all fees or other charges payable in connection with the Advances and any costs of collection (including reasonable attorneys’ fees) and other amounts payable by the Borrower under this Agreement, and any and all other present or future obligations of the Borrower and the other respective Loan

Parties under this Agreement and the related agreements, whether absolute or contingent, whether or not due or mature.

- “Event” means any of the events listed in Section 10.

- “Fixed Rate Advance” means any advance made under the Credit Line that accrues interest at a fixed rate.

- “Guarantor” means any party who guaranties the payment and performance of the Credit Line Obligations.

- “Guaranty Agreement” means an agreement pursuant to which a Guarantor agrees to guaranty payment of the Credit Line Obligations.

- “Interest Period” means, for a Fixed Rate Advance, the number of days, weeks or months requested by the Borrower and confirmed in the Advance Advice relating to the Fixed Rate Advance, commencing on the date of (i) the extension of the Fixed Rate Advance or (ii) any renewal of the Fixed Rate Advance and, in each case, ending on the last day of the period. If the last day is not a Business Day, then the Interest Period will end on the immediately succeeding Business Day. If the last Business Day would fall in the next calendar month, the Interest Period will end on the immediately preceding Business Day. Each monthly or longer Interest Period that commences on the last Business Day of a calendar month (or on any day for which there is no numerically corresponding day in the appropriate subsequent calendar month) will end on the last Business Day of the appropriate calendar month.

- “Joint Borrower” has the meaning specified in Section 7(a).

- “LIBOR” means, as of any date of determination for Variable Rate Advances, the prevailing London Interbank Offered Rate for deposits in U.S. dollars having a maturity of 30 days as published in The Wall Street Journal “Money Rates” Table on the date of the Advance.

If the rate ceases to be regularly published by The Wall Street Journal, LIBOR will be determined by the Bank in its sole and absolute discretion. For any day that is not a Business Day, LIBOR will be the applicable LIBOR in effect immediately prior to the day.

- “Loan Party” means each Borrower, Guarantor and Pledgor, each in their respective capacities under this Agreement or any related agreement.

- “Person” means any natural person, company, corporation, firm, partnership, joint venture, limited liability company or limited liability partnership, association, organization or any other legal entity.

- “Pledgor” means each Person who pledges to the Bank any Collateral to secure the Credit Line Obligations (or to secure the obligations of any Guarantor with respect to the guaranty of the Credit Line Obligations). Pledgors will include (i) each Borrower who pledges Collateral to secure the Credit Line Obligations, (ii) each Guarantor who has pledged collateral to secure the Credit Line Obligations or its obligations under a Guaranty Agreement, (iii) any spouse of a Borrower who executes a spouse’s pledge and consent agreement with respect to a jointly held collateral account, (iv) any other joint account holder who executes a joint account holder pledge and consent agreement with respect to a jointly held

HB Rev 11/08 HB LOAD SPEDOC UX E HB V102 5 ©2008 UBS Bank USA  All rights reserved. Sign and date the application on page 4

	UBS Bank USA
		Variable Credit Line Account Number: (if applicable)
		5V	66035	CP
		Fixed Credit Line Account Number: (if applicable)
		5F
		SS# / TIN
Credit Line Agreement			Internal Use Only

collateral account, and (v) any other Person who executes a pledge agreement with respect to the Credit Line.

- “Premier Credit Line” means any Credit Line with an Approved Amount equal to or greater than $100,000.

- “Prime Credit Line” means any Credit Line with an Approved Amount less than $100,000.

- “Prime Rate” means the floating “Prime Rate” as published in The Wall Street Journal “Money Rates” Table from time to time. The Prime Rate will change as and when the Prime Rate as published in The Wall Street Journal changes. In the event that The Wall Street Journal does not publish a Prime Rate, the Prime Rate will be the rate as determined by the Bank in its sole and absolute discretion.

- “Securities Intermediary” has the meaning specified in Section 9.

- “UBS Bank USA Fixed Funding Rate” means, as of any date of determination for Fixed Rate Advances, an internally computed rate established from time-to-time by the Bank, in its sole discretion, based upon the LIBOR swap curve for a corresponding period as well as the Bank’s assessment of other lending rates charged in the financial markets.

- “UBS Financial Services Inc.” means UBS Financial Services Inc. and its successors.

- “UBS-I means UBS International Inc. and its successors.

- “Variable Rate Advance” means any advance made under the Credit Line that accrues interest at a variable rate.”

2) Establishment of Credit Line; Termination

a) Upon the effectiveness of this Agreement, the Bank establishes an UNCOMMITTED, DEMAND revolving line of credit (the “Credit Line”) in an amount up to the Approved Amount. The Bank may, from time to time upon request of the Borrower, without obligation and in its sole and absolute discretion, authorize and make one or more Advances to the Borrower. The Borrower acknowledges that the Bank has no obligation to make any Advances to the Borrower. The Bank may carry each Variable Rate Advance in a Variable Rate Account and may carry each Fixed Rate Advance in a Fixed Rate Account, but all Advances will constitute extensions of credit pursuant to a single Credit Line. The Approved Amount will be determined, and may be adjusted from time to time, by the Bank in its sole and absolute discretion.

b) THE BORROWER AND EACH OTHER LOAN PARTY UNDERSTAND AND AGREE THAT THE BANK MAY DEMAND FULL OR PARTIAL PAYMENT OF THE CREDIT LINE OBLIGATIONS, AT ITS SOLE AND ABSOLUTE DISCRETION AND WITHOUT CAUSE, AT ANY TIME, AND THAT NEITHER FIXED RATE ADVANCES NOR VARIABLE RATE ADVANCES ARE EXTENDED FOR ANY SPECIFIC TERM OR DURATION.

c) UNLESS DISCLOSED IN WRITING TO THE BANK AT THE TIME OF THE APPLICATION, AND APPROVED BY THE BANK, THE BORROWER AGREES NOT TO USE THE PROCEEDS OF ANY ADVANCE EITHER TO PURCHASE, CARRY OR TRADE IN SECURITIES OR TO REPAY ANY DEBT (I) USED TO PURCHASE, CARRY OR TRADE IN SECURITIES OR (II) TO ANY AFFILIATE OF THE BANK. THE BORROWER WILL BE DEEMED TO REPEAT THE AGREEMENT IN THIS SECTION 2(C) EACH TIME IT REQUESTS AN ADVANCE.

d) Prior to the first Advance under the Credit Line, the Borrower must sign and deliver to the Bank a Federal Reserve Form U-1 and all other documentation as the Bank may require. The Borrower acknowledges that neither the Bank nor any of its affiliates has advised the Borrower in any manner regarding the purposes for which the Credit Line will be used.

e) The Borrower consents and agrees that, in connection with establishing the Credit Line Account, approving any Advances to the Borrower or for any other purpose associated with the Credit Line, the Bank may obtain a consumer or other credit report from a credit reporting agency relating to the Borrower’s credit history. Upon request by the Borrower, the Bank will inform the Borrower: (i) whether or not a consumer or other credit report was requested; and (ii) if so, the name and address of the consumer or other credit reporting agency that furnished the report.

f) The Borrower understands that the Bank will, directly or indirectly, pay a portion of the interest that it receives to the Borrower’s financial advisor at UBS Financial Services Inc. or one of its affiliates. To the extent permitted by applicable law, the Bank may also charge the Borrower fees for establishing and servicing the Credit Line Account.

g) Following each month in which there is activity in the Borrower’s Credit Line Account in amounts greater than $1, the Borrower will receive an account statement showing the new balance, the amount of any new Advances, year to date interest charges, payments and other charges and credits that have been registered or posted to the Credit Line Account.

h) Each of the Loan Parties understands and agrees that the Bank may, at any time, in its sole and absolute discretion, terminate and cancel the Credit Line regardless of whether or not an Event has occurred. In the event the Bank terminates and cancels the Credit Line the Credit Line Obligations shall be immediately due and payable in full. If the Credit Line Obligations are not paid in full, the Bank shall have the right, at its option, to exercise any or all of its remedies described in Section 10 of this Agreement.

3) Terms of Advances

a) Advances made under this Agreement will be available to the Borrower in the form, and pursuant to procedures, as are established from time to time by the Bank in its sole and absolute discretion. The Borrower and each Loan Party agree to promptly provide all documents, financial or other information in connection with any Advance as the Bank may request. Advances will be made by wire transfer of funds to an account as specified in writing by the Borrower or by any other method agreed upon by the Bank and the Borrower. The Borrower acknowledges and agrees that the Bank will not make any Advance to the Borrower unless the collateral maintenance requirements that are established by the Bank in its sole and absolute discretion have been satisfied.

b) Each Advance made under a Premier Credit Line will be a Variable Rate Advance unless otherwise designated as a Fixed Rate Advance in an Advance Advice sent by the Bank to the Borrower. The Bank will not designate any Advance as a Fixed Rate Advance unless it has been requested to do so by the Borrower (acting directly or indirectly through the Borrower’s UBS Financial Services Inc. financial advisor or other agent designated by the Borrower and acceptable to the Bank). Each Advance Advice will be conclusive and binding upon the Borrower, absent manifest error, unless the Borrower otherwise notifies the Bank in writing no later than the close of business, New York time, on the third Business Day after the Advance Advice is received by the Borrower.

HB Rev 11/08 HB LOAD SPEDOC UX E HB V102 6 ©2008 UBS Bank USA  All rights reserved. Sign and date the application on page 4

	UBS Bank USA
		Variable Credit Line Account Number: (if applicable)
		5V	66035	CP
		Fixed Credit Line Account Number: (if applicable)
		5F
		SS# / TIN
Credit Line Agreement			Internal Use Only

c) Each Advance made under a Prime Credit Line will be a Variable Advance.

d) Unless otherwise agreed by the Bank: (i) all Fixed Rate Advances must be in an amount of at least $100,000; and (ii) all Variable Rate Advances taken by wire transfer must be in an amount of at least $2,500. If the Borrower is a natural person, the initial Variable Rate Advance under the Credit Line must be in an amount equal to at least $25,001 (the “Initial Advance Requirement”). If the Initial Advance requested by the Borrower is made in the form of a check drawn on the Credit Line that does not satisfy the Initial Advance Requirement, then, in addition to and not in limitation of the Bank’s rights, remedies, powers or privileges under this Agreement or applicable law, the Bank may, in its sole and absolute discretion:

(i) pay the check drawn by the Borrower if, prior to paying that check, the Bank makes another Advance to the Borrower, which Advance shall be in an amount not less than $25,001; or

(ii) pay the check drawn by the Borrower; or

(iii) decline to pay (bounce) the check.

If the Bank elects option (ii), no interest shall accrue on the amount of the Advance made by paying the check, and the amount of that Advance shall be due and payable to the Bank immediately (with or without demand by the Bank).

4) Interest

a) Each Fixed Rate Advance will bear interest at a fixed rate and for the Interest Period each as specified in the related Advance Advice. The rate of interest payable on each Fixed Rate Advance will be determined by adding a percentage rate to the UBS Bank USA Fixed Funding Rate, as of the date that the fixed rate is determined.

b) Each Variable Rate Advance under a Premier Credit Line will bear interest at a variable rate equal to LIBOR, adjusted daily, plus the percentage rate that (unless otherwise specified by the Bank in writing) is shown on Schedule I below for the Approved Amount of the Credit Line. For Premier Credit Lines, the rate of interest payable on Variable Rate Advances is subject to change without notice in accordance with fluctuations in LIBOR and in the Approved Amount. On each day that LIBOR changes or the Approved amount crosses one of the thresholds that is indicated on Schedule I (or that is otherwise specified by the Bank in writing), the interest rate on all Variable Rate Advances will change accordingly.

c) Each Variable Rate Advance under a Prime Credit Line will bear interest at a variable rate equal to the Prime Rate, adjusted daily, plus the percentage rate that (unless otherwise specified by the Bank in writing) is shown on the attached Schedule II and that corresponds to the aggregate principal amount outstanding under the Prime Credit Line on that day. For Prime Credit Lines, the rate of interest payable on Variable Rate Advances is subject to change without notice in accordance with fluctuations in the Prime Rate and in the aggregate amount outstanding under the Prime Credit Line. On each date that the Prime Rate changes or the aggregate principal amount outstanding under the Prime Credit Line crosses one of the thresholds that is indicated on Schedule II (or that is otherwise specified by the Bank in writing), the interest rate on all Variable Rate Advances will change accordingly.

5) Payments

a) Each Fixed Rate Advance will be due and payable in full ON DEMAND or, if not earlier demanded by the Bank, on the last day of the applicable Interest Period. Any Fixed Rate Advance as to which the Bank has not made a demand for payment and

that is not paid in full or renewed, which renewal is in the sole and absolute discretion of the Bank, (pursuant to procedures as may be established by the Bank) as another Fixed Rate Advance on or before the last day of its Interest Period, will be automatically renewed on that date as a U.S. dollar denominated, Variable Rate Advance in an amount (based, in the case of any conversion of a non-U.S. dollar denominated Fixed Rate Advance, upon the applicable, spot currency exchange rate as of the maturity date, as determined by the Bank) equal to the unpaid principal balance of the Fixed Rate Advance plus any accrued but unpaid interest on the Fixed Rate Advance, which Variable Rate Advance will then accrue additional interest at a variable rate as provided in this Agreement.

b) Each Variable Rate Advance will be due and payable ON DEMAND.

c) The Borrower promises to pay the outstanding principal amount of each Advance, together with all accrued but unpaid interest on each Advance, any and all fees or other charges payable in connection with each Advance, on the date the principal amount becomes due (whether by reason of demand, the occurrence of a stated maturity date, by reason of acceleration or otherwise). The Borrower further promises to pay interest in respect of the unpaid principal balance of each Advance from the date the Advance is made until it is paid in full. All interest will be computed on the basis of the number of days elapsed and a 360-day year. Interest on each Advance will be payable in arrears as follows:

(i) for Fixed Rate Advances – on the last day of the Interest Period (or if the Interest Period is longer than three months, on the last day of each three month period following the date of the Advance) and on each date that all or any portion of the principal amount of the Fixed Rate Advance becomes due or is paid; and

(ii) for Variable Rate Advances – on the twenty-second day of each month other than December, and on the thirty-first day of December, and on each date that all or any portion of the principal amount of the Variable Rate Advance becomes due or is paid.

To the extent permitted by law, and without limiting any of the Bank’s other rights and remedies under the Agreement, interest charges on any Advance that are not paid when due will be treated as principal and will accrue interest at a variable rate from the date the payment of interest was due until it is repaid in full.

d) All payments of principal, interest or other amounts payable under this Agreement will be made in immediately available funds and in the same currency in which the Advance was made, which unless otherwise agreed by the Bank, will be U.S. dollars, UBS Financial Services Inc. or UBS International Inc., as applicable, may act as collecting and servicing agent for the Bank for the Advances. All payments will be made by wire transfer of funds to an account specified by the Bank or by another method agreed upon by the Bank and the Borrower. Upon receipt of all payments, the Bank will credit the same to the Credit Line Account. The Bank shall apply the proceeds of any payments in the following order; first to any Breakage Costs, Breakage Fee, other fees, costs of collection and expenses, second to the outstanding principal amount of the related Advance and third to accrued interest.

e) All payments must be made to the Bank free and clear of any and all present and future taxes (including withholding taxes), levies, imposts, duties, deductions, fees, liabilities and similar charges other than those imposed on the overall net income of the Bank. If so requested by the Bank, the Borrower will deliver to the Bank the original or a certified copy of each receipt evidencing payment of any taxes or, if no taxes are payable in respect of any payment

HB Rev 11/08 HB LOAD SPEDOC UX E HB V102 7 ©2008 UBS Bank USA  All rights reserved. Sign and date the application on page 4

	UBS Bank USA
		Variable Credit Line Account Number: (if applicable)
		5V	66035	CP
		Fixed Credit Line Account Number: (if applicable)
		5F
		SS# / TIN
Credit Line Agreement			Internal Use Only

under this Agreement, a certificate from each appropriate taxing authority, or an opinion of counsel in form and substance and from counsel acceptable to the Bank in its sole and absolute discretion, in either case stating that the payment is exempt from or not subject to taxes. If any taxes or other charges are required to be withheld or deducted from any amount payable by the Borrower under this Agreement, the amount payable will be increased to the amount which, after deduction from the increased amount of all taxes and other charges required to be withheld or deducted from the amount payable, will yield to the Bank the amount stated to be payable under this Agreement. If any of the taxes or charges are paid by the Bank, the Borrower will reimburse the Bank on demand for the payments, together with all interest and penalties that may be imposed by any governmental agency. None of the Bank, UBS Financial Services Inc., UBS-I or their respective employees has provided or will provide legal advice to the Borrower or any Loan Party regarding compliance with (or the implications of the Credit Line and the related guaranties and pledges under) the laws (including tax laws) of the jurisdiction of the Borrower or any Loan Party or any other jurisdiction. The Borrower and each Loan Party are and shall be solely responsible for, and the Bank shall have no responsibility for, the compliance by the Loan Parties with any and all reporting and other requirements arising under applicable laws.

f) In no event will the total interest and fees, if any, charged under this Agreement exceed the maximum interest rate or total fees permitted by law. In the event any excess interest or fees are collected, the same will be refunded or credited to the Borrower. If the amount of interest payable by the Borrower for any period is reduced pursuant to this Section 5(f), the amount of interest payable for each succeeding period will be increased to the maximum rate permitted by law until the amount of the reduction has been received by the Bank.

6) Prepayments; Breakage Charges

a) The Borrower may repay any Variable Rate Advance at any time, in whole or in part, without penalty.

b) The Borrower may repay any Fixed Rate Advance, in whole or in part. The Borrower agrees to reimburse the Bank, immediately upon demand, for any loss or cost (“Breakage Costs”) that the Bank notifies the Borrower has been incurred by the Bank as a result of (i) any payment of the principal of a Fixed Rate Advance before the expiration of the Interest Period for the Fixed Rate Advance (whether voluntarily, as a result of acceleration, demand or otherwise), or (ii) the Customer’s failure to take any Fixed Rate Advance on the date agreed upon, including any loss or cost (including loss of profit or margin) connected with the Bank’s re-employment of the amount so prepaid or of those funds acquired by the Bank to fund the Advance not taken on the agreed upon date.

Breakage Costs will be calculated by determining the differential between the stated rate of interest (as determined in accordance with Section 4(a) of the Agreement) for the Fixed Rate Advance and prevailing UBS Bank USA Fixed Funding Rate and multiplying the differential by the sum of the outstanding principal amount of the Fixed Rate Advance (or the principal amount of Fixed Rate Advance not taken by the Borrower) multiplied by the actual number of days remaining in the interest Period for the Fixed Rate Advance (based upon a 360-day year). The Borrower also agrees to promptly pay to the Bank an administrative fee (“Breakage Fee”) in connection with any permitted or required prepayment. The Breakage Fee will be calculated by multiplying the outstanding principal amount of the Fixed Rate Advance (or the principal amount of Fixed Rate Advance not taken by the Borrower) by two basis points (0.02%) (with a minimum Breakage Fee of $100.00). Any written notice from the Bank as to the amount of the loss or cost will be conclusive absent manifest error.

7) Joint Credit Line Account Agreement; Suspension and Cancellation

a) If more than one Person is signing this Agreement as the “Borrower”, each party (a “Joint Borrower”) will be jointly and severally liable for the Credit Line Obligations, regardless of any change in business relations, divorce, legal separation, or other legal proceedings or in any agreement that may affect liabilities between the parties. Except as provided below for the reinstatement of a suspended or cancelled Credit Line, and unless otherwise agreed by the Bank in writing, the Bank may rely on, and each Joint Borrower will be responsible for, requests for Advances, directions, instructions and other information provided to the Bank by any Joint Borrower.

b) Any Joint Borrower may request the Bank to suspend or cancel the Credit Line by sending the Bank a written notice of the request addressed to the Bank at the address shown on the Borrower’s periodic Credit Line Account statements. Any notice will become effective three Business Days after the date that the Bank receives it, and each Joint Borrower will continue to be responsible for paying: (i) the Credit Line Obligations as of the effective date of the notice, and (ii) all Advances that any Joint Borrower has requested but that have not yet become part of the Credit Line Obligations as of the effective date of the notice. No notice will release or in any other way affect the Bank’s interest in the Collateral. All subsequent requests to reinstate credit privileges must be signed by all Joint Borrowers comprising the Borrower, including the Joint Borrower requesting the suspension of credit privileges. Any reinstatement will be granted or denied in the sole and absolute discretion of the Bank.

c) All Credit Line Obligations will become immediately due and payable in full as of the effective date of any suspension or cancellation of the Credit Line. The borrower will be responsible for the payment of all charges incurred on the Advances after the effective date. The Bank will not release any Loan Party from any of the obligations under this Agreement or any related agreement until the Credit Line Obligations have been paid in full and this Agreement has been terminated.

8) Collateral; Grant of Security Interest; Set-off

a) To secure payment or performance of the Credit Line Obligations, the Borrower assigns, transfers and pledges to the Bank, and grants to the Bank a first priority lien and security interest in the following assets and rights of the Borrower, wherever located and whether owned now or acquired or arising in the future: (i) each Collateral Account; (ii) any and all money, credit balances, certificated and uncertificated securities, security entitlements, commodity contracts, certificates of deposit, instruments, documents, partnership interests, general intangibles, financial assets and other investment property now or in the future credited to or carried, held or maintained in any Collateral Account; (iii) any and all over-the-counter options, futures, foreign exchange, swap or similar contracts between the Borrower and either UBS Financial Services Inc. or any of its affiliates; (iv) any and all accounts of the Borrower at the Bank or any of its affiliates; (v) any and all supporting obligations and other rights ancillary or attributable to, or arising in any way in connection with, any of the foregoing; and (vi) any and all interest, dividends, distributions and other proceeds of any of the foregoing, including proceeds of proceeds (collectively, the “Collateral”).

b) The Borrower and if applicable, any Pledgor on the Collateral Account, will take all actions reasonably requested by the Bank to evidence, maintain and perfect the Bank’s first priority security interest in, and to enable the Bank to obtain control over, the Collateral and any additional collateral pledged by the Pledgors, including but not limited to making, executing, recording and

HB Rev 11/08 HB LOAD SPEDOC UX E HB V102 8 ©2008 UBS Bank USA  All rights reserved. Sign and date the application on page 4

	UBS Bank USA
		Variable Credit Line Account Number: (if applicable)
		5V	66035	CP
		Fixed Credit Line Account Number: (if applicable)
		5F
		SS# / TIN
Credit Line Agreement			Internal Use Only

delivering to the Bank (and authorizes the Bank to file, without the signature of the Borrower and any Pledgor where permitted by applicable law) financing statements and amendments thereto, control agreements, notices, assignments, listings, powers, consents and other documents regarding the Collateral and the Bank’s security interest in the Collateral in such jurisdiction and in a form as the Bank reasonably may require. Each Loan Party irrevocably authorizes and appoints each of the Bank and UBS Financial Services Inc., as collateral agent, to act as their agent and attorney-in-fact to file any documents or to execute any documents in their name, with or without designation of authority. Each Loan Party acknowledges that it will be obligated in respect of the documentation as if it had executed the documentation itself.

c) The Borrower (and, if applicable, any other Pledgor on the Collateral Account) agrees to maintain in a Collateral Account, at all times, Collateral having an aggregate lending value as specified by the Bank from time to time.

d) The Bank’s sole duty for the custody, safe keeping and physical preservation of any Collateral in its possession will be to deal with the Collateral in the same manner as the Bank deals with similar property for its own account. The Borrower (and, if applicable, any other Pledgor on the Collateral Account) agrees that the Bank will have no responsibility to act on any notice of corporate actions or events provided to holders of securities or other investment property included in the Collateral. The Borrower (and, if applicable, any other Pledgor on the Collateral Account) agrees to (i) notify the Bank promptly upon receipt of any communication to holders of the investment property disclosing or proposing any stock split, stock dividend, extraordinary cash dividend, spin-off or other corporate action or event as a result of which the Borrower or Pledgor would receive securities, cash (other than ordinary cash dividends) or other assets in respect of the investment property, and (ii) immediately upon receipt by the Borrower of Pledgor or any of these assets, cause them to be credited to a Collateral Account or deliver them to or as directed by the Bank as additional Collateral.

e) The Borrower (and, if applicable, any other Pledgor on the Collateral Account) agrees that all principal, interest, dividends, distributions, premiums or other income payments received by the Bank or credited to the Collateral Account in respect of any Collateral may be held by the Bank as additional Collateral or applied by the Bank to the Credit Line Obligations. The Bank may create a security interest in any of the Collateral and may, at any time and at its option, transfer any securities or other investment property constituting Collateral to a securities account maintained in its name or cause any Collateral Account to be redesignated or renamed in the name of the Bank.

f) The Borrower (and, if applicable, any other Pledgor on the Collateral Account) agrees that if a Collateral Account has margin features, the margin features will be removed by UBS Financial Services Inc. or UBS International Inc., as applicable, so long as there is no outstanding margin debit in the Collateral Account.

g) If the Collateral Account permits cash withdrawals in the form of check writing, access card charges, bill payment and/or electronic funds transfer services (for example, Resource Management Account^®, Business Services Account BSA^®, certain Basic Investment Accounts and certain accounts enrolled in UBS Financial Services Inc. Investment Consulting Services programs), the Borrower (and, if applicable, any other Pledgor on the Collateral Account) agrees that the “Withdrawal Limit” for the Collateral Account, as described in the documentation governing the account will be reduced on an ongoing basis so that the aggregate lending value of the Collateral remaining in the Collateral Account following the withdrawal may not be less than the amount required pursuant to Section 8(c)

h) In addition to the Bank’s security interest, the Borrower (and, if applicable, any other Pledgor on the Collateral Account) agrees that the Bank will at all times have a right to set off any or all of the Credit Line Obligations at or after the time at which they become due, whether upon demand, at a stated maturity date, by acceleration or otherwise, against all securities, cash, deposits or other property in the possession of or at any time in any account maintained with the Bank or any of its affiliates by or for the benefit of the Borrower, whether carried individually or jointly with others. This right is in addition to, and not in limitation of, any right the Bank may have at law or otherwise.

i) The Bank reserves the right to disapprove any Collateral and to require the Borrower at any time to deposit into the Borrower’s Collateral Account additional Collateral in the amount as the Bank requests or to substitute new or additional Collateral for any Collateral that has previously been deposited in the Collateral Account.

9) Control

For the purpose of giving the Bank control over each Collateral Account and in order to perfect the Bank’s security interests in the Collateral, the Borrower and each Pledgor on the applicable Collateral Account consents to compliance by UBS Financial Services Inc., UBS-I or any other intermediary (in any case, the “Securities Intermediary”) maintaining a Collateral Account with entitlement orders and instructions from the Bank (or from any assignee or successor of the Bank) regarding the Collateral Account and any financial assets or other property held therein without the further consent of the Borrower or any other Pledgor on the applicable Collateral Account. Without limiting the foregoing, the Borrower and each Pledgor on the Collateral Account acknowledges, consents and agrees that, pursuant to a control agreement entered into between the Bank and the Securities Intermediary:

a) The Securities Intermediary will comply with entitlement orders originated by the Bank regarding any Collateral Account without further consent from the Borrower or any Pledgor. The Securities intermediary will treat all assets credited to a Collateral Account, including money and credit balances, as financial assets for purposes of Article 8 of the Uniform Commercial Code.

b) In order to enable the Borrower and any Pledgor on the applicable Collateral Account to trade financial assets that are from time to time credited to a Collateral Account, the Securities Intermediary may comply with entitlement orders originated by the Borrower or any Pledgor on the applicable Collateral Account (or if so agreed by the Bank, by an investment adviser designated by the Borrower or any Pledgor on the applicable Collateral Account and acceptable to the Bank and the Securities Intermediary) regarding the Collateral Account, but only until the time that the Bank notifies the Securities Intermediary, that the Bank is asserting exclusive control over the Collateral Account. After the Securities Intermediary has received a notice of exclusive control and has had a reasonable opportunity to comply, it will no longer comply with entitlement orders originated by the Borrower or any Pledgor (or by any investment adviser designated by the Borrower or any Pledgor) concerning the Collateral Account. Notwithstanding the foregoing, however, and irrespective of whether it has received any notice of exclusive control, the Securities Intermediary will not comply with any entitlement order originated by the Borrower or any Pledgor (or by any investment adviser designated by the Borrower or any Pledgor) to withdraw any financial assets from a Collateral Account or to pay any money, free credit balance or other amount owing on a Collateral Account (other than cash withdrawals and payments not exceeding the “Withdrawal Limit” as contemplated in Section 8 (g)) without the prior consent of the Bank.

HB Rev 11/08 HB LOAD SPEDOC UX E HB V102 9 ©2008 UBS Bank USA  All rights reserved. Sign and date the application on page 4

	UBS Bank USA
		Variable Credit Line Account Number: (if applicable)
		5V	66035	CP
		Fixed Credit Line Account Number: (if applicable)
		5F
		SS# / TIN
Credit Line Agreement			Internal Use Only

10) Remedies

a) If any of the following events (each, an “Event”) occurs:

(i) the Borrower fails to pay any amount due under this Agreement;

(ii) the Borrower and/or any other relevant Loan Party fails to maintain sufficient Collateral in a Collateral Account as required by the Bank or any Guarantor fails to maintain collateral as required by the Bank under its Guaranty Agreement;

(iii) the Borrower or any other Loan Party breaches or fails to perform any other covenant, agreement, term or condition that is applicable to it under this Agreement or any related agreement, or any representation or other statement of the Borrower (or any Loan Party) in this Agreement or in any related agreement is incorrect in any material respect when made or deemed made;

(iv) the Borrower or any other Loan Party dies or is declared (by appropriate authority) incompetent or of unsound mind or is indicated or convicted of any crime or, if not an individual, ceases to exist;

(v) any voluntary or involuntary proceeding for bankruptcy, reorganization, dissolution or liquidation or similar action is commenced by or against the Borrower or any other Loan Party, or a trustee in bankruptcy, receiver, conservator or rehabilitator is appointed, or an assignment for the benefit of creditors is made, with respect to the Borrower or any other Loan Party or its property;

(vi) the Borrower or any Loan Party is insolvent, unable to pay its debts as they fall due, stops, suspends or threatens to stop or suspend payment of all or a material part of its debts, begins negotiations or takes any proceeding or other step with a view to readjustment, rescheduling or deferral of all or any part of its indebtedness, which it would or might otherwise be unable to pay when due, or proposes or makes a general assignment or an arrangement or composition with or for the benefit of its creditors;

(vii) a Collateral Account (or any account in which collateral provided by a Loan Party is maintained) or any portion thereof is terminated, attached or subjected to a levy;

(viii) the Borrower or any Loan Party fails to provide promptly all financial and other information as the Bank may request from time to time;

(ix) any indebtedness of the Borrower or any other Loan Party in respect of borrowed money (including indebtedness guarantied by the Borrower or any other Loan Party) or in respect of any swap, forward, cap, floor, collar, option or other derivative transaction, repurchase of similar transaction or any combination of these transactions is not paid when due, or any event or condition causes the indebtedness to become, or permits the holder to declare the indebtedness to be, due and payable prior to its stated maturity;

(x) final judgment for the payment of money is rendered against Borrower (or any Loan Party) and, within thirty days from the entry of judgment, has not been discharged or stayed pending appeal or has not been discharged within thirty days from the entry of a final order of affirmance on appeal;

(xi) any legal proceeding is instituted or any other event occurs or condition exists that in the Bank’s judgment calls into question

(A) the validity or binding effect of this Agreement or any related agreement or any of the Borrower’s (or any other Loan Party’s) obligations under this Agreement or under any related agreement or (B) the ability of the Borrower (or any Loan Party) to perform its obligations under this Agreement, or under any related agreement; or

(xii) the Bank otherwise deems itself or its security interest in the Collateral insecure or the Bank believes in good faith that the prospect of payment or other performance by any Loan Party is impaired.

then, the Credit Line Obligations will become immediately due and payable (without demand) and the Bank may, in its sole and absolute discretion, liquidate, withdraw or sell all or any part of the Collateral and apply the same, as well as the proceeds of any liquidation or sale, to any amounts owed to the Bank, including any applicable Breakage Costs and Breakage Fee. The Bank will not be liable to any Loan Party in any way for any adverse consequences (for tax effect or otherwise) resulting from the liquidation of appreciated Collateral. Without limiting the generality of the foregoing, the sale may be made in the Bank’s sole and absolute discretion by public sale on any exchange or market where business is then usually transacted or by private sale, and the Bank may be the purchaser at any public or private sale. Any Collateral that may decline speedily in value or that customarily is sold on a recognized exchange or market may be sold without providing any Loan Party with prior notice of the sale. Each Loan Party agrees that, for all other Collateral, two calendar days notice to the Loan Party, sent to its last address shown in the Bank’s account records, will be deemed reasonable notice of the time and place of any public sale or time after which any private sale or other disposition of the Collateral may occur. Any amounts due and not paid on any Advance following an Event will bear interest from the day following the Event until fully paid at a rate per annum equal to the interest rate applicable to the Advance immediately prior to the Event plus 2.00%. In addition to the Bank’s rights under this Agreement, the Bank will have the right to exercise any one or more of the rights and remedies of a secured creditor under the Utah Uniform Commercial Code, as then in effect, or under any other applicable law.

b) Nothing contained in this Section 10 will limit the right of the Bank to demand full or partial payment of the Credit Line Obligations, in its sole and absolute discretion and without cause, at any time, whether or not an Event has occurred and is continuing.

c) All rights and remedies of the Bank under this Agreement are cumulative and are in addition to all other rights and remedies that the Bank may have at law or equity or under any other contract or other writing for the enforcement of the security interest herein or the collection of any amount due under this Agreement.

d) Any non-exercise of rights, remedies and powers by the Bank under this Agreement and the other documents delivered in connection with this Agreement shall not be construed as a waiver of any rights, remedies and powers. The Bank fully reserves its rights to invoke any of its rights, remedies and powers at any time it may deem appropriate.

11) Representations, Warranties and Covenants by the Loan Parties

Each Borrower and each other Loan Party (if applicable) makes the following representations, warranties and covenants (and each Borrower will be deemed to have repeated each representation and warranty each time a Borrower requests an Advance) to the Bank:

HB Rev 11/08 HB LOAD SPEDOC UX E HB V102 10 ©2008 UBS Bank USA  All rights reserved. Sign and date the application on page 4

	UBS Bank USA
		Variable Credit Line Account Number: (if applicable)
		5V	66035	CP
		Fixed Credit Line Account Number: (if applicable)
		5F
		SS# / TIN
Credit Line Agreement			Internal Use Only

a) Except for the Bank’s rights under this Agreement and the rights of the Securities Intermediary under any account agreement, the Borrower and each relevant Pledgor owns the Collateral, free of any interest, lien or security interest in favor of any third party and free of any impediment to transfer;

b) Each Loan Party: (i) if a natural Person, is of the age of majority; (ii) is authorized to execute and deliver this Agreement and to perform its obligations under this Agreement and any related agreement; (iii) is not an employee benefit plan, as that term is defined by the Employee Retirement Income Security Act of 1974, or an Individual Retirement Credit Line Account (and none of the Collateral is an asset of a plan or account); and (iv) unless the Loan Party advises the Bank to the contrary, in writing, and provides the Bank with a letter of approval, where required, from its employer, is not an employee or member of any exchange or of any corporation or firm engaged in the business of dealing, either as a broker or as principal, in securities, bills of exchange, acceptances or other forms of commercial paper;

c) Neither the Borrower nor any Pledgor on the Collateral Account has pledged or will pledge the Collateral or grant a security interest in the Collateral to any party other than the Bank or the Securities Intermediary, or has permitted or will permit the Collateral to become subject to any liens or encumbrances (other than those of the Bank and the Securities Intermediary), during the term of this Agreement;

d) No Loan Party is in default under any material contract, judgment, decree or order to which it is a party or by which it or its properties may be bound;

e) Each Loan Party has duly filed all tax and information returns required to be filed and has paid all taxes, fees, assessments and other governmental charges or levies that have become due and payable, except to the extent such taxes or other charges are being contested in good faith and are adequately reserved against in accordance with GAAP.

f) The Borrower and each relevant Pledgor (i) is and at all times will continue to be the legal and beneficial owner of all assets held in or credited to any Collateral Account or otherwise included in the Collateral, and (ii) does not hold any assets held in or credited to any Collateral Account or otherwise included in the Collateral in trust or subject to any contractual or other restrictions on use that would prevent the use of such assets to (a) repay the Bank or (b) be pledged as Collateral in favor of the Bank.

The provisions of this Section 11 will survive the termination of this Agreement or any related agreement and the repayment of the Credit Line Obligations.

12) Indemnification; Limitation on Liability of the Bank and the Securities Intermediary

Borrower agrees to indemnify and hold harmless the Bank and the Securities Intermediary, their affiliates and their respective directors, officers, agents and employees against any and all claims, causes of action, liabilities, lawsuits, demands and damages, for example, any and all court costs and reasonable attorneys fees, in any way relating to or arising out of or in connection with this Agreement, except to the extent caused by the Bank’s or Securities Intermediary’s breach of its obligations under this Agreement. Neither the Bank nor the Securities Intermediary will be liable to any party for any consequential damages arising out of any act or omission by either of them with respect to this Agreement or any Advance or Collateral Account. The provisions of this Section 12 will survive the termination of this Agreement or any related agreement and the repayment of the Credit Line Obligations.

13) Acceptance of Application and Agreement; Applicable Law

THIS APPLICATION AND AGREEMENT WILL BE RECEIVED AND ACCEPTED BY BANK IN THE STATE OF UTAH, OR IF THIS APPLICATION AND AGREEMENT IS DELIVERED TO BANK’S AGENT, UBS FINANCIAL SERVICES INC., IT WILL BE RECEIVED AND ACCEPTED WHEN RECEIVED BY UBS FINANCIAL SERVICES INC.’S UNDERWRITING DEPARTMENT. DELIVERY OF THE APPLICATION AND AGREEMENT TO THE BORROWER’S FINANCIAL ADVISOR AT UBS FINANCIAL SERVICES INC. WILL NOT BE CONSIDERED RECEIPT OR ACCEPTANCE BY BANK. ALL DECISIONS MADE BY BANK REGARDING THE CREDIT LINE WILL BE MADE IN UTAH.

THIS AGREEMENT WILL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF UTAH APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED ENTIRELY IN THE STATE OF UTAH AND, IN CONNECTION WITH THE CHOICE OF LAW GOVERNING INTEREST, THE FEDERAL LAWS OF THE UNITED STATES, EXCEPT THAT WITH RESPECT TO THE COLLATERAL ACCOUNT AND THE BANK’S SECURITY INTEREST THEREIN, THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, INCLUDING, WITHOUT LIMITATION, THE NEW YORK UNIFORM COMMERCIAL CODE, AND FOR PURPOSES OF THIS AGREEMENT, THE COLLATERAL ACCOUNT AND THE BANK’S SECURITY INTEREST THEREIN, THE JURISDICTION OF UBS FINANCIAL SERVICES INC. AND UBS-1 SHALL BE DEEMED TO BE THE STATE OF NEW YORK.

14) Assignment

This Agreement may not be assigned by the Borrower without the prior written consent of the Bank. This Agreement will be binding upon and inure to the benefit of the heirs, successors and permitted assigns of the Borrower. The Bank may assign this Agreement, and this Agreement will inure to the benefit of the Bank’s successors and assigns.

15) Amendment

This Agreement may be amended only by the Bank, including, but not limited to, (i) the addition or deletion of any provision of this Agreement and (ii) the amendment of the (x) “Spread Over LIBOR/UBS Bank USA Fixed Funding Rate” in Schedule I or (y) “Spread Over Prime” in Schedule II to this Agreement, at any time by sending written notice, signed by an authorized officer of the Bank, of an amendment to the Borrower. The amendment shall be effective as of the date established by the Bank. This Agreement may not be amended orally. The Borrower or the Bank may waive compliance with any provision of this Agreement, but any waiver must be in writing and will not be deemed to be a waiver of any other provision of this Agreement. The provisions of this Agreement constitute the entire agreement between the Bank and the Borrower with respect to the subject matter hereof and supersede all prior or contemporaneous agreements, proposals, understandings and representations, written or oral, between the parties with respect to the subject matter hereof.

16) Severability

If any provision of this Agreement is held to be invalid, illegal, void or unenforceable, by reason of any law, rule, administrative order or judicial or arbitral decision, the determination will not affect the validity of the remaining provisions of this Agreement.

17) Choice of Forum; Waiver of Jury Trial

a) ANY SUIT, ACTION OR PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT OR ANY JUDGMENT ENTERED BY ANY COURT REGARDING THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT WILL BE BROUGHT AND MAINTAINED EXCLUSIVELY IN THE

HB Rev 11/08 HB LOAD SPEDOC UX E HB V102 11 ©2008 UBS Bank USA.  All rights reserved. Sign and date the application on page 4

	UBS Bank USA
		Variable Credit Line Account Number: (if applicable)
		5V	66035	CP
		Fixed Credit Line Account Number: (if applicable)
		5F
		SS# / TIN
Credit Line Agreement			Internal Use Only

THIRD JUDICIAL DISTRICT COURT FOR THE STATE OF UTAH OR IN THE UNITED STATES DISTRICT COURT FOR THE STATE OF UTAH. EACH OF THE LOAN PARTIES IRREVOCABLY SUBMITS TO THE JURISDICTION OF THE COURTS OF THE THIRD JUDICIAL DISTRICT COURT FOR THE STATE OF UTAH AND OF THE UNITED STATES DISTRICT COURT FOR THE STATE OF UTAH FOR THE PURPOSE OF ANY SUCH ACTION OR PROCEEDING AS SET FORTH ABOVE AND IRREVOCABLY AGREES TO BE BOUND BY ANY JUDGMENT RENDERED THEREBY IN CONNECTION WITH SUCH ACTION OR PROCEEDING. EACH OF THE LOAN PARTIES IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY OBJECTION WHICH IT MAY HAVE NOW OR IN THE FUTURE TO THE LAYING OF VENUE OF ANY SUCH ACTION OR PROCEEDING BROUGHT IN ANY SUCH COURT REFERRED TO ABOVE AND ANY CLAIM THAT ANY SUCH ACTION OR PROCEEDING HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.

b) EACH OF THE LOAN PARTIES (FOR ITSELF, ANYONE CLAIMING THROUGH IT OR IN ITS NAME, AND ON BEHALF OF ITS EQUITY HOLDERS) IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY REGARDING ANY CLAIM BASED UPON OR ARISING OUT OF THIS AGREEMENT OR ANY OF THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT.

c) Any arbitration proceeding between the Borrower (or any other Loan Party) and the Securities intermediary, regardless of whether or not based on circumstances related to any court proceedings between the Bank and the Borrower (or the other Loan Party), will not provide a basis for any stay of the court proceedings.

d) Nothing in this Section 17 will be deemed to alter any agreement to arbitrate any controversies which may arise between the Borrower (or any other Loan Party) and UBS Financial Services Inc. or its predecessors, and any claims between the Borrower or the Loan Party, as applicable and UBS Financial Services Inc. or its employees (whether or not they have acted upon as agents of the Bank) will be arbitrated as provided in any agreement between the Borrower or the Loan Party, as applicable, and UBS Financial Services Inc.

18) State Specific Provisions and Disclosures

a) For residents of Ohio:

The Ohio laws against discrimination require that all creditors make credit equally available to all creditworthy customers, and that credit reporting agencies maintain separate credit histories on each individual upon request. The Ohio civil rights commission administers compliance with this law.

b) For residents of Oregon:

NOTICE TO BORROWER: DO NOT SIGN THIS AGREEMENT BEFORE YOU READ IT. THIS AGREEMENT PROVIDES FOR THE PAYMENT OF PENALTY IF YOU WISH TO REPAY A FIXED RATE ADVANCE PRIOR TO THE DATE PROVIDED FOR REPAYMENT IN THE AGREEMENT.

c) For residents of Vermont:

NOTICE TO BORROWER: THE ADVANCES MADE UNDER THIS AGREEMENT ARE DEMAND LOANS AND SO MAY BE COLLECTED BY THE LENDER AT ANY TIME. A NEW LOAN MUTUALLY AGREED UPON AND SUBSEQUENTLY ISSUED MAY CARRY A HIGHER OR LOWER RATE OF INTEREST.

NOTICE TO JOINT BORROWER: YOUR SIGNATURE ON THE AGREEMENT MEANS THAT YOU ARE EQUALLY LIABLE FOR

REPAYMENT OF THIS LOAN. IF THE BORROWER DOES NOT PAY, THE LENDER HAS THE LEGAL RIGHT TO COLLECT FROM YOU.

d) For residents of California:

(i) Any person, whether married, unmarried, or separated, may apply for separate credit.

(ii) As required by law, you are notified that a negative credit report reflecting on your credit record may be submitted to a credit reporting agency if you fail to fulfill the terms of your credit obligations.

(iii) The Borrower will notify the Bank, within a reasonable time, of any change in the Borrower’s name, address, or employment.

(iv) The Borrower will not attempt to obtain any Advance if the Borrower knows that the Borrower’s credit privileges under the Credit Line have been terminated or suspended.

(v) The Borrower will notify the Bank by telephone, telegraph, letter, or any other reasonable means that an unauthorized use of the Credit Line has occurred or may occur as the result of the loss or theft of a credit card or other instrument identifying the Credit Line, within a reasonable time after the Borrower’s discovery of the loss or theft, and will reasonably assist the Bank in determining the facts and circumstances relating to any unauthorized use of the Credit Line.

19) Account Agreement

Each Loan Party acknowledges and agrees that this Agreement supplements their account agreement(s) with the Securities Intermediary relating to the Collateral Account and, if applicable, any related account management agreement(s) between the Loan Party and the Securities Intermediary. In the event of a conflict between the terms of this Agreement and any other agreement between the Loan Party and the Securities Intermediary, the terms of this Agreement will prevail.

20) Notices

Unless otherwise required by law, all notices to a Loan Party may be oral or in writing, in the Bank’s discretion, and if in writing, delivered or mailed by the United States mail, or by overnight carrier or by telecopy to the address of the Loan Party shown on the records of the Bank. Each Loan Party agrees to send notices to the Bank, in writing, at such address as provided by the Bank from time to time.

HB Rev 11/08 HB LOAD SPEDOC UX E HB V102 12 ©2008 UBS Bank USA.  All rights reserved. Sign and date the application on page 4

	UBS Bank USA
		Variable Credit Line Account Number: (if applicable)
		5V	66035	CP
		Fixed Credit Line Account Number: (if applicable)
		5F
		SS# / TIN
Credit Line Agreement			Internal Use Only

Schedule to UBS Bank USA Credit Line Agreement Schedule of Percentage Spreads Over LIBOR or the UBS Bank USA Fixed Funding Rate, as applicable
Aggregate Approved Amount	Spread Over LIBOR/UBS Bank
	USA Fixed Funding Rate
$100,000 to $249,999	5.00%
$250,000 to $499,999	3.00%
$500,000 to $999,999	2.00%
$1,000,000 to $2,499,999	1.75%
$2,500,000 to $4,999,999	1.50%
$5,000,000 and over	1.25%
Schedule II to UBS Bank USA Credit Line Agreement Schedule of Percentage Spreads Over Prime Outstanding Amount under Credit Line	Spread Over Prime
$0 to $49,999	3.50%
$50,000 to $99,999	3.00%

NOTICE TO CO-SIGNER (Traduccion en Ingles Se Requiere Por La Ley)

You are being asked to guarantee this debt. Think carefully before you do. If the borrower doesn’t pay the debt, you will have to. Be sure you can afford to pay if you have to, and that you want to accept this responsibility.

You may have to pay to the full amount of the debt if the borrower does not pay. You may also have to pay late fees or collection costs, which increase this amount.

The creditor can collect this debt from you without first trying to collect from the borrower. The creditor can use the same collection methods against you that can be used against the borrower, such as suing you, garnishing your wages, etc. If the debt is ever in default, that fact may become a part of your credit record.

This notice is not the contract that makes you liable for the debt.

AVISO PARA EL FIADOR (Spanish Translation Required By Law)

Se le esta pidiendo que garantice esta deuda. Peinselo con cuidado antes de ponerse de cuerdo. Si la persona que ha pedido este prestamo no paga la deuda, usted tendra que pagarla. Este seguro de que usted podra pagar si sea obligado a pagarla y de que usted desea aceptar la responsabilidad.

Si la persona que ha pedido el prestamo no paga la deuda, es possible que usted tenga que pagar la suma total de la deuda, mas los cargos por tardarse en el pago o el costo de cobranza, lo cual aumenta el total de esta suma.

El acreedor (financiero) puede cobrarle a usted sin, primeramente, tratar de cobrarle al duedor. Los mismos metodos de cobranza que pueden usarse contra el deudor, podran usarse contra usted, tales como presentar una demanda en corte, quitar parte de su sueldo, etc. Si alguna vez no se cumpla con la obligacion de pagar esta deuda, se puede incluir esa informacion en la historia de credito de usted.

Este aviso no es el contrato mismo en que se le echa a usted la responsabilidad de la deuda.

         HB Rev 11/08 HB LOAD SPEDOC UX E HB V102 13 ©2008 UBS Bank USA  All rights reserved. Sign and date the application on page 4

VARIABLE CREDIT LINE ACCOUNT NUMBER	:	5V66035
FIXED CREDIT LINE ACCOUNT NUMBER	:

CREDIT LINE SUPPLEMENTAL LIMITED LIABILITY COMPANY FORM (LENDING)

To UBS Bank USA and/or its successor firms, subsidiaries, affiliates and any third party service providers, (collectively, “UBS Bank USA”):

In consideration of UBS Bank USA opening and maintaining one or more loan, or collateral accounts for the limited liability company identified in the signature area below (“LLC”), the undersigned, constituting all of the managing members or managers, as applicable, of the LLC, jointly and severally consent, agree, warrant and represent as follows:

1) Attached to this Credit Line Supplemental Limited Liability Company Form is a true and complete copy of the LLC’s agreement, operating agreement or other similar document or agreement, and all amendments thereto.

2) The LLC is a duly formed and validly existing limited liability company in good standing in the jurisdiction of its formation, and is authorized to:

(a) enter into a Credit Line Agreement with UBS Bank USA under which UBS Bank USA will establish one or more loan accounts for the benefit of the LLC (the “Credit Line Agreement”); and

(b) enter into a Credit Line Guaranty Agreement for the benefit of UBS Bank USA under which the LLC will become liable to UBS Bank USA for the obligations of the third party named in the signature area below, arising under or in connection with the third party’s Credit Line Agreement with UBS Bank USA, ((the “Credit Line Guaranty Agreement”); and

(c) enter into any other agreements or documents in connection with the Credit Line Agreement and/or the Credit Line Guaranty Agreement.

3) The LLC is authorized to:

(a) use any loan accounts established under the Credit Line Agreement to borrow and/or obtain credit from time to time from UBS Bank USA;

(b) guaranty the obligations of others to UBS Bank USA, in United States dollars or any foreign currency; and

(c) pledge, mortgage, assign or subject to a security interest or lien on any property of any sort of the LLC as security for any liability of the LLC.

4) Each of the undersigned is authorized individually, without counter signature or co-signature, to act on behalf of the LLC to:

(a) enter into Credit Line Agreement, established loan accounts and pledge the LLC’s assets as collateral under the Credit Line Agreement or any related agreement, as applicable;

(b) enter into the Credit Line Agreement, assume all liabilities and pledge the LLC’s assets as collateral under the Guaranty Agreement or any related agreement, as applicable;

(c) execute on behalf of the LLC any and all relevant documents, and deal with UBS Bank USA in connection with all aspect of the Credit Line Agreement, loan and collateral accounts, Credit Line Guaranty Agreement and any related agreement with no limits as to amount;

(d) obtain all services that UBS Bank USA offers, including the services set forth in this Supplemental Limited Liability Form;

(e) bind the LLC in respect of any agreements entered into with UBS Bank USA; and

(f) take any other actions on behalf of the LLC necessary or appropriate to carry out the intent of the foregoing.

5) Each of the undersigned acting as specified in this Supplemental Limited Liability Form is authorized to appoint one or more attorneys-in-fact or agents to act on behalf of the LLC in the same capacity as set forth in this Supplemental Limited Liability Company Form, and is authorized to execute and deliver to UBS Bank USA any powers of attorney or other documents to effect or evidence such appointment.

6) UBS Bank USA is authorized, but not obligated, to deal with any of the undersigned individually, as follows, subject to the LLC having completed documentation relating to the relevant products and services, and subject to UBS Bank USA policy and practice as in effect from time to time:

(a) to accept all instructions of any nature in connection with any loan or collateral account given verbally, in writing, or by electronic communication by him or her on behalf of the LLC, as the action of the LLC without limit or further inquiry as to his or her authority or the validity or legality of such actions under any and all laws, rules and regulations applicable to the LLC and the conduct of its business and affairs;

(b) to extend loans in connection with the loan accounts or other credit facility for the LLC; and

C0519863.2

UBS Bank USA

KU

ADDENDUM TO CREDIT LINE ACCOUNT APPLICATION AND

AGREEMENT

Credit Line Account		Account Number
Spansion LLC	5V	66035	CP
Collateral Account		Account Number
Spansion LLC	CP	15255	CPG2

This Addendum (this Addendum) is attached to incorporated by reference into and is fully a part of the Credit Line Account Application and Agreement between UBS Bank USA (the Bank) and the borrower named in the signature area below (the Borrower) dated as of the date hereof (as amended or otherwise modified from time to time the Agreement) This Addendum and the Agreement shall not become effective and binding upon the Bank until this Addendum has been executed by the Borrower and accepted by the Bank at its home office. Any conflict between the terms of the Agreement and this Addendum shall be resolved in accordance with the terms of this Addendum Defined terms used herein to have the respective meanings set forth in the Agreement unless otherwise defined in this Addendum

A The Bank UBS Financial Services Inc and the Borrower each acknowledge and agree that

Definitions

1 The agreement is amended by adding the following definitions in Section 1

•   Additional Payments has the meaning specified in Section 5 g)

•   ARS Collateral means any and all Collateral consisting of Auction Rate Securities

•   ARS Payments has the meaning specified in Section 5 g)

•   Auction Rate Securities means any and all securities determined by the Bank in its sole and absolute discretion as being commonly referred to as Auction Rate Securities which for greater certainty include without limitation debt securities on which the interest rate payable is periodically re-set by an auction process and/or equity securities on which any dividend payable is periodically re set by an auction process

•   Taxable SLARC Maximum Auction Rate means the applicable reset rate maximum auction rate or other similar rate as may be specified in the prospectus or other documentation governing any applicable Taxable Student Loan Auction Rate Securities as representing the failed auction rate or similar rate payable on such Auction Rate Securities in each case expressed as a per annum rate and as calculated in the Bank s sole and absolute discretion

•   Taxable Student Loan Auction Rate Securities means any and all Auction Rate Securities Collateral consisting of securities determined by the Bank in its sole and absolute discretion as being commonly referred to as Student Loan Auction Rate Securities and on which the interest or dividend rate paid or payable to the Borrower by the issues of such securities is taxable to the Borrower

Terms of Advances

2 The Agreement is amended by adding the following as Section 3 e)

The Borrower acknowledges that the Bank will not make an Advance against the ARS Collateral in amounts equal to the fair market or par value of the ARS Collateral unless the Borrower arranges for another person or entity to provide additional collateral or assurances on terms and conditions satisfactory to the Bank in requesting an Approved Amount equal to the par value of the ARS Collateral the Borrower has arranged for UBS Financial Services Inc to provide directly or through a third party the pledge of additional collateral and/or assurances to the Bank so that the Bank will consider making Advances from time to time in accordance with the terms of this Agreement and in amounts equal to in the aggregate the par value of the ARS Collateral at the date of an Advance in addition the Borrower the Bank and UBS Financial Services Inc acknowledge and agree that if (a) the Bank is repaid all of the Credit Line Obligations due to the Bank under the Agreement and this Addendum and (b) as part of such repayment the Bank realizes on the additional collateral and/or assurances pledged or otherwise provided by UBS Financial Services and/or any such third party to the Bank then the Agreement shall not terminate and the Bank shall automatically assume and be subrogated to all of the Banks rights claims and interest in and under the Agreement and this Addendum including without limitation the security interest in the Collateral including without limitation the ARS Collateral granted the Bank under the Agreement and this Addendum (further including without limitation interest dividends distributions premiums other income and payments received in respect of any and all such Collateral) to the extent of the amount that the Bank has realized on all or any part of the additional collateral and/or assurances pledged or otherwise provided by UBS Financial Services and/or any such third party to the Bank in order to effect the repayment of the Credit Line Obligations due to the Bank under the Agreement Upon such automatic assignment and subrogation UBS Financial Services Inc and any such third party shall be entitled to directly exercise any and all rights and remedies afforded the Bank under the Agreement this Addendum and any and all other documents and agreements entered into in connection with the Agreement and/or this Addendum.

KU Rev 08/08 Zero Net Cost LTPV Loan Addendum

1 of 5

	Credit Line Account Number
	5V        66035	CP

Interest

3 The Agreement is amended by adding the following as a new Section 4 d) Section 4 e) and Section 4 f)

d) Notwithstanding anything to the contrary in this Agreement and subject to the provisions of Sections 4 e) and f) of this Agreement the interest rate charged on any and all outstanding Variable Rate Advances shall be the lesser of (i) the amount prescribed by Sections 4 a) b) or c) of this Agreement as applicable and (ii) the then applicable weighted average rate of interest or dividend rate paid to the Borrower by the issuer of the ARS Collateral

e) The Bank and the Borrower acknowledge and agree that the Bank shall be entitled to determine or adjust at any time and from time to time the interest rate payable by the Borrower to the Bank on all or any part of the outstanding Variable Rate Advances to reflect any changes in the composition of the ARS Collateral to address any inability to determine interest rates or for any other reason that in the Bank s sole and absolute discretion is necessary to give effect to the intent of the provisions of this Agreement including without limitation this Section 4 (it being acknowledged and agreed that the provisions of this Section 4 are intended to cause the interest payable by the Borrower under this Agreement to equal the interest or dividend rate payable to the Borrower by the issuer of any ARS Collateral) and any and all such adjustments by the Bank hereunder shall be conclusive and binding on the Bank and the Borrower absent manifest error

f) If and to the extent that any or all of the ARS Collateral consists of Taxable Student Loan Auction Rate Securities then notwithstanding anything to the contrary in this Agreement, when calculating such weighted average interest rate the interest rate paid to the Borrower with respect to such Taxable Student Loan Auction Rate Securities shall be deemed to be equal to (i) for the period from the date of this Addendum through and including January 21 2009 the applicable coupon rate(s) and (ii) from January 22 2009 and thereafter the then applicable Taxable SLARC Maximum Auction Rate for and to the extent of such Taxable Student Loan Auction Rate Securities The Borrower will be charged interest on the Loan in months in which the Borrower does not receive interest on the Taxable Student Loan Auction Rate Securities

Payments

4 The Agreement is amended by adding the following as Section 5 g)

The Borrower will make additional payments ( Additional Payments ) as follows

• The proceeds of any liquidation redemption sale or other disposition of all or part of the ARS Collateral will be automatically transferred to the Bank as payments The amount of these payments will be determined by the proceeds received in the Collateral Account and may be as much as the total Credit Line Obligations

• All other interest dividends distributions premiums other income and payments that are received in the Collateral Account in respect of any ARS Collateral will be automatically transferred to the Bank as payments These are referred to as ARS Payments The amount of each ARS Payment will vary based on the proceeds received in the Collateral Account The Bank estimates that the ARS Payments will range from zero to fifteen ($15 00) dollars per month per $1 000 in par value of Pledged ARS The Bank will notify the Borrower at least ten (10) days in advance of any ARS Payment that falls outside of this range If the Borrower would prefer to have advance notice of each payment to be made to Advances the Borrower may cancel ARS Payments as described below

The Borrower agrees that any cash check or other deposit (other than a deposit of securities) made to the Collateral Account is an individual authorization to have such amount transferred to the Bank as a payment The amount of each payment is the amount of the deposit

Each additional Payment will be applied as of the date received by the Bank in the manner set forth in the last sentence of Section 5 d) The Borrower acknowledges that neither the Bank nor UBS Financial Services Inc sets or arranges for any schedule of Additional Payments instead Additional Payments will be transferred automatically from the Collateral Account whenever amounts are received in the Collateral Account generally on the second Business Day after receipt

The Borrower may elect to stop ARS Payments at any time and this election will cancel all ARS Payments that would occur three (3) Business Days or more after the Bank receives such notice If the Borrower stops ARS Payments the Borrower will continue to be obligated to pay principal interest and other amounts pursuant to the Agreement If the Borrower elects to cancel ARS Payments all other Additional Payments will be cancelled Cancelling ARS Payments and Additional Payments may result in higher interest charges by the Bank because amounts received in the Collateral Account will not be automatically transferred and credited Any amounts received in the Collateral Account will remain in the Collateral Account unless the Bank permits you to withdraw all or part of such amounts Your notice to cancel must be sent to Attention Head of Credit Risk Monitoring UBS Bank USA 299 South Main Street Suite 2275 Salt Lake City Utah 84111 or call (801) 741 0310

Important Disclosure About Required Payments If Additional Payments are sufficient to pay all accrued interest on Advances on or before a due date then the Borrower need not make an additional interest payment Excess Additional Payments will be applied against principal However if Additional Payments are not sufficient to pay all accrued interest on Advances on or before a due date then the Bank may in its sole discretion (1) capitalize unpaid interest as an additional Advance or (2) require the Borrower to make payment of all accrued and unpaid interest

KU Rev 08/08 Zero Net Cost LTPV Loan Addendum

2 of 5

	Credit Line Account Number
	5V        66035	CP

Remedies

5 The Agreement is amended by adding the following as Section 10 e)

  The Borrower agrees that in the event the Bank determines to liquidate or sell any Collateral the Bank shall to the fullest extent permitted by applicable law have the right to do so in any manner including without limitation the sale of Collateral individually or in a block for cash or for credit in a public or private sale with or without public notice through the use of sealed bids or otherwise with the aid of any advisor or agent who may be an affiliate of the Bank or in any other manner as the Bank in its sole discretion shall choose The Borrower acknowledges that the price the Bank obtains for Collateral in the Bank s chosen method of sale may be lower than might be otherwise obtained in another method of sale and the Borrower hereby agrees that any such sale shall not be considered to be not commercially reasonable solely because of such lower price The Borrower understands that there may not be a liquid market for the Collateral and that as a result the price received for the Collateral upon liquidation or sale by the Bank may be substantially less than the Borrower paid for such Collateral or than the last market value available for it if any The Borrower further agrees that any sale by the Bank shall not be considered to be not commercially reasonable solely because there are few (including only one) or no third parties who submit bids or otherwise offer to buy the Collateral The Borrower understands that the Bank s sale of any of the Collateral may be subject to various state and federal property and/or securities laws and regulations and that compliance with such laws and regulations may result in delays and/or a lower price being obtained for the Collateral The Borrower agrees that the Bank shall have the right to restrict any prospective purchasers to those who in the Bank s sole discretion the Bank deems to be qualified The Borrower acknowledges that the Bank shall have sole authority to determine without limitation the time place method of advertisement and manner of sale and that the Bank may delay or adjourn any such sale in its sole discretion The Borrower expressly authorizes the Bank to take any action with respect to the Collateral as the Bank deems necessary or advisable to facilitate any liquidation or sale and the Borrower agrees that the Bank shall not be held liable for taking or failing to take any such action regardless if a greater price may have been obtained for the Collateral if such action was or was not taken as applicable The Borrower hereby waives to the fullest extent permitted by law any legal right of appraisal notice valuation stay extension moratorium or redemption that the Borrower would otherwise have with respect to a sale of the Collateral

Representations, Warranties and Covenants by the Loan Parties

6 The Agreement is amended by adding the following as Section 11 g)

g) If at any time there are Credit Line Obligations outstanding under the Credit Line then in connection with any ARS Collateral if at any time such ARS Collateral may be sold exchanged redeemed transferred or otherwise conveyed by the Borrower for gross proceeds that are in the aggregate not less than the par value of such Auction Rate Securities to any party including without limitation to UBS Financial Services Inc and/or any of its affiliates (any such sale exchange redemption transfer or conveyance referred to herein as ARS Liquidation ) the Borrower agrees (i) to immediately effect such ARS Liquidation to the extent necessary to satisfy all Credit Line Obligations in full and (ii) that the proceeds of any such ARS Liquidation so effected shall be immediately and automatically used to pay down any and all such outstanding Credit Line Obligations to the extent of such proceeds The Borrower hereby acknowledges and agrees with the Bank and directs UBS Financial Services Inc that to the extent permitted by applicable law this Section 11 g) shall constitute an irrevocable instruction direction and standing sell order to UBS Financial Services Inc to effect an ARS Liquidation to the extent it is possible to do so at any time during the term of this Agreement The Borrower further agrees with the Bank and UBS Financial Services Inc to execute and deliver to the Bank and/or UBS Financial Services Inc such further documents and agreements as may be necessary in the sole and absolute discretion of the Bank and/or UBS Financial Services Inc to effect the foregoing irrevocable instruction direction and standing sell order

Waivers

7 The Agreement is amended by adding the following as Section 21

  The Borrower hereby (i) acknowledges and admits its indebtedness and obligations to the Bank under the Agreement, and (ii) acknowledges admits and agrees that it has no and shall assert no defenses offsets counterclaims or claims in respect of its obligations under the Agreement, in each case notwithstanding any claim or asserted claim that it may have or purport to have against any affiliate of the Bank

Schedules I and II

8           a)                Schedule I of the Agreement is amended in its entirety to read as follows

$25 001 to $499 999                                                                 2 750%

$500 000 to $999 999                                                               1 750%

$1 000 000 to $4 999 999                                                         1 500%

$5 000 000 and over                                                                 1 250%

b)                Schedule II of the Agreement is deleted in its entirety and replaced with      [intentionally Deleted]

KU Rev 08/08 Zero Net Cost LTPV Loan Addendum

3 of 5

	Credit Line Account Number
	5V        66035	CP

No Fixed Rate Advances/Prime Credit Lines

9 The Bank and the Borrower acknowledge and agree that notwithstanding anything to the contrary in the Agreement (a) the Borrower shall not request and the Bank shall not make a Fixed Rate Advance and (b) there shall be no Prime Credit Line facilities available under the Agreement

Alternative Financing

10 If at any time the Bank exercises its right of demand under Section 5 a) Section 5 b) and Section 10 b) of the Loan Agreement for any reason other than (i) the occurrence of an Event under Sections 10 a) (iv) (v) (vii) (ix) (if and to the extent any indebtedness specified thereunder is to the Bank or any of the Banks affiliates) or (xi) of the Agreement or (ii) in connection with any termination for cause by UBS Financial Services Inc of the overall customer relationship between UBS Financial Services Inc and the Borrower or its affiliates then UBS Financial Services Inc shall or shall cause one or more of its affiliates to provide as soon as reasonably possible alternative financing on substantially the same terms and conditions as those under the Agreement and the Bank agrees that the Agreement shall remain in full force and effect until such time as such alternative financing has been established

Margin Calls, Interest Payments

11 Notwithstanding anything to the contrary in the Agreement the Bank and the Borrower acknowledge and agree that UBS Financial Services Inc or any affiliate thereof may in its sole and absolute discretion elect to (i) provide additional collateral to the Bank in the form of United States Treasury Securities if and to the extent that the Borrower does not maintain in a Collateral Account Collateral having an aggregate lending value as specified by the Bank from time to time and/or (ii) satisfy any and all amounts of accrued and unpaid interest that are otherwise due and payable by the Borrower to the Bank under the Agreement to the extent that the amount of any Additional Payments under the Agreement are insufficient to satisfy any and all such amounts

Collateral Account Features

12 Section 8 f) of the Agreement is deleted in its entirety and replaced with the following

    If a Collateral Account has margin features the margin features will be removed by UBS Financial Services Inc or UBS International Inc as applicable so long as there is no outstanding margin debt in the Collateral Account If a Collateral Account has Resource Management Account^® or Business Services Account BSA^® features such as check writing cards bill payment or electronic funds transfer services all such features shall be removed by UBS Financial Services Inc or UBS International Inc as applicable

No Credit Line Checks

13 The Bank and the Borrower acknowledge and agree that notwithstanding anything to the contrary in the Agreement the Credit Line shall not have Credit Line checks

Headings

14 The headings of each of Section of this Addendum is for descriptive purposes only and shall not be deemed to modify or qualify the terms conditions rights or obligations described in such Section

8 This Addendum may be signed in multiple original counterparts each of which shall be deemed an original and all of which together shall constitute one and the same instrument

[Signature page(s) follows]

KU Rev 08/08 Zero Net Cost LTPV Loan Addendum

4 of 5

	Credit Line Account Number
	5V        66035	CP

IN WITNESS WHEREOF, each of the parties has signed this Addendum pursuant to due and proper authority as of the date set forth below.

12/23/08	Eric Branderiz, Corporate VP and Controller Spansion Inc. Managing Member Spansion LLC	/s/ Eric Branderiz
Date	Print Name and Title	Signature
12/23/08	Mark Mohler, Treasurer Spansion Inc. Managing Member Spansion LLC	/s/ Mark Mohler
Date	Print Name and Title	Signature

UBS BANK USA
By	[ILLEGIBLE]
Name	[ILLEGIBLE]
Title	AVP
By	/s/ Jeffrey Abbott
Name	Jeffrey Abbott
Title	AVP
UBS FINANCIAL SERVICES INC.
By	/s/ Brian C. Arthur
Name	Brian C. Arthur
Title	Director
By	/s/ Paul Collins
Name	Paul Collins
Title	Director
Date	1/5         2008

KU Rev 08/08 Zero Net Cost LTPV Loan Addendum

5 of 5

Re: Account Number CP-15255 (the “Account”)

ADDENDUM TO CREDIT LINE AGREEMENT

The attached “Credit Line Agreement” sets forth certain terms related to the extension of credit by UBS Bank USA (the “Bank”) with respect to certain assets held through the above-referenced non-discretionary corporate cash management Account with UBS Financial Services Inc. (the “Firm”). The party signing this Addendum as Client where indicated below (the “Client”) understands and agrees that, notwithstanding anything to the contrary contained in either the Credit Line Agreement (including, without limitation, Section 19 of the Credit Line Agreement) or the existing Corporate Cash Management Account Agreement applicable to the Account (the “Account Agreement”), the terms of the Credit Line Agreement supplement, but do not replace, the existing Account Agreement as follows: (i) the terms of the Credit Line Agreement (as amended from time to time in accordance with its terms) shall govern with respect to any matters, issues or disputes related directly to, or arising directly from, the extension of credit and/or the status of Client as borrower and the Bank as lender pursuant to the Credit Line Agreement (e.g., matters relating to the loan account(s) established at the Bank pursuant to the Credit Line Agreement, the terms of any borrowing or extension of credit under the Credit Line Agreement, and/or the indemnification of the Bank as a lender); and (ii) the terms of the Account Agreement (as amended from time to time in accordance with its terms) shall govern with respect to all other matters (e.g., matters relating to the Account established at the Firm pursuant to the Account Agreement, the Firm’s trading authority and activities and/or the indemnification of the Firm for the services it provides under the Account Agreement).

Without limiting the generality of the foregoing, Client further understands and agrees that:

(A) If applicable, Client may continue to receive Financial Advisor Reports with respect to the Account, as described in Section 8 of the Account Agreement, and Client’s receipt of such reports remains subject to the provisions of Section 8 of the Account Agreement.

(B) Solely with respect to disputes arising out of the extension of credit and/or the status of Client as borrower and the Bank as lender pursuant to the Credit Agreement, the choice of law provisions of Section 13 of the Credit Line Agreement and the dispute resolution provisions of Section 17 of the Credit Line Agreement shall govern. With respect to any other disputes relating to the Account, the choice of law provisions of Section 14 of the Account Agreement and the dispute resolution provisions of Section 15 of the Account Agreement shall continue to govern.

(C) If Client elected or in the future elects to adopt Exhibit B to the Account Agreement, the Firm may continue to exercise the limited discretion described therein with respect to the Account.

(D) If Client elected or in the future elects to adopt Exhibit C to the Account Agreement, the terms set forth in Exhibit C shall continue to govern with respect to the Account and any investment policy statement associated with the Account.

Acknowledged and agreed this 23^rd day of December, 2008

Client’s Name:    Spansion LLC
By:	/s/ Mark Mohler
Name:	Mark Mohler
Title:	Corporate Treasurer

UBS Bank USA

KM

IMPORTANT NOTICE ON INTEREST RATES AND PAYMENTS

Credit Line Account		Account Number
Spansion LLC	5V	66035	CP
Collateral Account		Account Number
Spansion LLC	CP	15255	CPG2

This document contains important information regarding the interest rate and interest payments on your Credit Line. You should carefully review this Notice and your Credit Line Application and Agreement, including the Addendum, (the “Agreement”) and speak to your Financial Advisor regarding any questions or concerns you may have with your Agreement. Defined terms used in this Notice have the respective meanings set forth in the Agreement unless defined in this Notice.

The Agreement provides you with a “no net cost” Credit Line. This means that the interest that you pay on the Credit Line Obligations will not exceed the interest that you receive on the Auction Rate Securities that you have pledged to the Bank as security for the Credit Line and which are held in the Collateral Account. Although you may be able to capitalize interest you will not be charged interest on interest.

The Credit Line statements that you receive from the Bank while the Credit Line is outstanding are for information purposes only. The interest charge(s) on these statements are approximations due to timing and systems limitations. You will receive a final confirmation from the Bank of the interest charged on the Credit Line. This does not change the “no net cost” nature of the Credit Line.

If you have Taxable Student Loan Auction Rate Securities pledged as Collateral you may not receive an interest payment in months in which you are charged interest on the Credit Line. Certain taxable student loan ARS made high interest rate payments to UBSFS investors for several months during the first half of 2008, and then ceased making interest payments in subsequent months. These taxable student loan ARS will not make any further interest payments until a future date determined in accordance with the terms of the Auction Rate Securities. For the purpose of determining loan interest payments for loans against these Taxable Student Loan Auction Rate Securities, the high interest payments will be taken into consideration (and the interest rate annualized). For example, you will be charged (i) for the period from the date of the Addendum through and including January 21, 2009, the applicable coupon rate(s) on the Taxable Student Loan Auction Rate Securities and (ii) from January 22, 2009 and thereafter you will be charged that average annualized rate (e.g., T-bills plus 120 basis points), for each month in which your loan is outstanding, including months for which the annualized interest was paid in a prior month and for which no additional or current payment is being made to you.

Interest on the Credit Line accrues daily and is charged in accordance with the Bank’s regular interest billing cycle. The Bank’s billing cycle may not be the same as the cycle on which the Auction Rate Security pay interest.

Please acknowledge your receipt and review of this Notice by signing below.

12/23/08	Eric Branderiz, VP/Controller Spansion Inc. Managing Member Spansion LLC	/s/ Eric Branderiz
Date	Print Name and Title	Signature
12/23/08	Mark Mohler, Treasurer Spansion Inc. Managing Member Spansion LLC	/s/ Mark Mohler
Date	Print Name and Title	Signature

Date:     12/23    , 2008

1 of 1

5V	66035	CP	FR U- 1
5F			OMB No. 7100-0115
			Approval expires March 31, 2011

BOARD OF GOVERNORS OF THE FEDERAL RESERVE SYSTEM

Statement of Purpose for an Extension of Credit Secured by Margin Stock

(Federal Reserve Form U-1)

UBS BANK USA

Name of Bank

This report is required by law (15 U.S.C. §§78g and 78w, 12 CFR 221).   The Federal Reserve may not conduct or sponsor, and an organization (or a person) is not required to respond to, a collection of information unless it displays currently valid OMB control number. Public reporting burden for this collection of information is estimated to average 10 minutes per response, including the time to gather and maintain data in the required form and to review instructions and complete the information collection. Send comments regarding this burden estimated or any other aspect of this collection of information, including suggestions for reducing this burden to: Secretary, Board of Governors of the Federal Reserve System, 20th and C Streets, N.W., Washington, DC 20551; and to the Office of Management and Budget, Paperwork Reduction Project (7100-0011), Washington, DC 20503.

Instructions

1. This form must be completed when a bank extends credit excess of $100,000 secured direclty or indirectly, in whole or in part, by any margin stock.

2. The term “margin stock” is defined in Regulation U (12 CFR 221) and includes, principally: (1) stocks that are registered on a national securities exchange; (2) debt securities (bonds) that are convertible into margin stocks; (3) any over-the-counter security designated as qualified for trading in the National Market System under a designation plan approved by the Securities and Exchange Commission (NMS security); and (4) shares of most mutual funds, unless 95 percent of the assets of the fund are continuously invested in U.S. government, agency, state, or municipal obligations.

3. Please print or type (if space is inadequate, attach separate sheet).

Part I         To be completed by borrower(s)	Maximum available credit as determined by UBS Bank USA from time to time based, in part, on the value of the securities pledged as collateral for the credit facility.
1. What is the amount of the credit being extended?
2. Will any part of this credit be used to purchase or carry margin stock?                            ¨     Yes    þ    No
If the answer is “no”, describe the specific purpose of the credit	The UBS Credit Line proceeds will only be used for legally permissible purposes, including personal, household, family or business purposes; but no portion of the UBS Credit Line proceeds will be used to purchase, trade or carry securities, or to repay debt incurred to purchase, trade or carry securities.

I (We) have read this form and certify that to the best of my (our) knowledge and belief the information given is true, accurate, and complete, and that the margin stock and any other securities collateralizing this credit are authentic, genuine, unaltered, and not stolen, forged, or counterfeit.

Signed:		Signed
/s/ ERIC BRANDERIZ                                                         12/23/2008		/s/ MARK MOHLER                                                         12/23/08
Borrower’s signature	Date	Borrower’s signature	Date
Eric Branderiz, Corp. VP & Controller Spansion Inc. Managing Member Spansion LLC		Mark Mohler, Treasurer Spansion Inc. Managing Member Spansion LLC
Print or type name		Print or type name

This form should not be signed if blank.

A borrower who falsely certifies the purpose of a credit on this form or otherwise willfully or intentionally evades the provisions of Regulation U will also violate Federal Reserve Regulation X, “Borrowers of Securities Credit.”

	1

VARIABLE CREDIT LINE ACCOUNT NUMBER	:	5V66035
FIXED CREDIT LINE ACCOUNT NUMBER	:	_____________

CREDIT LINE SUPPLEMENTAL LIMITED LIABILITY COMPANY FORM (LENDING)

To UBS Bank USA and/or its successor firms, subsidiaries, affiliates and any third party service providers, (collectively, “UBS Bank USA”):

In consideration of UBS Bank USA opening and maintaining one or more loan, or collateral accounts for the limited liability company identified in the signature area below (“LLC”), the undersigned, constituting all of the managing members or managers, as applicable, of the LLC, jointly and severally consent, agree, warrant and represent as follows:

1) Attached to this Credit Line Supplemental Limited Liability Company Form is a true and complete copy of the LLC’s agreement, operating agreement or other similar document or agreement, and all amendments thereto.

2) The LLC is a duly formed and validly existing limited liability company in good standing in the jurisdiction of its formation, and is authorized to:

(a) enter into a Credit Line Agreement with UBS Bank USA under which UBS Bank USA will establish one or more loan accounts for the benefit of the LLC (the “Credit Line Agreement”); and

(b) enter into a Credit Line Guaranty Agreement for the benefit of UBS Bank USA under which the LLC will become liable to UBS Bank USA for the obligations of the third party named in the signature area below, arising under or in connection with the third party’s Credit Line Agreement with UBS Bank USA, ((the “Credit Line Guaranty Agreement”); and

(c) enter into any other agreements or documents in connection with the Credit Line Agreement and/or the Credit Line Guaranty Agreement.

3) The LLC is authorized to:

(a) use any loan accounts established under the Credit Line Agreement to borrow and/or obtain credit from time to time from UBS Bank USA;

(b) guaranty the obligations of others to UBS Bank USA, in United States dollars or any foreign currency; and

(c) pledge, mortgage, assign or subject to a security interest or lien on any property of any sort of the LLC as security for any liability of the LLC.

4) Each of the undersigned is authorized individually, without counter signature or co-signature, to act on behalf of the LLC to:

(a) enter into the Credit Line Agreement, establish loan accounts and pledge the LLC’s assets as collateral under the Credit Line Agreement or any related agreement, as applicable;

(b) enter into the Credit Line Guaranty Agreement, assume all liabilities and pledge the LLC’s assets as collateral under the Guaranty Agreement or any related agreement, as applicable;

(c) execute on behalf of the LLC any and all relevant documents, and deal with UBS Bank USA in connection with all aspects of the Credit Line Agreement, loan and collateral accounts, Credit Line Guaranty Agreement and any related agreement with no limits as to amount;

(d) obtain all services that UBS Bank USA offers, including the services set forth in this Supplemental Limited Liability Form;

(e) bind the LLC in respect of any agreements entered into with UBS Bank USA; and

(f) take any other actions on behalf of the LLC necessary or appropriate to carry out the intent of the foregoing.

5) Each of the undersigned acting as specified in this Supplemental Limited Liability Form is authorized to appoint one or more attorneys-in-fact or agents to act on behalf of the LLC in the same capacity as set forth in this Supplemental Limited Liability Company Form, and is authorized to execute and deliver to UBS Bank USA any powers of attorney or other documents to effect or evidence such appointment.

6) UBS Bank USA is authorized, but not obligated, to deal with any of the undersigned individually, as follows, subject to the LLC having completed documentation relating to the relevant products and services, and subject to UBS Bank USA policy and practice as in effect from time to time:

(a) to accept all instructions of any nature in connection with any loan or collateral account given verbally, in writing, or by electronic communication by him or her on behalf of the LLC, as the action of the LLC without limit or further inquiry as to his or her authority or the validity or legality of such actions under any and all laws, rules and regulations applicable to the LLC and the conduct of its business and affairs;

(b) to extend loans in connection with the loan accounts or other credit facility for the LLC; and

(c) to act, in effecting any of the transactions, upon instructions contained in any message received by it, transmitted by any form or agency or communication, which UBS Bank USA believes in good faith to have been originated by any one of the undersigned acting as specified in this Supplemental Limited Liability Company Form.

7) Any borrowings made from time to time on behalf of the LLC with UBS Bank USA are ratified, confirmed, authorized and approved.

8) UBS Bank USA is authorized to rely upon the authority conferred by this Supplemental Limited Liability Company Form until UBS Bank USA receives an updated Supplemental Limited Liability Company Form revoking or modifying this Supplemental Limited Liability Company Form. In the event that UBS Bank USA, for any reason, is uncertain as to the continuing effectiveness of the authority conferred by this Supplemental Limited Liability Company Form or any other agreements, consents or resolutions of the LLC, UBS Bank USA may refrain from taking any action with respect to the loan or collateral account until such time as it is satisfied as to its authority and UBS Bank USA will be indemnified by the LLC against and held harmless from any claims, demands, expenses, loss or damage, including legal fees and cost, resulting from or arising out of its refraining form taking any action.

9) In consideration of UBS Bank USA acting in reliance on this Supplemental Limited Liability Company Form, it shall be fully protected in acting and the LLC agrees to indemnify and save harmless UBS Bank USA from and against any and all loss, damage, liability, claims and expenses arising by reason of its acting in reliance on this Supplemental Limited Liability Company Form.

10) Each of the undersigned certifies, and is authorized and directed to certify on behalf of the LLC, to UBS Bank USA:

(a) that is Supplemental Limited Liability Company Form has been duly adopted, is in full force and effect and is in accordance with the provisions of applicable law and regulation and the certificate of formation and limited liability company agreement, or other similar document or agreement of the LLC, as applicable;

(b) the identities of the managing members or managers of the LLC and, from time to time in the future, any changes as may occur in the identities of the managing members or managers, as applicable, as the changes are made; and

(c) the UBS Bank USA shall be fully protected in relying on certifications of each managing member or manager in this Supplemental Limited Liability Company Form and will be indemnified and saved harmless by the undersigned and the LLC from any and all loss, damage, liability, claims and expenses resulting from honoring the signature of any of the undersigned certified in this Supplemental Limited Liability Company Form or refusing to honor any signature not certified in this Supplemental Limited Liability Company Form.

11) The undersigned each certifies that there is no provision in the certificate of formation, limited liability company agreement, operating agreement or other similar document or agreement of the LLC limiting the power of the undersigned to adopt this Supplemental Limited Liability Company Form and that the same is in conformity with the provisions of the certificate of formation and limited liability company agreement, operating agreement or, other similar document or agreement of the LLC, none of which requires or provides for any vote or consent of other than the undersigned to authorize the adoption of this Supplemental Limited Liability Company Form and/or the transactions contemplated hereby.

12) The undersigned further certify that they are all of the managing members or duly elected or appointed qualified managers of the LLC and that set forth opposite each respective name is the true and correct signature of the person.

13) The undersigned further authorize UBS Bank USA, in the event of death or retirement of any of the members of the LLC or the termination of the LLC, to take such proceedings, require papers, retain portion of or restrict transactions in the loan and collateral accounts as you may deem advisable to protect you against any liability, penalty or loss under any present or future law or otherwise. It is further agreed that in the event of the death or retirement of any member of the LLC the remaining members will immediately notify you of such fact.

14) This Agreement shall inure to the benefit of UBS Bank USA and the benefit of any successor corporations or firms, and of the assigns of UBS Bank USA and/or any successor corporations or firms.

PLEASE COMPLETE THE FOLLOWING INFORMATION:

Name of LLC:

 Spansion LLC

Jurisdiction where LLC is organized:

 Delaware

Name of third-party who’s Credit Line Agreement is being guaranteed (if applicable)

2

Each of the undersigned certifies that the undersigned comprise all of the managing members or managers, as applicable, of the LLC (if additional space is required, attach a separate sheet).

12/23/08                      (Date)	Eric Brandeziz, Corp. VP / Controller Spansion Inc. Managing Member Spansion LLC 915 DeGuigne Drive Sunnyvale, CA 94065 (Print Name and Address of Member)	/s/ Eric Brandeziz (Signature)
12/23/08 (Date)	Mark Mohler, Treasurer Spansion Inc. Managing Member Spansion LLC 915 DeGuigne Drive Sunnyvale CA 94065 (Print Name and Address of Member)	/s/ Mark Mohler (Signature)
(Date)	(Print Name and Address of Member)	(Signature)
(Date)	(Print Name and Address of Member)	(Signature)

[ILLEGIBLE] Rev 9/04

3

EX-10.59

Exhibit 10.59

SETTLEMENT AGREEMENT

This Settlement Agreement (the “Agreement”) is entered into on March 16, 2009 between Spansion LLC and Spansion, Inc., (together, “Spansion”) and Samsung Electronics Co., Ltd. (“Samsung”) (each, a “Party” and collectively, the “Parties”) for purposes of resolving patent disputes between the parties through licenses and covenants. For good and valuable consideration, the sufficiency of which is hereby acknowledged, the Parties agree to be bound by the following terms:

1. Definitions.

a. “Change-in-Control” means a transaction or a series of related transactions in which (i) one or more related entities or persons who did not previously own at least a fifty percent (50%) interest in the Party in question obtain at least a fifty percent (50%) interest in such Party or (ii) the acquisition of all or substantially all assets of the Party in question or (iii) a merger as a result of which the stockholders of the Party in question prior to the transaction do not thereafter own a majority of the Party in question or of the ultimate parent of the such Party. Notwithstanding the foregoing, circumstances in which existing debt holders of a Party exchange debt for equity in such Party shall not by itself be considered a Change-in-Control for purposes of this definition, provided that such debt holders are strictly financial or financial services entities (e.g., banks, lenders, investors, etc.) and not, e.g., entities which make and/or sell products that include semiconductor products or services related thereto.

b. “Effective Date” means the date of approval of this Agreement by the Samsung board of directors (“BOD”), which shall occur no later than seven (7) business

Page 2 of 12

CONFIDENTIAL

days after the date this Agreement is entered into. Samsung shall notify Spansion immediately of such approval by its BOD. In the event such approval is not obtained in the required time period the execution of this Agreement shall be null and void and the Parties shall not be bound to any of the terms and/or conditions of this Agreement and shall have no further obligation or liability in connection with this Agreement

c. “Final Order” means, as applicable, an order or judgment of a court of competent jurisdiction with respect to the relevant subject matter, which has not been reversed, stayed, modified, or amended, and as to which the time to appeal or seek certiorari has expired and no appeal or petition for certiorari has been timely taken, or as to which any appeal that has been taken or any petition for certiorari that has been or may be filed has been resolved by the highest court to which the order or judgment was appealed or from which certiorari was sought.

d. “Subsidiary” or “Subsidiaries” means any corporation, company, or other business entity that is: (i) directly or indirectly controlled by a Party as of the date this Agreement is entered into; or (ii) created after such date as a result of a reorganization of a Party, provided that, in the case of Spansion, any such entity is not the result of a merger, acquisition (by or of Spansion), or purchase of third party assets. A Subsidiary shall cease to be a Subsidiary under this Agreement as of the date such Subsidiary is no longer controlled by a Party. For purposes of this Agreement, “control” means beneficial ownership of greater than fifty percent (50%) of the voting securities of such corporation, company or other business entity.

Page 3 of 12

CONFIDENTIAL

2. Patent Licenses and Covenants.

a. License. Spansion hereby grants to Samsung a non-exclusive, worldwide, fully paid-up, royalty-free, perpetual and irrevocable right and license, to develop, make, have made, use, offer to sell, sell import, and otherwise commercially exploit products and methods covered by any claim of all patents and patent applications owned or controlled by Spansion and/or its Subsidiaries as of the date this Agreement is entered into or in the future (the “Licensed Patents”). The license granted in this Section 2.a to Samsung is not transferable and is without the right to sublicense, except to Subsidiaries of Samsung. This license is irrevocable and not subject to rejection or assignment in any bankruptcy or other insolvency proceeding.

b. Spansion Covenant. Spansion (on behalf of itself and its Subsidiaries) hereby covenants not to sue Samsung or its Subsidiaries, or the distributors, resellers, retailers and customers of Samsung or its Subsidiaries under the Licensed Patents for making, having made, using, having used, selling, having sold, offering for sale, having offered for sale, importing or having imported any products or services of Samsung and/or its Subsidiaries or practicing any methods claimed in the Licensed Patents in connection with any products or services of Samsung and/or its Subsidiaries (the “Covenant Not to Sue”). The Covenant Not to Sue shall be worldwide and shall continue in perpetuity.

c. Samsung Covenant. Samsung hereby covenants not to assert its patents or patent applications owned by Samsung and controlled by its Semiconductor Division (the “Samsung Semiconductor Patents”) now or in the future against Spansion

Page 4 of 12

CONFIDENTIAL

and its Subsidiaries personally with respect to any product it makes (or has exclusively made for it) and sells exclusively under a brand it owns or controls. Neither Spansion nor its Subsidiaries may assign, delegate, sell, transfer, sublicense or otherwise dispose of, voluntarily or involuntarily, by operation of law or otherwise, any or all of its or their rights under the covenant set forth in this Section 2.c to any other person, third party, business or entity. Any such purported assignment, delegation, sale, transfer, sublicense or other disposition shall be deemed a breach of this Agreement and shall be null and void. In the event of a Change-in-Control of Spansion the covenant set forth in this Section 2.c shall immediately terminate.

d. Settlement. Subject to Section 7 below, within ten (10) days after the date by which both (i) the court (the “Bankruptcy Court”) with jurisdiction over any Spansion chapter 11 proceeding (the “Bankruptcy Cases”) issues a Final Order approving this Agreement (as required to be obtained by Spansion as set forth in Section 7) and (ii) the dismissals of litigation required pursuant to Section 3 below are obtained, Samsung shall make an initial payment to Spansion’s Counsel, King & Spalding in the amount of forty million dollars (US$40,000,000.00) by direct wire transfer to King & Spalding. Samsung shall further pay to Spansion by wire transfer in the amount of thirty million dollars (US$30,000,000.00) in six equal monthly installments of five million dollars (US$5,000,000) each beginning thirty (30) days after such initial payment is made. The payments herein are subject to withholding taxes required by the Korean tax authorities pursuant to the Tax Treaty between the U.S.A. and Korea. Samsung shall withhold and timely

Page 5 of 12

CONFIDENTIAL

pay any such tax amounts from each of the payments provided herein to the Tax Authorities and promptly furnish Spansion with certificates or receipts as proof of tax payment.

3. Stays of Litigation. Immediately upon entering into this Agreement, the Parties agree to seek approval to stay all proceedings and actions, including International Trade Commission Investigation No. 337-TA-664 (the “ITC Action”) and Civil Action No. 08-855-SLR (D. Del) (the “Civil Action”) and in the action now pending in Japan, entitled H21(WA)1989 and H21(WA)1986 (the “Japanese Action”). The Parties shall jointly cooperate in effecting all such stays of litigation and other proceedings until the Bankruptcy Court issues a Final Order approving this Agreement. In the event the Court or ITC will not agree to stay the litigations as set forth herein, the Parties agree to seek approval to dismiss or terminate the litigation(s) without prejudice to re-filing if this settlement is not approved under the terms set forth herein. The Parties agree that the intent of this provision is to cease all activity related to the litigations and avoid incurring any costs and fees with respect to the litigations until a Final Order approving this Agreement is issued and the Parties agree to cooperate to avoid any unfair prejudice to any Party in the event that (1) this agreed upon settlement agreement is not approved by the Bankruptcy Court or (2) the stays contemplated by this provision are not approved by the relevant courts or agencies, including all reasonable extensions of time.

4. Dismissals of Litigation. Upon the entry of a Final Order approving this Agreement, Spansion shall, within ten (10) business days, file a notice of dismissal with prejudice of the Civil Action and a motion to terminate with prejudice the ITC Action, and such dismissal and termination shall be against all defendants and respondents, respectively.

Page 6 of 12

CONFIDENTIAL

Upon the entry of a Final Order approving this Agreement, Samsung shall, within ten (10) business days file a notice of dismissal with prejudice of its counterclaims in the Civil Action and in the Japanese Action. The Parties shall jointly cooperate in effecting all such dismissals with prejudice.

5. Representation and Warranty. Spansion represents and warrants that: (i) it has full corporate power and authority to execute and deliver this Agreement subject to approval by the Bankruptcy Court; (ii) it has the right to grant the license, the Covenant Not to Sue and the releases herein and that the license shall be final subject to approval by the Bankruptcy Court, (iii) it has not granted and will not grant any licenses or other rights, under the Licensed Patents or otherwise, that would conflict with or prevent the rights granted to Samsung hereunder; (iv) that during the period of time from ninety (90) days prior to the date this Agreement is entered into and the Effective Date, it has not assigned or transferred or otherwise encumbered any patents and/or patent applications owned or controlled by Spansion and/or its Subsidiaries; and (v) that the Licensed Patents include all patents involved in the ITC and Delaware actions, all foreign counterparts, and all patents acquired or controlled as a result of the acquisition of Saifun Semiconductor. The Parties acknowledge that this is a license of intellectual property subject to Section 365(n) of title 11 of the United States Code.

6. Waivers and Releases. Each of Spansion and Samsung, for itself and its Subsidiaries, and their past, present, and future partners, directors, officers, shareholders, executives, administrators, parent companies, subsidiaries, divisions, employees, servants, insurers, representatives, affiliates, agents, assigns, attorneys, predecessors, and successors in interest, do hereby irrevocably release, remise, acquit, and forever discharge the other

Page 7 of 12

CONFIDENTIAL

Party, its Subsidiaries, their respective past, present, and future partners, directors, officers, shareholders, executives, administrators, parent companies, subsidiaries, divisions, employees, servants, insurers, representatives, affiliates, agents, assigns, attorneys, predecessors, and successors in interest, and in the case of Spansion, for itself and its Subsidiaries, the customers of Samsung and its Subsidiaries (but solely in connection with Samsung products and services), from any and all actions, causes of action, claims, suits, demands, rights, debts, dues, obligations, accounts, contracts, agreements, controversies, rights, judgments, damages, losses, costs, expenses, fees, attorneys’ fees, sanctions, executions, liabilities, obligations, and any and all other liabilities of any kind whatsoever, either in law or equity, whether known or unknown, suspected or unsuspected, that either of the Parties ever had, now has, or may have, prior to or as of the Effective Date, arising out of or relating in any way to the Licensed Patents or the Samsung Semiconductor Patents. For the avoidance of doubt the releases set forth above do not cover amounts that may be owed as the purchase price for the sale of products and services between the Parties.

The Parties intend the above releases to be effective regardless of whether the basis for any claims released is now known to or anticipated by the Parties and shall be effective even if facts relevant to this Agreement are found, after the Effective Date, to be different from the facts believed or assumed to be true as of the Effective Date. The Parties acknowledge that they are each aware of California Civil Code Section 1542, which provides as follows:

Page 8 of 12

CONFIDENTIAL

A general release does not extend to claims which the creditor does not know or suspect to exist in his favor at the time of executing the release, which if known by him must have materially affected his settlement with the debtor.

The Parties agree to expressly waive any rights either of them may have under this Code section or under federal, state or common law statutes or judicial decisions of similar nature, and knowingly and voluntarily waive such unknown claims.

7. Bankruptcy Court Approval. The payments pursuant to Section 2.d. are expressly subject to approval by the Bankruptcy Court by a Final Order approving this Agreement in form and substance reasonably acceptable to Samsung (the “Bankruptcy Court Order”) that includes, without limitation, findings that (i) the Spansion assets that are the subject hereof are property of the debtors’ estates in the Bankruptcy Cases, (ii) all the representations and warranties of Spansion in Section 5 above are true and accurate, (iii) the license granted to Samsung is irrevocable and not subject to rejection or assignment in any bankruptcy or other insolvency proceeding, (iv) the Bankruptcy Court has jurisdiction to approve and enforce this Agreement and all actions contemplated hereby, and (v) any liens or encumbrances, whether granted as adequate protection or otherwise, shall not interfere in any way with the license and covenants contained in Sections 2(a) and (b) herein. In addition, in no event shall the license in Section 2(a) herein itself be subject to any lien, including any lien granted as adequate protection. Any motion seeking approval of the proposed Bankruptcy Court Order must be reasonably acceptable to Samsung. Spansion will take all actions necessary and both parties will cooperate fully in order to obtain prompt approval of this Agreement in its original form in the Bankruptcy Cases.

Page 9 of 12

CONFIDENTIAL

8. Successors. The license in Section 2.a above and the Covenant Not to Sue shall be binding on successors in interest to, all transferees or assignees of and any exclusive licensee of any Licensed Patents, or any rights granted in any Licensed Patents. Spansion (on behalf of itself and its Subsidiaries) represents, warrants and covenants that it shall not assign any of the Licensed Patents without obtaining a written agreement by the assignee of such patent to be bound by the licenses and the Covenant Not to Sue.

9. Term and Termination.

a. Term. This Agreement shall commence as of the Effective Date and shall expire upon the expiration of the last to expire of the Licensed Patents (the “Term”) unless otherwise terminated in accordance with its terms.

b. Termination. Subject to Section 11.d, this Agreement shall terminate: (i) automatically unless the Bankruptcy Court Order is issued within sixty days of the filing of the motion seeking its approval (or such other period of time as the Parties agree in writing, such agreement not to be unreasonably withheld); (ii) automatically upon the failure by the Parties to obtain the dismissals of litigation required by Section 4 within thirty days of the first filed notice of dismissal related thereto (or such other period of time as the Parties agree in writing, such agreement not to be unreasonably withheld); (iii) at Samsung’s election upon written notice in the event any motion or other pleading by Spansion to the Bankruptcy Court describing this Agreement is not reasonably satisfactory to Samsung; and (iv) at Samsung’s election upon written notice in the event the Bankruptcy Court modifies the terms and conditions of this Agreement from its

Page 10 of 12

CONFIDENTIAL

original form. Other than as set forth in this Section 9.b, this Agreement may only be terminated by mutual written agreement of the Parties.

10. Confidentiality. The Parties warrant and represent that they and their counsel have kept — and agree, warrant, and represent that they and their counsel will keep — all negotiations to resolve the litigation, and all terms of this Agreement strictly confidential to the extent permitted by law; provided that Samsung may disclose in relevant part as reasonably necessary the scope of the license, Covenant Not to Sue and release granted herein to its (and its Subsidiaries’) third party customers and business partners (e.g., distributors, resellers, retailers, etc.); provided further that Spansion may disclose as reasonably necessary the terms of this Agreement to obtain Creditor Approval and entry of the Bankruptcy Court Order.

11. Miscellaneous.

a. Choice of Laws. This Agreement shall be construed and interpreted in accordance with the laws of the State of New York, without regard to conflict of law provisions. Any actions to enforce this Agreement or based on any of the issues in this Agreement shall be brought in the State or Federal Courts of New York.

b. No Admission of Infringement, Enforcement or Validity. This Agreement represents the settlement of disputed claims asserted by each Party. Nothing contained herein is or is to be construed as an admission or evidence of liability on the part of the other Party.

c. Supplemental Terms. This Agreement sets forth the entire agreement among the Parties as it relates to the subject matter of this Agreement, and replaces and

Page 11 of 12

CONFIDENTIAL

supersedes any and all prior agreements, promises, proposals, representations, understandings and negotiations, written or not, relating to the same. No modification, amendment, supplement to or waiver of any provision of this Agreement will be binding upon the Parties unless made in a writing signed by the Parties. A failure of a Party to exercise any right provided for herein shall not be deemed to be a waiver of any right hereunder. If any provision of this Agreement is found or held to be invalid or unenforceable, the meaning of such provision will be construed, to the extent feasible, so as to render the provision enforceable, and if no feasible interpretation shall save such provision, it will be severed from the remainder of this Agreement, as appropriate. The remainder of this Agreement shall remain in full force and effect unless the severed provision is essential and material to the rights or benefits received by a Party.

d. Survival. Sections 1,2.a, 2.b, 2.c and 5 shall survive any termination of this Agreement.

12. Subject to Bankruptcy Court Approval. The Parties agree to the terms herein subject to the Bankruptcy Court Order, provided that if this Agreement is modified by the Bankruptcy Court in any way, the Parties agree that Samsung may unilaterally terminate this Agreement upon written notice. The Parties agree to use their best efforts to obtain the Bankruptcy Court’s approval of this Agreement in its original form.

Page 12 of 12

CONFIDENTIAL

Agreed to this 16 day of March, 2009.

On behalf of Spansion LLC and Spansion, Inc.

/s/ Robert C. Melendres
Name:	Robert C. Melendres
Title:	EVP & CLO
On behalf of Samsung Electronics Co., Ltd.
/s/ Jeong-Taek Kong
Name:	Jeong-Taek Kong
Title:	Sr. VP, IP Team

EX-21

Exhibit 21

SPANSION INC.

LIST OF SUBSIDIARIES

as of December 31, 2008

Name of Subsidiary	State or Jurisdiction in Which Incorporated or Organized
Domestic Subsidiaries
Spansion Technology, Inc.	Delaware
Spansion LLC (1)	Delaware
Spansion International, Inc. (2)	Delaware
Cerium Laboratories LLC (2)	Delaware
Foreign Subsidiaries
Spansion (China) Co. Limited (3)	China
Spansion (EMEA) SAS (2)	France
Spansion Japan Limited (2)	Japan
Spansion (Penang) Sdn. Bhd. (2)	Malaysia
Spansion (Kuala Lumpur) Sdn. Bhd. (2)	Malaysia
Spansion Holdings (Singapore) Pte. Ltd. (2)	Singapore
Spansion Asia Holdings (Singapore) Pte. Ltd. (2)	Singapore
Spansion (Thailand) Limited (2)	Thailand
Saifun Semiconductors Ltd. (2)	Israel
Spansion Semiconductor Trading (Shanghai) Co. Ltd. (4)	China
Saifun (BVI) Ltd. (5)	Israel
Tulip Semiconductor Holdings (2005) Ltd. (5)	Israel
Tulip Semiconductor L.P. (5)	Israel
Tulip Semiconductor Ltd. (5)	Israel
Saifun Semiconductors USA, Inc. (5) (6)

⁽¹⁾ Subsidiary of Spansion Inc. (60 percent) and Spansion Technology, Inc. (40 percent)

⁽²⁾ Subsidiary of Spansion LLC

⁽³⁾ Subsidiary of Spansion Holdings (Singapore) Pte. Ltd.

⁽⁴⁾ Subsidiary of Spansion Asia Holdings (Singapore) Pte. Ltd.

⁽⁵⁾ Subsidiary of Saifun Semiconductors Ltd.

⁽⁶⁾ Dissolved as of February 18, 2009 in Delaware; withdrew as a corporation qualified to do business as a foreign corporation in California on January 14, 2009.

EX-23.1

Exhibit 23.1

Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statements (Form S-8 No. 333-150025) pertaining to the Saifun Semiconductors Ltd. 1997 Share Option Plan, Saifun Semiconductors Ltd. 2001 Share Option Plan, and Saifun Semiconductors Ltd. 2003 Share Option Plan, (Form S-8 No. 333-131689) pertaining to the 2007 Equity Incentive Plan of Spansion Inc., (Form S-8 No. 333-143835) pertaining to the 2005 Equity Incentive Plan of Spansion Inc. and (Form S-3 No. 333-139833) and related prospectus of Spansion Inc. of our audit reports dated April 29, 2009, with respect to the consolidated financial statements of Spansion Inc. and the effectiveness of internal control over financial reporting of Spansion Inc., included in this Annual Report (Form 10-K) for the fiscal year ended December 28, 2008.

/s/ Ernst & Young LLP

San Francisco, California

May 12, 2009

EX-31.1

Exhibit 31.1

Certification of Chief Executive Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, John H. Kispert, certify that:

1. I have reviewed this annual report on Form 10-K of Spansion Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 12, 2009

/S/    JOHN H. KISPERT        

John H. Kispert 

President, Chief Executive Officer and

Interim Chief Financial Officer

EX-31.2

Exhibit 31.2

Certification of Chief Financial Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, John H. Kispert, certify that:

1. I have reviewed this annual report on Form 10-K of Spansion Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 12, 2009

/s/    JOHN H. KISPERT        

John H. Kispert

President, Chief Executive Officer and

Interim Chief Financial Officer

EX-32.1

Exhibit 32.1

Certification of Chief Executive Officer Pursuant to 18 U.S.C. § 1350, as Adopted as Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Spansion Inc. (the “Company”) hereby certifies, to such officer’s knowledge, that:

(i.) the Annual Report on Form 10-K of the Company for the year ended December 28, 2008 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii.) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 12, 2009	/s/    JOHN H. KISPERT
	John H. Kispert President, Chief Executive Officer and Interim Chief Financial Officer

EX-32.2

Exhibit 32.2

Certification of Chief Financial Officer Pursuant to 18 U.S.C. § 1350, as Adopted as Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Spansion Inc. (the “Company”) hereby certifies, to such officer’s knowledge, that:

(i.) the Annual Report on Form 10-K of the Company for the year ended December 28, 2008 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii.) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 12, 2009	/S/    JOHN H. KISPERT
	John H. Kispert President, Chief Executive Officer and Interim Chief Financial Officer